Citrus Sinensis ID: 008650
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | 2.2.26 [Sep-21-2011] | |||||||
| Q5XF57 | 579 | Probable receptor-like se | yes | no | 0.964 | 0.929 | 0.578 | 0.0 | |
| Q8RXC8 | 460 | Receptor-like cytosolic s | no | no | 0.578 | 0.702 | 0.542 | 3e-96 | |
| Q8H1D6 | 467 | Receptor-like cytosolic s | no | no | 0.510 | 0.610 | 0.531 | 1e-87 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.535 | 0.417 | 0.425 | 3e-67 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.593 | 0.347 | 0.421 | 8e-67 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.525 | 0.384 | 0.445 | 3e-66 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.654 | 0.514 | 0.373 | 5e-66 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.5 | 0.427 | 0.446 | 7e-66 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.553 | 0.436 | 0.414 | 2e-64 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.491 | 0.368 | 0.433 | 3e-64 |
| >sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/574 (57%), Positives = 423/574 (73%), Gaps = 36/574 (6%)
Query: 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAK 66
+KIL+ SLD ++S+ +LSWAI VLA+P+D +VA+H+LVGEE +K K+++QIR AK
Sbjct: 10 NKILVAISLDRDESQNVLSWAINVLAKPSDTVVALHLLVGEEPRKLPMKKKKRTQIRHAK 69
Query: 67 AHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMS 126
AHVISMLGEFA T QVNLEAKVGFS++IGRGLI+E KSISA YLVL H ++
Sbjct: 70 AHVISMLGEFAYTCCHNQVNLEAKVGFSSNIGRGLIDEVKSISAHYLVLSRPTTHEFRIW 129
Query: 127 RDVTRYCFQHAPGGCTIHIFGETK-----------------SENPSPRTVLDELEGES-N 168
D+ RY AP C++ + G + SE SPR+VL+ L +S +
Sbjct: 130 NDIKRYVSDFAPSSCSVVLVGNQRKPHKDCYSDSAISLDINSEKYSPRSVLNTLSRDSLS 189
Query: 169 TTEDDTFSVEDSSISQS---PPQAPKTKGLSNTRMRMSPGKFFTS-ILSSPLRKRNGS-L 223
++ DD S S +S S P PK K +S P KF +S I++SPLRK GS
Sbjct: 190 SSGDDASSFNGSMVSSSFASPSDKPKHKSIS-------PYKFISSLIMNSPLRKWRGSET 242
Query: 224 SNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNK 283
NK K QPL+ CF+Y EIS ATN+FH N+VG GGYSEVY+G+L DGR+IAVKRLAK++
Sbjct: 243 KNKPKPQPLIQCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESG 302
Query: 284 DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLE 343
D KEKEFL ELGII HV HPNTA L+GCC+E GLYL+F FS+NG L +ALH+ + SL+
Sbjct: 303 DMNKEKEFLTELGIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLD 362
Query: 344 WPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403
WP+RYKI +GVARGLHYLHK C RIIHRDIK+SNVLLGPD+EPQITDFGLAKWLPNK T
Sbjct: 363 WPVRYKIAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWT 422
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463
HHA IP+EGTFGYLAPE M G IDEKTD++AFG+LLLEIITGR+PV+ ++++++LWAKP
Sbjct: 423 HHAVIPVEGTFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVNPTQKHILLWAKP 482
Query: 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEF 523
ME+GN +ELVDP L+ +YD QM++LVL A +CV+Q+ RP+M++VLELLT+G+++E
Sbjct: 483 AMETGNTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEI 542
Query: 524 AKSWRMPEFTSDELDDC------SMFFGYEVPTD 551
AKSWRMP+ +++ DD SM FGY+VP+D
Sbjct: 543 AKSWRMPKDMTNDDDDNNEWDDYSMIFGYDVPSD 576
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (904), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 178/328 (54%), Positives = 221/328 (67%), Gaps = 5/328 (1%)
Query: 230 QPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEK 289
Q L FS +I AT+NF EN++G+GGY++VY+G L +G+ IAVKRL K D ++
Sbjct: 125 QSSLQNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGTPD-EQTA 183
Query: 290 EFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK 349
EFL ELGII HV HPNTA +GCCIE G++L+F S G+L + LH L W RY
Sbjct: 184 EFLSELGIIAHVDHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYN 243
Query: 350 IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIP 409
+ LG A GL YLH+GC+RRIIHRDIKA N+LL DF+PQI DFGLAKWLP + THH
Sbjct: 244 VALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSK 303
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469
EGTFGY APEYFMHGI+DEKTDVFAFGVLLLE+ITG +D S+Q+LVLWAKPL+E
Sbjct: 304 FEGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALDESQQSLVLWAKPLLERKA 363
Query: 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEF----AK 525
+ ELVDPSL EY+ +++ RL A C+ Q+S RP MS+V+ELL D AK
Sbjct: 364 IKELVDPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELLLGHEDVVMTPREAK 423
Query: 526 SWRMPEFTSDELDDCSMFFGYEVPTDID 553
M S+EL D + + D+D
Sbjct: 424 IKMMQRTYSEELLDSVEYNSTKYLGDLD 451
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H1D6|RBK1_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK1 OS=Arabidopsis thaliana GN=RBK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (830), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 153/288 (53%), Positives = 204/288 (70%), Gaps = 3/288 (1%)
Query: 230 QPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKE- 288
+P F+YEE++ AT+ F+ ENM+G+GG++EVYKG L +G +A+K+L K+ ++
Sbjct: 135 KPSWRNFTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKEEEERV 194
Query: 289 KEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY 348
+FL ELGII HV HPN A L G + GL+ + ++ G+L + L + LEW IRY
Sbjct: 195 SDFLSELGIIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFGS-EECLEWKIRY 253
Query: 349 KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408
K+ LG+A GL YLH C RRIIHRDIKASN+LL D+E QI+DFGLAKWLP HH
Sbjct: 254 KVALGIADGLSYLHNACPRRIIHRDIKASNILLNHDYEAQISDFGLAKWLPENWPHHVVF 313
Query: 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDS-SRQNLVLWAKPLMES 467
PIEGTFGYLAPEYFMHGI+DEK DVFAFGVLLLEIIT R+ VD+ SRQ++V WAKP +E
Sbjct: 314 PIEGTFGYLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDTASRQSIVAWAKPFLEK 373
Query: 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
++ ++VDP L ++ +M R++L A CV +A RP M+ +++LL
Sbjct: 374 NSMEDIVDPRLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQLL 421
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 256 bits (655), Expect = 3e-67, Method: Compositional matrix adjust.
Identities = 138/324 (42%), Positives = 197/324 (60%), Gaps = 25/324 (7%)
Query: 235 CFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLME 294
F+YEE+S ATN F N++GQGG+ V+KG L +G+++AVK+L + + ++ E+EF E
Sbjct: 341 TFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGS--SQGEREFQAE 398
Query: 295 LGIIGHVCHPNTATLVGCCIENGL-YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG 353
+GII V H + LVG CI + L++ F N L+ LH + ++EW R KI +G
Sbjct: 399 VGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVG 458
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGT 413
A+GL YLH+ C +IIHRDIKASN+L+ FE ++ DFGLAK + T H + + GT
Sbjct: 459 SAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRVMGT 517
Query: 414 FGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR----QNLVLWAKPLM---- 465
FGYLAPEY G + EK+DVF+FGV+LLE+ITGR+P+D + +LV WA+PL+
Sbjct: 518 FGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVS 577
Query: 466 ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL---------- 515
E GN +VD L EYD ++M R+V A CVR T+ RP M +V +L
Sbjct: 578 ELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPSDLN 637
Query: 516 ---TSGHDSEFAKSWRMPEFTSDE 536
T GH + + S ++ S +
Sbjct: 638 QGITPGHSNVYGSSGGSTDYDSSQ 661
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 254 bits (650), Expect = 8e-67, Method: Compositional matrix adjust.
Identities = 148/351 (42%), Positives = 209/351 (59%), Gaps = 20/351 (5%)
Query: 179 DSSISQSPPQAPKTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQP------- 231
DSS++ SP T L + +S F ++ L K+ G L +K + +
Sbjct: 551 DSSVNPSPRNGMSTGTLHTLVVILSI--FIVFLVFGTLWKK-GYLRSKSQMEKDFKSLEL 607
Query: 232 LLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEF 291
++ FS +I ATNNF S N +G+GG+ VYKG L DG IAVK+L+ +K +E F
Sbjct: 608 MIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNRE--F 665
Query: 292 LMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALH--DERSKSLEWPIRY 348
L E+G+I + HPN L GCC+E G L L++ F +N +L AL E L+WP R
Sbjct: 666 LNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRR 725
Query: 349 KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408
KI +GVARGL YLH+ + +I+HRDIKA+NVLL P+I+DFGLAK L + + H +
Sbjct: 726 KICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAK-LDEEDSTHIST 784
Query: 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGR-KPVDSSRQN---LVLWAKPL 464
I GTFGY+APEY M G + +K DV++FG++ LEI+ GR ++ S+ N L+ W + L
Sbjct: 785 RIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVL 844
Query: 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
E NL ELVDP L EY+ ++ ++ IA C RPSMSEV+++L
Sbjct: 845 REKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKML 895
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 253 bits (646), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 136/305 (44%), Positives = 186/305 (60%), Gaps = 12/305 (3%)
Query: 236 FSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMEL 295
FSYEE+ ATN F EN++G+GG+ VYKG L D R +AVK+L + ++EF E+
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGG--GQGDREFKAEV 475
Query: 296 GIIGHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGV 354
I V H N ++VG CI EN LI+++ N NL LH + L+W R KI G
Sbjct: 476 DTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKIAAGA 535
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTF 414
ARGL YLH+ C RIIHRDIK+SN+LL +F ++DFGLAK L C H + GTF
Sbjct: 536 ARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAK-LALDCNTHITTRVMGTF 594
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR----QNLVLWAKPLM----E 466
GY+APEY G + EK+DVF+FGV+LLE+ITGRKPVD+S+ ++LV WA+PL+ E
Sbjct: 595 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNATE 654
Query: 467 SGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKS 526
+ T L DP L Y +M R++ A C+R ++ RP MS+++ S + +
Sbjct: 655 TEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLAEEDLTNG 714
Query: 527 WRMPE 531
R+ E
Sbjct: 715 MRLGE 719
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (643), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 144/386 (37%), Positives = 221/386 (57%), Gaps = 21/386 (5%)
Query: 184 QSPPQAPKTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISS 243
Q+P + G N++ + + G F S R+GS + T F+YEE++
Sbjct: 289 QNPTKGYSGPGGYNSQQQSNSGNSFGSQRGGGGYTRSGSAPDSAVMGSGQTHFTYEELTD 348
Query: 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH 303
T F N++G+GG+ VYKG L+DG+ +AVK+L + + ++EF E+ II V H
Sbjct: 349 ITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGS--GQGDREFKAEVEIISRVHH 406
Query: 304 PNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
+ +LVG CI + LI+ + N L+ LH + LEW R +I +G A+GL YLH
Sbjct: 407 RHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLH 466
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF 422
+ C +IIHRDIK++N+LL +FE Q+ DFGLAK L + H + + GTFGYLAPEY
Sbjct: 467 EDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK-LNDSTQTHVSTRVMGTFGYLAPEYA 525
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKPVDS----SRQNLVLWAKPLM----ESGNLTELV 474
G + +++DVF+FGV+LLE+ITGRKPVD ++LV WA+PL+ E+G+ +ELV
Sbjct: 526 QSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELV 585
Query: 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS---------GHDSEFAK 525
D LE Y +++ R++ A CVR + RP M +V+ L S G+ +
Sbjct: 586 DRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQSS 645
Query: 526 SWRMPEFTSDELDDCSMFFGYEVPTD 551
++ ++ +D + M FG++ +D
Sbjct: 646 AYDSGQYNNDTMKFRKMAFGFDDSSD 671
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (642), Expect = 7e-66, Method: Compositional matrix adjust.
Identities = 130/291 (44%), Positives = 186/291 (63%), Gaps = 12/291 (4%)
Query: 234 TCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLM 293
+ F+YEE+S ATN F N++GQGG+ V+KG L G+++AVK+L + + E+EF
Sbjct: 266 STFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGS--GQGEREFQA 323
Query: 294 ELGIIGHVCHPNTATLVGCCIEN-GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVL 352
E+ II V H + +L+G C+ L++ F N NL+ LH + ++EW R KI L
Sbjct: 324 EVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIAL 383
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEG 412
G A+GL YLH+ C +IIHRDIKASN+L+ FE ++ DFGLAK + T H + + G
Sbjct: 384 GSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRVMG 442
Query: 413 TFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR----QNLVLWAKPLM--- 465
TFGYLAPEY G + EK+DVF+FGV+LLE+ITGR+PVD++ +LV WA+PL+
Sbjct: 443 TFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRA 502
Query: 466 -ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
E G+ L D + EYD ++M R+V A CVR ++ RP MS+++ L
Sbjct: 503 SEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRAL 553
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (630), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 136/328 (41%), Positives = 195/328 (59%), Gaps = 19/328 (5%)
Query: 213 SSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRK 272
S + ++G L N + FSYEE+ ATN F EN++G+GG+ VYKG L DGR
Sbjct: 348 SGSYQSQSGGLGNSK------ALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRV 401
Query: 273 IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-NGLYLIFNFSQNGNLD 331
+AVK+L + ++EF E+ + + H + ++VG CI + LI+++ N +L
Sbjct: 402 VAVKQLKIGG--GQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLY 459
Query: 332 AALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITD 391
LH E+S L+W R KI G ARGL YLH+ C RIIHRDIK+SN+LL +F+ +++D
Sbjct: 460 FHLHGEKS-VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSD 518
Query: 392 FGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVD 451
FGLA+ L C H + GTFGY+APEY G + EK+DVF+FGV+LLE+ITGRKPVD
Sbjct: 519 FGLAR-LALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 577
Query: 452 SSR----QNLVLWAKPL----MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSA 503
+S+ ++LV WA+PL +E+ L DP L G Y +M R++ A CVR +
Sbjct: 578 TSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLAT 637
Query: 504 WRPSMSEVLELLTSGHDSEFAKSWRMPE 531
RP M +++ S + R+ E
Sbjct: 638 KRPRMGQIVRAFESLAAEDLTNGMRLGE 665
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (628), Expect = 3e-64, Method: Compositional matrix adjust.
Identities = 124/286 (43%), Positives = 191/286 (66%), Gaps = 12/286 (4%)
Query: 236 FSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMEL 295
F+ E+ AT+ F ++ ++G+GG+ VY+G++ DG ++AVK L +DN++ +++EF+ E+
Sbjct: 337 FTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQN--RDREFIAEV 394
Query: 296 GIIGHVCHPNTATLVGCCIENGLY-LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGV 354
++ + H N L+G CIE LI+ NG++++ LH+ +L+W R KI LG
Sbjct: 395 EMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHE---GTLDWDARLKIALGA 451
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTF 414
ARGL YLH+ R+IHRD KASNVLL DF P+++DFGLA+ + + H + + GTF
Sbjct: 452 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHISTRVMGTF 510
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR----QNLVLWAKPLMESG-N 469
GY+APEY M G + K+DV+++GV+LLE++TGR+PVD S+ +NLV WA+PL+ +
Sbjct: 511 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLANREG 570
Query: 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
L +LVDP+L G Y+ D M ++ IA CV Q + RP M EV++ L
Sbjct: 571 LEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL 616
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | ||||||
| 224117562 | 613 | predicted protein [Populus trichocarpa] | 1.0 | 0.910 | 0.680 | 0.0 | |
| 356550768 | 604 | PREDICTED: probable receptor-like serine | 0.996 | 0.920 | 0.651 | 0.0 | |
| 359485059 | 664 | PREDICTED: probable receptor-like serine | 0.994 | 0.835 | 0.658 | 0.0 | |
| 356564870 | 605 | PREDICTED: probable receptor-like serine | 0.998 | 0.920 | 0.641 | 0.0 | |
| 297735321 | 884 | unnamed protein product [Vitis vinifera] | 0.994 | 0.627 | 0.658 | 0.0 | |
| 357479815 | 621 | Nodulation receptor kinase [Medicago tru | 0.976 | 0.877 | 0.660 | 0.0 | |
| 449465234 | 614 | PREDICTED: probable receptor-like serine | 0.992 | 0.902 | 0.620 | 0.0 | |
| 255587649 | 563 | conserved hypothetical protein [Ricinus | 0.905 | 0.896 | 0.621 | 0.0 | |
| 145334833 | 579 | protein kinase-like protein [Arabidopsis | 0.964 | 0.929 | 0.578 | 0.0 | |
| 297796675 | 569 | ATP binding protein [Arabidopsis lyrata | 0.942 | 0.924 | 0.588 | 0.0 |
| >gi|224117562|ref|XP_002331667.1| predicted protein [Populus trichocarpa] gi|222874086|gb|EEF11217.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 848 bits (2190), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/613 (68%), Positives = 478/613 (77%), Gaps = 55/613 (8%)
Query: 1 MVHSAPSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQS 60
M+ SKILIG SLDP+ S ELLSWA +VLAQ ND IVAIHVLVGEESKKR + K+Q
Sbjct: 1 MIPPGASKILIGISLDPDHSIELLSWATRVLAQSNDTIVAIHVLVGEESKKRELIKKKQW 60
Query: 61 QIRRAKAHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRN 120
QIR+AKAHVI++LGEFA T QSKQ+NLEA+VGFS+ I R LIEEAKSISADYL+LRGSRN
Sbjct: 61 QIRQAKAHVITVLGEFARTCQSKQINLEARVGFSSDIARVLIEEAKSISADYLLLRGSRN 120
Query: 121 HSNKMSRDVTRYCFQHAP--------GGC------------------------------- 141
SN+ +V RYCF+HAP G C
Sbjct: 121 RSNRTWHEVIRYCFEHAPETCTVLSLGKCEPQKNAATIKEHLSNVPFIAENLQPSSWWLS 180
Query: 142 --------------TI--HIFGETKSENPSPRTVLDELEGESNTTEDDTFSVEDSSISQS 185
TI HI ET+ +N SPRTVL +LE ES++TEDDT S DSS ++S
Sbjct: 181 KNADGNTRSGSTSSTIENHINSETEKQNSSPRTVLHQLEAESHSTEDDTLSFGDSSTTES 240
Query: 186 PPQAPKTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSAT 245
PP A G S T+ ++S K +SI +SP+RKRN NKEK QPLL CF++EEI++AT
Sbjct: 241 PPLATNINGRSKTKKQISTCKLISSIFASPMRKRNRIFLNKEKQQPLLKCFTFEEIANAT 300
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
NNFH +N+VG+GGYSEVY+G+LSDGR IAVK LAKDN+DA KEKEFLMELGIIGHV HPN
Sbjct: 301 NNFHPDNIVGRGGYSEVYRGDLSDGRAIAVKMLAKDNRDASKEKEFLMELGIIGHVFHPN 360
Query: 306 TATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
TA L+GCCIENGLYLIFNFSQNGNL +ALH + +SL+WPIRYKI LGVARGLHYLHK C
Sbjct: 361 TANLLGCCIENGLYLIFNFSQNGNLASALHGKTGESLQWPIRYKIALGVARGLHYLHKCC 420
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
K RIIHRDIKASNVLLGPD+EPQITDFGLAKWLPNK THHA IPIEGTFGYLAPEYFMHG
Sbjct: 421 KHRIIHRDIKASNVLLGPDYEPQITDFGLAKWLPNKVTHHAVIPIEGTFGYLAPEYFMHG 480
Query: 426 IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485
I+DEKTDVFAFGVLLLEIITGR+PVDSS+QNL+LWAKPLMESGN+TEL DP LEG++D++
Sbjct: 481 IVDEKTDVFAFGVLLLEIITGRRPVDSSKQNLLLWAKPLMESGNITELADPELEGKFDSE 540
Query: 486 QMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFTSDELDDCSMFFG 545
Q+ R+VL A YCVR++S WRPSMSEVLELLTSGHDSE A+SWRMP+FTSDELDD SM FG
Sbjct: 541 QVDRVVLTASYCVRESSTWRPSMSEVLELLTSGHDSEVARSWRMPKFTSDELDDYSMIFG 600
Query: 546 YEVPTDIDLEEFL 558
YEVP DI LE++L
Sbjct: 601 YEVPVDIALEDYL 613
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550768|ref|XP_003543756.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2135), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/606 (65%), Positives = 471/606 (77%), Gaps = 50/606 (8%)
Query: 1 MVHSAPSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQS 60
MV P++IL+G SLDP+DSKELLSWAI+VLA PND IVA+HVLV + KKR S+ +RQS
Sbjct: 1 MVLPCPAQILVGLSLDPDDSKELLSWAIRVLANPNDTIVAVHVLVAADKKKRVSVRRRQS 60
Query: 61 QIRRAKAHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRN 120
Q+R+AKA+VIS+LGEFA +S SKQVNLEA+V ++++G GL+EE KSI+ADYL++RGSRN
Sbjct: 61 QLRQAKAYVISVLGEFAQSSWSKQVNLEARVALNSTVGEGLVEEVKSINADYLLIRGSRN 120
Query: 121 HSNKM--SRDVTRYCFQHAPGGCTIHIFGE------------------------------ 148
+NK+ S+ +T+YCF+HA GCT+ G
Sbjct: 121 RTNKIGTSKGITKYCFEHAHDGCTMVSVGRRTKADQNANSNSTRFQDKKQPSSRWFKKNN 180
Query: 149 ----------------TKSENPSPRTVLDELEGESNTTEDDTFSVEDSSISQSPPQAPKT 192
TK++N SPRTVLD LEG+SN+TEDDTFS SS + +P K
Sbjct: 181 QYGKGASPILEDYISGTKAQNRSPRTVLDGLEGQSNSTEDDTFSTRVSSTTNTPSSDSKR 240
Query: 193 KGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSEN 252
+ S R P +F S L+SP R +N S+S EK QPLL CFSYE+IS+AT +FH +N
Sbjct: 241 R--SKIRKPQFPFRFIVSFLASPFRSKNFSISKNEKRQPLLKCFSYEQISNATKDFHQDN 298
Query: 253 MVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+VG+GGYSEVYKG+LSDGR IAVKRLAKDNKD KEKEFLMELG+IGHVCHPNTATLVGC
Sbjct: 299 LVGRGGYSEVYKGDLSDGRTIAVKRLAKDNKDPNKEKEFLMELGVIGHVCHPNTATLVGC 358
Query: 313 CIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
CIENGLYLIFN+SQNGNL ALH + L+WPIRYKI +GVARGLHYLHK CK RIIHR
Sbjct: 359 CIENGLYLIFNYSQNGNLATALHGKAGDPLDWPIRYKIAIGVARGLHYLHKCCKHRIIHR 418
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTD 432
DIKASNVLLGPD+EPQITDFGLAKWLPNK THHA IP+EGTFGYLAPEYFMHGI+DEKTD
Sbjct: 419 DIKASNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEGTFGYLAPEYFMHGIVDEKTD 478
Query: 433 VFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVL 492
VFAFG+LLLEI+TGR+PVDSS+QNL+LWAKPLMESGN+ EL DP LEG+YD +Q++R+VL
Sbjct: 479 VFAFGILLLEIVTGRRPVDSSKQNLLLWAKPLMESGNIAELADPRLEGKYDGEQLYRVVL 538
Query: 493 IADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFTSDELDDCSMFFGYEVPTDI 552
A YCVRQT+ WRP MSEVLELLTSG +SE KSWR+P+FTSDELDD SM FGY+VP+D+
Sbjct: 539 TASYCVRQTATWRPPMSEVLELLTSGQESEVGKSWRIPKFTSDELDDYSMVFGYDVPSDV 598
Query: 553 DLEEFL 558
LE++L
Sbjct: 599 SLEDYL 604
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485059|ref|XP_002271849.2| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2070), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/601 (65%), Positives = 463/601 (77%), Gaps = 46/601 (7%)
Query: 1 MVHSAPSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQS 60
M AP+KILIG SLD +DSKELLSWAI++LA PND +VA+HV+VGE+ KK M K Q+
Sbjct: 63 MAPMAPAKILIGISLDSDDSKELLSWAIRILAHPNDTVVALHVIVGEDMKKPELMTKDQT 122
Query: 61 QIRRAKAHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRN 120
+ RRAKA VIS++GEFA T QSKQ+NLE KVGFS+SIG+GL+EEAKSISA++L++ GSRN
Sbjct: 123 RFRRAKAFVISLVGEFAETCQSKQINLEVKVGFSSSIGKGLVEEAKSISAEFLLIGGSRN 182
Query: 121 HSNKMSRDVTRYCFQHAPGGCTIHIFGE-------------------------------- 148
SN++SR TRYCF++A GC + G+
Sbjct: 183 RSNRISRKKTRYCFENAQEGCAVISIGKCGQTQKYSDSNSTHSEEFRQISSRRSNKEVVS 242
Query: 149 ---------TKSENPSPRTVLDELEGESNTTEDDTFSVEDSSISQSPPQAPKTKGLSNTR 199
+K E + + VLD EGES+TTED +FS DSSI++SPP A K KG SN R
Sbjct: 243 AVQKLVTSKSKREKSTRKAVLDGSEGESHTTED-SFSFGDSSITESPPLASKLKGQSNFR 301
Query: 200 MRMSPGKFFTSILSSPL----RKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVG 255
++SP K +S L SP RKRN LS+KEKHQPLL CFSYEEIS ATNNFH +NMVG
Sbjct: 302 KQLSPIKIISSFLLSPFNLSGRKRNERLSDKEKHQPLLRCFSYEEISKATNNFHPDNMVG 361
Query: 256 QGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE 315
QGGYSEVY+G+L +G+ +AVKRLAKDN D KEKEFL+ELGIIGHVCHPNTA LVGCCIE
Sbjct: 362 QGGYSEVYRGHLDNGQIVAVKRLAKDNADENKEKEFLIELGIIGHVCHPNTANLVGCCIE 421
Query: 316 NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIK 375
NGL+LIFNFS NG L +ALH + K LEWP RYKIV GVARGLHYLHK CK RIIHRDIK
Sbjct: 422 NGLHLIFNFSPNGTLSSALHGKTGKPLEWPDRYKIVTGVARGLHYLHKCCKHRIIHRDIK 481
Query: 376 ASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFA 435
ASNVLLG DFEPQI+DFGLAKWLPNK THH+ IPIEGTFGYLAPEYFMHGI+DEKTDVFA
Sbjct: 482 ASNVLLGSDFEPQISDFGLAKWLPNKWTHHSVIPIEGTFGYLAPEYFMHGIVDEKTDVFA 541
Query: 436 FGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIAD 495
FGVLLLEIITGR+PVDSS+QNL+LWAKPLMESG++ EL DP L G+YD +QM+RLVL A
Sbjct: 542 FGVLLLEIITGRRPVDSSKQNLLLWAKPLMESGDIYELADPKLGGKYDVEQMYRLVLTAS 601
Query: 496 YCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFTSDELDDCSMFFGYEVPTDIDLE 555
YCVRQTS WRPSMSEVL LLT G DS A+ WR+P++TSDE+D+ SM FG +VPTDI L+
Sbjct: 602 YCVRQTSIWRPSMSEVLALLTDGGDSAVARRWRVPKYTSDEMDEYSMVFGSDVPTDIVLD 661
Query: 556 E 556
+
Sbjct: 662 D 662
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564870|ref|XP_003550670.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2068), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/606 (64%), Positives = 468/606 (77%), Gaps = 49/606 (8%)
Query: 1 MVHSAPSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQS 60
MV +P+KIL+G SLDP+D+KELLSWAI+VLA PND IVA+HVLV + KKR S+ +RQS
Sbjct: 1 MVLPSPAKILVGLSLDPDDNKELLSWAIRVLANPNDTIVAVHVLVVADKKKRVSVRRRQS 60
Query: 61 QIRRAKAHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRN 120
Q+R+AKA+VIS+LGEF SKQVNLEA+V ++S+G GL+EEAKSISADYL++RGSRN
Sbjct: 61 QLRQAKAYVISVLGEFVQCCWSKQVNLEARVALNSSVGEGLVEEAKSISADYLLIRGSRN 120
Query: 121 HSNKM--SRDVTRYCFQHAPGGCTIHIFGE------------------------------ 148
+NK+ S+ +T+YCF+HA GCT+ G
Sbjct: 121 RTNKIGTSKGITKYCFEHAHDGCTMVSVGRLTKANQSANSNSTRFQDKRQPSSRWFKKDN 180
Query: 149 ----------------TKSENPSPRTVLDELEGESNTTEDDTFSVEDSSISQSPPQAPKT 192
+K++N SPRTVL+ LEG+SN+TEDDTFS SS + +P +
Sbjct: 181 QYGKGTSPVLKDYISGSKAQNRSPRTVLNGLEGQSNSTEDDTFSTRVSSTTYTPSSSDSK 240
Query: 193 KGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSEN 252
+ + + S +F S L+SP R +N S+S EK QPLL CFSYE+IS+AT +FH +N
Sbjct: 241 RRSKIRKPQFS-FRFIASFLASPFRSKNFSISKNEKRQPLLKCFSYEQISNATKDFHRDN 299
Query: 253 MVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+VG+GGYSEVYKG+LSDGR IAVKRLAKDNKD KEKEFLMELG+IGHVCHPNTATLVGC
Sbjct: 300 LVGRGGYSEVYKGDLSDGRSIAVKRLAKDNKDPNKEKEFLMELGVIGHVCHPNTATLVGC 359
Query: 313 CIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
CIENGLYLI N+SQNGNL LH + SL+WPIRYKI +GVARGLHYLHK CK RIIHR
Sbjct: 360 CIENGLYLILNYSQNGNLATTLHGKAGDSLDWPIRYKIAIGVARGLHYLHKCCKHRIIHR 419
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTD 432
DIKASNVLLGPD+EPQITDFGLAKWLPNK THHA IP+EGTFGYLAPEYFMHGI+DEKTD
Sbjct: 420 DIKASNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEGTFGYLAPEYFMHGIVDEKTD 479
Query: 433 VFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVL 492
VFAFG+LLLEI+TGR+PVDSS+QNL+LWAKPLMESGN+ EL DP +EG+YD +Q+HR+VL
Sbjct: 480 VFAFGILLLEIVTGRRPVDSSKQNLLLWAKPLMESGNIAELADPRMEGKYDGEQLHRVVL 539
Query: 493 IADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFTSDELDDCSMFFGYEVPTDI 552
A YCVRQT+ WRP MSEVLELLTSG +SE KSWR+P+F S+ELDD SM FGY+VP+DI
Sbjct: 540 TASYCVRQTATWRPPMSEVLELLTSGQESEIGKSWRIPKFISEELDDYSMVFGYDVPSDI 599
Query: 553 DLEEFL 558
LE++L
Sbjct: 600 SLEDYL 605
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735321|emb|CBI17761.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2068), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/601 (65%), Positives = 463/601 (77%), Gaps = 46/601 (7%)
Query: 1 MVHSAPSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQS 60
M AP+KILIG SLD +DSKELLSWAI++LA PND +VA+HV+VGE+ KK M K Q+
Sbjct: 283 MAPMAPAKILIGISLDSDDSKELLSWAIRILAHPNDTVVALHVIVGEDMKKPELMTKDQT 342
Query: 61 QIRRAKAHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRN 120
+ RRAKA VIS++GEFA T QSKQ+NLE KVGFS+SIG+GL+EEAKSISA++L++ GSRN
Sbjct: 343 RFRRAKAFVISLVGEFAETCQSKQINLEVKVGFSSSIGKGLVEEAKSISAEFLLIGGSRN 402
Query: 121 HSNKMSRDVTRYCFQHAPGGCTIHIFGE-------------------------------- 148
SN++SR TRYCF++A GC + G+
Sbjct: 403 RSNRISRKKTRYCFENAQEGCAVISIGKCGQTQKYSDSNSTHSEEFRQISSRRSNKEVVS 462
Query: 149 ---------TKSENPSPRTVLDELEGESNTTEDDTFSVEDSSISQSPPQAPKTKGLSNTR 199
+K E + + VLD EGES+TTED +FS DSSI++SPP A K KG SN R
Sbjct: 463 AVQKLVTSKSKREKSTRKAVLDGSEGESHTTED-SFSFGDSSITESPPLASKLKGQSNFR 521
Query: 200 MRMSPGKFFTSILSSPL----RKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVG 255
++SP K +S L SP RKRN LS+KEKHQPLL CFSYEEIS ATNNFH +NMVG
Sbjct: 522 KQLSPIKIISSFLLSPFNLSGRKRNERLSDKEKHQPLLRCFSYEEISKATNNFHPDNMVG 581
Query: 256 QGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE 315
QGGYSEVY+G+L +G+ +AVKRLAKDN D KEKEFL+ELGIIGHVCHPNTA LVGCCIE
Sbjct: 582 QGGYSEVYRGHLDNGQIVAVKRLAKDNADENKEKEFLIELGIIGHVCHPNTANLVGCCIE 641
Query: 316 NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIK 375
NGL+LIFNFS NG L +ALH + K LEWP RYKIV GVARGLHYLHK CK RIIHRDIK
Sbjct: 642 NGLHLIFNFSPNGTLSSALHGKTGKPLEWPDRYKIVTGVARGLHYLHKCCKHRIIHRDIK 701
Query: 376 ASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFA 435
ASNVLLG DFEPQI+DFGLAKWLPNK THH+ IPIEGTFGYLAPEYFMHGI+DEKTDVFA
Sbjct: 702 ASNVLLGSDFEPQISDFGLAKWLPNKWTHHSVIPIEGTFGYLAPEYFMHGIVDEKTDVFA 761
Query: 436 FGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIAD 495
FGVLLLEIITGR+PVDSS+QNL+LWAKPLMESG++ EL DP L G+YD +QM+RLVL A
Sbjct: 762 FGVLLLEIITGRRPVDSSKQNLLLWAKPLMESGDIYELADPKLGGKYDVEQMYRLVLTAS 821
Query: 496 YCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFTSDELDDCSMFFGYEVPTDIDLE 555
YCVRQTS WRPSMSEVL LLT G DS A+ WR+P++TSDE+D+ SM FG +VPTDI L+
Sbjct: 822 YCVRQTSIWRPSMSEVLALLTDGGDSAVARRWRVPKYTSDEMDEYSMVFGSDVPTDIVLD 881
Query: 556 E 556
+
Sbjct: 882 D 882
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479815|ref|XP_003610193.1| Nodulation receptor kinase [Medicago truncatula] gi|355511248|gb|AES92390.1| Nodulation receptor kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1992), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/574 (66%), Positives = 447/574 (77%), Gaps = 29/574 (5%)
Query: 5 APSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRR 64
+ S ILIG SLDPNDSKELLSWAI+VLA PND IVA+HVL E KKR S+ +RQSQ+R+
Sbjct: 5 SSSTILIGLSLDPNDSKELLSWAIRVLANPNDTIVAVHVL--ENMKKRVSVRRRQSQLRQ 62
Query: 65 AKAHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRG-SRNHSN 123
AKA+VIS+LGEFA T SKQVNLEAKV S+++G GL+EEAKSISAD+L+L G +RN +
Sbjct: 63 AKAYVISVLGEFAQTCWSKQVNLEAKVALSSTVGGGLVEEAKSISADFLLLLGGTRNKTI 122
Query: 124 KM--SRDVTRYCFQHAPGGCTIHIFG---------------ETKSENPSPRTVLDE--LE 164
K+ S+ +T YCF+H GCTI G E +N SPRTVL + LE
Sbjct: 123 KIGTSKGITNYCFEHVHEGCTIVSVGRNTKTEQNINSTDFQEMNQQNSSPRTVLLDGLLE 182
Query: 165 GESNTTEDDTFSVEDSSISQSPPQAPKTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLS 224
G+SN+TEDDTFS SS++ +P PK K S R F S L SP R + ++S
Sbjct: 183 GQSNSTEDDTFSTRASSLTYTPSSGPKIKRKSQLSFR-----FIISFLGSPFRIKTFNMS 237
Query: 225 NKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKD 284
EKHQPLL CFSYE IS+ATN+FH +N+VG+GGYSEVYKG+L +G IAVKRLAKDNKD
Sbjct: 238 KIEKHQPLLNCFSYENISNATNDFHQDNLVGRGGYSEVYKGDLCNGETIAVKRLAKDNKD 297
Query: 285 AKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHD--ERSKSL 342
KEKEFLMELGIIGHVCHPNTA+L+G C ENGLYLIFN+SQNGNL ALH + SL
Sbjct: 298 PNKEKEFLMELGIIGHVCHPNTASLLGYCFENGLYLIFNYSQNGNLSTALHGYGKAGNSL 357
Query: 343 EWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402
+WPIRYKI +GVARGLHYLHK CK RIIHRDIKASNVLLGPD+EPQITDFGLAKWLPNK
Sbjct: 358 DWPIRYKIAIGVARGLHYLHKCCKHRIIHRDIKASNVLLGPDYEPQITDFGLAKWLPNKW 417
Query: 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK 462
THHA IP+EGTFGYLAPE FMHGI+DEKTD+FAFGVLLLEI+TGR+PVDSS+QN++LWAK
Sbjct: 418 THHAVIPVEGTFGYLAPEVFMHGIVDEKTDIFAFGVLLLEIVTGRRPVDSSKQNILLWAK 477
Query: 463 PLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSE 522
PLMESGN+ EL DP +EG YD +Q++R+VL A YCVRQT+ WRP+M+EVLELLT+G D E
Sbjct: 478 PLMESGNIAELADPRMEGRYDVEQLYRVVLTASYCVRQTAIWRPAMTEVLELLTNGQDYE 537
Query: 523 FAKSWRMPEFTSDELDDCSMFFGYEVPTDIDLEE 556
KSWR+P+FTSDELDD SM FG ++ L +
Sbjct: 538 VGKSWRIPKFTSDELDDYSMIFGNHCCEEVSLRQ 571
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465234|ref|XP_004150333.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Cucumis sativus] gi|449515351|ref|XP_004164713.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1878), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/612 (62%), Positives = 442/612 (72%), Gaps = 58/612 (9%)
Query: 4 SAPSKILIGF-SLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMA---KRQ 59
S+P K+L+G S D +SK LLSWAI VLA +D IVA HVLV +++K+R S A K Q
Sbjct: 4 SSPIKVLVGIPSDDIEESKMLLSWAINVLAHQHDCIVATHVLVSDDTKRRASTAMTMKIQ 63
Query: 60 SQIRRAKAHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSR 119
SQ+RRAKA+VIS+LGEFA SQSKQVNLEA+VGF++SIGRGLIEEAKSISAD LVLRG R
Sbjct: 64 SQLRRAKAYVISILGEFANISQSKQVNLEARVGFNSSIGRGLIEEAKSISADLLVLRGVR 123
Query: 120 NHSNKMSRDVTRYCFQHAPGGCTIHIFGETKS----------------------ENPSPR 157
N SN+ + RYCF++AP CT+ G+ + E+
Sbjct: 124 NKSNRTPSSIARYCFENAPEKCTLIFLGKQEQLKQYFDSHSDSLPSKDVKMGTGEDKCEG 183
Query: 158 TVLDELEGESN----------------------TTEDDTFSVED-SSISQSPPQAPKTKG 194
VL + ESN TTEDD+ + D S+I PP K
Sbjct: 184 EVLRAQKAESNRVPPLMAADDEVEASGDSVSNTTTEDDSSTSGDCSTIGSPPPLVSPFKS 243
Query: 195 LSNT----RMRMSPGKFFTSILSSPLRKRNGSLSNKEKH-QPLLTCFSYEEISSATNNFH 249
S R RMSP K +S + SP RKRN S S K+ H QPLL CFSYEEI +ATNNFH
Sbjct: 244 QSGDSQRHRQRMSPCKLISSFIGSPFRKRNCSFSEKQSHDQPLLRCFSYEEILNATNNFH 303
Query: 250 SENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
E MVGQGGYSEVYKG LSDG+ IAVKRL KDNKD KEKEFLMELGIIGHV HPNTA+L
Sbjct: 304 PEEMVGQGGYSEVYKGELSDGKMIAVKRLTKDNKDGNKEKEFLMELGIIGHVFHPNTASL 363
Query: 310 VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
+GCCIENGLYLIFNFSQNGNL +ALH + SK LEW +RYKI LG+A+GLHYLH+ CK RI
Sbjct: 364 LGCCIENGLYLIFNFSQNGNLSSALHGKSSKILEWSVRYKIALGIAKGLHYLHECCKHRI 423
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
IHRDIKASNVLLGPD+EPQITDFGLAKWLPNK THHA +PIEGTFGYLAPEYFMHG +DE
Sbjct: 424 IHRDIKASNVLLGPDYEPQITDFGLAKWLPNKWTHHAVVPIEGTFGYLAPEYFMHGFVDE 483
Query: 430 KTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHR 489
KTDVFAFGVLLLEI+TGRKPVDSS+Q+L+LWAKPLMESG + +L DP L+ YD ++ R
Sbjct: 484 KTDVFAFGVLLLEIVTGRKPVDSSKQSLLLWAKPLMESGEIGKLADPRLKC-YDAKELQR 542
Query: 490 LVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFTS---DELDDCSMFFGY 546
+VL A CVRQ+S RP+MSEVL++L G+DSE AKS R P+ S +ELDD SM FGY
Sbjct: 543 VVLAASCCVRQSSVERPTMSEVLDVLNKGYDSEIAKSLRTPKLRSNDDNELDDYSMIFGY 602
Query: 547 EVPTDIDLEEFL 558
EVP DI LE++L
Sbjct: 603 EVPIDILLEDYL 614
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587649|ref|XP_002534342.1| conserved hypothetical protein [Ricinus communis] gi|223525458|gb|EEF28040.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 723 bits (1865), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/607 (62%), Positives = 437/607 (71%), Gaps = 102/607 (16%)
Query: 5 APSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKK---RGSMAKRQSQ 61
AP+KILIG SLDP+DSKELLSWAI VLAQPND IVA+HVLVGE KK R + +RQSQ
Sbjct: 6 APAKILIGLSLDPDDSKELLSWAITVLAQPNDHIVAVHVLVGETKKKKKQRELIRRRQSQ 65
Query: 62 IRRAKAHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNH 121
IR+AK HVISMLGEFA T QSKQ+NLEA+VGFS+SI +GLIEE KSISADYL+L G R+
Sbjct: 66 IRQAKTHVISMLGEFATTCQSKQINLEARVGFSSSISKGLIEEVKSISADYLILHGLRSR 125
Query: 122 SNKMSRDVTRYCFQHAPGGCTIHIFG---------------------------------- 147
SN RYCF+HAP GCT+ G
Sbjct: 126 SN-------RYCFKHAPEGCTVISIGKCEQPPKNSISTLVKEIPQSSSRWLCNYNLSNSF 178
Query: 148 ---------------ETKSE-NPSPRTVLDELEGESNTTEDDTFSVEDSSISQSPPQAPK 191
ETKS+ +PSPRTVL E++GES++TEDD+ S+E SS +S P PK
Sbjct: 179 NSGRTDSLVEKDNGSETKSQKSPSPRTVLAEVDGESHSTEDDSISIEGSSSIES-PLPPK 237
Query: 192 TKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSE 251
+ S +R ++S K +SI +SPLRKRNGS SNKEK QPLL CFSYEEI++ATNNFH++
Sbjct: 238 FRTGSKSRKQISACKIISSIFTSPLRKRNGSFSNKEKQQPLLNCFSYEEIANATNNFHTD 297
Query: 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
N+VG+GGYSEVY+G+LSDGR IAVKRLAKDNKDA KEK+FL ELGIIGHVCHPNTA LVG
Sbjct: 298 NIVGRGGYSEVYRGDLSDGRTIAVKRLAKDNKDATKEKDFLTELGIIGHVCHPNTANLVG 357
Query: 312 CCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
CCIENG YLIFNFSQNG L +ALH+
Sbjct: 358 CCIENGFYLIFNFSQNGTLASALHE----------------------------------- 382
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKT 431
NV + QITDFGLAKWLPNK THHA IPIEGTFGYLAPEYFMHGI+DEKT
Sbjct: 383 ------NVWMIIRKNKQITDFGLAKWLPNKWTHHAVIPIEGTFGYLAPEYFMHGIVDEKT 436
Query: 432 DVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLV 491
DVFAFGVLLLEII+GR+PVDSS+QNL++WAKPLMESG+LTEL DP LEG++D DQMH++V
Sbjct: 437 DVFAFGVLLLEIISGRRPVDSSKQNLLIWAKPLMESGSLTELADPELEGKFDEDQMHKVV 496
Query: 492 LIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFTSDELDDCSMFFGYEVPTD 551
L A YCVRQ+S WRPSMSEVLELLTSG DSE AK+WRMP+FTS++LDD SM FGY+VP D
Sbjct: 497 LTASYCVRQSSIWRPSMSEVLELLTSGSDSEVAKTWRMPKFTSEDLDDYSMVFGYDVPVD 556
Query: 552 IDLEEFL 558
I LE++L
Sbjct: 557 IVLEDYL 563
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145334833|ref|NP_001078762.1| protein kinase-like protein [Arabidopsis thaliana] gi|75321844|sp|Q5XF57.1|Y5576_ARATH RecName: Full=Probable receptor-like serine/threonine-protein kinase At5g57670 gi|53749128|gb|AAU90049.1| At5g57670 [Arabidopsis thaliana] gi|56790248|gb|AAW30041.1| At5g57670 [Arabidopsis thaliana] gi|332009551|gb|AED96934.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/574 (57%), Positives = 423/574 (73%), Gaps = 36/574 (6%)
Query: 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAK 66
+KIL+ SLD ++S+ +LSWAI VLA+P+D +VA+H+LVGEE +K K+++QIR AK
Sbjct: 10 NKILVAISLDRDESQNVLSWAINVLAKPSDTVVALHLLVGEEPRKLPMKKKKRTQIRHAK 69
Query: 67 AHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMS 126
AHVISMLGEFA T QVNLEAKVGFS++IGRGLI+E KSISA YLVL H ++
Sbjct: 70 AHVISMLGEFAYTCCHNQVNLEAKVGFSSNIGRGLIDEVKSISAHYLVLSRPTTHEFRIW 129
Query: 127 RDVTRYCFQHAPGGCTIHIFGETK-----------------SENPSPRTVLDELEGES-N 168
D+ RY AP C++ + G + SE SPR+VL+ L +S +
Sbjct: 130 NDIKRYVSDFAPSSCSVVLVGNQRKPHKDCYSDSAISLDINSEKYSPRSVLNTLSRDSLS 189
Query: 169 TTEDDTFSVEDSSISQS---PPQAPKTKGLSNTRMRMSPGKFFTS-ILSSPLRKRNGS-L 223
++ DD S S +S S P PK K +S P KF +S I++SPLRK GS
Sbjct: 190 SSGDDASSFNGSMVSSSFASPSDKPKHKSIS-------PYKFISSLIMNSPLRKWRGSET 242
Query: 224 SNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNK 283
NK K QPL+ CF+Y EIS ATN+FH N+VG GGYSEVY+G+L DGR+IAVKRLAK++
Sbjct: 243 KNKPKPQPLIQCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESG 302
Query: 284 DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLE 343
D KEKEFL ELGII HV HPNTA L+GCC+E GLYL+F FS+NG L +ALH+ + SL+
Sbjct: 303 DMNKEKEFLTELGIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLD 362
Query: 344 WPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403
WP+RYKI +GVARGLHYLHK C RIIHRDIK+SNVLLGPD+EPQITDFGLAKWLPNK T
Sbjct: 363 WPVRYKIAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWT 422
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463
HHA IP+EGTFGYLAPE M G IDEKTD++AFG+LLLEIITGR+PV+ ++++++LWAKP
Sbjct: 423 HHAVIPVEGTFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVNPTQKHILLWAKP 482
Query: 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEF 523
ME+GN +ELVDP L+ +YD QM++LVL A +CV+Q+ RP+M++VLELLT+G+++E
Sbjct: 483 AMETGNTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEI 542
Query: 524 AKSWRMPEFTSDELDDC------SMFFGYEVPTD 551
AKSWRMP+ +++ DD SM FGY+VP+D
Sbjct: 543 AKSWRMPKDMTNDDDDNNEWDDYSMIFGYDVPSD 576
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297796675|ref|XP_002866222.1| ATP binding protein [Arabidopsis lyrata subsp. lyrata] gi|297312057|gb|EFH42481.1| ATP binding protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/556 (58%), Positives = 414/556 (74%), Gaps = 30/556 (5%)
Query: 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAK 66
+KIL+ SLD N+S+ +LSWAI VLA+P+D IVA+H+LVGEE +K K+++QIR AK
Sbjct: 10 NKILVAISLDRNESQNVLSWAINVLAKPSDTIVALHLLVGEEPRKLPMKKKKRTQIRHAK 69
Query: 67 AHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMS 126
AHVISMLGEFA T QVNLEAKVGFS++IGRGLI+E KSISA YLVL H ++
Sbjct: 70 AHVISMLGEFAYTCCHNQVNLEAKVGFSSNIGRGLIDEVKSISAHYLVLSRPTTHEFRIW 129
Query: 127 RDVTRYCFQHAPGGCTIHIFG-----------------ETKSENPSPRTVLDELEGES-N 168
D+TRY AP C++ + G + KSE SPR+VL+ L +S +
Sbjct: 130 NDITRYVSDFAPSSCSVVLVGNQRKPHKDCYSDSAISRDIKSEKYSPRSVLNALSRDSLS 189
Query: 169 TTEDDTFSVEDSSISQS---PPQAPKTKGLSNTRMRMSPGKFFTS-ILSSPLRKRNGS-L 223
++ DD S S +S S P PK K MSP +F +S I++SPLRK GS
Sbjct: 190 SSGDDASSFNGSMVSSSFASPSGKPKHKP-------MSPYRFISSLIMNSPLRKWRGSET 242
Query: 224 SNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNK 283
+K K QPL+ CF+Y EIS ATN F EN+VG GGYSEVY+G+L DGR+IAVKRLAK++
Sbjct: 243 KSKLKPQPLIQCFTYNEISKATNGFDQENIVGIGGYSEVYRGDLWDGRRIAVKRLAKESG 302
Query: 284 DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLE 343
D KEKEFL ELGII HV HPNTA L+GCC+E GLYL+F FS+NG L +ALH++ + SL+
Sbjct: 303 DMNKEKEFLTELGIISHVSHPNTALLLGCCVERGLYLVFRFSENGTLYSALHEKENGSLD 362
Query: 344 WPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403
WPIRYKI +GVARGLHYLHK C RIIHRDIK+SNVLLGPD+EPQITDFGLAKWLPNK T
Sbjct: 363 WPIRYKIAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWT 422
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463
HHA IP+EGTFGYLAPE M G +DEKTD++AFG+LLLEIITGR+PV+ ++++++LWAKP
Sbjct: 423 HHAVIPVEGTFGYLAPESLMQGTVDEKTDIYAFGILLLEIITGRRPVNPTQKHILLWAKP 482
Query: 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEF 523
ME+GN ELVDP L+ +YD QM+RL+L A +CV+Q+ RP+M++VLELLT+G+++E
Sbjct: 483 AMETGNTRELVDPKLQDKYDDQQMNRLILTASHCVQQSPILRPTMTQVLELLTNGNEAEI 542
Query: 524 AKSWRMPEFTSDELDD 539
AKSWRMP+ +++ DD
Sbjct: 543 AKSWRMPKDMTNDHDD 558
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | ||||||
| TAIR|locus:2172555 | 579 | AT5G57670 [Arabidopsis thalian | 0.964 | 0.929 | 0.571 | 3.7e-167 | |
| TAIR|locus:2044420 | 392 | AT2G18890 [Arabidopsis thalian | 0.573 | 0.816 | 0.564 | 5.2e-97 | |
| TAIR|locus:2144970 | 511 | AT5G18910 [Arabidopsis thalian | 0.498 | 0.544 | 0.546 | 1.3e-86 | |
| TAIR|locus:2096209 | 460 | RBK2 "ROP binding protein kina | 0.577 | 0.7 | 0.534 | 1.6e-86 | |
| TAIR|locus:2155700 | 456 | AT5G65530 [Arabidopsis thalian | 0.543 | 0.664 | 0.514 | 4.4e-86 | |
| TAIR|locus:2162848 | 429 | AT5G35960 [Arabidopsis thalian | 0.675 | 0.878 | 0.458 | 1e-84 | |
| TAIR|locus:2160801 | 705 | AT5G63940 [Arabidopsis thalian | 0.589 | 0.466 | 0.432 | 4e-81 | |
| TAIR|locus:2195975 | 794 | AT1G77280 [Arabidopsis thalian | 0.528 | 0.371 | 0.432 | 5.1e-81 | |
| TAIR|locus:2142514 | 467 | RBK1 "ROP binding protein kina | 0.507 | 0.605 | 0.533 | 5.4e-79 | |
| TAIR|locus:2026957 | 756 | AT1G21590 [Arabidopsis thalian | 0.532 | 0.392 | 0.421 | 4.6e-78 |
| TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1626 (577.4 bits), Expect = 3.7e-167, P = 3.7e-167
Identities = 328/574 (57%), Positives = 415/574 (72%)
Query: 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAK 66
+KIL+ SLD ++S+ +LSWAI VLA+P+D +VA+H+LVGEE +K K+++QIR AK
Sbjct: 10 NKILVAISLDRDESQNVLSWAINVLAKPSDTVVALHLLVGEEPRKLPMKKKKRTQIRHAK 69
Query: 67 AHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMS 126
AHVISMLGEFA T QVNLEAKVGFS++IGRGLI+E KSISA YLVL H ++
Sbjct: 70 AHVISMLGEFAYTCCHNQVNLEAKVGFSSNIGRGLIDEVKSISAHYLVLSRPTTHEFRIW 129
Query: 127 RDVTRYCFQHAPGGCTIHIFGETK-----------------SENPSPRTVLDELEGES-N 168
D+ RY AP C++ + G + SE SPR+VL+ L +S +
Sbjct: 130 NDIKRYVSDFAPSSCSVVLVGNQRKPHKDCYSDSAISLDINSEKYSPRSVLNTLSRDSLS 189
Query: 169 TTEDDTFSVEDSSISQS---PPQAPKTKGLSNTRMRMSPGKFFTS-ILSSPLRKRNGS-L 223
++ DD S S +S S P PK K +S P KF +S I++SPLRK GS
Sbjct: 190 SSGDDASSFNGSMVSSSFASPSDKPKHKSIS-------PYKFISSLIMNSPLRKWRGSET 242
Query: 224 SNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLXXXXX 283
NK K QPL+ CF+Y EIS ATN+FH N+VG GGYSEVY+G+L DGR+IAVKRL
Sbjct: 243 KNKPKPQPLIQCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESG 302
Query: 284 XXXXXXXFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLE 343
FL ELGII HV HPNTA L+GCC+E GLYL+F FS+NG L +ALH+ + SL+
Sbjct: 303 DMNKEKEFLTELGIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLD 362
Query: 344 WPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403
WP+RYKI +GVARGLHYLHK C RIIHRDIK+SNVLLGPD+EPQITDFGLAKWLPNK T
Sbjct: 363 WPVRYKIAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWT 422
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463
HHA IP+EGTFGYLAPE M G IDEKTD++AFG+LLLEIITGR+PV+ ++++++LWAKP
Sbjct: 423 HHAVIPVEGTFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVNPTQKHILLWAKP 482
Query: 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEF 523
ME+GN +ELVDP L+ +YD QM++LVL A +CV+Q+ RP+M++VLELLT+G+++E
Sbjct: 483 AMETGNTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEI 542
Query: 524 AKSWRMP-EFTSD-----ELDDCSMFFGYEVPTD 551
AKSWRMP + T+D E DD SM FGY+VP+D
Sbjct: 543 AKSWRMPKDMTNDDDDNNEWDDYSMIFGYDVPSD 576
|
|
| TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 964 (344.4 bits), Expect = 5.2e-97, P = 5.2e-97
Identities = 185/328 (56%), Positives = 238/328 (72%)
Query: 230 QPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLXXXXXXXXXX 288
+P CFS++EI ATN F SEN+VG+GG++EVYKG L +G +IAVKR+
Sbjct: 50 RPKWKCFSFQEIYDATNGFSSENLVGRGGFAEVYKGILGKNGEEIAVKRITRGGRDDERR 109
Query: 289 XX-FLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIR 347
FLME+G IGHV HPN +L+GCCI+NGLYL+F FS G+L + LHD LEW R
Sbjct: 110 EKEFLMEIGTIGHVSHPNVLSLLGCCIDNGLYLVFIFSSRGSLASLLHDLNQAPLEWETR 169
Query: 348 YKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407
YKI +G A+GLHYLHKGC+RRIIHRDIK+SNVLL DFEPQI+DFGLAKWLP++ +HH+
Sbjct: 170 YKIAIGTAKGLHYLHKGCQRRIIHRDIKSSNVLLNQDFEPQISDFGLAKWLPSQWSHHSI 229
Query: 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES 467
PIEGTFG+LAPEY+ HGI+DEKTDVFAFGV LLE+I+G+KPVD+S Q+L WAK +++
Sbjct: 230 APIEGTFGHLAPEYYTHGIVDEKTDVFAFGVFLLELISGKKPVDASHQSLHSWAKLIIKD 289
Query: 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSW 527
G + +LVDP + E+D Q+HR+ A C+R +S RPSM EVLE+L G D E K W
Sbjct: 290 GEIEKLVDPRIGEEFDLQQLHRIAFAASLCIRSSSLCRPSMIEVLEVL-QGEDIEKEK-W 347
Query: 528 RMPEFTSDELDDCSMFFGYEVPTDIDLE 555
+M E +E+ + F+GYE D + +
Sbjct: 348 KMEE--EEEVKE--EFWGYEDLEDCECD 371
|
|
| TAIR|locus:2144970 AT5G18910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 866 (309.9 bits), Expect = 1.3e-86, P = 1.3e-86
Identities = 153/280 (54%), Positives = 214/280 (76%)
Query: 236 FSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLXXXXXXXXXXXXFLMEL 295
FS +I +ATN++ EN++G+GGY+EVYKG ++DG+ +A+K+L +L EL
Sbjct: 180 FSLRDIQTATNDYSRENLIGEGGYAEVYKGQMADGQIVAIKKLTRGSAEEMTMD-YLSEL 238
Query: 296 GIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVA 355
GII HV HPN A L+G C+E G++L+ S NG+L + L++ + K L W +RYK+ +G A
Sbjct: 239 GIIVHVDHPNIAKLIGYCVEGGMHLVLELSPNGSLASLLYEAKEK-LNWSMRYKVAMGTA 297
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415
GL+YLH+GC+RRIIH+DIKASN+LL +FE QI+DFGLAKWLP++ THH +EGTFG
Sbjct: 298 EGLYYLHEGCQRRIIHKDIKASNILLTQNFEAQISDFGLAKWLPDQWTHHTVSKVEGTFG 357
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD 475
YL PE+FMHGI+DEKTDV+A+GVLLLE+ITGR+ +DSS+ ++V+WAKPL++ + +LVD
Sbjct: 358 YLPPEFFMHGIVDEKTDVYAYGVLLLELITGRQALDSSQHSIVMWAKPLIKENKIKQLVD 417
Query: 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
P LE +YD +++ RLV IA C+ QTS RP MS+V+E+L
Sbjct: 418 PILEDDYDVEELDRLVFIASLCIHQTSMNRPQMSQVVEIL 457
|
|
| TAIR|locus:2096209 RBK2 "ROP binding protein kinases 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 865 (309.6 bits), Expect = 1.6e-86, P = 1.6e-86
Identities = 176/329 (53%), Positives = 218/329 (66%)
Query: 230 QPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLXXXXXXXXXXX 289
Q L FS +I AT+NF EN++G+GGY++VY+G L +G+ IAVKRL
Sbjct: 125 QSSLQNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGTPDEQTAE 184
Query: 290 XFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK 349
FL ELGII HV HPNTA +GCCIE G++L+F S G+L + LH L W RY
Sbjct: 185 -FLSELGIIAHVDHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYN 243
Query: 350 IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIP 409
+ LG A GL YLH+GC+RRIIHRDIKA N+LL DF+PQI DFGLAKWLP + THH
Sbjct: 244 VALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSK 303
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469
EGTFGY APEYFMHGI+DEKTDVFAFGVLLLE+ITG +D S+Q+LVLWAKPL+E
Sbjct: 304 FEGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALDESQQSLVLWAKPLLERKA 363
Query: 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEF-----A 524
+ ELVDPSL EY+ +++ RL A C+ Q+S RP MS+V+ELL GH+ A
Sbjct: 364 IKELVDPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELLL-GHEDVVMTPREA 422
Query: 525 KSWRMPEFTSDELDDCSMFFGYEVPTDID 553
K M S+EL D + + D+D
Sbjct: 423 KIKMMQRTYSEELLDSVEYNSTKYLGDLD 451
|
|
| TAIR|locus:2155700 AT5G65530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 832 (297.9 bits), Expect = 4.4e-86, Sum P(2) = 4.4e-86
Identities = 159/309 (51%), Positives = 212/309 (68%)
Query: 236 FSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLXXXXXXXXXXXX-FLME 294
F+++E+ +AT+NF+ ENM+G+GG++EVYKG L DG +A+K+L FL E
Sbjct: 132 FTFDELVAATDNFNPENMIGKGGHAEVYKGVLPDGETVAIKKLTRHAKEVEERVSDFLSE 191
Query: 295 LGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGV 354
LGII HV HPN A L G + GL+ + +S +G+L + L + L+W RYK+ +G+
Sbjct: 192 LGIIAHVNHPNAARLRGFSCDRGLHFVLEYSSHGSLASLLFGSE-ECLDWKKRYKVAMGI 250
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTF 414
A GL YLH C RRIIHRDIKASN+LL D+E QI+DFGLAKWLP HH PIEGTF
Sbjct: 251 ADGLSYLHNDCPRRIIHRDIKASNILLSQDYEAQISDFGLAKWLPEHWPHHIVFPIEGTF 310
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDS-SRQNLVLWAKPLMESGNLTEL 473
GYLAPEYFMHGI+DEKTDVFAFGVLLLEIITGR+ VD+ SRQ++V+WAKPL+E N+ E+
Sbjct: 311 GYLAPEYFMHGIVDEKTDVFAFGVLLLEIITGRRAVDTDSRQSIVMWAKPLLEKNNMEEI 370
Query: 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFT 533
VDP L ++D +M R++ A C+ S RP M+ +++LL D + A+ +
Sbjct: 371 VDPQLGNDFDETEMKRVMQTASMCIHHVSTMRPDMNRLVQLLRG--DDQLAEQ-KPGGAR 427
Query: 534 SDELDDCSM 542
+ LDDC +
Sbjct: 428 TVSLDDCDL 436
|
|
| TAIR|locus:2162848 AT5G35960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 848 (303.6 bits), Expect = 1.0e-84, P = 1.0e-84
Identities = 178/388 (45%), Positives = 245/388 (63%)
Query: 152 ENPSPRTVLDEL-EGESNTTEDDTFSVEDSSISQSPPQAPKTKG---LSNTRMRM-SPGK 206
++ SP VL+E E + +T SS + Q ++K L N ++ + G
Sbjct: 30 DSSSPTGVLEEFFRTEEFNSSSETVKNPSSSRFRKMVQLLRSKSKKSLENVKIPFHNNGV 89
Query: 207 FFTSILSSPLRKRNGSLSNKEKHQPLLT---CFSYEEISSATNNFHSENMVGQGGYSEVY 263
+S + N S+ + H L + F++ ++ SATNNF EN++G+GGY+EVY
Sbjct: 90 IKSSFRRCSSMRENLRFSSNDSHFLLHSPRRIFTFSDLKSATNNFSLENLIGKGGYAEVY 149
Query: 264 KGNLSDGRKIAVKRLXXXXXXXXXXXXFLMELGIIGHVCHPNTATLVGCCIENGLYLIFN 323
KG L +G+ +A+KRL FL E+GI+ HV HPN A L+G +E G++L+
Sbjct: 150 KGMLPNGQMVAIKRLMRGNSEEIIVD-FLSEMGIMAHVNHPNIAKLLGYGVEGGMHLVLE 208
Query: 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP 383
S +G+L + L+ + K ++W IRYKI LGVA GL YLH+GC RRIIHRDIKA+N+LL
Sbjct: 209 LSPHGSLASMLYSSKEK-MKWSIRYKIALGVAEGLVYLHRGCHRRIIHRDIKAANILLTH 267
Query: 384 DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEI 443
DF PQI DFGLAKWLP THH EGTFGYLAPEY HGI+DEKTDVFA GVLLLE+
Sbjct: 268 DFSPQICDFGLAKWLPENWTHHIVSKFEGTFGYLAPEYLTHGIVDEKTDVFALGVLLLEL 327
Query: 444 ITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSA 503
+TGR+ +D S+Q+LVLWAKPLM+ + EL+DPSL GEY+ Q+ ++L A ++Q+S
Sbjct: 328 VTGRRALDYSKQSLVLWAKPLMKKNKIRELIDPSLAGEYEWRQIKLVLLAAALSIQQSSI 387
Query: 504 WRPSMSEVLELLTSG-HDSEFAKSWRMP 530
RP MS+V+E+L D + R+P
Sbjct: 388 ERPEMSQVVEILKGNLKDLKCIMKCRVP 415
|
|
| TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 685 (246.2 bits), Expect = 4.0e-81, Sum P(2) = 4.0e-81
Identities = 151/349 (43%), Positives = 214/349 (61%)
Query: 202 MSPGKFFTSILSSPLRKRNGSLSNKEKHQPL-----LTC--FSYEEISSATNNFHSENMV 254
+S +F + ++ SPL GS + E+ + L TC F+YEE+ S T+NF SEN+V
Sbjct: 309 VSISRFGSELMQSPLSPFIGSNNIPEELEGLHEKYSSTCRLFTYEEVLSITSNFASENLV 368
Query: 255 GQGGYSEVYKGNLSDGRKIAVKRLXXXXXXXXXXXXFLMELGIIGHVCHPNTATLVGCCI 314
G+GG S VY+G+L DGR++AVK L F++E+ +I V H N +L G C
Sbjct: 369 GEGGNSYVYRGDLPDGRELAVKILKPCLDVLKE---FILEIEVITSVHHKNIVSLFGFCF 425
Query: 315 ENG-LYLIFNFSQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
EN L L++++ G+L+ LH R +K W RYK+ +GVA L YLH +IH
Sbjct: 426 ENNNLMLVYDYLPRGSLEENLHGNRKDAKKFGWMERYKVAVGVAEALDYLHNTHDPEVIH 485
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKT 431
RD+K+SNVLL DFEPQ++DFG A + H A I GTFGYLAPEYFMHG + +K
Sbjct: 486 RDVKSSNVLLADDFEPQLSDFGFASLASSTSQHVAGGDIAGTFGYLAPEYFMHGKVTDKI 545
Query: 432 DVFAFGVLLLEIITGRKP--VDSSR--QNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487
DV+AFGV+LLE+I+GRKP VD S+ ++LVLWA P+++SG +L+DPSLE + D +
Sbjct: 546 DVYAFGVVLLELISGRKPICVDQSKGQESLVLWANPILDSGKFAQLLDPSLENDNSNDLI 605
Query: 488 HRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFTSDE 536
+L+L A C+++T RP + VL++L E A W + + E
Sbjct: 606 EKLLLAATLCIKRTPHDRPQIGLVLKILQG---EEEATEWGKQQVRASE 651
|
|
| TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 5.1e-81, Sum P(2) = 5.1e-81
Identities = 135/312 (43%), Positives = 197/312 (63%)
Query: 234 TC--FSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLXXXXXXXXXXXXF 291
TC F Y+E+ S T+NF ++N +G+GG S V++G LS+GR +AVK L F
Sbjct: 429 TCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILKQTEDVLND---F 485
Query: 292 LMELGIIGHVCHPNTATLVGCCIEN-GLYLIFNFSQNGNLDAALHDERSKSLE--WPIRY 348
+ E+ II + H N +L+G C E+ L L++N+ G+L+ LH + L W RY
Sbjct: 486 VAEIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAFCWSERY 545
Query: 349 KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408
K+ +GVA L YLH + +IHRD+K+SN+LL DFEPQ++DFGLA+W TH
Sbjct: 546 KVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASISTTHIICS 605
Query: 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSS----RQNLVLWAKPL 464
+ GTFGYLAPEYFM+G +++K DV+AFGV+LLE+++GRKP+ S +++LV+WAKP+
Sbjct: 606 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISSGCPKGQESLVMWAKPI 665
Query: 465 MESGNLTELVDPSLEGEYDT--DQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSE 522
++ G ++L+DPSL + DQM R+ L A C+R++ RP MS VL+LL D+
Sbjct: 666 LDDGKYSQLLDPSLRDNNNNNDDQMQRMALAATLCIRRSPQARPKMSIVLKLLKGDEDT- 724
Query: 523 FAKSWRMPEFTS 534
W M + S
Sbjct: 725 --LEWAMQQVNS 734
|
|
| TAIR|locus:2142514 RBK1 "ROP binding protein kinases 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 794 (284.6 bits), Expect = 5.4e-79, P = 5.4e-79
Identities = 153/287 (53%), Positives = 199/287 (69%)
Query: 236 FSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLXXXXXXXXXXXX-FLME 294
F+YEE++ AT+ F+ ENM+G+GG++EVYKG L +G +A+K+L FL E
Sbjct: 141 FTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKEEEERVSDFLSE 200
Query: 295 LGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGV 354
LGII HV HPN A L G + GL+ + ++ G+L + L + LEW IRYK+ LG+
Sbjct: 201 LGIIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFGSE-ECLEWKIRYKVALGI 259
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTF 414
A GL YLH C RRIIHRDIKASN+LL D+E QI+DFGLAKWLP HH PIEGTF
Sbjct: 260 ADGLSYLHNACPRRIIHRDIKASNILLNHDYEAQISDFGLAKWLPENWPHHVVFPIEGTF 319
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDS-SRQNLVLWAKPLMESGNLTEL 473
GYLAPEYFMHGI+DEK DVFAFGVLLLEIIT R+ VD+ SRQ++V WAKP +E ++ ++
Sbjct: 320 GYLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDTASRQSIVAWAKPFLEKNSMEDI 379
Query: 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520
VDP L ++ +M R++L A CV +A RP M+ +++LL G D
Sbjct: 380 VDPRLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQLLR-GED 425
|
|
| TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 654 (235.3 bits), Expect = 4.6e-78, Sum P(2) = 4.6e-78
Identities = 131/311 (42%), Positives = 198/311 (63%)
Query: 236 FSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLXXXXXXXXXXXXFLMEL 295
F+Y+E+ S T+NF ++N +G+GG S V++G L +GR++AVK L F+ E+
Sbjct: 397 FTYKELVSVTSNFCADNFIGKGGSSRVFRGYLPNGREVAVKILKRTECVLKD---FVAEI 453
Query: 296 GIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSK--SLEWPIRYKIVL 352
II + H N +L+G C EN L L++N+ G+L+ LH + + W RYK+ +
Sbjct: 454 DIITTLHHKNVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNERYKVAV 513
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEG 412
G+A L YLH + +IHRD+K+SN+LL DFEPQ++DFGLAKW T + G
Sbjct: 514 GIAEALDYLHNDAPQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASESTTQIICSDVAG 573
Query: 413 TFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDS----SRQNLVLWAKPLMESG 468
TFGYLAPEYFM+G ++ K DV+A+GV+LLE+++GRKPV+S ++ +LV+WAKP+++
Sbjct: 574 TFGYLAPEYFMYGKMNNKIDVYAYGVVLLELLSGRKPVNSESPKAQDSLVMWAKPILDDK 633
Query: 469 NLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWR 528
++L+D SL+ + ++DQM ++ L A C+R RP+M VLELL D E K W
Sbjct: 634 EYSQLLDSSLQDDNNSDQMEKMALAATLCIRHNPQTRPTMGMVLELLKG--DVEMLK-WA 690
Query: 529 MPEFTSDELDD 539
+ S+ L+D
Sbjct: 691 KLQ-VSNPLED 700
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5XF57 | Y5576_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5783 | 0.9641 | 0.9291 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00031465001 | SubName- Full=Chromosome chr11 scaffold_56, whole genome shotgun sequence; (576 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 558 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-09 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-08 | |
| pfam00582 | 139 | pfam00582, Usp, Universal stress protein family | 1e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 3e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| COG0589 | 154 | COG0589, UspA, Universal stress protein UspA and r | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 7e-48
Identities = 86/282 (30%), Positives = 136/282 (48%), Gaps = 37/282 (13%)
Query: 252 NMVGQGGYSEVYKGNLSDG----RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
+G+G + EVYKG L ++AVK L K++ ++ K+FL E ++ + HPN
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 308 TLVGCCIENG-LYLIFNFSQNGNLDAALHDER-------SKSLEWPIRYKIVLGVARGLH 359
L+G C E LYL+ + + G+L L R +L + +A+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFG 415
YL ++ +HRD+ A N L+G D +I+DFGL++ + + + +PI
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---- 172
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELV 474
++APE GI K+DV++FGVLL EI T G P VL + G L
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---EYLRKGYR--LP 227
Query: 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516
P EY D+++ L+L C + RP+ SE++E L
Sbjct: 228 KP----EYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 83/273 (30%), Positives = 132/273 (48%), Gaps = 34/273 (12%)
Query: 255 GQGGYSEVYKGNLSDG-----RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
G+G + EVYKG L ++AVK L K++ ++ +EFL E I+ + HPN L
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 310 VGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
+G C E L ++ + G+L L R K L L +ARG+ YL +
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KN 123
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA---IPIEGTFGYLAPEYFMHG 425
IHRD+ A N L+G + +I+DFGL++ L + + +PI ++APE G
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKEG 179
Query: 426 IIDEKTDVFAFGVLLLEIIT-GRKP--VDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482
K+DV++FGVLL EI T G +P S+ + ++ G P
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-----VLEYLKKGYRLPK--P----PN 228
Query: 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
++++L+L C + RP+ SE++E+L
Sbjct: 229 CPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G G + VYK + G+ +AVK L K ++ +KK++ E+ I+ + HPN L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 313 CIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
+ LYL+ + + G+L L R L KI L + RGL YLH IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHS---NGIIH 121
Query: 372 RDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAPEYFMHGI-ID 428
RD+K N+LL + +I DFGLAK + GT Y+APE + G
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT----FVGTPWYMAPEVLLGGNGYG 177
Query: 429 EKTDVFAFGVLLLEIITGRKP 449
K DV++ GV+L E++TG+ P
Sbjct: 178 PKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 84/277 (30%), Positives = 135/277 (48%), Gaps = 35/277 (12%)
Query: 251 ENMVGQGGYSEVYKGNLSD-----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+G+G + EVYKG L ++AVK L K++ ++ +EFL E I+ + HPN
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPN 62
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
L+G C E LY++ + + G+L + L R K L L +ARG+ YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEYLES- 120
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN---KCTHHAAIPIEGTFGYLAPEY 421
+ IHRD+ A N L+G + +I+DFGL++ L + +PI ++APE
Sbjct: 121 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPES 174
Query: 422 FMHGIIDEKTDVFAFGVLLLEIIT-GRKP--VDSSRQNLVLWAKPLMESGNLTELVDPSL 478
G K+DV++FGVLL EI T G +P S+ + +++G P
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-----VLEYLKNGYRLPQ--P-- 225
Query: 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+++ L+L C + RP+ SE++E+L
Sbjct: 226 --PNCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 65/194 (33%), Positives = 104/194 (53%), Gaps = 11/194 (5%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+GG+ VY + G+K+A+K + K++ + E E L E+ I+ + HPN L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGV 59
Query: 313 CIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
+ LYL+ + + G+L L E L +I+L + GL YLH IIH
Sbjct: 60 FEDENHLYLVMEYCEGGSL-KDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 372 RDIKASNVLLG-PDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDE 429
RD+K N+LL + + ++ DFGL+K L + + I GT Y+APE + G E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK--TIVGTPAYMAPEVLLGKGYYSE 173
Query: 430 KTDVFAFGVLLLEI 443
K+D+++ GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 11/209 (5%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G + +VY + G+ +A+K + K K + L E+ I+ + HPN L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNIVRLYDV 65
Query: 313 CIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
+ LYL+ + + G+L L S + R+ + + L YLH + I+H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-ARF-YLRQILSALEYLHS---KGIVH 120
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKT 431
RD+K N+LL D ++ DFGLA+ L + GT Y+APE + +
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGKGYGKAV 177
Query: 432 DVFAFGVLLLEIITGRKPVDSSRQNLVLW 460
D+++ GV+L E++TG+ P Q L L+
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELF 206
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 1e-38
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 20/206 (9%)
Query: 255 GQGGYSEVYKGNL-----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
G+G + EVYKG L K+AVK L K+ ++ +EFL E I+ + HPN L
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 310 VGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
+G C + LY++ + G+L L K L ++ L +A+G+ YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLES---KN 122
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC----THHAAIPIEGTFGYLAPEYFMH 424
+HRD+ A N L+ + +I+DFGL++ + +PI+ ++APE
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPESLKD 178
Query: 425 GIIDEKTDVFAFGVLLLEIIT-GRKP 449
G K+DV++FGVLL EI T G +P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 8e-35
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 252 NMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
++G+G + VY + G +AVK + ++ + E+ I+ + HPN
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 311 GCCIE---NGLYLIFNFSQNGNLDAALHDERSKSLEWP-IRYKIVLGVARGLHYLHKGCK 366
G + N L + + G+L + L ++ L P IR K + GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIR-KYTRQILEGLAYLHS--- 119
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI 426
I+HRDIK +N+L+ D ++ DFG AK L + T + GT ++APE
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 427 IDEKTDVFAFGVLLLEIITGRKP 449
D+++ G ++E+ TG+ P
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 65/200 (32%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
+G+GG+ EVYK + G+++A+K + K KKEK + E+ I+ HPN G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEK-IINEIQILKKCKHPNIVKYYG 64
Query: 312 CCIENG-LYLIFNFSQNGNLDAALHDERSKSL-EWPIRYKIVLGVARGLHYLHKGCKRRI 369
++ L+++ F G+L L +++L E I Y + + +GL YLH I
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAY-VCKELLKGLEYLHS---NGI 119
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
IHRDIKA+N+LL D E ++ DFGL+ L + + + GT ++APE D
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYDY 176
Query: 430 KTDVFAFGVLLLEIITGRKP 449
K D+++ G+ +E+ G+ P
Sbjct: 177 KADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 70/285 (24%), Positives = 128/285 (44%), Gaps = 57/285 (20%)
Query: 252 NMVGQGGYSEVYKG-NLSDGRKIAVKRL------AKDNKDAKKEKEFLMELGIIGHVCHP 304
+G+G + +VY SDG+ +K + K+ +DA E + L +L HP
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN------HP 59
Query: 305 NTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKS--------LEWPIRYKIVLGVA 355
N E G L ++ ++ G+L + ++ + L+W + ++ L
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA-- 115
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415
L YLH R+I+HRDIK N+ L + ++ DFG++K L + A + GT
Sbjct: 116 --LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL--AKTVVGTPY 168
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD 475
YL+PE + + K+D+++ G +L E+ T + P + NL EL
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE---------------NLLELAL 213
Query: 476 PSLEGEYD------TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514
L+G+Y + ++ LV +++ RPS++++L+
Sbjct: 214 KILKGQYPPIPSQYSSELRNLV---SSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 29/217 (13%)
Query: 253 MVGQGGYSEVYKGN-LSDGRKI----AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
++G G + VYKG + +G K+ A+K L ++ K KE L E ++ V HP+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVDHPHVV 72
Query: 308 TLVGCCIENGLYLIFNFSQNGNLDAALHDERSK-----SLEWPIRYKIVLGVARGLHYLH 362
L+G C+ + + LI G L + + + L W ++ +A+G+ YL
Sbjct: 73 RLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA----IPIEGTFGYLA 418
++R++HRD+ A NVL+ +ITDFGLAK L + A +PI+ ++A
Sbjct: 127 ---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMA 179
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSR 454
E +H I K+DV+++GV + E++T G KP +
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 74/258 (28%), Positives = 128/258 (49%), Gaps = 19/258 (7%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+F N +G+G + V+K +D R A+K++ + ++ +E + E ++ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
++ G L ++ +++NG+L L +R + L ++ + + GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
++I+HRDIK+ N+ L +I D G+AK L + A I GT YL+PE
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCED 175
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN-LVLWA-----KPL--MESGNLTELVDP 476
+EK+DV+A GV+L E TG+ P D++ Q L+L P+ M S L +L+D
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235
Query: 477 SLEGEY----DTDQMHRL 490
L +Y DT Q+ R
Sbjct: 236 CLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 248 FHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
F E +G G + EV++G + ++A+K L D+ K+++F E+ + + H +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLI 65
Query: 308 TLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366
+L C +Y+I + G+L A L + L + VA G+ YL +
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE--- 122
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWL--PNKCTHHAAIPIEGTFGYLAPEYFMH 424
+ IHRD+ A N+L+G D ++ DFGLA+ + + IP + T APE H
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAASH 178
Query: 425 GIIDEKTDVFAFGVLLLEIIT 445
G K+DV++FG+LL E+ T
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 247 NFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKD-NKDAKKEKEFLMELGIIGHV-CHP 304
++ +G+G + EVY D + +A+K LAK +K+ + FL E+ I+ + P
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 305 NTATLVGCCIENG-LYLIFNFSQNGNLDAAL-HDERSKSLEWPIRYKIVLGVARGLHYLH 362
N L + G LYL+ + G+L+ L R L I+ + L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 363 KGCKRRIIHRDIKASNVLLGPD-FEPQITDFGLAKWLPNKCTH----HAAIPIEGTFGYL 417
+ IIHRDIK N+LL D ++ DFGLAK LP+ + GT GY+
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 418 APEYFMHGI---IDEKTDVFAFGVLLLEIITGRKPVDSS 453
APE + +D+++ G+ L E++TG P +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214
|
Length = 384 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 80/285 (28%), Positives = 117/285 (41%), Gaps = 40/285 (14%)
Query: 252 NMVGQGGYSEVYKGNLSDGR------KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+G G + EVY+G ++AVK L + + E +FLME I+ H N
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD-ESDFLMEALIMSKFNHQN 70
Query: 306 TATLVGCCIENGLYLI-FNFSQNGNLDAALHDERSK-----SLEWPIRYKIVLGVARGLH 359
L+G E I G+L + L + R + SL VA+G
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 360 YLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHH----AAIPIEG 412
YL + IHRDI A N LL GP +I DFG+A+ + + A +PI+
Sbjct: 131 YLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK- 186
Query: 413 TFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLT 471
++ PE F+ GI KTDV++FGVLL EI + G P V+
Sbjct: 187 ---WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM------------ 231
Query: 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516
E V + + I C + T RP+ + +LE +
Sbjct: 232 EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 66/200 (33%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 251 ENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
++ +G G Y EVY+G +AVK L +D + + EFL E ++ + HPN L
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 67
Query: 310 VGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
+G C E Y+I F GNL L + + + + + ++ + YL K +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KN 124
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC-THHAA--IPIEGTFGYLAPEYFMHG 425
IHRD+ A N L+G + ++ DFGL++ + T HA PI+ T APE +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 180
Query: 426 IIDEKTDVFAFGVLLLEIIT 445
K+DV+AFGVLL EI T
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G+G + +V G+ G+K+AVK L D+ A+ FL E ++ + HPN L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA---FLAEASVMTTLRHPNLVQLLGVV 69
Query: 314 IE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
++ N LY++ + G+L L + + L V G+ YL + + +HR
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA--IPIEGTFGYLAPEYFMHGIIDEK 430
D+ A NVL+ D +++DFGLAK + +P++ T APE K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWT----APEALREKKFSTK 179
Query: 431 TDVFAFGVLLLEIIT-GRKP 449
+DV++FG+LL EI + GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 76/265 (28%), Positives = 118/265 (44%), Gaps = 24/265 (9%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G G V K + G+ +AVK + + + +K+ L EL I+ P G
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 314 IENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
NG + + + G+LD L E + I KI + V +GL YLH+ K +IIHR
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHR 125
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTD 432
D+K SN+L+ + ++ DFG++ L N A GT Y+APE K+D
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 433 VFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD---PSL-EGEYDTDQMH 488
+++ G+ L+E+ TGR P P L +V+ P L G++ D
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDP------PDGIFELLQYIVNEPPPRLPSGKFSPD--- 232
Query: 489 RLVLIADYCVRQTSAWRPSMSEVLE 513
+ C+ + RPS E+LE
Sbjct: 233 -FQDFVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 76/274 (27%), Positives = 134/274 (48%), Gaps = 19/274 (6%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAK-DNKDAKKEKEFLMELGIIGHVC 302
NF E +G+G +S VYK L DGR +A+K++ + DAK ++ L E+ ++ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 303 HPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIR--YKIVLGVARGLH 359
HPN + IEN L ++ + G+L + + + P R +K + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAP 419
++H +RI+HRDIK +NV + ++ D GL ++ +K T AA + GT Y++P
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSP 175
Query: 420 EYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479
E + K+D+++ G LL E+ + P + NL K + E + P L
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EKCDY-----PPLP 229
Query: 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
++ ++++ LV C+ RP +S VL+
Sbjct: 230 ADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 21/263 (7%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
GQG VYK + G+ A+K++ D D + K+ L EL + P G
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 314 IENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
+ G + ++ + G+L L ++ + P+ I + +GL YLH KR IIHR
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHR 124
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPN--KCTHHAAIPIEGTFGYLAPEYFMHGIIDEK 430
DIK SN+L+ E +I DFG++K L N + GT Y++PE
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF----VGTVTYMSPERIQGESYSYA 180
Query: 431 TDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRL 490
D+++ G+ LLE G+ P Q + LM++ PSL E + +
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQ-PSFFE--LMQAICDGPP--PSLPAEEFSPEFRDF 235
Query: 491 VLIADYCVRQTSAWRPSMSEVLE 513
+ C+++ RPS +E+L+
Sbjct: 236 I---SACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 254 VGQGGYSEVYK-GNLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVG 311
+G+G + +V G+ A+K L K K+ + L E I+ + HP L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 312 CCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVARGLHYLHKGCKR 367
E LYL+ ++ G L + L E S E Y +IVL L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLHS---L 112
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII 427
II+RD+K N+LL D ++TDFGLAK GT YLAPE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 428 DEKTDVFAFGVLLLEIITGRKPVDSSRQNLV 458
+ D ++ GVLL E++TG+ P + + +
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI 201
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 57/205 (27%), Positives = 107/205 (52%), Gaps = 9/205 (4%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
N+ +++G+G + VYKG NL G +A+K+++ + + K + E+ ++ ++ HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 306 TATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
+G + LY+I +++NG+L + + + V V +GL YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQVLQGLAYLHE- 117
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
+ +IHRDIKA+N+L D ++ DFG+A L + + GT ++APE
Sbjct: 118 --QGVIHRDIKAANILTTKDGVVKLADFGVATKLND--VSKDDASVVGTPYWMAPEVIEM 173
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKP 449
+D+++ G ++E++TG P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 40/222 (18%)
Query: 253 MVGQGGYSEVYKG------NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGI---IGHVCH 303
+G+G + +V K N ++ +AVK L KD+ K + + E+ + IG H
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGK--H 75
Query: 304 PNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDER------SKSLEWPIRYKIVL---- 352
N L+G C + G LY++ ++ +GNL L R S P +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 353 ----GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCT 403
VARG+ +L ++ IHRD+ A NVL+ D +I DFGLA+ + + K T
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT 445
+ +P++ ++APE + ++DV++FGVLL EI T
Sbjct: 193 -NGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G G + EV++G ++ +AVK L D K +FL E I+ + HP L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 314 -IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
+E +Y++ + G+L L ++L+ P + VA G+ YL + IHR
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHR 127
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPN---KCTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
D+ A NVL+G + ++ DFGLA+ + + A PI+ T APE ++
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT----APEAALYNRFSI 183
Query: 430 KTDVFAFGVLLLEIIT-GRKP 449
K+DV++FG+LL EI+T GR P
Sbjct: 184 KSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 31/221 (14%)
Query: 252 NMVGQGGYSEVYKGNLSD-------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
N +G G + EVY+G +D ++AVK L K D +K KEFL E ++ + HP
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHP 59
Query: 305 NTATLVGCCIEN-GLYLIFNFSQNGNLDAALHDERSKSLEWPIR-----YKIVLGVARGL 358
N L+G C+ N Y+I + G+L + L D R + P+ I L VA+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGP-----DFEPQITDFGLAKWLPN----KCTHHAAIP 409
YL + IHRD+ A N L+ D +I DFGLA+ + + +P
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+ ++APE + G ++DV++FGVL+ EI+T G++P
Sbjct: 177 VR----WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 255 GQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314
G G + EV+ G + K+AVK L + FL E I+ + H L C
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 315 ENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373
E +Y++ + G+L L K L P + +A G+ YL R IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRD 128
Query: 374 IKASNVLLGPDFEPQITDFGLAKWLPNK--CTHHAA-IPIEGTFGYLAPEYFMHGIIDEK 430
+ A N+L+G + +I DFGLA+ + + A PI+ T APE +G K
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRFTIK 184
Query: 431 TDVFAFGVLLLEIIT-GRKP 449
+DV++FG+LL EI+T GR P
Sbjct: 185 SDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 14/197 (7%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G+G + V +G + G+K+AVK + D + FL E ++ + H N L+G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 314 IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373
+ NGLY++ GNL L + + L VA G+ YL ++++HRD
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRD 125
Query: 374 IKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDV 433
+ A N+L+ D +++DFGLA+ ++ +P++ T APE H K+DV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGS-MGVDNSKLPVKWT----APEALKHKKFSSKSDV 180
Query: 434 FAFGVLLLEIIT-GRKP 449
+++GVLL E+ + GR P
Sbjct: 181 WSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 43/244 (17%)
Query: 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAK-----DNK--DAKKEKEFLMELGI 297
++F ++G+G +S V ++ A+K L K + K K EKE L L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN- 59
Query: 298 IGHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY---KIVLG 353
HP L E LY + ++ NG L + S + R+ +I+L
Sbjct: 60 ----GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAEILLA 114
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK----------CT 403
L YLH + IIHRD+K N+LL D +ITDFG AK L
Sbjct: 115 ----LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 404 HHAAIPIE--------GTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ 455
+ I GT Y++PE + +D++A G ++ +++TG+ P S +
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227
Query: 456 NLVL 459
L
Sbjct: 228 YLTF 231
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 9e-23
Identities = 72/279 (25%), Positives = 134/279 (48%), Gaps = 21/279 (7%)
Query: 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAK-DNKDAKKEKEFLMELGIIGHVCHP 304
NF E +G+G +SEVY+ L D + +A+K++ + DAK ++ + E+ ++ + HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 305 NTATLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIR--YKIVLGVARGLHYL 361
N + IE N L ++ + G+L + + + P R +K + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
H RR++HRDIK +NV + ++ D GL ++ +K T AA + GT Y++PE
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPER 177
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD-PSLEG 480
+ K+D+++ G LL E+ + P + NL + + E D P L
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-------EQCDYPPLPT 230
Query: 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519
E+ ++++ LV C+ RP + V ++ H
Sbjct: 231 EHYSEKLRELV---SMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-22
Identities = 74/279 (26%), Positives = 135/279 (48%), Gaps = 21/279 (7%)
Query: 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAK-DNKDAKKEKEFLMELGIIGHVCHP 304
NF E +G+G +SEVY+ L DG +A+K++ D DAK + + E+ ++ + HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 305 NTATLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIR--YKIVLGVARGLHYL 361
N IE N L ++ + G+L + + + P + +K + + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
H RR++HRDIK +NV + ++ D GL ++ +K T AA + GT Y++PE
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPER 177
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD-PSLEG 480
+ K+D+++ G LL E+ + P + NL K + E D P L
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-------EQCDYPPLPS 230
Query: 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519
++ ++++ +LV + C+ RP ++ V ++ H
Sbjct: 231 DHYSEELRQLV---NMCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKD---AKKEKEFLME-LGIIGHVCHPNTA 307
++G+G Y VY G + G+ IAVK++ D + A+KE E L E + ++ + H N
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 308 TLVGCCIENGLYLIF-NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366
+G C+++ IF F G++ + L R L P+ K + G+ YLH C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNC- 122
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAK---WLPNKCTHHAAI-PIEGTFGYLAPEYF 422
++HRDIK +NV+L P+ ++ DFG A+ W+ TH + + GT ++APE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKPVDS 452
K+D+++ G + E+ TG+ P+ S
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-21
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G G + V+ G + RK+A+K + + A E++F+ E ++ + HP L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 314 IENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
E + L+F F ++G L L +R K + L V G+ YL +IHR
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPN---KCTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
D+ A N L+G + +++DFG+ +++ + + P++ + +PE F
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----WSSPEVFSFSKYSS 180
Query: 430 KTDVFAFGVLLLEIIT-GRKPVDSSRQN 456
K+DV++FGVL+ E+ + G+ P + +R N
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYE-NRSN 207
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 80/275 (29%), Positives = 128/275 (46%), Gaps = 37/275 (13%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G+G + +VYKG L ++AVK K K FL E I+ HPN L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGVC 61
Query: 314 IENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIR--YKIVLGVARGLHYLH-KGCKRRI 369
++ +Y++ G+L L R K ++ ++ L A G+ YL K C
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---- 114
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAK----WLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
IHRD+ A N L+G + +I+DFG+++ + IPI+ T APE +G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYG 170
Query: 426 IIDEKTDVFAFGVLLLEIIT-GRKPVD--SSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482
++DV+++G+LL E + G P S++Q + +ESG + P L
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRERIESG--YRMPAPQLC--- 220
Query: 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517
++++RL+L C RPS SE+ L
Sbjct: 221 -PEEIYRLML---QCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 77/279 (27%), Positives = 138/279 (49%), Gaps = 39/279 (13%)
Query: 251 ENMVGQGGYSEVYKGNLS-DGRK---IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
E ++G G + EV +G L G+K +A+K L K K+ +FL E I+G HPN
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 307 ATLVGCCIE-NGLYLIFNFSQNGNLDAAL--HDERSKSLEWPIRYKIVLGVARGLHYLHK 363
L G + + +I + +NG+LD L +D + ++ G+A G+ YL +
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSE 124
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK----CTHHAAIPIEGTFGYLAP 419
+HRD+ A N+L+ + +++DFGL++ L + T IPI T AP
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----AP 177
Query: 420 EYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPV-DSSRQNLVLWAKPLMESGNLTELVD-P 476
E + +DV++FG+++ E+++ G +P D S Q+++ K + + L +D P
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI---KAVEDGYRLPPPMDCP 234
Query: 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
S +++L+L C ++ RP+ S+++ L
Sbjct: 235 SA--------LYQLML---DCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 7e-21
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G G + V+ G +A+K + + A E +F+ E ++ + HPN L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 314 IENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
+ ++++ + NG L L ER L + V + YL IHR
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPNK---CTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
D+ A N L+G D +++DFGLA+++ + + P++ + PE F +
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK----WAPPEVFDYSRFSS 180
Query: 430 KTDVFAFGVLLLEIITGRK 448
K+DV++FGVL+ E+ + K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKE-FLMELGIIGHVCHPNTATLVGC 312
+G G + EV+ G + K+A+K L K E FL E ++ + HP L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 313 CIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
+ +Y+I + +NG+L L L + +A G+ ++ + + IHR
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHR 126
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPNK---CTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
D++A+N+L+ +I DFGLA+ + + A PI+ T APE +G
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTFTI 182
Query: 430 KTDVFAFGVLLLEIIT-GRKP 449
K+DV++FG+LL EI+T GR P
Sbjct: 183 KSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G G + EV+ G + K+AVK L + FL E I+ + H L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 314 IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373
E +Y++ + G+L L D ++L+ P + VA G+ Y+ + IHRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 374 IKASNVLLGPDFEPQITDFGLAKWLP-NKCT--HHAAIPIEGTFGYLAPEYFMHGIIDEK 430
++++N+L+G +I DFGLA+ + N+ T A PI+ T APE ++G K
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTIK 183
Query: 431 TDVFAFGVLLLEIIT-GRKP 449
+DV++FG+LL E++T GR P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 78/271 (28%), Positives = 124/271 (45%), Gaps = 27/271 (9%)
Query: 254 VGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G G + VY L + K+A+KR+ + + E E+ + HPN
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYTS 67
Query: 313 CIENG-LYLIFNFSQNGN-LDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
+ L+L+ + G+ LD L+ I ++ V +GL YLH I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQI 124
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWL--PNKCTHHAAIPIEGTFGYLAPEYF--MHGI 426
HRDIKA N+LLG D +I DFG++ L T GT ++APE +HG
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG- 183
Query: 427 IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK-PLMESGNLTELVD-PSLEGEYDT 484
D K D+++FG+ +E+ TG P ++K P M+ LT D PSLE D
Sbjct: 184 YDFKADIWSFGITAIELATGAAP----------YSKYPPMKVLMLTLQNDPPSLETGADY 233
Query: 485 DQMHRLV--LIADYCVRQTSAWRPSMSEVLE 513
+ + +I+ C+++ + RP+ E+L+
Sbjct: 234 KKYSKSFRKMISL-CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 35/229 (15%)
Query: 240 EISSATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLM 293
EI + F E +G+G + +VYKG L +A+K L K+N + K ++EF
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQ 57
Query: 294 ELGIIGHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLDAAL--------------HDER 338
E ++ + HPN L+G C E ++F + +G+L L +
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 339 SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398
SL+ I + +A G+ YL +HRD+ A N L+G +I+DFGL++ +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 399 PN----KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEI 443
+ + + +P+ ++ PE ++G ++D+++FGV+L EI
Sbjct: 175 YSADYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKE-----FLMELGIIGHVCHPNTA 307
+G+G Y +VYK N G +A+K++ +N EKE + E+ ++ + HPN
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMEN-----EKEGFPITAIREIKLLQKLRHPNIV 61
Query: 308 TLVGCCIE---NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
L +Y++F + + +L L K E I+ + + GL YLH
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKC-YMKQLLEGLQYLHS- 118
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL----PNKCTHHAAIPIEGTFGYLAPE 420
I+HRDIK SN+L+ D ++ DFGLA+ T+ T Y PE
Sbjct: 119 --NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-----TLWYRPPE 171
Query: 421 YFMHGII-DEKTDVFAFGVLLLEIITGR 447
+ + D+++ G +L E+ G+
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-20
Identities = 79/291 (27%), Positives = 138/291 (47%), Gaps = 32/291 (10%)
Query: 236 FSYEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLME 294
+ +I S+ EN++ +G YKG ++ +G + VK + N E
Sbjct: 683 ITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP------SSE 733
Query: 295 LGIIGHVCHPNTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG 353
+ +G + HPN L+G C E G YLI + + NL L ++L W R KI +G
Sbjct: 734 IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIG 788
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL--PNKCTHHAAIPIE 411
+A+ L +LH C ++ ++ +++ EP + L L KC +A
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA---- 843
Query: 412 GTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSS---RQNLVLWAKPLMESG 468
Y+APE I EK+D++ FG++L+E++TG+ P D+ ++V WA+
Sbjct: 844 ----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC 899
Query: 469 NLTELVDPSLEGEYDTDQ--MHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517
+L +DPS+ G+ +Q + ++ +A +C RP ++VL+ L S
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 253 MVGQGGYSEVYKGNLS--DGR--KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
++G+G + V +G LS DG K+AVK + D + +EFL E + HPN
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 309 LVGCCIE----NGL---YLIFNFSQNGNLDAALHDER----SKSLEWPIRYKIVLGVARG 357
L+G C E + +I F ++G+L + L R + L K ++ +A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGT 413
+ YL R IHRD+ A N +L D + DFGL+K + + + A +P++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 414 FGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
++A E + K+DV+AFGV + EI T G+ P
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVK--RLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
+G+G EVYK + + G+++A+K RL K NK+ + E+ I+ HPN
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL-----IINEILIMKDCKHPNIVDY 80
Query: 310 VGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
+ L+++ + G+L + + E I Y + V +GL YLH +
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-VCREVLQGLEYLHS---QN 136
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWL----PNKCTHHAAIPIEGTFGYLAPEYFMH 424
+IHRDIK+ N+LL D ++ DFG A L + + + GT ++APE
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS------VVGTPYWMAPEVIKR 190
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKP 449
K D+++ G++ +E+ G P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 254 VGQGGYSEVYKG--NLSDGRKI--AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
+G G + V KG + G+++ AVK L K A +KEFL E ++ + HP L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL-KQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 310 VGCCIENGLYLIFNFSQNGNLDAALHDER----SKSLEWPIRYKIVLGVARGLHYLHKGC 365
+G C L L+ + G L L R S E VA G+ YL
Sbjct: 62 IGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES-- 113
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL-PN----KCTHHAAIPIEGTFGYLAPE 420
+ +HRD+ A NVLL + +I+DFG+++ L + T P++ + APE
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK----WYAPE 168
Query: 421 YFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+G K+DV+++GV L E + G KP
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
E +GQG + EV+ G + ++A+K L + FL E ++ + H L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 67
Query: 311 GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
E +Y++ + G+L L E K L P + +A G+ Y+ + +
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 124
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNK---CTHHAAIPIEGTFGYLAPEYFMHGII 427
HRD++A+N+L+G + ++ DFGLA+ + + A PI+ T APE ++G
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRF 180
Query: 428 DEKTDVFAFGVLLLEIIT-GRKP 449
K+DV++FG+LL E+ T GR P
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 70/282 (24%), Positives = 127/282 (45%), Gaps = 47/282 (16%)
Query: 247 NFHSENMVGQGGYSEVYK-GNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+F +G+G Y VYK LSD + A+K + + K+ ++ + E+ I+ V HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 306 T-----ATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIR----YKIVLGVAR 356
A L G N L ++ ++ G+L A+ + K I ++I + + R
Sbjct: 61 IISYKEAFLDG----NKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416
GL LH+ ++I+HRD+K++N+LL + +I D G++K L + A GT Y
Sbjct: 115 GLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHY 167
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476
+APE + K+D+++ G LL E+ T P E+ ++ +L
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP---------------FEARSMQDLRYK 212
Query: 477 SLEGEYD------TDQMHRLVLIADYCVRQTSAWRPSMSEVL 512
G+Y + + + ++ RP+ ++L
Sbjct: 213 VQRGKYPPIPPIYSQDLQNFIR---SMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 32/220 (14%)
Query: 254 VGQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
+G+G + +V+ G +AVK L K+ K+F E ++ + H N
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENIV 71
Query: 308 TLVGCCIENG-LYLIFNFSQNGNLDAAL--HDERSKSLEWPIR----------YKIVLGV 354
G C E ++F + ++G+L+ L H + L+ P +I + +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPI 410
A G+ YL + +HRD+ N L+G D +I DFG+++ + + H +PI
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
++ PE M+ ++DV++FGV+L EI T G++P
Sbjct: 189 R----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+GQG + EV+ G + K+A+K L + FL E I+ + H L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 314 IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373
E +Y++ F G+L L + K L+ P + +A G+ Y+ + IHRD
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127
Query: 374 IKASNVLLGPDFEPQITDFGLAKWLPNK---CTHHAAIPIEGTFGYLAPEYFMHGIIDEK 430
++A+N+L+G + +I DFGLA+ + + A PI+ T APE ++G K
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTIK 183
Query: 431 TDVFAFGVLLLEIIT-GRKP 449
+DV++FG+LL E++T GR P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 252 NMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
N +G G + +VY NL G +AVK + + D K KE E+ ++ + HPN
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 311 GCCIENGLYLIF-NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
G + IF + G L+ L R Y L + GL YLH I
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY--TLQLLEGLAYLHS---HGI 120
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT--HHAAIPIEGTFGYLAPEYFMHGII 427
+HRDIK +N+ L + ++ DFG A L N T + GT Y+APE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 428 DEK---TDVFAFGVLLLEIITGRKP 449
D+++ G ++LE+ TG++P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 254 VGQGGYSEVYKG--NLSDGRKI--AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
+G G + V +G + S G+ I AVK L K +K + +FL E I+ + H N L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 310 VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
G + + L ++ + G+L L + + +A G+ YL +R
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRF 118
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH-----HAAIPIEGTFGYLAPEYFMH 424
IHRD+ A N+LL D + +I DFGL + LP H H +P F + APE
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP----FAWCAPESLRT 174
Query: 425 GIIDEKTDVFAFGVLLLEIIT-GRKP 449
+DV+ FGV L E+ T G +P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 69/218 (31%), Positives = 117/218 (53%), Gaps = 27/218 (12%)
Query: 248 FHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDA---KKEKEFLMELGIIGHVCH 303
F ++G G + VYKG + +G K+ + K+ ++A K KE L E ++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 304 PNTATLVGCCIENGLYLIFNFSQNGNLDAAL--HDERSKS---LEWPIRYKIVLGVARGL 358
P+ L+G C+ + + LI G L + H + S L W ++ +A+G+
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 122
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL-PNKCTHHA---AIPIEGTF 414
+YL + RR++HRD+ A NVL+ +ITDFGLAK L ++ +HA +PI+
Sbjct: 123 NYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK--- 176
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVD 451
++A E +H I ++DV+++GV + E++T G KP D
Sbjct: 177 -WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVG 311
+G+G Y +VYK + G+ +A+K + + +E+E E I+ HPN AT G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 312 CCIENG-------LYLIFNFSQNG---NLDAALHDE-RSKSLEWPIRYKIVLGVARGLHY 360
I+ L+L+ G +L L + + EW I Y I+ RGL Y
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAY-ILRETLRGLAY 128
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE 420
LH+ ++IHRDIK N+LL + E ++ DFG++ L T GT ++APE
Sbjct: 129 LHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMAPE 183
Query: 421 -----YFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
D ++DV++ G+ +E+ G+ P
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 253 MVGQGGYSEVYKGNLSD--GRKI--AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
+G+G + +VY+G KI AVK + +EK FL E I+ HP+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIVK 71
Query: 309 LVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
L+G EN ++++ + G L + L SL+ ++ L YL +R
Sbjct: 72 LIGVITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLE---SKR 127
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA---AIPIEGTFGYLAPEYFMHG 425
+HRDI A NVL+ ++ DFGL+++L ++ + A +PI+ ++APE
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPESINFR 183
Query: 426 IIDEKTDVFAFGVLLLEIIT-GRKP 449
+DV+ FGV + EI+ G KP
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 31/212 (14%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
++G+G Y VY +LS +IA+K + + +D++ + E+ + ++ H N +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 312 CCIENGLYLIFNFSQ--NGNLDAALHDERSK-----SLEWPIRY--KIVLGVARGLHYLH 362
ENG + IF Q G+L A L RSK E I + K +L GL YLH
Sbjct: 73 SDSENGFFKIF-MEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQIL---EGLKYLH 125
Query: 363 KGCKRRIIHRDIKASNVLLGP-DFEPQITDFGLAKWLP--NKCTHHAAIPIEGTFGYLAP 419
+I+HRDIK NVL+ +I+DFG +K L N CT GT Y+AP
Sbjct: 126 ---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE----TFTGTLQYMAP 178
Query: 420 EYFMHGI--IDEKTDVFAFGVLLLEIITGRKP 449
E G D+++ G ++E+ TG+ P
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 52/299 (17%)
Query: 273 IAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIFNFSQNGNL 330
+AVK L KDN K + + E+ ++ + H N L+G C + G LY+I ++ GNL
Sbjct: 47 VAVKML-KDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 331 DAALHDER----------SKSLEWPIRYKIVLG----VARGLHYLHKGCKRRIIHRDIKA 376
L R +K E + +K ++ VARG+ YL RR IHRD+ A
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAA 162
Query: 377 SNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTD 432
NVL+ D +I DFGLA+ + + K T + +P++ ++APE + ++D
Sbjct: 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVK----WMAPEALFDRVYTHQSD 218
Query: 433 VFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLV 491
V++FG+L+ EI T G P P + L +L+ + ++ H L
Sbjct: 219 VWSFGILMWEIFTLGGSPY------------PGIPVEELFKLLREGHRMDKPSNCTHELY 266
Query: 492 LIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFTSDELDDCSMFFGYEVPT 550
++ C RP+ +++E L ++ S+E D SM F P+
Sbjct: 267 MLMRECWHAVPTQRPTFKQLVEALD-----------KVLAAVSEEYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 80/280 (28%), Positives = 136/280 (48%), Gaps = 40/280 (14%)
Query: 251 ENMVGQGGYSEVYKGNLS-DGRK---IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
+ ++G G + EV++G L GRK +A+K L K K+ ++FL E I+G H N
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 307 ATLVGCCIE-NGLYLIFNFSQNGNLDAAL--HDERSKSLEWPIRYKIVLGVARGLHYLHK 363
L G + +I + +NG LD L HD S + ++ G+A G+ YL
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAGMKYL-- 123
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK-----CTHHAAIPIEGTFGYLA 418
+HRD+ A N+L+ + E +++DFGL++ L + T IPI T A
Sbjct: 124 -SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT----A 178
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPV-DSSRQNLVLWAKPLMESGNLTELVD- 475
PE + +DV++FG+++ E+++ G +P D S ++ K + + L +D
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM---KAINDGFRLPAPMDC 235
Query: 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
PS +++L+L C +Q A RP +++ LL
Sbjct: 236 PS--------AVYQLML---QCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 253 MVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
++G+G + EV+KG L D +AVK +D K K FL E I+ HPN L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 313 CIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH-KGCKRRII 370
C + +Y++ G+ + L ++ + L+ K L A G+ YL K C I
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA---IPIEGTFGYLAPEYFMHGII 427
HRD+ A N L+G + +I+DFG+++ + + IPI+ T APE +G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGRY 171
Query: 428 DEKTDVFAFGVLLLEIIT 445
++DV+++G+LL E +
Sbjct: 172 SSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 66/243 (27%), Positives = 104/243 (42%), Gaps = 22/243 (9%)
Query: 252 NMVGQGGYSEVYKG---NLSD--GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
+G+G + +V L D G ++AVK L ++ + +F E+ I+ + H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRTLDHENI 68
Query: 307 ATLVGCC---IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
G C L LI + +G+L L R + + + +G+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGS 127
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA-----IPIEGTFGYLA 418
+R IHRD+ A N+L+ + +I+DFGLAK LP ++ PI F Y A
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---FWY-A 180
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478
PE +DV++FGV L E+ T P S + +T L++
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 479 EGE 481
EGE
Sbjct: 241 EGE 243
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-18
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 39/229 (17%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKK-EKEFLMELGIIGHVCHPNTATLV 310
++G+GG EVY + R++A+K++ +D + +K FL E I + HP +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 311 GCCIENGL--------------YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVAR 356
C + L+ + Q +L L ++ S I +KI +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE- 127
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--------------LPNKC 402
Y+H + ++HRD+K N+LLG E I D+G A + N C
Sbjct: 128 ---YVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 403 THHAAIP--IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
IP I GT Y+APE + E TD++A GV+L +++T P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVK--RLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATL 309
+G+G Y VYK + G+ +A+K + +D ++ KE L + C P
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQ-------CDSPYIVKY 63
Query: 310 VGCCIENG-LYLIFNFSQNGN-LDAALHDERSKSL-EWPIRYKIVLGVARGLHYLHKGCK 366
G +N L+++ + G+ D + +K+L E I I+ +GL YLH
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAA-ILYQTLKGLEYLHS--- 117
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI 426
+ IHRDIKA N+LL + + ++ DFG++ L + T + GT ++APE
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 427 IDEKTDVFAFGVLLLEIITGRKP 449
+ K D+++ G+ +E+ G+ P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 24/201 (11%)
Query: 272 KIAVKRLAKDNKDAKKEKEFLM-ELGIIGHV-CHPNTATLVGCCIENG-LYLIFNFSQNG 328
K+AVK L K + E+E LM EL I+ H+ H N L+G C G + +I + G
Sbjct: 67 KVAVKML-KPTAHSS-EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124
Query: 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYL-HKGCKRRIIHRDIKASNVLLGPDFEP 387
+L L +R L VA+G+ +L K C IHRD+ A NVLL
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIV 180
Query: 388 QITDFGLAKWLPNKCTH----HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEI 443
+I DFGLA+ + N + +A +P++ ++APE + + ++DV+++G+LL EI
Sbjct: 181 KICDFGLARDIMNDSNYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGILLWEI 236
Query: 444 IT-GRKP-----VDSSRQNLV 458
+ G P VDS L+
Sbjct: 237 FSLGSNPYPGMPVDSKFYKLI 257
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
+ +G+G V K L + I A+K + D + K+ L EL I P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ-KQILRELEINKSCKSP 59
Query: 305 NTATLVGCCIENG---LYLIFNFSQNGNLDAALHDERSKSL---EWPIRYKIVLGVARGL 358
G ++ + + + + G+LD+ + + E + KI V +GL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-KIAESVLKGL 118
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLA 418
YLH R+IIHRDIK SN+LL + ++ DFG++ L N A GT Y+A
Sbjct: 119 SYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS----LAGTFTGTSFYMA 171
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
PE +DV++ G+ LLE+ R P
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 75/266 (28%), Positives = 124/266 (46%), Gaps = 43/266 (16%)
Query: 272 KIAVKRLAKD--NKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328
K+AVK L D KD + + +IG H N L+G C ++G LY+I ++ G
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKG 109
Query: 329 NLDAALHDERSKSLEWP----------IRYKIVLG----VARGLHYLHKGCKRRIIHRDI 374
NL L R +E+ + +K ++ VARG+ YL ++ IHRD+
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDL 166
Query: 375 KASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPEYFMHGIIDEK 430
A NVL+ D +I DFGLA+ + + K T + +P++ ++APE I +
Sbjct: 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQ 222
Query: 431 TDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHR 489
+DV++FGVLL EI T G P P + L +L+ + ++ +
Sbjct: 223 SDVWSFGVLLWEIFTLGGSPY------------PGVPVEELFKLLKEGHRMDKPSNCTNE 270
Query: 490 LVLIADYCVRQTSAWRPSMSEVLELL 515
L ++ C + RP+ +++E L
Sbjct: 271 LYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 66/230 (28%), Positives = 115/230 (50%), Gaps = 48/230 (20%)
Query: 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKI--AVKRLAK-----DNKDAKKEKEFLMELGI 297
N+ ++++G+G + +V K + DG ++ A+KR+ + D++D E E L +LG
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG- 65
Query: 298 IGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIV----- 351
HPN L+G C G LYL ++ +GNL L +S+ LE + I
Sbjct: 66 ----HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTAS 119
Query: 352 -----------LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400
VARG+ YL +++ IHRD+ A N+L+G ++ +I DFGL++
Sbjct: 120 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---- 172
Query: 401 KCTHHAAIPIEGTFG-----YLAPEYFMHGIIDEKTDVFAFGVLLLEIIT 445
+ ++ T G ++A E + + +DV+++GVLL EI++
Sbjct: 173 ----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 44/223 (19%)
Query: 251 ENMVGQGGYSEVYKGNLS-DGRKI--AVKRLAK-----DNKDAKKEKEFLMELGIIGHVC 302
E+++G+G + +V + + DG K+ A+K L + D++D E E L +LG
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG-----H 61
Query: 303 HPNTATLVGCCIENG-LYLIFNFSQNGNL------------DAALHDER--SKSLEWPIR 347
HPN L+G C G LY+ ++ GNL D A E + +L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 348 YKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407
+ VA G+ YL +++ IHRD+ A NVL+G + +I DFGL++
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR--------GEE 170
Query: 408 IPIEGTFG-----YLAPEYFMHGIIDEKTDVFAFGVLLLEIIT 445
+ ++ T G ++A E + + K+DV++FGVLL EI++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 61/214 (28%), Positives = 110/214 (51%), Gaps = 27/214 (12%)
Query: 253 MVGQGGYSEVYKGN-LSDGRKIAVK---RLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
++G G + VYKG + DG + + ++ ++N K KE L E ++ V P
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 309 LVGCCIENGLYLIFNFSQNGNLDAALHDERSKS-----LEWPIRYKIVLGVARGLHYLHK 363
L+G C+ + + L+ G L + + + + L W ++ +A+G+ YL +
Sbjct: 74 LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP-NKCTHHA---AIPIEGTFGYLAP 419
R++HRD+ A NVL+ +ITDFGLA+ L ++ +HA +PI+ ++A
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----WMAL 180
Query: 420 EYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDS 452
E +H ++DV+++GV + E++T G KP D
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 60/193 (31%), Positives = 101/193 (52%), Gaps = 28/193 (14%)
Query: 273 IAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIFNFSQNGNL 330
+AVK L KD+ K + + E+ ++ + H N L+G C ++G LY+I ++ GNL
Sbjct: 50 VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 108
Query: 331 DAALHDERSKSLEW----------PIRYKIVLG----VARGLHYLHKGCKRRIIHRDIKA 376
L R +E+ + +K ++ VARG+ YL ++ IHRD+ A
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAA 165
Query: 377 SNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTD 432
NVL+ + +I DFGLA+ + N K T + +P++ ++APE + ++D
Sbjct: 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK----WMAPEALFDRVYTHQSD 221
Query: 433 VFAFGVLLLEIIT 445
V++FGVL+ EI T
Sbjct: 222 VWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 64/224 (28%), Positives = 119/224 (53%), Gaps = 27/224 (12%)
Query: 251 ENMVGQGGYSEVYKGNLS-DGRK---IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
E ++G G + EV +G L G++ +A+K L K K+ ++FL E I+G HPN
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 307 ATLVGCCIENGLYLIFN-FSQNGNLDAALHDERSKSLEWPI--RYKIVLGVARGLHYLHK 363
L G ++ +I F +NG LD+ L R ++ + ++ G+A G+ YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYL-- 122
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC---THHAA----IPIEGTFGY 416
+ +HRD+ A N+L+ + +++DFGL+++L + T+ ++ IPI T
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT--- 178
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPV-DSSRQNLV 458
APE + +DV+++G+++ E+++ G +P D S Q+++
Sbjct: 179 -APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
E +G G + EV+ + K+AVK + + + FL E ++ + H L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKLH 67
Query: 311 GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
+ +Y+I F G+L L + P +A G+ ++ + R I
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYI 124
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNK---CTHHAAIPIEGTFGYLAPEYFMHGII 427
HRD++A+N+L+ +I DFGLA+ + + A PI+ T APE G
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFGSF 180
Query: 428 DEKTDVFAFGVLLLEIIT-GRKP 449
K+DV++FG+LL+EI+T GR P
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 69/267 (25%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCH 303
N + +VG+G Y V K N + G +A+K+ K+++D + K+ + E+ ++ + H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRH 59
Query: 304 PNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
N L G LYL+F + + L+ L + L + + + + Y H
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK----CTHHAAIPIEGTFGYLA 418
IIHRDIK N+L+ ++ DFG A+ L + T + A T Y A
Sbjct: 118 S---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-----TRWYRA 169
Query: 419 PE----YFMHGIIDEKTDVFAFGVLLLEIITGRK--PVDSSRQNLVLWAK---PLMESGN 469
PE +G + DV+A G ++ E++ G P DS L L K PL S
Sbjct: 170 PELLVGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226
Query: 470 LTELVDPSLEGEYDTDQMHRLVLIADY 496
+P G + L Y
Sbjct: 227 ELFSSNPRFAGVAFPEPSQPESLERRY 253
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 64/203 (31%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 254 VGQGGYSEVYKGNLSD-GRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLV- 310
+G+GG+ EV + G+ A K+L K K K E+ L E I+ V +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 311 GCCIENGLYLIFNFSQNGNLDAAL--HDERSKSLEWPIRY--KIVLGVARGLHYLHKGCK 366
++ L L+ G+L + E I Y +I+ G L +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ--- 113
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI 426
RRI++RD+K NVLL +I+D GLA L GT GY+APE +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEV 170
Query: 427 IDEKTDVFAFGVLLLEIITGRKP 449
D D FA G L E+I GR P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKE-------FLMELGIIGHVCHP 304
++G G + VY G N S G +AVK++ + A + E+ ++ + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 305 NTATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
N +G + + L + + G++ A L + E + V + +GL+YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP----NKCTHHAAIPIEGTFGYLAP 419
R IIHRDIK +N+L+ +I+DFG++K L + T+ A ++G+ ++AP
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 420 EYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
E K D+++ G L++E++TG+ P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 255 GQGGYSEVYK-GNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGI-IGHVCHPNTATLVGC 312
G+G Y V K ++ G +AVKR+ + +++++K LM+L I + V P T T G
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 313 CIENGLYLIFNFSQNGNLDAALHD--ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
G I + +LD ++ ++ I KI + + + L YLH K +I
Sbjct: 69 LFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVI 126
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF-----MHG 425
HRD+K SNVL+ + + ++ DFG++ +L + A G Y+APE G
Sbjct: 127 HRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKG 183
Query: 426 IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL-EGEYDT 484
D K+DV++ G+ ++E+ TGR P DS W P + + E P L ++
Sbjct: 184 -YDVKSDVWSLGITMIELATGRFPYDS-------WKTPFQQLKQVVEEPSPQLPAEKFSP 235
Query: 485 DQMHRLVLIADY---CVRQTSAWRPSMSEVLE 513
+ D+ C+++ RP+ E+L+
Sbjct: 236 E-------FQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G G + +VYK + G A K + + ++ ++F++E+ I+ HPN L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKII--QIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 314 I-ENGLYLIFNFSQNGNLDAALHDERSKSLEWP-IRYKIVLGVARGLHYLHKGCKRRIIH 371
EN L+++ F G LD+ + E + L P IRY + + L++LH ++IH
Sbjct: 72 FYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHS---HKVIH 126
Query: 372 RDIKASNVLLGPDFEPQITDFGL-AKWLPNKCTHHAAIPIEGTFGYLAPEY-----FMHG 425
RD+KA N+LL D + ++ DFG+ AK I GT ++APE F
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFKDN 183
Query: 426 IIDEKTDVFAFGVLLLEIITGRKP 449
D K D+++ G+ L+E+ P
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 62/226 (27%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRL-------AKD--NKDAKKEKEFLMELGIIGHVCH 303
+G+G Y+ VYK + GR +A+K++ AKD N A +E + L EL H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61
Query: 304 PNTATLVGC-CIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVA------- 355
PN L+ ++ + L+F F + +L+ + D+ IVL A
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDK-----------SIVLTPADIKSYML 109
Query: 356 ---RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN---KCTHHAAIP 409
RGL YLH I+HRD+K +N+L+ D ++ DFGLA+ + K TH
Sbjct: 110 MTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-- 164
Query: 410 IEGTFGYLAPEYFM------HGIIDEKTDVFAFGVLLLEIITGRKP 449
T Y APE G+ D+++ G + E++ R P
Sbjct: 165 ---TRWYRAPELLFGARHYGVGV-----DMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 25/208 (12%)
Query: 252 NMVGQGGYSEVYKGNL--SDGRKI--AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
++G+G + VY G L SDG+KI AVK L + D ++ ++FL E I+ HPN
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 308 TLVGCCIEN-GLYLI-FNFSQNGNLDAALHDERSKSLEWPIRYKIVLG--VARGLHYLHK 363
+L+G C+ + G L+ + ++G+L + RS++ ++ I G VA+G+ YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPTVKDLIGFGLQVAKGMEYL-- 114
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK------CTHHAAIPIEGTFGYL 417
++ +HRD+ A N +L F ++ DFGLA+ + +K A +P++ ++
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WM 169
Query: 418 APEYFMHGIIDEKTDVFAFGVLLLEIIT 445
A E K+DV++FGVLL E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 77/293 (26%), Positives = 142/293 (48%), Gaps = 56/293 (19%)
Query: 254 VGQGGYSEVYKGNLSD--GR----KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
+G+G + +V K GR +AVK L K+N + + ++ L E ++ V HP+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKML-KENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 308 TLVGCCIENG-LYLIFNFSQNGNLDAALHDER--------------SKSL----EWPIRY 348
L G C ++G L LI +++ G+L + L + R S L E +
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 349 KIVLGVA----RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404
++ A RG+ YL + +++HRD+ A NVL+ + +I+DFGL++ + + ++
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 405 ----HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDS-SRQNLV 458
IP++ ++A E I ++DV++FGVLL EI+T G P + +
Sbjct: 184 VKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-- 237
Query: 459 LWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEV 511
L+ L+++G E E +++M+ L+L C +Q RP+ +++
Sbjct: 238 LFN--LLKTGYRME------RPENCSEEMYNLML---TCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 72/262 (27%), Positives = 123/262 (46%), Gaps = 41/262 (15%)
Query: 273 IAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIFNFSQNGNL 330
+AVK L D D K + + E+ ++ + H N L+G C ++G LY++ ++ GNL
Sbjct: 47 VAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 331 DAALHDERSKSLEWP----------IRYKIVLG----VARGLHYLHKGCKRRIIHRDIKA 376
L R +++ + +K ++ VARG+ YL ++ IHRD+ A
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAA 162
Query: 377 SNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTD 432
NVL+ D +I DFGLA+ + N K T + +P++ ++APE + ++D
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK----WMAPEALFDRVYTHQSD 218
Query: 433 VFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLV 491
V++FGVLL EI T G P P + L +L+ + + H L
Sbjct: 219 VWSFGVLLWEIFTLGGSPY------------PGIPVEELFKLLKEGHRMDKPANCTHELY 266
Query: 492 LIADYCVRQTSAWRPSMSEVLE 513
+I C + RP+ +++E
Sbjct: 267 MIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 6e-17
Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 40/218 (18%)
Query: 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD------AKKEKEFLMELGIIGH 300
+ +G+G Y VYK + G +A+K++ DN++ A +E L EL
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK---- 56
Query: 301 VCHPNTATL--VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGL 358
HPN L V E LYL+F + +L L I+ I+ + RGL
Sbjct: 57 --HPNIVKLLDV-IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS-IMYQLLRGL 111
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNKC-THHAAIPIEGTFG 415
Y H RI+HRD+K N+L+ D ++ DFGLA+ +P + TH T
Sbjct: 112 AYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TLW 163
Query: 416 YLAPEYFMH------GIIDEKTDVFAFGVLLLEIITGR 447
Y APE + + D+++ G + E+ITG+
Sbjct: 164 YRAPEILLGSKHYSTAV-----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVKR--LAKDNKDAKKE-KEFLMELGIIGHVCHPNTAT 308
++G G + VY+G NL DG AVK LA D + ++ K+ E+ ++ + HPN
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 309 LVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR 367
+G E LY+ G+L L ++ S P+ + GL YLH R
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYLHD---R 121
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-GI 426
+HRDIK +N+L+ + ++ DFG+AK + A +G+ ++APE G
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 427 IDEKTDVFAFGVLLLEIITGRKP 449
D+++ G +LE+ TG+ P
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 15/195 (7%)
Query: 254 VGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G + EV+ G L +D +AVK ++ + +FL E I+ HPN L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKS-CRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 313 CIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
C + +Y++ Q G+ L E + L+ ++V A G+ YL IH
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CIH 117
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA----IPIEGTFGYLAPEYFMHGII 427
RD+ A N L+ +I+DFG+++ + IP++ T APE +G
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT----APEALNYGRY 173
Query: 428 DEKTDVFAFGVLLLE 442
++DV++FG+LL E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 28/265 (10%)
Query: 254 VGQGGYSEVY-KGNLSDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVG 311
+G G + VY N +AVK+++ K +K ++ + E+ + + HPNT G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 312 CCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
C + E+ +L+ + D L + K L+ I G +GL YLH I
Sbjct: 89 CYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---I 143
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM---HGII 427
HRDIKA N+LL + ++ DFG A A GT ++APE + G
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 428 DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487
D K DV++ G+ +E+ + P+ + L+ +S P+L+ TD
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--------PTLQSNEWTDSF 249
Query: 488 HRLVLIADYCVRQTSAWRPSMSEVL 512
V DYC+++ RP+ +E+L
Sbjct: 250 RGFV---DYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 19/231 (8%)
Query: 284 DAKKE--KEFLMELGIIGHVCH-PNTATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERS 339
AK K+ L EL I+ H C P + G + EN + + F G+LD
Sbjct: 41 GAKSSVRKQILRELQIM-HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP 99
Query: 340 KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399
+E I KI + V GL YL+ RI+HRDIK SN+L+ + ++ DFG++ L
Sbjct: 100 IPVE--ILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155
Query: 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL 459
N A GT Y++PE G K+DV++ G+ ++E+ G+ P S +
Sbjct: 156 NS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
Query: 460 WAKPLMESGNLTELVD---PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS 507
P+ L ++V P L + + V D C+ + RP+
Sbjct: 212 QDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFV---DACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 8e-17
Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 254 VGQGGYSEV-YKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
VG+G Y EV + +DG++ +K+L N ++ K E ++ + HPN
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 313 CI-ENG-LYLIFNFSQNGNLDAALHDERSKSL------EWPIRYKIVLGVARGLHYLHKG 364
E+G LY++ F + G+L L +++ K L EW ++ +A L YLH+
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYLHE- 120
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
+ I+HRD+K NV L ++ D G+A+ L N+C A + GT Y++PE F +
Sbjct: 121 --KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSN 176
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW 460
+ K+DV+A G + E+ T + ++ N +++
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-17
Identities = 64/278 (23%), Positives = 123/278 (44%), Gaps = 32/278 (11%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRL--AKDNKDAKKEKEFL-MELGIIGHV 301
N+ ++GQG + VY ++ GR++AVK++ D+ + KKE L E+ ++ ++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 302 CHPNTATLVGCCIENG-LYLIFNFSQNGNL--DAALHDERSKSLEWPIRYKIVLGVARGL 358
H GC ++ L + + G++ + ++++ +I+ G+
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGV 117
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI-PIEGTFGYL 417
YLH I+HRDIK +N+L ++ DFG +K L C+ + + GT ++
Sbjct: 118 EYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 418 APEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA--KPLMESGNL-TELV 474
+PE K DV++ G ++E++T + P WA + + + T+
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPP----------WAEFEAMAAIFKIATQPT 224
Query: 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVL 512
+P L D + L + + RPS E+L
Sbjct: 225 NPQLPSHVSPDARNFLRR----TFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G G + EV+ G ++ K+AVK L + FL E ++ + H L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 70
Query: 314 I-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
E +Y+I + G+L L + + P +A G+ Y+ + + IHR
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPNK---CTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
D++A+NVL+ +I DFGLA+ + + A PI+ T APE G
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFGSFTI 183
Query: 430 KTDVFAFGVLLLEIIT-GRKP 449
K+DV++FG+LL EI+T G+ P
Sbjct: 184 KSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 247 NFHSENMVGQGGYSEVY----KGNLSDGRK--IAVKRLAKDNKDAKKEKEFLMELGIIGH 300
N +G+G + EV+ KG +G + + VK L K KD + EF EL +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-TKDENLQSEFRRELDMFRK 64
Query: 301 VCHPNTATLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKS-------LEWPIRYKIVL 352
+ H N L+G C E Y+I ++ G+L L +SK L + +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH---AAIP 409
+A G+ +L R +HRD+ A N L+ E +++ L+K + N + A IP
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT 445
+ +LAPE K+DV++FGVL+ E+ T
Sbjct: 182 LR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 28/268 (10%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G G + V+ G K+A+K + N+ A E++F+ E ++ + HP L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 314 IENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
+ LY++ F +NG L L + K L + + V G+ YL + IHR
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPNK---CTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
D+ A N L+ +++DFG+ +++ + + A P++ + PE F
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK----WSPPEVFNFSKYSS 180
Query: 430 KTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMH 488
K+DV++FGVL+ E+ T G+ P + V+ + G L P L + M+
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM---ISRGF--RLYRPKLASMTVYEVMY 235
Query: 489 RLVLIADYCVRQTSAWRPSMSEVLELLT 516
C + RP+ +E+L +T
Sbjct: 236 S-------CWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 253 MVGQGGYSEVYKGN-LSDGRKIAVK---RLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
++G G + VYKG + +G + + ++ + K EF+ E I+ + HP+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 309 LVGCCIENGLYLIFNFSQNGNLDAALHDERSKS-----LEWPIRYKIVLGVARGLHYLHK 363
L+G C+ + L+ +G L +H+ + L W ++ +A+G+ YL +
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
RR++HRD+ A NVL+ +ITDFGLA+ L + A + ++A E
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 424 HGIIDEKTDVFAFGVLLLEIIT-GRKPVD 451
+ ++DV+++GV + E++T G KP D
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 62/210 (29%), Positives = 89/210 (42%), Gaps = 33/210 (15%)
Query: 254 VGQGGYSEVYK-GNLSDGRKIAVKRLAKDN-------KDAKKEKEFLMELGIIGHVCHPN 305
+G GG+ V S R A+K + K + + EKE L E HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE------CNHPF 54
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
L + +Y++ + G L L D R E+ R+ + V YLH
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARF-YIACVVLAFEYLHN- 111
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
R II+RD+K N+LL + ++ DFG AK L + GT Y+APE
Sbjct: 112 --RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPE---- 162
Query: 425 GIIDEK-----TDVFAFGVLLLEIITGRKP 449
II K D ++ G+LL E++TGR P
Sbjct: 163 -IILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 46/278 (16%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-----KDAKKEKEFLMELGIIGHVCHPNT 306
++G+G Y VY+G ++ GR +A+K + D D ++E L +L PN
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLR---QSQPPNI 64
Query: 307 ATLVGCCIEN-GLYLIFNFSQNGN----LDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
G ++ L++I +++ G+ + A E+ S+ I+ V L Y+
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYI 117
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
HK +IHRDIKA+N+L+ ++ DFG+A L GT ++APE
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMAPEV 172
Query: 422 FMHGII-DEKTDVFAFGVLLLEIITGRKP---VDSSRQ-NLVLWAKPLMESGNLTELVDP 476
G D K D+++ G+ + E+ TG P VD+ R L+ +KP P
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP------------P 220
Query: 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514
LE + + V C+ + R S E+L+
Sbjct: 221 RLEDNGYSKLLREFVA---ACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 68/271 (25%), Positives = 127/271 (46%), Gaps = 37/271 (13%)
Query: 254 VGQGGYSE-VYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G + + + + DG++ +K + K+ +E E+ ++ ++ HPN
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 313 CIENG-LYLIFNFSQNGNLDAALHDERS------KSLEWPIRYKIVLGVARGLHYLHKGC 365
ENG LY++ ++ + G+L ++ +R + L+W ++ + L ++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKHVHD-- 119
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
R+I+HRDIK+ N+ L D ++ DFG+A+ L + T A GT YL+PE +
Sbjct: 120 -RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--TVELARTCIGTPYYLSPEICENR 176
Query: 426 IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485
+ K+D++A G +L E+ T K E+GN+ LV + G Y
Sbjct: 177 PYNNKSDIWALGCVLYEMCT---------------LKHAFEAGNMKNLVLKIIRGSYPPV 221
Query: 486 QMH---RLVLIADYCVRQTSAWRPSMSEVLE 513
H L + ++ RPS++ +LE
Sbjct: 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 247 NFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKE-KEFLMELGIIGHVCHP 304
+F ++G+G + +V D +K+ A+K + K K + L E I+ + HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 305 NTATLVGCC-----IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLH 359
LV EN +YL+ + G+L L ++ K E +++ I + L
Sbjct: 61 ---FLVNLWYSFQDEEN-MYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWIC-EIVLALE 114
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA-KWLPNKCTHHAAIPIEGTFGYLA 418
YLH + IIHRDIK N+LL ITDF +A K P+ T + GT GY+A
Sbjct: 115 YLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS----GTPGYMA 167
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
PE D ++ GV E + G++P
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 40/236 (16%)
Query: 246 NNFHSENMVGQGGYSEVYKGN---LSDGRK---IAVKRLAKDNKDAKKEKEFLMELGIIG 299
NN +GQG + V++ L +AVK L K+ A + +F E ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMA 63
Query: 300 HVCHPNTATLVGCCIENG-LYLIFNFSQNGNLD--------------------AALHDER 338
HPN L+G C + L+F + G+L+ A
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 339 SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398
L + I VA G+ YL +R+ +HRD+ N L+G + +I DFGL++ +
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 399 PN----KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+ K + + AIPI ++ PE + ++DV+A+GV+L EI + G +P
Sbjct: 181 YSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 30/272 (11%)
Query: 254 VGQGGYSEVYK-------GNLSDGRKIAVKRLA--KDNKDAKKE-KEFLMELGIIG-HVC 302
+G G + VYK NL ++I V A KD ++ K + + E+ II +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 303 HPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIR--YKIVLGVARGLH 359
HPN +EN LY++ + + L + + K + + I + + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAP 419
YLHK ++RI+HRD+ +N++LG D + ITDFGLAK K + GT Y P
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182
Query: 420 EYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479
E + EK DV+AFG +L ++ T + P S+ N++ A ++E+ + +P E
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST--NMLSLATKIVEA-----VYEPLPE 235
Query: 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEV 511
G Y D + + C+ + RP + +V
Sbjct: 236 GMYSED----VTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 75/280 (26%), Positives = 140/280 (50%), Gaps = 40/280 (14%)
Query: 251 ENMVGQGGYSEVYKGNLS-DGRK---IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
E ++G G + EV G L G++ +A+K L K K+ ++FL E I+G HPN
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 307 ATLVGCCIENG-LYLIFNFSQNGNLDAAL--HDERSKSLEWPIRYKIVLGVARGLHYLHK 363
L G ++ + ++ + +NG+LDA L HD + ++ ++ G+A G+ YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYL-- 122
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK-----CTHHAAIPIEGTFGYLA 418
+HRD+ A N+L+ + +++DFGL++ L + T IPI T A
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT----A 177
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPV-DSSRQNLVLWAKPLMESGNLTELVD- 475
PE + +DV+++G+++ E+++ G +P + S Q+++ K + E L +D
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---KAIEEGYRLPAPMDC 234
Query: 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
P+ +H+L+L C ++ RP +++ +L
Sbjct: 235 PA--------ALHQLML---DCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 57/224 (25%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 247 NFHSENMVGQGGYSEVY--KGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
+ +G+G + ++Y K SD +K + K+++ E+ ++ + HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 305 NTATLVGCCIENG-LYLIFNFSQNGNLDAALHDER------SKSLEWPIRYKIVLGVARG 357
N T ENG L+++ + G+L ++ +R + L W ++ ++ G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLG 113
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416
L ++H R+I+HRDIK+ N+ L + ++ DFG+A+ L + + A GT Y
Sbjct: 114 LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPYY 168
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDS-SRQNLVL 459
L+PE + + KTD+++ G +L E+ T + P + + LVL
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVK------RLAKDNKDAKKE--KEFLMELGIIGHVCH 303
++G+G Y VY N++ G +AVK +A + +K+ K E+ + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 304 PNTATLVGCCIENGLYLIF-NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
N +G IF + G++ + L E + V GL YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE-- 420
+ I+HRD+KA N+L+ D +I+DFG++K + + + ++G+ ++APE
Sbjct: 126 S---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 421 YFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
+ K D+++ G ++LE+ GR+P
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 254 VGQGGYSEVYKGNLSD------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
+GQG + VY+G ++A+K + +N ++ EFL E ++ +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-NENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 308 TLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIR--------YKIVLGVARGL 358
L+G ++ G+L + L R ++ P ++ +A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTF 414
YL ++ +HRD+ A N ++ D +I DFG+ + + + +P+
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT 445
++APE G+ K+DV++FGV+L E+ T
Sbjct: 187 -WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 44/222 (19%)
Query: 252 NMVGQGGYSEVYKGNLS-DGRKI--AVKRLAK-----DNKDAKKEKEFLMELGIIGHVCH 303
+++G+G + +V K + DG ++ A+KR+ + D++D E E L +LG H H
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG---H--H 55
Query: 304 PNTATLVGCCIENG-LYLIFNFSQNGNL------------DAALHDERSKSLEWPIR--Y 348
PN L+G C G LYL ++ +GNL D A S + +
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 349 KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408
VARG+ YL + ++ IHRD+ A N+L+G ++ +I DFGL++ +
Sbjct: 116 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEV 164
Query: 409 PIEGTFG-----YLAPEYFMHGIIDEKTDVFAFGVLLLEIIT 445
++ T G ++A E + + +DV+++GVLL EI++
Sbjct: 165 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 8e-16
Identities = 65/270 (24%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 254 VGQGGYSE--VYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
+G+G + E +Y+ D + K + K+ ++ L E+ I+ + HPN
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 312 CCIENGLYLI-FNFSQNGNL-------DAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
+++ LI ++ G L L +E + W + ++IV V+ Y+HK
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM--VLWYL-FQIVSAVS----YIHK 119
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
I+HRDIK N+ L ++ DFG++K L ++ + A + GT Y++PE
Sbjct: 120 A---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AETVVGTPYYMSPELCQ 174
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483
+ K+D++A G +L E++T ++ D++ ++ + GN T +V
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK---IVQGNYTPVVSVY------ 225
Query: 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+ ++ LV ++Q RP+ EVL+
Sbjct: 226 SSELISLV---HSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G+G + +V G+ G K+AVK + D + FL E ++ + H N L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 314 IEN--GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
+E GLY++ + G+L L L K L V + YL +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKT 431
RD+ A NVL+ D +++DFGL K + +P++ T APE K+
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKWT----APEALREKKFSTKS 180
Query: 432 DVFAFGVLLLEIIT-GRKP 449
DV++FG+LL EI + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 66/269 (24%), Positives = 123/269 (45%), Gaps = 22/269 (8%)
Query: 254 VGQGGYSEVYK-GNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G + V K SDG+ + K + N K++++ + E+ I+ + HPN
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 313 CIENG---LYLIFNFSQNGNLDAALHDERS--KSLEWPIRYKIVLGVARGLHYLHKGC-- 365
I+ LY++ + + G+L + + K +E ++I+ + L+ H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
++HRD+K +N+ L + ++ DFGLAK L + A GT Y++PE H
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYMSPEQLNHM 185
Query: 426 IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485
DEK+D+++ G L+ E+ P ++R L L +K ++ G + Y ++
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASK--IKEGKF-----RRIPYRYSSE 237
Query: 486 QMHRLVLIADYCVRQTSAWRPSMSEVLEL 514
L + + RPS E+L+L
Sbjct: 238 ----LNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 30/271 (11%)
Query: 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPN 305
F +G+G + EVYK + + +A+K + D ++A+ E E + E+ + P
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 306 TATLVGCCIEN-GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
G ++ L++I + G + L + L+ I+ V GL YLH+
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGG---SCLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
K IHRDIKA+N+LL + + ++ DFG++ L + T GT ++APE
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVSGQLTS--TMSKRNTFVGTPFWMAPEVIKQ 172
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKP---VDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481
DEK D+++ G+ +E+ G P + R VL+ P PSLEG
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLFLIPKNNP--------PSLEGN 221
Query: 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVL 512
+ V C+ + RPS E+L
Sbjct: 222 KFSKPFKDFV---SLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 71/268 (26%), Positives = 121/268 (45%), Gaps = 23/268 (8%)
Query: 248 FHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNT 306
F +G+G + EVYKG + +++ ++ D ++A+ E E + E+ ++ P
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 307 ATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
G ++ L++I + G +AL + LE I+ + +GL YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGG---SALDLLKPGPLEETYIATILREILKGLDYLHS-- 119
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
R IHRDIKA+NVLL + ++ DFG+A L + T GT ++APE
Sbjct: 120 -ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 426 IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485
D K D+++ G+ +E+ G P VL+ P P+LEG+Y
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP--------PTLEGQYSKP 228
Query: 486 QMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+ C+ + +RP+ E+L+
Sbjct: 229 ----FKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 71/262 (27%), Positives = 121/262 (46%), Gaps = 23/262 (8%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTATLVGC 312
+G+G + EV+KG + +K+ ++ D ++A+ E E + E+ ++ P G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 313 CIEN-GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
+++ L++I + G +AL L+ I+ + +GL YLH K IH
Sbjct: 71 YLKDTKLWIIMEYLGGG---SALDLLEPGPLDETQIATILREILKGLDYLHSEKK---IH 124
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKT 431
RDIKA+NVLL E ++ DFG+A L + T GT ++APE D K
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 432 DVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLV 491
D+++ G+ +E+ G P VL+ P P+LEG Y L
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP--------PTLEGNYSKP----LK 230
Query: 492 LIADYCVRQTSAWRPSMSEVLE 513
+ C+ + ++RP+ E+L+
Sbjct: 231 EFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 254 VGQGGYSEV----YKGNLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTAT 308
+G G + V +KG+ G+ A+K L+K K+ E ++ E I+ + HP
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 309 LVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVARGLHYLHKGC 365
L G ++ LYL+ + G L + L Y ++VL L YLH
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEYLHS-- 119
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC-THHAAIPIEGTFGYLAPEYFMH 424
I++RD+K N+LL D +ITDFG AK + + T + GT YLAPE +
Sbjct: 120 -LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT------LCGTPEYLAPEIILS 172
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKP-VDSSRQNL 457
+ D +A G+L+ E++ G P D + +
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 21/224 (9%)
Query: 254 VGQGGYSEVYKG---NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
+G G + V KG + +AVK L DN D + E L E ++ + +P ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 311 GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
G C L+ ++ G L+ L + + + ++V V+ G+ YL + +
Sbjct: 63 GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT--ELVHQVSMGMKYLEE---TNFV 117
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEYFMHG 425
HRD+ A NVLL +I+DFGL+K L K H P++ + APE +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYAPECMNYY 173
Query: 426 IIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESG 468
K+DV++FGVL+ E + G+KP + N V ++ESG
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT---QMIESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G G + +VYK N G A K + + K ++ +++++E+ I+ HP L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 313 CI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
+ L+++ F G +DA + E + L P I + L YLH +IIH
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIML-ELDRGLTEPQIQVICRQMLEALQYLHS---MKIIH 133
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII---- 427
RD+KA NVLL D + ++ DFG++ N T GT ++APE M +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 428 -DEKTDVFAFGVLLLEI 443
D K D+++ G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G Y VYK + G +A+K++ + K L E+ ++ + HPN L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 313 CIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
G LYL+F F +L + D + E I+ + + +GL + H I+H
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKS-YLYQLLQGLAFCHS---HGILH 121
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWL---PNKCTHHAAIPIEGTFGYLAPE-YFMHGII 427
RD+K N+L+ + ++ DFGLA+ TH+ T Y APE
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-----TRWYRAPELLLGDKGY 176
Query: 428 DEKTDVFAFGVLLLEIITGR 447
D+++ G + E+++ R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G G + +VYK + +A ++ D K ++ +++++E+ I+ HPN L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVI-DTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 314 I-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
EN L+++ F G +DA + E + L P + L+YLH+ +IIHR
Sbjct: 72 YYENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI-----I 427
D+KA N+L D + ++ DFG++ N T GT ++APE M
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 428 DEKTDVFAFGVLLLEIITGRKP 449
D K DV++ G+ L+E+ P
Sbjct: 186 DYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 29/211 (13%)
Query: 250 SENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
+ + VG G Y +V + GRK+A+K+L++ + A K EL ++ H+ H N
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIG 78
Query: 309 LVGC-----CIEN--GLYLIFNFSQNGNLDAALHD-ERSKSL-EWPIRYKIVLGVARGLH 359
L+ +E+ +YL+ + + A L++ + + L + I++ +V + RGL
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHL-----MGADLNNIVKCQKLSDDHIQF-LVYQILRGLK 132
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAP 419
Y+H IIHRD+K SN+ + D E +I DFGLA+ ++ T + A T Y AP
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAP 184
Query: 420 E---YFMHGIIDEKTDVFAFGVLLLEIITGR 447
E +MH ++ D+++ G ++ E++TG+
Sbjct: 185 EIMLNWMH--YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 84/300 (28%), Positives = 130/300 (43%), Gaps = 54/300 (18%)
Query: 184 QSPPQAP---KTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEE 240
Q PP P + + +R R P L+ PL +R+ SL+ P + S
Sbjct: 5 QPPPGVPLPSTARHTTKSRPRRRPD------LTLPLPQRDPSLAVPLPLPPPSSSSSSSS 58
Query: 241 ISSATNNFHSE----------NMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEK 289
SSA+ + S N +G G VYK + GR A+K + +++D + +
Sbjct: 59 SSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR-R 117
Query: 290 EFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAA-LHDERSKSLEWPIR 347
+ E+ I+ V HPN NG + ++ F G+L+ + DE+ +
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA------ 171
Query: 348 YKIVLGVAR----GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP---N 400
VAR G+ YLH+ R I+HRDIK SN+L+ +I DFG+++ L +
Sbjct: 172 -----DVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223
Query: 401 KCTHHAAIPIEGTFGYLAPEY----FMHGIIDEKT-DVFAFGVLLLEIITGRKPVDSSRQ 455
C GT Y++PE HG D D+++ GV +LE GR P RQ
Sbjct: 224 PCNSSV-----GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ 278
|
Length = 353 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 1e-14
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
F +VG G Y +VYKG ++ G+ A+K + + ++ K+ + L H H N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNI 65
Query: 307 ATLVGCCI-------ENGLYLIFNFSQNGNLDAALHDERSKSL--EWPIRYKIVLGVARG 357
AT G I ++ L+L+ F G++ + + + +L EW I Y I + RG
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-IAY-ICREILRG 123
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYL 417
L +LH+ ++IHRDIK NVLL + E ++ DFG++ L GT ++
Sbjct: 124 LSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWM 178
Query: 418 APEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPV 450
APE D K+D+++ G+ +E+ G P+
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-----ELGIIGHVCHPNT 306
+G G +S Y+ ++ G +AVK++ ++ E+E ++ E+ ++ + HP+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQV-TYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 307 ATLVGCCIENGLYLIF-NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
++G E+ + +F + G++ L + I Y + RGL YLH+
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY--TEQLLRGLSYLHE-- 121
Query: 366 KRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHAAIP--IEGTFGYLAPE 420
+IIHRD+K +N+L+ G +I DFG A L K T + GT ++APE
Sbjct: 122 -NQIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 421 YFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
DV++ G +++E+ T + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 64/253 (25%), Positives = 107/253 (42%), Gaps = 56/253 (22%)
Query: 253 MVGQGGYSEVYK-GNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
+VG+G Y V K + G+ +A+K+ + D +K + E+ ++ + H N L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 312 CCIENG-LYLIFNFSQNGNLDAALHDERSK---SLEWPIRYKIVLGVARGLHYLHKGCKR 367
LYL+F F +D + D+ K L+ K + + RG+ + H
Sbjct: 68 VFRRKKRLYLVFEF-----VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---H 119
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKWL--PNK-CTHHAAIPIEGTFGYLAPEYFMH 424
IIHRDIK N+L+ ++ DFG A+ L P + T + A T Y APE +
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-----TRWYRAPELLVG 174
Query: 425 GIIDEK----TDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480
D K D++A G L+ E++TG +P G
Sbjct: 175 ---DTKYGRAVDIWAVGCLVTEMLTG----------------------------EPLFPG 203
Query: 481 EYDTDQMHRLVLI 493
+ D DQ++ ++
Sbjct: 204 DSDIDQLYHIIKC 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 253 MVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
M+G+G + V + L +K+AVK L D + +EFL E + HPN
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 309 LVGCCIENGL-------YLIFNFSQNGNLDAALHDER----SKSLEWPIRYKIVLGVARG 357
L+G + + +I F ++G+L L R +L + ++ +A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYL 417
+ YL + IHRD+ A N +L + + DFGL+K + + + + +L
Sbjct: 126 MEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 418 APEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
A E + +DV+AFGV + EI+T G+ P
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 34/222 (15%)
Query: 254 VGQGGYSEVYKGNL-----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
+G+ + ++YKG+L + +A+K L KD + ++ EF E ++ + HPN
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 309 LVGCCI-ENGLYLIFNFSQNGNLDAAL------------HDER---SKSLEWPIRYKIVL 352
L+G E + ++F + G+L L DE SL+ I +
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAI 408
+A G+ YL +H+D+ A N+L+G +I+D GL++ + + + + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
PI ++ PE M+G +D+++FGV+L EI + G +P
Sbjct: 189 PIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 71/273 (26%), Positives = 119/273 (43%), Gaps = 40/273 (14%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVG 311
+G G + VY ++ +A+K+++ K + +K ++ + E+ + + HPNT G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 312 CCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
C + E+ +L+ + D + + K L+ I G +GL YLH + I
Sbjct: 83 CYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---I 137
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM---HGII 427
HRDIKA N+LL ++ DFG A + A GT ++APE + G
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLV------SPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 428 DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV------DPSLEGE 481
D K DV++ G+ +E + RKP PL ++ L P+L
Sbjct: 192 DGKVDVWSLGITCIE-LAERKP-------------PLFNMNAMSALYHIAQNDSPTLSSN 237
Query: 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514
+D V D C+++ RPS E+L+
Sbjct: 238 DWSDYFRNFV---DSCLQKIPQDRPSSEELLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 70/291 (24%), Positives = 119/291 (40%), Gaps = 43/291 (14%)
Query: 254 VGQGGYSEVY-----KGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
+G+G + +V N G +AVK L ++ + + E+ I+ + H N
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVK 70
Query: 309 LVGCCIENG---LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG--------VARG 357
GCC E G L LI + G+L ++ ++K+ L + G
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSL-----------RDYLPKHKLNLAQLLLFAQQICEG 119
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEG 412
+ YLH + IHRD+ A NVLL D +I DFGLAK +P + P+
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-- 174
Query: 413 TFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN---LVLWAKPLMESGN 469
F Y A E +DV++FGV L E++T S + ++ + M
Sbjct: 175 -FWY-AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232
Query: 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520
L EL++ + + + ++ C + +RP+ ++ +L H
Sbjct: 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 72/271 (26%), Positives = 122/271 (45%), Gaps = 29/271 (10%)
Query: 248 FHSENMVGQGGYSEVYKGNLSDGRK---IAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCH 303
F +G+G + EV+KG D R +A+K + D ++A+ E E + E+ ++
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 61
Query: 304 PNTATLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
P G ++ L++I + G +AL R+ + ++ + +GL YLH
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGG---SALDLLRAGPFDEFQIATMLKEILKGLDYLH 118
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF 422
K IHRDIKA+NVLL + ++ DFG+A L + T GT ++APE
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVI 173
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482
D K D+++ G+ +E+ G P VL+ P P+L GE+
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP--------PTLTGEF 225
Query: 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
D C+ + ++RP+ E+L+
Sbjct: 226 SKPFKE----FIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 40/283 (14%)
Query: 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAK-DNKDAKKEKEFLMELGII--GHV 301
N+ + +G G +VYK G +AVK++ + NK+ K LM+L ++ H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKR--ILMDLDVVLKSHD 72
Query: 302 CHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWP----IRYKIVLGVARG 357
C P G I + I L + D+ K ++ P I K+ + + +
Sbjct: 73 C-PYIVKCYGYFITDSDVFICM-----ELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYL 417
LHYL + K +IHRD+K SN+LL ++ DFG++ L + + G Y+
Sbjct: 127 LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAYM 181
Query: 418 APEYF----MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473
APE + D + DV++ G+ L+E+ TG+ P + + E LT++
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK----------TEFEVLTKI 231
Query: 474 VD---PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+ PSL + D C+ + RP E+L+
Sbjct: 232 LQEEPPSLPPNEGFSPDFCSFV--DLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G G Y V + G+K+A+K++ K L EL I+ H H N +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 313 CIENG-----LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR 367
G +Y++ + ++ +L +H ++ + E IRY + + RGL Y+H
Sbjct: 73 LRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEH-IRY-FLYQLLRGLKYIHSAN-- 127
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIE--GTFGYLAPE--YFM 423
+IHRD+K SN+L+ D E +I DFG+A+ L + T H E T Y APE +
Sbjct: 128 -VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL 186
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPV 450
D+++ G + E++ GR+ +
Sbjct: 187 PE-YTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 61/236 (25%), Positives = 113/236 (47%), Gaps = 36/236 (15%)
Query: 240 EISSATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLM 293
EI+ +T F E +G+ + +VYKG+L + +A+K L KD + +EF
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKH 57
Query: 294 ELGIIGHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLDAAL------------HDERS- 339
E + + HPN L+G E L +IF++ + +L L D+++
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 340 -KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398
+LE IV +A G+ +L ++H+D+ NVL+ +I+D GL + +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 399 PN----KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
K ++ +PI +++PE M+G +D++++GV+L E+ + G +P
Sbjct: 175 YAADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 36/216 (16%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAK-------KEKEFLMELGIIGHVCHPN 305
+ +G Y V+ S G A+K + K + K E++ L P
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS------QAQSPY 54
Query: 306 TATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVARGLHYLH 362
L + LYL+ + G+L + L + S + Y +IVL L YLH
Sbjct: 55 VVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLA----LEYLH 110
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW-LPNKCTHHAAIP-----IEGTFGY 416
IIHRD+K N+L+ + ++TDFGL+K L + + I GT Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 417 LAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKP 449
+APE + H + D ++ G +L E + G P
Sbjct: 168 IAPEVILGQGHS---KTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 28/266 (10%)
Query: 254 VGQGGYSEVY-KGNLSDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVG 311
+G G + VY ++ +A+K+++ K + +K ++ + E+ + + HPN+ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 312 CCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
C + E+ +L+ + D L + K L+ I G +GL YLH +I
Sbjct: 93 CYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMI 147
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM---HGII 427
HRDIKA N+LL + ++ DFG A A GT ++APE + G
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIAS------PANSFVGTPYWMAPEVILAMDEGQY 201
Query: 428 DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487
D K DV++ G+ +E+ + P+ + L+ ES P+L+ +D
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--------PTLQSNEWSDYF 253
Query: 488 HRLVLIADYCVRQTSAWRPSMSEVLE 513
V D C+++ RP+ E+L+
Sbjct: 254 RNFV---DSCLQKIPQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 66/207 (31%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 254 VGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEF---LMELGIIGHVCHPNTATL 309
+G+GG+ EV + + G+ A K+L K K KK K + ++E I+ V H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNK--KRLKKRKGYEGAMVEKRILAKV-HSRFIVS 57
Query: 310 VGCCIEN--GLYLIFNFSQNGNLDAALH--DERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
+ + L L+ G+L ++ DE + P + GL +LH+
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-- 115
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL---PNKCTHHAAIPIEGTFGYLAPEYF 422
RRII+RD+K NVLL D +I+D GLA L +K +A GT G++APE
Sbjct: 116 -RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELL 169
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKP 449
D D FA GV L E+I R P
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 36/242 (14%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKK-------EKEFLMELGIIGHVCHPN 305
+ +G + VY S G A+K L K + AK E+ +M G P
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE-----SPY 58
Query: 306 TATLVGCCIENG--LYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVARGLHYL 361
A L ++ LYL+ + G+ + + +W +Y ++VLGV L
Sbjct: 59 VAKLY-YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGV----EDL 113
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAP 419
H+ R IIHRDIK N+L+ ++TDFGL++ K GT YLAP
Sbjct: 114 HQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK--------FVGTPDYLAP 162
Query: 420 EYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479
E + D+ +D ++ G ++ E + G P + + V + L N E V
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNILSRRINWPEEVKEFCS 221
Query: 480 GE 481
E
Sbjct: 222 PE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 47/219 (21%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAK---DNKDAKKEKEFLMELGIIGHVCHPNTATL 309
+G G Y V + GRK+A+K+++ D DAK+ L E+ ++ H+ H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR---ILREIKLLRHLRHEN---- 60
Query: 310 VGCCIE----------NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLH 359
+ ++ N +Y++ + +L + + + + I+Y + + RGL
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDH-IQY-FLYQILRGLK 117
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG---- 415
YLH +IHRD+K SN+L+ + + +I DFGLA+ T
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR----GVDPDEDEKGFLTEYVVTR 170
Query: 416 -YLAPEYFMHGII------DEKTDVFAFGVLLLEIITGR 447
Y APE ++ + D+++ G + E++T +
Sbjct: 171 WYRAPE-----LLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 62/222 (27%), Positives = 114/222 (51%), Gaps = 33/222 (14%)
Query: 253 MVGQG--GYSEVYKGNLSDGRKIAVK--RLAK---DNKDAKKEKEFLMELGIIGHVCHPN 305
+VG+G G + + + SD +K A+K RL K +D++KE L ++ HPN
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK------HPN 59
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSK------SLEWPIRYKIVLGVARGL 358
+G LY++ + G+L + +R K L+W + ++ LGV
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV--QMCLGV---- 113
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLA 418
++H+ +R++HRDIK+ N+ L + + ++ DFG A+ L + + A GT Y+
Sbjct: 114 QHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVP 168
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDS-SRQNLVL 459
PE + + + K+D+++ G +L E+ T + P + S +NL+L
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 37/283 (13%)
Query: 254 VGQGGYSEVYKGNLSDGRKIA---VKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
+G G + +V G G A VK L + + ++ FL E+ + HPN +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 311 GCCIENGLY-LIFNFSQNGNLDAALHDERSKSLEWP---IRYKIVLGVARGLHYLHKGCK 366
G CIE+ Y L+ F G+L L R + + ++ VA GL +LH+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-- 119
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLA------KWLPNKCTHHAAIPIEGTFGYLAPE 420
IH D+ N L D +I D+GLA + K H A+P+ +LAPE
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH--AVPLR----WLAPE 172
Query: 421 Y-------FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473
+ +K+++++ GV + E+ T + + + + E +L
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD--IKL 230
Query: 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516
P L+ +Y R + +C RP+ EV ELLT
Sbjct: 231 PKPQLDLKYS----DRWYEVMQFCWLDPET-RPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 254 VGQGGYSEVYKGNLSDGR---KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
+G+G + V +G L+ K+AVK + + ++FL E + HPN L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 311 GCCIEN-------GLYLIFNFSQNGNLDAALHDER----SKSLEWPIRYKIVLGVARGLH 359
G C++ +I F ++G+L + L R + L + K + +A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH----AAIPIEGTFG 415
YL + IHRD+ A N +L + + DFGL+K + N + A +P++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK---- 179
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
++A E + K+DV++FGV + EI T G+ P
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 21/186 (11%)
Query: 270 GRKIAVKRLAKDNK-----DAKKEKEFLMELGIIGHVCHPNTATLVGCCIE---NGLYLI 321
G ++AVK L ++ D KKE E L L H N G C E NG+ LI
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNL------YHENIVKYKGICTEDGGNGIKLI 86
Query: 322 FNFSQNGNLDAALHDERSK-SLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVL 380
F +G+L L ++K +L+ ++Y + + +G+ YL R+ +HRD+ A NVL
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYLGS---RQYVHRDLAARNVL 141
Query: 381 LGPDFEPQITDFGLAKWLP-NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVL 439
+ + + +I DFGL K + +K + ++ + APE + +DV++FGV
Sbjct: 142 VESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVT 201
Query: 440 LLEIIT 445
L E++T
Sbjct: 202 LYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
+G G + V G +A+K + + + E EF+ E ++ + H L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 314 I-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
+ +Y++ + NG L L E K + ++ V G+ YL ++ IHR
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124
Query: 373 DIKASNVLLGPDFEPQITDFGLAKW-LPNKCTHH--AAIPIEGTFGYLAPEYFMHGIIDE 429
D+ A N L+ +++DFGL+++ L ++ T + P+ + PE ++
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLLYSKFSS 180
Query: 430 KTDVFAFGVLLLEIIT-GRKPVD 451
K+DV+AFGVL+ E+ + G+ P +
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH-PN 305
F +VG G Y +VYKG ++ G+ A+K + + +E+E +E+ ++ H N
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEEIKLEINMLKKYSHHRN 74
Query: 306 TATLVGCCI-------ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGL 358
AT G I ++ L+L+ F G++ + + + +L+ I + RGL
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLA 418
+LH ++IHRDIK NVLL + E ++ DFG++ L GT ++A
Sbjct: 135 AHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMA 189
Query: 419 PEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPV 450
PE D ++D+++ G+ +E+ G P+
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 247 NFHSENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKE---FLMELGIIGHVC 302
N+ ++GQG + VY +D GR++AVK++ D + + KE E+ ++ ++
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 303 HPNTATLVGCC---IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLH 359
H GC +E L + G++ L + +L + K + G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVS 120
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI-PIEGTFGYLA 418
YLH I+HRDIK +N+L ++ DFG +K L C + + GT +++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
PE K D+++ G ++E++T + P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 54/231 (23%)
Query: 248 FHSENMVGQGGYSEVYKG---NLSDGRKIAVKRLAKDNKD-------AKKEKEFLMELGI 297
+ E +G+G Y VYK N DG++ A+K+ D + A +E L EL
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK- 60
Query: 298 IGHVCHPNTATLVGCCIENG---LYLIFNFSQNGNLDAALHDERS-----------KSLE 343
H N +LV +E+ +YL+F+++++ +L + R KSL
Sbjct: 61 -----HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 344 WPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ----ITDFGLAK--W 397
W I G+HYLH ++HRD+K +N+L+ + + I D GLA+
Sbjct: 115 WQI--------LNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
Query: 398 LPNKCTHHAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIIT 445
P K P+ T Y APE + H + D++A G + E++T
Sbjct: 164 APLKPLADLD-PVVVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 58/222 (26%), Positives = 109/222 (49%), Gaps = 35/222 (15%)
Query: 254 VGQGGYSEVYKG---NLS---DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
+G+G + +V+ NLS D +AVK L A+K+ F E ++ ++ H +
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIV 70
Query: 308 TLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKSL----EWPIRYKIVLGVARGLH--- 359
G C + + L ++F + ++G+L+ L ++ P + K LG+++ LH
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 360 -------YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAI 408
YL + +HRD+ N L+G + +I DFG+++ + + + H +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
PI ++ PE M+ ++DV++FGV+L EI T G++P
Sbjct: 188 PIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 57/286 (19%)
Query: 254 VGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKEFLMELGII--GHVCHPNTATLV 310
+G+G + V K G +AVKR+ + D K++K LM+L ++ C P
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDC-PYIVKFY 69
Query: 311 G-------C--CIE------NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVA 355
G C C+E + Y + E I KI +
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP-----EE-------ILGKIAVATV 117
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC--THHAAIPIEGT 413
+ L+YL + + +IIHRD+K SN+LL + ++ DFG++ L + T A G
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA-----GC 170
Query: 414 FGYLAPEY---FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL 470
Y+APE D ++DV++ G+ L E+ TG+ P W + + L
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK-------W-NSVFD--QL 220
Query: 471 TELVD---PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
T++V P L + + V + C+ + + RP E+LE
Sbjct: 221 TQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 253 MVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLM---ELGIIGHVCHPNTAT 308
++G G + V+KG + +G I + K +D + F + +G + H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 309 LVGCCIENGLYLIFNFSQNGNLDAALHDER-----SKSLEWPIRYKIVLGVARGLHYLHK 363
L+G C L L+ S G+L + R + L W ++ +A+G++YL +
Sbjct: 74 LLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
R++HR++ A N+LL D QI DFG+A L + + ++A E +
Sbjct: 128 ---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 424 HGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSR 454
G ++DV+++GV + E+++ G +P R
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
NF +G+G Y VYK N G +A+K++ D + + E+ ++ + HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 306 TATLVGCC-IENGLYLIFNF-SQNGN--LDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
L+ EN LYL+F F Q+ +DA+ L ++++ G+A +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FC 116
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAP 419
H R++HRD+K N+L+ + ++ DFGLA+ +P + H + T Y AP
Sbjct: 117 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 169
Query: 420 EYFMHG-IIDEKTDVFAFGVLLLEIITGRK--PVDS 452
E + D+++ G + E++T R P DS
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 34/204 (16%)
Query: 266 NLSDGRK--IAVKRLAKD-NKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI-ENGLYLI 321
N+ GR +AVK L D NK+A+ + FL E+ I+ + PN L+G C+ E+ L +I
Sbjct: 40 NVRKGRPLLVAVKILRPDANKNARND--FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMI 97
Query: 322 FNFSQNGNL-----------------DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
+ +NG+L DA ++ + + L +A G+ YL
Sbjct: 98 TEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--- 154
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPE 420
+HRD+ N L+G + +I DFG+++ L + A +PI ++A E
Sbjct: 155 SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR----WMAWE 210
Query: 421 YFMHGIIDEKTDVFAFGVLLLEII 444
+ G +DV+AFGV L EI+
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 69/222 (31%), Positives = 102/222 (45%), Gaps = 22/222 (9%)
Query: 253 MVGQGGYSEVY---KGNLSD-GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
++GQG + +V+ K D G+ A+K L K + ME I+ V HP
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 309 L-VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG-VARGLHYLHKGCK 366
L E LYLI +F + G+L L E + E K L +A L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELALALDHLHS--- 116
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA--AIPIEGTFGYLAPEYFMH 424
II+RD+K N+LL + ++TDFGL+K + H A GT Y+APE
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ----NLVLWAK 462
+ D ++FGVL+ E++TG P + ++L AK
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 254 VGQGGYSEVYK-GNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G + V+K + G +A+K++A + + L E+ + HP L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 313 CIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
+G L+ + + L L DE + L + + +G+ Y+H I+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMH 122
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWL----PNKCTHHAAIPIEGTFGYLAPE------- 420
RD+K +N+L+ D +I DFGLA+ P +H A T Y APE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-----TRWYRAPELLYGARK 177
Query: 421 YFMHGIIDEKTDVFAFGVLLLEIITGR 447
Y D D++A G + E++ G
Sbjct: 178 Y------DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 35/263 (13%)
Query: 273 IAVKRLAKD-NKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330
+AVK L +D NK+A+ + FL E+ I+ + PN L+ CI + L +I + +NG+L
Sbjct: 49 VAVKMLREDANKNARND--FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 331 D---------AALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL 381
+ A ++ + + +A G+ YL +HRD+ N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLV 163
Query: 382 GPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFG 437
G ++ +I DFG+++ L + + A +PI +++ E + G +DV+AFG
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMSWESILLGKFTTASDVWAFG 219
Query: 438 VLLLEIIT--GRKPVD--SSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLI 493
V L EI+T +P S Q + + + G L P+L D +++L+L
Sbjct: 220 VTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPAL----CPDSLYKLML- 274
Query: 494 ADYCVRQTSAWRPSMSEVLELLT 516
C R+ + RPS E+ L
Sbjct: 275 --SCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 247 NFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
F N +G+G Y VY+ + +I A+K++ DN+ L E+ ++ ++ HPN
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 306 TATL----VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
L VG +++ ++L+ + + +L A+L D ++L + RGL YL
Sbjct: 68 IVELKEVVVGKHLDS-IFLVMEYCEQ-DL-ASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE- 420
H+ IIHRD+K SN+LL +I DFGLA+ P T Y APE
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT--PKVVTLWYRAPEL 179
Query: 421 YFMHGIIDEKTDVFAFGVLLLEIITGR 447
D++A G +L E++ +
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 77/256 (30%), Positives = 106/256 (41%), Gaps = 24/256 (9%)
Query: 253 MVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELG--IIGHVCHPNTATL 309
++G+G + +V SDG AVK L K KKE+ +M ++ ++ HP L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP---FL 58
Query: 310 VGC----CIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
VG LY + ++ G L H +R + P VA + YLH
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLHS-- 114
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAPEYFM 423
II+RD+K N+LL +TDFGL K P + T GT YLAPE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC----GTPEYLAPEVLR 169
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPV---DSSRQNLVLWAKPLMESGNLTELVDPSLEG 480
D D + G +L E++ G P D S+ + KPL G T L G
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVG 229
Query: 481 EYDTDQMHRLVLIADY 496
DQ RL AD+
Sbjct: 230 LLHKDQRRRLGAKADF 245
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAK-------KEKEFLMELGIIGHVCHPN 305
+G G + VY N G +A+K++ K K +E + L +L HPN
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLN-----EHPN 59
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK- 363
L EN LY +F + GNL + D + K + I+ + +GL ++HK
Sbjct: 60 IVKLKEVFRENDELYFVFEY-MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
G HRD+K N+L+ +I DFGLA+ + ++ + + T Y APE +
Sbjct: 119 G----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV---STRWYRAPEILL 171
Query: 424 H-GIIDEKTDVFAFGVLLLEIITGR 447
D++A G ++ E+ T R
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 273 IAVKRLAKD-NKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330
+AVK L D K A+ + FL E+ I+ + +PN L+G C+ + L +I + +NG+L
Sbjct: 47 VAVKMLRADVTKTARND--FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 331 DAAL----------HDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVL 380
+ L H S+ + + +A G+ YL +HRD+ N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 381 LGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAF 436
+G + +I DFG+++ L + + A +PI ++A E + G +DV+AF
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMAWESILLGKFTTASDVWAF 217
Query: 437 GVLLLEIIT 445
GV L E+ T
Sbjct: 218 GVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 15/216 (6%)
Query: 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPN 305
F ++G+GG+ EV + + G+ A K+L K K K E L E I+ V N
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV---N 58
Query: 306 TATLVGCC----IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
+ +V ++ L L+ G+L ++ E + GL L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
H+ RI++RD+K N+LL +I+D GLA +P T + GT GY+APE
Sbjct: 119 HQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEV 172
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL 457
+ D +A G LL E+I G+ P ++ +
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 268 SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG---LYLIFNF 324
+ G +AVK+L A+ ++F E+ I+ + H N G C G L L+ +
Sbjct: 31 NTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88
Query: 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK-------RRIIHRDIKAS 377
G+L L R + L + L Y + CK +R +HRD+
Sbjct: 89 LPYGSLRDYLQKHRER-----------LDHRKLLLYASQICKGMEYLGSKRYVHRDLATR 137
Query: 378 NVLLGPDFEPQITDFGLAKWLP-NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAF 436
N+L+ + +I DFGL K LP +K + P E + APE +DV++F
Sbjct: 138 NILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSF 197
Query: 437 GVLLLEIIT 445
GV+L E+ T
Sbjct: 198 GVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
VG G Y V + G ++AVK+L++ + K EL ++ H+ H N L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 313 CIE-------NGLYLIFNFSQNGNLDAALHD--ERSKSLEWPIRYKIVLGVARGLHYLHK 363
N +YL+ + + A L++ + K + +++ ++ + RGL Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS 138
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY-- 421
IIHRD+K SN+ + D E +I DFGLA+ ++ T + A T Y APE
Sbjct: 139 A---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIML 190
Query: 422 -FMHGIIDEKTDVFAFGVLLLEIITGR 447
+MH ++ D+++ G ++ E++TGR
Sbjct: 191 NWMH--YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 26/241 (10%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVG 311
+G G + VY ++ + +A+K+++ K + +K ++ + E+ + + HPNT G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 312 CCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
C + E+ +L+ + D L + K L+ + G +GL YLH +I
Sbjct: 83 CYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMI 137
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM---HGII 427
HRD+KA N+LL ++ DFG A + A GT ++APE + G
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVILAMDEGQY 191
Query: 428 DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW-----AKPLMESGNLTE----LVDPSL 478
D K DV++ G+ +E+ + P+ + L+ P ++SG+ +E VD L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 479 E 479
+
Sbjct: 252 Q 252
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 86/291 (29%)
Query: 242 SSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEF-----LMEL 295
S ++ +G+G + EVYK + GR +A+K++ N EK+ L E+
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-----EKDGFPITALREI 58
Query: 296 GIIGHVCHPNTATLVGCCIENG---------LYLIFNFSQNGNLDAALHDERSKSLEWPI 346
I+ + HPN L+ +E +Y++ + + +L L + K L
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPY-MDHDLSGLLENPSVK-LTESQ 116
Query: 347 RYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA 406
+L + G++YLH+ I+HRDIKA+N+L+ +I DFGLA+ +
Sbjct: 117 IKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLAR------PYDG 167
Query: 407 AIPIEGTFG---------------YLAPEYFMHGIIDEK-----TDVFAFGVLLLEIITG 446
P G Y PE + E+ D++ G + E+ T
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG----ERRYTTAVDIWGIGCVFAEMFTR 223
Query: 447 RKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYC 497
R P L+G+ D DQ+H LI C
Sbjct: 224 R----------------------------PILQGKSDIDQLH---LIFKLC 243
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 251 ENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
+ ++G G VYK +L R +AVK + D + +K+ + EL I+ P
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 310 VGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
G +EN + + F G+LD + + + +I + V +GL YL +
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDV------YRKIPEHVLGRIAVAVVKGLTYL---WSLK 115
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM---HG 425
I+HRD+K SN+L+ + ++ DFG++ L N A GT Y+APE +G
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYG 171
Query: 426 IIDEKTDVFAFGVLLLEIITGRKP 449
I +DV++ G+ +E+ GR P
Sbjct: 172 IH---SDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 25/228 (10%)
Query: 239 EEISSATNNFHSENMVGQGGYSEVYK-GNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGI 297
E + T+ + +G+G Y +VYK N DG AVK L + + ++E E I
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNI 71
Query: 298 IGHVC-HPNTATLVGC------CIENGLYLIFNFSQNGNLDAALHD--ERSKSLEWPIRY 348
+ + HPN G + L+L+ G++ + + L+ +
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 349 KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-KCTHHAA 407
I+ G GL +LH RIIHRD+K +N+LL + ++ DFG++ L + + + +
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 408 IPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPV 450
+ GT ++APE D + DV++ G+ +E+ G P+
Sbjct: 189 V---GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 7e-12
Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 18/134 (13%)
Query: 350 IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIP 409
+ + V +H++H + +IHRDIK++N+LL + ++ DFG +K +
Sbjct: 148 LFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469
GT Y+APE + +K D+F+ GVLL E++T ++P D N
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---------------N 249
Query: 470 LTELVDPSLEGEYD 483
+ E++ +L G YD
Sbjct: 250 MEEVMHKTLAGRYD 263
|
Length = 496 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 7e-12
Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 32/219 (14%)
Query: 254 VGQGGYSEVYKG---NL---SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
+G+G + +V+ NL D +AVK L + +A+K+ F E ++ ++ H +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--FHREAELLTNLQHEHIV 70
Query: 308 TLVGCCIE-NGLYLIFNFSQNGNL---------DAALHDERSKSLEWPIR--YKIVLGVA 355
G C+E + L ++F + ++G+L DA L E ++ E I +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIE 411
G+ YL + +HRD+ N L+G + +I DFG+++ + + + H +PI
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 412 GTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
++ PE M+ ++DV++ GV+L EI T G++P
Sbjct: 188 ----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 254 VGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKK---EKEFLMELGIIGHVCHPNTATL 309
+G+GG+ EV + + G+ A K+L D K KK EK L+E I+ V P L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKL--DKKRLKKKSGEKMALLEKEILEKVNSPFIVNL 58
Query: 310 V-GCCIENGLYLIFNFSQNGNLDAALHD--ERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366
+ L L+ + G+L +++ ER +E I Y + G+ +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA--QITCGILHLHS--- 113
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-KCTHHAAIPIEGTFGYLAPEYFMHG 425
I++RD+K NVLL +++D GLA L + K A GT GY+APE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA----GTNGYMAPEILKEE 169
Query: 426 IIDEKTDVFAFGVLLLEIITGRKP 449
D FA G + E++ GR P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 64/243 (26%), Positives = 107/243 (44%), Gaps = 28/243 (11%)
Query: 253 MVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
++G+GG+ EVY +D G+ A+K L K K+ + + I+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 312 CC-----IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY---KIVLGVARGLHYLHK 363
C + L I + G+L L S E +R+ +I+L GL ++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EAEMRFYAAEIIL----GLEHMH- 114
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
R +++RD+K +N+LL +I+D GLA K HA++ GT GY+APE
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV---GTHGYMAPEVLQ 168
Query: 424 HGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482
G+ D D F+ G +L +++ G P RQ K E +T + L +
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSP---FRQ---HKTKDKHEIDRMTLTMAVELPDSF 222
Query: 483 DTD 485
+
Sbjct: 223 SPE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 40/123 (32%), Positives = 68/123 (55%), Gaps = 8/123 (6%)
Query: 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEP 387
G+LD L +++ + I KI + V RGL YL + K +I+HRD+K SN+L+ E
Sbjct: 84 GSLDQVL--KKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEI 139
Query: 388 QITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGR 447
++ DFG++ L + A GT Y++PE ++D+++ G+ L+E+ GR
Sbjct: 140 KLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
Query: 448 KPV 450
P+
Sbjct: 196 YPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 53/226 (23%), Positives = 102/226 (45%), Gaps = 11/226 (4%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
++F + +G G V K I ++L + + EL ++ P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
G +G + + G+LD L + + E I K+ + V RGL YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE--ILGKVSIAVLRGLAYLRE- 121
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
K +I+HRD+K SN+L+ E ++ DFG++ L + A GT Y++PE
Sbjct: 122 -KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 176
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKPV--DSSRQNLVLWAKPLMESG 468
++D+++ G+ L+E+ GR P+ +++ ++ +P+++
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGE 222
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 62/226 (27%), Positives = 94/226 (41%), Gaps = 26/226 (11%)
Query: 234 TCFSYEEISS-ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEF 291
F+ + SS ++F +G G + V G A+K L K K+ +
Sbjct: 5 YMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH 64
Query: 292 LM-ELGIIGHVCHPNTATLV-GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWP---- 345
+ E I+ + HP ++ EN +Y + F G L L K+ +P
Sbjct: 65 VAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR----KAGRFPNDVA 120
Query: 346 --IRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403
++VL YLH + II+RD+K N+LL ++TDFG AK +P++
Sbjct: 121 KFYHAELVLA----FEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
+ GT YLAPE + D + GVLL E I G P
Sbjct: 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 68/283 (24%), Positives = 129/283 (45%), Gaps = 42/283 (14%)
Query: 254 VGQGGYSEVYKGNLSD------GRKIAVKRLAKDNKDAKKEKEFLMELGII-GHVCHPNT 306
+GQG + VY+GN D ++AVK + ++ ++ EFL E ++ G CH +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEASVMKGFTCH-HV 71
Query: 307 ATLVGCCIENGLYL-IFNFSQNGNLDAALHDERSKSLEWPIR--------YKIVLGVARG 357
L+G + L + +G+L + L R ++ P R ++ +A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA----IPIEGT 413
+ YL+ ++ +HRD+ A N ++ DF +I DFG+ + + + +P+
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW- 187
Query: 414 FGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTE 472
+APE G+ +D+++FGV+L EI + +P VL K +M+ G L
Sbjct: 188 ---MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--KFVMDGGYLD- 241
Query: 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+ + +++ L+ + C + RP+ E++ LL
Sbjct: 242 ------QPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
+ +G G Y +VYK +++ G +A+K + + D + + E+ ++ HPN
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ--QEISMLKECRHPNI 62
Query: 307 ATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
G + L+++ + G+L R E I Y + +GL YLH+
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-VCRETLKGLAYLHE-- 119
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA-----IPIEGTFGYLAPE 420
IHRDIK +N+LL D + ++ DFG++ L T A I GT ++APE
Sbjct: 120 -TGKIHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFI---GTPYWMAPE 171
Query: 421 YF---MHGIIDEKTDVFAFGVLLLEIITGRKP 449
G D K D++A G+ +E+ + P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 76/257 (29%), Positives = 111/257 (43%), Gaps = 26/257 (10%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELG--IIGHVCHPNTATL 309
++G+G + +V + ++ + AVK L K KKE++ +M ++ +V HP L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP---FL 58
Query: 310 VGCCIE----NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
VG + LY + ++ G L L ER LE R+ +A L YLH
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARF-YAAEIASALGYLHS-- 114
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAPEYFM 423
I++RD+K N+LL +TDFGL K N T GT YLAPE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC----GTPEYLAPEVLH 169
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW----AKPLMESGNLTELVDPSLE 479
D D + G +L E++ G P SR ++ KPL N+T LE
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKPNITNSARHLLE 228
Query: 480 GEYDTDQMHRLVLIADY 496
G D+ RL D+
Sbjct: 229 GLLQKDRTKRLGAKDDF 245
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 75/249 (30%), Positives = 110/249 (44%), Gaps = 24/249 (9%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGI-IGHVCHPNTATLV 310
+G+G + +V + +DG+ AVK L K KKE++ +M E + + +V HP LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP---FLV 59
Query: 311 GCCIE----NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366
G + LY + ++ G L H +R +S P +A L YLH
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHS--- 114
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
II+RD+K N+LL +TDFGL K +K T GT YLAPE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC----GTPEYLAPEVLRK 170
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKPV---DSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481
D D + G +L E++ G P D++ + KPL N++ LEG
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGL 230
Query: 482 YDTDQMHRL 490
D+ RL
Sbjct: 231 LQKDRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 21/208 (10%)
Query: 253 MVGQGGYSEV----YKGNLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTA 307
++G+G + +V KG AVK L KD + E M E ++
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 308 TLVGCCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVARGLHYLHK 363
T + C ++ L+ + + G+L + Y +IVLG L +LH+
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFLHE 114
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
R II+RD+K NVLL + +I DFG+ K GT Y+APE
Sbjct: 115 ---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILS 169
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPVD 451
+ D +A GVLL E++ G+ P +
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 55/189 (29%), Positives = 93/189 (49%), Gaps = 37/189 (19%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKE-F----LMELGIIGHVCHPNTA 307
+GQG + EV+K + + +A+K++ +N EKE F L E+ I+ + H N
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMEN-----EKEGFPITALREIKILQLLKHENVV 74
Query: 308 TLVGCC-----IENG----LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGL 358
L+ C N YL+F F ++ +L L ++ K I+ K++ + GL
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIK-KVMKMLLNGL 132
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL-------PNKCTHHAAIPIE 411
+Y+H+ +I+HRD+KA+N+L+ D ++ DFGLA+ PN+ T+
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV---- 185
Query: 412 GTFGYLAPE 420
T Y PE
Sbjct: 186 -TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 33/187 (17%)
Query: 252 NMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC---HPNTA 307
+G+G Y VYK +L+ GR +A+K++ + L E+ ++ + HPN
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 308 TL----VGCCIENG--LYLIFNFSQNGNLDAALHDERSKSLE-----WPIR---YKIVLG 353
L G + L L+F +D L SK + I+ +++
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQLL-- 117
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGT 413
RG+ +LH RI+HRD+K N+L+ D + +I DFGLA+ A + T
Sbjct: 118 --RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVT 169
Query: 414 FGYLAPE 420
Y APE
Sbjct: 170 LWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 253 MVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTATLV 310
++G+G + +V L GR AVK L KD + E M E I+ + T +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 311 GCCIE--NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
CC + + L+ + F G+L H ++S+ + + L +LH +
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHD---KG 116
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAK-WLPNKCTHHAAIPIEGTFGYLAPEYFMHGII 427
II+RD+K NVLL + ++ DFG+ K + N T GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC---GTPDYIAPEILQEMLY 173
Query: 428 DEKTDVFAFGVLLLEIITGRKPVDSSRQN 456
D +A GVLL E++ G P ++ ++
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 24/196 (12%)
Query: 273 IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLD 331
+AVK L D D +E +FL E+ I+ + PN A L+G C + L +I + +NG+L+
Sbjct: 49 VAVKVLRPDASDNARE-DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 332 AALHD---------ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG 382
L SKSL + + +A G+ YL +HRD+ N L+G
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164
Query: 383 PDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGV 438
++ +I DFG+++ L + + A +PI ++A E + G K+DV+AFGV
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLGKFTTKSDVWAFGV 220
Query: 439 LLLEIIT--GRKPVDS 452
L EI+T +P +
Sbjct: 221 TLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 37/100 (37%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIE 411
+A GL +LH + II+RD+K NV+L + +I DFG+ K K T
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---- 162
Query: 412 GTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVD 451
GT Y+APE + + D +AFGVLL E++ G+ P D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 253 MVGQGGYSEVYKGNLSD-----GRKIAVKRLAKDNKD---AKKEKEFLMELGIIGHVCHP 304
++G+G Y++V L K+ K L D++D + EK + HP
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHP 56
Query: 305 NTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
L C E+ L+ + + G+L + +R E Y + +A L+YLH+
Sbjct: 57 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHE 114
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAPEY 421
R II+RD+K NVLL + ++TD+G+ K P T GT Y+APE
Sbjct: 115 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC----GTPNYIAPEI 167
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVD 451
D +A GVL+ E++ GR P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 254 VGQGGYSEVYKGNLSDGRK---IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
+G G + V KG +K +A+K L +N+ + ++ E + E I+ + +P ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPYIVRMI 61
Query: 311 GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVL--GVARGLHYLHKGCKRR 368
G C L L+ + G L+ L K E + + L V+ G+ YL +
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEG---KN 115
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG-----YLAPEYFM 423
+HRD+ A NVLL +I+DFGL+K L +++ A + G + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA----RSAGKWPLKWYAPECIN 171
Query: 424 HGIIDEKTDVFAFGVLLLEIIT-GRKP 449
++DV+++G+ + E + G+KP
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 37/214 (17%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G Y VYKG N G+ +A+K++ ++++ + E+ ++ + HPN L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 313 CI-ENGLYLIFNF------------SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLH 359
+ E+ LYLIF F + +DA L KS Y+I+ G+
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAEL----VKSY----LYQILQGIL---- 115
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYL 417
+ H RR++HRD+K N+L+ ++ DFGLA+ +P + H + T Y
Sbjct: 116 FCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYR 168
Query: 418 APEYFMHGI-IDEKTDVFAFGVLLLEIITGRKPV 450
APE + D+++ G + E+ T +KP+
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 36/230 (15%)
Query: 236 FSYEEISSAT----NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKE 290
F EE++ + S VG G Y V + G K+A+K+L++ + K
Sbjct: 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR 60
Query: 291 FLMELGIIGHVCHPNTATL----VGCCIENGL---YLIFNFSQNGNLDAALHDERSKSLE 343
EL ++ H+ H N L + YL+ + Q +L + S E
Sbjct: 61 AYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLS---E 116
Query: 344 WPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403
++Y +V + GL Y+H IIHRD+K N+ + D E +I DFGLA+
Sbjct: 117 DKVQY-LVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR------- 165
Query: 404 HHAAIPIEG---TFGYLAPEY---FMHGIIDEKTDVFAFGVLLLEIITGR 447
HA + G T Y APE +MH ++ D+++ G ++ E++TG+
Sbjct: 166 -HADAEMTGYVVTRWYRAPEVILNWMH--YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 35/210 (16%)
Query: 254 VGQGGYSEVYKGNLSDGR-KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV-- 310
VG G Y V + R K+AVK+L++ + + EL ++ H+ H N L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 311 ---GCCIE--NGLYLIFNFSQNGNLD-----AALHDERSKSLEWPIRYKIVLGVARGLHY 360
IE N +YL+ N +L+ L DE + L + + RGL Y
Sbjct: 83 FTPATSIENFNEVYLVTNL-MGADLNNIVKCQKLSDEHVQFL--------IYQLLRGLKY 133
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE 420
+H IIHRD+K SNV + D E +I DFGLA+ ++ T + A T Y APE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVA-----TRWYRAPE 185
Query: 421 Y---FMHGIIDEKTDVFAFGVLLLEIITGR 447
+MH ++ D+++ G ++ E++ G+
Sbjct: 186 IMLNWMH--YNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 48/218 (22%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD------AKKEKEFLMELGIIGHVCHPNT 306
+G+G Y VYK + G +A+K++ + +D A +E L EL HPN
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNI 60
Query: 307 ATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIR------YKIVLGVARGLH 359
L+ EN LYL+F F +LD + + S Y+++ +G+
Sbjct: 61 VRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIA 113
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNKCTHHAAIPIEGTFGYL 417
Y H R++HRD+K N+L+ + ++ DFGLA+ +P + H + T Y
Sbjct: 114 YCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYR 166
Query: 418 APE------YFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
APE + + D+++ G + E++ R+P
Sbjct: 167 APEILLGSRQYSTPV-----DIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 3e-11
Identities = 50/200 (25%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTAT-LV 310
+GQG VY +++ G+++A+K++ N + +KE ++ E+ ++ +PN L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 311 GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
+ + L+++ + G+L + + + + L + L +LH ++I
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSN---QVI 137
Query: 371 HRDIKASNVLLGPDFEPQITDFGL-AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
HRDIK+ N+LLG D ++TDFG A+ P + + GT ++APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGP 194
Query: 430 KTDVFAFGVLLLEIITGRKP 449
K D+++ G++ +E++ G P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 253 MVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
++G+GG+ EVY +D G+ A+K L K K+ + + I+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 312 CCI-----ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY---KIVLGVARGLHYLHK 363
C + L I + G+L L S E +R+ +I+LG L ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-EKEMRFYATEIILG----LEHMHN 115
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
R +++RD+K +N+LL +I+D GLA K H + GT GY+APE
Sbjct: 116 ---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 168
Query: 424 HGII-DEKTDVFAFGVLLLEIITGRKP 449
G D D F+ G +L +++ G P
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 49/200 (24%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTATLVG 311
+GQG VY +++ G+++A+K++ N + +KE ++ E+ ++ HPN +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPNIVNYLD 83
Query: 312 C-CIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
+ + L+++ + G+L + + ++ + + L +LH ++I
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVI 137
Query: 371 HRDIKASNVLLGPDFEPQITDFGL-AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
HRDIK+ N+LLG D ++TDFG A+ P + + GT ++APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGP 194
Query: 430 KTDVFAFGVLLLEIITGRKP 449
K D+++ G++ +E++ G P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 4e-11
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKE---FLMELGIIGHVC 302
N+ ++GQG + VY ++ GR++A K++ D + + KE E+ ++ ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 303 HPNTATLVGCCIENG---LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLH 359
H GC + L + + G++ L + +L + K + G+
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMS 120
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI-PIEGTFGYLA 418
YLH I+HRDIK +N+L ++ DFG +K L C I + GT +++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
PE K DV++ G ++E++T + P
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 5e-11
Identities = 49/200 (24%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTATLVG 311
+GQG V+ +++ G+++A+K++ N + +KE ++ E+ ++ + +PN +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 312 C-CIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
+ + L+++ + G+L + + + + L + L +LH ++I
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL---QALEFLHAN---QVI 137
Query: 371 HRDIKASNVLLGPDFEPQITDFGL-AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
HRDIK+ NVLLG D ++TDFG A+ P + + GT ++APE
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGP 194
Query: 430 KTDVFAFGVLLLEIITGRKP 449
K D+++ G++ +E++ G P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 5e-11
Identities = 50/200 (25%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTAT-LV 310
+GQG VY +++ G+++A++++ N + +KE ++ E+ ++ +PN L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 311 GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
+ + L+++ + G+L + + + + L + L +LH ++I
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSN---QVI 138
Query: 371 HRDIKASNVLLGPDFEPQITDFGL-AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
HRDIK+ N+LLG D ++TDFG A+ P + + GT ++APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGP 195
Query: 430 KTDVFAFGVLLLEIITGRKP 449
K D+++ G++ +E+I G P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 21/160 (13%)
Query: 293 MELGIIGHVCHPNTATLVGCCIENGLY-LIFNFSQNGNLDAALHDER--------SKSLE 343
E ++ + HP +E + +I + + +LD L + + ++ E
Sbjct: 51 QEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110
Query: 344 WPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403
W I +++LGV HY+H+ RRI+HRD+KA N+ L + +I DFG+++ L C
Sbjct: 111 WFI--QLLLGV----HYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD 160
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEI 443
A GT Y++PE H D K+D+++ G +L E+
Sbjct: 161 --LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 254 VGQGGYSEV-YKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
VG G Y V + G K+A+K+L + + K EL ++ H+ H N L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 313 CIE-------NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
+ YL+ F +L + E+ E I++ +V + +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPF-MGTDLGKLMKHEKLS--EDRIQF-LVYQMLKGLKYIHAA- 137
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY---F 422
IIHRD+K N+ + D E +I DFGLA+ ++ T + T Y APE +
Sbjct: 138 --GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV-----TRWYRAPEVILNW 190
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGR 447
MH + D+++ G ++ E++TG+
Sbjct: 191 MH--YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 62/296 (20%), Positives = 109/296 (36%), Gaps = 51/296 (17%)
Query: 255 GQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314
+ K +AVK++ D+ + K E+ + HPN V I
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 315 ENG-LYLIFNFSQNGNLDAALHDERSKSL-EWPIRYKIVLGVARGLHYLH-KGCKRRIIH 371
+ LY++ G+ + L + L E I + I+ V L Y+H KG IH
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHSKGF----IH 124
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI---PIEGTF--GYLAPEYF---M 423
R +KAS++LL D + ++ + + + P +L+PE +
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483
G +EK+D+++ G+ E+ G P +L K G + L+D S Y+
Sbjct: 185 QG-YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV---RGTVPCLLDKSTYPLYE 240
Query: 484 TDQ---------------------------MHRLVLIADYCVRQTSAWRPSMSEVL 512
H+ V + C+++ RPS S++L
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL---CLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 28/188 (14%)
Query: 336 DERSKS---LEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDF 392
DE K LE I Y VARG+ +L R+ IHRD+ A N+LL + +I DF
Sbjct: 163 DELYKEPLTLEDLISYS--FQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDF 217
Query: 393 GLAKWL---PNKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GR 447
GLA+ + P+ A +P++ ++APE + ++DV++FGVLL EI + G
Sbjct: 218 GLARDIYKDPDYVRKGDARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 448 KPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS 507
P + + + ++ G T + P EY T +++ ++L C RP+
Sbjct: 274 SPYPGVQIDEEFCRR--LKEG--TRMRAP----EYATPEIYSIML---DCWHNNPEDRPT 322
Query: 508 MSEVLELL 515
SE++E+L
Sbjct: 323 FSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 15/216 (6%)
Query: 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHP 304
+F+ ++G+G + +V A+K L KD + E M E ++ P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 305 NTATLVGCCIE--NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
T + C + + LY + + G+L H ++ + P ++ GL +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAPE 420
+ R II+RD+K NV+L + +I DFG+ K + T GT Y+APE
Sbjct: 119 R---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC----GTPDYIAPE 171
Query: 421 YFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN 456
+ + D +A+GVLL E++ G+ P D ++
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 43/219 (19%)
Query: 253 MVGQGGYSEVYKGNLSDGR-----KIAVKRLAKDNKD---AKKEKEFLMELGIIGHV--- 301
++G+G Y++V L R K+ K L D++D + EK HV
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEK----------HVFET 51
Query: 302 --CHPNTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSL-EWPIRY---KIVLGV 354
HP L C E+ L+ + F G+L H +R + L E R+ +I L
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLA- 108
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEG 412
L++LH+ R II+RD+K NVLL + ++TD+G+ K P T G
Sbjct: 109 ---LNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC----G 158
Query: 413 TFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVD 451
T Y+APE D +A GVL+ E++ GR P D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 60/233 (25%), Positives = 109/233 (46%), Gaps = 36/233 (15%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKD-AKKEKE-------FLMELGIIGHVCHPN 305
VG+G Y VYK DG KD++D A K+ E E+ ++ + HPN
Sbjct: 9 VGRGTYGHVYKAKRKDG---------KDDRDYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 306 TATLVGCCIENG---LYLIFNFSQNGNLDAALHDERSKSLEWPIRY------KIVLGVAR 356
+L + + ++L+F+++++ SK+ + P++ ++ +
Sbjct: 60 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLL---GPDF-EPQITDFGLAKWLPNKCTHHAAI-PIE 411
G+HYLH ++HRD+K +N+L+ GP+ +I D G A+ + A + P+
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 412 GTFGYLAPEYFMHGIIDEKT-DVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463
TF Y APE + K D++A G + E++T +P+ RQ + + P
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNP 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 254 VGQGGYSEVYK-GNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVG 311
+G+G Y +V+K N +G K AVK L + D +E E E I+ + HPN G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIE--AEYNILKALSDHPNVVKFYG 82
Query: 312 CC----IENG--LYLIFNFSQNGNLDAALHD--ERSKSLEWPIRYKIVLGVARGLHYLHK 363
++NG L+L+ G++ + +R + +E PI I+ GL +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF- 422
+ IHRD+K +N+LL + ++ DFG++ L + T GT ++APE
Sbjct: 143 N---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVIA 197
Query: 423 ----MHGIIDEKTDVFAFGVLLLEIITGRKPV 450
+ D + DV++ G+ +E+ G P+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 34/212 (16%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G Y V+K N +A+KR+ D+ D L E+ ++ + H N L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 313 CI-ENGLYLIFNF----------SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
+ L L+F + S NG++D I + + +GL +
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP------------EIVKSFMFQLLKGLAFC 115
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAP 419
H ++HRD+K N+L+ + E ++ DFGLA+ +P +C + T Y P
Sbjct: 116 HS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV----TLWYRPP 168
Query: 420 EYFMHG-IIDEKTDVFAFGVLLLEIITGRKPV 450
+ + D+++ G + E+ +P+
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 45/210 (21%), Positives = 97/210 (46%), Gaps = 9/210 (4%)
Query: 247 NFHSENMVGQGGYSEVYK-GNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+ +VG+G + V+ +D + + +K++ + + E ++ + HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 306 TATLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
+E L ++ ++ G L + + L+ + + LH++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT- 119
Query: 365 CKRRIIHRDIKASNVLLGP-DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
+ I+HRD+K N+LL +I DFG++K L +K A + GT Y++PE
Sbjct: 120 --KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCE 174
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPVDSS 453
++K+D++A G +L E+ + ++ +++
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 71/300 (23%), Positives = 128/300 (42%), Gaps = 58/300 (19%)
Query: 248 FHSENMVGQGGYSEVYKGNLSDG-----RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC 302
+++ +G + ++ G L D ++ VK + KD+ + L E ++ +
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQESCLLYGLS 66
Query: 303 HPNTATLVGCCIENGL--YLIFNFSQNGNLDAALHDERSKSLEWPI----RYKIVLG--V 354
H N ++ CIE+G ++++ + GNL L R P + + + +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL-PNKCTHHAA-----I 408
A G+ YLHK R +IH+DI A N ++ + + +ITD L++ L P +H
Sbjct: 127 ACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD--YHCLGDNENR 181
Query: 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG 468
P++ ++A E ++ +DV++FGVLL E++T L P +E
Sbjct: 182 PVK----WMALESLVNKEYSSASDVWSFGVLLWELMT-------------LGQTPYVE-- 222
Query: 469 NLTELVDP-----SLEGEYDTDQ----MHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519
+DP L+ Y Q L + C RPS S++++ LT H
Sbjct: 223 -----IDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 69/259 (26%), Positives = 109/259 (42%), Gaps = 35/259 (13%)
Query: 253 MVGQGGYSEVY-----KGNLSDGRKIAVKRLAKDNKD---AKKEKEFLMELGIIGHVCHP 304
++G+G Y++V K + K+ K L D++D + EK + +P
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-----SNP 56
Query: 305 NTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
L C + L+L+ + G+L + +R E Y + +A L++LH+
Sbjct: 57 FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLHE 114
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAPEY 421
R II+RD+K NVLL D ++TD+G+ K P T GT Y+APE
Sbjct: 115 ---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC----GTPNYIAPEI 167
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN----------LVLWAKPLMESGNLT 471
D +A GVL+ E++ GR P D N V+ KP+ L+
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLS 227
Query: 472 ELVDPSLEGEYDTDQMHRL 490
L+G + D RL
Sbjct: 228 VKASHVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 55/195 (28%), Positives = 102/195 (52%), Gaps = 35/195 (17%)
Query: 268 SDGRKIAVKRLAKDNKDAKKE--KEFLM-ELGIIGHVCHPN-----TATLVGCCIENGLY 319
S GR++AVK++ D +K+ +E L E+ I+ HPN ++ LVG + L+
Sbjct: 42 STGRQVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG----DELW 92
Query: 320 LIFNFSQNGNL-DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASN 378
++ F + G L D H ++ E I + L V + L +LH + +IHRDIK+ +
Sbjct: 93 VVMEFLEGGALTDIVTH---TRMNEEQIAT-VCLAVLKALSFLHA---QGVIHRDIKSDS 145
Query: 379 VLLGPDFEPQITDFG----LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVF 434
+LL D +++DFG ++K +P + + + GT ++APE + D++
Sbjct: 146 ILLTSDGRVKLSDFGFCAQVSKEVPRRKS------LVGTPYWMAPEVISRLPYGTEVDIW 199
Query: 435 AFGVLLLEIITGRKP 449
+ G++++E++ G P
Sbjct: 200 SLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 72/235 (30%), Positives = 110/235 (46%), Gaps = 22/235 (9%)
Query: 247 NFHSENMVGQGGYSEVY---KGNLSD-GRKIAVKRLAKDN--KDAKKEKEFLMELGIIGH 300
NF ++G G Y +V+ K + D G+ A+K L K + AK + E ++ H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 301 VCH-PNTATL-VGCCIENGLYLIFNFSQNGNLDAAL-HDERSKSLEWPIRY-KIVLGVAR 356
+ P TL + L+LI ++ G L L ER K E I +IVL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA--- 117
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416
L +LHK II+RDIK N+LL + +TDFGL+K A GT Y
Sbjct: 118 -LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTIEY 172
Query: 417 LAPEYFMHGII--DEKTDVFAFGVLLLEIITGRKP--VDSSRQNLVLWAKPLMES 467
+AP+ G D+ D ++ GVL+ E++TG P VD + + ++ +++S
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 21/178 (11%)
Query: 315 ENGLYLIFNFSQNGNLDAALHDERSKSLEWP------IRYKIVLGVARGLHYLHKGCKRR 368
++ L LI + G+L+ + + L + + Y+IVL L +H R+
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA----LDEVHS---RK 189
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIID 428
++HRD+K++N+ L P ++ DFG +K + + A GT YLAPE +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 429 EKTDVFAFGVLLLEIITGRKPVDSSRQ----NLVLWAK----PLMESGNLTELVDPSL 478
+K D+++ GV+L E++T +P Q VL+ K P S + L+DP L
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLL 307
|
Length = 478 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 254 VGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKE-KEFLMELGIIGHVCHPNTATLVG 311
+G+G + +VY+ D R+I A+K L+K AKKE + E I+ + +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 312 CCI----ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR 367
++ LYL+ ++ G L L E + E ++ I V L +LHK
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVL-ALEHLHK---Y 115
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII 427
I++RD+K N+LL + DFGL+K N + GT YLAPE ++
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEV----LL 169
Query: 428 DEK-----TDVFAFGVLLLEIITGRKP 449
DEK D ++ GVL+ E+ G P
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 55/227 (24%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD-----AKKEKEFLMELGIIGH 300
NF +G+G Y+ VYKG N + G +A+K + D ++ A +E + EL
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK---- 56
Query: 301 VCHPNTATLVGCC-IENGLYLIFNFSQN------------GNLDAALHDERSKSLEWPIR 347
H N L EN L L+F + G LD KS + +
Sbjct: 57 --HENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNT----VKSFTYQL- 109
Query: 348 YKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407
+G+ + H+ R++HRD+K N+L+ E ++ DFGLA+
Sbjct: 110 -------LKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAF--------G 151
Query: 408 IPIEG------TFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGR 447
IP+ T Y AP+ + D+++ G ++ E+ITGR
Sbjct: 152 IPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 254 VGQGGYSEVYKG---NL---SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
+G+G + +V+ NL D +AVK L + ++ A+++ F E ++ + H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTVLQHQHIV 70
Query: 308 TLVGCCIE-NGLYLIFNFSQNGNL---------DAALHDERSKS----LEWPIRYKIVLG 353
G C E L ++F + ++G+L DA + L I
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIP 409
+A G+ YL +HRD+ N L+G +I DFG+++ + + + +P
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
I ++ PE ++ ++D+++FGV+L EI T G++P
Sbjct: 188 IR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 18/184 (9%)
Query: 270 GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-------GLYLIF 322
G +AVK+L++ ++ K EL ++ V H N +L+ +YL+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG 382
+ NL +H E + Y+++ G+ +LH IIHRD+K SN+++
Sbjct: 106 EL-MDANLCQVIHMELDHERMSYLLYQMLCGI----KHLHSA---GIIHRDLKPSNIVVK 157
Query: 383 PDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLE 442
D +I DFGLA+ CT+ P T Y APE + E D+++ G ++ E
Sbjct: 158 SDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 443 IITG 446
++ G
Sbjct: 215 LVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 247 NFHSENMVGQGGYSEVY----KGNLSDGRKIAVKRLAKDN--KDAKKEKEFLMELGIIGH 300
NF ++G G Y +V+ G G+ A+K L K + AK + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 301 VCH-PNTATL-VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY---KIVLGVA 355
V P TL + L+LI ++ G L L+ +R E +R +IVL
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVLA-- 117
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK-WLPNKCTHHAAIPIEGTF 414
L +LH+ II+RDIK N+LL + +TDFGL+K +L A GT
Sbjct: 118 --LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE--EEERAYSFCGTI 170
Query: 415 GYLAPEYFMHGII--DEKTDVFAFGVLLLEIITGRKP 449
Y+APE G D+ D ++ GVL E++TG P
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 15/216 (6%)
Query: 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPN 305
F ++G+GG+ EV + + G+ A KRL K K K E L E I+ V N
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV---N 58
Query: 306 TATLVGCC----IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
+ +V ++ L L+ G+L +++ + E + GL L
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
H+ ++RD+K N+LL +I+D GLA +P + + GT GY+APE
Sbjct: 119 HR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEV 172
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL 457
+ D + G L+ E+I G+ P ++ +
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 26/207 (12%)
Query: 255 GQGGYSEV----YKGNLSDGRKIAVKRLAKDNKDAKKEKEFLME----LGIIGHVCHPNT 306
G+G + +V YK G A+K L K + A+ E E LM HP
Sbjct: 8 GRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 307 ATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
L C E+ + + ++ G+L +H + S + Y V GL YLH+
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF-SEPRAVFY--AACVVLGLQYLHE-- 119
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAK---WLPNKCTHHAAIPIEGTFGYLAPEYF 422
+I++RD+K N+LL + +I DFGL K ++ + GT +LAPE
Sbjct: 120 -NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-----GTPEFLAPEVL 173
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKP 449
D + GVL+ E++ G P
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 254 VGQGGYSEVYKGN--LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC---HPNTAT 308
+G+G Y +V+K + GR +A+KR+ + + E+ ++ H+ HPN
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 309 LVGCCI------ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVARGLHY 360
L C E L L+F ++ + D + ++ P ++ + RGL +
Sbjct: 69 LFDVCTVSRTDRETKLTLVF---EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE 420
LH R++HRD+K N+L+ + ++ DFGLA+ + + + T Y APE
Sbjct: 126 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRAPE 179
Query: 421 YFMHGIIDEKTDVFAFGVLLLEIITGRKPV 450
+ D+++ G + E+ RKP+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 44/181 (24%), Positives = 88/181 (48%), Gaps = 11/181 (6%)
Query: 270 GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC-CIENGLYLIFNFSQNG 328
G+++AVK++ D + ++ + E+ I+ H N + + + L+++ F + G
Sbjct: 47 GKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104
Query: 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ 388
L + R + + L V R L YLH + +IHRDIK+ ++LL D +
Sbjct: 105 ALTDIVTHTRMNEEQIA---TVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIK 158
Query: 389 ITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRK 448
++DFG + + ++ GT ++APE + D+++ G++++E+I G
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 449 P 449
P
Sbjct: 217 P 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 38/93 (40%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416
GL +LHK + II+RD+K NVLL D +I DFG+ K N A GT Y
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDY 162
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
+APE +E D ++FGVLL E++ G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 60/231 (25%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 254 VGQGGYSEVYKGNLSDG---RKIAVKRLAKD--NKDAKKEKEFLMELGIIGHVCHPNTAT 308
VG+G Y VYK DG ++ A+K++ + A +E L EL HPN
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELK------HPNVIA 62
Query: 309 LVGCCIENG---LYLIFNFSQNGNLDAALHDERSKSLEWPIRY------KIVLGVARGLH 359
L + + ++L+F+++++ SK+ + P++ ++ + G+H
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 360 YLHKGCKRRIIHRDIKASNVLL---GPDF-EPQITDFGLAKWLPNKCTHHAAI-PIEGTF 414
YLH ++HRD+K +N+L+ GP+ +I D G A+ + A + P+ TF
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 415 GYLAPEYFMHGIIDEKT-DVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL 464
Y APE + K D++A G + E++T +P+ RQ + + P
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPF 229
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 253 MVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELG--IIGHVCHPNTATL 309
++G+G + +V DG+ AVK L K +KE++ +M ++ +V HP L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP---FL 58
Query: 310 VGCCIE----NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
VG LY + +F G L H +R +S P +A L YLH
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHS-- 114
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
I++RD+K N+LL +TDFGL K GT YLAPE
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 426 IIDEKTDVFAFGVLLLEIITGRKP 449
D D + G +L E++ G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 255 GQGGYSEVYKGNL---SDGR--------KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH 303
GQG ++ +YKG L SD + +K L D++D+ F ++ + H
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL---AFFETASLMSQLSH 60
Query: 304 PNTATLVGCCIENGLYLIFNFSQNGNLDAALHDER-SKSLEWPIRYKIVLGVARGLHYLH 362
+ L G C+ + ++ + + G LD LH E+ + SL W + + +A LHYL
Sbjct: 61 KHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 363 KGCKRRIIHRDIKASNVLL---GPDFEPQ----ITDFGLAKWLPNKCTHHAAIPIEGTFG 415
++++H ++ N+L+ G + ++D G+ + ++ IP
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------ 169
Query: 416 YLAPEYFMHGI--IDEKTDVFAFGVLLLEI 443
++APE +G + D ++FG LLEI
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 18/207 (8%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIG---HVCHPNTATL 309
+G G Y VYK + G +A+K + + + E+ ++ HPN L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 310 VGCCI------ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
+ C E + L+F +L L L ++ RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
C I+HRD+K N+L+ + ++ DFGLA+ A P+ T Y APE +
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLL 180
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPV 450
D+++ G + E+ RKP+
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 247 NFHSENMVGQGGYSEVYKGNLSDGRK-IAVKRLA-------KDNKDAKKEKEFLMELGII 298
+ VG G + V+ A+K +A K + EK L E+
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-- 59
Query: 299 GHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVA 355
HP L + LY++ + G L + L + S + Y +IV
Sbjct: 60 ----HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA-- 113
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415
L YLH + I++RD+K N+LL + ++TDFG AK L ++ + GT
Sbjct: 114 --LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPE 163
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
YLAPE ++ D +A G+L+ E++ G P
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 33/213 (15%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAK--DNK-DAKKEKEFLMELGIIGHVCHPNTATL 309
+G+G Y V N K+A+K++A DN+ DAK+ L E+ ++ H+ H N +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT---LREIKLLRHLDHENVIAI 69
Query: 310 VGCC------IENGLYLIFNFSQNGNLDAALHD--ERSKSL-EWPIRYKIVLGVARGLHY 360
N +Y+++ +D LH S++L + +Y + + RGL Y
Sbjct: 70 KDIMPPPHREAFNDVYIVYEL-----MDTDLHQIIRSSQTLSDDHCQY-FLYQLLRGLKY 123
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE 420
+H ++HRD+K SN+LL + + +I DFGLA+ T Y APE
Sbjct: 124 IHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPE 178
Query: 421 YFMHGIIDEKT---DVFAFGVLLLEIITGRKPV 450
++ E T DV++ G + E++ GRKP+
Sbjct: 179 LLLN--CSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
++F + +G G V+K + I ++L + + EL ++ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
G +G + + G+LD L +++ + I K+ + V +GL YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLRE- 121
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
K +I+HRD+K SN+L+ E ++ DFG++ L + A GT Y++PE
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 176
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKPV 450
++D+++ G+ L+E+ GR P+
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 34/239 (14%)
Query: 254 VGQGGYSEVYKGNLSDG-------RKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPN 305
+GQG + VY+G ++ G ++A+K + + ++ EFL E ++ CH +
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCH-H 70
Query: 306 TATLVGCCIENGLYL-IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG--------VAR 356
L+G + L I G+L + L R + P++ L +A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA----IPIEG 412
G+ YL+ + +HRD+ A N ++ DF +I DFG+ + + + +P+
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 186
Query: 413 TFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNL 470
+++PE G+ +DV++FGV+L EI T +P VL + +ME G L
Sbjct: 187 ---WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL--RFVMEGGLL 240
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 51/167 (30%), Positives = 88/167 (52%), Gaps = 23/167 (13%)
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL---PNKCTHHAA-IP 409
VARG+ +L R+ IHRD+ A N+LL + +I DFGLA+ + P+ +A +P
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESG 468
++ ++APE + ++DV++FGVLL EI + G P + N + ++ G
Sbjct: 240 LK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR--LKDG 293
Query: 469 NLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
T + P E T +++R++L C + RP+ S ++E+L
Sbjct: 294 --TRMRAP----ENATPEIYRIML---ACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 31/272 (11%)
Query: 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC- 312
+G+G Y VYK + + D K + +MEL I+ P G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 313 CIENGLYLIFNFSQNGNLDAALHDERSKS--LEWPIRYKIVLGVARGLHYLHKGCKRRII 370
IE +Y+ + G+LD L+ + + + +I V +GL +L + + II
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDE- 429
HRD+K +NVL+ + + ++ DFG++ N A I G Y+APE G ++
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSG---NLVASLAKTNI-GCQSYMAPERIKSGGPNQN 181
Query: 430 -----KTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD---PSLEGE 481
++DV++ G+ +LE+ GR P + L+ +VD P+L
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF--------AQLSAIVDGDPPTLPSG 233
Query: 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
Y D + C+ + RP+ +++LE
Sbjct: 234 YSDDAQDFVAK----CLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 247 NFHSENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKE---FLMELGIIGHVC 302
N+ ++G+G + EVY +D GR++AVK++ D + KE E+ ++ ++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 303 HPNTATLVGCC---IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLH 359
H GC E L + + G++ L + +L + + + +G+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVS 120
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI-PIEGTFGYLA 418
YLH I+HRDIK +N+L ++ DFG +K + C I + GT +++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
PE K DV++ ++E++T + P
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-09
Identities = 28/134 (20%), Positives = 50/134 (37%), Gaps = 13/134 (9%)
Query: 8 KILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKA 67
+IL+ S+ L WA ++ + +V +HV+ + + + A+A
Sbjct: 1 RILVAVDGSEE-SERALRWAARLARRLGAELVLLHVV---DPPPSSAAELAELLEEEARA 56
Query: 68 HVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMSR 127
+L V +E V ++E A+ + AD +V+ GSR S
Sbjct: 57 ----LLEALREALAEAGVKVETVVLEGDP-AEAILEAAEELGADLIVM-GSRGRSGLRRL 110
Query: 128 ---DVTRYCFQHAP 138
V +HAP
Sbjct: 111 LLGSVAERVLRHAP 124
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 253 MVGQGGYSEVYKGNLSDG------------RKIAVKRLAKDNKDAKKEKEFLMELGIIGH 300
++G+GGY +V++ G +K + R KD K E+ L
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEA------ 56
Query: 301 VCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLH 359
V HP L+ G LYLI + G L +H ER + ++ L
Sbjct: 57 VKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALE 114
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYL 417
+LH+ + II+RD+K N+LL ++TDFGL K TH GT Y+
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC----GTIEYM 167
Query: 418 APEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
APE M + D ++ G L+ +++TG P
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 53/156 (33%), Positives = 81/156 (51%), Gaps = 28/156 (17%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRL--AKDNK-DAKK---EKEFLMELGIIGHVCHPNT 306
+G+G Y V+K + +A+K++ A N DA++ E FL ELG HPN
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNI 69
Query: 307 ATLVGCC-IENG--LYLIFNFSQNGNLDAALHDE-RSKSLEWPI--RYKIVLGVARGLHY 360
L+ EN +YL+F + ++ LH R+ LE + RY I+ + + L Y
Sbjct: 70 VKLLNVIKAENDKDIYLVFEY-----METDLHAVIRANILE-DVHKRY-IMYQLLKALKY 122
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396
+H G +IHRD+K SN+LL D ++ DFGLA+
Sbjct: 123 IHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 7/199 (3%)
Query: 253 MVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTATLV 310
M+G+G + +V+ L + A+K L KD + E M E ++ T +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 311 GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
C + L F D H + + P + GL +LH + I+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KGIV 118
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEK 430
+RD+K N+LL D +I DFG+ K N GT Y+APE + +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 431 TDVFAFGVLLLEIITGRKP 449
D ++FGVLL E++ G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH 303
TN + VG G + V + G+ +A+K++ K K EL ++ H+ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 304 PNTATLVGCCIE--NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
N +L I +Y + +L L S+ LE + + RGL Y+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTEL-LGTDLHRLL---TSRPLEKQFIQYFLYQILRGLKYV 124
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
H ++HRD+K SN+L+ + + +I DFGLA+ + T + + T Y APE
Sbjct: 125 HSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS-----TRYYRAPEI 176
Query: 422 FMH-GIIDEKTDVFAFGVLLLEIITGRKPV 450
+ D + D+++ G + E++ G KP+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPN 305
F ++G+GG+ EV + + G+ A K+L K K K E L E I+ V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 306 TATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVAR---GLHYL 361
+L ++ L L+ G+L +++ + + + V A GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAAEITCGLEDL 118
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
H+ RI++RD+K N+LL +I+D GLA +P T + GT GY+APE
Sbjct: 119 HR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---GTVGYMAPEV 172
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKP 449
+ D + G L+ E+I G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 45/149 (30%), Positives = 75/149 (50%), Gaps = 23/149 (15%)
Query: 325 SQNGNLDAALHDERSKSLEWPIRYKIVLG----VARGLHYL-HKGCKRRIIHRDIKASNV 379
S + + + DE WP+ +L VA+G+ +L K C IHRD+ A NV
Sbjct: 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNV 243
Query: 380 LLGPDFEPQITDFGLAKWLPNKCTH----HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFA 435
LL +I DFGLA+ + N + +A +P++ ++APE + ++DV++
Sbjct: 244 LLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK----WMAPESIFDCVYTVQSDVWS 299
Query: 436 FGVLLLEIIT-GRKP-----VDSSRQNLV 458
+G+LL EI + G+ P V+S +V
Sbjct: 300 YGILLWEIFSLGKSPYPGILVNSKFYKMV 328
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 57/237 (24%), Positives = 91/237 (38%), Gaps = 41/237 (17%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVCH 303
++F ++G+G + EV+ D ++ A+K L K + + + + E I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 304 PNTATLVGCCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
P L E LYL+ + G+L L + E R+ I V L +
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVL-ALDSV 117
Query: 362 HK-GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK------------------------ 396
HK G IHRDIK N+L+ D ++ DFGL K
Sbjct: 118 HKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 397 ----WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
+ A + GT Y+APE + D ++ GV+L E++ G P
Sbjct: 174 LVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 254 VGQGGYSEVYKG--NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
+G+G Y+ VYKG L+D +A+K + ++++ + E+ ++ + H N TL
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71
Query: 312 CC-IENGLYLIFNFSQNGNLDAALH---DERSKSLEWPIRYKIVLGVARGLHYLHKGCKR 367
E L L+F + LD L D+ S+ + + RGL+Y H+ R
Sbjct: 72 IIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---R 123
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGL--AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
+++HRD+K N+L+ E ++ DFGL AK +P K + + T Y P+ + G
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV----TLWYRPPDILL-G 178
Query: 426 IIDEKT--DVFAFGVLLLEIITGR 447
D T D++ G + E+ TGR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 11/214 (5%)
Query: 247 NFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHP 304
+F+ ++G+G + +V ++ A+K L KD + E M E ++ P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 305 NTATLVGCCIE--NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
T + C + + LY + + G+L ++ + P +A GL +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF 422
+ II+RD+K NV+L + +I DFG+ K N GT Y+APE
Sbjct: 119 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEII 173
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN 456
+ + D +AFGVLL E++ G+ P + ++
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPN 305
F ++G+GG+ EV + + G+ A K+L K K K E L E I+ V N
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV---N 58
Query: 306 TATLVGCC----IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
+ +V ++ L L+ G+L +++ + + + GL L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
+ RI++RD+K N+LL +I+D GLA +P T + GT GY+APE
Sbjct: 119 QR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPEV 172
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKP 449
+ D + G L+ E+I G+ P
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 32/207 (15%)
Query: 254 VGQGGYSEVYK-GNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G Y V+K N G+ +A+K+ + D +K L E+ ++ + HPN L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL--- 65
Query: 313 CIE-----NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK-GCK 366
IE L+L+F + + L+ ++ + + + KI+ + +++ HK C
Sbjct: 66 -IEVFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC- 121
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWL---PNKCTHHAAIPIEGTFGYLAPEYFM 423
IHRD+K N+L+ + ++ DFG A+ L + T + A T Y APE
Sbjct: 122 ---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-----TRWYRAPELL- 172
Query: 424 HGIIDEK----TDVFAFGVLLLEIITG 446
+ D + DV+A G + E++TG
Sbjct: 173 --VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 50/167 (29%), Positives = 87/167 (52%), Gaps = 23/167 (13%)
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL---PNKCTH-HAAIP 409
VA+G+ +L R+ IHRD+ A N+LL + +I DFGLA+ + P+ A +P
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESG 468
++ ++APE + ++DV++FGVLL EI + G P + + + ++ G
Sbjct: 245 LK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEG 298
Query: 469 NLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
T + P +Y T +M++ +L C + RP+ SE++E L
Sbjct: 299 --TRMRAP----DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 253 MVGQGGYSEV-YKGNLSDGRKIAVKRLAKDNKDAKKE-KEFLMELGIIGHVCHPNTATL- 309
++G+G + +V + G+ A+K L K+ AK E L E ++ + HP +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 310 VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
++ L + + G L L ER S + Y + L YLH G +I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA--EIVSALDYLHSG---KI 116
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIP-IEGTFGYLAPEYFMHGIID 428
++RD+K N++L D +ITDFGL K T A + GT YLAPE
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 429 EKTDVFAFGVLLLEIITGRKP 449
D + GV++ E++ GR P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 42/183 (22%), Positives = 87/183 (47%), Gaps = 11/183 (6%)
Query: 268 SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC-CIENGLYLIFNFSQ 326
S G+ +AVK++ D + ++ + E+ I+ H N + + + L+++ F +
Sbjct: 43 SSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100
Query: 327 NGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386
G L + R + + L V + L LH + +IHRDIK+ ++LL D
Sbjct: 101 GGALTDIVTHTRMNEEQIA---AVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGR 154
Query: 387 PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITG 446
+++DFG + + ++ GT ++APE + D+++ G++++E++ G
Sbjct: 155 VKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
Query: 447 RKP 449
P
Sbjct: 213 EPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 35/107 (32%), Positives = 49/107 (45%), Gaps = 12/107 (11%)
Query: 349 KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT--DFGLAKWLPNKCTHHA 406
KI+ + L+ LHK IIH DIK NVL + +I D+GL K + +
Sbjct: 113 KIIRQLVEALNDLHK---HNIIHNDIKLENVLYD-RAKDRIYLCDYGLCKIIGTPSCY-- 166
Query: 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSS 453
+GT Y +PE D D +A GVL E++TG+ P
Sbjct: 167 ----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209
|
Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 253 MVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTATLV 310
++G+G + +V L G AVK L KD + E M E ++ T +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 311 GCCIE--NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVAR---GLHYLHKGC 365
C + L+ + F G+L + D+ L Y+ A GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVCGLQFLHS-- 114
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
+ II+RD+K NV+L D +I DFG+ K N + A GT Y+APE
Sbjct: 115 -KGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 426 IIDEKTDVFAFGVLLLEIITGRKP 449
D ++FGVLL E++ G+ P
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 48/233 (20%)
Query: 252 NMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKE-----FLMELGIIGHVCHPN 305
+G+G Y +VYK D G +A+K++ DN EKE + E+ I+ + H N
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDN-----EKEGFPITAIREIKILRQLNHRN 67
Query: 306 TATLVGCCIEN-----------GLYLIFNFSQN---GNLDAALHD---ERSKSLEWPIRY 348
L + YL+F + + G L++ L + KS
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-----M 122
Query: 349 KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408
K +L GL+Y HK + +HRDIK SN+LL + ++ DFGLA+ L N
Sbjct: 123 KQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLAR-LYNSEESRPYT 175
Query: 409 PIEGTFGYLAPEYFMHGIIDEK----TDVFAFGVLLLEIITGRKPVDSSRQNL 457
T Y PE + +E+ DV++ G +L E+ T +KP+ + Q L
Sbjct: 176 NKVITLWYRPPELLLG---EERYGPAIDVWSCGCILGELFT-KKPIFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 247 NFHSENMVGQGGYSEVY----KGNLSDGRKIAVKRLAKDN--KDAKKEKEFLMELGIIGH 300
NF ++G G Y +V+ G+ A+K L K + AK + E ++ H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 301 VCH-PNTATL-VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY---KIVLGVA 355
V P TL E L+LI ++ G + L+ +R E +R+ +I+L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILA-- 117
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415
L +LHK I++RDIK N+LL + +TDFGL+K ++ GT
Sbjct: 118 --LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-EKERTYSFCGTIE 171
Query: 416 YLAPEYFMHGIIDEKT------DVFAFGVLLLEIITGRKP 449
Y+APE II K D ++ G+L+ E++TG P
Sbjct: 172 YMAPE-----IIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 68/246 (27%), Positives = 106/246 (43%), Gaps = 16/246 (6%)
Query: 253 MVGQGGYSEV-YKGNLSDGRKIAVKRLAKDNKDAKKE-KEFLMELGIIGHVCHPN-TATL 309
++G+G + +V + GR A+K L K+ AK E L E ++ + HP TA
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 310 VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
+ L + ++ G L L ER S + Y + L YLH ++ +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALDYLHS--EKNV 117
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAK-WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIID 428
++RD+K N++L D +ITDFGL K + + T GT YLAPE
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVLEDNDYG 174
Query: 429 EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS----LEGEYDT 484
D + GV++ E++ GR P ++ + L+ LME + P L G
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKK 233
Query: 485 DQMHRL 490
D RL
Sbjct: 234 DPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 254 VGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G Y+ V+KG +A+K + ++++ + E+ ++ ++ H N TL
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA-IREVSLLKNLKHANIVTLHDI 71
Query: 313 C-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVL-GVARGLHYLHKGCKRRII 370
E L L+F + + D + + +L KI + + RGL Y HK R+I+
Sbjct: 72 IHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKIL 125
Query: 371 HRDIKASNVLLGPDFEPQITDFGL--AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIID 428
HRD+K N+L+ E ++ DFGL AK +P K + + T Y P+ + G +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----TLWYRPPDVLL-GSTE 180
Query: 429 EKT--DVFAFGVLLLEIITGR 447
T D++ G +L E+ TGR
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 16/192 (8%)
Query: 270 GRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLV--GCCIENGLYLIFNFSQ 326
G ++A+K L D ++ + F E + + HPN L+ G L+ +F +
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 327 NGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG-PDF 385
L L + + R ++L V L H + I+HRD+K N+++
Sbjct: 63 GRTLREVLAADGALPAGETGR--LMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGV 117
Query: 386 EP--QITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGV 438
P ++ DFG+ LP T + GT Y APE + +D++A+G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 439 LLLEIITGRKPV 450
+ LE +TG++ V
Sbjct: 178 IFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 12/201 (5%)
Query: 253 MVGQGGYSEV-YKGNLSDGRKIAVKRLAKDNKDAKKE-KEFLMELGIIGHVCHPNTATL- 309
++G+G + +V + GR A+K L K+ AK E + E ++ + HP L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 310 VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
+ L + ++ G L L ER + E Y + L YLH R +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--EIVSALEYLHS---RDV 116
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI-PIEGTFGYLAPEYFMHGIID 428
++RDIK N++L D +ITDFGL K + A + GT YLAPE
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 429 EKTDVFAFGVLLLEIITGRKP 449
D + GV++ E++ GR P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 37/110 (33%), Positives = 61/110 (55%), Gaps = 19/110 (17%)
Query: 354 VARGLHYL-HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH----HAAI 408
VA+G+ +L K C IHRD+ A N+LL +I DFGLA+ + N + +A +
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT------GRKPVDS 452
P++ ++APE + + ++DV+++G+LL EI + PVDS
Sbjct: 279 PVK----WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 49/189 (25%), Positives = 92/189 (48%), Gaps = 27/189 (14%)
Query: 270 GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT-----ATLVGCCIENGLYLIFNF 324
GR++AVK + D + ++ + E+ I+ H N + LVG L+++ F
Sbjct: 46 GRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG----EELWVLMEF 99
Query: 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD 384
Q G L + R + + VL + L YLH + +IHRDIK+ ++LL D
Sbjct: 100 LQGGALTDIVSQTRLNEEQIATVCESVL---QALCYLHS---QGVIHRDIKSDSILLTLD 153
Query: 385 FEPQITDFG----LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLL 440
+++DFG ++K +P + + + GT ++APE + D+++ G+++
Sbjct: 154 GRVKLSDFGFCAQISKDVPKRKS------LVGTPYWMAPEVISRTPYGTEVDIWSLGIMV 207
Query: 441 LEIITGRKP 449
+E++ G P
Sbjct: 208 IEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVK--RLAKDNKDAKKEKEFLMELGIIGHVCH 303
+F +G G Y +VYK N++ G A+K +L A ++E +M + H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM----MKDCKH 65
Query: 304 PNTATLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
N G + + L++ F G+L H S E I Y + +GL+YLH
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-ESQIAY-VSRETLQGLYYLH 123
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF 422
K +HRDIK +N+LL + ++ DFG++ + + GT ++APE
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI--GTPYWMAPEVA 178
Query: 423 M---HGIIDEKTDVFAFGVLLLEIITGRKPV 450
G ++ D++A G+ +E+ + P+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEF-LMELGIIGHVCHP 304
N F +VG+G Y V K + ++I + KD+++ ++ KE L EL ++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 305 NTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
N L G LYL+F + + N+ L + + +R + + + +H+ HK
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCHK 118
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
I+HRDIK N+L+ + ++ DFG A+ L ++ ++ T Y +PE +
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLL 174
Query: 424 HGIIDEKTDVFAFGVLLLEIITGR 447
+ D+++ G +L E+ G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 64/276 (23%), Positives = 123/276 (44%), Gaps = 32/276 (11%)
Query: 251 ENMVGQGGYSEVYKGNLS-DGRK---IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
E ++G G + E+ +G L ++ +A+ L + K+ + FL E +G H N
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 307 ATLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
L G N + ++ + NG LD+ L + L ++ G+A G+ YL
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYL---S 124
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYL--APEYFM 423
+ +H+ + A VL+ D +I+ F L + + G L APE
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 424 HGIIDEKTDVFAFGVLLLEIIT-GRKPV-DSSRQNLVLWAKPLMESGNLTELVD-PSLEG 480
+ +DV++FG+++ E+++ G +P D S Q+++ K + + L + P+L
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI---KAVEDGFRLPAPRNCPNL-- 236
Query: 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516
+H+L+L C ++ RP S++ +L+
Sbjct: 237 ------LHQLML---DCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 270 GRKIAVKRLAKDNKDAKKE-KEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQN 327
G+ A+K L K+ AK E L E ++ + HP L + L + ++
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79
Query: 328 GNLDAALHDERSKSLEWPIRY--KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385
G L L ER S + Y +IV L YLH +++RD+K N++L D
Sbjct: 80 GELFFHLSRERVFSEDRARFYGAEIVSA----LGYLHS---CDVVYRDLKLENLMLDKDG 132
Query: 386 EPQITDFGLAKWLPNKCTHHAAIP-IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEII 444
+ITDFGL K + A + GT YLAPE D + GV++ E++
Sbjct: 133 HIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 445 TGRKPVDSSRQNLVLWAKPLME 466
GR P ++ + L+ LME
Sbjct: 190 CGRLPF-YNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 61/228 (26%), Positives = 92/228 (40%), Gaps = 20/228 (8%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKE-KEFLMELGIIGHVCH 303
+F VGQGGY +V+ D +I A+KR+ K E + L E I+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 304 PNTATLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVA-RGLHYL 361
L+ + LYL + G+ L++ S + Y + A LH L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
IHRD+K N L+ ++TDFGL+K + A + G+ Y+APE
Sbjct: 121 G------YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-----ANSVVGSPDYMAPEV 169
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR-----QNLVLWAKPL 464
D D ++ G +L E + G P S +NL W + L
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|216006 pfam00582, Usp, Universal stress protein family | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-07
Identities = 27/141 (19%), Positives = 54/141 (38%), Gaps = 10/141 (7%)
Query: 8 KILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKA 67
+IL+ S+ L WA+++ + ++ +HV+ E S + + + +
Sbjct: 4 RILVAVDGSEE-SERALEWALELAKRRGAELILLHVIDPEPSGAASEALEEEEEEELEEE 62
Query: 68 HVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMSR 127
+ A + V + + G ++E A+ AD +V+ GSR S
Sbjct: 63 EAEAEALAAAAEAGGVVVEVVVRGG---DPAEAILEVAEEEDADLIVM-GSRGRSGLRRL 118
Query: 128 ---DVTRYCFQHAPGGCTIHI 145
V +HAP C + +
Sbjct: 119 LLGSVAEKVLRHAP--CPVLV 137
|
The universal stress protein UspA is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, though UspA lacks ATP-binding activity. Length = 139 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 41/211 (19%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVK--RLAKDNK---DAKKEKEFLMELGIIGHVCHPNTAT 308
G+G Y+ VYKG + G+ +A+K RL + A +E L +L H N T
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK------HANIVT 67
Query: 309 LVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEW------PIRYKIVL-GVARGLHY 360
L + L L+F + L + + ++ ++ L + RGL Y
Sbjct: 68 LHDIIHTKKTLTLVFEY---------LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL--AKWLPNKCTHHAAIPIEGTFGYLA 418
H+ RR++HRD+K N+L+ E ++ DFGL AK +P+K + + T Y
Sbjct: 119 CHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----TLWYRP 171
Query: 419 PEYFMHGIIDEKT--DVFAFGVLLLEIITGR 447
P+ + G + T D++ G + E+ TGR
Sbjct: 172 PDVLL-GSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 30/164 (18%)
Query: 252 NMVGQGGYSEVYKG-NLSDGRKIAVKR--LAKDNKDAKKEKEF----------LMELGII 298
+G+G Y +V K + G+ +A+K+ + + + D K+++ L EL I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 299 GHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK------IVL 352
+ H N LV +E + +L K ++ IR I+L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDL--------KKVVDRKIRLTESQVKCILL 126
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396
+ GL+ LHK +HRD+ +N+ + +I DFGLA+
Sbjct: 127 QILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 33/121 (27%), Positives = 54/121 (44%), Gaps = 18/121 (14%)
Query: 350 IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIP 409
I + GL YLH +RIIHRD+K N+ + + I D G A++ A +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLG 215
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEII------------TGRKPVDSSRQNL 457
+ GT APE + K D+++ G++L E++ T + V S +L
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275
Query: 458 V 458
+
Sbjct: 276 L 276
|
Length = 357 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 61/243 (25%), Positives = 91/243 (37%), Gaps = 55/243 (22%)
Query: 255 GQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVGC 312
G+G V+ L G+ A+K L K K K L E I+ + HP TL
Sbjct: 10 GKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY-A 68
Query: 313 CIENGLYLIF--NFSQNGNLDAALHDERSKSL-EWPIRY---KIVLGVARGLHYLH-KGC 365
+ YL ++ G L L + K L E R+ +++L L YLH G
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYLHLLG- 123
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL-------------------PNKCTHH- 405
I++RD+K N+LL ++DF L+K N
Sbjct: 124 ---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 406 -AAIPIE------GTFGYLAPEYFMHGII-----DEKTDVFAFGVLLLEIITGRKPVDSS 453
+ P GT Y+APE +I D + G+LL E++ G P S
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPE-----VISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235
Query: 454 RQN 456
++
Sbjct: 236 NRD 238
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 59/238 (24%), Positives = 97/238 (40%), Gaps = 23/238 (9%)
Query: 216 LRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGR--KI 273
L K+ S S KE + YE+ F+ +G G + V + +
Sbjct: 9 LHKKKDSDSTKEPKRK--NKMKYED-------FNFIRTLGTGSFGRVILATYKNEDFPPV 59
Query: 274 AVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLD 331
A+KR K +K+ + + E I+ ++ HP L G + LYL+ F G
Sbjct: 60 AIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119
Query: 332 AALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITD 391
L R+K + + YL I++RD+K N+LL D ++TD
Sbjct: 120 TFL--RRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTD 174
Query: 392 FGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
FG AK + + + GT Y+APE ++ + D + G+ + EI+ G P
Sbjct: 175 FGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 271 RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-------GLYLIFN 323
R +A+K+L++ ++ K EL ++ V H N +L+ +YL+
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP 383
+ NL + E + Y+++ G+ +LH IIHRD+K SN+++
Sbjct: 103 L-MDANLCQVIQMELDHERMSYLLYQMLCGI----KHLHSA---GIIHRDLKPSNIVVKS 154
Query: 384 DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEI 443
D +I DFGLA+ T P T Y APE + E D+++ G ++ E+
Sbjct: 155 DCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 444 ITGRKPVDSSRQNLVLWAKPLMESG 468
+ K + R + W K + + G
Sbjct: 212 VR-HKILFPGRDYIDQWNKVIEQLG 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVK--RLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
VG G Y +VYK NL G AVK +L + + ++E M + H N
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFM----VKECKHCNIVAYF 72
Query: 311 GCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
G + L++ + G+L H S E I Y + +GL YLH K
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLS-ELQIAY-VCRETLQGLAYLHSKGK--- 127
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM---HGI 426
+HRDIK +N+LL + + ++ DFG+A + + GT ++APE +G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGG 185
Query: 427 IDEKTDVFAFGVLLLEIITGRKPV 450
++ D++A G+ +E+ + P+
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 15/104 (14%)
Query: 348 YKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA-KWLPNKCTHHA 406
Y+I+ RGL YLH I+HRDIK N+L+ + +I DFGLA P++ H
Sbjct: 110 YQIL----RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162
Query: 407 AIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGR 447
+ T Y APE M H D+++ G + E++ R
Sbjct: 163 QEVV--TQYYRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+++ +G+G Y+ VYKG K+ ++ + ++ + E ++ + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 306 TATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVL-GVARGLHYLHK 363
L + L L+F + D + ++ P K+ L + RGL Y+H+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT---DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGL--AKWLPNKCTHHAAIPIEGTFGYLAPEY 421
R I+HRD+K N+L+ E ++ DFGL AK +P+ + + T Y P+
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV----TLWYRPPDV 174
Query: 422 FMHGIIDEKT--DVFAFGVLLLEIITG 446
+ G + T D++ G + +E+I G
Sbjct: 175 LL-GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 50/216 (23%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD------AKKEKEFLMELGIIG 299
+ N + +G Y VY+ + G +A+K+L + + + +E L++L
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ--- 62
Query: 300 HVCHPNTATL----VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVA 355
HPN T+ VG ++ +Y++ + ++ +L + + + + ++L +
Sbjct: 63 ---HPNIVTVKEVVVGSNLDK-IYMVMEYVEH-DLKSLM-ETMKQPFLQSEVKCLMLQLL 116
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415
G+ +LH I+HRD+K SN+LL +I DFGLA+ + + + + T
Sbjct: 117 SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLW 171
Query: 416 YLAPEYFM-HGIIDEKTDVFAFGVLLLEIITGRKPV 450
Y APE + D+++ G + E++T +KP+
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 18/184 (9%)
Query: 271 RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-------GLYLIFN 323
R +A+K+L++ ++ K EL ++ V H N L+ +Y++
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP 383
+ NL + E + Y+++ G+ +LH IIHRD+K SN+++
Sbjct: 110 L-MDANLCQVIQMELDHERMSYLLYQMLCGI----KHLHSA---GIIHRDLKPSNIVVKS 161
Query: 384 DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEI 443
D +I DFGLA+ T P T Y APE + E D+++ G ++ E+
Sbjct: 162 DCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 444 ITGR 447
I G
Sbjct: 219 IKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 66/229 (28%), Positives = 95/229 (41%), Gaps = 45/229 (19%)
Query: 247 NFHSENMVGQGGYSEV----YKGNLSDGRKIAVKRLAKDNKDAKK--EKEFLMELGIIGH 300
+ +GQG Y V S+ +A+K++ N +KK K L EL ++ H
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKIT--NVFSKKILAKRALRELKLLRH 57
Query: 301 V-CHPNTATLVGCCIE-----NGLYLI-----FNFSQNGNLDAALHDERSKSLEWPIRYK 349
H N L I N LYL + Q L D +S Y+
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF----IYQ 113
Query: 350 IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL-------PNKC 402
I+ GL Y+H ++HRD+K N+L+ D E +I DFGLA+
Sbjct: 114 IL----CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKT-DVFAFGVLLLEIITGRKPV 450
T + A T Y APE + K DV++ G +L E++ GRKPV
Sbjct: 167 TEYVA-----TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 12/157 (7%)
Query: 303 HPNTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
HP L C ++ L+ + + G+L +RS+ + P V L +L
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAP 419
H+ +I+RD+K N+LL + ++ DFG+ K L T GT Y+AP
Sbjct: 113 HR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC----GTPDYIAP 165
Query: 420 EYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN 456
E D +A GVL+ E++ G+ P ++ ++
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 19/143 (13%)
Query: 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL-HKGCKRRIIHRDIKASNVLLGP 383
S + + L D+ S+ L VARG+ +L K C +HRD+ A NVLL
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQ 272
Query: 384 DFEPQITDFGLAKWLPNKCTHHAA----IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVL 439
+I DFGLA+ + + + + +P++ ++APE + +DV+++G+L
Sbjct: 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVK----WMAPESIFDNLYTTLSDVWSYGIL 328
Query: 440 LLEIIT-GRKP-----VDSSRQN 456
L EI + G P VDS+ N
Sbjct: 329 LWEIFSLGGTPYPGMIVDSTFYN 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 61/201 (30%), Positives = 87/201 (43%), Gaps = 14/201 (6%)
Query: 254 VGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKE-KEFLMELGIIGHVCHPNTATLVG 311
+G+G + +V + D ++I A+K + K + ++ E L E ++ V P L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 312 CCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
LYL+ F G L L E L Y L A L LHK +I
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLHK---FNVI 115
Query: 371 HRDIKASNVLLGPDFEPQIT--DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIID 428
+RD+K N+LL D++ I DFGL K N GT YLAPE +
Sbjct: 116 YRDLKPENILL--DYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 429 EKTDVFAFGVLLLEIITGRKP 449
+ D + GVLL E++TG P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 36/143 (25%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 255 GQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314
G+ SE+Y + ++ VK L K N +K++ EFL + + HPN +G C+
Sbjct: 9 GKVLLSEIYTD--TGVARVVVKEL-KANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV 65
Query: 315 ENGLY-LIFNFSQNGNLDAAL--HDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
E Y L+F + + G+L + L ++ + + ++ +A G+ ++H K +H
Sbjct: 66 EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLH 122
Query: 372 RDIKASNVLLGPDFEPQITDFGL 394
D+ N L D ++ D+G+
Sbjct: 123 SDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 354 VARGLHYL-HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEG 412
VA G+ +L K C +HRD+ A NVL+ +I DFGLA+ + + I
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY---ISKGS 300
Query: 413 TF---GYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT 445
TF ++APE + + +DV++FG+LL EI T
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 254 VGQGGYSEVYKG--NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
+G+G Y+ V+KG L++ +A+K + ++++ + E+ ++ + H N TL
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71
Query: 312 CC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVL-GVARGLHYLHKGCKRRI 369
+ L L+F + D + + ++ KI L + RGL Y H+ R++
Sbjct: 72 IVHTDKSLTLVFEYLDK---DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 370 IHRDIKASNVLLGPDFEPQITDFGL--AKWLPNKCTHHAAIPIEGTFGYLAPEYFM-HGI 426
+HRD+K N+L+ E ++ DFGL AK +P K + + T Y P+ +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----TLWYRPPDVLLGSSE 181
Query: 427 IDEKTDVFAFGVLLLEIITGR 447
+ D++ G + E+ +GR
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL--- 309
+G+G Y VYK + IA+K++ + +D + E+ ++ + H N L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 310 VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIV----LGVARGLHYLHKGC 365
V E LYL+F + LD L S ++ +++ + RG+ Y H
Sbjct: 70 VHS--EKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS-- 120
Query: 366 KRRIIHRDIKASNVLLGPDFEP-QITDFGLAK--WLPNKCTHHAAIPIEGTFGYLAPEYF 422
R++HRD+K N+L+ ++ DFGLA+ +P + H + T Y APE
Sbjct: 121 -HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEIL 175
Query: 423 MHGIIDEKT--DVFAFGVLLLEIITGRK--PVDS 452
+ G T D+++ G + E++ + P DS
Sbjct: 176 L-GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208
|
Length = 294 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 58/246 (23%), Positives = 103/246 (41%), Gaps = 35/246 (14%)
Query: 270 GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGN 329
+++AVK++ D + K L E+ II + H N + +G L +
Sbjct: 30 DKRVAVKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE 87
Query: 330 LDAA-----LHD-------ERSKSLEWPIR---YKIVLGVARGLHYLHKGCKRRIIHRDI 374
L++ + E+ E R Y+++ RGL Y+H ++HRD+
Sbjct: 88 LNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL----RGLKYIHSA---NVLHRDL 140
Query: 375 KASNVLLGP-DFEPQITDFGLAKWLPNKCTHHAAIPIEG--TFGYLAPEYFMHGIIDEKT 431
K +NV + D +I DFGLA+ + +H + EG T Y +P + K
Sbjct: 141 KPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS-EGLVTKWYRSPRLLLSPNNYTKA 199
Query: 432 -DVFAFGVLLLEIITGRKPVDSSRQ----NLVLWAKPLMESGNLTEL--VDPSLEGEYDT 484
D++A G + E++TG+ + + L+L + P++ + EL V PS
Sbjct: 200 IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGG 259
Query: 485 DQMHRL 490
+ L
Sbjct: 260 EPRRPL 265
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 22/214 (10%)
Query: 247 NFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+F ++G+G + EV +++ A+K L+K + + F E I + H N
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHAN 101
Query: 306 TATLVGCCI----ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVARGLH 359
+ +V + LY++ + G+L L +W Y ++VL + +H
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTAEVVLALD-AIH 159
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAP 419
IHRD+K N+LL ++ DFG + + GT Y++P
Sbjct: 160 ------SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISP 212
Query: 420 EYFM----HGIIDEKTDVFAFGVLLLEIITGRKP 449
E G + D ++ GV L E++ G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 51/226 (22%), Positives = 95/226 (42%), Gaps = 35/226 (15%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G Y +VYK + + G+ +A+K+ + + L E+ ++ + +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL-L 67
Query: 313 CIEN--------GLYLIFNFSQNGNLDAALH---DERSKSLEWPIRYKIV----LGVARG 357
+E+ LYL+F + LD+ L D + P+ K + + +G
Sbjct: 68 DVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEP-QITDFGLAK--WLPNKCTHHAAIPIEGTF 414
+ + HK ++HRD+K N+L+ +I D GL + +P K H + T
Sbjct: 123 VAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TL 175
Query: 415 GYLAPEYFMHGI-IDEKTDVFAFGVLLLEIITGRK--PVDSSRQNL 457
Y APE + D+++ G + E+ + P DS Q L
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL 221
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 32/133 (24%), Positives = 50/133 (37%), Gaps = 9/133 (6%)
Query: 20 SKELLSWAIKVLAQPNDRIVAIHVLV----GEESKKRGSMAKRQSQIRRAKAHVISMLGE 75
SK L WA+ LA IV +HV S + +A Q +A +L
Sbjct: 12 SKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKE--LLLP 69
Query: 76 FAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVL-RGSRNHSNKMSR--DVTRY 132
+ K V E V + + ++E LV+ S NH + + DV
Sbjct: 70 YRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASS 129
Query: 133 CFQHAPGGCTIHI 145
+ AP CT+++
Sbjct: 130 VLKEAPDFCTVYV 142
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 47/225 (20%)
Query: 254 VGQGGYSEVYKGNLSDG---RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
+G G + +V G ++ G ++ VK L + + +++ +FL E + H N +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 311 GCCIENGLYL-IFNFSQNGNLDAALHDERSKSLEWP---IRYKIVLGVARGLHYLHKGCK 366
G C E YL + F G+L L R L P ++ +A GL +LHK
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLA--------------KWLPNKCTHHAAIPIEG 412
IH D+ N LL D +I D+GL+ W+P +
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----------- 167
Query: 413 TFGYLAPEYF--MHG---IIDE--KTDVFAFGVLLLEIIT-GRKP 449
++APE +HG ++D+ +++V++ GV + E+ G +P
Sbjct: 168 ---WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 49/210 (23%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 243 SATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV 301
+AT+ + E + G+G Y+ VYKG + +G+ +A+K ++ ++ + E ++ +
Sbjct: 3 AATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA-IREASLLKGL 60
Query: 302 CHPNTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVL-GVARGLH 359
H N L + L +F + D A + + P ++ + + RGL
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYMHT---DLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAP 419
Y+H + I+HRD+K N+L+ E ++ DFGLA+ +++ + T Y P
Sbjct: 118 YIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPP 172
Query: 420 EYFMHGIIDEKT--DVFAFGVLLLEIITGR 447
+ + G D + D++ G + +E++ G+
Sbjct: 173 DVLL-GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 34/112 (30%), Positives = 49/112 (43%), Gaps = 14/112 (12%)
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGT 413
V R + YLH+ RIIHRDIKA N+ + + + DFG A + P + GT
Sbjct: 191 VLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGT 246
Query: 414 FGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPV----------DSSRQ 455
APE D+++ G++L E+ T + DS RQ
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQ 298
|
Length = 391 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 52/268 (19%), Positives = 110/268 (41%), Gaps = 41/268 (15%)
Query: 262 VYKGNLSDGRKIAVKRLAKDNKDAKKEKE-FLMELGIIGHVCHPNTATLVGCCIENG--- 317
+YKG + +++ ++ K +K K + E+ + + N + G I+
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 318 --LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIK 375
L LI + G L L E K L + + + + +GL+ L+K + ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 376 ASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIID------- 428
+ + L+ +++ +I GL K L + P ++ YF + +++
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSS--------PPFKNVNFMV--YFSYKMLNDIFSEYT 200
Query: 429 EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY-DTDQM 487
K D+++ GV+L EI TG+ P ++ + + + +L+ D
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFEN------------LTTKEIYDLIINKNNSLKLPLDCP 248
Query: 488 HRLVLIADYCVRQTSAWRPSMSEVLELL 515
+ I + C S RP++ E+L L
Sbjct: 249 LEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 36/194 (18%)
Query: 270 GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-------GLYLIF 322
G+ +A+K+L++ ++ K EL ++ V H N L+ +YL+
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100
Query: 323 NFSQNGNLDAAL---------HDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373
+DA L H+ S L Y+++ G+ +LH IIHRD
Sbjct: 101 EL-----MDANLCQVIQMDLDHERMSYLL-----YQMLCGI----KHLHSA---GIIHRD 143
Query: 374 IKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDV 433
+K SN+++ D +I DFGLA+ T P T Y APE + E D+
Sbjct: 144 LKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 200
Query: 434 FAFGVLLLEIITGR 447
++ G ++ E+I G
Sbjct: 201 WSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 42/210 (20%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEF--LMELGIIGHVCHPNTATLVG 311
G+G +SEV K + G+ A+K + K K ++ + L + HPN L+
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP--HPNILRLIE 65
Query: 312 CCIENG---LYLIFNFSQNGNLDAALHD-----------ERSKSLEWPIRYKIVLGVARG 357
+ L L+F +D L++ +R KS Y+++ +
Sbjct: 66 VLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKRVKS----YMYQLL----KS 112
Query: 358 LHYLH-KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416
L ++H G I HRDIK N+L+ D ++ DFG + + +K + I T Y
Sbjct: 113 LDHMHRNG----IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYI---STRWY 164
Query: 417 LAPEYFM-HGIIDEKTDVFAFGVLLLEIIT 445
APE + G K D++A G + EI++
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 50/243 (20%), Positives = 103/243 (42%), Gaps = 36/243 (14%)
Query: 238 YEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAV-KRLAKDNKDAKKEKEFLMELG 296
Y++ S N + +G G + EV+ ++ K ++ +++ + ++E+
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 297 IIGHVCHPNTATLVGCCIENG---LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG 353
++ + H N + + LY++ F G+L + ++ + I ++
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI--QKCYKMFGKIEEHAIVD 122
Query: 354 VARGL-------HYLHKGCK-RRIIHRDIKASNVLLGPDFE-----------------PQ 388
+ R L H L G R++HRD+K N+ L +
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 389 ITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI--IDEKTDVFAFGVLLLEIITG 446
I DFGL+K + + H+ + GT Y +PE +H D+K+D++A G ++ E+ +G
Sbjct: 183 IGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 447 RKP 449
+ P
Sbjct: 240 KTP 242
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 13/212 (6%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLMELG--IIGHVC 302
++F ++G+G + EV + +I A+K L K + E E ++ C
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 303 HPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
T EN LYL+ ++ G+L L + E R+ I V +H +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL-AIHSIH 119
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF 422
+ +HRDIK NVLL + ++ DFG + T +++ + GT Y++PE
Sbjct: 120 Q---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEIL 175
Query: 423 M-----HGIIDEKTDVFAFGVLLLEIITGRKP 449
G + D ++ GV + E++ G P
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 15/86 (17%)
Query: 316 NGLYLIFNFSQNGNLDAALH-----DERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
N +YL+ + G++ + LH DE + K + VA L YLH+ II
Sbjct: 77 NNVYLVMEYLIGGDVKSLLHIYGYFDE-------EMAVKYISEVALALDYLHR---HGII 126
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAK 396
HRD+K N+L+ + ++TDFGL+K
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW-LPNKCTHHAAIPIE----- 411
L YLH I+HRD+K N+L+ ++TDFGL+K L + T+ IE
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 412 -------GTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
GT Y+APE + + D +A G++L E + G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIE--GT 413
RGL Y+H ++HRD+K SN+LL + + +I DFGLA+ + + H E T
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR-IADPEHDHTGFLTEYVAT 172
Query: 414 FGYLAPEYFMHGIIDEKT-DVFAFGVLLLEIITGR 447
Y APE ++ K D+++ G +L E+++ R
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 16/143 (11%)
Query: 315 ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY---KIVLGVARGLHYLHKGCKRRIIH 371
EN LYL+ ++ G+L L + E R+ ++V+ + +H LH +H
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVHQLH------YVH 125
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM-----HGI 426
RDIK N+L+ + ++ DFG L T +++ + GT Y++PE G
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEDGKGK 184
Query: 427 IDEKTDVFAFGVLLLEIITGRKP 449
+ D ++ GV + E++ G P
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 16/168 (9%)
Query: 303 HPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
HPN T L++I F G+ ++ L + + + I+ G RGL+YL
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYL 117
Query: 362 HK-GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG----- 415
H+ G IHR+IKAS++L+ D ++ L + F
Sbjct: 118 HQNGY----IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP 173
Query: 416 YLAPEYF---MHGIIDEKTDVFAFGVLLLEIITGRKP-VDSSRQNLVL 459
+L+PE ++G + K+D+++ G+ E+ TGR P D R ++L
Sbjct: 174 WLSPELLRQDLYG-YNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 19/144 (13%)
Query: 316 NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIV-LGVARGLHYLHKGCKRRIIHRDI 374
+ LYL+ + G+L + L+ + E ++ + L +A +H +H+ +HRDI
Sbjct: 74 DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA--IHSVHQ---MGYVHRDI 128
Query: 375 KASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF---------MHG 425
K NVL+ ++ DFG A L ++ +P+ GT Y+APE +G
Sbjct: 129 KPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDGKGTYG 187
Query: 426 IIDEKTDVFAFGVLLLEIITGRKP 449
+ + D ++ GV+ E+I GR P
Sbjct: 188 V---ECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 31/102 (30%), Positives = 47/102 (46%), Gaps = 20/102 (19%)
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC------THHAAIP 409
R L Y+H + HRD+K N+L D + +I DFGLA+ N T + A
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-- 168
Query: 410 IEGTFGYLAPE----YFMHGIIDEKTDVFAFGVLLLEIITGR 447
T Y APE +F D+++ G + E++TG+
Sbjct: 169 ---TRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 63/251 (25%), Positives = 99/251 (39%), Gaps = 63/251 (25%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKK-------EKEFLMELGI 297
++F S ++G+G + EV D G A+K L K + K+ E++ L+E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE--- 57
Query: 298 IGHVCHPNTATLVGCCI----ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIV 351
+ A +V + LYLI F G++ L + + S E Y + V
Sbjct: 58 ------ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV 111
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN--------KCT 403
L + +H L IHRDIK N+LL +++DFGL L T
Sbjct: 112 LAI-DAIHQLG------FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164
Query: 404 HHA-------------------------AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGV 438
H+ A GT Y+APE FM ++ D ++ GV
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 439 LLLEIITGRKP 449
++ E++ G P
Sbjct: 225 IMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 14/204 (6%)
Query: 253 MVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
++G+G + EV +K+ A+K L+K + + F E I + +
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 312 CCIENG--LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
C ++ LY++ + G+L L +W Y V L +H +
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFY--TAEVVLALDAIHS---MGL 163
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH----G 425
IHRD+K N+LL ++ DFG + + GT Y++PE G
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 426 IIDEKTDVFAFGVLLLEIITGRKP 449
+ D ++ GV L E++ G P
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 31/118 (26%), Positives = 47/118 (39%), Gaps = 40/118 (33%)
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH---------HAAIPIE--------- 411
IHRDIK N+LL +++DFGL L K +H HA
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 412 --------------------GTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
GT Y+APE F+ +++ D ++ GV++ E++ G P
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|223662 COG0589, UspA, Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 27/139 (19%), Positives = 53/139 (38%), Gaps = 9/139 (6%)
Query: 8 KILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGS----MAKRQSQIR 63
KIL+ + +++ L A+ + + ++ + V+ E S A
Sbjct: 7 KILVAVDVGSEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAPIPLSEE 66
Query: 64 RAKAHVISMLGEFAGTSQSKQVNL-EAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHS 122
+ +L E +++ V + E +V + ++E A+ AD L++ GSR S
Sbjct: 67 ELEEEAEELLAEAKALAEAAGVPVVETEVVEGSPSAEEILELAEEEDAD-LIVVGSRGRS 125
Query: 123 NKMSR---DVTRYCFQHAP 138
V +HAP
Sbjct: 126 GLSRLLLGSVAEKVLRHAP 144
|
Length = 154 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 61/246 (24%), Positives = 96/246 (39%), Gaps = 55/246 (22%)
Query: 247 NFHSENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKK-------EKEFLMELGII 298
+F S ++G+G + EV D G A+K L K + K+ E++ L+E +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 299 GHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVAR 356
V + LYLI F G++ L + + + E Y + VL +
Sbjct: 62 WVV-----KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAI-D 115
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL----------------PN 400
+H L IHRDIK N+LL +++DFGL L P+
Sbjct: 116 SIHQLG------FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 401 KCT-----------------HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEI 443
T A GT Y+APE FM ++ D ++ GV++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 444 ITGRKP 449
+ G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 30/124 (24%), Positives = 48/124 (38%), Gaps = 47/124 (37%)
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLA---KWLPN-------------------------- 400
IHRDIK N+L+ D ++TDFGL +W +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 401 ---------------KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT 445
+C H+ + GT Y+APE + + D ++ GV+L E++
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLV---GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 446 GRKP 449
G+ P
Sbjct: 240 GQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 24/161 (14%)
Query: 246 NNFHSENMVGQGGYSEV-YKGNLSDGRKIAVKRLAKD---NKD----AKKEKEFLMELGI 297
+FH+ ++G+G + EV G+ A+K L K KD K E++ L E
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 298 IGHVCHPNTATLVGCCIE-NGLYLIFNFSQNGNLDAAL--HDERSKSLEWPIRYKIVLGV 354
P +L + LYLI F G+L L +D S+ + + VL +
Sbjct: 60 -----SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAI 114
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395
+H K IHRDIK N+L+ +++DFGL+
Sbjct: 115 E-AVH------KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 32/132 (24%), Positives = 49/132 (37%), Gaps = 51/132 (38%)
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLA---KWLPN---------------------- 400
K IHRDIK N+L+ D ++TDFGL +W N
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 401 -----------------------KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFG 437
+C H+ + GT Y+APE + + D ++ G
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLV---GTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 438 VLLLEIITGRKP 449
V+L E++ G+ P
Sbjct: 236 VILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.57 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.53 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.45 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.45 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.15 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.12 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.94 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 98.92 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 98.62 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.3 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.22 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.11 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.05 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.97 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.84 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.81 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.67 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.61 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.59 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.56 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.39 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.37 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.24 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.16 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.14 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.07 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.03 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.89 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.83 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.63 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.53 | |
| PLN02236 | 344 | choline kinase | 96.49 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 96.1 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-55 Score=445.21 Aligned_cols=284 Identities=49% Similarity=0.883 Sum_probs=252.7
Q ss_pred CccccCHHHHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeee
Q 008650 232 LLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311 (558)
Q Consensus 232 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 311 (558)
....|++.++..+|++|...+.||+|+||.||+|...+|..||||++....... ..+|.+|+.++.+++|||+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 567799999999999999999999999999999999999999999886554332 556999999999999999999999
Q ss_pred EEEeCc--EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEE
Q 008650 312 CCIENG--LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQI 389 (558)
Q Consensus 312 ~~~~~~--~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 389 (558)
||.+.+ .+|||||+++|+|.++|+......++|..|++||.++|.||+|||..+...||||||||+|||||+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999765 899999999999999998765437899999999999999999999987778999999999999999999999
Q ss_pred EeccccccCCC-CCCccccccc-ccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCC----chhHHHHhhh
Q 008650 390 TDFGLAKWLPN-KCTHHAAIPI-EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSS----RQNLVLWAKP 463 (558)
Q Consensus 390 ~DFG~a~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~----~~~~~~~~~~ 463 (558)
+|||+|+..+. .... .+. .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+.. ...++.|+.+
T Consensus 219 sDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred cCccCcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 99999977654 2221 112 6999999999999999999999999999999999999998853 3448899999
Q ss_pred hhhcCCcccccCCCCC-CCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 464 LMESGNLTELVDPSLE-GEYDT-DQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 464 ~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
.+..+.+.+++|+.+. ..++. ....++..++.+|++.+|..||+|.||++.|+....
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 9999999999999988 66665 688999999999999999999999999999965443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=381.89 Aligned_cols=257 Identities=29% Similarity=0.439 Sum_probs=212.8
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc--EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG--LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~lv~e 323 (558)
+.+..+.||+|+.|+||++. ..+++.+|+|++ ....++...+++.+|+++++..+||+||.+||.|..++ .+++||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34567899999999999994 457889999999 45566788899999999999999999999999998755 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
||++|+|+.++... +.+++...-+|+.+|++||.|||+. ++||||||||+|||++..|++||||||.+..+.+.
T Consensus 159 YMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999999654 6699999999999999999999963 78999999999999999999999999999887554
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
...++.||..|||||-+++..|+.++||||||++++|+.+|+.||.........|+..+ ..+++.. ....+
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll------~~Iv~~p-pP~lP 303 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL------CAIVDEP-PPRLP 303 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH------HHHhcCC-CCCCC
Confidence 44567899999999999999999999999999999999999999987522222222111 1111111 11112
Q ss_pred H-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcCC
Q 008650 484 T-DQMHRLVLIADYCVRQTSAWRPSMSEVLEL--LTSGH 519 (558)
Q Consensus 484 ~-~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~~ 519 (558)
. ....++..++..||++||.+|||+.|++++ +++..
T Consensus 304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 2 356689999999999999999999999985 44433
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=393.79 Aligned_cols=257 Identities=30% Similarity=0.529 Sum_probs=214.6
Q ss_pred CCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc--EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG--LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~lv~e~ 324 (558)
.+...+.||+|+||+||+|.+.....||||++..........+.|.+|+.+|.+++|||||+++|+|.+.. +.+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34555679999999999999865555999999877666666889999999999999999999999999874 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCc-EEecCCCCCceeecCCC-ceEEEeccccccCCCCC
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR-IIHRDIKASNVLLGPDF-EPQITDFGLAKWLPNKC 402 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~ 402 (558)
+++|+|..+++......+++..+++++.|||+||.|||+ ++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999987656789999999999999999999999 67 99999999999999998 99999999998765432
Q ss_pred CcccccccccccCcccchhhc--cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFM--HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
.......||+.|||||++. ...|+.|+||||||++||||+||+.||.......+ +......+ .+.
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--~~~v~~~~---------~Rp 265 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--ASAVVVGG---------LRP 265 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHhcC---------CCC
Confidence 2222356999999999999 66999999999999999999999999998765222 22222222 222
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..+......+..++.+||+.||..||++.+++..|+...
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 222234567888999999999999999999999998654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=368.27 Aligned_cols=260 Identities=25% Similarity=0.436 Sum_probs=216.6
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeE-EEe-Cc-EEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC-CIE-NG-LYLI 321 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~-~~-~~lv 321 (558)
.+|.++++||+|.||+||++ ...+|..+|.|.+.-...+.........|+.+|++|+|||||+++++ +.+ +. +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 35888999999999999999 67899999999998777777888889999999999999999999994 333 33 8999
Q ss_pred EEeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCC-cEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 322 FNFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKR-RIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
||+|.+|+|..++..- ..+.+++..+|+++.|++.||+++|+..++ -|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998653 345799999999999999999999984323 3999999999999999999999999999998
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
....+ ...+.+|||.||+||.+.+.+|+.||||||+||++|||+.-+.||.+.. ..... ..+..+++..+.
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L~-~KI~qgd~~~~p---- 249 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSLC-KKIEQGDYPPLP---- 249 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHHH-HHHHcCCCCCCc----
Confidence 76533 3445789999999999999999999999999999999999999998762 11111 123333333221
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
+..++..+..++..|+..||+.||+...+++.+.+.
T Consensus 250 ----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 250 ----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred ----HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 245667899999999999999999977777766654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=391.21 Aligned_cols=249 Identities=26% Similarity=0.456 Sum_probs=211.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
..|...++||+|||+.||.+.. .+|+.||+|++.+.. ..........+|++|.+.|+|||||+++++|++.. +|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688999999999999999965 889999999998754 33455667889999999999999999999999865 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
|+|.+++|..++. +.+.+++..++.++.||+.||.|||+ ++|+|||||..|+||+++.++||+|||+|..+..+.
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999996 55789999999999999999999999 899999999999999999999999999999886542
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
....+.||||.|+|||++.....+..+||||+||+||.||.|++||+...-... +.+ +.. .+.. .
T Consensus 173 --Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-y~~--Ik~---~~Y~-------~ 237 (592)
T KOG0575|consen 173 --ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-YNK--IKL---NEYS-------M 237 (592)
T ss_pred --cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-HHH--HHh---cCcc-------c
Confidence 344578999999999999999999999999999999999999999987532211 111 111 1111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.....+..+||.++|+++|.+|||+++|+..
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22344567889999999999999999999984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=369.59 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=202.0
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccH-HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|++.++||+|+||+||.++ ..+++.||+|+++|..... ...+....|..||..++||+||+++..|++.. +|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3579999999999999999994 4568999999998875433 35667889999999999999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
++|+.||.|..+|.++ +.+++..+..++++|+.||.|||+ ++||||||||+|||||.+|+++|+|||+++..-..
T Consensus 104 ld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999544 679999999999999999999999 99999999999999999999999999999854332
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.....++|||+.|||||++.+..|+..+|+|||||++|||++|..||...+.... ...+... . ...
T Consensus 179 --~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~--~~~I~~~-k---------~~~ 244 (357)
T KOG0598|consen 179 --GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM--YDKILKG-K---------LPL 244 (357)
T ss_pred --CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH--HHHHhcC-c---------CCC
Confidence 2233458999999999999999999999999999999999999999987643321 1111111 1 011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRP 506 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RP 506 (558)
.+.-...+..+++.+.|.+||++|.
T Consensus 245 ~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCccCCHHHHHHHHHHhccCHHHhc
Confidence 1222345788899999999999996
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=373.24 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=205.7
Q ss_pred hCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccH-----HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDA-----KKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
.+.|.+.+.||+|+||.|-+| +..+|+.||||++.+..... .......+|+++|++++|||||++++++....
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 355778899999999999999 77789999999998764222 12334569999999999999999999998866
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC---CceEEEeccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD---FEPQITDFGL 394 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~ 394 (558)
.|+||||+.||.|.+.+-.. +.+.+.....++.|++.|+.|||+ +||+||||||+|||+..+ ..+||+|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence 79999999999999988654 557777888899999999999999 999999999999999766 7799999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCC---CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI---IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
|+...+. ....+.||||.|.|||++.++. +..++|+||+||+||-+++|.+||.+........ ..+..|.+.
T Consensus 326 AK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~--eQI~~G~y~ 400 (475)
T KOG0615|consen 326 AKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK--EQILKGRYA 400 (475)
T ss_pred hhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH--HHHhcCccc
Confidence 9987632 3455789999999999998764 3458899999999999999999998653322111 111112211
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..........++..++|.+||..||+.|||+.|+|+.
T Consensus 401 ------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 401 ------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1112334667889999999999999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=365.88 Aligned_cols=203 Identities=30% Similarity=0.564 Sum_probs=182.9
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
..+|.....||+|+||+||+|. ..++..||||.+.+........+.+..|+.+|+.++|||||.+++++..++ +||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 3578888899999999999994 456899999999888767777888899999999999999999999998766 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC------CceEEEeccccc
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD------FEPQITDFGLAK 396 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DFG~a~ 396 (558)
|||.||+|..+|+.. +.+++..+..++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999764 479999999999999999999999 899999999999999765 458999999999
Q ss_pred cCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ 455 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~ 455 (558)
.+.+.. ...+.||++.|||||+++...|+.|+|+||+|+|||+|++|+.||+....
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 987543 34567899999999999999999999999999999999999999986543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=375.00 Aligned_cols=276 Identities=24% Similarity=0.400 Sum_probs=226.2
Q ss_pred CCccccCHHHHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeee
Q 008650 231 PLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310 (558)
Q Consensus 231 ~~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 310 (558)
......+.+++.+..+++.+...||+|.||+||+|.+.. .||||++..+...++..+.|.+|+..+++.+|.||+-++
T Consensus 377 ~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFM 454 (678)
T KOG0193|consen 377 NRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFM 454 (678)
T ss_pred cccCCccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeee
Confidence 334444556777777888999999999999999998753 499999999888889999999999999999999999999
Q ss_pred eEEEeCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEE
Q 008650 311 GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT 390 (558)
Q Consensus 311 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 390 (558)
|+|..+...+|+.+|+|.+|+.+||..+ ..|+....+.||.||++|+.|||. ++|||||||..||||.+++.|||+
T Consensus 455 G~~~~p~~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 455 GACMNPPLAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred hhhcCCceeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEe
Confidence 9999999999999999999999998765 569999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCcccchhhcc---CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhc
Q 008650 391 DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH---GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES 467 (558)
Q Consensus 391 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 467 (558)
|||++..-.............|...|||||+++. .+|++.+||||||||+|||+||..||.....+...|..
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV----- 605 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV----- 605 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-----
Confidence 9999965443333333444568999999999964 47999999999999999999999999854333222211
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 468 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
|.---..|... .......+|.+|+..||..++++||.+.+|+..|+....
T Consensus 606 GrG~l~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 606 GRGYLMPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cccccCccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11100111111 122345678899999999999999999999998876554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=376.98 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=220.4
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
+......+...+.||+|.||+||.|.+.....||+|.+.... .....|++|+++|++|+|+|||+++++|..+. +|
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 333444567789999999999999999888899999996543 33456889999999999999999999999866 99
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
||||||+.|+|.++|+......+...+...++.|||+|++||++ +++|||||...||||++++.+||+|||+|+...
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999988667789999999999999999999999 899999999999999999999999999999655
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
++... ......-...|.|||.+..+.++.|||||||||+||||+| |+.||.......+ .+.++...
T Consensus 355 d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev------------~~~le~Gy 421 (468)
T KOG0197|consen 355 DDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV------------LELLERGY 421 (468)
T ss_pred CCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH------------HHHHhccC
Confidence 44332 2222234567999999999999999999999999999999 9999987654322 23444555
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
+-..+..++..+.+++..||+.+|++|||+..+...|.....
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 555566777889999999999999999999999988876544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=367.18 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=211.4
Q ss_pred hhhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-E
Q 008650 243 SATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-L 318 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~ 318 (558)
...++|.+++.||+|+|++|++| ...+++.||||++.|... .+...+-..+|-.+|.+| .||.|++|+-.|.++. +
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 44578999999999999999999 556799999999977643 334455667888999999 7999999999998866 9
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
|+|+||+++|.|.++|+.. +.|++..++.++.+|+.||+|||+ +|||||||||+|||||.||++||+|||.|+.+
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999654 779999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCc-----------ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhc
Q 008650 399 PNKCTH-----------HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES 467 (558)
Q Consensus 399 ~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 467 (558)
...... ....+++||..|.+||++..+..+..+|+|+||||||+|+.|..||...++.+.- .+..-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF-qkI~~-- 301 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF-QKIQA-- 301 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH-HHHHH--
Confidence 643222 1124588999999999999999999999999999999999999999887654331 11111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 468 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
++-.+.. ...+...+|+.+.|..||.+|+|..||-++
T Consensus 302 ------l~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 ------LDYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------hcccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111222 223567889999999999999999998886
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=342.36 Aligned_cols=261 Identities=22% Similarity=0.314 Sum_probs=208.6
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
+.|+.+..+|+|+||+||++ +..+|+.||||++.....++...+-.++|+++|++++|+|+|.|+++|.... ++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777889999999999999 4557999999999777777777888899999999999999999999998765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
||+..-|.++-+. ...++...+.+++.|++.|+.|+|+ +++|||||||+||||+.+|.+||||||+|+.+...
T Consensus 82 ~~dhTvL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 82 YCDHTVLHELERY--PNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred ecchHHHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 9998666555432 3468999999999999999999999 89999999999999999999999999999988642
Q ss_pred cccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-------------hhcCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL-------------MESGN 469 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~-------------~~~~~ 469 (558)
....+..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|..-|.+..+....+.... ..++-
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 223344668999999999987 5899999999999999999999999987654322221111 11112
Q ss_pred cccccCCCCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 LTELVDPSLEGE-----YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 ~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+..+.-|..... ..+....-+.+++..||+.||.+|++-+|++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 222222222211 11334457889999999999999999999886
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=351.88 Aligned_cols=270 Identities=22% Similarity=0.373 Sum_probs=218.5
Q ss_pred hhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
....|.+.++||.|..++||+| ....++.||||++..+..+.. ...+.+|+..|+.++||||++++..|..+. +|+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 4467999999999999999999 667789999999987665444 788999999999999999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|.||.+|++.+++...-...+++..+..|+.++++||.|||. +|.||||||+.||||+.+|.|||+|||.+..+...
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999988777789999999999999999999999 99999999999999999999999999998766543
Q ss_pred CC-cccc-cccccccCcccchhhcc--CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 402 CT-HHAA-IPIEGTFGYLAPEYFMH--GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 402 ~~-~~~~-~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
.. .... .++.||++|||||+++. ..|+.|+||||||++..||.+|..||....+.-+.... + .+......-..
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--L-qn~pp~~~t~~ 256 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--L-QNDPPTLLTSG 256 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--h-cCCCCCccccc
Confidence 32 1222 56789999999999654 36999999999999999999999999876554322211 1 11222111122
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcCCC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL--LTSGHD 520 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~~~ 520 (558)
+..+........+..++..||+.||.+|||++++++. ++....
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 2222223344578999999999999999999999974 444443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=335.73 Aligned_cols=237 Identities=25% Similarity=0.360 Sum_probs=202.2
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|+....||.|+||+|.+++. .+|..||+|++.+... .-.......+|..+|+.+.||+++++++.+.+.. +|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4688899999999999999954 4688999999987653 3344566778999999999999999999998865 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||.+||.|..+|+.. +.+++..++.++.+|+.||+|||+ .+|++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999999654 579999999999999999999999 89999999999999999999999999999987543
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
..+.||||.|+|||.++...|+.++|+|||||++|||+.|..||...+. ...+.+.+...-. +
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v~------------f 260 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKVK------------F 260 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCccc------------C
Confidence 4468999999999999999999999999999999999999999987665 3333332222212 2
Q ss_pred CHHHHHHHHHHHHHhhccCCCCC
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWR 505 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~R 505 (558)
+......+.+|+...|+.|-.+|
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhh
Confidence 33334468889999999999999
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=351.46 Aligned_cols=257 Identities=24% Similarity=0.429 Sum_probs=204.7
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEE-eC--cEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI-EN--GLYLI 321 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~--~~~lv 321 (558)
.+|...+.||+|+||.||++.. ++|+..|||.+..... .....+.+|+.+|++++|||||+++|... .. .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 4577789999999999999954 4589999999866532 22666889999999999999999999743 33 48899
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC-CCceEEEeccccccCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP-DFEPQITDFGLAKWLPN 400 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~ 400 (558)
|||+++|+|.+++..... .+++..+..++.||++||.|||+ +|||||||||+||||+. ++.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999999987665 79999999999999999999998 99999999999999999 79999999999987664
Q ss_pred -CCCcccccccccccCcccchhhccCC-CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 401 -KCTHHAAIPIEGTFGYLAPEYFMHGI-IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 401 -~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
...........||+.|||||++..+. ...++|||||||++.||+||+.||... .....+...........
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~~~P------- 242 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGREDSLP------- 242 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccCCCC-------
Confidence 11222233567999999999999654 335999999999999999999999863 11111111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
..+........+++.+|++.+|+.|||+.++|+...-.
T Consensus 243 --~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 243 --EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred --CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 22334556788899999999999999999999975443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=359.10 Aligned_cols=261 Identities=27% Similarity=0.439 Sum_probs=205.7
Q ss_pred hhCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeC
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIEN 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 316 (558)
..++|.+.+.||+|+||.||+|.. .+++.||||++... ........+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 456799999999999999999953 23568999998643 3344556789999999999 899999999988753
Q ss_pred c--EEEEEEeccCCCHHHHHhhccC-------------------------------------------------------
Q 008650 317 G--LYLIFNFSQNGNLDAALHDERS------------------------------------------------------- 339 (558)
Q Consensus 317 ~--~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 339 (558)
+ .+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 3 8899999999999999865321
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccccccccc
Q 008650 340 -----KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTF 414 (558)
Q Consensus 340 -----~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 414 (558)
..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.............+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 247788889999999999999998 899999999999999999999999999998764332222222334678
Q ss_pred CcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHH
Q 008650 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLI 493 (558)
Q Consensus 415 ~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 493 (558)
.|+|||++.+..++.++|||||||+||||++ |..||........ .... ...+... ..+......+.++
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~-~~~~~~~---------~~~~~~~~~l~~l 309 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQR-LKDGTRM---------RAPENATPEIYRI 309 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHH-HhcCCCC---------CCCCCCCHHHHHH
Confidence 8999999999999999999999999999997 9999986433211 1111 1111111 0112234568899
Q ss_pred HHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 494 ADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 494 i~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
+.+||+.+|.+|||+.|+++.|+...
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.86 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=205.7
Q ss_pred hhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeeccccc---HHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-
Q 008650 244 ATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD---AKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG- 317 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~- 317 (558)
..+.|.+.+.||+|+||+|+.| ...+++.||+|++.+.... ......+.+|+.+++.+. ||||+++++++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999 5567899999977654211 133455668999999999 999999999997654
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-CceEEEeccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFGLAK 396 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~ 396 (558)
.|+||||+.+|+|.+++.. .+.+.+..+.+++.|++.|++|||+ +||+||||||+|||++.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999976 4678889999999999999999999 899999999999999999 999999999999
Q ss_pred cCCCCCCcccccccccccCcccchhhccCC-CC-ccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcC--Cccc
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGI-ID-EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG--NLTE 472 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~ 472 (558)
... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.......... +..+ .+..
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k---i~~~~~~~p~ 244 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK---IRKGEFKIPS 244 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH---HhcCCccCCC
Confidence 874 1223345678999999999999877 76 789999999999999999999998543322211 1111 1111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+ . ...+..++.+||+.+|.+|+|+.++++.
T Consensus 245 ~~--------~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 245 YL--------L---SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred Cc--------C---CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 11 0 4578899999999999999999999953
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=360.64 Aligned_cols=243 Identities=24% Similarity=0.369 Sum_probs=202.1
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-E
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-L 318 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~ 318 (558)
...++|.+..+||+|+||+|+++.. .+++.||||+++|+.. ..+.....+.|.+|+.... ||.+++++.+|.... +
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 3446899999999999999999955 4688999999988753 3445566777888877775 999999999998765 9
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
|+||||+.||++..+ .+.+.+++..+..++++|+.||+|||+ ++|||||||.+|||||.+|++||+|||+++..
T Consensus 445 ~fvmey~~Ggdm~~~---~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH---IHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEecCCCcEEEE---EecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999994433 344679999999999999999999999 99999999999999999999999999999864
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
.. ....+.++||||.|||||++.+..|+..+|+|||||+|||||.|..||.+.+...+ +|..+
T Consensus 519 m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---------------FdsI~ 581 (694)
T KOG0694|consen 519 MG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---------------FDSIV 581 (694)
T ss_pred CC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---------------HHHHh
Confidence 32 22356679999999999999999999999999999999999999999997654322 22222
Q ss_pred CC--CCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008650 479 EG--EYDTDQMHRLVLIADYCVRQTSAWRPSM 508 (558)
Q Consensus 479 ~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~ 508 (558)
.+ .|+.-.+.+.+.++.++|+++|++|..+
T Consensus 582 ~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 21 2334445678889999999999999877
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=356.31 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=210.2
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-CcEEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-NGLYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e 323 (558)
..|.....||+|..|.||.| ...+++.||||++...... ...-+++|+.+|+..+|+|||++++.|.- +.++.|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 45777789999999999999 5567899999999766533 33457899999999999999999998765 45999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|++||+|.+.+... .+++.++..|+.+++.||.|||. ++|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 351 ym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred ecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999998543 48999999999999999999999 9999999999999999999999999999998876543
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
...+.+|||+|||||+.....|++|.||||||++++||+-|..||-.+......|.. ......++ ..+
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI---a~ng~P~l-------k~~ 492 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPKL-------KNP 492 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH---hhcCCCCc-------CCc
Confidence 455678999999999999999999999999999999999999999876554443322 22111111 123
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......|.+++.+||+.|+++||++.|+|++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 3455689999999999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=352.22 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=210.1
Q ss_pred hCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc--EEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG--LYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~l 320 (558)
.++|...+.||.|+||.||+| ...+|..||||++++.... .....-++|+..|++++ |||||+|.+++.+.+ +|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 467999999999999999999 5567999999999665433 44445578999999999 999999999988754 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
|||||+. +|++++... ...+++..++.|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+|+.+..
T Consensus 88 VfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence 9999965 999999765 7889999999999999999999999 9999999999999999888999999999998765
Q ss_pred CCCcccccccccccCcccchhh-ccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-hhc-----------
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYF-MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL-MES----------- 467 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~-~~~----------- 467 (558)
... .+..+.|.+|+|||++ +.+.|+.+.||||+|||++|+.+-+.-|.+..+-...|..-- +..
T Consensus 163 kpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 KPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred CCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 432 3345689999999997 578899999999999999999999999987654433332211 111
Q ss_pred ------CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 468 ------GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 468 ------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
-.+....-..+..-. +....+..+++.+|+..||.+|||+.|.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 011111111111112 2366789999999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=349.75 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=209.3
Q ss_pred hCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GLYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~l 320 (558)
.+.|..++.||+|+||.||+| +..+|+.||+|++..+...+.......+|+.||++|.||||++|.+...+. .+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356778899999999999999 677899999999998887778888889999999999999999999998765 4999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
|+|||+. +|.-++... .-.|++.++.-++.||+.||+|||. ++|+|||||.+|||||.+|.+||+|||+|+.+..
T Consensus 196 VFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999987 777777442 3469999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC--C
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP--S 477 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~--~ 477 (558)
.... ..+..+-|.+|+|||++.+. .|+..+|+||.||||.||++|+..|.+.... .+....+..-|...+-.-+ .
T Consensus 271 ~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 271 SGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCCChhcccccc
Confidence 4332 23445679999999999876 6999999999999999999999999876432 2222222211111111111 0
Q ss_pred CC--------CCCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 478 LE--------GEYDT-------DQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 478 l~--------~~~~~-------~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+. ..+.. ......++|+..+|..||.+|.|+.++|+
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00 01111 11245778999999999999999999887
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.12 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=204.6
Q ss_pred hhhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
...++|.++..||+|+||.||+| ...+|..||+|+++|..- ..........|-.+|....+|+||+||..|++.. +|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35578999999999999999999 455799999999988753 3345667788999999999999999999999866 99
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
|||||++||++..+|.. .+.+++..+..++.+++.|+..||+ .|+|||||||+|+|||..|++||+|||++.-+.
T Consensus 218 LiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999954 4779999999999999999999999 999999999999999999999999999985331
Q ss_pred C-----------------------CCC-----c-----------------ccccccccccCcccchhhccCCCCccccch
Q 008650 400 N-----------------------KCT-----H-----------------HAAIPIEGTFGYLAPEYFMHGIIDEKTDVF 434 (558)
Q Consensus 400 ~-----------------------~~~-----~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvw 434 (558)
. ... . ......+|||-|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 000 0 001245699999999999999999999999
Q ss_pred hHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHH
Q 008650 435 AFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS---MSEV 511 (558)
Q Consensus 435 SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~ev 511 (558)
|||||+||||.|.+||.+..+... |.+..--. ..+.-........+..++|.+|+. ||+.|.. +.||
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T-~rkI~nwr--------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQET-YRKIVNWR--------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh--------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 999999999999999998765422 22211100 111111112223678899999999 9999975 5666
Q ss_pred HH
Q 008650 512 LE 513 (558)
Q Consensus 512 l~ 513 (558)
-+
T Consensus 443 K~ 444 (550)
T KOG0605|consen 443 KK 444 (550)
T ss_pred hc
Confidence 55
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=318.43 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=213.4
Q ss_pred hCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+++.||+|-||.||.| ..+++..||+|++.+... ......++.+|++|.++|+||||+++|++|.++. .||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357899999999999999999 556788999999987653 2344567889999999999999999999999876 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
+||..+|+|...|...+...+++...+.+..|+|.||.|+|. ++|+||||||+|+|++.++.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999988888889999999999999999999998 899999999999999999999999999987643
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.....+.|||..|++||+..+..++..+|+|++|++.||++.|..||.+..... .+.+... .++.
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tYkrI~k-----~~~~------- 240 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TYKRIRK-----VDLK------- 240 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HHHHHHH-----cccc-------
Confidence 334567899999999999999999999999999999999999999999765322 2221111 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
++........++|.+|+..+|.+|.+..|++..
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 123344578899999999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=316.93 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=208.1
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-cEEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-GLYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 323 (558)
.+|...+.||+|.||.||+| +..+|+.||||+++............++|+..|+.++|+||+.++++|... ++.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46778899999999999999 667899999999987766666677889999999999999999999999765 5999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|++. +|+..+++. ...+....+..++.++++||+|||. +.|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 82 fm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9976 899888654 4568888999999999999999999 8999999999999999999999999999998865433
Q ss_pred cccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC----
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL---- 478 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l---- 478 (558)
... ..+-|.+|+|||.+.+. .|+..+||||.|||+.||+-|.+-|.+..+ +.+....+..-|...+-.-|.+
T Consensus 157 ~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 157 IQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCcccCccccccc
Confidence 322 22679999999998765 699999999999999999999877766432 2222222211111111000100
Q ss_pred ------------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 479 ------------EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 479 ------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
....-+...+...+++..+|..||.+|+|+.|.+++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 011223445667999999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=349.55 Aligned_cols=248 Identities=25% Similarity=0.418 Sum_probs=212.7
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|.||.||+|+ ..+.+.||+|.+.|........+.+.+|++|++.++|||||.++++|.... +++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578889999999999999994 457889999999998888888999999999999999999999999998765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.| +|..+|.. .+.++++.+..|+.+++.||+|||+ ++|+|||+||.|||++.+|.+|+||||+|+.+....
T Consensus 82 ~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t- 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT- 154 (808)
T ss_pred hhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence 9988 99999954 4679999999999999999999999 899999999999999999999999999999876532
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
.....+.|||.|||||+..+++|+..+|+||+|||+|||++|++||..... ....+.+..+ +. ..+
T Consensus 155 -~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si--~~Lv~~I~~d--------~v---~~p 220 (808)
T KOG0597|consen 155 -SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI--TQLVKSILKD--------PV---KPP 220 (808)
T ss_pred -eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH--HHHHHHHhcC--------CC---CCc
Confidence 233457799999999999999999999999999999999999999975432 2222211111 11 123
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+..++...|.+||.+|.|-.+++.+
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 3556789999999999999999999998874
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=338.84 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=202.2
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.|...+.||+|+||+||+|. ..+++.||+|.+.+.... ......+.+|+.++++++|+||+.+++++.+++ .++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37788999999999999994 467999999998754322 233456789999999999999999999987765 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+|+|..++.......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999999988865555568999999999999999999999 8999999999999999999999999999987643322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHH--HHhhhhhhcCCcccccCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLV--LWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .... ..... ...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-~~~~~----------~~~ 223 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR-RVKED----------QEE 223 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH-Hhhcc----------ccc
Confidence 1234699999999999999999999999999999999999999986432211 1111 00000 011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 514 (558)
++......+.+++.+||+.||.+||+ +.++++.
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 22233457889999999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=354.17 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=214.4
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecc-cccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKD-NKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.-|.+++.||.|+.|.|-.| +..+|+.+|||++.+. .........+.+|+-+|+.+.|||++++|+++.+.. +|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34788999999999999999 6678999999999877 344555677889999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|.|.++|.. .+++++..+.+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|..-.++.
T Consensus 92 Eyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999999954 4679999999999999999999998 899999999999999999999999999998654432
Q ss_pred CcccccccccccCcccchhhccCCCC-ccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIID-EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
...+-||+|-|.|||++++.+|+ .++||||+|||||.||||+.||++.+... ++.+..++.
T Consensus 167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~---------------LLlKV~~G~ 228 (786)
T KOG0588|consen 167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV---------------LLLKVQRGV 228 (786)
T ss_pred ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH---------------HHHHHHcCc
Confidence 33456899999999999999885 68999999999999999999999653321 111111221
Q ss_pred --CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcCCCcccc
Q 008650 482 --YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL--LTSGHDSEFA 524 (558)
Q Consensus 482 --~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~~~~~~~ 524 (558)
.+.....+.++|+.+|+..||++|.|+.||+++ |.+..+....
T Consensus 229 f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 229 FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 134455678999999999999999999999996 5555554444
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=338.78 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=203.7
Q ss_pred hCCCcccceEeeeCceEEEEEEECC-----------------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCee
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSD-----------------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 307 (558)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... .......|.+|+.++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3578899999999999999996432 3369999986542 345567899999999999999999
Q ss_pred eeeeEEEeCc-EEEEEEeccCCCHHHHHhhccC-----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcE
Q 008650 308 TLVGCCIENG-LYLIFNFSQNGNLDAALHDERS-----------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369 (558)
Q Consensus 308 ~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~-----------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~i 369 (558)
++++++.+.+ .++||||+.+|+|.+++..... ..+++..+++++.||+.||.|||+ .+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 9999998755 8999999999999998865321 246778899999999999999999 899
Q ss_pred EecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc--CC
Q 008650 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT--GR 447 (558)
Q Consensus 370 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt--g~ 447 (558)
+||||||+|||++.++.+||+|||+++.+.............++..|+|||++.++.++.++|||||||++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999986644332222223446889999999999999999999999999999986 66
Q ss_pred CCCCCCchh-HHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 448 KPVDSSRQN-LVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 448 ~Pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.||...... ................. ...++.....+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 788754322 11111111111110000 01112234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=346.91 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=218.2
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc--EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG--LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~lv~ 322 (558)
++|...+.+|+|+||.++.+ ...++..|++|++.............++|+.+++++.|||||.+.+.|.+++ +++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998 4456889999999888777777778999999999999999999999998765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
+|++||+|.+.|...++..++++.+++++.|++.|+.|||+ +.|+|||||+.|||++.++.+||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999998887889999999999999999999998 899999999999999999999999999999987654
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
. ...+..||+.||.||++.+.+|+.|+|||||||++|||++-+.+|...+..... .... .......
T Consensus 161 ~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li--~ki~----------~~~~~Pl 226 (426)
T KOG0589|consen 161 S--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI--LKIN----------RGLYSPL 226 (426)
T ss_pred h--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHH--HHHh----------hccCCCC
Confidence 2 344577999999999999999999999999999999999999999876433111 1111 1112233
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+..+..++..++..||+.+|..||++.++|..
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 45667789999999999999999999999985
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=335.29 Aligned_cols=249 Identities=22% Similarity=0.401 Sum_probs=209.4
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
-+|.+.+.||+|+||.|-+| ....|+.||||.++++. .+......+.+|++||+.|+||||+.+|++|.+.+ ..+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 35788899999999999999 55789999999998875 44566778889999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||..+|.|++++... +.+++..+..++.||..|+.|+|. ++++|||||.+|||||.++++||+|||++..+...
T Consensus 133 EYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 133 EYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 999999999999543 679999999999999999999998 89999999999999999999999999999887654
Q ss_pred CcccccccccccCcccchhhccCCCC-ccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIID-EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
....++||+|.|.+||++.+.+|. +.+|-|||||+||.|+.|..||++.......- .+..|.+.+ +
T Consensus 207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr---QIs~GaYrE---P----- 273 (668)
T KOG0611|consen 207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR---QISRGAYRE---P----- 273 (668)
T ss_pred --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH---HhhcccccC---C-----
Confidence 234568999999999999999885 78999999999999999999999865432211 122222222 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
.......-+|.+||..+|++|.|+.+|...-.
T Consensus 274 ---~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 274 ---ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ---CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11223445789999999999999999988543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=322.83 Aligned_cols=260 Identities=21% Similarity=0.324 Sum_probs=207.9
Q ss_pred CCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe---CcEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE---NGLYLIF 322 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~lv~ 322 (558)
+|+.++.|++|+||.||+| +.++++.||+|+++.+..........++|+++|.+.+|||||.+-++... +..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4788999999999999999 55689999999998766555556678899999999999999999998765 3499999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
|||+. +|..+++... .++....+.-+..|++.||.|||. +.|+||||||+|+|++..|.+||+|||+|+.+....
T Consensus 157 e~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99987 8888887654 578888999999999999999998 899999999999999999999999999999887652
Q ss_pred CcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC--
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE-- 479 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-- 479 (558)
...+..+-|.+|+|||.+.+. .|++.+|+||+|||+.||++++.-|.+.... .+..+.+..-|...+.+.+.+.
T Consensus 232 --k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 232 --KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred --ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHhCCCccccCCCcccc
Confidence 334456789999999999875 6999999999999999999999999875432 2222222222222222222211
Q ss_pred -----------------CCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 -----------------GEYDTD-QMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 -----------------~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+... ..+.=++++..+|..||.+|.|++|-|+.
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111111 23566788899999999999999998874
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=349.80 Aligned_cols=259 Identities=23% Similarity=0.385 Sum_probs=203.6
Q ss_pred hhCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeC
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIEN 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 316 (558)
..++|++.+.||+|+||.||+|.. .++..||||++.... .......+.+|+.++..+ +||||+++++++.++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 345789999999999999999853 245689999986433 234456788999999999 899999999999876
Q ss_pred c-EEEEEEeccCCCHHHHHhhccC--------------------------------------------------------
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERS-------------------------------------------------------- 339 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 339 (558)
+ .++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 5 8999999999999999865321
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 340 -----------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 340 -----------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
..+++..+++++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 246788899999999999999998 899999999999999999999999999998765433
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.........++..|+|||++.+..++.++|||||||++|||++ |..||.........+. .+..+... .
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~--~~~~~~~~---------~ 337 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK--MIKEGYRM---------L 337 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH--HHHhCccC---------C
Confidence 2222222335678999999999999999999999999999998 8999976433221111 11111100 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.+.....++.+++.+||+.||++|||+.||++.|++
T Consensus 338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 111123468899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=336.44 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=204.9
Q ss_pred HhhhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHH------------HHHHHHHHHHHhcccccCCeee
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAK------------KEKEFLMELGIIGHVCHPNTAT 308 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~ 308 (558)
....|+|++...||+|.||.|-+| +..+++.||||++.+...... ......+|+.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345689999999999999999999 556799999999976543211 1246788999999999999999
Q ss_pred eeeEEEe---CcEEEEEEeccCCCHHHHHhhccCCC-CCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC
Q 008650 309 LVGCCIE---NGLYLIFNFSQNGNLDAALHDERSKS-LEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD 384 (558)
Q Consensus 309 l~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 384 (558)
|+++..+ +.+|||+|||..|.+...= .... +.+.++++++.++..||+|||. ++||||||||+|+||+.+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 9999875 3499999999999886543 2233 8999999999999999999999 999999999999999999
Q ss_pred CceEEEeccccccCCCCCCc---ccccccccccCcccchhhccCC----CCccccchhHHHHHHHHHcCCCCCCCCchhH
Q 008650 385 FEPQITDFGLAKWLPNKCTH---HAAIPIEGTFGYLAPEYFMHGI----IDEKTDVFAFGVLLLEIITGRKPVDSSRQNL 457 (558)
Q Consensus 385 ~~~kl~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~ 457 (558)
|++||+|||.+...+..... .......|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-+.....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999999866332111 1122357999999999997742 3578999999999999999999998653211
Q ss_pred HHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 458 VLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 458 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.. ..++...+.-...++..+.+.+++.++|..||++|.+..+|..+..-
T Consensus 327 --l~---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 327 --LF---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred --HH---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11 11222233333334566789999999999999999999999886543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=340.66 Aligned_cols=258 Identities=27% Similarity=0.439 Sum_probs=206.6
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCC----EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGR----KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 320 (558)
.+|+..+.||+|+||.||+|.+ .++. .||+|++... ........+.+|+.+++.++||||+++++++..+..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCcee
Confidence 5689999999999999999964 3344 3899998543 33455667889999999999999999999998888899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
++||+.+|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999997543 458889999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||........ .. ....+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--~~-~~~~~~~--------- 229 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SS-ILEKGER--------- 229 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--HH-HHhCCCC---------
Confidence 433222222335778999999999999999999999999999998 9999986543221 11 1111110
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
...+......+..++.+||+.+|++||++.+++..|.....
T Consensus 230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 01111223468889999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.37 Aligned_cols=247 Identities=20% Similarity=0.317 Sum_probs=200.0
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccH-HHHHHHHHHHHHhcccccCCeeeeeeEEEe--C---cEEEEEEe
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVGCCIE--N---GLYLIFNF 324 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~---~~~lv~e~ 324 (558)
...||+|++|.||+|.. +|+.||||++.+..... .....|.+|+.+|++++||||+++++++.+ + ..++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999987 68899999997654322 334678899999999999999999999876 2 37899999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+|+|.+++... ..+++.....++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999999654 4688999999999999999999972 478899999999999999999999999998654322
Q ss_pred ccccccccccCcccchhhcc--CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMH--GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
....||..|+|||++.+ ..++.++|||||||++|||++|+.||........ .......+. +...
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~--~~~i~~~~~---------~~~~ 243 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI--YDLIINKNN---------SLKL 243 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHhcCC---------CCCC
Confidence 12358899999999976 6899999999999999999999999986543211 111111111 1111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 223455789999999999999999999999998753
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=350.19 Aligned_cols=260 Identities=25% Similarity=0.424 Sum_probs=203.6
Q ss_pred hhCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeC
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIEN 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 316 (558)
..++|.+.+.||+|+||.||+|.. .++..||+|++.... .......+.+|+.+++.+ +|+||+++++++.++
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 345789999999999999999853 234579999996543 234456788999999999 799999999999876
Q ss_pred c-EEEEEEeccCCCHHHHHhhcc---------------------------------------------------------
Q 008650 317 G-LYLIFNFSQNGNLDAALHDER--------------------------------------------------------- 338 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 338 (558)
+ .++||||+.+|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 5 999999999999999886431
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 339 -----------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 339 -----------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
...+++..+++++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++.+.........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 1247788899999999999999999 89999999999999999999999999999876443322222
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQ 486 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 486 (558)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.........+ . ....+ . .. ..+...
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~-~-~~~~~-~----~~----~~~~~~ 340 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY-K-MVKRG-Y----QM----SRPDFA 340 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH-H-HHHcc-c----Cc----cCCCCC
Confidence 22335678999999999999999999999999999997 999997643321111 1 11111 0 00 011112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 487 MHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 487 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+.+++.+||+.+|.+|||+.+|++.|++.
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 35788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=340.11 Aligned_cols=253 Identities=25% Similarity=0.443 Sum_probs=210.8
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
..|+..++||+|.||.||+| +..+++.||+|++..+.. .....++..|+.+|.+++++||.++|+.+..+. ++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 35777789999999999999 667899999999976543 344567889999999999999999999998766 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
||.||++.+.|.. +..+++....-++.+++.||.|||. ++.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 92 y~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999999954 3445777778899999999999999 8999999999999999999999999999988766433
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
...+++|||.|||||+++...|+.|+||||||++.+||.+|.+|+....+..+.+ ++.+...+.+.
T Consensus 167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L~ 232 (467)
T KOG0201|consen 167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRLD 232 (467)
T ss_pred --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCccc
Confidence 3367889999999999998899999999999999999999999998765532221 22222223333
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcC
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL--LTSG 518 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~ 518 (558)
......|.+++..||..+|+.||++.++++. ++.+
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 3445568999999999999999999999985 5553
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=334.65 Aligned_cols=262 Identities=20% Similarity=0.306 Sum_probs=202.6
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|+||+||+|... +++.||+|++............+.+|+.+++.++||||+++++++.+++ .++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999654 6889999999765444445567889999999999999999999987755 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.++.+..+.. ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 999987765543 23468999999999999999999998 8999999999999999999999999999987644322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhh-------------hhhcCCc
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP-------------LMESGNL 470 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~-------------~~~~~~~ 470 (558)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............. .......
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 12223568999999999999899999999999999999999999998653321111000 0001111
Q ss_pred ccccCCCCCCC------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 471 TELVDPSLEGE------YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 471 ~~~~d~~l~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.....+..... +.......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111100 01123456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.10 Aligned_cols=256 Identities=26% Similarity=0.477 Sum_probs=205.6
Q ss_pred CCCcccceEeeeCceEEEEEEECC------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSD------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
++|++.+.||+|+||.||+|.... ...+|+|.+... ........|.+|+.++..++||||+++++++.+.. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468889999999999999995432 257999998643 33455667889999999999999999999987755 8
Q ss_pred EEEEEeccCCCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC
Q 008650 319 YLIFNFSQNGNLDAALHDERS--------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD 384 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 384 (558)
+++|||+.+++|.+++..... ..+++..++.++.|++.||.|||+ ++++|+||||+||+++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence 999999999999999965422 457888999999999999999999 899999999999999999
Q ss_pred CceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhh
Q 008650 385 FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKP 463 (558)
Q Consensus 385 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 463 (558)
+.+||+|||++................+++.|+|||++.++.++.++|||||||++|||++ |..||......... .
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~--~- 237 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI--E- 237 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH--H-
Confidence 9999999999986543322222233457889999999999999999999999999999998 99999765432211 1
Q ss_pred hhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.+..+... ..+.....++.+++.+||+.+|.+||++.||++.|++
T Consensus 238 ~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 1122345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=361.66 Aligned_cols=257 Identities=24% Similarity=0.452 Sum_probs=212.3
Q ss_pred hCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
..+....+.||+|.||+||+|... +...||||.++ +..+.....+|.+|++++..++|||||+|+|+|.+++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LK-d~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALK-DKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhc-ccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 345566789999999999999542 34679999995 4455667889999999999999999999999999877
Q ss_pred EEEEEEeccCCCHHHHHhhccC--------C----CCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC
Q 008650 318 LYLIFNFSQNGNLDAALHDERS--------K----SLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~--------~----~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 385 (558)
+++|+|||..|+|.++|+.... . +++..+.+.||.|||.|+.||-+ +.+|||||...|+||+++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceeccce
Confidence 9999999999999999976421 2 27888999999999999999998 8999999999999999999
Q ss_pred ceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhh
Q 008650 386 EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPL 464 (558)
Q Consensus 386 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 464 (558)
.|||+|||+++.+-..+.........-..+|||||.++.++++++||||||||+|||+++ |+.||.+.....+. ..
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI---e~ 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI---EC 717 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH---HH
Confidence 999999999987654444333322234678999999999999999999999999999999 99999876544322 22
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
+..+++ -..+...+.++..|+..||+.+|.+||+++||-..|..
T Consensus 718 i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 718 IRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred HHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 333333 12244556689999999999999999999999999976
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.11 Aligned_cols=259 Identities=21% Similarity=0.335 Sum_probs=210.5
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--- 316 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 316 (558)
.....++|.+.+.||+|+||+||+|. ..+|+.||||++............+.+|+.++..++|+||+++++.+...
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 34456799999999999999999994 56799999999977666666677888999999999999999998776421
Q ss_pred ------cEEEEEEeccCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceE
Q 008650 317 ------GLYLIFNFSQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ 388 (558)
Q Consensus 317 ------~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 388 (558)
.+++||||+.+|+|.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEE
Confidence 1679999999999999986532 3468999999999999999999999 8999999999999999999999
Q ss_pred EEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcC
Q 008650 389 ITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG 468 (558)
Q Consensus 389 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 468 (558)
|+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .+
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~--~~~~~-~~ 260 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV--MHKTL-AG 260 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHh-cC
Confidence 9999999876543333333456799999999999999999999999999999999999999986543211 11111 11
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 469 NLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 469 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
... ..+......+.+++.+||+.+|.+||++.++++.
T Consensus 261 ~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 1122334578899999999999999999999874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.44 Aligned_cols=243 Identities=21% Similarity=0.288 Sum_probs=196.8
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
+.||+|+||.||++.. .+|+.||+|++.+... .......+.+|+.++++++||||+++++++..++ .++||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999954 5789999999975432 2344566788999999999999999999988765 99999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccc
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 408 (558)
+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~ 153 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cccc
Confidence 999998643 568999999999999999999999 899999999999999999999999999987532211 1223
Q ss_pred ccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHH
Q 008650 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMH 488 (558)
Q Consensus 409 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 488 (558)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ... .+. . .++.....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--~~~-~~~------~----~~p~~~~~ 220 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE--LIL-MEE------I----RFPRTLSP 220 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH--HHH-cCC------C----CCCCCCCH
Confidence 4569999999999999999999999999999999999999997654322111 111 111 0 11223345
Q ss_pred HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 489 RLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 489 ~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
.+.+++.+||+.||++|| ++.++++.
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 688999999999999999 79998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=339.81 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=203.8
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||.||+|... +++.||+|++.+... .......+.+|+.++..++||||+++++++.++. .|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999654 689999999976532 2234567889999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999643 468899999999999999999999 8999999999999999999999999999986543
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .... ...+........
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--i~~~---~~~~~~~~~~~~ 225 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN--LKYW---KETLQRPVYDDP 225 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH--HHhc---cccccCCCCCcc
Confidence 22335699999999999999999999999999999999999999986543221110 0000 000110000000
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 12234578899999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.16 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=201.1
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||.||+|.. .+++.||+|++.+... .......+.+|+.++++++||||+++++++.+++ .|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5689999999999999999955 4689999999975432 2234566889999999999999999999988765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999999653 468889999999999999999999 899999999999999999999999999998764322
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ +. . +..+.. .+
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~-~-i~~~~~----------~~ 234 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-YE-K-ILAGRL----------KF 234 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-HH-H-HhcCCc----------CC
Confidence 234699999999999999999999999999999999999999976543211 11 1 111111 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 514 (558)
+......+.+++.+||+.||.+||+ +.++++.
T Consensus 235 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1112346789999999999999997 6777764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.09 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=200.7
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.+++.++||||+++++++.++. .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4688999999999999999955 4789999999965432 2234556888999999999999999999887765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999999653 468899999999999999999999 89999999999999999999999999999865432
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..... +.. .+
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~--~~i~~-~~~----------~~ 217 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY--EKILA-GKL----------EF 217 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-CCc----------CC
Confidence 12346999999999999999999999999999999999999999865432111 11111 110 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 514 (558)
+......+.+++.+||+.||.+||+ +.++++.
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1222346889999999999999995 8888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=343.07 Aligned_cols=241 Identities=28% Similarity=0.494 Sum_probs=202.9
Q ss_pred ccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 250 SENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 250 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
-++-||.|+.|.||+|++. ++.||||+++.-. ..++.-|++|+|+||+.|.|+|.... .+||||||..|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3578999999999999874 7889999984211 14677899999999999999999866 88999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccc
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 408 (558)
.|+.+|+.. ..+.......+..+||.|++|||. +.|||||||.-||||..+..+||+|||-++...+. ....
T Consensus 198 qL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 198 QLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred cHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 999999654 568888889999999999999999 89999999999999999999999999999876654 2334
Q ss_pred ccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHH
Q 008650 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMH 488 (558)
Q Consensus 409 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 488 (558)
.++||..|||||++++.+.++|+|||||||||||||||..||.+-..+...|.. -...+....+..+..
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV-----------GsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV-----------GSNSLHLPVPSTCPD 338 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec-----------cCCcccccCcccCch
Confidence 578999999999999999999999999999999999999999875544333321 112233334556667
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 489 RLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 489 ~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
-|..|+.+||+..|..||++.+++.+|.=+.
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 8999999999999999999999999987544
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=327.88 Aligned_cols=255 Identities=22% Similarity=0.352 Sum_probs=203.5
Q ss_pred hCCCcccceEeeeCceEEEEEEE----CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
.++|++.+.||+|+||.||+|.. ..+..||+|.+.... .......+.+|+.++.+++||||+++++++..+. .+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 45689999999999999999954 235689999986543 3444567899999999999999999999987755 99
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+|+|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.++++|||.+....
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999999654 3468999999999999999999998 899999999999999999999999999876543
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
.... .......++..|+|||++.++.++.++|||||||++|||++ |+.||........ .. .+..+..
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--~~-~~~~~~~-------- 226 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--IK-AVEDGFR-------- 226 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HH-HHHCCCC--------
Confidence 2211 11112335678999999999999999999999999999875 9999986543221 11 1111110
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
...+......+.+++.+||+.+|.+||++.+|++.|.+
T Consensus 227 -~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 -LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 01122334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=339.94 Aligned_cols=261 Identities=27% Similarity=0.429 Sum_probs=205.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeC
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIEN 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 316 (558)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... .......+..|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 345799999999999999999942 235789999986432 344456788899999999 799999999988653
Q ss_pred --cEEEEEEeccCCCHHHHHhhccC-------------------------------------------------------
Q 008650 317 --GLYLIFNFSQNGNLDAALHDERS------------------------------------------------------- 339 (558)
Q Consensus 317 --~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 339 (558)
.+++++||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 38899999999999999864321
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccC
Q 008650 340 ----KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415 (558)
Q Consensus 340 ----~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 415 (558)
..+++..+.+++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++..+.............++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 257899999999999999999998 8999999999999999999999999999987654332222223456788
Q ss_pred cccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHH
Q 008650 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIA 494 (558)
Q Consensus 416 y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 494 (558)
|+|||++.+..++.++|||||||+||||++ |..||......... .. .+..+... ..+......+.+++
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~-~~-~~~~~~~~---------~~~~~~~~~~~~l~ 309 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF-CR-RLKEGTRM---------RAPEYATPEIYSIM 309 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH-HH-HHhccCCC---------CCCccCCHHHHHHH
Confidence 999999999999999999999999999998 99999754322111 11 11111110 11122345788999
Q ss_pred HHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 495 DYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 495 ~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.+||+.+|++||++.|+++.|....
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=329.97 Aligned_cols=261 Identities=22% Similarity=0.350 Sum_probs=195.4
Q ss_pred CCCcccceEeeeCceEEEEEEE-C-CCCEEEEEEeecccccHHHHHHHHHHHHHhccc---ccCCeeeeeeEEEe-----
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-S-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV---CHPNTATLVGCCIE----- 315 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 315 (558)
++|++.+.||+|+||+||+|.. . +++.||+|++............+.+|+.+++.+ .||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999964 3 467899999865543333334455666666555 69999999998852
Q ss_pred -CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 316 -NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 316 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
...++||||+. ++|..++.......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 23899999996 589998876555668999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-Hhhhhhh---cCCc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLME---SGNL 470 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~---~~~~ 470 (558)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... ....
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9865433 1223356899999999999999999999999999999999999999865432111 1100000 0000
Q ss_pred c-------cccCCCCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 471 T-------ELVDPSLEG---EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 471 ~-------~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
. ..+.+.... ...+.....+.+++.+||+.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000000 000122346788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=334.58 Aligned_cols=261 Identities=22% Similarity=0.368 Sum_probs=203.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|++.+.||+|+||.||++.. .++..+|+|.+.... .......+.+|++++++++||||+++++++.+++ .++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 46899999999999999999955 468889999986542 3445667899999999999999999999988765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 83 EHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999999653 4588999999999999999999972 369999999999999999999999999997654322
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHH-h-hhhhhc--CCccc------
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW-A-KPLMES--GNLTE------ 472 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~-~-~~~~~~--~~~~~------ 472 (558)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . ...... +....
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 123459999999999999999999999999999999999999997543321110 0 000000 00000
Q ss_pred -------------------------ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 473 -------------------------LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 473 -------------------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+................+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000011234578999999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=339.39 Aligned_cols=262 Identities=19% Similarity=0.306 Sum_probs=197.3
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------cEE
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------GLY 319 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 319 (558)
+|++.+.||+|+||.||+|. ..+++.||||++............+.+|+.++++++||||+++++++... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 48889999999999999995 45789999999865433344456788999999999999999999987532 279
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+. ++|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6898888543 468999999999999999999999 899999999999999999999999999998653
Q ss_pred CCCCc-ccccccccccCcccchhhcc--CCCCccccchhHHHHHHHHHcCCCCCCCCchhHH-HHhhhh-----------
Q 008650 400 NKCTH-HAAIPIEGTFGYLAPEYFMH--GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLV-LWAKPL----------- 464 (558)
Q Consensus 400 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~-~~~~~~----------- 464 (558)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 32211 11233569999999999876 6789999999999999999999999976432110 000000
Q ss_pred hhcCCcccccC---CCCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 465 MESGNLTELVD---PSLEGEY---DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 465 ~~~~~~~~~~d---~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+........+. +...... .+.....+.+++.+||+.+|++|||+.|+++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 0000000 01123467899999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=326.43 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=207.1
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.++|++.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.+++.++|+||+++++.+.+++ .+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 46789999999999999999988788899999986532 23467889999999999999999999887655 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++.......+++..++.++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999999977666678999999999999999999998 8999999999999999999999999999987654322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
. ......++..|+|||++.++.++.++|||||||++|+|++ |+.||........... +..+. .. ..
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~---~~~~~-----~~----~~ 225 (261)
T cd05072 159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA---LQRGY-----RM----PR 225 (261)
T ss_pred e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH---HHcCC-----CC----CC
Confidence 1 1122346778999999998999999999999999999998 9999976433221111 11110 00 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.......+.+++.+||..+|++|||++++++.|+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11233468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=341.88 Aligned_cols=260 Identities=26% Similarity=0.418 Sum_probs=205.7
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeC
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIEN 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 316 (558)
..++|.+.+.||+|+||.||+|... .+..||||++.... .......+.+|+.+++++. ||||+++++++.+.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 3567899999999999999999542 23479999996543 3444567899999999996 99999999999875
Q ss_pred c-EEEEEEeccCCCHHHHHhhcc---------------------------------------------------------
Q 008650 317 G-LYLIFNFSQNGNLDAALHDER--------------------------------------------------------- 338 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 338 (558)
. .|+||||+.+|+|.++|+..+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 5 999999999999999886532
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee
Q 008650 339 -------------------------------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL 381 (558)
Q Consensus 339 -------------------------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 381 (558)
...+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEE
Confidence 1247788889999999999999998 899999999999999
Q ss_pred cCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHH
Q 008650 382 GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLW 460 (558)
Q Consensus 382 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~ 460 (558)
+.++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|||++ |..||.........+
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999999987644332222233457789999999999999999999999999999997 999997643322111
Q ss_pred hhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 461 AKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 461 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
. ....+. ....+......+.+++.+||+.+|++|||+.+|.+.|...
T Consensus 351 ~--~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 N--KIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred H--HHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1 111110 1111223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.43 Aligned_cols=250 Identities=30% Similarity=0.553 Sum_probs=196.3
Q ss_pred ccceEeeeCceEEEEEEEC-----CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 250 SENMVGQGGYSEVYKGNLS-----DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 250 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
+.+.||.|.||.||+|.+. .+..|+||.+.. .........|.+|++.+++++||||++++|++.+.. .++|+|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4678999999999999665 356799999943 444556788999999999999999999999999644 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+|+|.++|.......+++..++.|+.||+.||.|||+ ++++|+||+++|||++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987756779999999999999999999999 8999999999999999999999999999987633322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
........+...|+|||.+.+..++.++||||||+++|||++ |+.||........ .... ..+.... .
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~--~~~~-~~~~~~~---------~ 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI--IEKL-KQGQRLP---------I 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH--HHHH-HTTEETT---------S
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccc-cccccce---------e
Confidence 222233447788999999999999999999999999999999 7899976543321 1111 1111111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
+......+.+++..||..+|++|||+.++++.|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112344688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=328.84 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=205.6
Q ss_pred hCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+++++.+.|+||+++++++..+.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 356888999999999999999553 34789999986543 3345678899999999999999999999998765
Q ss_pred EEEEEEeccCCCHHHHHhhcc------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC
Q 008650 318 LYLIFNFSQNGNLDAALHDER------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 385 (558)
.+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCC
Confidence 999999999999999997542 2357888999999999999999998 8999999999999999999
Q ss_pred ceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhh
Q 008650 386 EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPL 464 (558)
Q Consensus 386 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 464 (558)
.+||+|||++..+.............+++.|+|||++.++.++.++|||||||++|||++ |+.||.......... .
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~---~ 236 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE---C 236 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---H
Confidence 999999999976543322222223346788999999999999999999999999999998 999997644332111 1
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
...+.... .+......+.+++.+||+.+|++|||+.||++.|++
T Consensus 237 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111111 111234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=340.08 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=204.0
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH-HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||+||+|.. .+++.||+|++.+..... .....+..|+.++..++|+||+++++++.+++ .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4789999999999999999955 478999999997653222 44567888999999999999999999988765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999654 568999999999999999999999 899999999999999999999999999998765432
Q ss_pred ---------------------------CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch
Q 008650 403 ---------------------------THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ 455 (558)
Q Consensus 403 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~ 455 (558)
.........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00122235699999999999999999999999999999999999999986543
Q ss_pred hHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 008650 456 NLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS-MSEVLEL 514 (558)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~ 514 (558)
.... ....... ..+...........+.+++..|++ +|.+||+ +.++++.
T Consensus 236 ~~~~--~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETY--NKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH--HHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2211 1111100 000000011134568889999997 9999999 9999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.73 Aligned_cols=249 Identities=20% Similarity=0.347 Sum_probs=201.1
Q ss_pred CcccceEeeeCceEEEEEEE-CC-CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SD-GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
|.+.+.||+|+||.||+|.. .+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++..++ .|+||||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 88899999999999999943 44 6788888775433 344456778999999999999999999998765 9999999
Q ss_pred ccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 325 SQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 325 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
+.+|+|.+++... ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988643 23468899999999999999999998 899999999999999999999999999998765443
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..... +... ..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~--~~~~~-~~~~---------~~ 291 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM--QQVLY-GKYD---------PF 291 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-CCCC---------CC
Confidence 322334567999999999999999999999999999999999999999765432111 11111 1111 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+......+.+++.+||+.+|++||++.+++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1223356889999999999999999999875
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.45 Aligned_cols=248 Identities=25% Similarity=0.422 Sum_probs=192.2
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.+|...+.||+|+||.||+|.. .+++.||||++.... .......+.+|+.+++.++|+||+++++++.+++ .++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 3466778999999999999954 478999999985433 3445667889999999999999999999997765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+|+|... ....+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 153 ~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 153 FMDGGSLEGT------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred cCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999998643 235677788999999999999998 8999999999999999999999999999987643221
Q ss_pred cccccccccccCcccchhhcc-----CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMH-----GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
......||..|+|||++.. ...+.++|||||||++|||++|+.||....... |....... ... .
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~-~~~------~ 292 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAI-CMS------Q 292 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHH-hcc------C
Confidence 1223469999999999843 234568999999999999999999997432211 11100000 000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...........+.+++.+||+.+|++|||+.|+++.
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122334578999999999999999999999984
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=323.47 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=206.4
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
..++|++.+.||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++||||+++++++..++ .+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 3467899999999999999999777778899999865432 2456889999999999999999999987655 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++.......+++..+..++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999976554568999999999999999999998 899999999999999999999999999998765332
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.. ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......... .+... . ...
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~~~-~--------~~~ 224 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ---QVDQG-Y--------RMP 224 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHHcC-C--------CCC
Confidence 11 1111223467999999998899999999999999999999 999997654322111 11111 0 001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.+......+.+++.+||+.+|++||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 112234578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=325.06 Aligned_cols=255 Identities=28% Similarity=0.460 Sum_probs=205.7
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
..+|.+.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++.+.|+||+++++++..+. .+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 34588889999999999999954 468899999986432 33567889999999999999999999987655 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++.......+++..++.++.|++.||.|||+ ++++||||||+|||+++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999976655678999999999999999999998 899999999999999999999999999998765432
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.. ......++..|+|||++.+..++.++|||||||++|||++ |..||........ + ... ..+ ....
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~-~~~-~~~---------~~~~ 225 (263)
T cd05052 159 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-Y-ELL-EKG---------YRME 225 (263)
T ss_pred ee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-H-HHH-HCC---------CCCC
Confidence 21 1112234678999999999999999999999999999998 9999976433211 1 111 111 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.+......+.+++.+||+.+|++|||+.++++.|+..
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1222345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=337.39 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=215.1
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EE
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LY 319 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~ 319 (558)
......|++++.||+||.+.||++...+.+.||+|++.....+......|.+|+..|.++. |.+||+|++|-..++ +|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3455679999999999999999998888899999999887888899999999999999997 999999999987665 99
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+|||+- ..+|..+|.........| .+..++.|++.|+.++|. .||||.||||.|+|+= .|.+||+|||+|..+.
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 999985 448999997665444445 678899999999999999 9999999999999994 5799999999999999
Q ss_pred CCCCcccccccccccCcccchhhccCC-----------CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGI-----------IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG 468 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 468 (558)
.+.+.......+||+.||+||.+.... .++++||||||||||+|+.|+.||..-.. .|+
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---~~a------- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---QIA------- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---HHH-------
Confidence 888888888899999999999985432 56799999999999999999999975422 122
Q ss_pred CcccccCCCCCCCCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 469 NLTELVDPSLEGEYDTDQ-MHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 469 ~~~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
++..+.++....+|+..- ..++++++..||++||.+|||+.|+|+.
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 234455665544444211 2239999999999999999999999985
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=327.74 Aligned_cols=259 Identities=22% Similarity=0.391 Sum_probs=203.9
Q ss_pred hhhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
..+++|++.+.||+|+||.||+|... ++..||+|++.... ......++.+|+.+++.++||||+++++++.++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 35678999999999999999998542 35679999985432 234456788999999999999999999998765
Q ss_pred c-EEEEEEeccCCCHHHHHhhccC--------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCce
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERS--------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEP 387 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 387 (558)
. .++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCE
Confidence 5 8999999999999999865332 235778889999999999999998 899999999999999999999
Q ss_pred EEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhh
Q 008650 388 QITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLME 466 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 466 (558)
+|+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||........ .....
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~--~~~~~- 235 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV--LRFVM- 235 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHH-
Confidence 9999999986544332222222346788999999999999999999999999999999 7899976433211 11111
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 467 SGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 467 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.+.... .+......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 236 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 111233468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.10 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=197.8
Q ss_pred CCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.|...+.||+|+||+||+| ...+++.||+|++.+... .......+.+|+.+++.++||||+++++++.++. .++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999 445788999999976432 3345567889999999999999999999998765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999998653 468899999999999999999998 8999999999999999999999999999754311000
Q ss_pred ---------------------------------------------cccccccccccCcccchhhccCCCCccccchhHHH
Q 008650 404 ---------------------------------------------HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGV 438 (558)
Q Consensus 404 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGv 438 (558)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012356999999999999989999999999999
Q ss_pred HHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHH--hhccCCCCCCCHHHHHHH
Q 008650 439 LLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADY--CVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 439 vl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dp~~RPt~~evl~~ 514 (558)
++|||++|+.||............ ...... +..........++.+++.+ |+..++..||++.++++.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i--~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKV--INWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHH--Hccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999999865433221111 110000 0000011123456777777 556677779999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=333.47 Aligned_cols=241 Identities=23% Similarity=0.282 Sum_probs=193.4
Q ss_pred EeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCH
Q 008650 254 VGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330 (558)
Q Consensus 254 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL 330 (558)
||+|+||.||+|.. .+++.||+|++.+.. ........+.+|+.++.+++||||+++++++.+++ .++||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999955 468899999996543 22344567889999999999999999999987755 9999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccccc
Q 008650 331 DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPI 410 (558)
Q Consensus 331 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 410 (558)
.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 153 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF 153 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence 9998653 468999999999999999999999 899999999999999999999999999997543221 122345
Q ss_pred ccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHH
Q 008650 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRL 490 (558)
Q Consensus 411 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 490 (558)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ....... . ..++......+
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~--~~~~~~~-~----------~~~~~~~~~~~ 220 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM--YRKILQE-P----------LRFPDGFDRDA 220 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH--HHHHHcC-C----------CCCCCcCCHHH
Confidence 699999999999999999999999999999999999999986543211 1111111 0 01122234568
Q ss_pred HHHHHHhhccCCCCCCC---HHHHHHH
Q 008650 491 VLIADYCVRQTSAWRPS---MSEVLEL 514 (558)
Q Consensus 491 ~~li~~cl~~dp~~RPt---~~evl~~ 514 (558)
.+++.+||+.||.+||+ +.|++..
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 89999999999999985 5565553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=326.01 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=202.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCC----EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGR----KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 320 (558)
.+|.+.+.||+|+||+||+|.+ .+++ .+++|.+... .......++..|+.++.++.||||+++++++.....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEE
Confidence 4678889999999999999965 3454 4777777432 22344567788888999999999999999987777899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
++||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++.+..
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999996543 468999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
...........++..|+|||++.++.++.++|||||||++|||++ |+.||......... ..+..+.... .+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~---~~~~~~~~~~--~~~-- 234 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP---DLLEKGERLA--QPQ-- 234 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHCCCcCC--CCC--
Confidence 333222333457889999999999999999999999999999998 99999865433211 1112211111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.....+..++.+||..+|++|||+.|+++.|...
T Consensus 235 -----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 235 -----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred -----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1223567789999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=336.44 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=201.0
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-C-CCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-D-GRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
.++|.+.+.||+|+||.||+|... + +..||+|++.+... .......+.+|+.+++.++||||+++++++.+++ .++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 356899999999999999999543 3 36899999865432 2334567889999999999999999999998766 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999654 468999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. .. .+..
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-~~-i~-~~~~---------- 245 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY-QK-IL-EGII---------- 245 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH-HH-Hh-cCCC----------
Confidence 2 12356999999999999989999999999999999999999999865433211 11 11 1110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
.++......+.+++.+||+.+|.+|+ +++++++.
T Consensus 246 ~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01112234578899999999999995 89998875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=333.99 Aligned_cols=243 Identities=21% Similarity=0.293 Sum_probs=196.2
Q ss_pred ceEeeeCceEEEEEE-ECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 252 NMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
+.||+|+||.||++. ..+++.||+|++.+... .......+.+|+.+++.++||||+++++++..++ .++||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999995 45789999999976432 2344567889999999999999999999987765 99999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccc
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 408 (558)
+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 153 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMK 153 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccc
Confidence 999888543 468999999999999999999998 899999999999999999999999999987543221 1223
Q ss_pred ccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHH
Q 008650 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMH 488 (558)
Q Consensus 409 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 488 (558)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..... ... . .++.....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~--~~~~~-~~~------~----~~p~~~~~ 220 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELIL-MED------I----KFPRTLSA 220 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH--HHHhc-cCC------c----cCCCCCCH
Confidence 45699999999999999999999999999999999999999976433211 11111 000 0 11222345
Q ss_pred HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 489 RLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 489 ~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
.+.+++.+||+.||++|| ++.|+++.
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 688999999999999997 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.92 Aligned_cols=257 Identities=25% Similarity=0.427 Sum_probs=205.6
Q ss_pred hCCCcccceEeeeCceEEEEEEECC----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSD----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
.++|++.+.||+|+||.||+|.... ...||+|.+.... .......|.+|+.+++.++||||+++++++.+++ .+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 4578999999999999999996532 4579999885433 3455667889999999999999999999987765 89
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+|+||||+|||++.++.++|+|||++....
T Consensus 82 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 82 IITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999996543 468999999999999999999998 899999999999999999999999999998775
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
............+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... . .+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~--~-~~~~~~~~------- 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI--K-AVEDGYRL------- 227 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH--H-HHHcCCCC-------
Confidence 2222222222345678999999999999999999999999999998 99999754332111 1 11111000
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
..+......+.+++.+||+.+|++||++.||++.|.+.
T Consensus 228 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 --PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112345688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=322.13 Aligned_cols=255 Identities=23% Similarity=0.287 Sum_probs=211.8
Q ss_pred CCCcccceEeeeCceEEEEEEECC-CCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
+.|.+.+.||.|.-|+||+++..+ +..+|+|++.+.... .........|-+||+.+.||.++.||..+..+. .+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567888999999999999997654 688999999876533 455667788999999999999999999998777 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC--
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-- 400 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-- 400 (558)
|||+||+|..+++.+..+.+++..++.++.+++.||+|||. .|||+|||||+||||.++|++.|+||.++....-
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999999999988899999999999999999999999 9999999999999999999999999998754311
Q ss_pred -------------------------------CCC---------------------cccccccccccCcccchhhccCCCC
Q 008650 401 -------------------------------KCT---------------------HHAAIPIEGTFGYLAPEYFMHGIID 428 (558)
Q Consensus 401 -------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 428 (558)
... ......++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 0111246799999999999999999
Q ss_pred ccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-
Q 008650 429 EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS- 507 (558)
Q Consensus 429 ~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt- 507 (558)
.++|+|+|||+|||||.|+.||.+...... +..++-+.+.-...+..+..+.+||.+.|..||++|..
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T-----------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET-----------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhh-----------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcc
Confidence 999999999999999999999987644321 22233333332223356678999999999999999998
Q ss_pred ---HHHHHHH
Q 008650 508 ---MSEVLEL 514 (558)
Q Consensus 508 ---~~evl~~ 514 (558)
+.||-++
T Consensus 383 ~rGA~eIK~H 392 (459)
T KOG0610|consen 383 KRGAAEIKRH 392 (459)
T ss_pred ccchHHhhcC
Confidence 7777663
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.28 Aligned_cols=256 Identities=23% Similarity=0.435 Sum_probs=203.3
Q ss_pred CCCcccceEeeeCceEEEEEEE-----CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
++|++.+.||+|+||+||+|.. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++..+. .+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4678889999999999999953 346789999996433 3445567889999999999999999999987755 89
Q ss_pred EEEEeccCCCHHHHHhhcc---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC
Q 008650 320 LIFNFSQNGNLDAALHDER---------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD 384 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 384 (558)
++|||+.+++|.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+|||++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence 9999999999999985332 1247888899999999999999998 899999999999999999
Q ss_pred CceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhh
Q 008650 385 FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKP 463 (558)
Q Consensus 385 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 463 (558)
+.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||......... .
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~---~ 237 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI---E 237 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---H
Confidence 9999999999987644322222233446788999999998899999999999999999998 99999765332111 1
Q ss_pred hhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
........ ..+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 238 ~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 0111233568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=322.77 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=207.1
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEe
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNF 324 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 324 (558)
.++|++.+.||+|+||.||+|...++..+|+|.+...... ...+.+|+.++++++|+|++++++++.++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEe
Confidence 3568899999999999999998888888999999764432 3458899999999999999999999877779999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+++|.+++.......+++..++.++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++..+......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999999976555668999999999999999999999 89999999999999999999999999999876443211
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
......++..|+|||++.+..++.++||||||+++|+|++ |..||.......... . +..+ .....+
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~--~-~~~~---------~~~~~~ 225 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE--Q-VERG---------YRMPCP 225 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH--H-HHcC---------CCCCCC
Confidence 1112235678999999998899999999999999999999 899997643321111 1 1111 011112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
......+.+++.+||..+|++|||+.++.+.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2334578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=322.28 Aligned_cols=251 Identities=24% Similarity=0.440 Sum_probs=201.7
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
++|++.+.||+|+||.||++...++..+|+|.+...... ...+.+|+.+++.++||||+++++++.++. .++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 468888999999999999998888888999998644322 346888999999999999999999987755 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+++|+|.++++... ..+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||.++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 81 MENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999999986543 358899999999999999999998 89999999999999999999999999999865433221
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
. .....++..|+|||++.+..++.++||||||+++|+|++ |+.||........ ...... +.. ...+
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~--~~~i~~-~~~--~~~~------- 223 (256)
T cd05114 157 S-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV--VEMISR-GFR--LYRP------- 223 (256)
T ss_pred c-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHHC-CCC--CCCC-------
Confidence 1 112235678999999998889999999999999999999 9999976543211 111111 110 0111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
......+.+++.+||+.+|++||++.++++.|.
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112346899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=333.95 Aligned_cols=243 Identities=24% Similarity=0.317 Sum_probs=195.5
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
+.||+|+||.||++.. .+|+.||+|++.+... .......+.+|+.+++.++||||+++++++..++ .++||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999954 5789999999975432 2334556788999999999999999999988765 99999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccc
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 408 (558)
+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~ 153 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence 999888543 468999999999999999999998 899999999999999999999999999987532221 1122
Q ss_pred ccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHH
Q 008650 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMH 488 (558)
Q Consensus 409 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 488 (558)
...||+.|+|||++.++.++.++|||||||++|||++|+.||.......... ..... .. . ++.....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-~~~~~--~~------~----~p~~~~~ 220 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-LILME--EI------R----FPRTLSP 220 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH-HHhcC--CC------C----CCCCCCH
Confidence 3569999999999999999999999999999999999999997654322111 10000 00 1 1122345
Q ss_pred HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 489 RLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 489 ~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
.+.+++.+||+.||.+|| ++.++++.
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 688999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=322.02 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=201.7
Q ss_pred eEeeeCceEEEEEEE---CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEeccCCC
Q 008650 253 MVGQGGYSEVYKGNL---SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGN 329 (558)
Q Consensus 253 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~gs 329 (558)
.||+|+||.||+|.+ .++..+|+|++............+.+|+.+++.+.||||+++++++..+..++||||+.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999953 35788999998766555666778999999999999999999999987777999999999999
Q ss_pred HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccc-cc
Q 008650 330 LDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA-AI 408 (558)
Q Consensus 330 L~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~-~~ 408 (558)
|.+++... ..+++..+.+++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+........ ..
T Consensus 82 L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 82 LNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 99999643 468899999999999999999998 8999999999999999999999999999987654322111 11
Q ss_pred ccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 409 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
...++..|+|||.+....++.++|||||||++|||++ |..||......... . .+..+.. ...+....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~--~-~i~~~~~---------~~~~~~~~ 224 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT--Q-MIESGER---------MECPQRCP 224 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--H-HHHCCCC---------CCCCCCCC
Confidence 2235678999999988889999999999999999998 99999865432211 1 1111111 11122334
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 488 HRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
..+.+++.+||+.+|++||++.+|.+.|.+
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=317.19 Aligned_cols=251 Identities=27% Similarity=0.448 Sum_probs=207.7
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|.+.+.||+|+||.||+|.. .+++.|++|.+............+.+|+.+++.++||||+++++++.+++ .++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999955 46899999999766555667778999999999999999999999988765 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+++|.+++.......+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++..+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 999999999987655678999999999999999999998 89999999999999999999999999999876543221
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
.....|++.|+|||++.++.++.++|+|||||++|+|++|+.||......... .. ...+... ....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~-~~~~~~~---------~~~~ 223 (256)
T cd08529 158 --ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI--LK-IIRGVFP---------PVSQ 223 (256)
T ss_pred --hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHcCCCC---------CCcc
Confidence 22345899999999999999999999999999999999999999865432111 11 1111111 1111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 334578999999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=330.90 Aligned_cols=261 Identities=21% Similarity=0.345 Sum_probs=202.3
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|++.+.||+|+||.||++... ++..+|+|.+.... .......+.+|+++++.++|+||+++++++.+++ .++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 468999999999999999999554 68889999886542 3445567889999999999999999999998766 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|.+++... ..+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 83 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999999653 4588999999999999999999972 479999999999999999999999999997654321
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccc---------
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL--------- 473 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 473 (558)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||.................+.....
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 1234589999999999998999999999999999999999999976433222111100000000000
Q ss_pred --------------------cCCCCC---CCCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 474 --------------------VDPSLE---GEYD-TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 474 --------------------~d~~l~---~~~~-~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+.... .... .....++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000 0000 0123568899999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.61 Aligned_cols=261 Identities=20% Similarity=0.292 Sum_probs=196.8
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++.++. .++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 468999999999999999999654 789999999865432 222345678999999999999999999988765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+. ++|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 83 EYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred ECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9996 5777777543 3558888999999999999999999 899999999999999999999999999987543221
Q ss_pred CcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc----------
Q 008650 403 THHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT---------- 471 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 471 (558)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................+...
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 12223458999999999875 45889999999999999999999999865332221111111000000
Q ss_pred -cccCCCCCCCCC---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 472 -ELVDPSLEGEYD---------TDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 472 -~~~d~~l~~~~~---------~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
...........+ ......+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000 011245778999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=324.52 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=209.1
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
...+|++.+.||.|+||.||+|...+++.+|+|.+.... ......+..|+.+++.++|+||+++++++.+.. .++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 345688999999999999999988779999999986543 233456888999999999999999999987765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++++|.+++.......+++..++.++.+++.||.|||+ ++++|+||||+|||++.++.+||+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999999987666678999999999999999999998 899999999999999999999999999998764432
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
... ....++..|+|||.+.++.++.++||||||+++|+|++ |+.||......... ...... ....
T Consensus 159 ~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~--~~~~~~----------~~~~ 224 (261)
T cd05148 159 YLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY--DQITAG----------YRMP 224 (261)
T ss_pred ccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH--HHHHhC----------CcCC
Confidence 211 13346788999999998899999999999999999998 89999765432111 111111 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 122334578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=325.25 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=202.7
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
+|++.+.||+|+||+||++.. .+++.||+|++...... ......+.+|+.+++.++||||+++++++.++. .++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999954 57899999999654322 233456778999999999999999999987655 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+|+|..++.......+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999998876555678999999999999999999999 8999999999999999999999999999987643322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-HhhhhhhcCCcccccCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.. ....+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~ 224 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----------DQEEY 224 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----------ccccc
Confidence 12346899999999999999999999999999999999999999864332111 00000110 01112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
+......+.+++.+||+.||.+|| ++.++++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 223445688999999999999999 88888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.94 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=208.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFN 323 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e 323 (558)
..++|++.++||+|+||.||+|...+++.||+|.+...... ...+.+|+.++++++|+||+++++++.++..+++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e 80 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITE 80 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEE
Confidence 34678999999999999999998888999999998755432 346888999999999999999999987777999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++.......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999999977666678999999999999999999998 8999999999999999999999999999987653221
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
. ......++..|+|||++..+.++.++||||||+++|||++ |+.||.......... . +..+. ....
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~--~-~~~~~---------~~~~ 224 (260)
T cd05067 158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ--N-LERGY---------RMPR 224 (260)
T ss_pred c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH--H-HHcCC---------CCCC
Confidence 1 1122346788999999999999999999999999999999 999997654321111 0 11110 0011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
+.....++.+++.+||+.+|++|||++++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 12233579999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=349.48 Aligned_cols=259 Identities=25% Similarity=0.333 Sum_probs=211.4
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCC-CEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeE-EE----eC
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDG-RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGC-CI----EN 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~----~~ 316 (558)
...++++.+.|.+|||+.||.|....+ ..||+|++... +........+|+.+|+.|. |+|||.+++. .. ++
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 345678899999999999999966555 99999998655 5778888999999999998 9999999993 32 12
Q ss_pred ---cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecc
Q 008650 317 ---GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFG 393 (558)
Q Consensus 317 ---~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 393 (558)
..+|.||||.+|.|-+++.......|++..+++|+.++++|+.+||. ++.+|||||||-+||||+.+|+.||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 16799999999999999987666679999999999999999999997 34679999999999999999999999999
Q ss_pred ccccCCCCCCccc-------ccccccccCcccchhh---ccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhh
Q 008650 394 LAKWLPNKCTHHA-------AIPIEGTFGYLAPEYF---MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463 (558)
Q Consensus 394 ~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 463 (558)
.|.-.-....... .....-|+.|+|||++ .+.+.++|+|||+|||+||-|+....||+....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------- 263 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------- 263 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence 9865322221110 0112368999999997 567899999999999999999999999986421
Q ss_pred hhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
..+++-.......+.+..+|.+||..||+++|++||++.+|+..+.....
T Consensus 264 -------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 -------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 12333333333346788899999999999999999999999998877544
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=311.15 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=206.8
Q ss_pred hCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
+++|++.++||+|.|+.||++ +..+|+.+|+|++...........++.+|+.|-+.++||||++|.+.+.+.+ .|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 457888999999999999999 7778999999999766655667777889999999999999999999988776 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---CCceEEEeccccccCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---DFEPQITDFGLAKWLP 399 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~~ 399 (558)
|++.|+.|..-|-.. ..+++..+-.++.||+++|.|+|. ++|||||+||+|+|+.. ..-+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999996655332 457888888999999999999999 89999999999999954 3459999999999887
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.+ .......|||.|||||+++..+|+..+|||+.|||||-|+.|+.||.++...... .. +..+.+ ...
T Consensus 165 ~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly-e~--I~~g~y------d~~ 232 (355)
T KOG0033|consen 165 DG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-EQ--IKAGAY------DYP 232 (355)
T ss_pred Cc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH-HH--Hhcccc------CCC
Confidence 33 2334567999999999999999999999999999999999999999986544221 11 111111 112
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+.+...++..+++.+||..||.+|.|+.|.|+.
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 22233445678889999999999999999887763
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=326.33 Aligned_cols=260 Identities=21% Similarity=0.303 Sum_probs=197.3
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.+++.++||||+++++++..+. .++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 5799999999999999999954 4789999999864432 223345778999999999999999999987665 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+ +|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 9975 898888543 3457889999999999999999998 8999999999999999999999999999976543221
Q ss_pred cccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh-hhhh------------cCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK-PLME------------SGN 469 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~-~~~~------------~~~ 469 (558)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .... ...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1223458999999999875 56899999999999999999999999765432111100 0000 001
Q ss_pred cccccCCCCCCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 LTELVDPSLEGEY----DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 ~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
......+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111110000 0112356789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.46 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=201.5
Q ss_pred CcccceEeeeCceEEEEEEECC-CC--EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------c
Q 008650 248 FHSENMVGQGGYSEVYKGNLSD-GR--KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-------G 317 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~ 317 (558)
|.+.+.||+|+||.||+|...+ +. .+|+|.+............+.+|+.+++.++|+||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999996544 33 589999876555566677889999999999999999999987431 2
Q ss_pred EEEEEEeccCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecc
Q 008650 318 LYLIFNFSQNGNLDAALHDER----SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFG 393 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 393 (558)
.++++||+.+|+|..++...+ ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 2347899999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCccc
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTE 472 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 472 (558)
+++.+.............+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .. ..+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~-~~~~~~~~~~ 234 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IY-DYLRQGNRLK 234 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HH-HHHHcCCCCC
Confidence 9987654322211222346778999999999999999999999999999999 899997643321 11 1112211111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
........+.+++.+||+.+|++|||+.++++.|+..
T Consensus 235 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 235 ---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1122345688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.72 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=199.9
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||+||+|.. .+++.||||++.+... .......+.+|+.++..++||||+++++++.++. .++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999955 5689999999975432 2334556778999999999999999999998766 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999998653 468999999999999999999999 899999999999999999999999999987643211
Q ss_pred Ccc------------------------------------cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcC
Q 008650 403 THH------------------------------------AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITG 446 (558)
Q Consensus 403 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg 446 (558)
... .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000 11134699999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 008650 447 RKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS---MSEVLEL 514 (558)
Q Consensus 447 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~ 514 (558)
..||......... ........ .+...........+.+++.+|+. +|.+|++ +.|+++.
T Consensus 236 ~~Pf~~~~~~~~~--~~i~~~~~-------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQETY--RKIINWKE-------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHHHH--HHHHcCCC-------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999865432211 11111100 00000011223467788899996 9999998 8888874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.43 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=206.1
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCC----EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGR----KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 319 (558)
.++|++.+.||+|+||+||+|.+ .+++ .||+|++... ........+.+|+.++..+.|+||+++++++.....+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcE
Confidence 35788899999999999999954 4554 4899998543 3345567788999999999999999999999887789
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
++++|+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999998654 3468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......... .+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~~~~~~------- 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD---LLEKGERL------- 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHHCCCcC-------
Confidence 4322222222335778999999999999999999999999999998 999997654322111 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..+......+.+++.+||+.||++||++.++++.|....
T Consensus 231 --~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 231 --PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred --CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111123446889999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=321.33 Aligned_cols=255 Identities=26% Similarity=0.420 Sum_probs=207.1
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEe
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNF 324 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 324 (558)
.++|++.+.||+|+||.||+|...++..||+|++...... ...+.+|+.+++.++|+||+++++++.++..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEc
Confidence 3569999999999999999997766678999999754332 3468889999999999999999998877779999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+|+|.+++.......+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||.+..+......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999976555568999999999999999999998 89999999999999999999999999999866443221
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
......++..|+|||++.++.++.++|||||||++|+|++ |..||.......... . ...+. .....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~--~-~~~~~---------~~~~~ 225 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD--Q-VERGY---------RMPCP 225 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH--H-HhcCC---------CCCCc
Confidence 1122346778999999999999999999999999999999 888997654322111 1 11110 00112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
......+.+++.+|++.+|++||++.++++.|+..
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 23455788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.57 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=195.0
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||+||+|. ..+++.||+|++.+... .......+..|+.++..++|+||+++++.+.++. .|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478999999999999999995 45689999999976432 2334456778999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999653 568999999999999999999998 899999999999999999999999999987653211
Q ss_pred C---------------------------------cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCC
Q 008650 403 T---------------------------------HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449 (558)
Q Consensus 403 ~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~P 449 (558)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 0011235799999999999999999999999999999999999999
Q ss_pred CCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 008650 450 VDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVR--QTSAWRPSMSEVLEL 514 (558)
Q Consensus 450 f~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~dp~~RPt~~evl~~ 514 (558)
|........ +.. .... .....+.+ .. .....+.+++.+++. .++..||++.|+++.
T Consensus 236 f~~~~~~~~-~~~-i~~~-~~~~~~p~----~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQET-YKK-VMNW-KETLIFPP----EV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHHHH-HHH-HHcC-cCcccCCC----cC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 986543221 111 1110 00000111 10 112345555565333 344467999999885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=318.92 Aligned_cols=248 Identities=26% Similarity=0.425 Sum_probs=197.1
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGN 329 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gs 329 (558)
+.||+|+||.||+|.. .+++.+|+|.+... ........+.+|+++++.++||||+++++++..+. .++||||+.+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3689999999999955 57899999988543 33455667899999999999999999999987765 899999999999
Q ss_pred HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccccc
Q 008650 330 LDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIP 409 (558)
Q Consensus 330 L~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 409 (558)
|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++..............
T Consensus 80 L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 80 FLTFLRTE-GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99998643 3458999999999999999999998 8999999999999999999999999999986543221111111
Q ss_pred cccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHH
Q 008650 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMH 488 (558)
Q Consensus 410 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 488 (558)
..++..|+|||.+.++.++.++|||||||++|||++ |..||........... .... .....+.....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~---~~~~---------~~~~~~~~~~~ 223 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA---IEQG---------VRLPCPELCPD 223 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH---HHcC---------CCCCCcccCCH
Confidence 123567999999999999999999999999999998 9999975433221111 1110 11111222345
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 489 RLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 489 ~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
.+.+++.+||+.+|++|||+.+|++.|.
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 7889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=321.28 Aligned_cols=255 Identities=29% Similarity=0.460 Sum_probs=203.5
Q ss_pred CcccceEeeeCceEEEEEEEC-C---CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc------
Q 008650 248 FHSENMVGQGGYSEVYKGNLS-D---GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG------ 317 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 317 (558)
|.+.+.||+|+||.||+|... + +..||+|++............+.+|+..++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999553 2 367999999765555566678999999999999999999999875422
Q ss_pred -EEEEEEeccCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEec
Q 008650 318 -LYLIFNFSQNGNLDAALHDER----SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDF 392 (558)
Q Consensus 318 -~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 392 (558)
.++++||+.+|+|..++...+ ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 689999999999999886542 2358899999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 393 GLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 393 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
|+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||........ ...... +...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~--~~~~~~-~~~~ 234 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI--YDYLRH-GNRL 234 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHc-CCCC
Confidence 99987654332222222335778999999988899999999999999999999 9999976543211 111111 1111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
..+......+.+++.+||+.+|++|||+.|+++.|..
T Consensus 235 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 235 ---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred ---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1122334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.29 Aligned_cols=261 Identities=26% Similarity=0.449 Sum_probs=207.3
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEE
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCI 314 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 314 (558)
....++|++.+.||+|+||.||++... ....+|+|.+.... .......+.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 345567899999999999999999543 23679999986543 344556788999999999 7999999999987
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhc--------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCce
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDE--------------RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNV 379 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI 379 (558)
.++ .+++|||+.+|+|..++... ....+++..+++++.|++.||.|||+ .+|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeE
Confidence 765 89999999999999999642 23468899999999999999999998 8999999999999
Q ss_pred eecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHH
Q 008650 380 LLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLV 458 (558)
Q Consensus 380 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~ 458 (558)
|++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999987654332222222345678999999999999999999999999999998 9999976533211
Q ss_pred HHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 459 LWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 459 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
. . ....+. ....+......+.+++.+||+.+|++|||+.|+++.|+..
T Consensus 244 ~--~-~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 F--K-LLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred H--H-HHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1 1 111111 1111223345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=318.05 Aligned_cols=259 Identities=24% Similarity=0.430 Sum_probs=208.7
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ........+.+|+.+++.++||||+++++++.+.+ .++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999954 578999999886532 34455667889999999999999999999987655 89999
Q ss_pred EeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 323 NFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 323 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||+.+|+|..++... ....+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999888543 23457889999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.........+....... ....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~-------- 227 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC-DYPP-------- 227 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC-CCCC--------
Confidence 322 11234588999999999988899999999999999999999999976543322222211111 1111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11123345788999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=323.56 Aligned_cols=257 Identities=28% Similarity=0.428 Sum_probs=202.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG 317 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 317 (558)
.+++|.+.+.||+|+||.||+|... .+..||+|.+.... .......|.+|+.+++.++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3567999999999999999999554 35678999885432 3444567899999999999999999999887655
Q ss_pred -EEEEEEeccCCCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC---ceE
Q 008650 318 -LYLIFNFSQNGNLDAALHDERS-----KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF---EPQ 388 (558)
Q Consensus 318 -~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k 388 (558)
.++||||+.+++|.+++...+. ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceE
Confidence 8999999999999999976532 258899999999999999999999 8999999999999998755 599
Q ss_pred EEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhc
Q 008650 389 ITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMES 467 (558)
Q Consensus 389 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 467 (558)
|+|||+++.+.............++..|+|||++.++.++.++|||||||++|||++ |..||........ .......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--~~~~~~~ 237 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--MEFVTGG 237 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHHcC
Confidence 999999987643322111112234578999999999999999999999999999997 9999986543221 1111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 468 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
.. ...+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 238 ~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred Cc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 1112223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=324.18 Aligned_cols=260 Identities=24% Similarity=0.374 Sum_probs=208.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEECC-----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSD-----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-- 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 316 (558)
..++|.+.+.||+|+||.||+|.... +..|++|++.. .........+.+|+.+++.++|+||+++++++.++
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 45789999999999999999996554 67899998853 34456677788999999999999999999998763
Q ss_pred cEEEEEEeccCCCHHHHHhhccC------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEE
Q 008650 317 GLYLIFNFSQNGNLDAALHDERS------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT 390 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 390 (558)
..+++++|+.+++|.+++..... ..+++..++.++.+++.||.|||+ ++++|+||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEEC
Confidence 38999999999999999866432 458899999999999999999998 899999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCC
Q 008650 391 DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGN 469 (558)
Q Consensus 391 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 469 (558)
|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||....... +.........
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~ 237 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAAYLKDGYR 237 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHHHHHcCCC
Confidence 9999987644332222223346788999999998899999999999999999999 999997653321 1111111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 470 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
. .........+.+++.+||+.+|++|||+.++++.|....
T Consensus 238 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 238 L----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred C----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 011122346889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.12 Aligned_cols=258 Identities=22% Similarity=0.394 Sum_probs=205.4
Q ss_pred hCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
..+|.+.+.||+|+||.||++.. .++..+|+|.+.... ......+.+|+.++++++||||+++++++..++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 35788999999999999999953 234568999886432 445667899999999999999999999998755
Q ss_pred EEEEEEeccCCCHHHHHhhcc-----------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc
Q 008650 318 LYLIFNFSQNGNLDAALHDER-----------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 386 (558)
.+++|||+.+++|.+++.... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999999986542 1348999999999999999999998 89999999999999999999
Q ss_pred eEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhh
Q 008650 387 PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLM 465 (558)
Q Consensus 387 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 465 (558)
+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......... . .+
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~--~-~i 235 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI--E-CI 235 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--H-HH
Confidence 99999999986644322222222346788999999999999999999999999999998 99999765432211 1 11
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 466 ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..+.... ... .....+.+++.+||+.+|.+|||+.++++.|++..
T Consensus 236 ~~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 TQGRVLQ-----RPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HcCCcCC-----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111111 111 12346899999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=327.86 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=206.1
Q ss_pred hhCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeC
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIEN 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 316 (558)
..++|.+.+.||+|+||.||++.. .++..+|+|.+.... .......+.+|+.+++++ +|+||+++++++...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 345799999999999999999953 234579999986543 234456788999999999 799999999998765
Q ss_pred c-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
+ .+++|||+.+|+|.+++.......+++..+..++.+++.||.|||+ ++|+|+||||+|||++.++.++|+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence 5 9999999999999999976554558999999999999999999998 89999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
................++..|+|||++.++.++.++|||||||++|+|++ |..||......... .. ....+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~-~~-~~~~~------ 260 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF-YK-LIKEG------ 260 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH-HH-HHHcC------
Confidence 86654322212222346788999999999999999999999999999998 99999765432111 11 11111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.....+.....++.+++.+||..+|++|||+.|+++.|.+
T Consensus 261 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 ---YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0001111223578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.83 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=197.6
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||+||++. ..+++.||||++.+... .......+.+|+.++++++||||+++++++.++. .|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 478899999999999999994 45789999999865432 2334567888999999999999999999998766 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998643 568899999999999999999999 899999999999999999999999999986432110
Q ss_pred Cc------------c---------------------------------cccccccccCcccchhhccCCCCccccchhHH
Q 008650 403 TH------------H---------------------------------AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFG 437 (558)
Q Consensus 403 ~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlG 437 (558)
.. . .....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 0 00124699999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 008650 438 VLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWR---PSMSEVLEL 514 (558)
Q Consensus 438 vvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~evl~~ 514 (558)
|++|||++|+.||........ +.. ...... .+. +.. .......+.+++.+||+ +|.+| +++.|+++.
T Consensus 236 vil~elltG~~Pf~~~~~~~~-~~~-i~~~~~--~~~---~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHET-YRK-IINWRE--TLY---FPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHH-HHH-HHccCC--ccC---CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999976543221 111 111000 000 000 11223467889999997 66665 599998885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.65 Aligned_cols=263 Identities=28% Similarity=0.446 Sum_probs=208.9
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEEC--CC---CEEEEEEeecc-cccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNLS--DG---RKIAVKRLAKD-NKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE 315 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~---~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 315 (558)
...-++..+.+.||+|+||+||+|... ++ ..||||..... ........+|++|.++|++++|||||++||++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 334445566789999999999999543 22 22899998753 3567888999999999999999999999999987
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
.. +++|||+|.||+|.++|..... .++......++.+.|.||+|||+ +++|||||-..|+|++.++.+||+|||+
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccc
Confidence 66 9999999999999999976543 69999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTEL 473 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 473 (558)
++.-........ .-.-...|+|||.+..+.|++++|||||||++||+++ |..||.+.....+. ..+.
T Consensus 309 s~~~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~kI~------- 376 (474)
T KOG0194|consen 309 SRAGSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---AKIV------- 376 (474)
T ss_pred ccCCcceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---HHHH-------
Confidence 875431111110 1124578999999999999999999999999999999 89999876544221 1110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCc
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDS 521 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 521 (558)
....+-..+......+..++.+||..+|++||||.++.+.|......
T Consensus 377 -~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 377 -KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred -hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 11111122223455678888999999999999999999998875443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=319.15 Aligned_cols=251 Identities=22% Similarity=0.393 Sum_probs=201.8
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
.+|.+.+.||+|+||+||.|...++..+|+|.+..... ....+.+|+.++++++||||+++++++.+.. .+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 45888899999999999999877777799999865432 2356889999999999999999999987655 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+|+|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+|||++.++.+||+|||.++........
T Consensus 81 ~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 81 MSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999986543 368999999999999999999998 89999999999999999999999999998865443221
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
......++..|+|||++.++.++.++|||||||++|+|++ |+.||.......... .... +... ..+
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~--~~~~-~~~~---------~~~ 223 (256)
T cd05113 157 -SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE--KVSQ-GLRL---------YRP 223 (256)
T ss_pred -ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH--HHhc-CCCC---------CCC
Confidence 1112235678999999998899999999999999999999 999997654321111 1111 1110 001
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
......+.+++.+||+.+|.+|||+.++++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112457899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=319.01 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=205.3
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEec
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFS 325 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~ 325 (558)
++|.+...||+|+||.||+|....+..+|+|.+..... ....+.+|+.+++.+.|+|++++++++..+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcC
Confidence 46888999999999999999877777899998865432 234578899999999999999999998777799999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
.+++|.+++.......+++..+..++.+++.||.|||+ .+++|+||||+||++++++.++|+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence 99999999976555568999999999999999999998 8999999999999999999999999999976643321 1
Q ss_pred cccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 406 AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
......++..|+|||++.++.++.++||||||+++|+|++ |+.||......... . ....... ...+.
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~-~~~~~~~----------~~~~~ 226 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-E-QVERGYR----------MPCPQ 226 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H-HHHcCCC----------CCCCc
Confidence 1122346778999999998999999999999999999999 99999765432111 1 1111100 01122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.....+.+++.+||+.+|++||++.+|++.|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 334578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.71 Aligned_cols=254 Identities=21% Similarity=0.289 Sum_probs=201.6
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||+||++.. .+|+.||+|++.+... .......+..|+.+++.++|+||+++++++.++. .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4789999999999999999954 5789999999976532 2334566788999999999999999999988765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999654 2468999999999999999999999 899999999999999999999999999998765432
Q ss_pred CcccccccccccCcccchhhc------cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFM------HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ .............
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~~~i~~~~~~~~~--- 230 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--YNNIMNFQRFLKF--- 230 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH--HHHHHcCCCccCC---
Confidence 21 222346999999999986 45688999999999999999999999976543211 1111111110000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.........+.+++..||+ +|.+|||+.++++.
T Consensus 231 ----~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 ----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0111234568889999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=323.97 Aligned_cols=257 Identities=25% Similarity=0.444 Sum_probs=202.5
Q ss_pred CCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 247 NFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
+|++.+.||+|+||.||+|... ....+++|.+.... .......+.+|+.+++.++||||+++++.+..++ .+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999542 23568888885443 3444567889999999999999999999987665 89
Q ss_pred EEEEeccCCCHHHHHhhcc----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCC
Q 008650 320 LIFNFSQNGNLDAALHDER----------------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKAS 377 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~ 377 (558)
+++||+.+++|.+++...+ ...+++..++.++.|++.||.|||+ .+++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhh
Confidence 9999999999999986432 1347888999999999999999998 89999999999
Q ss_pred ceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchh
Q 008650 378 NVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQN 456 (558)
Q Consensus 378 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~ 456 (558)
|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999986543322222223346778999999998899999999999999999998 99999764332
Q ss_pred HHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 457 LVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.. +. ....+ .....+......+.+++.+||+.+|++||++.|+++.|++..
T Consensus 237 ~~-~~--~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 RL-FN--LLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HH-HH--HHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11 11 11110 111112223457889999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.66 Aligned_cols=263 Identities=17% Similarity=0.174 Sum_probs=189.7
Q ss_pred HHHHHhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc------ccCCeeeee
Q 008650 238 YEEISSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV------CHPNTATLV 310 (558)
Q Consensus 238 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~ 310 (558)
.+++...+++|.+.+.||+|+||+||+|.. .+++.||||++.... .....+..|+.+++.+ .|.+++.++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 344555678999999999999999999954 568889999995432 1222334455555444 455689999
Q ss_pred eEEEeCc--EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC---
Q 008650 311 GCCIENG--LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF--- 385 (558)
Q Consensus 311 ~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 385 (558)
+++..+. .++||+++ +++|.+++... ..+++..+..|+.||+.||.|||+. .+||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccc
Confidence 9887543 78888877 67888888543 5689999999999999999999961 4899999999999998765
Q ss_pred -------------ceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCC
Q 008650 386 -------------EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDS 452 (558)
Q Consensus 386 -------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~ 452 (558)
.+||+|||.+..... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998864321 22345799999999999999999999999999999999999999986
Q ss_pred CchhHHHHhhhhhhcCCcc-------------ccc------CCCCCC---------C--CCHHHHHHHHHHHHHhhccCC
Q 008650 453 SRQNLVLWAKPLMESGNLT-------------ELV------DPSLEG---------E--YDTDQMHRLVLIADYCVRQTS 502 (558)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~-------------~~~------d~~l~~---------~--~~~~~~~~l~~li~~cl~~dp 502 (558)
............. .+.+. .++ .+.... . ........+.+|+.+||+.||
T Consensus 348 ~~~~~~~~~i~~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 348 HDNLEHLHLMEKT-LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CChHHHHHHHHHH-cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 5432111000000 00000 000 000000 0 000113457799999999999
Q ss_pred CCCCCHHHHHHH
Q 008650 503 AWRPSMSEVLEL 514 (558)
Q Consensus 503 ~~RPt~~evl~~ 514 (558)
.+|||+.|++++
T Consensus 427 ~~R~ta~e~L~H 438 (467)
T PTZ00284 427 QKRLNARQMTTH 438 (467)
T ss_pred hhCCCHHHHhcC
Confidence 999999999973
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=328.53 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=195.8
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~ 322 (558)
+|.+.+.||+|+||.||+|.. .+++.||+|++.+... .......+..|..++..+ +|++|+.+++++.+++ .++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 578899999999999999954 4678999999976432 223345567788888777 4889999999987755 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|...+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999888543 458899999999999999999998 899999999999999999999999999997543221
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... .. ..+
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~--~~i~~-~~----------~~~ 220 (323)
T cd05616 156 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF--QSIME-HN----------VAY 220 (323)
T ss_pred --CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH--HHHHh-CC----------CCC
Confidence 1223456999999999999999999999999999999999999999865433221 11111 11 011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSM-----SEVLE 513 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~ 513 (558)
+......+.+++.+||+.+|++|++. .++++
T Consensus 221 p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 221 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 22334578899999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=337.44 Aligned_cols=253 Identities=20% Similarity=0.234 Sum_probs=195.3
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.|...+.||+|+||+||+|. ..+++.||+|++.+... .......+.+|+.+++.++|+||+++++.+.++. .|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58889999999999999995 45788999999975432 2344567888999999999999999999998766 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC-
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC- 402 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 402 (558)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999998653 468899999999999999999999 899999999999999999999999999975321000
Q ss_pred --------------------------------------------CcccccccccccCcccchhhccCCCCccccchhHHH
Q 008650 403 --------------------------------------------THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGV 438 (558)
Q Consensus 403 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGv 438 (558)
.........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000112346999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 008650 439 LLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS---MSEVLEL 514 (558)
Q Consensus 439 vl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~ 514 (558)
+||||++|+.||........... ..... ..+.............+++.+++ .+|.+|++ +.++++.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~--i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMK--VINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHH--HHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99999999999986543322111 11100 00010111122345666677765 59999987 8887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=329.04 Aligned_cols=246 Identities=23% Similarity=0.379 Sum_probs=193.3
Q ss_pred CcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHH---hcccccCCeeeeeeEEEeCc-EEEE
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGI---IGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
|.+.+.||+|+||.||+|.. .+++.||||++.+... .......+.+|..+ ++.++||||+++++++.+++ .|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67789999999999999954 5789999999975432 12233445556554 46778999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+|+|...+.. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988853 458999999999999999999999 89999999999999999999999999998753322
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ...... .. .
T Consensus 155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~--~~i~~~-~~----------~ 219 (324)
T cd05589 155 G--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF--DSIVND-EV----------R 219 (324)
T ss_pred C--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhC-CC----------C
Confidence 1 1223456999999999999999999999999999999999999999865432211 111111 10 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
++......+.+++.+||+.||.+|| ++.++++.
T Consensus 220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1122345678899999999999999 56777663
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=322.60 Aligned_cols=257 Identities=21% Similarity=0.388 Sum_probs=205.0
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG 317 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 317 (558)
..++|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++|+||+++++++..+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 3467899999999999999999543 24689999985433 3445567889999999999999999999987765
Q ss_pred -EEEEEEeccCCCHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceE
Q 008650 318 -LYLIFNFSQNGNLDAALHDER--------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ 388 (558)
Q Consensus 318 -~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 388 (558)
.++||||+.+|+|..++.... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence 999999999999999986532 2246888999999999999999998 8999999999999999999999
Q ss_pred EEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhc
Q 008650 389 ITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMES 467 (558)
Q Consensus 389 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 467 (558)
|+|||+++.+.............++..|+|||.+.++.++.++|||||||++|||++ |..||.......... ....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~~~~ 236 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK---FVID 236 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH---HHhc
Confidence 999999986544322222233447889999999998899999999999999999998 999997644322111 1111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 468 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
+.... .+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 237 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111 11122457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=318.52 Aligned_cols=250 Identities=23% Similarity=0.405 Sum_probs=200.8
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
.+|++.+.||+|+||.||+|...++..+|+|++.+.... ...+.+|+.+++.++||||+++++++.+.+ .++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 457889999999999999998777788999998654332 235778999999999999999999987655 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...+....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 81 MANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999996543 368999999999999999999999 89999999999999999999999999999865432211
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
. .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.......... .. ..+ .....+
T Consensus 157 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~~-~~~---------~~~~~~ 223 (256)
T cd05059 157 S-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE--SV-SAG---------YRLYRP 223 (256)
T ss_pred c-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HH-HcC---------CcCCCC
Confidence 1 111224567999999999999999999999999999999 899997654322111 11 111 011112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
......+.+++.+||+.+|++|||+.++++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 22355799999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=316.40 Aligned_cols=263 Identities=23% Similarity=0.364 Sum_probs=204.2
Q ss_pred hhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe------C
Q 008650 244 ATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE------N 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~ 316 (558)
....|...+.||+|+||.|+.+ +..+|+.||||++...-...-..+..++|+.+|++++|+||+.+++.+.. +
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999 66789999999997655566777889999999999999999999998864 2
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
++|+|+|+| +.+|...++.+ ..++...+..++.|+++||.|+|+ .+|+||||||+|+|++.+..+||+|||+|+
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccccee
Confidence 499999999 45888888654 448899999999999999999999 799999999999999999999999999999
Q ss_pred cCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-----------
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL----------- 464 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~----------- 464 (558)
...........+....|.+|.|||++.. ..|+...||||.||||.||++|+.-|.+...... .....
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q-l~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ-LQLILELLGTPSEEDL 252 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH-HHHHHHhcCCCCHHHH
Confidence 8865422222244568999999999854 5799999999999999999999999987532111 10000
Q ss_pred --hhcCCcccccC-------CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 465 --MESGNLTELVD-------PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 465 --~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+...+....+. ..+...+ +.......+++.+||..||.+|+|++|.|+.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 01000111000 0000111 1233567889999999999999999999985
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=329.21 Aligned_cols=243 Identities=26% Similarity=0.381 Sum_probs=194.5
Q ss_pred ceEeeeCceEEEEEEE----CCCCEEEEEEeecccc--cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 252 NMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNK--DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+.||+|+||.||++.. .+++.||+|++.+... .......+..|+.+++.++||||+++++++..++ .|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999954 3578999999975432 2233456778999999999999999999988765 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+++|.+++... ..+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 9999999998643 467888889999999999999999 8999999999999999999999999999875432211
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .+.. ..+.
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~--~~~~~-~~~~----------~~~~ 221 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT--IDKIL-KGKL----------NLPP 221 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH--HHHHH-cCCC----------CCCC
Confidence 12235699999999999998899999999999999999999999986543211 11111 1110 1112
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 485 DQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
.....+.+++.+||+.+|++|| ++.++++.
T Consensus 222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 2234688999999999999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.64 Aligned_cols=259 Identities=29% Similarity=0.493 Sum_probs=210.8
Q ss_pred CCCcccceEeeeCceEEEEEEECC--CC----EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSD--GR----KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.+.+....||+|.||.||.|...+ |. .||||.+.+ ..+.....+|++|..+|++++|||||+++|+|.+.. .
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 455667899999999999995543 43 489999954 455778889999999999999999999999999866 8
Q ss_pred EEEEEeccCCCHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecc
Q 008650 319 YLIFNFSQNGNLDAALHDER-----SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFG 393 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 393 (558)
++++|||++|+|..+|+..+ ...+.....+.++.|||+|+.||++ +++|||||...|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 89999999999999998763 3457888999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCccc
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTE 472 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 472 (558)
+|+.+-............-...|||||.++.+.++.|+|||||||+|||++| |..||....+..+. ..+.+++.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~--~~~~~ggR--- 922 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL--LDVLEGGR--- 922 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH--HHHHhCCc---
Confidence 9995443322222211123468999999999999999999999999999999 99999876443221 11233332
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
-..+..+...+.+++.+||+.+|++||++..+++.+.....
T Consensus 923 -------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 923 -------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred -------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 22245566678899999999999999999999997766443
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=321.70 Aligned_cols=264 Identities=25% Similarity=0.399 Sum_probs=203.0
Q ss_pred CcccceEeeeCceEEEEEE-----ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cEE
Q 008650 248 FHSENMVGQGGYSEVYKGN-----LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GLY 319 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~ 319 (558)
|...+.||+|+||+||++. ..++..||+|.+.... .......+.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 3788999999999998763 2457889999986542 234456788999999999999999999987642 388
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
++|||+.+++|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++..+.
T Consensus 85 lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999998643 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCccc-ccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh---hhcCCcccccC
Q 008650 400 NKCTHHA-AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL---MESGNLTELVD 475 (558)
Q Consensus 400 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~d 475 (558)
....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.............. .....+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 4322111 1122356779999999988999999999999999999999999875432211111000 00111111122
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.......+......+.+++.+||+.+|++|||+.++++.|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2222222233456799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=320.25 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=194.9
Q ss_pred EeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCH
Q 008650 254 VGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330 (558)
Q Consensus 254 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL 330 (558)
||+|+||+||++.. .+|+.||+|.+...... ......+..|++++++++||||+++++++.++. .++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999954 56899999999654322 223345567999999999999999999987655 8999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccccc
Q 008650 331 DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPI 410 (558)
Q Consensus 331 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 410 (558)
..++.......+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence 998876655668999999999999999999999 8999999999999999999999999999987654322 1234
Q ss_pred ccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHH--HHhhhhhhcCCcccccCCCCCCCCCHHHHH
Q 008650 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLV--LWAKPLMESGNLTELVDPSLEGEYDTDQMH 488 (558)
Q Consensus 411 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 488 (558)
.||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........ .. +.. . ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~----~~~--~---~~~~~~ 224 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-DE----VKF--E---HQNFTE 224 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-cc----ccc--c---cccCCH
Confidence 589999999999999999999999999999999999999975432111 11111110 01 000 0 012344
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 489 RLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 489 ~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
.+.+++.+||+.+|++||++.|+++.+.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 6889999999999999999988775444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.83 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=195.5
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccC-CeeeeeeEEEeCc-EEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHP-NTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~-~~lv~ 322 (558)
+|++.+.||+|+||.||+|.. .+++.||+|++.+... .......+..|..++..+.|+ +|+.+++++.+++ .|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 488899999999999999955 4678999999976432 233456678899999999765 5788888887655 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999988543 468899999999999999999999 899999999999999999999999999987532211
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... .. ... ..+
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~--i~-~~~----------~~~ 220 (324)
T cd05587 156 --KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS--IM-EHN----------VSY 220 (324)
T ss_pred --CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--HH-cCC----------CCC
Confidence 122235699999999999999999999999999999999999999986543322111 11 110 111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSM-----SEVLE 513 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~ 513 (558)
+......+.+++.+||+.+|.+|++. .++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 221 PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 22234568899999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=338.47 Aligned_cols=254 Identities=20% Similarity=0.245 Sum_probs=196.7
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||+||+|. ..+++.||+|++.+... .......+.+|+.+++.++|+||+++++.+.+++ .++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 468999999999999999995 45689999999965432 2233456778999999999999999999998766 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|.+++... +.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999999653 468889999999999999999999 899999999999999999999999999975321000
Q ss_pred -----------------------------------------CcccccccccccCcccchhhccCCCCccccchhHHHHHH
Q 008650 403 -----------------------------------------THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLL 441 (558)
Q Consensus 403 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 441 (558)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011346999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 008650 442 EIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRP---SMSEVLEL 514 (558)
Q Consensus 442 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~evl~~ 514 (558)
||++|+.||........... ...... .+...........+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 236 ell~G~~Pf~~~~~~~~~~~--i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLK--VINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHH--HhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999987543322111 111000 0000011122345667777766 5999999 88998875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=323.88 Aligned_cols=257 Identities=22% Similarity=0.380 Sum_probs=205.2
Q ss_pred CCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.+|.+.+.||+|+||.||+|.. .++..+++|.+.... ....+.+.+|+.++++++|+||+++++++.++. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 4588889999999999999953 234568899875432 344567889999999999999999999998765 8
Q ss_pred EEEEEeccCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC
Q 008650 319 YLIFNFSQNGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD 384 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 384 (558)
++||||+.+++|.+++.... ...+++..+++++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccC
Confidence 99999999999999996542 2347899999999999999999998 899999999999999999
Q ss_pred CceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhh
Q 008650 385 FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKP 463 (558)
Q Consensus 385 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 463 (558)
+.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |+.||......... .
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~ 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---E 236 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H
Confidence 9999999999976544322222223447889999999999999999999999999999999 99999765432211 1
Q ss_pred hhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.+..+.... ........+.+++.+||+.+|++|||+.+|++.|....
T Consensus 237 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 237 CITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111111111 11123456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=323.57 Aligned_cols=265 Identities=22% Similarity=0.399 Sum_probs=206.8
Q ss_pred hhhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
...++|++.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+.+++.++||||+++++++.++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 35678999999999999999998542 24579999986443 234445688999999999999999999998765
Q ss_pred c-EEEEEEeccCCCHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCce
Q 008650 317 G-LYLIFNFSQNGNLDAALHDER--------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEP 387 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 387 (558)
. .++||||+.+|+|.+++.... ...+.+..+.+++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcE
Confidence 5 899999999999999996532 1234667788999999999999998 899999999999999999999
Q ss_pred EEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhh
Q 008650 388 QITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLME 466 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 466 (558)
+|+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||....... .......
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~ 236 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFVMD 236 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc
Confidence 9999999986544322222222345778999999999999999999999999999998 788997643321 1111111
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCccc
Q 008650 467 SGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEF 523 (558)
Q Consensus 467 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 523 (558)
+.... .+......+.+++.+||+.+|++|||+.++++.|++.....+
T Consensus 237 -~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~ 283 (288)
T cd05061 237 -GGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 283 (288)
T ss_pred -CCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCC
Confidence 11111 111223579999999999999999999999999998655443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=330.36 Aligned_cols=251 Identities=25% Similarity=0.314 Sum_probs=197.0
Q ss_pred CCcccceEeeeCceEEEEEEE----CCCCEEEEEEeecccc--cHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-E
Q 008650 247 NFHSENMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNK--DAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-L 318 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~ 318 (558)
+|++.+.||+|+||.||++.. .+++.||+|++.+... .......+..|+.++..+. |+||+.+++++.+++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999854 3688999999975432 2233456778999999995 999999999887665 8
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999998643 458899999999999999999998 89999999999999999999999999999865
Q ss_pred CCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchh--HHHHhhhhhhcCCcccccC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQN--LVLWAKPLMESGNLTELVD 475 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~d 475 (558)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .......... .+
T Consensus 156 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~~ 227 (332)
T cd05614 156 LSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-------CD 227 (332)
T ss_pred cccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-------CC
Confidence 332221 22235699999999999865 4789999999999999999999999743211 1111111111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
+.+ +......+.+++.+||+.||++|| ++.++++.
T Consensus 228 ~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 PPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111 122344678899999999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=316.73 Aligned_cols=259 Identities=25% Similarity=0.455 Sum_probs=208.4
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||.||+|. ..+++.+|||.+.... ........+.+|+.+++.+.|+||+++++++.+++ .+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468888999999999999995 4689999999886543 23345567889999999999999999999988765 89999
Q ss_pred EeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 323 NFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 323 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||+.+++|.+++... ....+++..++.++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 23468999999999999999999998 8999999999999999999999999999887654
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
.... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||................ ...+..
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~-- 228 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ------CDYPPL-- 228 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc------CCCCCC--
Confidence 3221 123458999999999999899999999999999999999999997543322222111111 011111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
........+.+++.+||+.+|++||||.+|++.+++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 -PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1123455788999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=326.89 Aligned_cols=242 Identities=23% Similarity=0.354 Sum_probs=189.9
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcc-cccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGH-VCHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||.||+|.. .+++.||+|++.+... .......+..|..++.. .+||||+++++++..+. .++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999955 4688999999975432 22334445566666664 47999999999987665 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 9999988653 468999999999999999999999 899999999999999999999999999997643322 222
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... . .+ .++....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~--i~~-~------~~----~~~~~~~ 220 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS--ILN-D------RP----HFPRWIS 220 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH--HHc-C------CC----CCCCCCC
Confidence 345699999999999999999999999999999999999999986543322111 111 0 01 1122233
Q ss_pred HHHHHHHHHhhccCCCCCCCHH-HHHH
Q 008650 488 HRLVLIADYCVRQTSAWRPSMS-EVLE 513 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~~-evl~ 513 (558)
..+.+++.+||+.+|++||++. ++++
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 4678899999999999999875 4544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=330.51 Aligned_cols=244 Identities=21% Similarity=0.305 Sum_probs=194.9
Q ss_pred ceEeeeCceEEEEEE-ECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 252 NMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
+.||+|+||.||++. ..+|+.||+|++.+... .......+..|+.++..++||||+++++++..+. .++||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999995 45789999999976432 2334556788999999999999999999987765 99999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccc
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 408 (558)
+|..++... ..+++..+..++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 154 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence 999888543 4689999999999999999999952 5899999999999999999999999999875432211 122
Q ss_pred ccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHH
Q 008650 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMH 488 (558)
Q Consensus 409 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 488 (558)
...||+.|+|||++.++.++.++|||||||++|+|++|+.||......... .... ... .. ++.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~--~~i~-~~~------~~----~p~~~~~ 221 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF--ELIL-MEE------IR----FPRTLSP 221 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH--HHHh-cCC------CC----CCCCCCH
Confidence 356999999999999999999999999999999999999999765432111 1110 100 01 1122334
Q ss_pred HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 489 RLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 489 ~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
.+.+++.+||+.||++|+ ++.++++.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 688899999999999996 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=321.25 Aligned_cols=260 Identities=20% Similarity=0.308 Sum_probs=193.6
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc---ccCCeeeeeeEEEeC------
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV---CHPNTATLVGCCIEN------ 316 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~------ 316 (558)
+|++.+.||+|+||+||+|.. .+++.||+|.+............+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478899999999999999954 5789999999865432222223345566666554 699999999987531
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..+++|||+.+ +|..++.......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 27899999985 88888876555568999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHH-hhhhhh---cCCccc
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW-AKPLME---SGNLTE 472 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~-~~~~~~---~~~~~~ 472 (558)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ...... ...+..
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 7643321 123458999999999999999999999999999999999999997653321110 000000 000000
Q ss_pred -------ccCCCCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 473 -------LVDPSLE---GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 473 -------~~d~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
...+... ....+.....+.+++.+||+.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 0011123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=328.00 Aligned_cols=252 Identities=22% Similarity=0.354 Sum_probs=211.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~l 320 (558)
...|.+.+.||+|.||.||++.. .+|+.+|+|.+.+.... ......+.+|+.+|+++. |||||.+++.+.+.. .++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 45688889999999999999954 45999999999776532 224567889999999999 999999999998766 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC----CceEEEeccccc
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD----FEPQITDFGLAK 396 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~ 396 (558)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+ .||+||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999765 39999999999999999999999 899999999999999543 579999999999
Q ss_pred cCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... .+..+++
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---~i~~~~~------ 255 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---AILRGDF------ 255 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---HHHcCCC------
Confidence 8765 233456789999999999999999999999999999999999999999876443322 1122222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+.............+++..|+..||.+|+|+.++|+.
T Consensus 256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 23333444557788999999999999999999999994
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=323.02 Aligned_cols=256 Identities=21% Similarity=0.344 Sum_probs=202.1
Q ss_pred CCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.+|.+.+.||+|+||.||+|... ++..||+|++.... .......+..|+.++..++||||+++++++.+.. .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 35778899999999999999543 25789999996443 2344566889999999999999999999987755 8
Q ss_pred EEEEEeccCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC
Q 008650 319 YLIFNFSQNGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD 384 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 384 (558)
++++||+.+++|..++.... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence 99999999999999985321 2347888899999999999999998 899999999999999999
Q ss_pred CceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhh
Q 008650 385 FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKP 463 (558)
Q Consensus 385 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 463 (558)
+.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||....... +...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~ 238 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VIEM 238 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH
Confidence 9999999999886644322222223346789999999998999999999999999999998 888987643321 1111
Q ss_pred hhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
+..+... ..+......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 239 -i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 -IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111 1122334568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.41 Aligned_cols=239 Identities=26% Similarity=0.348 Sum_probs=193.1
Q ss_pred ceEeeeCceEEEEEEE----CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEecc
Q 008650 252 NMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQ 326 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~ 326 (558)
+.||+|+||.||++.. .+|+.||+|++.+..........+.+|+.++++++||||+++++++.+++ .|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999853 36889999999765443444556778999999999999999999988765 999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccc
Q 008650 327 NGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA 406 (558)
Q Consensus 327 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 406 (558)
+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~ 154 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence 99999998543 468999999999999999999999 899999999999999999999999999997654321 12
Q ss_pred ccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHH
Q 008650 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQ 486 (558)
Q Consensus 407 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 486 (558)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... ... ..+...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~--i~~-~~~----------~~p~~~ 221 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM--ILK-AKL----------GMPQFL 221 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH--HHc-CCC----------CCCCCC
Confidence 2345699999999999988899999999999999999999999986543221111 111 110 111223
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHH
Q 008650 487 MHRLVLIADYCVRQTSAWRPSMSE 510 (558)
Q Consensus 487 ~~~l~~li~~cl~~dp~~RPt~~e 510 (558)
...+.+++.+||+.||++||++.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 346888999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=332.12 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=198.7
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------ 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 316 (558)
..++|++.+.||+|+||.||++.. .+|+.||+|++.+..........+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347899999999999999999954 5689999999976555555667788999999999999999999988542
Q ss_pred -cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 317 -GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 317 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
..|+||||+.+ +|...+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 26899999976 5655553 247888899999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-----------
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL----------- 464 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~----------- 464 (558)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..|....
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHHH
Confidence 7643321 122346899999999999999999999999999999999999999865321 1111100
Q ss_pred ----------hh-cCCc-----ccccCCCCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 465 ----------ME-SGNL-----TELVDPSLE---GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 465 ----------~~-~~~~-----~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.. .... .+....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0000 000000000 00111123568899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=334.36 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=201.0
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
..++|++.+.||+|+||.||++.. .+++.||+|++.+... .......+.+|+.+++.++||||+++++++.++. .++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 456799999999999999999954 5688999999965432 2233445778999999999999999999988766 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+++|+|..++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999854 347888889999999999999999 8999999999999999999999999999987543
Q ss_pred CCCcccccccccccCcccchhhccC----CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHG----IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.. ...... .
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~-i~~~~~--~---- 265 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YSK-IMDHKN--S---- 265 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-HHH-HHcCCC--c----
Confidence 221 122345699999999998653 488999999999999999999999986543211 111 111100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAW--RPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 514 (558)
+...........+.+++.+||+.+|.+ |||+.++++.
T Consensus 266 -~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 -LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000011123457888999999999988 9999999885
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=335.38 Aligned_cols=256 Identities=21% Similarity=0.249 Sum_probs=194.1
Q ss_pred hhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
..++|.+.+.||+|+||.||++ ...+++.||+|.... ..+.+|+.++++++||||+++++++..+. .++|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 3467999999999999999999 456789999997532 23678999999999999999999988765 8899
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
+|++. ++|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 162 ~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 162 LPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 99985 6888887543 458899999999999999999999 89999999999999999999999999999754322
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch------hHHHHhhhhhhcCC------
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ------NLVLWAKPLMESGN------ 469 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~------~~~~~~~~~~~~~~------ 469 (558)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............+.
T Consensus 236 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 236 N-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred c-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1 1122345699999999999999999999999999999999999988753210 00000000000000
Q ss_pred ------ccccc---------CCCCCCCC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 ------LTELV---------DPSLEGEY--DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 ------~~~~~---------d~~l~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.... .+..+... .......+.+++.+||+.||.+|||+.|+++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 00000000 01234578899999999999999999999973
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.66 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=205.5
Q ss_pred hCCCcccceEeeeCceEEEEEEECC-----------------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCee
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSD-----------------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 307 (558)
..+|.+.+.||+|+||.||+|.... +..||+|.+.... .......+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578999999999999999985432 2458999986543 235567788999999999999999
Q ss_pred eeeeEEEeCc-EEEEEEeccCCCHHHHHhhccC---------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCC
Q 008650 308 TLVGCCIENG-LYLIFNFSQNGNLDAALHDERS---------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKAS 377 (558)
Q Consensus 308 ~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~ 377 (558)
++++++..+. .++++|++.+++|..++..... ..+++..++.++.|++.||.|||+ .+++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence 9999998755 9999999999999999965431 258999999999999999999998 89999999999
Q ss_pred ceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc--CCCCCCCCch
Q 008650 378 NVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT--GRKPVDSSRQ 455 (558)
Q Consensus 378 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt--g~~Pf~~~~~ 455 (558)
||+++.++.++|+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999986544332222334457889999999998899999999999999999998 7788875432
Q ss_pred hHH-HHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 456 NLV-LWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 456 ~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
... ............... ...+.....++.+++.+||+.+|++|||+.||++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 211 111111111111111 11122233579999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=316.85 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=195.0
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe---C-c--EE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE---N-G--LY 319 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~-~--~~ 319 (558)
.|...+++|.|+||.||+|.. .+++.||||+...+..- -.+|+++|+.+.|||||++.-+|.. + . +.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 466678999999999999954 45789999998665432 2269999999999999999988763 2 2 56
Q ss_pred EEEEeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-CceEEEeccccc
Q 008650 320 LIFNFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFGLAK 396 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~ 396 (558)
+||||++. +|...++.. .+..++...+.-+..||++||.|||+ .+|+||||||.|+|+|.+ |.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999987 898888742 23456777777799999999999999 899999999999999987 999999999999
Q ss_pred cCCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchh--HHHHhhhh-------hh
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQN--LVLWAKPL-------ME 466 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~--~~~~~~~~-------~~ 466 (558)
.+..+..+.. ...|..|+|||.+.+. .|+.+.||||.|||+.||+-|+.-|.+.... +....+.+ +.
T Consensus 175 ~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 175 VLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 8876544432 3478999999999765 6999999999999999999999999875432 11111111 00
Q ss_pred --cCCcccccCCCCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 467 --SGNLTELVDPSLEGE-----YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 467 --~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.+..+.-.+.+... +......+..+++.++|+.+|.+|.++.|++..
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111112222222211 223345678899999999999999999999974
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=327.73 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=192.2
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||+||+|.. .+++.||+|++.+... .......+..|+.++.++ +||||+++++++.++. .++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999954 5688999999976532 234455677888888776 7999999999988765 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccc
Confidence 9998888543 468999999999999999999999 899999999999999999999999999987532211 112
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCc------hhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR------QNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~------~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 33569999999999999999999999999999999999999995311 1111111111111111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPS------MSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt------~~evl~~ 514 (558)
.+......+.+++.+||+.||.+||+ +.++++.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 12233456889999999999999998 5676653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=332.36 Aligned_cols=257 Identities=19% Similarity=0.277 Sum_probs=199.8
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
....++|++.+.||+|+||.||++.. .+++.+|+|++.+... .......+.+|+.+++.++||||+++++++.++. .
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34457899999999999999999955 4688999999965332 2233455778999999999999999999988766 9
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
|+||||+.+|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999998543 47888999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcccchhhccC----CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHG----IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
..... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||........ + .........
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-~-~~i~~~~~~---- 265 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-Y-SKIMDHKNS---- 265 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-H-HHHHhCCcc----
Confidence 43221 122345699999999999754 378999999999999999999999986543211 1 111111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAW--RPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 514 (558)
+...........+.+++..||+.++.+ |+|+.|++++
T Consensus 266 ---~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 ---LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000111223456778889999855544 8899999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.24 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=214.6
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
....+.+.||+|-||+|..+....+.+||||+++... .....++|.+|+++|.+++||||+.|+|+|..++ +++++||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 4467789999999999999988888999999996543 3455789999999999999999999999998766 8899999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+++|+|..++.......+.-.....|+.||+.|++||.+ .++|||||.+.|+|+|.++++||+|||+++.+-.....
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999977654444556677899999999999998 89999999999999999999999999999976655554
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc--CCCCCCCCchh-HHHHhhhhhhcCCcccccCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT--GRKPVDSSRQN-LVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt--g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
......+-..+|||||.+.-++++++||||+||+++||+++ ...||...... .+.-+..+...+..... ..
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~------l~ 767 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV------LS 767 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee------cc
Confidence 44334445789999999999999999999999999999866 88999875443 22233333332222221 11
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.+.-....+.+++..||+.+-.+||+++++...|.+.
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2344556788999999999999999999999988764
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=324.25 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=206.5
Q ss_pred hhCCCcccceEeeeCceEEEEEEE--------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL--------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCI 314 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 314 (558)
..++|.+.+.||+|+||.||+|.. .++..+|+|.+... ........+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 346788999999999999999953 12457999988643 2344556788999999999 7999999999998
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCce
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDERS--------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNV 379 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI 379 (558)
... .+++|||+.+|+|.+++...+. ..+++..+..++.||+.||.|||+ ++++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 765 8999999999999999976432 347788899999999999999998 8999999999999
Q ss_pred eecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHH
Q 008650 380 LLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLV 458 (558)
Q Consensus 380 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~ 458 (558)
|++.++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 999999999999999987654333222223346788999999999999999999999999999998 888987543321
Q ss_pred HHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 459 LWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 459 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
..... ..+.. ...+......+.+++.+||+.+|++|||+.|+++.|++...
T Consensus 248 -~~~~~-~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 248 -LFKLL-KEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -HHHHH-HcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 11111 11110 01112334578889999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.98 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=199.6
Q ss_pred ceEeeeCceEEEEEEEC-C---CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNLS-D---GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~ 327 (558)
+.||+|+||.||+|... . +..+|+|.+...... .....+.+|+.+++.+.|+||+++++++..+..+++|||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCC
Confidence 46999999999999432 2 268999998655433 456778999999999999999999999887779999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccc-
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA- 406 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~- 406 (558)
|+|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 9999999654 368999999999999999999998 8999999999999999999999999999987644332211
Q ss_pred ccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHH
Q 008650 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485 (558)
Q Consensus 407 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 485 (558)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ... +..... ...+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~--~~~-~~~~~~---------~~~~~~ 222 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV--IAM-LESGER---------LPRPEE 222 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH--HHH-HHcCCc---------CCCCCC
Confidence 111224568999999999999999999999999999998 9999976543211 111 111110 011222
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 486 QMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 486 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
....+.+++.+||..+|++||++.+|++.|++..
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 3457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.53 Aligned_cols=249 Identities=22% Similarity=0.388 Sum_probs=198.4
Q ss_pred eEeeeCceEEEEEEEC---CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEeccCCC
Q 008650 253 MVGQGGYSEVYKGNLS---DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGN 329 (558)
Q Consensus 253 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~gs 329 (558)
.||+|+||.||+|... ++..||+|++... ........+.+|+.++++++||||+++++++..+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCC
Confidence 3899999999999543 3557999998644 33445567889999999999999999999987777999999999999
Q ss_pred HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccc-cc
Q 008650 330 LDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA-AI 408 (558)
Q Consensus 330 L~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~-~~ 408 (558)
|.+++... ...+++..+++++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++..+........ ..
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99998643 3468999999999999999999998 8999999999999999999999999999986544322111 11
Q ss_pred ccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 409 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
...+++.|+|||++.+..++.++|||||||++|+|++ |..||........ . .....+. ....+....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~-~~~~~~~---------~~~~~~~~~ 224 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--M-SFIEQGK---------RLDCPAECP 224 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--H-HHHHCCC---------CCCCCCCCC
Confidence 1224678999999998889999999999999999996 9999986543211 1 1111111 111222334
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 488 HRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
..+.+++.+||..+|++||++.+|++.|+..
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 6788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=319.17 Aligned_cols=245 Identities=25% Similarity=0.343 Sum_probs=194.1
Q ss_pred EeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCH
Q 008650 254 VGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330 (558)
Q Consensus 254 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL 330 (558)
||+|+||+||++.. .+++.||+|++.+.... ......+..|+.+++.++|+||+++.+++..+. .++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999954 57899999999754322 223456778999999999999999999887655 9999999999999
Q ss_pred HHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccc
Q 008650 331 DAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408 (558)
Q Consensus 331 ~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 408 (558)
...+... ....+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.++|+|||++..+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 8887542 33468999999999999999999999 89999999999999999999999999999876543221 22
Q ss_pred ccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhH--HHHhhhhhhcCCcccccCCCCCCCCCHHH
Q 008650 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL--VLWAKPLMESGNLTELVDPSLEGEYDTDQ 486 (558)
Q Consensus 409 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 486 (558)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ........ ... ..++...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---------~~~--~~~~~~~ 224 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL---------NDS--VTYPDKF 224 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc---------ccC--CCCcccC
Confidence 3469999999999999999999999999999999999999997543211 11111000 000 0112234
Q ss_pred HHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 487 MHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 487 ~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
...+.+++.+||+.+|++|| +++++++.
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 45788999999999999999 67777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.55 Aligned_cols=252 Identities=26% Similarity=0.345 Sum_probs=200.9
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.|+..+.||+|+||+||++. ..+++.||+|.+.+.... ......+.+|+.++++++|+||+.+++.+.+++ .++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 36778899999999999994 457899999998754322 233456778999999999999999999987755 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999999866555568999999999999999999998 8999999999999999999999999999976543322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-HhhhhhhcCCcccccCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ........ .. ..+
T Consensus 158 ~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~--~~--------~~~ 224 (285)
T cd05630 158 I---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VQ--------EEY 224 (285)
T ss_pred c---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh--hh--------hhc
Confidence 1 2345999999999999999999999999999999999999999864321110 00001000 00 011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 514 (558)
.......+.+++.+||+.||++||| +.|+++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1223346889999999999999999 8888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=327.01 Aligned_cols=242 Identities=24% Similarity=0.384 Sum_probs=192.3
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||+||+|.. .+++.||+|++.+... .......+..|..++..+ +||||+++++++.+++ .|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999955 4688999999975432 223445677888888776 6999999999988765 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|..++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTT 153 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccc
Confidence 9999988643 468999999999999999999998 899999999999999999999999999987532221 122
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .... .+.. ..+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~--~~i~-~~~~----------~~~~~~~ 220 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF--EAIL-NDEV----------VYPTWLS 220 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH--HHHh-cCCC----------CCCCCCC
Confidence 3356999999999999999999999999999999999999999865433211 1111 1110 0111233
Q ss_pred HHHHHHHHHhhccCCCCCCCH------HHHHH
Q 008650 488 HRLVLIADYCVRQTSAWRPSM------SEVLE 513 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~------~evl~ 513 (558)
..+.+++.+||+.||.+||++ .++++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 568899999999999999998 55555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=331.50 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=199.8
Q ss_pred hhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------ 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 316 (558)
..++|.+.+.||+|+||.||++. ..+++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999995 45688999999976555556667788999999999999999999987532
Q ss_pred -cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 317 -GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 317 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
..++||||+.+ +|...+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 26899999976 56666632 47888999999999999999998 89999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-----------
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL----------- 464 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~----------- 464 (558)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+....
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 8654322 1223468999999999999999999999999999999999999997643211 111000
Q ss_pred ----------h-hcCCcccccCCC------C--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 465 ----------M-ESGNLTELVDPS------L--EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 465 ----------~-~~~~~~~~~d~~------l--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. .......+..+. . ...........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 000000000000 0 001111224568899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=312.92 Aligned_cols=253 Identities=22% Similarity=0.380 Sum_probs=202.9
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeeccccc---HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKD---AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
++|.+.+.||+|++|.||+|. ..+++.+|+|.+...... ......+.+|+.++++++||||+++++++.++. .++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 578999999999999999995 457899999998654322 223456888999999999999999999998765 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
++||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999998653 458889999999999999999998 8999999999999999999999999999976543
Q ss_pred CCCccc-ccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 401 KCTHHA-AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
...... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||............ .... ..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~---------~~ 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI--ATQP---------TN 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH--hccC---------CC
Confidence 221111 12345889999999999989999999999999999999999999765332221111 0000 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+......+.+++.+||..+|++|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11122334568899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=310.88 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=205.7
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-Cc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-NG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~-~~lv~e 323 (558)
+|++.+.||+|++|.||++. ..+++.+|+|++............+.+|+.++++++|+|++++++.+.. +. .+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48889999999999999995 4467899999997665555666778899999999999999999998764 33 789999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+++++|.+++.......+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999999977655678999999999999999999998 8999999999999999999999999999987643221
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||......... .... .+... ..+
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~-~~~~~---------~~~ 223 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV--YRII-EGKLP---------PMP 223 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHH-hcCCC---------CCc
Confidence 223356899999999999999999999999999999999999999865432211 1111 11111 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+.+++.+||+.+|++|||+.++++.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2344578899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=326.77 Aligned_cols=243 Identities=21% Similarity=0.358 Sum_probs=193.9
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
++||+|+||.||+|.. .+++.||+|++.+... .......+..|..++..+ +||||+++++++.+++ .|+||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999955 4688999999976432 233445677888888766 7999999999998765 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|...+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT 153 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence 9999888643 468899999999999999999999 899999999999999999999999999987543221 122
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ...... . .. ++....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~i~~~-~---~~-------~p~~~~ 220 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF--ESILHD-D---VL-------YPVWLS 220 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH--HHHHcC-C---CC-------CCCCCC
Confidence 3456999999999999999999999999999999999999999865433221 111111 1 00 111123
Q ss_pred HHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 008650 488 HRLVLIADYCVRQTSAWRP-------SMSEVLEL 514 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RP-------t~~evl~~ 514 (558)
..+.+++.+||+.+|++|| ++.++++.
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 4688999999999999999 88888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=316.64 Aligned_cols=253 Identities=27% Similarity=0.481 Sum_probs=201.3
Q ss_pred CcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEec
Q 008650 248 FHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 325 (558)
|++.+.||+|+||+||++... +++.||+|++..............+|+.++++++||||+++++++.++. .+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999654 5678999999877655555555667999999999999999999998765 89999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
.+++|.+++. ....+++..++.++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||.+..... ...
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred cccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccc
Confidence 9999999997 33568999999999999999999999 8999999999999999999999999999976421 112
Q ss_pred cccccccccCcccchhhc-cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 406 AAIPIEGTFGYLAPEYFM-HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
......+|..|+|||++. +..++.++||||||+++|+|++|..||.......................... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 227 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ------SR 227 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS------HT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc------cc
Confidence 233456899999999998 88899999999999999999999999987622111111111100000000000 00
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.....+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01268999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=324.83 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=204.0
Q ss_pred hCCCcccceEeeeCceEEEEEEEC--------CCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEe
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS--------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIE 315 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 315 (558)
.++|.+.+.||+|+||.||++... +...+|+|.+.... .......+..|+.+++.+ +||||+++++++.+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 357999999999999999998532 23569999996543 344456788899999999 79999999999987
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCcee
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDERS--------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVL 380 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl 380 (558)
++ .++||||+.+|+|.+++..... ..+++..+.+++.|++.||+|||+ ++++||||||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheE
Confidence 65 9999999999999999976432 247889999999999999999998 89999999999999
Q ss_pred ecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHH
Q 008650 381 LGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVL 459 (558)
Q Consensus 381 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~ 459 (558)
++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~- 251 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 251 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH-
Confidence 99999999999999976643221111112234578999999999999999999999999999998 8999975433211
Q ss_pred HhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 460 WAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 460 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
... ...+. ....+......+.+++.+||+.+|++|||+.+|++.|....
T Consensus 252 -~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 252 -FKL-LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred -HHH-HHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111 11111 11112233457888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.44 Aligned_cols=246 Identities=22% Similarity=0.317 Sum_probs=193.4
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||.||+|.. .+++.||+|++.+... .......+..|..++..+ +||||+++++++.++. .|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999954 5688999999976532 233455678899999888 6999999999998765 8999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence 9999888543 569999999999999999999998 89999999999999999999999999998753221 1122
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch------hHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ------NLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~------~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||+.... ....+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 345699999999999999999999999999999999999999963211 111111111111111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPS------MSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt------~~evl~~ 514 (558)
.+......+.+++.+||+.||.+||| +.++++.
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11223446888999999999999997 6777653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.92 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=207.0
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFN 323 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e 323 (558)
...+|.+.+.||+|+||.||++...++..+|+|.+... ......+.+|+.+++.++|+||+++++++.+...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEE
Confidence 34678999999999999999998777888999988643 233457889999999999999999999988866999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++.......+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999999976655678899999999999999999998 8999999999999999999999999999976643321
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
. ......++..|+|||++..+.++.++|+|||||++|+|++ |+.||.......... ....+. ....
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~~~~~---------~~~~ 224 (260)
T cd05073 158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---ALERGY---------RMPR 224 (260)
T ss_pred c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHhCCC---------CCCC
Confidence 1 1122336678999999998899999999999999999999 999997653321111 111110 0011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.......+.+++.+||+.+|++||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=312.04 Aligned_cols=259 Identities=26% Similarity=0.434 Sum_probs=208.8
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||.||+|... +|+.+|+|.+.... ........+.+|+.++++++|+|++++++++.+++ .+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999654 89999999986433 33344667889999999999999999999988765 89999
Q ss_pred EeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 323 NFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 323 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||+.+++|..++... ....+++..++.++.+++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988643 23458899999999999999999998 8999999999999999999999999999886544
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||............... .+....
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~-------- 227 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPP-------- 227 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCC--------
Confidence 3221 12345889999999999889999999999999999999999999755433222211111 111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.........+.+++.+||..+|++|||+.+|++.|.+.
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 01113445788999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=334.62 Aligned_cols=261 Identities=25% Similarity=0.427 Sum_probs=204.5
Q ss_pred hhhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEe
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIE 315 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 315 (558)
...++|.+.+.||+|+||.||+|... .++.||+|++..... ......+.+|+.++.++. ||||+++++++..
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 34456888999999999999999642 346799999965432 334456889999999997 9999999999987
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhccC-------------------------------------------------------
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDERS------------------------------------------------------- 339 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 339 (558)
++ .++|+||+.+|+|.++++..+.
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 55 8999999999999999965321
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCc
Q 008650 340 -----------------------------------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASN 378 (558)
Q Consensus 340 -----------------------------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N 378 (558)
..+++..++.++.||+.||.|||+ ++++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 235677788999999999999998 899999999999
Q ss_pred eeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhH
Q 008650 379 VLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNL 457 (558)
Q Consensus 379 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~ 457 (558)
||++.++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986543322222223357889999999998899999999999999999998 899997543221
Q ss_pred HHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 458 VLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 458 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
... ..+..+. +...+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 350 ~~~--~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 QFY--NAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHH--HHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1111110 1111222345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.67 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=200.6
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--cEEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--GLYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~lv~ 322 (558)
..+|.+.+.||+|+||.||++... |..+|+|.+.... ..+.+.+|+.++++++|+|++++++++... ..++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 357889999999999999999664 7889999985432 245688999999999999999999986543 389999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++.......+++..++.++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999999976655568999999999999999999998 899999999999999999999999999987643322
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||........ ... +..+. ...
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~--~~~-~~~~~---------~~~ 219 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPR-VEKGY---------KMD 219 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH-HhcCC---------CCC
Confidence 12235678999999999899999999999999999997 9999975432211 111 11111 011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=319.91 Aligned_cols=254 Identities=21% Similarity=0.366 Sum_probs=201.4
Q ss_pred CCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
++|...+.||+|+||.||++.. .++..+|+|.+.... ......+.+|+++++.++|+||+++++++.++. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 5678889999999999999953 235678999875432 455667899999999999999999999988755 8
Q ss_pred EEEEEeccCCCHHHHHhhccC-------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC
Q 008650 319 YLIFNFSQNGNLDAALHDERS-------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 385 (558)
+++|||+.+++|.+++..... ..+++..++.++.|++.||.|||+ .+++||||||+|||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCC
Confidence 999999999999999975432 347889999999999999999998 8999999999999999999
Q ss_pred ceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhh
Q 008650 386 EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPL 464 (558)
Q Consensus 386 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 464 (558)
.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||........... .
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--~ 237 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC--I 237 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH--H
Confidence 999999999976543322111222335788999999999999999999999999999998 9999976433221111 1
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
. .+... ..+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 238 ~-~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 T-QGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-cCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 11000 111122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=315.11 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=206.7
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
..++|.+.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+||+++++++.++. .+++|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 4578999999999999999999877788899999875443 2356889999999999999999999987744 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++.......+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999977655678999999999999999999998 899999999999999999999999999998765321
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
. .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||........... .... . ...
T Consensus 158 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~--~~~~--~--------~~~ 224 (261)
T cd05034 158 Y-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ--VERG--Y--------RMP 224 (261)
T ss_pred h-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--HHcC--C--------CCC
Confidence 1 11112235678999999998899999999999999999998 9999976543211111 1110 0 001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.+......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111224578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.30 Aligned_cols=260 Identities=26% Similarity=0.418 Sum_probs=202.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeC-
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIEN- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 316 (558)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... .......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35799999999999999999952 357889999996433 334456788999999999 689999999988653
Q ss_pred -cEEEEEEeccCCCHHHHHhhccC--------------------------------------------------------
Q 008650 317 -GLYLIFNFSQNGNLDAALHDERS-------------------------------------------------------- 339 (558)
Q Consensus 317 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 339 (558)
..+++|||+.+|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 38899999999999999865321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccccc
Q 008650 340 ---------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPI 410 (558)
Q Consensus 340 ---------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 410 (558)
..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 236778889999999999999998 89999999999999999999999999999875433222222223
Q ss_pred ccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHH
Q 008650 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHR 489 (558)
Q Consensus 411 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 489 (558)
.+++.|+|||++.+..++.++||||||+++|+|++ |..||......... .. ....+.... . +......
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~-~~~~~~~~~-----~----~~~~~~~ 310 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CR-RLKEGTRMR-----A----PDYTTPE 310 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-HH-HHhccCCCC-----C----CCCCCHH
Confidence 46778999999999999999999999999999997 99999764322111 11 111111100 0 1112246
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 490 LVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 490 l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
+.+++..||+.+|++|||+.||++.|....
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.36 Aligned_cols=262 Identities=22% Similarity=0.351 Sum_probs=201.4
Q ss_pred hCCCcccceEeeeCceEEEEEEECC---------------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeee
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSD---------------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 309 (558)
.++|.+.+.||+|+||.||++.... ...||+|.+.... .......|.+|++++++++|+|++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 3579999999999999999985432 2358999986542 34455678899999999999999999
Q ss_pred eeEEEeCc-EEEEEEeccCCCHHHHHhhccC----------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCc
Q 008650 310 VGCCIENG-LYLIFNFSQNGNLDAALHDERS----------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASN 378 (558)
Q Consensus 310 ~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N 378 (558)
++++..+. .++||||+.+++|.+++..... ..+++..++.++.+++.||.|||+ .+++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 99997655 8999999999999999864321 236888899999999999999998 899999999999
Q ss_pred eeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc--CCCCCCCCchh
Q 008650 379 VLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT--GRKPVDSSRQN 456 (558)
Q Consensus 379 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt--g~~Pf~~~~~~ 456 (558)
|+++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999976543322222222345778999999999999999999999999999988 67788764332
Q ss_pred HH-HHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 457 LV-LWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 457 ~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
.. ............ . .....+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 240 ~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGR-Q-----IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhccc-c-----ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11 111111111000 0 000111123357999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=311.19 Aligned_cols=250 Identities=20% Similarity=0.369 Sum_probs=204.2
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|++.+.||+|+||.||++.. .+++.+|+|.+..... ......+..|+.+++.++|+||+++++.+.+++ .+++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 478889999999999999954 4789999999864432 345567788999999999999999999988765 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+++++|.+++.......+++..++.++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999999876666678999999999999999999998 8999999999999999999999999999987644322
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||........... ...+.... .+.
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~---------~~~ 222 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK---VCQGSYKP---------LPS 222 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH---HhcCCCCC---------CCc
Confidence 12234689999999999998999999999999999999999999986543222111 11111111 112
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....+.+++.+||+.+|++|||+.+++..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 233468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=317.11 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=201.5
Q ss_pred CCCcccceEeeeCceEEEEEEEC-----------------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeee
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-----------------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 308 (558)
++|++.+.||+|+||.||++... ++..+|+|++... ........+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 56899999999999999998432 2346899998643 23455667899999999999999999
Q ss_pred eeeEEEeCc-EEEEEEeccCCCHHHHHhhccC---------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCc
Q 008650 309 LVGCCIENG-LYLIFNFSQNGNLDAALHDERS---------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASN 378 (558)
Q Consensus 309 l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N 378 (558)
+++++..++ .+++|||+.+++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 999987755 8999999999999999876432 236778899999999999999999 899999999999
Q ss_pred eeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc--CCCCCCCCchh
Q 008650 379 VLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT--GRKPVDSSRQN 456 (558)
Q Consensus 379 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt--g~~Pf~~~~~~ 456 (558)
||++.++.++|+|||++..+.............+++.|+|||+...+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986544322222222335678999999988999999999999999999998 77888754322
Q ss_pred HHH-HhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 457 LVL-WAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 457 ~~~-~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
... .......... .....+ .+......+.+++.+||+.+|++||++.+|++.|++
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTGEFFRDQG-RQVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHhhcc-ccccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111 1111111100 000001 112233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=321.95 Aligned_cols=256 Identities=26% Similarity=0.449 Sum_probs=199.8
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCC--EEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGR--KIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~l 320 (558)
++|++.+.||+|+||.||+|... ++. .+++|.+.. .........+.+|+.++.++ +||||+++++++.+.+ .++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 57899999999999999999654 343 468888753 22344556788999999999 6999999999987755 899
Q ss_pred EEEeccCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc
Q 008650 321 IFNFSQNGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 386 (558)
++||+++++|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence 999999999999996532 1247889999999999999999998 89999999999999999999
Q ss_pred eEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhh
Q 008650 387 PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLM 465 (558)
Q Consensus 387 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 465 (558)
+||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||......... ....
T Consensus 158 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~--~~~~ 232 (297)
T cd05089 158 SKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY--EKLP 232 (297)
T ss_pred EEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HHHh
Confidence 99999999864322111 111123567999999998899999999999999999997 99999765432211 1111
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 466 ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
. ......+......+.+++.+||+.+|.+|||+.++++.|+....
T Consensus 233 ~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 233 Q----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred c----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 01111112233568899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=297.15 Aligned_cols=265 Identities=25% Similarity=0.363 Sum_probs=210.1
Q ss_pred HHHhhhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe---
Q 008650 240 EISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE--- 315 (558)
Q Consensus 240 ~~~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--- 315 (558)
.+....++|++.+.||+|||+-||.+ ...+++.||+|++.... .+.....++|+...++++|||+++++++...
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 34456688999999999999999999 56788999999997654 5667778999999999999999999988642
Q ss_pred -C--cEEEEEEeccCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEE
Q 008650 316 -N--GLYLIFNFSQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT 390 (558)
Q Consensus 316 -~--~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 390 (558)
. ..|+++.|...|+|.+.+.... +..+++.+.+.|+.+|++||.+||... .++.||||||.|||+.+.+.++|.
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEE
Confidence 1 2899999999999999886543 336899999999999999999999832 249999999999999999999999
Q ss_pred eccccccCCCCCCcc-------cccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHH
Q 008650 391 DFGLAKWLPNKCTHH-------AAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW 460 (558)
Q Consensus 391 DFG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~ 460 (558)
|||.+...+-..... .......|..|.|||.+. +...++++|||||||+||+||.|..||+..-
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~------ 245 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY------ 245 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh------
Confidence 999998764321111 011233688999999985 4457899999999999999999999997431
Q ss_pred hhhhhhcCCccc-ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 461 AKPLMESGNLTE-LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 461 ~~~~~~~~~~~~-~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
..++.+.- .....+........++.+.+++.+|++.||.+||++.+++..+..
T Consensus 246 ----~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 246 ----QQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ----hcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 11222221 122223333334467889999999999999999999999998865
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=302.89 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=207.0
Q ss_pred hhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccc------cHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEe
Q 008650 244 ATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNK------DAKKEKEFLMELGIIGHVC-HPNTATLVGCCIE 315 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 315 (558)
.-+.|...+.||+|..++|-++ ...+|..+|+|++..... .......-..|+.||+++. ||+|+.+.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788899999999999998 667899999999854321 1223345567999999996 9999999999988
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
+. +++|+++|+.|.|.++|... -.+++....+|+.|+.+|+.|||. ++||||||||+|||++++.++||+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 77 89999999999999999654 568999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhcc------CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcC
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMH------GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG 468 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 468 (558)
+..++.+... ...||||+|+|||.++. ..|+..+|+||+|||||.|+.|..||....+.++ ...+..|
T Consensus 170 a~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM---LR~ImeG 243 (411)
T KOG0599|consen 170 ACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM---LRMIMEG 243 (411)
T ss_pred eeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH---HHHHHhc
Confidence 9988765432 34689999999999853 3588899999999999999999999986544322 1223333
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 469 NLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 469 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+++ +......+......+++.+||+.||.+|.|.+|.|+.
T Consensus 244 kyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 KYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 332 1122233456678899999999999999999999874
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=316.96 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=200.2
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.|+..+.||+|+||+||+|.. .+++.+|+|.+...... ......+.+|+.+++.++|+||+.+++++..++ .+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367788999999999999954 57899999998654322 223455778999999999999999999887665 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|..++.......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999998876555579999999999999999999998 8999999999999999999999999999976543221
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-HhhhhhhcCCcccccCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.....|+..|+|||++.+..++.++|+|||||++|+|++|+.||......... .......... . .+
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~------~----~~ 224 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE------E----VY 224 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc------c----cc
Confidence 12346999999999999999999999999999999999999999865432111 0010011100 0 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 514 (558)
.......+.+++..||+.+|++||+ +.+++..
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1223346788999999999999999 6677663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.62 Aligned_cols=260 Identities=27% Similarity=0.469 Sum_probs=204.0
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC--------CCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS--------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCI 314 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 314 (558)
...+|.+.+.||+|+||.||+|... ....+|+|.+... ........+..|+.+++++ .||||+++++++.
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 3457889999999999999999531 2456899988643 3345566788999999999 5999999999988
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCce
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNV 379 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI 379 (558)
+++ .+++|||+.+|+|.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeE
Confidence 765 899999999999999996542 1347888999999999999999998 8999999999999
Q ss_pred eecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHH
Q 008650 380 LLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLV 458 (558)
Q Consensus 380 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~ 458 (558)
|++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|+|++ |..||........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987643322211112234568999999999999999999999999999999 8999976433211
Q ss_pred HHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 459 LWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 459 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
. . ....+... ..+......+.+++.+||+.+|++|||+.++++.|.+..
T Consensus 246 ~--~-~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 F--K-LLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred H--H-HHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1 1 11111110 112223446889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=312.63 Aligned_cols=249 Identities=27% Similarity=0.464 Sum_probs=204.7
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.++|++.+.||.|+||.||+|... |+.+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.. .++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 457889999999999999999764 78999999965432 5667889999999999999999999988644 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++.......+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||.++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999999976655578999999999999999999998 8999999999999999999999999999987643222
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
...++..|+|||++..+.++.++||||||+++|+|++ |+.||.......... ....+ .....
T Consensus 158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~~~~~---------~~~~~ 220 (256)
T cd05039 158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---HVEKG---------YRMEA 220 (256)
T ss_pred -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHhcC---------CCCCC
Confidence 1235678999999998899999999999999999997 999997654322110 11111 01111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
+......+.+++.+||+.+|++|||+.++++.|.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 12234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=339.60 Aligned_cols=258 Identities=20% Similarity=0.302 Sum_probs=192.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------ 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 316 (558)
...+|.+.+.||+|+||.||+|.. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 346799999999999999999955 5689999999854321 234699999999999999998876421
Q ss_pred -c--EEEEEEeccCCCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-ceEEE
Q 008650 317 -G--LYLIFNFSQNGNLDAALHD--ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-EPQIT 390 (558)
Q Consensus 317 -~--~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~ 390 (558)
. +++||||+++ +|..++.. .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeee
Confidence 1 6689999985 67666643 234568999999999999999999999 8999999999999998665 69999
Q ss_pred eccccccCCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHH-hhhhhh--
Q 008650 391 DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW-AKPLME-- 466 (558)
Q Consensus 391 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~-~~~~~~-- 466 (558)
|||+++.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|..||.+........ ......
T Consensus 214 DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 214 DFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred ccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999987654322 2234689999999998764 68999999999999999999999998653321110 000000
Q ss_pred --------cCCcccccCCC-----CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 467 --------SGNLTELVDPS-----LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 467 --------~~~~~~~~d~~-----l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+..+. +...++.....++.+++.+||+.+|.+|||+.|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00111111111 1111122234578899999999999999999999874
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.49 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=202.0
Q ss_pred HHHHhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 239 EEISSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 239 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
.++....++|++.+.||+|+||.||++.. .+++.+|+|++.+... .......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34455668999999999999999999955 4688999999865332 223345577899999999999999999999876
Q ss_pred c-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
. .++||||+++|+|..++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 6 99999999999999998543 47888899999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhccC----CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMHG----IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
..+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ + ..........
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~-~~i~~~~~~~ 266 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-Y-SKIMNHKNSL 266 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-H-HHHHcCCCcc
Confidence 87643321 122345699999999999753 378999999999999999999999986543211 1 1111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAW--RPSMSEVLELL 515 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~L 515 (558)
.+ .........+.+++.+||+.++.+ ||++.++++..
T Consensus 267 ~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 267 TF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11 011233456888999999844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=322.53 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=197.1
Q ss_pred ccceEeee--CceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEec
Q 008650 250 SENMVGQG--GYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 250 ~~~~lG~G--~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 325 (558)
+.++||+| +|++||++ ...+|+.||+|++............+.+|+.+++.++||||+++++++..++ .++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999 4567999999999765544555666778999999999999999999998766 99999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc-
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH- 404 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~- 404 (558)
.+|+|.+++.......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999976545568999999999999999999998 89999999999999999999999999875443221110
Q ss_pred ----ccccccccccCcccchhhcc--CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccC---
Q 008650 405 ----HAAIPIEGTFGYLAPEYFMH--GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD--- 475 (558)
Q Consensus 405 ----~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d--- 475 (558)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||............ . .+......+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~-~~~~~~~~~~~~ 235 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--L-NGTVPCLLDTTT 235 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH--h-cCCccccccccc
Confidence 01112347788999999976 35899999999999999999999999754322111110 0 000000000
Q ss_pred ----------------C-----------------CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 476 ----------------P-----------------SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 476 ----------------~-----------------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. .............+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 00001112334578899999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=310.22 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=198.6
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCH
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL 330 (558)
++||+|+||.||+|...++..+|+|++.... .......+.+|+.+++.++||||+++++++.... .++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999988888999999986543 3444556889999999999999999999987755 8999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccccc
Q 008650 331 DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPI 410 (558)
Q Consensus 331 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 410 (558)
.+++.... ..+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 80 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 80 LSFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 99986543 457899999999999999999998 899999999999999999999999999997644322211 1112
Q ss_pred ccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHH
Q 008650 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHR 489 (558)
Q Consensus 411 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 489 (558)
.++..|+|||++.++.++.++||||||+++|+|++ |..||.......... ....+. ....+......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~ 222 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE---QVEKGY---------RMSCPQKCPDD 222 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHHcCC---------CCCCCCCCCHH
Confidence 35678999999999999999999999999999998 999997654322111 111111 11112223457
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 490 LVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 490 l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
+.+++.+||+.+|++||++.|+++.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.80 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=198.5
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 316 (558)
.++|.+.+.||+|+||.||++. ...++.||||++.+..........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4689999999999999999995 45688999999976554455567788999999999999999999987532
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..|+||||+.+ +|...+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 37999999975 67666632 47888899999999999999998 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh-----------
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM----------- 465 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~----------- 465 (558)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+.....
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 654322 1223468999999999999999999999999999999999999997643211 1111000
Q ss_pred -----------hcCCcc-----cccCCCC---CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 466 -----------ESGNLT-----ELVDPSL---EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 466 -----------~~~~~~-----~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...... .+....+ ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 0000000 001111123468899999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.05 Aligned_cols=262 Identities=21% Similarity=0.306 Sum_probs=202.1
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC-eeeeeeEEEe-C------
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN-TATLVGCCIE-N------ 316 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~-~------ 316 (558)
..|...+.||+|+||+||+| ...+|+.||+|++......+......++|+.++++++|+| |+.+++++.. +
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34666788999999999999 5668999999999776554445566789999999999999 9999999865 2
Q ss_pred cEEEEEEeccCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERS--KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
.+++|+||++. +|..++..... ..++...+..++.||+.||+|||+ ++|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 48899999976 88888876543 357778899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC----
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN---- 469 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~---- 469 (558)
|+...-.. .......+|.+|.|||++.+. .|++..||||+|||++||++++.-|.+...... ....+..-|.
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q-l~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ-LFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH-HHHHHHHcCCCCcc
Confidence 98654222 223345699999999999876 799999999999999999999999987654221 1111111111
Q ss_pred -ccccc-----CCCCCCCC-C-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 -LTELV-----DPSLEGEY-D-------TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 -~~~~~-----d~~l~~~~-~-------~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.... +....... + +.......+++.+||+.+|..|.|+...+++
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11100 00111111 0 0111367889999999999999999999985
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=320.15 Aligned_cols=249 Identities=22% Similarity=0.356 Sum_probs=213.4
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-CcEEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-NGLYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e 323 (558)
.=|.+.+.||+|.|+.|-+| +.-+|+.||||++.+...+......++.|++.|+.++|||||+||++... ..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45788899999999999999 55689999999999888877778889999999999999999999999865 45999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec-CCCceEEEeccccccCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG-PDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~ 402 (558)
+-.+|+|.++|-.. ...+.+..+.+++.||+.|+.|+|+ ..+|||||||+||.+- +-|-+||.|||++..+..+.
T Consensus 98 LGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999654 3569999999999999999999999 8999999999998775 45889999999998765543
Q ss_pred CcccccccccccCcccchhhccCCCC-ccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIID-EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
...+.||+..|-|||++.+..|+ +.+||||||||||-|++|+.||+..+.+. .+..++|-.. .
T Consensus 174 ---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-----------TLTmImDCKY--t 237 (864)
T KOG4717|consen 174 ---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-----------TLTMIMDCKY--T 237 (864)
T ss_pred ---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------hhhhhhcccc--c
Confidence 33457899999999999999887 67899999999999999999998765432 2333444332 2
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+.....++.++|..||.+||.+|.+.+||+..
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 356778899999999999999999999999874
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.72 Aligned_cols=238 Identities=26% Similarity=0.364 Sum_probs=187.9
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHH-HhcccccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELG-IIGHVCHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||+||+|.. .+|+.||+|++.+... .......+..|.. +++.++||||+++++++.++. .++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999955 5789999999975432 1223345555554 467889999999999987765 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTT 153 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccc
Confidence 9999988643 468899999999999999999998 899999999999999999999999999987532221 122
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...... +.. .+ .....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~~-~~~------~~----~~~~~ 220 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM--YDNILN-KPL------RL----KPNIS 220 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH--HHHHHc-CCC------CC----CCCCC
Confidence 345699999999999999999999999999999999999999986543211 111111 110 11 11224
Q ss_pred HHHHHHHHHhhccCCCCCCCHH
Q 008650 488 HRLVLIADYCVRQTSAWRPSMS 509 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~~ 509 (558)
..+.+++.+||+.+|.+||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCC
Confidence 5688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.96 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=190.0
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcc-cccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGH-VCHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||+||+|.. .+++.||+|++.+... .......+..|..++.. ++||||+++++++.+++ .++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 4688999999976432 12233456677777775 48999999999998765 8999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|..++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence 9999998643 468889999999999999999999 899999999999999999999999999987532211 112
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . +.... +.. +....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~-~--i~~~~------~~~----~~~~~ 220 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ-S--IRMDN------PCY----PRWLT 220 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH-H--HHhCC------CCC----CccCC
Confidence 23569999999999999999999999999999999999999998654321111 1 11110 111 11223
Q ss_pred HHHHHHHHHhhccCCCCCCCHH-HHHH
Q 008650 488 HRLVLIADYCVRQTSAWRPSMS-EVLE 513 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~~-evl~ 513 (558)
..+.+++.+||+.+|++||++. ++++
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 4678899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.96 Aligned_cols=242 Identities=23% Similarity=0.333 Sum_probs=189.9
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||.||+|.. .+|+.||+|++.+... .......+..|..++... +||||+++++++.+++ .|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999955 4688999999976432 122344566777777654 7999999999998765 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRA 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cce
Confidence 9999988653 468899999999999999999999 899999999999999999999999999987532211 122
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.. +... .+.+ +....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-~~~--~~~~------~~~~----~~~~~ 220 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-FES--IRVD------TPHY----PRWIT 220 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHH--HHhC------CCCC----CCCCC
Confidence 345699999999999999999999999999999999999999986543211 111 1110 0111 11223
Q ss_pred HHHHHHHHHhhccCCCCCCCHH-HHHH
Q 008650 488 HRLVLIADYCVRQTSAWRPSMS-EVLE 513 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~~-evl~ 513 (558)
..+.+++.+||+.||++||++. ++++
T Consensus 221 ~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 221 KESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 4678899999999999999984 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.71 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=193.7
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||+||+|.. .+++.||+|++.+... .......+..|..++..+ +||||+++++++.+.+ .++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999955 4688999999976532 233445667888888877 6999999999987765 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|...+... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT 153 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence 9999888543 468999999999999999999998 899999999999999999999999999987532211 112
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..... .... .++....
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~--~~~i~-~~~~----------~~~~~~~ 220 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL--FQSIL-EDEV----------RYPRWLS 220 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH--HHHHH-cCCC----------CCCCcCC
Confidence 234699999999999999999999999999999999999999976543211 11111 1110 1112234
Q ss_pred HHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 008650 488 HRLVLIADYCVRQTSAWRPSM-----SEVLEL 514 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~-----~evl~~ 514 (558)
..+.+++.+||+.||.+|||+ .++++.
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 568899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.91 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=199.4
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCC--EEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGR--KIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~ 319 (558)
.++|++.+.||+|+||.||+|... ++. .+++|.+.. .........+.+|+.++.++ +|+||+++++++.+++ .+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 367899999999999999999653 454 357777643 23345566788999999999 8999999999987765 99
Q ss_pred EEEEeccCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC
Q 008650 320 LIFNFSQNGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 385 (558)
+|+||+++++|.++++... ...+++..++.++.|++.||+|||+ ++++||||||+|||++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCC
Confidence 9999999999999997543 1357899999999999999999998 8999999999999999999
Q ss_pred ceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhh
Q 008650 386 EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPL 464 (558)
Q Consensus 386 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 464 (558)
.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||........ ....
T Consensus 162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~ 236 (303)
T cd05088 162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEKL 236 (303)
T ss_pred cEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--HHHH
Confidence 99999999986432111 1111224678999999988889999999999999999998 9999975433211 1111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..+ .....+......+.+++.+||+.+|++||++.++++.|....
T Consensus 237 -~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 237 -PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred -hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 110 011111123346889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=311.16 Aligned_cols=249 Identities=31% Similarity=0.531 Sum_probs=202.4
Q ss_pred ceEeeeCceEEEEEEECC----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEecc
Q 008650 252 NMVGQGGYSEVYKGNLSD----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQ 326 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~ 326 (558)
+.||+|+||.||+|.... +..+++|.+....... ....+.+|+.+++.++|+||+++++++.++. .+++|||+.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999995543 7889999997654333 5677889999999999999999999988755 999999999
Q ss_pred CCCHHHHHhhcc-------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 327 NGNLDAALHDER-------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 327 ~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+++|.+++.... ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 999999997642 3568999999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
............+++.|+|||.+....++.++||||||+++|+|++ |..||........ ...... +.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~-~~--------- 224 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--LEYLRK-GY--------- 224 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHc-CC---------
Confidence 5432222334558899999999998899999999999999999999 6999987633211 111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
....+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112223457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.57 Aligned_cols=261 Identities=22% Similarity=0.321 Sum_probs=198.1
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------cEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------GLY 319 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 319 (558)
+|++.+.||+|+||.||++.. .+++.||+|++..........+.+.+|+.+++.++|+||+++++++... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999954 5799999999865544445567788999999999999999999998653 478
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+|+||+. ++|...+.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999987 577777743 3468999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-HhhhhhhcCCccc-----
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLMESGNLTE----- 472 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~----- 472 (558)
.... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......... .............
T Consensus 155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 3221 112234589999999999774 5799999999999999999999999865432110 0000000000000
Q ss_pred ------ccC-----CCCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 473 ------LVD-----PSLEG--EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 473 ------~~d-----~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.. +.... .........+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 00000 0111224568899999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.32 Aligned_cols=247 Identities=28% Similarity=0.463 Sum_probs=202.3
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEec
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFS 325 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~ 325 (558)
++|++.+.||+|+||.||++.. +++.+|+|.+.... ....+.+|+.+++.++|||++++++++..+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECC
Confidence 4588999999999999999964 67889999985432 235688999999999999999999999888899999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
.+++|.+++.......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999999976655568999999999999999999998 899999999999999999999999999987643321
Q ss_pred cccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 406 AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
.....+..|+|||++.++.++.++|+|||||++|+|++ |+.||......... . ....+. ......
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~--~-~~~~~~---------~~~~~~ 220 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK--E-CVEKGY---------RMEPPE 220 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH--H-HHhCCC---------CCCCCC
Confidence 11234678999999998999999999999999999997 99999765432211 1 111111 111112
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.....+.+++.+||+.+|++||++.++++.|++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=317.94 Aligned_cols=257 Identities=25% Similarity=0.432 Sum_probs=203.3
Q ss_pred hCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
.++|.+.+.||+|+||.||+|... ++..||+|++.... .......+.+|+.++++++||||+++++++.++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 467999999999999999999643 46789999986433 3445567889999999999999999999987755
Q ss_pred EEEEEEeccCCCHHHHHhhcc--------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCC
Q 008650 318 LYLIFNFSQNGNLDAALHDER--------------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKAS 377 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~ 377 (558)
.++++||+.+|+|.+++.... ...+++..++.++.|++.||.|||+ ++++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence 899999999999999996432 1247788899999999999999998 89999999999
Q ss_pred ceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchh
Q 008650 378 NVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQN 456 (558)
Q Consensus 378 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~ 456 (558)
|||++.++.++|+|||++..+.............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543322111222235678999999998999999999999999999998 88898754322
Q ss_pred HHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 457 LVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.. .. ....+.... .+.....++.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ~~--~~-~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EV--IY-YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH--HH-HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 11 111222111 111234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=309.94 Aligned_cols=252 Identities=22% Similarity=0.365 Sum_probs=207.9
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|+..+.||.|+||.||.+. ..+++.+++|.+............+.+|+.++++++|+||+++++++.+.. .+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58889999999999999984 456899999998766555666778899999999999999999999998766 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+++|.+++.......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999999976655678999999999999999999998 8999999999999999999999999999987644332
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
......|++.|+|||++.+..++.++||||||+++|+|++|..||.......... .. ..++.... ..
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~--~~-~~~~~~~~---------~~ 223 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV--KI-VQGNYTPV---------VS 223 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH--HH-HcCCCCCC---------cc
Confidence 2223458999999999988889999999999999999999999997654322111 11 11111111 12
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
.....+.+++.+||+.+|.+||++.++++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2345688999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.84 Aligned_cols=241 Identities=26% Similarity=0.352 Sum_probs=189.1
Q ss_pred ceEeeeCceEEEEEE-ECCCCEEEEEEeecccc-cHHHHHHHHHHHH-HhcccccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNK-DAKKEKEFLMELG-IIGHVCHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||+||+|. ..+|+.||+|++.+... .......+..|.. +++.++||||+++++++..++ .++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999995 45789999999975432 2233445566655 467789999999999987755 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (325)
T cd05604 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTT 153 (325)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCc
Confidence 999988854 3568999999999999999999998 899999999999999999999999999987532221 122
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..... ... .+ .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~--~~~~~-~~~------~~----~~~~~ 220 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY--DNILH-KPL------VL----RPGAS 220 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH--HHHHc-CCc------cC----CCCCC
Confidence 3456999999999999999999999999999999999999999865432211 11111 110 01 11233
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHH
Q 008650 488 HRLVLIADYCVRQTSAWRPSMSEVL 512 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~~evl 512 (558)
..+.+++.+||+.+|.+||++.+.+
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCH
Confidence 4678899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=312.56 Aligned_cols=257 Identities=25% Similarity=0.434 Sum_probs=203.1
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCC---EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGR---KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
.++|+..+.||+|+||.||+|... ++. .+|+|.+.... .......+..|+.++++++|+||+++++++.+.+ .+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 457888999999999999999654 333 68999985442 3444567889999999999999999999988755 89
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+++|..++.... ..+++..+..++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 83 IITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999996543 568999999999999999999998 899999999999999999999999999998665
Q ss_pred CCCCcccc-cccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 400 NKCTHHAA-IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 400 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
........ .....++.|+|||++.++.++.++|||||||++|||++ |+.||........ .........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~--~~~i~~~~~-------- 228 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV--MKAINDGFR-------- 228 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhcCCC--------
Confidence 43222111 11223567999999998899999999999999999997 9999975443211 111111100
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
..........+.+++.+||+.+|++||++.+|++.|.+.
T Consensus 229 --~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 --LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112345688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.30 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=196.2
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||+||++.. .+++.||+|++.+... .......+..|+.++..++|+||+++++.+.++. .++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688999999999999999954 5689999999975432 2334566778999999999999999999988765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999998643 468999999999999999999999 899999999999999999999999999987543211
Q ss_pred Cc---------------------------------ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCC
Q 008650 403 TH---------------------------------HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449 (558)
Q Consensus 403 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~P 449 (558)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00 011235699999999999999999999999999999999999999
Q ss_pred CCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 008650 450 VDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS---MSEVLEL 514 (558)
Q Consensus 450 f~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~ 514 (558)
|......... ........ ...+.+ . ......+.+++.+|+ .+|.+|++ +.|+++.
T Consensus 236 f~~~~~~~~~--~~i~~~~~-~~~~p~----~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETPQETY--RKVMNWKE-TLVFPP----E--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCHHHHH--HHHHcCCC-ceecCC----C--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9865433211 11111000 000011 0 112345777777766 49999985 6666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=308.55 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=198.4
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCH
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL 330 (558)
+.||+|+||.||++...+++.||+|++...... .....+.+|+++++++.|+||+++++++.+.. .++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 368999999999997766999999998654432 45667899999999999999999999987765 9999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccccc
Q 008650 331 DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPI 410 (558)
Q Consensus 331 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 410 (558)
.+++.... ..+++..+..++.+++.||.|||+ ++++||||||+|||++.++.+||+|||++...............
T Consensus 80 ~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 80 LTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99986543 357889999999999999999998 89999999999999999999999999999865432221111122
Q ss_pred ccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHH
Q 008650 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHR 489 (558)
Q Consensus 411 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 489 (558)
.++..|+|||++.++.++.++|||||||++|+|++ |..||........... ...+ .....+......
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~~~~---------~~~~~~~~~~~~ 223 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---IESG---------YRMPAPQLCPEE 223 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---HhcC---------CCCCCCccCCHH
Confidence 34677999999998999999999999999999999 8999976543211110 1110 001112223457
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 490 LVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 490 l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
+.+++.+||+.+|++|||+.||++.|.
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=322.04 Aligned_cols=242 Identities=24% Similarity=0.380 Sum_probs=192.3
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~lv~ 322 (558)
+|...+.||+|+||+||+|.. .+|+.||+|++.+... .......+..|..++..+. |++|+++++++.+++ .|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999954 5789999999976432 2334456778888888886 567888888887655 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999988543 468999999999999999999998 899999999999999999999999999987543221
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..... ... .+
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~--~~i~~-~~~----------~~ 220 (323)
T cd05615 156 --VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF--QSIME-HNV----------SY 220 (323)
T ss_pred --ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-CCC----------CC
Confidence 1223356999999999999999999999999999999999999999875433211 11111 110 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSM 508 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~ 508 (558)
+......+.+++.+||+.+|.+|++.
T Consensus 221 p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 12233567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.31 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=205.5
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC--------CCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS--------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCI 314 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 314 (558)
...+|++.+.||+|+||.||+|... .+..||+|.+... ........+.+|+.+++++ .||||+++++++.
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 3456899999999999999999532 1236899988543 3345567889999999999 7999999999998
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCce
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNV 379 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI 379 (558)
+++ .++++||+.+|+|.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceE
Confidence 765 899999999999999996532 1247788899999999999999998 8999999999999
Q ss_pred eecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHH
Q 008650 380 LLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLV 458 (558)
Q Consensus 380 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~ 458 (558)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 244 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 244 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence 999999999999999987654322222222335678999999999999999999999999999998 899997653221
Q ss_pred HHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCc
Q 008650 459 LWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDS 521 (558)
Q Consensus 459 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 521 (558)
..... ..+.. ...+......+.+++.+||+.+|++|||+.|+++.|......
T Consensus 245 -~~~~~-~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 245 -LFKLL-KEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -HHHHH-HcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 11111 11111 111222345788999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=313.96 Aligned_cols=264 Identities=24% Similarity=0.374 Sum_probs=201.7
Q ss_pred CCCcccceEeeeCceEEEEEEE-----CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe---Cc
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE---NG 317 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 317 (558)
.+|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5788899999999999999853 357899999986443 4455678899999999999999999998753 23
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++|+||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 899999999999999996542 458999999999999999999998 8999999999999999999999999999987
Q ss_pred CCCCCCccc-ccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC-------
Q 008650 398 LPNKCTHHA-AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN------- 469 (558)
Q Consensus 398 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~------- 469 (558)
+........ .....++..|+|||++.++.++.++|||||||++|||++|..|+.......... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 234 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM---MGNDKQGQMIVYH 234 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh---cccccccccchHH
Confidence 654322111 111224556999999999899999999999999999999988765432211100 000000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 470 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
+.+.+...............+.+++.+||..+|++|||+.||++.|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0001111111111223345789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.37 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=189.4
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHH-HhcccccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELG-IIGHVCHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||+||+|.. .+++.||+|++.+.... ......+..|.. +++.++||||+++++++.+++ .|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999955 46788999999754321 222334455544 567889999999999987765 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|..++... ..+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~ 153 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTT 153 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCc
Confidence 9999998653 457888888999999999999999 899999999999999999999999999997543221 122
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..... ... .......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~~-~~~----------~~~~~~~ 220 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY--DNILN-KPL----------QLKPNIT 220 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH--HHHHh-CCc----------CCCCCCC
Confidence 3456999999999999999999999999999999999999999865432211 11111 000 1112234
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 488 HRLVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
..+.+++.+||+.+|.+||++.+.+..+
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 5688899999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=308.44 Aligned_cols=250 Identities=28% Similarity=0.451 Sum_probs=200.5
Q ss_pred ceEeeeCceEEEEEEECC--CC--EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNLSD--GR--KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~ 327 (558)
+.||+|++|.||+|.+.+ ++ .+|+|.+...... ...+.+.+|+.++++++||||+++++.+.+...++++||+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCC
Confidence 368999999999996532 33 6899999765543 667789999999999999999999999888569999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc-c
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH-A 406 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~ 406 (558)
++|.+++.......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++..+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999976543568999999999999999999998 899999999999999999999999999998765432211 1
Q ss_pred ccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHH
Q 008650 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485 (558)
Q Consensus 407 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 485 (558)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.||......... ....... ... ..+..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~--~~~~~~~--~~~-------~~~~~ 225 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL--KKIDKEG--ERL-------ERPEA 225 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHhcC--CcC-------CCCcc
Confidence 112457889999999999999999999999999999999 99999754332211 1111110 000 01112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 486 QMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 486 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
....+.+++.+||+.+|++|||+.++++.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 3457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=312.67 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=203.2
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-C---CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-D---GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
..+|.+.+.||+|+||.||+|... + +..+|+|.+.... .......+.+|+.++++++||||+++++++.+++ .+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999543 2 3379999986533 3445667899999999999999999999987655 89
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++..+.
T Consensus 82 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999996543 458999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCccc-ccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 400 NKCTHHA-AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 400 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
....... .....++..|+|||++.++.++.++|+|||||++||+++ |..||........ .........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--~~~~~~~~~-------- 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--IKAIEEGYR-------- 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--HHHHhCCCc--------
Confidence 4322111 111224568999999999899999999999999999887 9999976433211 111111100
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.......+..+.+++.+||+.+|++||++.++++.|...
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 --LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011122345688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=309.79 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=192.0
Q ss_pred ceEeeeCceEEEEEEECC---CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNLSD---GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||.||+|...+ +..+|+|.+..... ......+.+|+.++++++||||+++++++.+.. .++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 368999999999996543 45799998865432 344557889999999999999999999987655 8999999999
Q ss_pred CCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 328 GNLDAALHDERS---KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 328 gsL~~~l~~~~~---~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
|+|.+++..... ...++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999975432 245677788899999999999998 89999999999999999999999999999765433222
Q ss_pred ccccccccccCcccchhhccC-------CCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHG-------IIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
.......|+..|+|||++.+. .++.++||||||+++|||++ |+.||......... .. ...+.......+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-~~--~~~~~~~~~~~~ 233 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL-TY--TVREQQLKLPKP 233 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH-HH--HhhcccCCCCCC
Confidence 222234578899999998642 35789999999999999996 99999765432211 11 111111122222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
.+.. .....+.+++..|+ .+|++|||+.||+..|.
T Consensus 234 ~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2221 12345778889999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=313.71 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=205.4
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCC----EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGR----KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 320 (558)
.+|++.+.||+|+||.||+|... +|+ .+|+|.+.... .......+.+|+.+++.++||||+++++++..+..++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEE
Confidence 56888999999999999999543 343 58999885543 3455677889999999999999999999998877999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
|+||+.+|+|.+++.... ..+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999996543 358999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
...........++..|+|||.+....++.++|+||||+++|||++ |+.||........ ..........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~--------- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--PDLLEKGERL--------- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHHhCCCCC---------
Confidence 332222222234678999999998899999999999999999999 9999987543221 1111111110
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
..+......+.+++.+||..+|++||++.++++.|+..
T Consensus 231 -~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 -PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.41 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=204.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCC----EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGR----KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 319 (558)
.++|+..+.||+|+||.||+|.. .+|. .+|+|.+.... .......+.+|+.+++.++||||+++++++.....+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCce
Confidence 35678889999999999999954 4454 47888885432 344455688999999999999999999999877788
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+|+||||+|||++.++.+||+|||+++.+.
T Consensus 85 ~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999998654 3458899999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
............++..|+|||++.+..++.++|||||||++|||++ |..||......... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~~~------- 230 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---DLLEKGERL------- 230 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHCCCCC-------
Confidence 4332222223346788999999998999999999999999999997 99999765322111 111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..+......+.+++.+||..+|++||++.++++.|+...
T Consensus 231 --~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 231 --PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001112346788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=312.54 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=196.8
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||.||+|. ..+++.||+|.+.... .......+.+|+.++++++||||+++++++..++ .++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 357888999999999999994 4678999999986543 3445567889999999999999999999988765 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 80 FMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred cCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 99999996542 46888899999999999999999 899999999999999999999999999997654322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhH-----HHHhhhhhhcCCcccccCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL-----VLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~d~~l 478 (558)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||....... ..... ...... .+.+
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~ 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVDED-----PPVL 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHhccC-----CCCC
Confidence 223468999999999999999999999999999999999999997532110 00000 000000 0111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. .......+.+++.+||+.+|.+||++.|+++.
T Consensus 221 ~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 P---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred C---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 11233468899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=313.16 Aligned_cols=256 Identities=24% Similarity=0.438 Sum_probs=201.7
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CC---CEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DG---RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
++|.+.+.||+|+||.||+|... ++ ..||+|.+... ........|..|+.+++.+.||||+++++++.++. .++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 45788999999999999999653 33 36999998643 23555678999999999999999999999987765 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+++|.+++... ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++..+..
T Consensus 83 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 83 ITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999998654 3468999999999999999999998 8999999999999999999999999999876644
Q ss_pred CCCcccccc-cc--cccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 401 KCTHHAAIP-IE--GTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 401 ~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
......... .. .+..|+|||++.++.++.++|||||||++|||++ |..||......... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~--~~i~~~~~------- 229 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI--NAIEQDYR------- 229 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH--HHHHcCCc-------
Confidence 322111111 11 2457999999999999999999999999999887 99999765332111 11111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 230 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ---LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011122345688899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=314.74 Aligned_cols=251 Identities=25% Similarity=0.444 Sum_probs=199.4
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEe------
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIE------ 315 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------ 315 (558)
+++.|.+.+.||+|+||.||+|.. .+++.||+|++..... ....+..|+.++.++ +|+||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456788899999999999999954 5688999999865432 234577899999988 69999999999864
Q ss_pred -CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 316 -NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 316 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
...+++|||+.+++|.+++.......+++..+..++.|++.||.|||+ ++|+|+||||+||++++++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 237899999999999999977655678999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 469 (558)
+....... .......|++.|+|||++. +..++.++|||||||++|||++|..||............ ....
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---~~~~ 232 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNP 232 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---hcCC
Confidence 98654322 1223456899999999986 346888999999999999999999999754332221111 1101
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.... ........+.+++.+||+.+|.+|||+.++++
T Consensus 233 ~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111 11122346889999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.66 Aligned_cols=238 Identities=24% Similarity=0.320 Sum_probs=187.2
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHH-HhcccccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELG-IIGHVCHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||.||+|.. .+++.||+|++.+... .......+..|.. +++.++||||+++++++.+.+ .|+||||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999955 5688999999975432 2233445555554 578899999999999887755 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|...+... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETT 153 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccc
Confidence 9998888543 468888899999999999999998 899999999999999999999999999987532221 122
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... .. ...+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~-~~----------~~~~~~~~ 220 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM--YDNILH-KP----------LQLPGGKT 220 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH--HHHHhc-CC----------CCCCCCCC
Confidence 345699999999999999999999999999999999999999986543221 111111 10 01122234
Q ss_pred HHHHHHHHHhhccCCCCCCCHH
Q 008650 488 HRLVLIADYCVRQTSAWRPSMS 509 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~~ 509 (558)
..+.+++.+||+.+|.+||+..
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCC
Confidence 5688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=347.41 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=201.1
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .......+.+|+.++++++||||+++++++.+++ .+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999954 4689999999965432 2345567899999999999999999999998765 89999
Q ss_pred EeccCCCHHHHHhhcc---------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecc
Q 008650 323 NFSQNGNLDAALHDER---------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFG 393 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 393 (558)
||+++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 1235667788999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCC----------------cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhH
Q 008650 394 LAKWLPNKCT----------------HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL 457 (558)
Q Consensus 394 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~ 457 (558)
++........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 001113469999999999999999999999999999999999999997643221
Q ss_pred HHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhc
Q 008650 458 VLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRP-SMSEVLELLTS 517 (558)
Q Consensus 458 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~ 517 (558)
...... ..++... .........+.+++.+||+.||++|| ++.++++.|+.
T Consensus 239 i~~~~~---------i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ISYRDV---------ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhhhh---------ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111110 0000000 00112335688899999999999995 56777776665
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=349.05 Aligned_cols=256 Identities=21% Similarity=0.367 Sum_probs=201.1
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GL 318 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~ 318 (558)
...++|.+.+.||+|+||+||+|.. .++..+|+|++............|..|+.+++.++||||++++++|.+. .+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456899999999999999999954 4678899999876655566677899999999999999999999988642 38
Q ss_pred EEEEEeccCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhCC----CCcEEecCCCCCceeecCC--------
Q 008650 319 YLIFNFSQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGC----KRRIIHRDIKASNVLLGPD-------- 384 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~----~~~ivH~Dlkp~NIll~~~-------- 384 (558)
|+||||+.+|+|..+|.... ...+++..++.|+.||+.||.|||+.. .++||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999986532 356999999999999999999999732 1359999999999999642
Q ss_pred ---------CceEEEeccccccCCCCCCcccccccccccCcccchhhcc--CCCCccccchhHHHHHHHHHcCCCCCCCC
Q 008650 385 ---------FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH--GIIDEKTDVFAFGVLLLEIITGRKPVDSS 453 (558)
Q Consensus 385 ---------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~~Pf~~~ 453 (558)
+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||+|++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3489999999987643322 223469999999999864 45899999999999999999999999754
Q ss_pred chhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 454 RQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.... .....+.... .+. .......+.+|+..||+.+|.+||++.|++.
T Consensus 247 ~~~~-qli~~lk~~p--------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFS-QLISELKRGP--------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHH-HHHHHHhcCC--------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 3221 1111111110 010 0112356889999999999999999999995
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=320.15 Aligned_cols=246 Identities=22% Similarity=0.302 Sum_probs=192.1
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||+||+|.. .+++.||+|++.+... .......+..|..++.++ +||||+.+++++.+.. .++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999954 5678999999976532 234456678899998888 5999999999987755 8999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTT 153 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cce
Confidence 9999888543 468999999999999999999999 899999999999999999999999999987532211 122
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch----hHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ----NLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+....+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCCC
Confidence 345699999999999999999999999999999999999999964211 11111111111110 0112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSM------SEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~ 514 (558)
......+.+++.+||+.||.+|+++ .++++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 2233467889999999999999984 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=315.79 Aligned_cols=259 Identities=22% Similarity=0.376 Sum_probs=202.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-----CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---c
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---G 317 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~ 317 (558)
..|++.+.||+|+||.||++.. .++..||+|.+.... .......+.+|+.+++.+.||||+++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4578899999999999999963 357889999986443 344556788999999999999999999998764 3
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999986542 358999999999999999999998 8999999999999999999999999999987
Q ss_pred CCCCCCcc-cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH------------Hhhhh
Q 008650 398 LPNKCTHH-AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL------------WAKPL 464 (558)
Q Consensus 398 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~------------~~~~~ 464 (558)
+....... ......|+..|+|||++.+..++.++|||||||++|+|++++.|+......... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 65432211 112345778899999999889999999999999999999988775432111100 00001
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+. ....+......+.+++.+||+.+|++|||+.++++.|+..
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111 1111222346799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=310.82 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=199.5
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++..+. .++|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35799999999999999999964 5788999999864432 23345778999999999999999999987765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++..+....
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 86 EYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999998643 468999999999999999999998 899999999999999999999999999998764322
Q ss_pred CcccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
. ......|++.|+|||.+. ...++.++|||||||++|||++|+.||.......... .+.... ...+...
T Consensus 161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~~~~~~---~~~~~~~ 232 (267)
T cd06646 161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSN---FQPPKLK 232 (267)
T ss_pred c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---eeecCC---CCCCCCc
Confidence 1 122345889999999984 4457889999999999999999999996543221100 000000 0111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
. .......+.+++.+||+.+|++|||+.++++.|
T Consensus 233 ~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 D--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1 122345788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=305.60 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=205.3
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|++.+.||+|+||.+|++. ..+|+.||+|.+...........++.+|+.+++.++||||+++++++.+++ .++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 48889999999999999994 457899999999765444555678899999999999999999999987765 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+++|.+.+.......+++..+++++.|++.||.|||+ ++++|+||+|+|||++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 999999999976555568999999999999999999998 89999999999999999999999999999866443221
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
.....|++.|+|||++.++.++.++|+|||||++|+|++|+.||......... ..... +... ..+.
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~--~~~~~-~~~~---------~~~~ 223 (256)
T cd08218 158 --ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV--LKIIR-GSYP---------PVSS 223 (256)
T ss_pred --hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH--HHHhc-CCCC---------CCcc
Confidence 12245889999999999999999999999999999999999999764332211 11111 1111 1122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....+.+++.+||+.+|.+||++.+|++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 234568899999999999999999999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.34 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=200.6
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||.||++.. .++..+|+|.+.... .......+.+|++++++++||||+++++++.+++ .++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 4689999999999999999954 468889999886432 3445567889999999999999999999998765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+++++|.+++... ..+++..+..++.|++.||.|||+. .+++|+||||+|||++.++.+||+|||++..+.....
T Consensus 80 y~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 80 HMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccccc
Confidence 99999999999654 5688999999999999999999972 4899999999999999999999999999876543221
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-HhhhhhhcCCcc-----------
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLMESGNLT----------- 471 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~----------- 471 (558)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||......... +...........
T Consensus 156 ----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 156 ----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 2346899999999998888999999999999999999999999754322111 000000000000
Q ss_pred ---------cccCCCC---CCCCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ---------ELVDPSL---EGEYD-TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ---------~~~d~~l---~~~~~-~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+..+... ....+ ......+.+++.+||+.+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00000 0133468899999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.19 Aligned_cols=256 Identities=26% Similarity=0.433 Sum_probs=205.2
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||.|+||+||+|.. .++..+|+|++....... ....+.+|+.+++.++|+||+++++.+..+. .++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4789999999999999999964 468899999986554333 6677899999999999999999999887765 999999
Q ss_pred eccCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 324 FSQNGNLDAALHDERS-KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
++.+++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999999976543 568999999999999999999998 899999999999999999999999999997765443
Q ss_pred Ccc--cccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 403 THH--AAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 403 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
... ......|+..|+|||++... .++.++|+|||||++|+|++|+.||........... .... . .+.+.
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~--~~~~-~-----~~~~~ 228 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML--TLQN-D-----PPSLE 228 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH--HhcC-C-----CCCcC
Confidence 221 22334689999999999877 789999999999999999999999976533211111 0111 0 01111
Q ss_pred CCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 480 GEY-DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 480 ~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
... .......+.+++.+||+.+|++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111 1234467889999999999999999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=327.28 Aligned_cols=257 Identities=20% Similarity=0.244 Sum_probs=195.7
Q ss_pred hCCCcccceEeeeCceEEEEEEEC---CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS---DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
..+|.+.+.||+|+||.||++... .++.||+|.+.... .+.+|+.++++++||||+++++++.... .++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 457999999999999999999543 45789999885432 2457999999999999999999987655 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
+||++. ++|..++. ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++..+..
T Consensus 164 v~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 164 VMPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999986 57888873 34578999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh--HHHHhhh--hhhcCC--ccc--
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN--LVLWAKP--LMESGN--LTE-- 472 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~--~~~~~~~--~~~~~~--~~~-- 472 (558)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ...... +..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 43333333456999999999999999999999999999999999999999754321 0000000 000000 000
Q ss_pred ---------ccCCCCCCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 473 ---------LVDPSLEGEYD-------TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 473 ---------~~d~~l~~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+..+. ......+.+++.+||+.+|++|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0123467789999999999999999999985
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.99 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=196.4
Q ss_pred hhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------ 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 316 (558)
..++|.+.+.||+|+||+||+|. ..+++.||||++.+..........+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 45789999999999999999995 45788999999976544444556678999999999999999999987532
Q ss_pred -cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 317 -GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 317 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
..|++++++ +++|..++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence 268888887 7789887743 458999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....................+..
T Consensus 166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 875432 123468999999999977 57899999999999999999999999764321110000000000000000
Q ss_pred C-----------CCCCCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 D-----------PSLEGEYD-------TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d-----------~~l~~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. ..+..... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000000 0112347789999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=312.32 Aligned_cols=249 Identities=31% Similarity=0.512 Sum_probs=196.5
Q ss_pred ceEeeeCceEEEEEEECC-------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 252 NMVGQGGYSEVYKGNLSD-------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
+.||+|+||.||+|...+ +..+|+|.+.+.. .......+.+|+.+++.++||||+++++++..+. .+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999996532 2579999885432 2344567889999999999999999999987655 999999
Q ss_pred eccCCCHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-----ceEEEecc
Q 008650 324 FSQNGNLDAALHDER-----SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-----EPQITDFG 393 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DFG 393 (558)
|+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999997542 2347889999999999999999998 8999999999999999887 89999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCccc
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTE 472 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 472 (558)
++..+.............++..|+|||++.++.++.++|||||||++|+|++ |+.||......... . .+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~--~-~~~~~~--- 230 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL--Q-HVTAGG--- 230 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH--H-HHhcCC---
Confidence 9986644322222223346788999999999999999999999999999998 99999754332111 1 111110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
....+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 231 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 01112233467889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=312.78 Aligned_cols=261 Identities=20% Similarity=0.311 Sum_probs=197.4
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|++.+.||+|+||.||+|.. .++..||+|++............+.+|+.+++.++||||+++++++.++. .++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999965 46899999998655433334466788999999999999999999998755 9999999
Q ss_pred ccCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 325 SQNGNLDAALHDERS-KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
+. ++|..++..... ..+++..++.++.|++.||.|||+ ++++|+||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 588888765433 568999999999999999999998 8999999999999999999999999999976533211
Q ss_pred cccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcC-------------C
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG-------------N 469 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~-------------~ 469 (558)
......+++.|+|||++.+. .++.++|||||||++|+|+||+.||.........+........ +
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 11223478999999998754 5789999999999999999999999865432211111000000 0
Q ss_pred cccccCCCCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 LTELVDPSLE---GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 ~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
....+..... .........++.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0001113456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=330.75 Aligned_cols=258 Identities=19% Similarity=0.232 Sum_probs=193.6
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
...+|.+.+.||+|+||.||+|.. .+++.||||.... ..+.+|++++++++|+||+++++++..++ .++|
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 345799999999999999999955 4588899996422 23568999999999999999999987765 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|+++. ++|..++... ...+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 239 ~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 239 LPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 99985 6888887543 3468999999999999999999998 89999999999999999999999999999876443
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch------hHHHHhhhhhhcC----Ccc
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ------NLVLWAKPLMESG----NLT 471 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~------~~~~~~~~~~~~~----~~~ 471 (558)
..........||+.|+|||++.+..++.++|||||||+||||++|..|+..... ........+...+ .+.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 222223345699999999999999999999999999999999998876532210 0011111110000 000
Q ss_pred ccc----------------CCCCCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ELV----------------DPSLEGEYD---TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ~~~----------------d~~l~~~~~---~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
... .+....... ......+.+++.+||+.||.+|||+.|+|+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000000000 0112357889999999999999999999984
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.92 Aligned_cols=252 Identities=26% Similarity=0.385 Sum_probs=189.7
Q ss_pred eEeeeCceEEEEEEECC---CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 253 MVGQGGYSEVYKGNLSD---GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 253 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
.||+|+||.||+|...+ ...+++|.+... ........+.+|+.+++.++|+||+++++.+.+.. .++||||+.+|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999995433 346888887543 33445667889999999999999999999988655 99999999999
Q ss_pred CHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 329 NLDAALHDERS---KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 329 sL~~~l~~~~~---~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
+|.+++..... ...++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976542 234677888999999999999999 899999999999999999999999999987643322211
Q ss_pred cccccccccCcccchhhcc-------CCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 406 AAIPIEGTFGYLAPEYFMH-------GIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||........... .... ....+..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--~~~~-~~~~~~~~~ 234 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ--VVRE-QDIKLPKPQ 234 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH--Hhhc-cCccCCCCc
Confidence 1222346778999999753 356789999999999999999 8889876543221111 1111 111122222
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
+. ......+.+++..|+ .||++|||+.+|++.|.
T Consensus 235 ~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 235 LD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22 223345677888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=318.42 Aligned_cols=260 Identities=20% Similarity=0.311 Sum_probs=195.6
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|+||.||+|.. .+++.+|+|.+..... ......+.+|+.++++++||||+++++++..++ .++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 5789999999999999999954 4688899999865432 222345778999999999999999999988765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+ +|..++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 85 YLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 9975 787777543 3457889999999999999999999 8999999999999999999999999999976433221
Q ss_pred cccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh-hhhhc------------CC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK-PLMES------------GN 469 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~-~~~~~------------~~ 469 (558)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ..... ..
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223458999999999865 46899999999999999999999999765432111100 00000 00
Q ss_pred cccccCCCCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 LTELVDPSLEG----EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 ~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
....-.+.... .........+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 001122346789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=304.23 Aligned_cols=250 Identities=20% Similarity=0.379 Sum_probs=203.9
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|+..+.||+|+||.||++.. .+++.+|+|.+............+.+|+.+++.++|||++++++.+..+. .++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478899999999999999944 57889999999776555566778899999999999999999999887655 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-CceEEEeccccccCCCCCC
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~ 403 (558)
+++++|.+++.......+++..+.+++.+++.||.|||+ ++++|+||+|+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 999999999977655668999999999999999999998 899999999999999865 4689999999987654322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...... +....+ +
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~~~-~~~~~~---------~ 222 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VLKIMS-GTFAPI---------S 222 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HHHHHh-cCCCCC---------C
Confidence 1224589999999999988899999999999999999999999976533211 111111 111111 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+.+++.+||+.+|++|||+.|+++.
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1234468899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=308.49 Aligned_cols=254 Identities=25% Similarity=0.424 Sum_probs=205.8
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GLYLIF 322 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~lv~ 322 (558)
+|++.+.||.|+||.||++. ..++..+|+|.+............+..|+.+++.++|+||+++++++... ..+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47888999999999999994 45788999999976666666677889999999999999999999987642 279999
Q ss_pred EeccCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhCC--CCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 323 NFSQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGC--KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
||+.+++|.+++.... ...+++..++.++.+|+.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999986532 356899999999999999999999211 289999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
...... .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||........ .. ....+..
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~-~~~~~~~-------- 227 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL--AS-KIKEGKF-------- 227 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH--HH-HHhcCCC--------
Confidence 543321 1234589999999999998899999999999999999999999986542211 11 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+......+.+++.+||+.+|.+|||+.+|++.
T Consensus 228 -~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11223345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=306.88 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=200.9
Q ss_pred CCcccceEeeeCceEEEEEEECCCCEEEEEEeecccc----cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNK----DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
+|...+.||+|+||+||+|...+++.+|+|.+..... .......+.+|+.++++++|+||+++++++.++. .+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999877899999999864432 1233456888999999999999999999998766 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
+||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999643 458899999999999999999998 89999999999999999999999999998765321
Q ss_pred CC----cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 402 CT----HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 402 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
.. ........|+..|+|||++.+..++.++||||||+++|+|++|+.||........... .... ....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~---~~~~---~~~~~~ 229 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY---IGAH---RGLMPR 229 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH---hhhc---cCCCCC
Confidence 11 1111234589999999999998999999999999999999999999975432211110 0000 001111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+ +......+.+++.+||+.+|++||++.++++
T Consensus 230 ~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 L----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 2223456889999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=310.81 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=204.7
Q ss_pred hCCCcccceEeeeCceEEEEEEECC----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSD----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 320 (558)
.++|.+.+.||+|+||.||+|...+ ...+|+|...... .......+.+|+.+++.+.||||+++++++.++..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEE
Confidence 3568889999999999999996533 2468999885433 2445567899999999999999999999998877899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|.+++.... ..+++..++.++.+++.||.|||+ .+++|+||||+|||++.++.++|+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999996543 358999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
..... .....++..|+|||.+....++.++||||||+++|||++ |..||........... .......
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~--~~~~~~~--------- 227 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR--IENGERL--------- 227 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HHcCCcC---------
Confidence 32211 112235578999999988889999999999999999986 9999976543221111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..+......+.+++.+|+..+|++|||+.++++.|.+..
T Consensus 228 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 -PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223457889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.69 Aligned_cols=256 Identities=21% Similarity=0.262 Sum_probs=195.5
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||+||++.. .+++.||+|++.+.. ........+.+|..++..++|+||+++++++.+++ .|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999954 468999999997532 22334556788999999999999999999988765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|..++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999643 3468899999999999999999999 899999999999999999999999999987654332
Q ss_pred CcccccccccccCcccchhhcc-----CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMH-----GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
.. ......||+.|+|||++.. +.++.++|||||||++|+|++|+.||........ ............+ +.
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--~~~i~~~~~~~~~--~~ 231 (331)
T cd05597 157 TV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YGKIMNHKEHFQF--PP 231 (331)
T ss_pred Cc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH--HHHHHcCCCcccC--CC
Confidence 21 1122459999999999963 4578899999999999999999999976533211 1111111110110 00
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQ--TSAWRPSMSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~--dp~~RPt~~evl~~ 514 (558)
. .......+.+++.+|+.. ++..||++.++++.
T Consensus 232 ~----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 D----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 111334577777887654 33448899999886
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=310.24 Aligned_cols=248 Identities=28% Similarity=0.484 Sum_probs=192.9
Q ss_pred ceEeeeCceEEEEEEEC-CCC--EEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEEEEecc
Q 008650 252 NMVGQGGYSEVYKGNLS-DGR--KIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLIFNFSQ 326 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~ 326 (558)
+.||+|+||.||+|... ++. .+++|.+... ........+.+|+.++.++ +||||+++++++...+ .+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999654 444 4688887532 2344556788999999999 7999999999998765 899999999
Q ss_pred CCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEec
Q 008650 327 NGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDF 392 (558)
Q Consensus 327 ~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 392 (558)
+|+|.+++...+ ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 999999997543 1247889999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 393 GLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 393 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
|++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||........ ...... +
T Consensus 157 gl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~~-~--- 227 (270)
T cd05047 157 GLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEKLPQ-G--- 227 (270)
T ss_pred CCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH--HHHHhC-C---
Confidence 9986422111 1111224667999999998899999999999999999997 9999975432211 111111 0
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.....+......+.+++.+||+.+|.+|||+.++++.|...
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 ------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 01111112334688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=306.17 Aligned_cols=250 Identities=24% Similarity=0.447 Sum_probs=200.0
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-------HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-------AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
+|.+...||+|+||.||+|.. .+++.+|+|.+...... ......+.+|+.++++++||||+++++++.++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999954 56889999988654322 123356788999999999999999999987755
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++++||+++++|..++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 89999999999999999653 568889999999999999999998 8999999999999999999999999999987
Q ss_pred CCCCCCcc----cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccc
Q 008650 398 LPNKCTHH----AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473 (558)
Q Consensus 398 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 473 (558)
+....... ......|+..|+|||.+.++.++.++|+|||||++|+|++|+.||........... . .. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~-~~-----~ 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK--I-GE-----N 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH--H-hc-----c
Confidence 65321111 11234588999999999998999999999999999999999999986533211110 0 00 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
..+. .+......+.+++.+||+.+|++||++.|+++
T Consensus 228 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 12233457889999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=324.63 Aligned_cols=245 Identities=26% Similarity=0.456 Sum_probs=204.7
Q ss_pred CcccceEeeeCceEEEEE-EECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
|.-++.||.|+||-||-| +..+.+.||||++.-... ..+.-.+++.|+..|+++.|||+|.+.|||..+. .+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 666789999999999999 556788999999976543 3456678999999999999999999999998776 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
|-| +-.+++... ..++.+..+..|..+.+.||.|||+ .+.||||||..||||++.|.|||+|||.|......
T Consensus 108 ClG-SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 108 CLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred Hhc-cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 965 777777543 4678888999999999999999999 89999999999999999999999999999876543
Q ss_pred ccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.+++|||.|||||++. .|.|+.|+|||||||++.||.-.++|+...+.....+.. ..+.. |.+.
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI---AQNes-----PtLq-- 246 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNES-----PTLQ-- 246 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH---HhcCC-----CCCC--
Confidence 3467999999999984 578999999999999999999999998776554433322 22111 1121
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..++...|.+++..||+.-|++|||..++++.
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 34677789999999999999999999998874
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.77 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=202.0
Q ss_pred CcccceEeeeCceEEEEEEEC----CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc------
Q 008650 248 FHSENMVGQGGYSEVYKGNLS----DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG------ 317 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 317 (558)
|.+.+.||+|+||.||+|... +++.+|+|++............+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999542 4688999999766555666778899999999999999999999875421
Q ss_pred -EEEEEEeccCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEec
Q 008650 318 -LYLIFNFSQNGNLDAALHDER----SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDF 392 (558)
Q Consensus 318 -~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 392 (558)
.+++++|+.+|+|..++.... ...+++..+.+++.|++.||.|||+ ++|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 478899999999988875432 1247888999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 393 GLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 393 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
|+++...............+++.|++||.+....++.++|||||||++|+|++ |+.||........ ...........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~ 235 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI--YNYLIKGNRLK 235 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH--HHHHHcCCcCC
Confidence 99987644322222223346678999999999999999999999999999999 8999875533211 11111111110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.+......+.+++.+||+.+|++|||+.++++.|++.
T Consensus 236 ----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 ----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1112345789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=310.38 Aligned_cols=261 Identities=22% Similarity=0.348 Sum_probs=200.4
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|+....||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++|+|++++++++..+. .++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999654 6899999998655433334456789999999999999999999988765 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|..++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999988887743 3458999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh------------hcCCc
Q 008650 404 HHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM------------ESGNL 470 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~------------~~~~~ 470 (558)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.........+..... .....
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1122357889999999876 46889999999999999999999999765432111111000 00000
Q ss_pred -ccccCCCCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 471 -TELVDPSLEGEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 471 -~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.....+......+ ......+.+++.+||+.+|++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000111100000 122456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.88 Aligned_cols=250 Identities=25% Similarity=0.481 Sum_probs=200.7
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
.+|++.+.||+|+||.||+|...++..+|+|.+...... ...+..|++++++++|||++++++++.... .++++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 468888999999999999997777889999998654332 245788999999999999999999987655 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+++|.+++.... ..+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 81 MEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999986543 458899999999999999999998 89999999999999999999999999998765433221
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
......++..|+|||++.++.++.++||||||+++|||++ |+.||.......... ...... ....+.
T Consensus 157 -~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~--~~~~~~---~~~~~~------ 224 (256)
T cd05112 157 -SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE--TINAGF---RLYKPR------ 224 (256)
T ss_pred -ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH--HHhCCC---CCCCCC------
Confidence 1112235678999999998999999999999999999998 999997644322111 111110 111111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
.....+.+++.+||+.+|++|||+.++++.|
T Consensus 225 -~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 -LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1235789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.58 Aligned_cols=256 Identities=24% Similarity=0.432 Sum_probs=216.3
Q ss_pred CCCcccceEeeeCceEEEEEEECC----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSD----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
+...+.++||.|-||+||+|.++- ...||||.+ |....+....+|+.|..||.++.||||++|.|+..... ..+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTL-K~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeee-ccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 345678999999999999996542 346999999 45555778889999999999999999999999998876 889
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
|+|||++|+|+.+|+.+. +.+.+.+..-++.+|+.|+.||-+ .++|||||...|||++.+..+|++|||+++.+.+
T Consensus 708 iTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999998765 559999999999999999999998 8999999999999999999999999999998866
Q ss_pred CCCccccccccc--ccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 401 KCTHHAAIPIEG--TFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 401 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
+.. ....+.-| ..+|.|||.+...+++.+||||||||+|||.|+ |..||.+..+..+.. .+...
T Consensus 784 d~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk------------aIe~g 850 (996)
T KOG0196|consen 784 DPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK------------AIEQG 850 (996)
T ss_pred CCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH------------HHHhc
Confidence 542 22222222 468999999999999999999999999999988 999998765443322 23344
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.+...+.+.+..|.+|++.||++|-.+||.+.+|+..|.+..
T Consensus 851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 444556677889999999999999999999999999988743
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=320.17 Aligned_cols=256 Identities=20% Similarity=0.264 Sum_probs=197.0
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||+||++.. .+++.||+|++.+.. ........+..|..++..++|+||+.+++++.+++ .|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999955 468899999996532 22333455778999999999999999999998765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|..++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999653 2468899999999999999999998 899999999999999999999999999998764432
Q ss_pred CcccccccccccCcccchhhcc-----CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMH-----GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
.. ......||+.|+|||++.+ +.++.++|||||||+||+|++|+.||........ +. .......... +.+.
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~-~i~~~~~~~~-~p~~ 232 (331)
T cd05624 157 TV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YG-KIMNHEERFQ-FPSH 232 (331)
T ss_pred ce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-HH-HHHcCCCccc-CCCc
Confidence 21 1223469999999999875 5688999999999999999999999976543211 11 1111100000 0010
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAW--RPSMSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 514 (558)
.......+.+++.+|+..++.+ |+++.++++.
T Consensus 233 -----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 233 -----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1123456888889988866544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=308.08 Aligned_cols=249 Identities=26% Similarity=0.437 Sum_probs=202.3
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||.|+||.||+|.. .+++.+|+|.+.... .......+.+|+.+++.++|+||+++++++.++. .++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4688889999999999999954 468899999986543 2344566889999999999999999999988765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++.+.....
T Consensus 80 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 80 YCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999999998653 68999999999999999999998 8999999999999999999999999999987654321
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||........... +..... +.+...
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~~-----~~~~~~-- 221 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL---IPKNNP-----PSLEGN-- 221 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH---hhhcCC-----CCCccc--
Confidence 12234588999999999998899999999999999999999999976543211111 111111 111111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....+.+++.+||..+|++|||++++++.
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 134468889999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=313.92 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=202.0
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||+||++.. .+++.||+|++.... .......+.+|+++++.++||||+++++++.... .++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 5688899999999999999954 568899999886543 2445677899999999999999999999998765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+++++|..++... +.+++..+..++.+++.||.|||+. .+++||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 84 FMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred cCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 99999999988653 4689999999999999999999962 5899999999999999999999999999875432211
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh---------HHHHhhhhhhcCCccccc
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN---------LVLWAKPLMESGNLTELV 474 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~---------~~~~~~~~~~~~~~~~~~ 474 (558)
....|+..|+|||++.++.++.++|||||||++|+|++|+.||...... ...+....+.. .
T Consensus 160 ----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----- 229 (284)
T cd06620 160 ----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P----- 229 (284)
T ss_pred ----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c-----
Confidence 2346899999999998889999999999999999999999999864321 01111111111 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
.+.+. .......+.+++.+||+.+|++|||+.|+++..
T Consensus 230 ~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 01110 112345688999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.48 Aligned_cols=249 Identities=21% Similarity=0.412 Sum_probs=200.7
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.+|++.+.||+|+||.||+|. ..+++.+|+|.+...... ....+.+|+.+++.+.|+|++++++.+..+. .++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 578999999999999999995 457899999998754432 3456788999999999999999999987655 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999999854 347888999999999999999998 8999999999999999999999999999876543221
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||........... ....+. +.+ ..+
T Consensus 172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~--~~~~~~------~~~--~~~ 239 (296)
T cd06654 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IATNGT------PEL--QNP 239 (296)
T ss_pred c--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH--HhcCCC------CCC--CCc
Confidence 1 1224589999999999988899999999999999999999999976543211111 111110 000 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+.+++.+||..+|++|||+.++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 2334568889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=323.99 Aligned_cols=196 Identities=22% Similarity=0.381 Sum_probs=171.5
Q ss_pred CCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-c-----CCeeeeeeEEEeC-cE
Q 008650 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-H-----PNTATLVGCCIEN-GL 318 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~-~~ 318 (558)
+|.+.++||+|+||.|.+| +..+++.||||+++.. .....+...|+.+|..++ | -|+|+++++|... .+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 7889999999999999999 6678999999999654 445566778999999887 3 3899999998764 59
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC--ceEEEeccccc
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF--EPQITDFGLAK 396 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFG~a~ 396 (558)
+||+|++.. +|+++|..++..+++...++.++.||+.||.+||+ .+|||+||||+||||.+-+ .+||+|||.|.
T Consensus 264 ciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 264 CIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 999999865 99999999988899999999999999999999998 8999999999999996543 69999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCc
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR 454 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~ 454 (558)
....... +...+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 7544322 4557889999999999999999999999999999999988887654
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=308.25 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=197.4
Q ss_pred CcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEec
Q 008650 248 FHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 325 (558)
|++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++..+. .++|+||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 677889999999999999554 57788999885433 445667889999999999999999999987765 89999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
.+++|..++... ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 85 AGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 999999888643 3468999999999999999999999 8999999999999999999999999999876543221
Q ss_pred cccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 406 AAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||............ .. .......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~-~~~~~~~------ 229 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI--AK-SEPPTLA------ 229 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH--hh-cCCCCCC------
Confidence 122345899999999984 445788999999999999999999999765432211111 11 1111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 230 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 -QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112234578899999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=303.02 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=202.2
Q ss_pred hCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-CcEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-NGLYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv 321 (558)
.++|..+++||+|.||.|.++ ...+++.||+|++++.. ........-+.|-++|+..+||.+..|...|+. +.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999 55689999999998764 234455667789999999999999999776665 459999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||..||.|.-+|.. ...+++...+.+-.+|+.||.|||+ ++||+||||.+|.|||.+|++||+|||+++.- -
T Consensus 247 MeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--I 319 (516)
T ss_pred EEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhc--c
Confidence 999999999998854 4568999999999999999999999 89999999999999999999999999999852 2
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.......++||||.|+|||++....|+..+|+|.+||++|||++|+.||...... ..+......+-.
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-kLFeLIl~ed~k------------ 386 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-KLFELILMEDLK------------ 386 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-HHHHHHHhhhcc------------
Confidence 2334556789999999999999999999999999999999999999999865332 112222222222
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLE 513 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 513 (558)
++.....+...++.-.|..||.+|. .+.||.+
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 2223334567788999999999995 3455554
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=306.00 Aligned_cols=256 Identities=22% Similarity=0.381 Sum_probs=200.0
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeeccccc--------HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKD--------AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG 317 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 317 (558)
+|...+.||.|+||.||+|. ..+|+.+|+|.+...... ....+.+..|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 47788999999999999994 457899999988542211 112346778999999999999999999987655
Q ss_pred -EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 318 -LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 318 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
.++||||+.+++|.+++... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 89999999999999999654 568899999999999999999998 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccCC--CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGI--IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
...............|+..|+|||++.... ++.++|+||||+++|+|++|..||........... .. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~-~~~~~~-- 231 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK--LG-NKRSAP-- 231 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH--hh-ccccCC--
Confidence 654432222233455899999999997755 88999999999999999999999975433211111 00 011111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+...........+.+++.+||+.+|++|||+.+|++.
T Consensus 232 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 --PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111122334678889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.83 Aligned_cols=253 Identities=24% Similarity=0.421 Sum_probs=200.2
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||.||++... ++..||+|.+... ........+.+|+.++++++|+||+++++.+..++ .++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 36888999999999999999654 7899999998643 23445567889999999999999999999887655 999999
Q ss_pred eccCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 324 FSQNGNLDAALHDER-SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
|+++++|..++.... ...+++..+..++.+++.||.|||+. .+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999999886532 23689999999999999999999962 589999999999999999999999999997654322
Q ss_pred CcccccccccccCcccchhhccC------CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHG------IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
. ....|++.|+|||++.+. .++.++|||||||++|+|++|+.||.................+..
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------ 227 (286)
T cd06622 158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------ 227 (286)
T ss_pred c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC------
Confidence 1 224588999999998554 357899999999999999999999976433221111111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+......+.+++.+||+.+|++||++.+++..
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 ---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11222345678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=308.51 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=211.4
Q ss_pred CcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-CcEEEEEEec
Q 008650 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-NGLYLIFNFS 325 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~ 325 (558)
|.+.+.||+|+||.||+| +...|..+|+|.+..+ ....+++.|+.|+++...|++|++||.+.. .++++|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 778899999999999999 6678999999998643 456789999999999999999999998765 5599999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
..|+..++++. +..++.+..+..++...+.||+|||. ..-||||||..||||+.+|..||+|||.|-.+.+. -.
T Consensus 111 GAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA 184 (502)
T KOG0574|consen 111 GAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA 184 (502)
T ss_pred CCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence 99999999975 45779999999999999999999998 77899999999999999999999999999876542 23
Q ss_pred cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHH
Q 008650 406 AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 485 (558)
...++.|||-|||||++..-.|+.++||||||++..||..|+.||.+-.+....+..+. + |.-.-..+..
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT----~------PPPTF~KPE~ 254 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT----K------PPPTFKKPEE 254 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC----C------CCCCCCChHh
Confidence 34567899999999999999999999999999999999999999987554322221110 1 1111122456
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcCCC
Q 008650 486 QMHRLVLIADYCVRQTSAWRPSMSEVLEL--LTSGHD 520 (558)
Q Consensus 486 ~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~~~ 520 (558)
...++.+++.+||-.+|++|.|+.++++. ++++..
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 67889999999999999999999999885 444433
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=318.78 Aligned_cols=192 Identities=22% Similarity=0.345 Sum_probs=161.9
Q ss_pred hhhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
....+|.+.+.||+|+||.||+|... +++.||+|+..+.. ...|+.++++++|+||+++++++.++. .++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 34467999999999999999999554 57889999864322 346889999999999999999998766 889
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
|+|++. ++|..++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 135 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 999985 5888877543 3568999999999999999999999 8999999999999999999999999999975332
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPV 450 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf 450 (558)
.. ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 AP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred Cc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 21 122356999999999999999999999999999999999865554
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=303.81 Aligned_cols=248 Identities=23% Similarity=0.404 Sum_probs=201.7
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||.||+|... +++.+++|.+.... ....+.+|+.+++.++|+||+++++++.++. .++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 67899999999999999999665 48899999986432 2567889999999999999999999988765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 79 YCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred cCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999998643 3568999999999999999999998 8999999999999999999999999999987654321
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||............ .... .+. ...+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~~~~-----~~~--~~~~ 222 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---PNKP-----PPT--LSDP 222 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---ccCC-----CCC--CCch
Confidence 122344889999999999989999999999999999999999999764332111100 0000 000 0112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
......+.+++.+||+.+|++|||+.|+++
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 233457889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=306.96 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=192.3
Q ss_pred ceEeeeCceEEEEEEEC----CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-C-cEEEEEEec
Q 008650 252 NMVGQGGYSEVYKGNLS----DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-N-GLYLIFNFS 325 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~-~~~lv~e~~ 325 (558)
+.||+|+||.||+|... ++..+|+|.+... ........+.+|+.+++.++||||+++++++.. + ..++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999543 2357999988532 234456678899999999999999999998763 3 388999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc-
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH- 404 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~- 404 (558)
.+|+|.+++.... ...++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+......
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 80 KHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999996543 346777788999999999999998 89999999999999999999999999999765432111
Q ss_pred -ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcC-CCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 405 -HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITG-RKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 405 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.......++..|+|||++.+..++.++|||||||++|||++| ..||....... ........... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--~~~~~~~~~~~----------~~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYLLQGRRL----------LQ 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhcCCCC----------CC
Confidence 111123467889999999988999999999999999999995 56666433211 11111111000 00
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
+...+..+.+++.+||+.+|++||++.+|++.|++..
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1112346889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=316.33 Aligned_cols=256 Identities=20% Similarity=0.253 Sum_probs=195.6
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||+||++... +++.+|+|++.+... .......+..|+.++..++|+||+++++++.++. .++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999654 578899999965332 2233445778999999999999999999988765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999653 2458999999999999999999999 899999999999999999999999999987654322
Q ss_pred CcccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
. .......||+.|+|||++. .+.++.++|||||||++|||++|+.||......... ........... .+.
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~--~~i~~~~~~~~--~p~ 231 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY--GKIMNHKERFQ--FPA 231 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH--HHHhCCCcccc--CCC
Confidence 1 1122346999999999986 346889999999999999999999999865432211 11111110000 000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAW--RPSMSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 514 (558)
........+.+++.+|+..++.+ |+++.|+++.
T Consensus 232 ----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 232 ----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01123456778888888654444 7899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=305.45 Aligned_cols=251 Identities=22% Similarity=0.395 Sum_probs=196.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc---cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK---DAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GL 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~ 318 (558)
.+|+..+.||+|+||.||+|.. .++..||+|++..... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4789999999999999999954 5689999999865432 223445688899999999999999999988652 38
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++++||+.+++|.+++... ..+++...+.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++..+
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 8999999999999999653 358889999999999999999998 89999999999999999999999999999765
Q ss_pred CCCCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 399 PNKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 399 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
...... .......++..|+|||++.+..++.++|||||||++|+|++|+.||........... ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~--~~~~~-----~~-- 227 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK--IATQP-----TN-- 227 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH--HhcCC-----CC--
Confidence 432111 111234589999999999988899999999999999999999999986533211111 11110 01
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
...+......+..++ .||..+|++||++.||++
T Consensus 228 --~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 --PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 112222334566666 788899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.66 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=197.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++.+..++ .++++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 4788889999999999999954 568899999986543 233445778999999999999999999987765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++... +.+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 87 FCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999998543 468999999999999999999998 8999999999999999999999999999876543211
Q ss_pred cccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
......|++.|+|||++. .+.++.++|||||||++|+|++|..||.........+.. ...... .+....
T Consensus 162 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~~---~~~~~~ 233 (267)
T cd06645 162 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---TKSNFQ---PPKLKD 233 (267)
T ss_pred --ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh---hccCCC---CCcccc
Confidence 122346899999999984 456889999999999999999999998654332211111 001110 111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.......+.+++.+||+.+|++|||+.+|++
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0112346888999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.59 Aligned_cols=268 Identities=24% Similarity=0.374 Sum_probs=204.6
Q ss_pred CCCcccceEeeeCceEEEEEEEC-----CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe--C-c
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-----DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE--N-G 317 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~-~ 317 (558)
..|++.+.||+|+||.||+|... ++..+|+|.+...... .....|.+|+.+++.+.|+||+++++++.. . .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 45778899999999999999643 3678999999765443 456789999999999999999999998875 3 3
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 899999999999999996543 358999999999999999999998 8999999999999999999999999999987
Q ss_pred CCCCCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhh---cCCcccc
Q 008650 398 LPNKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLME---SGNLTEL 473 (558)
Q Consensus 398 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~---~~~~~~~ 473 (558)
....... .......++..|+|||++.+..++.++||||||+++|||++|..||.........+...... ...+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6533221 11112235667999999998899999999999999999999999987543221110000000 0000001
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
+........+.....++.+++.+||+.+|++|||+.||++.|...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111222335789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.36 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=204.2
Q ss_pred hhhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-cEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-GLY 319 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 319 (558)
...+.|+.-++||+||||+||-+ ...+|+.||.|.+.+... ....+.-.++|-.+|.+++.+.||.+-..|... .++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 44577888999999999999999 445799999999866542 234455678999999999999999998777664 499
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
||+..|.||+|.-+|.+.....+++..+..++.+|+.||++||+ .+||+|||||+|||||+.|+++|+|.|+|..++
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999999987777789999999999999999999998 899999999999999999999999999999988
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH--HhhhhhhcCCcccccCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL--WAKPLMESGNLTELVDPS 477 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~d~~ 477 (558)
+...... .+||.+|||||+++++.|+...|+|||||+||||+.|+.||......... ..+....
T Consensus 339 ~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----------- 404 (591)
T KOG0986|consen 339 EGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----------- 404 (591)
T ss_pred CCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-----------
Confidence 7655443 36999999999999999999999999999999999999999753221110 0000000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSM 508 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 508 (558)
-..+++...+++...+....|+.||.+|..-
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1122333445567788899999999999654
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=309.11 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=202.3
Q ss_pred CHHHHHhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEE
Q 008650 237 SYEEISSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCI 314 (558)
Q Consensus 237 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 314 (558)
+..++....+.|++.+.||.|+||.||+|.. .+++.+|+|++... ......+..|+.+++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 3445555667899999999999999999954 56889999998554 23345677899999888 6999999999985
Q ss_pred e-------CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCce
Q 008650 315 E-------NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEP 387 (558)
Q Consensus 315 ~-------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 387 (558)
. +..+++|||+.+|+|.+++.......+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCE
Confidence 2 238999999999999999977666678899999999999999999999 899999999999999999999
Q ss_pred EEEeccccccCCCCCCcccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh
Q 008650 388 QITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK 462 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 462 (558)
+|+|||++........ ......|++.|+|||++. ...++.++|||||||++|||++|+.||...........
T Consensus 161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~- 237 (282)
T cd06636 161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL- 237 (282)
T ss_pred EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-
Confidence 9999999876543211 122345899999999986 34688899999999999999999999975432211110
Q ss_pred hhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 463 PLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
... ...+.. ........+.+++.+||+.+|.+|||+.|+++
T Consensus 238 --~~~-----~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 --IPR-----NPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --Hhh-----CCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 000000 01123457899999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=321.03 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=186.0
Q ss_pred EeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc---ccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 254 VGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV---CHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 254 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
||+|+||+||+|.. .+++.||+|++.+... .......+..|..++... .||||+.+++++.++. .|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999954 5689999999965432 122334456677776655 6999999999987765 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~ 153 (330)
T cd05586 81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT 153 (330)
T ss_pred ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence 999998864 3568999999999999999999999 899999999999999999999999999987543221 122
Q ss_pred cccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHH
Q 008650 408 IPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQ 486 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 486 (558)
...+||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... .. +..+.. .+.. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~--~~-i~~~~~------~~~~---~~~ 221 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY--RN-IAFGKV------RFPK---NVL 221 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH--HH-HHcCCC------CCCC---ccC
Confidence 345699999999999765 4899999999999999999999999765432111 11 111111 0110 112
Q ss_pred HHHHHHHHHHhhccCCCCCC----CHHHHHH
Q 008650 487 MHRLVLIADYCVRQTSAWRP----SMSEVLE 513 (558)
Q Consensus 487 ~~~l~~li~~cl~~dp~~RP----t~~evl~ 513 (558)
...+.+++.+||+.+|.+|| ++.++++
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 34678899999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.75 Aligned_cols=195 Identities=25% Similarity=0.455 Sum_probs=158.6
Q ss_pred cceEeeeCceEEEEEEEC---CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cEEEEEEe
Q 008650 251 ENMVGQGGYSEVYKGNLS---DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GLYLIFNF 324 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~lv~e~ 324 (558)
.+.||+|+||+||+|... +++.||+|.+...... ..+.+|+.++++++||||+++++++... ..+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999654 5678999998654322 3467899999999999999999988642 37899999
Q ss_pred ccCCCHHHHHhhcc-------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee----cCCCceEEEecc
Q 008650 325 SQNGNLDAALHDER-------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL----GPDFEPQITDFG 393 (558)
Q Consensus 325 ~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG 393 (558)
+.+ +|..++.... ...+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 864 7877765321 2358889999999999999999998 899999999999999 456789999999
Q ss_pred ccccCCCCCCc-ccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCC
Q 008650 394 LAKWLPNKCTH-HAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSS 453 (558)
Q Consensus 394 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~ 453 (558)
+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99876543221 122345689999999999774 5899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=308.09 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=199.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.+.|++.+.||.|+||.||+|.. .+++.+++|.+... .......+.+|+.+++.+.|+||+++++++..++ .++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 35689999999999999999965 45889999998654 3455677889999999999999999999987655 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|..++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 89 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 89 EFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred ecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999999988875443 468999999999999999999998 899999999999999999999999999987543321
Q ss_pred CcccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
.......+++.|+|||++. ...++.++|||||||++|+|++|..||......... .... .......
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~~~-~~~~~~~---- 235 (292)
T cd06644 165 --QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKIA-KSEPPTL---- 235 (292)
T ss_pred --cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--HHHh-cCCCccC----
Confidence 1122345889999999985 345788999999999999999999999764322111 1111 1111110
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 236 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 ---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1122334568889999999999999999999873
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=303.49 Aligned_cols=251 Identities=32% Similarity=0.531 Sum_probs=200.6
Q ss_pred CcccceEeeeCceEEEEEEECC-----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 248 FHSENMVGQGGYSEVYKGNLSD-----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
|++.+.||.|+||.||++.... +..+|+|.+.... .......+..|+.+++.++|+||+++++++.+++ .+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 4567899999999999996543 3889999995443 2335677889999999999999999999988755 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+++++|.+++.......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999976544338999999999999999999998 89999999999999999999999999999876554
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
...... ...+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......... .... .+...
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~--~~~~-~~~~~--------- 223 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL--EYLK-KGYRL--------- 223 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHh-cCCCC---------
Confidence 222211 2337889999999988889999999999999999998 88998764322111 1111 11110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
........++.+++.+||..+|++|||+.++++.|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112345788899999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=290.04 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=201.9
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LY 319 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~ 319 (558)
...++..++..||.|+.|+|+++.. .+|..+|||.+.+.. +.+..+.+++.+.++...+ .|+||+.+|+|..+. .+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 3445667788999999999999954 568999999996654 4566778888898877765 899999999998654 88
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+.||.|.. .++.++.. -.+++++..+-++...+..||.||.. +++|+|||+||+|||+|+.|++||||||++-++-
T Consensus 168 IcMelMs~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 168 ICMELMST-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHHH-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee
Confidence 88888743 44555543 34679999999999999999999988 4799999999999999999999999999998775
Q ss_pred CCCCcccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
+...+ ....|-+.|||||-+. ...|+-++||||||++|+||.||+.||...........+.+- +.. |
T Consensus 244 dSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~eP----P 313 (391)
T KOG0983|consen 244 DSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEP----P 313 (391)
T ss_pred ccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCC----C
Confidence 54333 3345999999999985 346899999999999999999999999987665544433222 111 2
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+.... ..+..+.+++..||++|+.+||...++++.
T Consensus 314 ~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222221 134568899999999999999999999984
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=313.44 Aligned_cols=254 Identities=23% Similarity=0.306 Sum_probs=203.5
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccH-HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|+..+.||+|+||.||+|... +++.||+|.+.+..... .....+..|+++++.+.|+||+++++.+.++. .+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999554 58999999997654332 45567889999999999999999999987765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999976655679999999999999999999998 899999999999999999999999999987543221
Q ss_pred Cc---------------------------ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch
Q 008650 403 TH---------------------------HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ 455 (558)
Q Consensus 403 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~ 455 (558)
.. .......||..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 011124589999999999998899999999999999999999999976543
Q ss_pred hHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 008650 456 NLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS----MSEVLE 513 (558)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~evl~ 513 (558)
... +.. .. ...............+.+++.+||+.+|++||| +.|+++
T Consensus 238 ~~~-~~~-~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DET-FSN-IL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH-HHH-Hh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 111 01 111111111114567999999999999999999 666666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.71 Aligned_cols=260 Identities=23% Similarity=0.391 Sum_probs=201.0
Q ss_pred HHHHHhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEe
Q 008650 238 YEEISSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIE 315 (558)
Q Consensus 238 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 315 (558)
++.+....++|++.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 455566788999999999999999999944 568899999885432 2234567899999999 69999999998742
Q ss_pred ------CcEEEEEEeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCce
Q 008650 316 ------NGLYLIFNFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEP 387 (558)
Q Consensus 316 ------~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 387 (558)
+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 2389999999999999987642 23468899999999999999999998 899999999999999999999
Q ss_pred EEEeccccccCCCCCCcccccccccccCcccchhhcc-----CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh
Q 008650 388 QITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-----GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK 462 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 462 (558)
||+|||++..+..... ......|++.|+|||++.. ..++.++|||||||++|+|++|+.||...........
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~- 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK- 240 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-
Confidence 9999999987643221 1223458999999999853 4578899999999999999999999976533211100
Q ss_pred hhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 463 PLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
..........+ +......+.+++.+||+.+|++|||+.|+++.+
T Consensus 241 --~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 --IPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --ccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000011111 111234688999999999999999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=308.06 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=202.2
Q ss_pred CHHHHHhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEE
Q 008650 237 SYEEISSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCI 314 (558)
Q Consensus 237 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 314 (558)
...++...+++|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++.
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3455566788999999999999999999955 578899999986432 2234566788899888 7999999999986
Q ss_pred eC------cEEEEEEeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc
Q 008650 315 EN------GLYLIFNFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386 (558)
Q Consensus 315 ~~------~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 386 (558)
.. ..++|+||+.+++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCC
Confidence 42 379999999999999988642 33568999999999999999999998 89999999999999999999
Q ss_pred eEEEeccccccCCCCCCcccccccccccCcccchhhccC-----CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHh
Q 008650 387 PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG-----IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA 461 (558)
Q Consensus 387 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~ 461 (558)
+||+|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||...........
T Consensus 167 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~ 244 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244 (291)
T ss_pred EEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence 999999998865432211 1224589999999998654 368899999999999999999999976433211111
Q ss_pred hhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 462 KPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 462 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+..+....+.+ .......+.+++.+||+.+|++||++.|+++.
T Consensus 245 ---~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 ---IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111111111 12233468899999999999999999999873
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.00 Aligned_cols=261 Identities=21% Similarity=0.318 Sum_probs=196.7
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.+++.++||||+++++++..+. .++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 5789999999999999999955 4688999999864432 222345678999999999999999999998765 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+. ++|..++... ...+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||++........
T Consensus 85 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred ccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 997 5888888654 3458899999999999999999998 8999999999999999999999999999976433221
Q ss_pred cccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-Hhhhhhh---cCCccccc----
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLME---SGNLTELV---- 474 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~---~~~~~~~~---- 474 (558)
......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......... ....... ...+..+.
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 11223578999999998754 5788999999999999999999999865432111 0000000 00000000
Q ss_pred -----CCCCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 -----DPSLEGE----YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 -----d~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+..... ........+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0100000 011223467899999999999999999999983
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=303.19 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=198.4
Q ss_pred hhhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
.+++++.....||+|+||.||+|. ..++..||+|.+.... ......+.+|+.+++.++|+||+++++++..++ .++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 455667677899999999999995 4567889999986543 344567889999999999999999999988765 899
Q ss_pred EEEeccCCCHHHHHhhccCCCC--CHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC-CCceEEEecccccc
Q 008650 321 IFNFSQNGNLDAALHDERSKSL--EWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP-DFEPQITDFGLAKW 397 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~ 397 (558)
++||+.+++|..++.... ..+ ++..+..++.||+.||.|||+ ++|+||||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999997542 234 788888999999999999998 89999999999999976 67999999999976
Q ss_pred CCCCCCcccccccccccCcccchhhccCC--CCccccchhHHHHHHHHHcCCCCCCCCchh-HHHHhhhhhhcCCccccc
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHGI--IDEKTDVFAFGVLLLEIITGRKPVDSSRQN-LVLWAKPLMESGNLTELV 474 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvvl~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~ 474 (558)
...... ......|++.|+|||++.... ++.++||||||+++|+|++|+.||...... ...+......
T Consensus 159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 228 (268)
T cd06624 159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-------- 228 (268)
T ss_pred cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc--------
Confidence 543221 122235899999999987654 789999999999999999999999753221 1111110000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....+.....++.+++.+||+.+|++|||+.|++..
T Consensus 229 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ---IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0111222334568899999999999999999999873
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=301.64 Aligned_cols=253 Identities=22% Similarity=0.362 Sum_probs=203.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||.|+||.||+|.. .+++.+++|.+..... .....+.+|+.+++.++||||+++++++.++. .+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 35789999999999999999955 4678899999975432 35577889999999999999999999987765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++... ...+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 80 EYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred eCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999999988654 2468899999999999999999998 899999999999999999999999999997654322
Q ss_pred CcccccccccccCcccchhhccC---CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHG---IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
. ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............ ..... ....
T Consensus 156 ~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~---~~~~~---~~~~-- 225 (262)
T cd06613 156 A--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI---SKSNF---PPPK-- 225 (262)
T ss_pred h--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhccC---CCcc--
Confidence 1 12234588999999999776 8899999999999999999999999765433221111 11100 0011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
..........+.+++.+||..+|.+|||+.+|+.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1112344567899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=309.74 Aligned_cols=247 Identities=25% Similarity=0.421 Sum_probs=199.8
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
.|+..+.||+|+||.||+|. ..+++.||+|.+..... ......+.+|+.++++++||||+++++++..+. .++|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 36677889999999999995 45688899999864432 344567889999999999999999999987765 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+++|.+++.. ..+++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 84 LGGGSALDLLKP---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred cCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 999999998853 458899999999999999999998 8999999999999999999999999999987654321
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.........+. ...+ .......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~~~~---------~~~~~~~ 223 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL---IPKN---------SPPTLEG 223 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh---hhcC---------CCCCCCc
Confidence 12234588999999999998999999999999999999999999975432211110 1111 1111122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 334568899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=305.03 Aligned_cols=247 Identities=23% Similarity=0.410 Sum_probs=202.5
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
.|+..+.||.|+||.||+|.. .++..+|+|.+..... ......+.+|+.+++++.|+||+++++++.++. .++||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 477788999999999999954 4688999999865432 345677889999999999999999999998766 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+++|.+++.. ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 999999999853 458888999999999999999998 8999999999999999999999999999977644321
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
......++..|+|||++.+..++.++|+|||||++|||++|..||........... . ..........
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~---------~~~~~~~~~~ 223 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL---I---------PKNNPPTLTG 223 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh---h---------hcCCCCCCch
Confidence 12224588999999999988999999999999999999999999976533211111 0 1111122233
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 456678999999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=302.20 Aligned_cols=239 Identities=21% Similarity=0.364 Sum_probs=186.6
Q ss_pred ceEeeeCceEEEEEEECC-------------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 252 NMVGQGGYSEVYKGNLSD-------------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
+.||+|+||.||+|...+ ...+++|.+.... ......+..|+.+++.++||||+++++++.++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999996432 2358888875432 344557888999999999999999999988755
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc-------eEEE
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE-------PQIT 390 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~ 390 (558)
.+++|||+.+|+|..++... ...+++..+++++.||+.||.|||+ ++|+||||||+|||++.++. ++++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 89999999999999888643 3458999999999999999999998 89999999999999987664 8999
Q ss_pred eccccccCCCCCCcccccccccccCcccchhhc-cCCCCccccchhHHHHHHHHH-cCCCCCCCCchhHHHHhhhhhhcC
Q 008650 391 DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM-HGIIDEKTDVFAFGVLLLEII-TGRKPVDSSRQNLVLWAKPLMESG 468 (558)
Q Consensus 391 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvvl~ell-tg~~Pf~~~~~~~~~~~~~~~~~~ 468 (558)
|||++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|..||.......... .. .+
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~~-~~ 224 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER---FY-EG 224 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH---HH-hc
Confidence 99998754322 1234788999999987 467899999999999999998 5888987543221111 01 11
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 469 NLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 469 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
.. .. .......+.+++.+||+.||++||++.+|++.|+
T Consensus 225 ~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 QC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Cc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 10 00 1112346889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=301.32 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=189.1
Q ss_pred eEeeeCceEEEEEEECCC---CEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 253 MVGQGGYSEVYKGNLSDG---RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 253 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
.||+|+||.||+|...++ ..+++|.+.... .......+.+|+.+++.++||||+++++.+.+.. .++||||+.+|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999954433 345666664432 2345678999999999999999999999998765 89999999999
Q ss_pred CHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccc
Q 008650 329 NLDAALHDERS--KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA 406 (558)
Q Consensus 329 sL~~~l~~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 406 (558)
+|.+++..... ...++..+..++.||+.||.|||+ .+++||||||+|||++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 346677788999999999999998 8999999999999999999999999999864322211122
Q ss_pred ccccccccCcccchhhcc-------CCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 407 AIPIEGTFGYLAPEYFMH-------GIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 407 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
.....|+..|+|||++.. ..++.++|||||||++|||++ |..||........ ...... +....+.++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~-~~~~~~~~~~~ 234 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV--LNHVIK-DQQVKLFKPQL 234 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHh-hcccccCCCcc
Confidence 223458899999999853 245789999999999999997 5778865433211 111111 12223334443
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
...+ ...+.+++..|| .+|++||++.+|++.|.
T Consensus 235 ~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 ELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3332 345777889999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=302.20 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=199.0
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc---ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN---KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GL 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~ 318 (558)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+.... ........+.+|+.++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4789999999999999999954 568999999886432 1233456788899999999999999999988653 27
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
+++|||+++++|.+++... ..+++....+++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999998643 457888899999999999999998 89999999999999999999999999999865
Q ss_pred CCCCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 399 PNKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 399 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
...... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... . .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~-~~~~---------~ 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-K-IATQ---------P 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-H-HhcC---------C
Confidence 432111 11223458999999999988889999999999999999999999997643221111 1 1100 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....+......+.+++.+|+. +|++||++++|++.
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1112233445578888999995 99999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=307.70 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=202.8
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||.||+|... +++.||+|++............+.+|++++++++|+||+++++++..++ .+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999554 6889999998665444455677889999999999999999999998765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.++.+..++.. ...+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9998777766543 3458999999999999999999999 8999999999999999999999999999987655432
Q ss_pred cccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh-------------hcCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM-------------ESGN 469 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~-------------~~~~ 469 (558)
. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||.........+..... ....
T Consensus 156 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 S-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred c-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 1 22234588999999999888 8899999999999999999999999765332211111000 0000
Q ss_pred cc-----cccCCC-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 LT-----ELVDPS-LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 ~~-----~~~d~~-l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.. +..++. +...++......+.+++.+||..+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 000000 000111222567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.83 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=205.5
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEE-EeCcEEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC-IENGLYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~lv~e 323 (558)
+.|.+...||.|+||.||+|..+ ++-..|.|++.. ...+....|+-|+.||..+.||+||+|++.| .++.++++.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 45778889999999999999444 455567787743 3467788899999999999999999999865 4666999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
||.||-.+.++-.- ...+.+.++..++.+++.||.|||+ ++|||||||..|||++-+|.++|+|||.+..... .
T Consensus 110 FC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred ecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 99999999888654 4679999999999999999999999 8999999999999999999999999999865322 3
Q ss_pred cccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
.....++.|||+|||||+.+ ..+|+.++||||||++|.||..+.+|-....+..+.... .......++.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi---aKSePPTLlq--- 257 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSEPPTLLQ--- 257 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH---hhcCCCcccC---
Confidence 34456688999999999874 568999999999999999999999997765554333221 1222222222
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+..+...+.+++.+||..||..||++.++++.
T Consensus 258 ----PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 ----PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ----cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 45667789999999999999999999999875
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=301.88 Aligned_cols=238 Identities=22% Similarity=0.414 Sum_probs=188.9
Q ss_pred ceEeeeCceEEEEEEECC-C----------CEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEE
Q 008650 252 NMVGQGGYSEVYKGNLSD-G----------RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYL 320 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 320 (558)
+.||+|+||.||+|...+ + ..+++|.+..... ....+.+|+.+++.++||||+++++++..+..++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVRDENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEecCCcEE
Confidence 368999999999996543 3 2577887754322 1577889999999999999999999988766899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-------ceEEEecc
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-------EPQITDFG 393 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~DFG 393 (558)
||||+.+|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 78 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999976432 68899999999999999999998 8999999999999999888 79999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhccC--CCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCc
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG--IIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNL 470 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 470 (558)
++...... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||....... +..... ...
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~~~~~-~~~- 223 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KERFYQ-DQH- 223 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HHHHHh-cCC-
Confidence 99865431 123467889999999877 78999999999999999999 588886543211 111111 000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 471 TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 471 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
.. +......+.+++.+||..+|.+|||+.++++.|+
T Consensus 224 -~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -RL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0011157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.62 Aligned_cols=260 Identities=19% Similarity=0.309 Sum_probs=195.5
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|.+.+.||+|+||.||+|.. .+|+.+|+|++............+.+|+.+++.++||||+++++++.+.. .++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999955 57899999999755433334456778999999999999999999987765 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+ +|..++... ...+++..++.++.||++||.|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CDQ-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 974 787777543 3468999999999999999999999 8999999999999999999999999999986543221
Q ss_pred ccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh--hhcC------CcccccC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL--MESG------NLTELVD 475 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~--~~~~------~~~~~~d 475 (558)
......+++.|+|||++.+. .++.++|||||||++|+|++|..||.............. .... ......+
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 11223578999999998765 478999999999999999999998654322111111100 0000 0000000
Q ss_pred ----CCCCC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 476 ----PSLEG-----EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 476 ----~~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+.... .........+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 011123457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=304.34 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=200.6
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc---
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG--- 317 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--- 317 (558)
..+++|++.+.||+|+||.||+|.. .+++.+++|++.... .....+.+|+.+++++ .|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 3568899999999999999999965 467899999986543 2345688999999998 6999999999986533
Q ss_pred ----EEEEEEeccCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEe
Q 008650 318 ----LYLIFNFSQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITD 391 (558)
Q Consensus 318 ----~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 391 (558)
.++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECC
Confidence 799999999999999986543 4578999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCcccchhhcc-----CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhh
Q 008650 392 FGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-----GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLME 466 (558)
Q Consensus 392 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 466 (558)
||++........ ......|+..|+|||++.. ..++.++|||||||+||+|++|+.||........... . .
T Consensus 157 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~-~ 231 (275)
T cd06608 157 FGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK--I-P 231 (275)
T ss_pred Cccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH--h-h
Confidence 999876543221 1223458999999999853 3467899999999999999999999975432211110 1 1
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 467 SGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 467 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
..... .+ ..+......+.+++.+||..||++|||+.++++
T Consensus 232 ~~~~~-----~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPP-----TL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCC-----CC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 11 112224567889999999999999999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=304.89 Aligned_cols=250 Identities=27% Similarity=0.459 Sum_probs=192.3
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHH-hcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGI-IGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||.||++.. .+|+.||+|++....... ....+..|+.+ ++..+||||+++++++..++ .+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4788999999999999999954 579999999986543322 33455566665 66678999999999987655 99999
Q ss_pred EeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCC-cEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 323 NFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKR-RIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 323 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
||+. |+|..++... ....+++..++.++.|++.||.|||+ + +++||||||+|||++.++.+||+|||++..+.
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9996 6888777543 23468999999999999999999998 5 89999999999999999999999999998764
Q ss_pred CCCCcccccccccccCcccchhhcc----CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMH----GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD 475 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d 475 (558)
.... .....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||............ ... +..
T Consensus 156 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~-~~~----- 225 (283)
T cd06617 156 DSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-VVE-EPS----- 225 (283)
T ss_pred cccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH-HHh-cCC-----
Confidence 3221 122458899999999865 45688999999999999999999999753222111111 111 100
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+.+. .......+.+++.+||..+|++||++.++++
T Consensus 226 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.08 Aligned_cols=259 Identities=21% Similarity=0.336 Sum_probs=199.0
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|+..+.||.|+||.||+|.. .+++.||||++............+.+|++++++++||||+++++++.++. .++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999955 46899999998755444444567889999999999999999999987655 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+. ++|..++.......+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 689998877666778999999999999999999998 8999999999999999999999999999876543221
Q ss_pred ccccccccccCcccchhhccCC-CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCc-------------
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGI-IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL------------- 470 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------------- 470 (558)
......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||......... .......+..
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL-FRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCChhhhhhhhHHHH
Confidence 112234788999999887644 688999999999999999999999765332111 1100000000
Q ss_pred -----ccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 471 -----TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 471 -----~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.......+.. ........+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 00112346788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=307.98 Aligned_cols=249 Identities=21% Similarity=0.405 Sum_probs=201.1
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.+|+..+.||.|+||.||+|. ..+++.|++|.+..... .....+.+|+.+++.++||||+++++++..+. .++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 469999999999999999994 56789999999865432 23456788999999999999999999987755 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|..++.. ..+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 97 YLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred ecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999998854 358999999999999999999999 8999999999999999999999999999876543322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||........... .... ....+ ..+
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~--~~~~-~~~~~-------~~~ 238 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IATN-GTPEL-------QNP 238 (296)
T ss_pred c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhc-CCccc-------CCc
Confidence 1 1234589999999999988899999999999999999999999987543221111 1111 00000 011
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+.+++.+||..+|++|||+.++++.
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1233468889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=306.01 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=200.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|++.+.||.|+||.||+|.. .++..+|+|.+... .......+..|+.++++++|+||+++++.+.++. .++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 35689999999999999999965 46889999998644 3445567889999999999999999999988765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|..++... ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 82 EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999998653 2468999999999999999999999 899999999999999999999999999987653322
Q ss_pred CcccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
. ......||+.|+|||++. ...++.++||||||+++|+|++|+.||......... .. +..+... .
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~-~~~~~~~-----~ 227 (280)
T cd06611 158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LK-ILKSEPP-----T 227 (280)
T ss_pred c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HH-HhcCCCC-----C
Confidence 1 122345899999999985 345788999999999999999999999765332111 11 1111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+ ..+......+.+++.+||+.+|.+||++.++++.
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 0112234468889999999999999999999884
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=309.88 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=200.4
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||.||+|... +++.||+|++.+..........+.+|+.+++.++||||+++++++.++. .++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999664 5899999998765444445567889999999999999999999997765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|..+.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 99999998877533 458999999999999999999998 8999999999999999999999999999987644321
Q ss_pred cccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc-----------
Q 008650 404 HHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT----------- 471 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~----------- 471 (558)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+.......+.+.
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccch
Confidence 1223458899999999875 45788999999999999999999999754321 11111000000000
Q ss_pred ---cccCCCCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 472 ---ELVDPSLEGE-----YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 472 ---~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
....+..... ........+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000100000 01123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.59 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=200.7
Q ss_pred CCcccceEeeeCceEEEEEEECC--CCEEEEEEeeccc--------ccHHHHHHHHHHHHHhcc-cccCCeeeeeeEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNLSD--GRKIAVKRLAKDN--------KDAKKEKEFLMELGIIGH-VCHPNTATLVGCCIE 315 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 315 (558)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... ........+..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999996654 7889999885432 223445667889888865 789999999999887
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEec
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDF 392 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 392 (558)
++ .+++|||+.+++|.+++... ....+++..++.++.|++.||.|||+. .+++|+||+|+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 65 99999999999999888542 334689999999999999999999952 57999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccc
Q 008650 393 GLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTE 472 (558)
Q Consensus 393 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 472 (558)
|++....... ......|+..|+|||++.++.++.++||||||+++|+|++|+.||......... .... .+...
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~--~~~~-~~~~~- 231 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA--TKIV-EAVYE- 231 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH--HHHh-hccCC-
Confidence 9998755432 223345899999999999989999999999999999999999999754332211 1111 11111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
+... ......+.+++.+||+.||++||++.|+..+|+
T Consensus 232 ---~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 ---PLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---cCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111 112356889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=298.59 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=200.6
Q ss_pred CCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccc---cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK---DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
+|+..+.||+|+||+||+|... +++.|++|.+..... .......+.+|+.+++.++|+||+++++++.++. .+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999654 789999999865432 2345667889999999999999999999987755 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999999653 458899999999999999999998 89999999999999999999999999998875443
Q ss_pred CCcccccccccccCcccchhhccCC-CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGI-IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
. ......|++.|+|||.+.... ++.++|+||||+++|+|++|+.||.........+.. .......
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~--------- 221 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI--GRSKELP--------- 221 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH--HhcccCC---------
Confidence 2 122345899999999998776 899999999999999999999999765422211111 1101111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
..+......+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111223456888999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.06 Aligned_cols=246 Identities=25% Similarity=0.390 Sum_probs=200.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||.||++.. .+++.+|+|++.+... .......+.+|+++++++.||||+++++++.++. .++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999954 4689999999865432 2344567889999999999999999999988765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999998654 568999999999999999999999 89999999999999999999999999999876543
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+.. .. .+.. ..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~-~~-~~~~----------~~ 217 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEK-IL-EGKV----------RF 217 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-Hh-cCCc----------cC
Confidence 22345899999999998888999999999999999999999999765421 11111 11 1111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
+......+.+++.+||+.+|.+|+ ++.|+++.
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 112245788999999999999999 77777753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=304.79 Aligned_cols=238 Identities=22% Similarity=0.352 Sum_probs=185.2
Q ss_pred eEeeeCceEEEEEEECC-------------------------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCee
Q 008650 253 MVGQGGYSEVYKGNLSD-------------------------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307 (558)
Q Consensus 253 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 307 (558)
.||+|+||.||+|.... ...|++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999985321 1358888885432 33445788899999999999999
Q ss_pred eeeeEEEeCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-
Q 008650 308 TLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF- 385 (558)
Q Consensus 308 ~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~- 385 (558)
++++++.++. .++||||+++|+|..++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 9999998765 89999999999999998653 3468899999999999999999998 8999999999999997654
Q ss_pred ------ceEEEeccccccCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHH-cCCCCCCCCchhH
Q 008650 386 ------EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEII-TGRKPVDSSRQNL 457 (558)
Q Consensus 386 ------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~ell-tg~~Pf~~~~~~~ 457 (558)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3899999988643221 11247888999999876 56899999999999999995 6999997654322
Q ss_pred HHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 458 VLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 458 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
.... ...... ... .....+.+++.+||+.+|++|||+.+|++.|+
T Consensus 230 ~~~~--~~~~~~--------~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERF--YEKKHR--------LPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH--HHhccC--------CCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 000000 111 11236888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=308.11 Aligned_cols=250 Identities=21% Similarity=0.394 Sum_probs=200.5
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
..+|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++..+. .++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 36799999999999999999954 5799999999865433 23455788999999999999999999988765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++++|.+++.. ..+++..+..++.+++.||.|||+ .+++||||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999999854 357888999999999999999998 899999999999999999999999999987654332
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.. .....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.......... .....+ . + ....
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~~~~~~-~-----~--~~~~ 237 (297)
T cd06656 170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LIATNG-T-----P--ELQN 237 (297)
T ss_pred cC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--eeccCC-C-----C--CCCC
Confidence 11 123458999999999999889999999999999999999999997643211100 000000 0 0 0011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+......+.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22234567889999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.59 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=202.0
Q ss_pred CCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.+|.+...||+|+||.||+|... +.+.+++|.+.... .......+.+|+.++++++|+||+++++++.+.. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 56888999999999999999643 34679999885432 2335677899999999999999999999987755 8
Q ss_pred EEEEEeccCCCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEe
Q 008650 319 YLIFNFSQNGNLDAALHDERS-------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITD 391 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 391 (558)
++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999976542 258999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCc
Q 008650 392 FGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNL 470 (558)
Q Consensus 392 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 470 (558)
||++........ .......++..|+|||.+.++.++.++||||||+++|+|++ |..||.......... ....+..
T Consensus 161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~---~~~~~~~ 236 (275)
T cd05046 161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN---RLQAGKL 236 (275)
T ss_pred cccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH---HHHcCCc
Confidence 999875432211 11222346788999999998889999999999999999999 888996543321111 1111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 471 TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 471 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.. .........+.+++.+||+.+|++|||+.|+++.|.+
T Consensus 237 ~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 237 EL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 10 0111233478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.75 Aligned_cols=259 Identities=20% Similarity=0.304 Sum_probs=202.2
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||.||++.. .+++.|++|.+.+.... ......+.+|+.+++.++||||+++++.+..++ .++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4788999999999999999954 46889999998765322 234567889999999999999999999987765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++... ..+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999654 468999999999999999999998 899999999999999999999999999986421100
Q ss_pred -------------CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC
Q 008650 403 -------------THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469 (558)
Q Consensus 403 -------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 469 (558)
.........|+..|+|||++.+..++.++|+|||||++|||++|..||.+....... ..... +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~--~~~~~-~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF--GQVIS-DD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-cc
Confidence 001111245788999999999889999999999999999999999999765332111 11111 11
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 470 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
...+... ......+.+++.+||+.+|++||+..++.+.|...+
T Consensus 233 ---~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 233 ---IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred ---cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 0111111 123346889999999999999999877777777644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=310.08 Aligned_cols=194 Identities=24% Similarity=0.452 Sum_probs=157.4
Q ss_pred ceEeeeCceEEEEEEEC---CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe---CcEEEEEEec
Q 008650 252 NMVGQGGYSEVYKGNLS---DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE---NGLYLIFNFS 325 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~lv~e~~ 325 (558)
..||+|+||+||+|... ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ...++|+||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 58999999999999654 457899999865432 2346789999999999999999998854 2388999998
Q ss_pred cCCCHHHHHhhc-------cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee----cCCCceEEEeccc
Q 008650 326 QNGNLDAALHDE-------RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL----GPDFEPQITDFGL 394 (558)
Q Consensus 326 ~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~ 394 (558)
.+ +|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 676666422 12357889999999999999999998 899999999999999 5667899999999
Q ss_pred cccCCCCCCc-ccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCC
Q 008650 395 AKWLPNKCTH-HAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSS 453 (558)
Q Consensus 395 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~ 453 (558)
++........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9876443221 112235689999999999764 5899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=301.84 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=201.5
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GLYLI 321 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~lv 321 (558)
++|...+.||.|++|.||++.. .+++.+|+|.+..... ......+.+|++++++++||||+++++++.+. ..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4688889999999999999965 4688999999865433 35567789999999999999999999988642 38999
Q ss_pred EEeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 322 FNFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
|||+++++|.+++... ....+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999887542 33568889999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch---hHHHHhhhhhhcCCcccccCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ---NLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~d~ 476 (558)
.... ....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ........ ........+.+.
T Consensus 157 ~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (287)
T cd06621 157 NSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPELKDE 231 (287)
T ss_pred cccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCchhhccC
Confidence 3221 124578899999999999999999999999999999999999986521 11111111 111111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. .........+.+++.+||+.+|.+|||+.|+++.
T Consensus 232 -~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 -P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 0012245678999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=304.46 Aligned_cols=239 Identities=20% Similarity=0.382 Sum_probs=186.5
Q ss_pred ceEeeeCceEEEEEEEC-C-------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 252 NMVGQGGYSEVYKGNLS-D-------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
+.||+|+||.||+|... . ...+++|.+.... ......+..|+.+++.+.||||+++++++..+. .++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 36899999999999543 2 2347888875332 344567888999999999999999999988754 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc--------eEEEeccc
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE--------PQITDFGL 394 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DFG~ 394 (558)
||+.+|+|..++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. ++++|||+
T Consensus 79 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 79 EYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred ecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999996543 368999999999999999999998 89999999999999987765 69999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCC-CCCCCCchhHHHHhhhhhhcCCccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGR-KPVDSSRQNLVLWAKPLMESGNLTE 472 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~ 472 (558)
+...... ....+++.|+|||++.+. .++.++|||||||++|+|++|. .||.......... .... .
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~-~--- 221 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---FYED-R--- 221 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH---HHHc-c---
Confidence 8754322 224588999999999874 5899999999999999999984 6665433221111 1110 0
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
...+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 222 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111122356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=303.93 Aligned_cols=261 Identities=21% Similarity=0.303 Sum_probs=202.3
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|.+.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.++++++||||+++++++.++. .++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478899999999999999965 47899999999776544555677889999999999999999999988765 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+ +++|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999986543 568999999999999999999998 8999999999999999999999999999987654321
Q ss_pred ccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh--hhcC------------C
Q 008650 405 HAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL--MESG------------N 469 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~--~~~~------------~ 469 (558)
.......|+..|+|||++.+. .++.++||||||+++|+|++|..||....... .+.... .... +
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCChHHHhhccCcch
Confidence 112234589999999998654 46899999999999999999988886543221 111100 0000 0
Q ss_pred cccccCCCCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 LTELVDPSLEG----EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 ~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+..+.... .........+.+++.+||+.+|++|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0011234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=300.67 Aligned_cols=253 Identities=22% Similarity=0.385 Sum_probs=200.7
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccc----cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNK----DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
+|+..+.||+|+||.||++. ..+++.+|+|++..... .......+.+|+.++++++|+||+++++++.+++ .++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999994 46789999999865431 1234567889999999999999999999998765 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-ceEEEeccccccCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-EPQITDFGLAKWLP 399 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~ 399 (558)
|+||+.+++|.+++... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++ .+||+|||++..+.
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999643 468899999999999999999999 8999999999999998776 59999999998765
Q ss_pred CCCCcc--cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhH-HHHhhhhhhcCCcccccCC
Q 008650 400 NKCTHH--AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL-VLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 400 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~d~ 476 (558)
...... ......||..|+|||++.+..++.++||||||+++|+|++|+.||....... ........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~ 226 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA---------SA 226 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---------cc
Confidence 432111 1122458899999999988889999999999999999999999997533211 11100000 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
......+......+.+++.+||+.+|.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1112223344567889999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.89 Aligned_cols=261 Identities=21% Similarity=0.329 Sum_probs=199.4
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GLYLI 321 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~lv 321 (558)
++|++.+.||.|+||.||+|... +++.+|+|.+............+.+|+.++++++||||+++++++..+ ..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999654 688999999976544444445677899999999999999999998754 39999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
+||+.+ +|..++.... ..+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++......
T Consensus 85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999975 8988886543 368999999999999999999998 89999999999999999999999999999876543
Q ss_pred CCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHH--------------Hhh----
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL--------------WAK---- 462 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~--------------~~~---- 462 (558)
.. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......... |..
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 21 11224578999999998765 4689999999999999999999999764322110 000
Q ss_pred hhhhcCCcccccCCCCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 463 PLMESGNLTELVDPSLEGEYDTD-QMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 463 ~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+..............+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000011111111111112211 3456888999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=307.36 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=194.5
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e 323 (558)
+|...+.||+|+||.||++. ..+++.+|+|.+...... .....+.+|+.++.++. |+||+++++++..+. .+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 45667899999999999994 456899999998654432 45567889999999997 999999999887654 889999
Q ss_pred eccCCCHHH---HHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 324 FSQNGNLDA---ALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 324 ~~~~gsL~~---~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
|+.. ++.. .+.......+++..+.+++.+++.||+|||+. .+++||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 4443 33333346789999999999999999999972 4899999999999999999999999999976543
Q ss_pred CCCcccccccccccCcccchhhccC---CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHG---IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
.... ....|++.|+|||++.+. .++.++|||||||++|+|++|+.||......... ...... +.. +.
T Consensus 161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~-~~~-----~~ 230 (288)
T cd06616 161 SIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ-LTQVVK-GDP-----PI 230 (288)
T ss_pred CCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHH-HhhhcC-CCC-----Cc
Confidence 2211 223589999999999776 6899999999999999999999999754321111 111111 111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+...........+.+++.+||+.+|++|||+.+|++.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111222345578999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=316.07 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=210.2
Q ss_pred hhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-cEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-GLYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 321 (558)
-...|.+...||+|.|++|..| +..++..||+|.+.+...+......+.+|+++|+.++|||||+++++.... .+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467899999999999999999 456799999999998887777777799999999999999999999998754 59999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||..+|.+.++|... +...+..+..++.|+..|++|||+ +.|||||||.+||||+.+.++||+|||++..+...
T Consensus 134 ~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999654 445668888999999999999999 99999999999999999999999999999887643
Q ss_pred CCcccccccccccCcccchhhccCCC-CccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
....+.+|++.|.|||++.+..| ++++|+||+|++||.|+.|..||++. ++.++-...+.+
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~---------------~lk~Lr~rvl~g 270 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ---------------NLKELRPRVLRG 270 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc---------------ccccccchheee
Confidence 33446789999999999998876 57899999999999999999999864 222333333333
Q ss_pred CCC--HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYD--TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~--~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+. .....++.++++++|-.+|.+|++++++.+.
T Consensus 271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 222 2223468889999999999999999999874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.73 Aligned_cols=262 Identities=19% Similarity=0.288 Sum_probs=197.4
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|++|+||+|.. .+|+.||+|.+............+.+|+.++++++||||+++++++.++. .++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5788999999999999999955 47899999998665443444567889999999999999999999998765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC-CCceEEEeccccccCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP-DFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~ 402 (558)
|+. ++|...+.......+++..++.++.||+.||.|||+ ++++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 578777765544457888889999999999999998 89999999999999985 5679999999997654321
Q ss_pred CcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccC------
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD------ 475 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d------ 475 (558)
. ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||.......................+.
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 1 11223578999999998764 57899999999999999999999997654322111110000000000000
Q ss_pred ------CCCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 476 ------PSLEGE----YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 476 ------~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+..... ........+.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 01123456889999999999999999999997
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.30 Aligned_cols=260 Identities=22% Similarity=0.291 Sum_probs=199.3
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc---HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD---AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
+|.+.+.||+|+||.||+|.. .+++.||+|++...... ......+..|+.+++.++|+||+++++++.++. .++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477889999999999999954 46899999999765433 334556778999999999999999999998755 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+ +++|..++.... ..+++..++.++.||++||.|||+ ++++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999996543 368999999999999999999998 89999999999999999999999999999876543
Q ss_pred CCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhc-----------CC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES-----------GN 469 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~-----------~~ 469 (558)
... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...... .........- ..
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Ccc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhccc
Confidence 211 122346889999999865 46789999999999999999998888654321 1111111000 00
Q ss_pred cccccCCCCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 LTELVDPSLEGE-----YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 ~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
............ ........+.+++.+||+.+|++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 112234678899999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.49 Aligned_cols=253 Identities=25% Similarity=0.467 Sum_probs=211.4
Q ss_pred CcccceEeeeCceEEEEEEEC---CCC--EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEE
Q 008650 248 FHSENMVGQGGYSEVYKGNLS---DGR--KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIF 322 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~ 322 (558)
..+.+.||.|.||.||+|.+. .|+ .||||..+.+. ..+....|+.|..+|++++|||||+|+|+|.+...++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEE
Confidence 455678999999999999432 233 48899986544 455577899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
|+++.|.|..+|..+. ..++......++.||+.||.|||+ ..+|||||...|||+.....+||+|||+++++.+..
T Consensus 470 EL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999997654 568888889999999999999999 899999999999999999999999999999998765
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
..+.. ...-...|||||-+....++.+||||-|||++||++. |..||.+-.++.+. -.+...-+..
T Consensus 546 yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------------~~iEnGeRlP 612 (974)
T KOG4257|consen 546 YYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------------GHIENGERLP 612 (974)
T ss_pred hhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE------------EEecCCCCCC
Confidence 54433 3335678999999999999999999999999999987 99999876444221 2222333344
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.++.++..|..++.+||..+|.+||++.|+...|...
T Consensus 613 ~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 613 CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 4667777899999999999999999999988877653
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.43 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=200.1
Q ss_pred hhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------ 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 316 (558)
..++|+..+.||+|+||.||+|. ..+++.||+|++.+..........+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 45789999999999999999995 45789999999876544455556788899999999999999999987532
Q ss_pred -cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 317 -GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 317 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
..|+||||+.+ +|...+... +++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 26999999964 887777432 8888999999999999999998 89999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-----------
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL----------- 464 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~----------- 464 (558)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+....
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 87644322 22345889999999999999999999999999999999999999754321 1111100
Q ss_pred ----------hhc-C-----CcccccCCC----CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 465 ----------MES-G-----NLTELVDPS----LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 465 ----------~~~-~-----~~~~~~d~~----l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
... . .+.+..... ............+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0 000111110 0011112335568899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=301.75 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=202.2
Q ss_pred CCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
+|++.+.||.|+||.||+|... +++.||+|.+.+... .....+.+.+|++++++++||||+++++++.++. .++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999654 689999999976543 2345678899999999999999999999987665 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|..++... ..+++..+..++.|+++||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999999999654 568999999999999999999998 8999999999999999999999999999987654321
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
.....|+..|+|||++.+..++.++|+||||+++|+|++|+.||................. .....+
T Consensus 156 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~~~~~ 222 (258)
T cd05578 156 ---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET----------ADVLYP 222 (258)
T ss_pred ---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc----------ccccCc
Confidence 1234588999999999988899999999999999999999999986543211111111110 011112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH--HHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSM--SEVLE 513 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~--~evl~ 513 (558)
......+.+++.+||+.+|.+||+. .|+++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 2234678899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=301.68 Aligned_cols=251 Identities=23% Similarity=0.432 Sum_probs=202.6
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|.+.+.||+|+||.||+|.. .+|..+|+|.+............+.+|+.+++.++|+||+++++.+.++. .++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478889999999999999954 46889999998765443445567789999999999999999999987765 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-ceEEEeccccccCCCCCC
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-EPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 403 (558)
+.+++|.+++.......+++..+..++.+++.||.|||+ .+++|+||||+||+++.++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999999976655568999999999999999999998 8999999999999999886 469999999987654322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
. .....|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ...... +... + ..
T Consensus 158 ~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-~~~~----~-----~~ 223 (257)
T cd08225 158 L--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--VLKICQ-GYFA----P-----IS 223 (257)
T ss_pred c--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHhc-ccCC----C-----CC
Confidence 1 1224589999999999988999999999999999999999999975432211 111111 1111 1 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+.+++.+||+.+|++|||+.++++.
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 2233568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=313.69 Aligned_cols=262 Identities=20% Similarity=0.313 Sum_probs=196.4
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------c
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------G 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 317 (558)
+++|.+.+.||+|+||.||+|. ..+|+.||+|++.... .......+.+|+.++++++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 5789999999999999999994 4578999999985432 233455678899999999999999999987542 2
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++++||+.+ +|...+.. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 7899999975 78777743 458999999999999999999999 8999999999999999999999999999976
Q ss_pred CCCCCCcc-cccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-HhhhhhhcC---Ccc
Q 008650 398 LPNKCTHH-AAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLMESG---NLT 471 (558)
Q Consensus 398 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~---~~~ 471 (558)
........ ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ......... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 54322211 1123468999999998754 56899999999999999999999999754321110 000000000 000
Q ss_pred cccCCC-------C--CCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ELVDPS-------L--EGEY-----DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ~~~d~~-------l--~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+.+.. . .... .+.....+.+++.+||+.+|++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0 0000 01224568899999999999999999999996
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=297.75 Aligned_cols=253 Identities=26% Similarity=0.471 Sum_probs=202.6
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|.+.+.||+|+||.||+|.. .+++.|++|.+............+..|+.+++.++|+||+++++++...+ .++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478889999999999999954 57899999999766555567788999999999999999999999987655 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+++|.+++... ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999999653 457888999999999999999998 89999999999999999999999999999876544322
Q ss_pred cc--ccccccccCcccchhhccCC---CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 405 HA--AIPIEGTFGYLAPEYFMHGI---IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 405 ~~--~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.. .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||............ ...+. .+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~-----~~~~~ 228 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGAGH-----KPPIP 228 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--HhcCC-----CCCCC
Confidence 11 12345889999999998766 889999999999999999999999754322111110 11111 01111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
. .......+.+++.+||+.+|++|||+.+++.
T Consensus 229 ~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 D--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 1112456788999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.48 Aligned_cols=260 Identities=22% Similarity=0.320 Sum_probs=194.8
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++|+||+++++++.++. .++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 67899999999999999999554 689999999865432 122344678999999999999999999988765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+ +|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 84 YLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9985 8988886543 368899999999999999999998 8999999999999999999999999999875432211
Q ss_pred cccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh--hhcC---C--------
Q 008650 404 HHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL--MESG---N-------- 469 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~--~~~~---~-------- 469 (558)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.............. .... .
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1122347889999999875 4588999999999999999999999975542211111100 0000 0
Q ss_pred -ccccc-----CCCCCCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 -LTELV-----DPSLEGEY-DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 -~~~~~-----d~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
..... ...+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 00000000 0011256788999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=316.75 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=220.1
Q ss_pred HHHHHhhhCCCcccceEeeeCceEEEEEEECC-CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 238 YEEISSATNNFHSENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 238 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
++++.....+....+.||-|.||.||.|.|+. .-.||||.++.+ .....+|+.|..+|+.++|||+|+|+|+|..+
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 35565566677778999999999999996654 557999999543 56678899999999999999999999999876
Q ss_pred c-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
. .|||+|||.+|+|.++|+......++....+.++.||+.|+.||.. +++|||||...|+|+.++..+|++|||++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchh
Confidence 5 9999999999999999998877788888999999999999999998 89999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
+.+..+... .+....-...|.|||-+....++-|+|||+|||+|||+.| |-.||.+-.-+.+. .++
T Consensus 413 RlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY------------~LL 479 (1157)
T KOG4278|consen 413 RLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------------GLL 479 (1157)
T ss_pred hhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH------------HHH
Confidence 998765332 2222334678999999999999999999999999999999 99999875443221 233
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
....+-+-+..+...+.+|+..||+.+|.+||++.|+-+.++.
T Consensus 480 EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 480 EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 4444444555667789999999999999999999998887765
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.06 Aligned_cols=243 Identities=25% Similarity=0.411 Sum_probs=198.6
Q ss_pred eEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCH
Q 008650 253 MVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330 (558)
Q Consensus 253 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL 330 (558)
+||+|+||+||-|+.. +...+|||.+.... .....-+..|+.+-++++|.|||+++|.+.+++ .-+.||..+||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 7999999999999554 45679999986543 344556788999999999999999999998888 6688999999999
Q ss_pred HHHHhhccCCCC--CHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC-CCceEEEeccccccCCCCCCcccc
Q 008650 331 DAALHDERSKSL--EWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP-DFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 331 ~~~l~~~~~~~l--~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
.++|+.. -+++ ++...-.+..||++||.|||+ +.|||||||-+||||+. .|.+||+|||-++++..-. ..+
T Consensus 660 SsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~T 733 (1226)
T KOG4279|consen 660 SSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCT 733 (1226)
T ss_pred HHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC--ccc
Confidence 9999754 3555 788888899999999999999 89999999999999964 6899999999999876532 234
Q ss_pred cccccccCcccchhhccC--CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHH
Q 008650 408 IPIEGTFGYLAPEYFMHG--IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 485 (558)
.++.||..|||||++..| .|+..+|||||||++.||.||++||-..........+ -| + -...+..+.+
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk----VG----m--yKvHP~iPee 803 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK----VG----M--YKVHPPIPEE 803 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh----hc----c--eecCCCCcHH
Confidence 456799999999999877 4899999999999999999999999754322211111 00 0 1123445667
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 486 QMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 486 ~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
...+...++.+|+.++|.+||++.++|+
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 7888999999999999999999999997
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=300.30 Aligned_cols=246 Identities=25% Similarity=0.454 Sum_probs=200.1
Q ss_pred CcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEec
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 325 (558)
|...+.||+|+||.||+|.. .+++.+|+|.+..... ......+.+|+.++.+++||||+++++++.++. .++||||+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 67788999999999999954 5788999999854432 345567889999999999999999999998766 99999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
.+++|..++.. ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 99999999853 358899999999999999999998 8999999999999999999999999999876644321
Q ss_pred cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHH
Q 008650 406 AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 485 (558)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||........... ...+.. + .....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~-----~----~~~~~ 224 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL---IPKNNP-----P----TLEGN 224 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH---HhcCCC-----C----CCCcc
Confidence 12234588999999999988899999999999999999999999976433211111 111111 1 11222
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 486 QMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 486 ~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
....+.+++.+||+.+|.+||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 34568899999999999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.95 Aligned_cols=258 Identities=21% Similarity=0.351 Sum_probs=197.8
Q ss_pred CcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEec
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 325 (558)
|++.+.||.|++|.||+|.. .+|..||+|++............+.+|+.+++.++|||++++++++.++. .+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999954 57999999999765443344456888999999999999999999988765 89999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
. ++|..++.......+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 689999876554568999999999999999999998 89999999999999999999999999999765432111
Q ss_pred cccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC---------------
Q 008650 406 AAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN--------------- 469 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~--------------- 469 (558)
.....+++.|+|||++.+. .++.++||||||+++|+|++|+.||............ ....+.
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI-FRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHhCCCChHHhhhhhhchhh
Confidence 1223478899999988664 5789999999999999999999999765432111110 000000
Q ss_pred ---cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 ---LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 ---~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
......... ..........+.+++.+||+.+|.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0011223357889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=313.24 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=200.4
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-----CcE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-----NGL 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 318 (558)
.++|.+.+.||+|+||.||+|. ..+|+.||+|++............+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3689999999999999999995 4579999999997654334455667889999999999999999988752 238
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++||||+. ++|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999996 5898888543 458999999999999999999998 89999999999999999999999999999775
Q ss_pred CCCCCcc--cccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc----
Q 008650 399 PNKCTHH--AAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT---- 471 (558)
Q Consensus 399 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---- 471 (558)
....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||................+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 4332211 1123468999999999866 46899999999999999999999999765432111110000000000
Q ss_pred --------cccCC-CCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 --------ELVDP-SLEGEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 --------~~~d~-~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+. ....... ......+.+++.+||+.+|++|||+.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 0000111 1235678999999999999999999999884
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=300.39 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=201.4
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|+..+.||+|+||.||++.. .+++.+|+|.+..... ......+.+|+++++.+.||||+++++.+..+. .++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 3677888999999999999955 4689999999866533 355677889999999999999999999987665 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++.... ..+++.....++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999999996543 5688999999999999999999972 6899999999999999999999999999876533221
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCc---hhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR---QNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
. ...|+..|+|||++.+..++.++||||||+++|+|++|..||.... ............. . .+.+..
T Consensus 157 ~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~ 226 (265)
T cd06605 157 K----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-P-----PPRLPS 226 (265)
T ss_pred h----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-C-----CCCCCh
Confidence 1 1458899999999999999999999999999999999999997542 1111111111111 0 011111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
......+.+++.+||..+|++|||+.+++.
T Consensus 227 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 ---GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 114456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=307.91 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=196.8
Q ss_pred ceEeee--CceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQG--GYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
..||+| +||+||++.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++..+. .++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999955 57999999999766555556678889999999999999999999998765 8999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc--
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH-- 405 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-- 405 (558)
++|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999999976655568999999999999999999998 899999999999999999999999998654332211110
Q ss_pred ---cccccccccCcccchhhccC--CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh---------------
Q 008650 406 ---AAIPIEGTFGYLAPEYFMHG--IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM--------------- 465 (558)
Q Consensus 406 ---~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~--------------- 465 (558)
......++..|+|||++.++ .++.++|||||||++|+|++|+.||...............
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 01112356779999999764 4789999999999999999999999765332211110000
Q ss_pred -------------------hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 466 -------------------ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 466 -------------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+......+..+...........+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000001111112222233456678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=293.11 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=206.9
Q ss_pred CCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--c-EEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--G-LYLIF 322 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~-~~lv~ 322 (558)
+|...+.||+|++|.||+|... +++.+++|++............+.+|+.++++++|+||+++++.+.+. . .++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999654 789999999976655456677889999999999999999999998876 4 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++.... .+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999996543 78999999999999999999999 899999999999999999999999999998766543
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.........++..|+|||.+.+..++.++||||||+++|+|++|..||......... ...... .......
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~---------~~~~~~~ 225 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-LYKIGS---------SGEPPEI 225 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHhccc---------cCCCcCC
Confidence 311123345899999999999888999999999999999999999999865421111 111111 0111112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+......+.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 22335678999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.68 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=215.6
Q ss_pred CcccceEeeeCceEEEEEEEC--CCC--EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEE
Q 008650 248 FHSENMVGQGGYSEVYKGNLS--DGR--KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFN 323 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e 323 (558)
....++||+|.||.|++|.|. .|+ .||||.+..+... .....|++|+.+|.+|+|+|+++|||+..+....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhh
Confidence 355688999999999999553 454 4799999765543 37889999999999999999999999999988999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
+++.|+|.+.|+......|.......++.|||.||.||.. +++|||||...|+||...-.+||+|||+.+-+.....
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999988666778888899999999999999998 8999999999999999988999999999998876544
Q ss_pred ccccc-ccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 404 HHAAI-PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 404 ~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
..... ...-.+.|.|||.+++..++.+||||+|||+||||+| |..||-+.....+ -+.+|..-+..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI------------L~~iD~~erLp 335 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI------------LKNIDAGERLP 335 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH------------HHhccccccCC
Confidence 43221 2234678999999999999999999999999999999 8999987654322 12334333444
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhcCCCcc
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE--LLTSGHDSE 522 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~~~~~~ 522 (558)
.+..+.+.+.+++..||..+|++|||+..|.+ .|..+.+..
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~ 378 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAV 378 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCce
Confidence 46677889999999999999999999999973 455555543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=302.28 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=194.5
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
++++|.+.+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.+++.++|+||+++++++.++. .++|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 457899999999999999999954 5789999999865432 222345678999999999999999999988765 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
+||+. ++|...+... ...+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||+++.....
T Consensus 82 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 82 FEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred Eeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 99996 6776666443 2457888888999999999999998 89999999999999999999999999998764332
Q ss_pred CCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcC-----------C
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG-----------N 469 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~-----------~ 469 (558)
.. ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||................-+ .
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 21 11223578999999998764 5788999999999999999999999764432111111000000 0
Q ss_pred cccccCCCC----CCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 LTELVDPSL----EGEY-----DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 ~~~~~d~~l----~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
......... .... .......+.+++.+|++.||.+|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 0000 0011346788999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=300.38 Aligned_cols=248 Identities=25% Similarity=0.454 Sum_probs=197.8
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc---cCCeeeeeeEEEeCc-EEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC---HPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~-~~lv 321 (558)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+.+++.+. |||++++++++.++. .+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477888999999999999954 678999999986543 2344556778999988886 999999999987765 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+++|.+++.. ..+++..++.++.+++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 81 MEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999998854 368999999999999999999998 89999999999999999999999999999876544
Q ss_pred CCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
... .....|+..|+|||++.++ .++.++|+|||||++|+|++|..||......... . ..... ..+.+..
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~-~~~~~-----~~~~~~~ 224 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--M-LIPKS-----KPPRLED 224 (277)
T ss_pred ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--h-ccccC-----CCCCCCc
Confidence 321 2234589999999998765 4689999999999999999999999764322111 0 00010 1111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. .....+.+++.+||+.+|++||++.++++.
T Consensus 225 ~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 N---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred c---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1 134568899999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.83 Aligned_cols=247 Identities=21% Similarity=0.370 Sum_probs=196.4
Q ss_pred CcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEec
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 325 (558)
|.....||+|+||.||++.. .++..||||.+.... ......+.+|+.+++.++|+||+++++.+..++ .++||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34456799999999999954 468899999985432 344566889999999999999999999887655 89999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
.+++|.+++.. ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 102 ~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 102 EGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 99999998843 358899999999999999999999 8999999999999999999999999999876543322
Q ss_pred cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHH
Q 008650 406 AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 485 (558)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........... ... ...+.+.. ...
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~-----~~~~~~~~--~~~ 243 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRD-----NLPPRVKD--SHK 243 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh-----cCCCcccc--ccc
Confidence 12234589999999999988999999999999999999999999976543211111 100 11111111 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 486 QMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 486 ~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
....+..++.+||+.+|++|||+.++++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 23467889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=297.02 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=204.8
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|++.+.||+|+||.||++. ..+++.+++|.+............+.+|+.+++.++|+||+++++++.++. .++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47888999999999999994 457889999999765555556677889999999999999999999887655 9999999
Q ss_pred ccCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 325 SQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 325 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
+++++|..++.... ...+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999986532 3468999999999999999999998 899999999999999999999999999998765541
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||........... ...+... ..
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~---~~~~~~~---------~~ 221 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK---VQRGKYP---------PI 221 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhcCCCC---------CC
Confidence 1224588999999999999999999999999999999999999986543211111 1111111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.......+.+++.+||+.+|++|||+.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 22445679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.30 Aligned_cols=246 Identities=21% Similarity=0.338 Sum_probs=195.5
Q ss_pred cccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEecc
Q 008650 249 HSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQ 326 (558)
Q Consensus 249 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~ 326 (558)
.....||+|+||.||++.. .+++.||+|.+..... .....+.+|+.++..++||||+++++++..++ .++++||++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3345799999999999954 5789999999865432 23456788999999999999999999887655 999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccc
Q 008650 327 NGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA 406 (558)
Q Consensus 327 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 406 (558)
+++|..++.. ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 102 ~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 102 GGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred CCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 9999988743 358899999999999999999998 8999999999999999999999999999876543321 1
Q ss_pred ccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHH
Q 008650 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQ 486 (558)
Q Consensus 407 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 486 (558)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........... +....... .. .....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~~-----~~--~~~~~ 243 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRDSPPPK-----LK--NAHKI 243 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhccCCCC-----cc--ccCCC
Confidence 2234589999999999988999999999999999999999999975543221111 11111000 00 01122
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 487 MHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 487 ~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+.+++.+||+.+|++||++.++++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 3468889999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.56 Aligned_cols=248 Identities=25% Similarity=0.440 Sum_probs=205.0
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|++.+.||+|++|.||++.. .+++.|++|.+............+.+|++++++++|+|++++++++.++. .+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478889999999999999954 46889999999876655566678999999999999999999999987755 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998654 568999999999999999999998 89999999999999999999999999999876543321
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||.........+.... ... ...+.
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~---------~~~~~ 221 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---DDH---------PPLPE 221 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---cCC---------CCCCC
Confidence 2234589999999999888899999999999999999999999986553332222110 110 11122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.....+..++.+||..+|++|||+.+++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 23457889999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=349.34 Aligned_cols=257 Identities=28% Similarity=0.541 Sum_probs=209.4
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
..|...++||+|+||.||+|.. .++..||||++....... ..|+.++++++||||++++++|.++. .++|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 4577788999999999999965 578999999986433211 23578899999999999999998765 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+++|+|.++++ .++|..+.+++.|++.||+|||..+..+|+||||||+||+++.++.+++. ||........
T Consensus 764 y~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 764 YIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 999999999994 38899999999999999999996544799999999999999999988875 6655433211
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCC---chhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSS---RQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~---~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
....||+.|+|||++.+..++.++|||||||++|||+||+.||+.. ......|............++++.+..
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1235899999999999999999999999999999999999999643 234556666555555556667776644
Q ss_pred C--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 481 E--YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 481 ~--~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
. .+.....++.+++.+||+.+|++||||.||++.|++...
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3 345667788999999999999999999999999987543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=298.47 Aligned_cols=253 Identities=23% Similarity=0.414 Sum_probs=204.2
Q ss_pred hhhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
..+++|...+.||+|+||.||+|... ++..+++|++..... ....+.+|+.+++.++|+|++++++++..+. .++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34567888899999999999999654 688999999965433 4566889999999999999999999987765 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
++||+.+++|.+++.... ..+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999997643 468999999999999999999998 8999999999999999999999999999876543
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
... ......++..|+|||++.+..++.++|+||||+++|+|++|+.||........... ...........
T Consensus 169 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~----- 238 (286)
T cd06614 169 EKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL---ITTKGIPPLKN----- 238 (286)
T ss_pred chh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCCCcc-----
Confidence 321 12234588999999999988899999999999999999999999976543221111 11111111100
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.......+.+++.+||+.+|.+|||+.++++.
T Consensus 239 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 --PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred --hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11134568899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=290.39 Aligned_cols=249 Identities=27% Similarity=0.472 Sum_probs=202.6
Q ss_pred CCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|...+.||+|++|.||++... +++.+++|++..... .....+.+|+.+++.++|+|++++++++..+. .++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4778899999999999999654 788999999966543 45667889999999999999999999987755 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+++|.+++.... ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 79 CSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999999986543 568999999999999999999998 8999999999999999999999999999987654332
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||............ .......... ..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~-------~~ 221 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---ATNGPPGLRN-------PE 221 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---HhcCCCCcCc-------cc
Confidence 23345899999999999888999999999999999999999999865322111111 1111111111 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....+.+++.+||+.+|++|||+.++++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 124578999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.04 Aligned_cols=247 Identities=26% Similarity=0.443 Sum_probs=197.2
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
..|...+.||+|+||+||+|.. .+++.||+|++.... ........+.+|+.+++.++||||+++++++.+++ .++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999955 468999999986543 33445567889999999999999999999998765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+. |+|.+.+... ...+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 9997 5776666433 3468999999999999999999998 899999999999999999999999999987654321
Q ss_pred CcccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
...|++.|+|||++. .+.++.++||||||+++|||++|+.||............ . .... +.+
T Consensus 170 ------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~--~-~~~~-----~~~- 234 (307)
T cd06607 170 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--A-QNDS-----PTL- 234 (307)
T ss_pred ------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH--h-cCCC-----CCC-
Confidence 235888999999984 456889999999999999999999999765433221111 0 0000 001
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
........+.+++.+||+.+|++||++.+++..
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 --SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 112244578999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=296.44 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=204.7
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|++|.||+|... +++.|++|++...... .....+.+|+..+..++|+||+++++++..+. .++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 46888999999999999999554 5999999998765432 55677899999999999999999999988765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++... ..+++..++.++.|+++||.|||+. .+++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999999654 5689999999999999999999962 6899999999999999999999999999987654322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch-hHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ-NLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ........... ... + ..
T Consensus 156 ~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~-----~----~~ 223 (264)
T cd06623 156 QC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-GPP-----P----SL 223 (264)
T ss_pred cc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-CCC-----C----CC
Confidence 21 234588999999999999999999999999999999999999976542 11111111111 010 1 11
Q ss_pred CHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 483 DTD-QMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 483 ~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.. ....+.+++.+||..+|++|||+.++++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 112 44679999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=302.65 Aligned_cols=262 Identities=19% Similarity=0.271 Sum_probs=194.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc------
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG------ 317 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~------ 317 (558)
++|++.+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++.+. |+||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999954 46899999998655433334456788999999995 699999999886432
Q ss_pred EEEEEEeccCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC-CCceEEEecc
Q 008650 318 LYLIFNFSQNGNLDAALHDER---SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP-DFEPQITDFG 393 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG 393 (558)
.|++|||+.+ +|..++.... ...+++..++.++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 6999999986 7888876543 2358999999999999999999998 89999999999999998 8899999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh-hhhhcCC--
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK-PLMESGN-- 469 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~-~~~~~~~-- 469 (558)
++..+...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||............ .......
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 98765332111 112347889999999865 45789999999999999999999999764332111100 0000000
Q ss_pred -cccc---cC----CCCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 -LTEL---VD----PSLEG----EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 -~~~~---~d----~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.... .+ +.... ...+.....+.+++.+||+++|.+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 00 00000 001123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=304.52 Aligned_cols=263 Identities=24% Similarity=0.334 Sum_probs=197.0
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GLYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~l 320 (558)
.++|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.++++++|+||+++++++.+. ..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999955 5689999999865543333334566899999999999999999998753 3899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999975 7888876533 568999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc-----
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV----- 474 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----- 474 (558)
... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......................+
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 321 1122336888999999865 46889999999999999999999999765432111000000000000000
Q ss_pred -----CCCCCCC-C------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 -----DPSLEGE-Y------DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 -----d~~l~~~-~------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+... + .......+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 0 00124567889999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=302.86 Aligned_cols=261 Identities=20% Similarity=0.296 Sum_probs=197.1
Q ss_pred ccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 250 SENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 250 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
+.+.+|.|+++.||++.. +++.||+|++............+.+|+.+++.++|+||+++++++.++. .+++|||+.+|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 444555666666666644 7899999999776555667778999999999999999999999988765 89999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC-----
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT----- 403 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~----- 403 (558)
+|.+++.......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||.+..+.....
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999987655678999999999999999999998 8999999999999999999999999998875532211
Q ss_pred cccccccccccCcccchhhccC--CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh------hhc-------C
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHG--IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL------MES-------G 468 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~------~~~-------~ 468 (558)
........++..|+|||++... .++.++|||||||++|||++|+.||.............. +.. .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 1112234578899999999763 588999999999999999999999986533221111100 000 0
Q ss_pred Cccc----ccCCC----CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 469 NLTE----LVDPS----LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 469 ~~~~----~~d~~----l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.... ..++. ............+.+++.+||+.+|++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 1111223334678899999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=301.77 Aligned_cols=250 Identities=22% Similarity=0.407 Sum_probs=200.6
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||.||++. ..++..||+|.+.... ......+.+|+.+++.++|||++++++.+..++ .++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 3678999999999999999995 4578899999985432 233456889999999999999999999987765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++++|.+++.. ..+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred ecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999999854 347888999999999999999998 899999999999999999999999999987654332
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
. ......|++.|+|||++.++.++.++||||||+++|+|++|+.||........... ....+. + ....
T Consensus 170 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~--~~~~~~------~--~~~~ 237 (293)
T cd06647 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IATNGT------P--ELQN 237 (293)
T ss_pred c--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee--hhcCCC------C--CCCC
Confidence 2 12234588999999999988899999999999999999999999976543211110 000000 0 0011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+......+.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22234568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.04 Aligned_cols=246 Identities=22% Similarity=0.381 Sum_probs=197.1
Q ss_pred CcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEec
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 325 (558)
|...+.||+|++|.||++.. .+++.+++|++.... ......+.+|+.+++.++|||++++++++..++ .++++||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 44557999999999999954 578899999985432 334556889999999999999999999887655 99999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
.+++|.+++.. ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 99 EGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 99999999865 458899999999999999999999 8999999999999999999999999998876543322
Q ss_pred cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHH
Q 008650 406 AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 485 (558)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ...... ... +... ....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~--~~~~~~-~~~-----~~~~--~~~~ 240 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA--MKRIRD-NLP-----PKLK--NLHK 240 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH--HHHHHh-cCC-----CCCc--cccc
Confidence 11234589999999999988999999999999999999999999976443211 111111 111 1111 1112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 486 QMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 486 ~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
....+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 3457899999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=293.78 Aligned_cols=251 Identities=24% Similarity=0.437 Sum_probs=206.3
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|.+.+.||+|+||.||++.. .++..+++|++............+..|+++++.++|+|++++++.+..+. .++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 578889999999999999954 46899999999776655567778889999999999999999999987755 8999999
Q ss_pred ccCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 325 SQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 325 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
+++++|.+.+.... ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997653 4678999999999999999999998 899999999999999999999999999998765432
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||........ ..... ...... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~-~~~~~~---------~ 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL--ALKIL-KGQYPP---------I 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH--HHHHh-cCCCCC---------C
Confidence 122234689999999999988999999999999999999999999976542211 11111 111111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+......+.+++.+||..+|++|||+.++++.
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11334568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=308.28 Aligned_cols=267 Identities=21% Similarity=0.324 Sum_probs=201.6
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------c
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------G 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 317 (558)
.++|.+.+.||+|+||+||+|. ..+++.||+|.+............+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4679999999999999999994 45789999999875443344456678899999999999999999987542 2
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++++||+. ++|..++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999996 6888888543 568999999999999999999998 8999999999999999999999999999987
Q ss_pred CCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-Hhhhhhh---------
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLME--------- 466 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~--------- 466 (558)
..... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||......... .......
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 64432 11223458899999999865 46899999999999999999999999764321100 0000000
Q ss_pred --cCCccccc-------CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcCCC
Q 008650 467 --SGNLTELV-------DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL--LTSGHD 520 (558)
Q Consensus 467 --~~~~~~~~-------d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~~~ 520 (558)
.......+ +..... ........+.+++.+||+.+|++|||+.++++. +....+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00000000 000000 011234668899999999999999999999986 554433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.88 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=192.4
Q ss_pred CcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeC--c-EEEEE
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIEN--G-LYLIF 322 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~-~~lv~ 322 (558)
|++.+.||+|+||.||+|.. .+++.||+|++.+...... .....+|+.++.++. |+|++++++++.++ + .++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 56788999999999999954 5788999999865433222 234557888888886 99999999998765 4 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+. ++|.+.+.... ..+++..++.++.|++.||.|||+ .+++||||+|+||+++. +.+||+|||++..+....
T Consensus 80 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 80 ELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred ecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9997 47877775432 468999999999999999999999 89999999999999999 999999999998764432
Q ss_pred CcccccccccccCcccchhhc-cCCCCccccchhHHHHHHHHHcCCCCCCCCchhH-HHHhhhhhh-----------cCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFM-HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL-VLWAKPLME-----------SGN 469 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~-~~~~~~~~~-----------~~~ 469 (558)
.. ....++..|+|||++. ++.++.++|||||||++|||++|..||....... ..+...... ...
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 22 2235889999999765 4567899999999999999999999997654321 111111000 000
Q ss_pred cccccCCCCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 LTELVDPSLEG----EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 ~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+.... .........+.+++.+||+++|++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 0012335789999999999999999999999873
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.21 Aligned_cols=263 Identities=22% Similarity=0.332 Sum_probs=194.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 316 (558)
.++|++.+.||+|+||.||+|.. .+++.||+|.+............+.+|+.++++++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999955 4689999999865443333344567899999999999999999988643
Q ss_pred --cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 317 --GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 317 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
..++||||+.+ +|...+... ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 25899999975 787777543 3468999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCc--ccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 395 AKWLPNKCTH--HAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 395 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
+..+...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||.........-....+. +...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~-~~~~ 244 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC-GSIT 244 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCC
Confidence 9866432211 111234578899999998765 47889999999999999999999997654321110000000 0000
Q ss_pred c----------ccCC-CCCCCC---------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 472 E----------LVDP-SLEGEY---------DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 472 ~----------~~d~-~l~~~~---------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
. ..+. ...... .......+.+++.+||+.+|.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 0000 000000 0001235678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=304.20 Aligned_cols=264 Identities=22% Similarity=0.362 Sum_probs=194.5
Q ss_pred CCcccceEeeeCceEEEEEEEC---CCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--c-EE
Q 008650 247 NFHSENMVGQGGYSEVYKGNLS---DGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--G-LY 319 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~-~~ 319 (558)
.|.+.+.||+|+||.||+|... +++.||+|.+.... ........+.+|+.+++.++||||+++++++.+. . .+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999554 57899999997633 1122234567899999999999999999999865 4 89
Q ss_pred EEEEeccCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC----CCceEEEec
Q 008650 320 LIFNFSQNGNLDAALHDER---SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP----DFEPQITDF 392 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DF 392 (558)
+||||+.+ +|...+.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6666654322 2368899999999999999999998 89999999999999999 899999999
Q ss_pred cccccCCCCCC-cccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhH--------HHHhh
Q 008650 393 GLAKWLPNKCT-HHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL--------VLWAK 462 (558)
Q Consensus 393 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~--------~~~~~ 462 (558)
|++........ ........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 1122334689999999988764 58899999999999999999999997543221 00000
Q ss_pred --hhh------------hcCCcccccCCCCCCCCC---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 463 --PLM------------ESGNLTELVDPSLEGEYD---------T--DQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 463 --~~~------------~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+ .........+......++ . .....+.+++.+||+.+|++|||+.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 000000000000001111 0 223468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=307.58 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=198.9
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeC---cE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIEN---GL 318 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---~~ 318 (558)
..++|++.+.||+|+||.||+|.. .+++.+|+|++.+..........+.+|+.+++++ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 346789999999999999999965 4688999999865444444456677899999999 999999999988643 38
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++||||+. ++|..++... .+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++..+
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5898888543 68889999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCc---ccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC-----
Q 008650 399 PNKCTH---HAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN----- 469 (558)
Q Consensus 399 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~----- 469 (558)
...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......... .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL-EKIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHH
Confidence 543221 12223458999999998865 46789999999999999999999999754322110 000000000
Q ss_pred --------cccccCCCCC------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 --------LTELVDPSLE------GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 --------~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+++.... ..........+.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000 00011134578999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.58 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=197.4
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.|...+.||+|+||.||++.. .++..+|+|++.... ........+.+|+.+++.++|+|++++++++.++. .++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 377788999999999999954 568899999986543 23445567889999999999999999999998765 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+ +|.+.+... ...+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 9975 777776543 3568999999999999999999998 89999999999999999999999999998754332
Q ss_pred cccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
....|++.|+|||++. .+.++.++|||||||++|+|++|+.||........... ...... ..
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~--~~~~~~---------~~ 243 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNES---------PT 243 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH--HHhccC---------CC
Confidence 1235889999999984 45689999999999999999999999976432211111 111110 00
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.........+.+++.+||+.+|.+||++.++++.+..
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 1112234568899999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.86 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=195.2
Q ss_pred CcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhccc---ccCCeeeeeeEEEeC-c-----
Q 008650 248 FHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV---CHPNTATLVGCCIEN-G----- 317 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-~----- 317 (558)
|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++++ .|+|++++++++... .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999665 589999999975544333445566777766655 599999999998753 2
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.+++|||+.+ +|.+++.......+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8899999975 79888866544568999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhc---C--Cc--
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES---G--NL-- 470 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~---~--~~-- 470 (558)
+...... ....++..|+|||++.+..++.++|||||||++|+|++|+.||........ ........ . ..
T Consensus 157 ~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ-LDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH-HHHHHHHcCCCChHhcCC
Confidence 6443221 223478899999999999999999999999999999999999986543211 11000000 0 00
Q ss_pred -----ccccCCCCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 471 -----TELVDPSLEG---EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 471 -----~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.......... .........+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 011233467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.14 Aligned_cols=245 Identities=27% Similarity=0.355 Sum_probs=192.5
Q ss_pred EeeeCceEEEEEE-ECCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCH
Q 008650 254 VGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330 (558)
Q Consensus 254 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL 330 (558)
||+|+||+||++. ..+|+.||+|.+.+.... ......+..|+.+++.++||||+++++.+...+ .|+||||+.+++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999994 456899999998754322 233455678999999999999999999987655 9999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccccc
Q 008650 331 DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPI 410 (558)
Q Consensus 331 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 410 (558)
.+++.......+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccc
Confidence 999976655578999999999999999999999 8999999999999999999999999999876543211 1223
Q ss_pred ccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHH
Q 008650 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRL 490 (558)
Q Consensus 411 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 490 (558)
.++..|+|||++.++.++.++|||||||++|+|++|+.||........... +...... .....+......+
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~------~~~~~~~~~~~~~ 225 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE---LKRRTLE------MAVEYPDKFSPEA 225 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH---HHhcccc------ccccCCccCCHHH
Confidence 578899999999988899999999999999999999999976432110000 0000000 0111122234568
Q ss_pred HHHHHHhhccCCCCCC-----CHHHHHH
Q 008650 491 VLIADYCVRQTSAWRP-----SMSEVLE 513 (558)
Q Consensus 491 ~~li~~cl~~dp~~RP-----t~~evl~ 513 (558)
.+++.+||+.+|.+|| ++.++++
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHHh
Confidence 8999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=297.71 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=185.4
Q ss_pred eEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHH---HhcccccCCeeeeeeEEEeCc-EEEEEEecc
Q 008650 253 MVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELG---IIGHVCHPNTATLVGCCIENG-LYLIFNFSQ 326 (558)
Q Consensus 253 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~ 326 (558)
.||+|+||.||++.. .+++.+|+|.+.+.... ......+.+|.. ++....||||+.+++++..++ .++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999955 56899999998765322 122223334433 344457999999999887654 899999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccc
Q 008650 327 NGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA 406 (558)
Q Consensus 327 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 406 (558)
+++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 99999988643 468999999999999999999999 8999999999999999999999999999875533211
Q ss_pred ccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHH
Q 008650 407 AIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485 (558)
Q Consensus 407 ~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 485 (558)
....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||................ .. ....+..
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------~~----~~~~~~~ 221 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------TV----NVELPDS 221 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh------cC----CcCCccc
Confidence 22358999999999874 568999999999999999999999997542211111110000 01 1112223
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 486 QMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 486 ~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
....+.+++.+||+.+|.+|| ++.|+++.
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 445788999999999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.23 Aligned_cols=243 Identities=23% Similarity=0.359 Sum_probs=195.3
Q ss_pred EeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCH
Q 008650 254 VGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330 (558)
Q Consensus 254 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL 330 (558)
||.|+||.||+|.. .+++.+|+|++.+... .......+.+|+.+++.++||||+++++.+.++. .++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999955 4589999999976542 2345567889999999999999999999987765 9999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccccc
Q 008650 331 DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPI 410 (558)
Q Consensus 331 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 410 (558)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 9999654 458899999999999999999998 899999999999999999999999999998765432 11224
Q ss_pred ccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHH
Q 008650 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRL 490 (558)
Q Consensus 411 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 490 (558)
.|++.|+|||.+.+..++.++|+||||+++|+|++|..||................. .....++......+
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 223 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG---------NGKLEFPNYIDKAA 223 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc---------CCCCCCCcccCHHH
Confidence 589999999999888899999999999999999999999976542111111111110 01111222224578
Q ss_pred HHHHHHhhccCCCCCCC-----HHHHHH
Q 008650 491 VLIADYCVRQTSAWRPS-----MSEVLE 513 (558)
Q Consensus 491 ~~li~~cl~~dp~~RPt-----~~evl~ 513 (558)
.+++.+||+.+|++||+ +.|+++
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 99999999999999999 677766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=292.34 Aligned_cols=252 Identities=20% Similarity=0.350 Sum_probs=199.4
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeeccc---ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDN---KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GL 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~ 318 (558)
.+|.+.+.||+|+||.||+|. ..+++.||+|.+.... ........+.+|+.++++++|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 478999999999999999995 4568999999885432 2234556788999999999999999999998653 27
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++++||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 8999999999999998643 357888999999999999999998 89999999999999999999999999999865
Q ss_pred CCCCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 399 PNKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 399 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
...... .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||........... .. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~---------~~~ 225 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK--IA---------TQP 225 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH--HH---------cCC
Confidence 332111 111234589999999999988899999999999999999999999976432211111 00 011
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....+......+.+++.+||+ +|..||+..+++..
T Consensus 226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1122233445678999999999 57999999988763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=341.68 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=206.1
Q ss_pred hhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
-+-+|+-...||.|.||.||.| +..+|...|+|-+..........+.+.+|+.++..++|||+|++||+-.+.. ++|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3456777899999999999998 7778999999998766555566677889999999999999999999987755 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
||||.+|+|.+.+.. ++..++.....+..|++.|+.|||+ .|||||||||+||||+.+|.+|++|||.|..+...
T Consensus 1313 MEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999943 4557777777888999999999999 89999999999999999999999999999887665
Q ss_pred CCc--ccccccccccCcccchhhccC---CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 402 CTH--HAAIPIEGTFGYLAPEYFMHG---IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 402 ~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
... .......||+.|||||++.+. ....+.||||||||++||+||+.||............ ...|.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~--V~~gh------- 1458 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH--VAAGH------- 1458 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH--HhccC-------
Confidence 321 122345799999999999654 3567899999999999999999999765433221111 11111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
.+..+.....+=.+++..||+.||.+|-++.|+++.-.
T Consensus 1459 --~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1459 --KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred --CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 12223335556778999999999999999988887543
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.46 Aligned_cols=258 Identities=21% Similarity=0.340 Sum_probs=199.5
Q ss_pred CcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEec
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 325 (558)
|.+.+.||.|++|.||+|.. .+++.+++|.+............+..|+.+++.++|+||+++++++..+. .++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56678999999999999955 47889999998766544455667888999999999999999999987655 99999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
.+ +|...+.... ..+++..++.++.+++.||.|||+ .+|+|+||||+||+++.++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 75 8888876533 568999999999999999999999 899999999999999999999999999998765443 1
Q ss_pred cccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC-----cccccC----
Q 008650 406 AAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN-----LTELVD---- 475 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~-----~~~~~d---- 475 (558)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ........+. ...+.+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhhhh
Confidence 11223588899999999876 789999999999999999999999976543211 1000000000 000000
Q ss_pred -----CCCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 476 -----PSLE----GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 476 -----~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+... ..........+.+++.+||+++|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011234567999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=286.07 Aligned_cols=252 Identities=19% Similarity=0.258 Sum_probs=200.5
Q ss_pred hhCCCccc-ceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEe-----
Q 008650 244 ATNNFHSE-NMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIE----- 315 (558)
Q Consensus 244 ~~~~f~~~-~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 315 (558)
.+++|++. ++||-|-.|.|-.+ +..+++.+|+|++.... ...+|+++--.. .|||||.++++|.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 45667665 58999999999999 66789999999995331 244677664444 49999999999864
Q ss_pred CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---CCceEEEec
Q 008650 316 NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---DFEPQITDF 392 (558)
Q Consensus 316 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DF 392 (558)
..+.+|||.|+||.|...+.+.+...+++..+-.|..||+.|+.|||+ .+|.||||||+|+|... |..+||+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccc
Confidence 228899999999999999998888899999999999999999999999 89999999999999964 456999999
Q ss_pred cccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhH-HHHhhhhhhcCCcc
Q 008650 393 GLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL-VLWAKPLMESGNLT 471 (558)
Q Consensus 393 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~ 471 (558)
|+|+.-.. .....+.+-||.|.|||++....|+..+|+||+||++|-|++|..||.+..... .--.+..+..+.+.
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 99986443 334456789999999999999999999999999999999999999998753210 00111122222211
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+........++...++|+.+|+.+|.+|.|+.+++..
T Consensus 286 ------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 286 ------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1222234556778889999999999999999999885
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=312.83 Aligned_cols=247 Identities=22% Similarity=0.381 Sum_probs=196.6
Q ss_pred cccceEeeeCceEEEEE-EECCCCEEEEEEeecc--cccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc---EEEEE
Q 008650 249 HSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKD--NKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG---LYLIF 322 (558)
Q Consensus 249 ~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~lv~ 322 (558)
....+||+|+|-+||+| +..+|-.||--.+... ...+.....|..|+.+|+.|+||||+++|.++.+.. ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999 5556877874433222 344666788999999999999999999999997632 78999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-CceEEEeccccccCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFGLAKWLPNK 401 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~~~~ 401 (558)
|++..|+|..++... +..+......|+.||++||.|||+.. .+|||||||.+||||+.+ |.|||+|.|+|..+...
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999999654 56788899999999999999999854 689999999999999754 89999999999876542
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
....+.|||.|||||+.. ..|++.+||||||++++||+|+..||......-..+. .++.+ .-..-+.+.
T Consensus 200 ----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK-KV~SG-iKP~sl~kV---- 268 (632)
T KOG0584|consen 200 ----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK-KVTSG-IKPAALSKV---- 268 (632)
T ss_pred ----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH-HHHcC-CCHHHhhcc----
Confidence 223367999999999997 7899999999999999999999999987655433332 22222 112211111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...++.++|.+||.. ..+|||+.|+|..
T Consensus 269 ----~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 ----KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 123688899999999 9999999999984
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=320.67 Aligned_cols=266 Identities=18% Similarity=0.214 Sum_probs=183.8
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC--CCCEEEEEE--------------eecc-cccHHHHHHHHHHHHHhcccccCCe
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS--DGRKIAVKR--------------LAKD-NKDAKKEKEFLMELGIIGHVCHPNT 306 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~--------------~~~~-~~~~~~~~~~~~E~~~l~~l~h~ni 306 (558)
..++|.+.+.||+|+||+||++..+ ++...+.|. +.+. .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999998432 222222221 1111 1122344567899999999999999
Q ss_pred eeeeeEEEeCc-EEEEEEeccCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec
Q 008650 307 ATLVGCCIENG-LYLIFNFSQNGNLDAALHDER---SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG 382 (558)
Q Consensus 307 v~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 382 (558)
+++++++.+.+ .|++++++. ++|..++.... ........+..++.||+.||.|||+ ++||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 99999998765 889999885 46666664322 1123355677899999999999998 8999999999999999
Q ss_pred CCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCC-CCCCchhH-HHH
Q 008650 383 PDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP-VDSSRQNL-VLW 460 (558)
Q Consensus 383 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~P-f~~~~~~~-~~~ 460 (558)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||++|..+ |....... ...
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999876543221 22235699999999999999999999999999999999998754 43322111 111
Q ss_pred hhhhhh----cCCcc-------cccCCC----CCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 461 AKPLME----SGNLT-------ELVDPS----LEGEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 461 ~~~~~~----~~~~~-------~~~d~~----l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...... ...+. ..++.. ...... ......+.+++.+||+.||++|||+.|+++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 100000 00000 000000 000000 0112346778899999999999999999984
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=306.23 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=195.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 316 (558)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++.+..........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999954 5789999999876543334455688999999999999999999988643
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..++|++|+.. +|..++ ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 25899999864 676654 2358899999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC------
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN------ 469 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~------ 469 (558)
...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||................+..
T Consensus 166 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 166 HADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 653321 22457899999999876 468999999999999999999999998654221111000000000
Q ss_pred ------cccccC--CCC-CCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcC
Q 008650 470 ------LTELVD--PSL-EGEY---DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL--LTSG 518 (558)
Q Consensus 470 ------~~~~~d--~~l-~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~ 518 (558)
...... +.. +... .+.....+.+++.+||+.||++||++.+++.. +++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000000 000 0000 01123468899999999999999999999964 5443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.41 Aligned_cols=265 Identities=23% Similarity=0.317 Sum_probs=199.5
Q ss_pred HHHHHhhhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 238 YEEISSATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 238 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
..++...+++|.+.+.||+|+||.||+|. ..+++.||+|++.+..........+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34566678999999999999999999994 46789999999976544444456688899999999999999999987532
Q ss_pred -------cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEE
Q 008650 317 -------GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQI 389 (558)
Q Consensus 317 -------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 389 (558)
..+++++++ +++|..++.. ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEE
Confidence 256777765 7899888743 358999999999999999999999 89999999999999999999999
Q ss_pred EeccccccCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcC
Q 008650 390 TDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG 468 (558)
Q Consensus 390 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 468 (558)
+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..................
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998865332 123458999999999876 56889999999999999999999999754322110000000000
Q ss_pred Ccccc---------------cCCCCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 469 NLTEL---------------VDPSLEGEY---DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 469 ~~~~~---------------~d~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
....+ +.......+ .......+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 000000000 00123468899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.19 Aligned_cols=263 Identities=23% Similarity=0.351 Sum_probs=197.0
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------ 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 316 (558)
..++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999654 688999999976543334445677899999999999999999988643
Q ss_pred -----cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEe
Q 008650 317 -----GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITD 391 (558)
Q Consensus 317 -----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 391 (558)
..++++||+.+ +|...+... ...+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 38899999986 676666543 3468999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-HhhhhhhcC-
Q 008650 392 FGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLMESG- 468 (558)
Q Consensus 392 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~- 468 (558)
||++..+..... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||......... .........
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999987654332 111223468889999988654 5789999999999999999999999764322111 000000000
Q ss_pred --Cccccc--------CC------CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 469 --NLTELV--------DP------SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 469 --~~~~~~--------d~------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
....+. +. ...... ......+.+++.+||+.+|.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 00 000000 112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.84 Aligned_cols=260 Identities=22% Similarity=0.329 Sum_probs=197.1
Q ss_pred CcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--c-EEEEEE
Q 008650 248 FHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--G-LYLIFN 323 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~-~~lv~e 323 (558)
|++.+.||.|+||.||+|... +++.+|+|++............+.+|+.+++.++|+|++++++++.++ . .++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999654 588999999976643344456788999999999999999999999866 3 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+ +|..++.... ..+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 8888885432 468999999999999999999998 8999999999999999999999999999987654321
Q ss_pred cccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHH-HHhhhhhhc---CCccccc----
Q 008650 404 HHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLV-LWAKPLMES---GNLTELV---- 474 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~-~~~~~~~~~---~~~~~~~---- 474 (558)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ......... .......
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 11222347889999998765 4578999999999999999999999986543211 000000000 0000000
Q ss_pred ----------CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 475 ----------DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 475 ----------d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
...+...+.......+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000001112457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=291.46 Aligned_cols=248 Identities=22% Similarity=0.261 Sum_probs=190.4
Q ss_pred HHHHhhhCCCcccceE--eeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcc-cccCCeeeeeeEEE
Q 008650 239 EEISSATNNFHSENMV--GQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGH-VCHPNTATLVGCCI 314 (558)
Q Consensus 239 ~~~~~~~~~f~~~~~l--G~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~ 314 (558)
.+.....++|.+.+.+ |+|+||.||++. ..++..+|+|.+........ |+..... .+||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEe
Confidence 3444555677777766 999999999995 45788999999865432211 1111111 26999999999987
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-ceEEEec
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-EPQITDF 392 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DF 392 (558)
.++ .++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .++|+||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 765 99999999999999999654 378999999999999999999999 8999999999999999998 9999999
Q ss_pred cccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccc
Q 008650 393 GLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTE 472 (558)
Q Consensus 393 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 472 (558)
|++....... ...|+..|+|||++.+..++.++||||||+++|+|++|+.||................. .
T Consensus 155 g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~- 224 (267)
T PHA03390 155 GLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---Q- 224 (267)
T ss_pred ccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---c-
Confidence 9998654321 23589999999999999999999999999999999999999985433221111100000 0
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS-MSEVLE 513 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~ 513 (558)
.. ..........+.+++.+||+.+|.+||+ ++++++
T Consensus 225 ---~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 ---KK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---cc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 0111234457889999999999999996 688885
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=296.92 Aligned_cols=258 Identities=16% Similarity=0.246 Sum_probs=183.8
Q ss_pred hCCCcccceEeeeCceEEEEEEECC----CCEEEEEEeecccccHHH---------HHHHHHHHHHhcccccCCeeeeee
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSD----GRKIAVKRLAKDNKDAKK---------EKEFLMELGIIGHVCHPNTATLVG 311 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~ 311 (558)
.++|.+.+.||+|+||+||+|...+ +..+|+|+.......... ......+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4679999999999999999996544 455677754332211111 112334455667788999999999
Q ss_pred EEEeCc-----EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc
Q 008650 312 CCIENG-----LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386 (558)
Q Consensus 312 ~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 386 (558)
++.... .+++++++.. ++.+.+... ...++..+..++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence 765432 3556665533 566555432 335788889999999999999998 89999999999999999999
Q ss_pred eEEEeccccccCCCCCCc-----ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh-HHHH
Q 008650 387 PQITDFGLAKWLPNKCTH-----HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN-LVLW 460 (558)
Q Consensus 387 ~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~-~~~~ 460 (558)
++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999876432111 1112346999999999999999999999999999999999999999865221 1111
Q ss_pred h-h-hhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 461 A-K-PLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 461 ~-~-~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
. . .++.. +....+. .......+.+++..|++.+|++||++.++++.|.
T Consensus 245 ~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFIKR-----LHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHHHH-----hhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 0 01100 0000000 0112356889999999999999999999998763
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.05 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=199.1
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--c
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--G 317 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 317 (558)
+...+++|++.+.||.|+||.||+|. ..+++.||+|++.+..........+..|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 34567899999999999999999995 45799999999865544344556678899999999999999999998653 4
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++++||+ +++|..++.. ..+++..+..++.|++.||.|||+ .+|+||||+|+|||++.++.++|+|||++..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 89999998 5689888753 357888888999999999999999 8999999999999999999999999999875
Q ss_pred CCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHH-hhhhh----------
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW-AKPLM---------- 465 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~-~~~~~---------- 465 (558)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .....
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4322 122357889999999866 568999999999999999999999997643311100 00000
Q ss_pred -hcCCcccccCC-CCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 466 -ESGNLTELVDP-SLEGEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 466 -~~~~~~~~~d~-~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+...++.. ......+ ......+.+++.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0001111 1123578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=296.25 Aligned_cols=254 Identities=24% Similarity=0.434 Sum_probs=194.2
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~l 320 (558)
..++|.+.+.||+|+||+||+|... +++.||||.+.+... ......+..|+.++.+.. |+||+++++++.++. .++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3467889999999999999999665 488999999965432 334556677777676665 999999999998765 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
+|||+. ++|..++... ...+++..+..++.+++.||.|||+. .+|+||||+|+||+++.++.+||+|||++..+..
T Consensus 92 v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999985 4676666443 34789999999999999999999962 4899999999999999999999999999976643
Q ss_pred CCCcccccccccccCcccchhhccCC----CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGI----IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
.... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||............ .... ....+
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~-~~~~~--- 239 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK-ILQE-EPPSL--- 239 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH-HhcC-CCCCC---
Confidence 3221 2234788999999987553 889999999999999999999999764332111111 1111 11110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.. ......++.+++.+||+.+|++||++.++++.
T Consensus 240 --~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 --PP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 11234568999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.10 Aligned_cols=258 Identities=23% Similarity=0.337 Sum_probs=197.4
Q ss_pred hhhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc----
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG---- 317 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 317 (558)
...++|++.+.||+|+||.||+|. ..++..||||++.+..........+.+|+.+++.++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 356789999999999999999994 567999999998654444445567889999999999999999999886432
Q ss_pred ---EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 318 ---LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 318 ---~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
.++||+|+ +++|..++.. ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 48999998 7789888753 458999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC----
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN---- 469 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~---- 469 (558)
+....... ....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||........ ........+.
T Consensus 165 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 238 (343)
T cd07880 165 ARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHH
Confidence 98654321 22357899999999876 4588999999999999999999999986532111 0000000000
Q ss_pred ---------cccccC--CCCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 ---------LTELVD--PSLEG----EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 ---------~~~~~d--~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
...... +.... .........+.+++.+|++.+|++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000 001122345889999999999999999999996
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=293.63 Aligned_cols=259 Identities=21% Similarity=0.324 Sum_probs=195.8
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|+..+.||.|++|.||+|.. .+|+.||+|++..... ......+.+|+.++++++|+||+++++++.+.+ .++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588899999999999999965 4688999999865432 223455678999999999999999999998765 8999999
Q ss_pred ccCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 325 SQNGNLDAALHDER-SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 325 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
+.+ +|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 985 8888775543 2468999999999999999999998 8999999999999999999999999999976543211
Q ss_pred cccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhc-----------CCcc
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES-----------GNLT 471 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~-----------~~~~ 471 (558)
......+|+.|++||++.+. .++.++|||||||++|+|++|+.||........ ........ ....
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCc
Confidence 11223478999999998664 578999999999999999999999976532211 00000000 0000
Q ss_pred cccCCCCC------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 472 ELVDPSLE------GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 472 ~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
........ ....+.....+.+++.+|++.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0011123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=293.80 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=196.2
Q ss_pred CcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEEEEEe
Q 008650 248 FHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
|++.+.||+|+||+||+|... +++.|++|++...... .......+|+..+.+++ |+|++++++++.+++ .++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 567889999999999999664 5788999998654332 23334557899999999 999999999987755 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+ +|+|.+.+.......+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 9 8899998876654578999999999999999999998 89999999999999999999999999999866443221
Q ss_pred ccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh--------------hhhhcCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK--------------PLMESGN 469 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~--------------~~~~~~~ 469 (558)
....|+..|+|||++.. ..++.++|+||||+++|+|++|+.||.........+.. .......
T Consensus 156 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 156 ---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred ---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22348899999998854 45789999999999999999999999765432111110 0000000
Q ss_pred cccccCCCCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 LTELVDPSLEG---EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 ~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
....+...... .........+.+++.+||+.+|++|||+.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 0001113578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=291.97 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=185.8
Q ss_pred eEeeeCceEEEEEEE-CCCCEEEEEEeecccccH-HHHHHHHHH---HHHhcccccCCeeeeeeEEEeCc-EEEEEEecc
Q 008650 253 MVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA-KKEKEFLME---LGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQ 326 (558)
Q Consensus 253 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~ 326 (558)
+||+|+||.||+|.. .+++.||+|.+.+..... .....+..| +.+++...||||+.+++++.++. .++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999954 568899999987653221 112223333 34455567999999999887655 899999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccc
Q 008650 327 NGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA 406 (558)
Q Consensus 327 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 406 (558)
+|+|..++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 9999988854 3568999999999999999999999 8999999999999999999999999999876543221
Q ss_pred ccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHH
Q 008650 407 AIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485 (558)
Q Consensus 407 ~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 485 (558)
....|+..|+|||++.++ .++.++|||||||++|+|++|+.||................. .... .+..
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~----~~~~ 221 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------MAVE----LPDS 221 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc------cCCC----CCCc
Confidence 234599999999999755 689999999999999999999999976522111111101100 0111 1122
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008650 486 QMHRLVLIADYCVRQTSAWRP-----SMSEVLE 513 (558)
Q Consensus 486 ~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 513 (558)
....+.+++.+||..+|.+|| ++.++++
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 245788999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=288.91 Aligned_cols=246 Identities=24% Similarity=0.308 Sum_probs=189.0
Q ss_pred ceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHH-hcccccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 252 NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGI-IGHVCHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
+.||+|+||.||+|.. .+++.||+|.+.+.... ......+..|..+ .....|+|++++++++.+++ .|+++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999954 56899999998654322 2223334455444 44558999999999998755 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
++|..++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 9999999643 468899999999999999999998 8999999999999999999999999999875433 1
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||........ +.. . ..+... ..........
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~-~-~~~~~~------~~~~~~~~~~ 221 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDN-I-LSRRIN------WPEEVKEFCS 221 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHH-H-HhcccC------CCCcccccCC
Confidence 224588999999999888899999999999999999999999976543221 111 1 111100 0001111234
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 488 HRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 488 ~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
..+.+++.+||+.+|++||++.++.+.|.-
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 578999999999999999987766665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=325.04 Aligned_cols=256 Identities=25% Similarity=0.441 Sum_probs=196.1
Q ss_pred HhhhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeE--------
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC-------- 312 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-------- 312 (558)
....++|..+.+||+||||.||++ +.-||+.||||++.... .......+.+|+.+|.+|+|||||+++..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 345567888999999999999999 55699999999997765 56667788999999999999999999830
Q ss_pred --------------------------------------------------E--E--------------------------
Q 008650 313 --------------------------------------------------C--I-------------------------- 314 (558)
Q Consensus 313 --------------------------------------------------~--~-------------------------- 314 (558)
+ .
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0 0
Q ss_pred --------------------------eC-------c-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Q 008650 315 --------------------------EN-------G-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHY 360 (558)
Q Consensus 315 --------------------------~~-------~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~ 360 (558)
+. . +|+-||||+..+|+++++.+.... .....|+++.+|++||.|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHH
Confidence 00 1 578899999988888887654322 466789999999999999
Q ss_pred hhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC----------------CCCCcccccccccccCcccchhhcc
Q 008650 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP----------------NKCTHHAAIPIEGTFGYLAPEYFMH 424 (558)
Q Consensus 361 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~ 424 (558)
+|+ +|||||||||.||+|++++.|||+|||+|.... ........+...||.-|+|||++.+
T Consensus 713 IH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999 899999999999999999999999999998721 0011112345679999999999976
Q ss_pred C---CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccC
Q 008650 425 G---IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQT 501 (558)
Q Consensus 425 ~---~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d 501 (558)
. .|+.|+|+|||||||+||+. ||...-....... .+..+.++.- ..+.......=..+|.++++.|
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~--~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILT--NLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHH--hcccCCCCCC------cccccccchHHHHHHHHHhcCC
Confidence 4 49999999999999999986 5765422221111 1223333322 1222333445567899999999
Q ss_pred CCCCCCHHHHHH
Q 008650 502 SAWRPSMSEVLE 513 (558)
Q Consensus 502 p~~RPt~~evl~ 513 (558)
|.+|||+.|+|+
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=312.22 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=194.7
Q ss_pred CcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------cEE
Q 008650 248 FHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-------GLY 319 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~~~ 319 (558)
|...+.||+|+||.||+|+ ..+|+.||||.+++.. .........+|+++|++++|+|||++++.-.+. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4556789999999999995 7789999999997644 234445678999999999999999999985432 267
Q ss_pred EEEEeccCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec--CCC--ceEEEeccc
Q 008650 320 LIFNFSQNGNLDAALHDER-SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG--PDF--EPQITDFGL 394 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DFG~ 394 (558)
++||||.+|+|+..|.... ..++++...+.++.+++.||.|||+ ++|+||||||.||++- .+| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999997643 3579999999999999999999998 8999999999999994 334 379999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhc-cCCCCccccchhHHHHHHHHHcCCCCCCCCchh----HHHHhhhhhhcCC
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFM-HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN----LVLWAKPLMESGN 469 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~----~~~~~~~~~~~~~ 469 (558)
|+.++++. ...++.||+.|++||++. .+.|+.-+|.|||||++|+..||..||...... ...|.........
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99988765 344577999999999998 589999999999999999999999999764322 2333332221111
Q ss_pred cccccCCCCC------------CCCCHHHHHHHHHHHHHhhccCCCCCC
Q 008650 470 LTELVDPSLE------------GEYDTDQMHRLVLIADYCVRQTSAWRP 506 (558)
Q Consensus 470 ~~~~~d~~l~------------~~~~~~~~~~l~~li~~cl~~dp~~RP 506 (558)
..-...+.-+ .........++...+..+|..+|.+|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1111111111 122234456677777788888888887
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=293.09 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=202.3
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~lv 321 (558)
++|.+.+.||+|+||.||+|.. .+++.||+|++.+.. ........+.+|..+++++. |+||+++++++.++. .+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4788999999999999999955 479999999986643 23344567889999999999 999999999987655 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
||++.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999999654 469999999999999999999998 89999999999999999999999999999876443
Q ss_pred CCc------------------ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhh
Q 008650 402 CTH------------------HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463 (558)
Q Consensus 402 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 463 (558)
... .......|+..|+|||.+....++.++|+||||+++++|++|+.||........ . ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~-~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-F-QK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-H-HH
Confidence 221 122234578999999999988899999999999999999999999986542211 0 10
Q ss_pred hhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 008650 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSM----SEVLE 513 (558)
Q Consensus 464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~----~evl~ 513 (558)
.. . .....+......+.+++.+||+.+|++|||+ .++++
T Consensus 234 ~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 IL-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11 0 0111122234578999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=288.51 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=196.4
Q ss_pred EeeeCceEEEEEEEC-CCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCH
Q 008650 254 VGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330 (558)
Q Consensus 254 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL 330 (558)
||.|+||.||++... +|+.+++|.+..... .......+.+|++++++++||||+++++.+..+. .++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999665 599999999865432 2345667889999999999999999999887665 9999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC------c
Q 008650 331 DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT------H 404 (558)
Q Consensus 331 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~------~ 404 (558)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9999654 368999999999999999999998 8999999999999999999999999999876433211 0
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCH
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 484 (558)
.......++..|+|||++....++.++||||||+++|+|++|..||......... ..... +.... + . ..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~~~~-~~~~~---~---~--~~ 224 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF--QNILN-GKIEW---P---E--DV 224 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHhc-CCcCC---C---c--cc
Confidence 1222345888999999999888999999999999999999999999765433211 11111 11100 0 0 00
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 485 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.....+.+++.+||+.+|.+|||+.++.+.|+-
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 124578899999999999999999777766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.26 Aligned_cols=248 Identities=24% Similarity=0.421 Sum_probs=195.5
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
+.|...+.||+|+||.||+|.. .++..+|+|.+.... ........+.+|+.+++.++|+|++++++++..+. .++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3477778999999999999954 468889999986532 23344567889999999999999999999988765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+. |+|.+.+... ...+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9996 5787777543 3458899999999999999999998 89999999999999999999999999998765432
Q ss_pred CcccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
....|++.|+|||++. .+.++.++|||||||++|+|++|..||............ . .+.. +..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~-~~~~-----~~~- 234 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--A-QNES-----PAL- 234 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH--h-hcCC-----CCc-
Confidence 1235889999999985 356888999999999999999999998764332211111 1 1010 100
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
........+.+++.+||+.+|++||++.++++..
T Consensus 235 --~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 235 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred --CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1122345688999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=297.23 Aligned_cols=264 Identities=23% Similarity=0.319 Sum_probs=194.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 316 (558)
.++|++.+.||+|+||.||+|.. .+++.+|+|++............+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999954 4689999999865543333334567899999999999999999886432
Q ss_pred --cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 317 --GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 317 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
..++|++|+.+ +|...+... ...+++..+..++.|+++||.|||+ ++|+|+||||+|||++.++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 26899999875 676666543 3469999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCCcc---------cccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHH-hhh
Q 008650 395 AKWLPNKCTHH---------AAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW-AKP 463 (558)
Q Consensus 395 a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~-~~~ 463 (558)
+.......... ......|++.|+|||++.+. .++.++|||||||++|||++|+.||.........- ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 97654332111 11234578899999988654 58899999999999999999999997643321100 000
Q ss_pred hhhc---------CCcccccCCCCCCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 464 LMES---------GNLTELVDPSLEGEYD-------TDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 464 ~~~~---------~~~~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.... .......+.......+ ......+.+++.+||+.+|.+|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 0000000000000000 112256889999999999999999999886
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.82 Aligned_cols=266 Identities=21% Similarity=0.296 Sum_probs=202.7
Q ss_pred CCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------cEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------GLY 319 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 319 (558)
+|.+.+.||.|+||.||+|... +++.+|+|++..........+.+.+|+.+++.++|+||+++++++... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999654 589999999976544455567788999999999999999999988654 489
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
++|+|+.+ +|..++... ..+++..++.++.+|+.||.|||+ .+|+|+||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~~-~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMET-DLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhh-hHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 99999984 888888543 378999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCc-ccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh-hhh-----------
Q 008650 400 NKCTH-HAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK-PLM----------- 465 (558)
Q Consensus 400 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~-~~~----------- 465 (558)
..... .......+|+.|+|||++.+. .++.++|+||||+++|+|++|+.||............ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 54211 112234589999999999888 7899999999999999999999999765432110000 000
Q ss_pred hcCCcccccCC-CCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcC
Q 008650 466 ESGNLTELVDP-SLEGE-----YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL--LTSG 518 (558)
Q Consensus 466 ~~~~~~~~~d~-~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~ 518 (558)
........+.. ..... ........+.+++.+||+.+|.+|||+.++++. +++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 00000000000 00000 011234568899999999999999999999984 4443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=292.22 Aligned_cols=244 Identities=22% Similarity=0.366 Sum_probs=194.3
Q ss_pred cceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 251 ENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
...||+|+||.||++.. .+++.+|+|++.... ......+.+|+.+++.++|+||+++++++..++ .+++|||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 35799999999999955 578999999985432 344566889999999999999999999988755 99999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccc
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 408 (558)
+|.+++.. ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 103 ~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~ 174 (292)
T cd06657 103 ALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 174 (292)
T ss_pred cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccc
Confidence 99998743 357899999999999999999999 8999999999999999999999999999876644321 122
Q ss_pred ccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHH
Q 008650 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMH 488 (558)
Q Consensus 409 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 488 (558)
...|++.|+|||++.+..++.++|+||||+++|+|++|..||.......... .... ... +.+.. ......
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~~~~-~~~----~~~~~--~~~~~~ 244 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRD-NLP----PKLKN--LHKVSP 244 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh-hCC----cccCC--cccCCH
Confidence 3458999999999988889999999999999999999999997653321110 0100 000 11100 112234
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 489 RLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 489 ~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+.+++.+||+.+|.+||++.++++.
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 67889999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.43 Aligned_cols=260 Identities=22% Similarity=0.255 Sum_probs=205.1
Q ss_pred HHHHhhhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 239 EEISSATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 239 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
.++....++|.+.++||+|+||.|..+. ..+++.||.|++.+.. ........|..|-.+|..-+.+-|++++..|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 3455567899999999999999999994 4678999999997743 1123445688899999988899999999999886
Q ss_pred c-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
. +|+||+|++||+|-.++... ..+++..+..++..|..||+-||+ .|+|||||||+|||||..|++||+|||.+
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhH
Confidence 5 99999999999999999554 379999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhc----c-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCc
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFM----H-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL 470 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 470 (558)
-.+..+.. ......+|||-|++||+++ + +.|+..+|+||+||++|||+.|..||.... ++.-...+++-.+.
T Consensus 223 lkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--lveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 223 LKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--LVETYGKIMNHKES 299 (1317)
T ss_pred HhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--HHHHHHHHhchhhh
Confidence 88765433 3334567999999999995 3 679999999999999999999999998542 22212222221111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 008650 471 TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS---MSEVLEL 514 (558)
Q Consensus 471 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~ 514 (558)
-.+ + .....+.+..++|.+.+. +|+.|.. +.++-.+
T Consensus 300 l~F-----P--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 300 LSF-----P--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred cCC-----C--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 111 1 112355678888888776 5667777 8888764
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=293.24 Aligned_cols=245 Identities=27% Similarity=0.456 Sum_probs=193.6
Q ss_pred CcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
|...+.||+|+||+||+|.. .+++.|++|++..... .......+.+|+.+++.++|||++++++++.++. .++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999954 5688999999865432 3344567889999999999999999999998766 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+. |+|.+.+... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 5777777543 3468999999999999999999998 8999999999999999999999999999864322
Q ss_pred ccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.....|+..|+|||++. .+.++.++|||||||++|+|++|..||............ .. .......
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~-~~~~~~~------- 241 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQ-NDSPTLQ------- 241 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--Hh-cCCCCCC-------
Confidence 12345899999999984 456889999999999999999999999765432211111 11 1111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.......+.+++.+||+.+|.+||++.+++..
T Consensus 242 -~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223458889999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.36 Aligned_cols=261 Identities=21% Similarity=0.279 Sum_probs=191.5
Q ss_pred CCcccceEeeeCceEEEEEEEC-C--CCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEe-----Cc
Q 008650 247 NFHSENMVGQGGYSEVYKGNLS-D--GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIE-----NG 317 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-----~~ 317 (558)
+|.+.+.||+|+||.||++... + +..||+|++............+.+|+.+++++. ||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999553 4 778999998654333344566788999999994 9999999987542 22
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.+++++|+. ++|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 678888875 689888854 3568999999999999999999998 8999999999999999999999999999987
Q ss_pred CCCCCCc--ccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhH-HHHhhhhhh-------
Q 008650 398 LPNKCTH--HAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL-VLWAKPLME------- 466 (558)
Q Consensus 398 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~-~~~~~~~~~------- 466 (558)
+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .........
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 6433221 11223468999999998866 468999999999999999999999997543210 000000000
Q ss_pred ----cCCcccc---cCCCCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 467 ----SGNLTEL---VDPSLEG---EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 467 ----~~~~~~~---~d~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
....... ....-.. .........+.+++.+||+.+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0000000 000112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=291.15 Aligned_cols=243 Identities=24% Similarity=0.378 Sum_probs=196.4
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEe-CcEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVC-HPNTATLVGCCIE-NGLYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~~l 320 (558)
..+|..+.+||+|+||.|.+|..+ +.+.||||+++++.. ......--+.|-++|.... -|.+++++.++.. +.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457888999999999999999554 577899999987642 2223333456777777664 6788999998876 55999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.||+|-.++.. -+.+.+..+..+|.+||-||-|||+ +|||+||||.+|||||.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni- 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 501 (683)
T ss_pred EEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc-
Confidence 9999999999888744 4678889999999999999999999 999999999999999999999999999998522
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
.....+.+++|||.|+|||++...+|+.++|+|||||+||||+.|..||+++.....-.+ ++ +. +-
T Consensus 502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a--I~---------eh--nv 567 (683)
T KOG0696|consen 502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA--IM---------EH--NV 567 (683)
T ss_pred -cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HH---------Hc--cC
Confidence 223345578999999999999999999999999999999999999999998765432211 11 11 12
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPS 507 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt 507 (558)
.++...+.+.+.+....|...|.+|..
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccccC
Confidence 345556667888889999999999954
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=301.51 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=197.4
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-----
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN----- 316 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 316 (558)
...++|.+.+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++.+.|+||+++++++..+
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3467899999999999999999955 4688999999865443444556678899999999999999999876532
Q ss_pred --cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 317 --GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 317 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
..++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 278999998 6699888854 458999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhh-cCCcc-
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLME-SGNLT- 471 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~- 471 (558)
+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .. .... .+...
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~-~i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LK-RIMNLVGTPDE 237 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HH-HHHHhcCCCCH
Confidence 9865432 122358899999999865 3678999999999999999999999975433211 00 0000 00000
Q ss_pred ------------cccC---CCCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ------------ELVD---PSLEGEY---DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ------------~~~d---~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.++. ......+ .......+.+++.+||+.+|++|||+.||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 0000000 01124578999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=289.98 Aligned_cols=256 Identities=25% Similarity=0.316 Sum_probs=199.1
Q ss_pred CCcccceEeeeCceEEEEEEE----CCCCEEEEEEeecccc--cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-E
Q 008650 247 NFHSENMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNK--DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-L 318 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~ 318 (558)
+|++.+.||+|+||.||++.. .+++.||||.+.+... .......+.+|+.++.++ +||||+++++.+..+. .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999853 3578899999865422 123345678899999999 5999999999887665 8
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++||||+.+|+|..++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 8999999999999998643 458899999999999999999998 89999999999999999999999999998765
Q ss_pred CCCCCcccccccccccCcccchhhccCC--CCccccchhHHHHHHHHHcCCCCCCCCchh--HHHHhhhhhhcCCccccc
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGI--IDEKTDVFAFGVLLLEIITGRKPVDSSRQN--LVLWAKPLMESGNLTELV 474 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvvl~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~ 474 (558)
...... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...... ...........
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 227 (288)
T cd05583 156 LAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS------- 227 (288)
T ss_pred cccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-------
Confidence 433221 122345899999999987765 788999999999999999999999643211 11111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.+.. +......+.+++.+||+.+|++|||+.++.+.|+-..
T Consensus 228 ~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 228 KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 0111 1122346788999999999999999998888877643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.53 Aligned_cols=251 Identities=26% Similarity=0.343 Sum_probs=194.7
Q ss_pred CCcccceEeeeCceEEEEEEE----CCCCEEEEEEeecccc--cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-E
Q 008650 247 NFHSENMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNK--DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-L 318 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~ 318 (558)
+|++.+.||+|+||.||++.. .+|+.||+|++..... .......+.+|+.++..+ +|+||+.+++++..+. .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999964 3688999999865422 122345677899999999 5999999999987765 8
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+|||++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 8999999999999998653 468889999999999999999998 89999999999999999999999999999865
Q ss_pred CCCCCcccccccccccCcccchhhccC--CCCccccchhHHHHHHHHHcCCCCCCCCch--hHHHHhhhhhhcCCccccc
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHG--IIDEKTDVFAFGVLLLEIITGRKPVDSSRQ--NLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~ 474 (558)
...... ......|+..|+|||++.++ .++.++||||||+++|+|++|..||..... .............
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------ 228 (290)
T cd05613 156 HEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------ 228 (290)
T ss_pred cccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC------
Confidence 433211 12234589999999998753 478899999999999999999999964321 1111111111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
+ .++......+.+++.+||+.+|.+|| +..+++..
T Consensus 229 -~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 -P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 11222345688999999999999997 66777663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=289.50 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=197.7
Q ss_pred CcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEec
Q 008650 248 FHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 325 (558)
|+..+.||+|+||.||+|... +++.+|+|++............+..|+.+++.++|+|++++++++.+.. .++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999554 5899999999765433444567788999999999999999999987755 99999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
. ++|.+++.... ..+++..++.++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 8 58999996543 468999999999999999999999 8999999999999999999999999999987644322
Q ss_pred cccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-Hhhhhhh----------------c
Q 008650 406 AAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLME----------------S 467 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~----------------~ 467 (558)
......++..|+|||++.+. .++.++|||||||++|||++|+.||......... ....... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 12223467889999999776 7899999999999999999999999765422110 0000000 0
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 468 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
............. ..+.....+.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000 01112457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.41 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=200.6
Q ss_pred cceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 251 ENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
.++||.|.||+||-| +.++|+.||||++.+-......+..+.+|+.||++++||.||.+.-.|...+ .+.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 479999999999999 5678999999999888777777788999999999999999999988887655 88999988765
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC---CceEEEeccccccCCCCCCcc
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD---FEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~~~ 405 (558)
-|.-+| ....+.+++.....++.||+.||.|||. ++|+|+||||+||||... -++||||||+|+.+.+..-
T Consensus 649 MLEMIL-SsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 649 MLEMIL-SSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred HHHHHH-HhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 555455 5556779999999999999999999998 999999999999999654 3699999999999876543
Q ss_pred cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHH
Q 008650 406 AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 485 (558)
..+++|||.|+|||+++.+.|....|+||.|||+|.-++|..||....+-..+... ..++ .......+
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN--------AaFM---yPp~PW~e 790 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN--------AAFM---YPPNPWSE 790 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhc--------cccc---cCCCchhh
Confidence 34567999999999999999999999999999999999999999865433222211 1111 11222345
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 486 QMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 486 ~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
......++|...|+..-.+|-|...-+.
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 5567888999999999999999876554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=292.72 Aligned_cols=262 Identities=26% Similarity=0.371 Sum_probs=198.5
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcc--cccCCeeeeeeEEEe-----CcE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGH--VCHPNTATLVGCCIE-----NGL 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~-----~~~ 318 (558)
...++.++||+|.||.||+|.+. ++.||||++. ......|.+|-+|.+. +.|+||++++++-.. ...
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 34566789999999999999874 5899999996 4555667777777654 469999999998643 238
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhC------CCCcEEecCCCCCceeecCCCceEEEec
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG------CKRRIIHRDIKASNVLLGPDFEPQITDF 392 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~DF 392 (558)
+||++|.+.|+|.++|..+ .++|....+|+..+++||+|||+. ++.+|+|||||+.||||..|++..|+||
T Consensus 284 wLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 8999999999999999654 599999999999999999999973 4568999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCcccchhhccCC-CC-----ccccchhHHHHHHHHHcCCCCCCC--------------
Q 008650 393 GLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI-ID-----EKTDVFAFGVLLLEIITGRKPVDS-------------- 452 (558)
Q Consensus 393 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDvwSlGvvl~elltg~~Pf~~-------------- 452 (558)
|+|..+............+||.+|||||++.+.. +. .+.||||+|.|||||+++..-++.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999887655555455578999999999997642 11 368999999999999996554421
Q ss_pred -CchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 453 -SRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 453 -~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
.++.+......+........+.+.-. ....+.-+.+.+..||..||+.|.|+.=+.+++.+...
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 11222221111111111111111111 12345668889999999999999999988888776543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=285.40 Aligned_cols=250 Identities=23% Similarity=0.387 Sum_probs=194.2
Q ss_pred CCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecc---cccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKD---NKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
+|.+.+.||+|+||.||++... .+..+++|.+... .........+..|+.+++.++||||+++++++.+.. .++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999553 3455666665432 222334456778999999999999999999987655 8999
Q ss_pred EEeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 322 FNFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||+.+++|..++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988652 33568999999999999999999998 89999999999999975 569999999987764
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ...... .+. .+
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~~~~~-~~~-----~~--- 223 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS--VVLRIV-EGP-----TP--- 223 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHH-cCC-----CC---
Confidence 3322 1223458899999999988889999999999999999999999997543211 111111 111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+......+.+++.+||+.+|++||++.|+++.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 -SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1122344578899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=294.51 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=193.1
Q ss_pred CCCc-ccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHH------------HHHHHHHHHHHhcccccCCeeeeee
Q 008650 246 NNFH-SENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAK------------KEKEFLMELGIIGHVCHPNTATLVG 311 (558)
Q Consensus 246 ~~f~-~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~~ 311 (558)
++|. +.+.||.|+||+||+|.. .+++.||+|++........ ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 457899999999999954 5789999999865432210 1124778999999999999999999
Q ss_pred EEEeCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEE
Q 008650 312 CCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT 390 (558)
Q Consensus 312 ~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 390 (558)
++..+. .+++|||+. |+|.+++.. ...+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence 987765 899999997 589888854 3458899999999999999999998 899999999999999999999999
Q ss_pred eccccccCCCCCC------------cccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhH
Q 008650 391 DFGLAKWLPNKCT------------HHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL 457 (558)
Q Consensus 391 DFG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~ 457 (558)
|||++........ ........+++.|+|||++.+. .++.++|||||||++|+|++|+.||.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999976541110 0111123468899999999764 47899999999999999999999998654321
Q ss_pred HH-HhhhhhhcCC---ccccc--------CCCCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 458 VL-WAKPLMESGN---LTELV--------DPSLEG---EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 458 ~~-~~~~~~~~~~---~~~~~--------d~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.. .......... +.... ...... .........+.+++.+||+.+|++|||+.|++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11 1111110000 00000 000000 001122456889999999999999999999997
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=273.83 Aligned_cols=259 Identities=22% Similarity=0.371 Sum_probs=200.7
Q ss_pred CHHHHHhhhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEE
Q 008650 237 SYEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCI 314 (558)
Q Consensus 237 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 314 (558)
.++++...| .+.||+|+|+.|-.+ ...+|..||||++.+.. ........+|++++.+.+ |+||++|+++|.
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 356665444 357999999999998 77899999999997663 445667889999999986 999999999998
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC---ceEEE
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF---EPQIT 390 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 390 (558)
++. .|||||-|.||+|..+|... ..+++..+.++..+|+.||.|||+ +||.||||||+|||..... -+|||
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence 866 99999999999999999654 568999999999999999999999 9999999999999996554 48999
Q ss_pred eccccccCC--CCCC---cccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHH
Q 008650 391 DFGLAKWLP--NKCT---HHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW 460 (558)
Q Consensus 391 DFG~a~~~~--~~~~---~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~ 460 (558)
||.+..-+. .+.+ .....+.+|+..|||||+.. ...|+.++|.||||||||-|++|..||.+.=...-.|
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 998875432 1111 12234678999999999863 3468999999999999999999999997531111111
Q ss_pred ------------hhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 461 ------------AKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 461 ------------~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
....+.+|.+. +.+......+.+-.+++...+.+++.+|.++.++++
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYe------FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYE------FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCc------CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11112222221 111122345567788999999999999999999888
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=278.49 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=195.4
Q ss_pred CcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeC-cEEEEEEe
Q 008650 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIEN-GLYLIFNF 324 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~ 324 (558)
.+-+..||.|+||+|++- ..+.|+..|||++..... ....+.++.|.....+- +.||||++||.+..+ ..++.||+
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 344678999999999998 566799999999976543 56677888888765554 589999999987654 58999999
Q ss_pred ccCCCHHH---HHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 325 SQNGNLDA---ALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 325 ~~~gsL~~---~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|.- +|+. ++.......+++...-.|......||.||-.. ..||||||||+||||+..|.+||||||++-.+.+.
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 864 5544 44445556799999999999999999999873 67999999999999999999999999999766543
Q ss_pred CCcccccccccccCcccchhhcc--CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMH--GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
... +.-.|-..|||||-+.. ..|+-+|||||||++|||+.||+.|+..-.....+. .....++...+....
T Consensus 222 iAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql--~~Vv~gdpp~l~~~~-- 294 (361)
T KOG1006|consen 222 IAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL--CQVVIGDPPILLFDK-- 294 (361)
T ss_pred HHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH--HHHHcCCCCeecCcc--
Confidence 221 22358889999999853 359999999999999999999999997533322221 122233333332221
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+....|..++..|+..|-..||.+.+++++
T Consensus 295 --~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 --ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 123345679999999999999999999998874
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=295.80 Aligned_cols=261 Identities=20% Similarity=0.287 Sum_probs=192.4
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 316 (558)
..+|.+.+.||.|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 36899999999999999999954 5689999999865543 3446678899999999999999999876542
Q ss_pred --------cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC-CCce
Q 008650 317 --------GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP-DFEP 387 (558)
Q Consensus 317 --------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~ 387 (558)
..++|+||+. ++|..++.. ..+++..++.++.||+.||.|||+ .+|+||||||+||+++. ++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceE
Confidence 3689999997 588887743 358899999999999999999998 89999999999999974 5678
Q ss_pred EEEeccccccCCCCCCccc-ccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHh--h-
Q 008650 388 QITDFGLAKWLPNKCTHHA-AIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA--K- 462 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~--~- 462 (558)
||+|||++..+........ .....|+..|+|||++.. ..++.++|||||||++|+|++|+.||........... .
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999986543222111 122357889999998754 4688999999999999999999999976533211100 0
Q ss_pred -hhhhc---C----CcccccC-CCCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 463 -PLMES---G----NLTELVD-PSLEGEY-----DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 463 -~~~~~---~----~~~~~~d-~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.... . ....... ....... .......+.+++.+||+.+|.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 0 0000000 0000000 01223568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.79 Aligned_cols=259 Identities=26% Similarity=0.446 Sum_probs=213.7
Q ss_pred HHHHHhhhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEe
Q 008650 238 YEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIE 315 (558)
Q Consensus 238 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 315 (558)
++.+...++-|.+.++||.|.+|.||++ ..++++..|+|++..... ...++..|.++|+... |||++.++|++.-
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3444455677999999999999999999 566899999999866543 2334556888888875 9999999999852
Q ss_pred ------CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEE
Q 008650 316 ------NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQI 389 (558)
Q Consensus 316 ------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 389 (558)
+.++||||||.+|+..+++....+..+.|..+..|+..++.||.+||+ +.++|||||-.|||++.++.+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEE
Confidence 349999999999999999988888889999999999999999999998 88999999999999999999999
Q ss_pred EeccccccCCCCCCcccccccccccCcccchhhcc-----CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh
Q 008650 390 TDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-----GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL 464 (558)
Q Consensus 390 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 464 (558)
+|||.+..+.. +.....+..|||.|||||++.. ..|+..+|+||||++..||--|.+|+.+..+....+..
T Consensus 165 vDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-- 240 (953)
T KOG0587|consen 165 VDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-- 240 (953)
T ss_pred eeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC--
Confidence 99999987654 3444556789999999999853 34788999999999999999999999887655433221
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...|......+.....++.++|..||..|-++||++.+++++
T Consensus 241 --------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 --------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 112223333456778899999999999999999999998874
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=276.35 Aligned_cols=204 Identities=25% Similarity=0.460 Sum_probs=169.7
Q ss_pred CCCcccceEeeeCceEEEEEEE-C--C--CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-C-cE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-S--D--GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-N-GL 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~--~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~-~~ 318 (558)
..|.....||+|+||.||+|.. . + ...+|+|+++........-....+|+.+++.++|||++.|..++.. + .+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 4688889999999999999932 2 2 2378999997654434445567899999999999999999998876 3 39
Q ss_pred EEEEEeccCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC----CceEEEe
Q 008650 319 YLIFNFSQNGNLDAALHDER---SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD----FEPQITD 391 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 391 (558)
+++++|.+. +|..+|+-.+ ...++...+..|+-||+.|+.|||+ +-|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 7888876443 3468888999999999999999999 789999999999999877 8999999
Q ss_pred ccccccCCCCCCcc-cccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCC
Q 008650 392 FGLAKWLPNKCTHH-AAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSS 453 (558)
Q Consensus 392 FG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~ 453 (558)
||+++.+.+.-... ....++-|.+|+|||.+.+. .|+...||||.|||+.||+|-.+-|.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999876553332 33456789999999999875 6999999999999999999988888654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=299.80 Aligned_cols=240 Identities=22% Similarity=0.295 Sum_probs=193.1
Q ss_pred hhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~l 320 (558)
.+..|.+...+|.|+|+.|..+ ...+++..++|++.+...+ -.+|+.++... +||||+++.+.+.++. .|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 3567888888999999999998 5567889999999766322 22455555444 5999999999998765 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee-cCCCceEEEeccccccCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL-GPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DFG~a~~~~ 399 (558)
|||.+.++.|.+.+...+ .....+..|+++|+.|+.|||. +|||||||||+|||+ +..++++|+|||.++.+.
T Consensus 394 v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999998888775543 2226677899999999999999 999999999999999 689999999999998776
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.. ..+.+-|..|.|||++....|++++||||||++||+||+|+.||........... .+..
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~--~i~~------------ 528 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT--RIQM------------ 528 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH--hhcC------------
Confidence 54 2344578899999999999999999999999999999999999987644422111 1122
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.+....+....+++.+||+.||.+||+|.++...
T Consensus 529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 22223445678889999999999999999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=280.19 Aligned_cols=260 Identities=19% Similarity=0.284 Sum_probs=198.3
Q ss_pred hhhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhccccc--CC----eeeeeeEEEe
Q 008650 243 SATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH--PN----TATLVGCCIE 315 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~n----iv~l~~~~~~ 315 (558)
..+++|.+...+|+|+||.|-.+ +...+..||||+++.- .......+.|+++|.++.+ |+ ++.+.++|.-
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 34789999999999999999999 4455889999998532 2334456679999999952 32 7777777765
Q ss_pred -CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec------------
Q 008650 316 -NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG------------ 382 (558)
Q Consensus 316 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~------------ 382 (558)
+..++|+|.+ |-|+.++|..+...+++...+..++.|+++++.|||+ .+++|.||||+|||+-
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCC
Confidence 4489999987 5599999988888899999999999999999999999 8999999999999992
Q ss_pred --------CCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCc
Q 008650 383 --------PDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR 454 (558)
Q Consensus 383 --------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~ 454 (558)
++..++|+|||.|+.-... ..+++.|..|.|||++.+-.++.++||||+||||+||.||...|+...
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 1345899999999864332 245678999999999999999999999999999999999999998654
Q ss_pred h--hHHHHhhhh----------------hhcCCcc-----------cccCCCCC----CCCCHHHHHHHHHHHHHhhccC
Q 008650 455 Q--NLVLWAKPL----------------MESGNLT-----------ELVDPSLE----GEYDTDQMHRLVLIADYCVRQT 501 (558)
Q Consensus 455 ~--~~~~~~~~~----------------~~~~~~~-----------~~~d~~l~----~~~~~~~~~~l~~li~~cl~~d 501 (558)
. .+..+...+ ...+.+. ...++... -.....+..+|++|+..||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 2 222221111 0001000 00000000 0112344567999999999999
Q ss_pred CCCCCCHHHHHHH
Q 008650 502 SAWRPSMSEVLEL 514 (558)
Q Consensus 502 p~~RPt~~evl~~ 514 (558)
|.+|+|+.|.+..
T Consensus 394 P~~RiTl~EAL~H 406 (415)
T KOG0671|consen 394 PARRITLREALSH 406 (415)
T ss_pred ccccccHHHHhcC
Confidence 9999999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=312.73 Aligned_cols=147 Identities=26% Similarity=0.408 Sum_probs=129.7
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|... +++.||||++.+.. ........+..|+.++..++|+||+++++++.... .|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999554 78999999997543 23444567888999999999999999999887655 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
|||+.+++|..++... ..+++..++.|+.||+.||.|||. ++|+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999653 458889999999999999999998 899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=251.98 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=200.4
Q ss_pred CCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|...+.||+|.||+||+| ++.+++.||+|.+..+..++......++|+.+++.+.|.|||++++....+. +.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556688999999999999 6667999999999888777777788999999999999999999999977654 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
|.. .|..+.... ++.++...+..++.|+++||.|+|+ +++.|||+||.|.||+.+|++||+|||+++.+.-....
T Consensus 83 cdq-dlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hhH-HHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 965 777777544 4678999999999999999999999 89999999999999999999999999999876543222
Q ss_pred ccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcC--------Cccccc
Q 008650 405 HAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESG--------NLTELV 474 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~--------~~~~~~ 474 (558)
.....-|.+|.+|.++-+. .|+++.|+||.|||+.|+.. |+..|.+.... .+..+.+..-| .+..+-
T Consensus 158 --ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred --eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHHHhCCCccccCCccccCC
Confidence 2223479999999998765 58999999999999999998 66667655432 22222222111 111222
Q ss_pred CCCCCCCCCH-----HH----HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSLEGEYDT-----DQ----MHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~-----~~----~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
|-.....++. +. ...=.+++++.+.-+|.+|.++++.++.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2111122221 11 1234567888889999999999988873
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=275.99 Aligned_cols=237 Identities=25% Similarity=0.342 Sum_probs=191.1
Q ss_pred EeeeCceEEEEEEEC-CCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCH
Q 008650 254 VGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL 330 (558)
Q Consensus 254 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL 330 (558)
||+|+||.||++... +++.+|+|.+.+... .......+..|+.+++.++|+||+++++.+..+. .+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999654 589999999876542 2335667889999999999999999999987655 9999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccccc
Q 008650 331 DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPI 410 (558)
Q Consensus 331 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 410 (558)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTF 153 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCC
Confidence 9999654 358999999999999999999998 8999999999999999999999999999987644321 12234
Q ss_pred ccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHH
Q 008650 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRL 490 (558)
Q Consensus 411 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 490 (558)
.++..|+|||.+.+...+.++|+||||+++|+|++|..||....... ....... .. ...+......+
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~-~~----------~~~~~~~~~~l 220 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--IYEKILK-DP----------LRFPEFLSPEA 220 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhc-CC----------CCCCCCCCHHH
Confidence 58899999999998889999999999999999999999997654311 1111111 00 01111224568
Q ss_pred HHHHHHhhccCCCCCCCHHH
Q 008650 491 VLIADYCVRQTSAWRPSMSE 510 (558)
Q Consensus 491 ~~li~~cl~~dp~~RPt~~e 510 (558)
.+++.+||..+|++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 89999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.20 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=212.0
Q ss_pred CcccceEeeeCceEEEEEEE-CCCC----EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEE
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SDGR----KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIF 322 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~ 322 (558)
....++||+|+||+||+|-+ ..|+ +||+|++.. ........+++.|+-+|.++.|||+++|+++|..+.+.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHH
Confidence 34567999999999999943 4443 689999854 34456678899999999999999999999999988899999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
+|++.|+|.++++..+ ..+.....+.|..|||+||.|||. +++|||||-..|||+..-..+||.|||+++.+..+.
T Consensus 777 q~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999998754 568888889999999999999998 999999999999999999999999999999988776
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.........-.+.|||=|.+....|+.++|||||||++||+|| |..|++...... +..++....+-.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------------I~dlle~geRLs 920 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------------IPDLLEKGERLS 920 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------------hhHHHhccccCC
Confidence 6655555556788999999999999999999999999999999 999998764332 122222222333
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.++.....+..++.+||..|+..||+++++...+.+
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 355566678889999999999999999999987765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=273.66 Aligned_cols=218 Identities=18% Similarity=0.194 Sum_probs=173.1
Q ss_pred eCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCHHHHH
Q 008650 257 GGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAAL 334 (558)
Q Consensus 257 G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL~~~l 334 (558)
|.||.||++ +..+++.||+|++.+... +..|...+....||||+++++++.++. .+++|||+.+|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999 556789999999965431 223444444556999999999987755 89999999999999998
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccccccccc
Q 008650 335 HDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTF 414 (558)
Q Consensus 335 ~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 414 (558)
... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++++|||.+....... ....++.
T Consensus 77 ~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~ 146 (237)
T cd05576 77 SKF--LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVEN 146 (237)
T ss_pred HHh--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCc
Confidence 654 358999999999999999999998 899999999999999999999999999886654321 1234677
Q ss_pred CcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHH
Q 008650 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIA 494 (558)
Q Consensus 415 ~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 494 (558)
.|+|||.+.+..++.++||||+|+++|||++|+.||........ ... ....+......+.+++
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------~~~----~~~~~~~~~~~~~~li 209 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------THT----TLNIPEWVSEEARSLL 209 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------ccc----ccCCcccCCHHHHHHH
Confidence 89999999888899999999999999999999988764321100 000 0011222345688899
Q ss_pred HHhhccCCCCCCCH
Q 008650 495 DYCVRQTSAWRPSM 508 (558)
Q Consensus 495 ~~cl~~dp~~RPt~ 508 (558)
.+||+.||++||++
T Consensus 210 ~~~l~~dp~~R~~~ 223 (237)
T cd05576 210 QQLLQFNPTERLGA 223 (237)
T ss_pred HHHccCCHHHhcCC
Confidence 99999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=269.88 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=189.4
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH-HHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~ 319 (558)
..++|.++.+||+|+|+.|..+.+ ++.+.||+|++++.-.+. +...-...|-.+..+. +||.+|.+..+|..+. ++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 447899999999999999999954 568899999997754322 2222333455555544 5999999999997655 99
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+|.||..||+|--++. +...++++.+..+..+|+.||.|||+ +|||+||||.+|+|||.+|++||+|+|+++.--
T Consensus 328 fvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999977664 44679999999999999999999999 999999999999999999999999999998532
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCC-----chhHHHHhhhhhhcCCccccc
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSS-----RQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~-----~~~~~~~~~~~~~~~~~~~~~ 474 (558)
. ....+.+++|||.|+|||.+++..|+.++|+|+|||+++||+.|+.||+-. ......+...+ ++
T Consensus 403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------il 472 (593)
T KOG0695|consen 403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------IL 472 (593)
T ss_pred C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hh
Confidence 2 223455789999999999999999999999999999999999999999731 11111121111 12
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRP 506 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 506 (558)
.+.++. +...+-+...++...|+.||.+|.
T Consensus 473 ekqiri--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 473 EKQIRI--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhcccc--cceeehhhHHHHHHhhcCCcHHhc
Confidence 222222 222223455677889999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=280.53 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=199.7
Q ss_pred hCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecc-----cccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-C-
Q 008650 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKD-----NKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-N- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~- 316 (558)
.++|-++++||+|||++||+| ++...+.||||+-... .......+...+|..|-+.|.||.||++|+++.- .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 356888999999999999999 6677889999986432 1223345677899999999999999999999863 3
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---CCceEEEecc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---DFEPQITDFG 393 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG 393 (558)
..+-|+|||+|.+|+.+|... ..+++..+..|+.||+.||.||..- +.+|||-||||.||||-. -|.+||+|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 388999999999999999654 5689999999999999999999874 368999999999999944 4789999999
Q ss_pred ccccCCCCCCcc-----cccccccccCcccchhhccC----CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHH-hhh
Q 008650 394 LAKWLPNKCTHH-----AAIPIEGTFGYLAPEYFMHG----IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW-AKP 463 (558)
Q Consensus 394 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~-~~~ 463 (558)
+++.+.++.... .+....||.+|++||.+.-+ ..+.|+||||.|||+|+.+.|+.||......-... ...
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 999987665432 23346799999999998644 46789999999999999999999998653221111 111
Q ss_pred hhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
++.. .+.-.| ..+....+...+|.+||+..-++|....++..
T Consensus 699 IlkA---tEVqFP-----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 699 ILKA---TEVQFP-----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhcc---eeccCC-----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111 111111 11233456778899999999999998887765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=273.66 Aligned_cols=266 Identities=20% Similarity=0.292 Sum_probs=219.2
Q ss_pred CHHHHHhhhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeee
Q 008650 237 SYEEISSATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310 (558)
Q Consensus 237 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 310 (558)
...++.....+++...++-+|.||.||+|.+. +.+.|-+|.++ ....+-....++.|-..+..+.|||+..+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 45567777788999999999999999999443 23456778773 444566677888999999999999999999
Q ss_pred eEEEeCc--EEEEEEeccCCCHHHHHhhccC------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec
Q 008650 311 GCCIENG--LYLIFNFSQNGNLDAALHDERS------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG 382 (558)
Q Consensus 311 ~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 382 (558)
+++.++. .+.+|.++.-|+|..+|...+. +.++..+...++.|++.|++|||+ ++|||.||...|.+||
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceeh
Confidence 9998754 8899999999999999974332 346667778899999999999998 9999999999999999
Q ss_pred CCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHh
Q 008650 383 PDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWA 461 (558)
Q Consensus 383 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~ 461 (558)
+..++||+|=.+++.+...+.+...........||+||.+.+..|+..+|||||||+||||+| |+.|+..-++..+.
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-- 508 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-- 508 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH--
Confidence 999999999999998877777766666667789999999999999999999999999999999 99999765443221
Q ss_pred hhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 462 KPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 462 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
..+....+...+.+++.+|+.++.-||...|++||+++|++.-|++.
T Consensus 509 ----------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 509 ----------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ----------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 11222333334556677899999999999999999999999998764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=304.00 Aligned_cols=262 Identities=27% Similarity=0.453 Sum_probs=208.8
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEEEC----C----CCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeee
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGNLS----D----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVG 311 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~ 311 (558)
+....++..+.+.||+|.||.|++|... . ...||||.++..... ...+.+..|+++|+.+. |+||+.++|
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 3344555667779999999999999432 1 346899999655444 77788999999999996 999999999
Q ss_pred EEEeCc-EEEEEEeccCCCHHHHHhhcc------------C--CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCC
Q 008650 312 CCIENG-LYLIFNFSQNGNLDAALHDER------------S--KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKA 376 (558)
Q Consensus 312 ~~~~~~-~~lv~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp 376 (558)
+|.+++ +++|+||+..|+|..+|+..+ . ..+.....+.++.|||.|++||++ .++|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhh
Confidence 998855 999999999999999998766 0 137888999999999999999999 8999999999
Q ss_pred CceeecCCCceEEEeccccccCCCCCCccccccccc--ccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCC
Q 008650 377 SNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEG--TFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSS 453 (558)
Q Consensus 377 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~ 453 (558)
.|||+..+..+||+|||+|+.......... ....| ...|||||.+....|+.|+|||||||+|||++| |..||.+-
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999996544332221 11122 345999999999999999999999999999999 99999863
Q ss_pred chhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 454 RQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
......+. .+. +..+...+.....++.+++..||+.+|++||++.++.+.|...
T Consensus 526 ~~~~~l~~--~l~---------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 PPTEELLE--FLK---------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CcHHHHHH--HHh---------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 21111111 222 2223333445567888999999999999999999999999873
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=276.77 Aligned_cols=262 Identities=23% Similarity=0.365 Sum_probs=197.4
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhc--ccccCCeeeeeeEEEeC-----
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIG--HVCHPNTATLVGCCIEN----- 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~----- 316 (558)
...+..+.+.||+|.||+||+|.+. |+.||||++... .+..+.+|.+|.+ .|+|+||+.+++.-..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 3457788899999999999999885 889999999643 3344666666665 45899999999886432
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhh-----CCCCcEEecCCCCCceeecCCCceEEEe
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK-----GCKRRIIHRDIKASNVLLGPDFEPQITD 391 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~D 391 (558)
.++||++|.+.|||+++|.. ..++.+..++++..+|.||+|||. ..+..|.|||||+.|||+..+|.+.|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 28999999999999999965 468999999999999999999997 2346799999999999999999999999
Q ss_pred ccccccCCCCCCc--ccccccccccCcccchhhccCC----C-C-ccccchhHHHHHHHHHcC----------CCCCCCC
Q 008650 392 FGLAKWLPNKCTH--HAAIPIEGTFGYLAPEYFMHGI----I-D-EKTDVFAFGVLLLEIITG----------RKPVDSS 453 (558)
Q Consensus 392 FG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~-~-~ksDvwSlGvvl~elltg----------~~Pf~~~ 453 (558)
+|+|-........ ......+||.+|||||++...- + + ..+||||||.|+||+... +.||.+-
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999776544221 2233457999999999995432 1 1 358999999999999752 3566542
Q ss_pred ---chhHHHHhhhhhhcCCcccccCCCCC-CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 454 ---RQNLVLWAKPLMESGNLTELVDPSLE-GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 454 ---~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.++.......+. .+-+.|.+. ...+.+.+..+.+++..||..+|..|.|+--+-+.|.+..
T Consensus 440 Vp~DPs~eeMrkVVC-----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVC-----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCCCHHHHhccee-----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 222222111111 111112222 2234577889999999999999999999999888887654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=290.00 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=205.3
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCC-EEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGR-KIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
..++.....||-||||.|=++.....+ .+|+|++++.. .+......+..|-+||...+.|.||++|-.|.++. +|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 355667788999999999998664433 48999997764 34556677889999999999999999999998876 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
||-|-||.|..+|+.. +.++...+..++..+++|++|||. ++||+|||||+|.+|+.+|.+||.|||+|+.+..+
T Consensus 499 mEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 499 MEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999764 568888999999999999999998 99999999999999999999999999999987654
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
. .+-++||||.|.|||++.++..+.++|.||||+++|||++|.+||.+..+....- .++.+-+.. .
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn--~ILkGid~i---------~ 639 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN--LILKGIDKI---------E 639 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH--HHHhhhhhh---------h
Confidence 3 3346889999999999999999999999999999999999999999875543211 112211111 2
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 514 (558)
++......-.+++.+..+.+|.+|.. +.+|-++
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 23344456778899999999999976 5566554
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=284.20 Aligned_cols=204 Identities=24% Similarity=0.337 Sum_probs=171.5
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.-|..++.||-|+||+|.++. ..+...||.|.+.+.+ ...........|-.||..-..+-||+||..|.+++ +|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 347778899999999999994 4457789999998764 23344556667899999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC----
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL---- 398 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~---- 398 (558)
+|++||++-.+|.. .+-|++..++.++.++..|+++.|+ .|+|||||||+|||||.+|++||+|||++.-+
T Consensus 709 dYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999888854 4679999999999999999999998 89999999999999999999999999998532
Q ss_pred -----CCCCCc-------------------------------ccccccccccCcccchhhccCCCCccccchhHHHHHHH
Q 008650 399 -----PNKCTH-------------------------------HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLE 442 (558)
Q Consensus 399 -----~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~e 442 (558)
.++... ......+||+.|+|||++....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 111000 01123569999999999999999999999999999999
Q ss_pred HHcCCCCCCCCc
Q 008650 443 IITGRKPVDSSR 454 (558)
Q Consensus 443 lltg~~Pf~~~~ 454 (558)
|+.|+.||-...
T Consensus 864 m~~g~~pf~~~t 875 (1034)
T KOG0608|consen 864 MLVGQPPFLADT 875 (1034)
T ss_pred HhhCCCCccCCC
Confidence 999999997543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.96 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=168.2
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC-C----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeE------
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS-D----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC------ 312 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------ 312 (558)
..++|.+.+.||+|+||.||+|... + +..||+|++........ +..+ .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----WMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----HHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4578999999999999999999654 4 68999999854322111 1111 1122222222222211
Q ss_pred -EEeCcEEEEEEeccCCCHHHHHhhccCC------------------CCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecC
Q 008650 313 -CIENGLYLIFNFSQNGNLDAALHDERSK------------------SLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373 (558)
Q Consensus 313 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~D 373 (558)
..++..++|+||+.+++|.+++...... ......+..++.||+.||.|||+ ++|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCc
Confidence 1123489999999999999998653211 11233456799999999999998 8999999
Q ss_pred CCCCceeecC-CCceEEEeccccccCCCCCCcccccccccccCcccchhhccC----------------------CCCcc
Q 008650 374 IKASNVLLGP-DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG----------------------IIDEK 430 (558)
Q Consensus 374 lkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k 430 (558)
|||+|||++. ++.+||+|||+++.+..... .......||+.|+|||.+... .++.+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999999986 58999999999986543322 222345689999999976322 23456
Q ss_pred ccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcC-Ccc---cccCCCCCCC----CC--HHHHHHHHHHHHHhhcc
Q 008650 431 TDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG-NLT---ELVDPSLEGE----YD--TDQMHRLVLIADYCVRQ 500 (558)
Q Consensus 431 sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~---~~~d~~l~~~----~~--~~~~~~l~~li~~cl~~ 500 (558)
+|||||||+||||+++..|++.... .+...+...+ ... ..+.+..... +. ........+++.+||+.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLI---QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHH---HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 7999999999999998877654311 1111111100 000 0111110000 00 00112345799999999
Q ss_pred CCCCCCCHHHHHHH
Q 008650 501 TSAWRPSMSEVLEL 514 (558)
Q Consensus 501 dp~~RPt~~evl~~ 514 (558)
||++|||+.|++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=246.98 Aligned_cols=204 Identities=27% Similarity=0.450 Sum_probs=167.3
Q ss_pred hhhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEe-CcEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIE-NGLY 319 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~~ 319 (558)
...+.......||+|++|.|-+- ...+|...|+|.+... ......+..++|+.+..+. ..|.+|.+||...+ .+.+
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 34455566788999999999887 4568999999999543 4456677888999887665 58999999998765 4599
Q ss_pred EEEEeccCCCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 320 LIFNFSQNGNLDAALHD--ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
+.||.|.. +|+.+... .+++.+++...-+|+..+..||.|||+ +..++|||+||+||||+.+|++|+||||++-.
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999865 77666543 345679999999999999999999999 47899999999999999999999999999987
Q ss_pred CCCCCCcccccccccccCcccchhhcc----CCCCccccchhHHHHHHHHHcCCCCCCCC
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMH----GIIDEKTDVFAFGVLLLEIITGRKPVDSS 453 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDvwSlGvvl~elltg~~Pf~~~ 453 (558)
+.+..... -..|-..|||||.+.. ..|+-|+||||||+++.||.+++.||+.-
T Consensus 199 L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 199 LVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 75532211 1348889999999843 37999999999999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=259.37 Aligned_cols=238 Identities=26% Similarity=0.386 Sum_probs=189.8
Q ss_pred CceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCHHHHHh
Q 008650 258 GYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALH 335 (558)
Q Consensus 258 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL~~~l~ 335 (558)
+||.||+|... +|+.+++|++........ ...+.+|+..+++++|+|++++++++..+. .++++||+.+++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999665 589999999965543221 577889999999999999999999988754 899999999999999986
Q ss_pred hccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccC
Q 008650 336 DERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415 (558)
Q Consensus 336 ~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 415 (558)
... .+++..++.++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 80 ~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 80 KRG--RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred hcc--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 543 38899999999999999999999 899999999999999999999999999998765532 2223458899
Q ss_pred cccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHH
Q 008650 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIAD 495 (558)
Q Consensus 416 y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~ 495 (558)
|++||.+.+..++.++||||||+++|+|++|..||........... ....+.... ..........+.+++.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~--~~~~~~~~~-------~~~~~~~~~~~~~~i~ 222 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK--KIGKPKPPF-------PPPEWKISPEAKDLIR 222 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH--HHhccCCCC-------ccccccCCHHHHHHHH
Confidence 9999999988899999999999999999999999976322111111 111111110 0000003357889999
Q ss_pred HhhccCCCCCCCHHHHHH
Q 008650 496 YCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 496 ~cl~~dp~~RPt~~evl~ 513 (558)
+||..+|++||++.++++
T Consensus 223 ~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHccCCchhccCHHHHhh
Confidence 999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-34 Score=261.77 Aligned_cols=265 Identities=23% Similarity=0.383 Sum_probs=195.8
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-----C---
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-----N--- 316 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~--- 316 (558)
+.|.-...||+|.||+||+|+ ..+|+.||+|++.-++.........++|+.+|..+.|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345667899999999999994 4568889999876555445556678899999999999999999998742 1
Q ss_pred -cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 317 -GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 317 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
..|+||.+|+. +|.-+|.+ ....++...+.+++.++..||.|+|. ..|+|||+|++|+||+.+|.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 28999999976 77777743 33568888899999999999999998 88999999999999999999999999999
Q ss_pred ccCCCCC--CcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhh-hhhc---C
Q 008650 396 KWLPNKC--THHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP-LMES---G 468 (558)
Q Consensus 396 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~-~~~~---~ 468 (558)
+.+.... .....+..+-|.+|++||.+.+. .|+++.|||+.|||+.||.||.+-+++....-...... +... .
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 7654321 22223344569999999998765 69999999999999999999999888754322111111 1100 0
Q ss_pred Ccccc-----cC----CCCC-CCCC--HHH------HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 469 NLTEL-----VD----PSLE-GEYD--TDQ------MHRLVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 469 ~~~~~-----~d----~~l~-~~~~--~~~------~~~l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
.+.+. +. +.+. +.+. .+. ...-.+++.+++..||.+|++.++++..-
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 00000 00 0000 0000 011 12567889999999999999999999853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=283.14 Aligned_cols=255 Identities=21% Similarity=0.298 Sum_probs=178.4
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-----------------CCCCEEEEEEeecccccHHHHHH--------------HH
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-----------------SDGRKIAVKRLAKDNKDAKKEKE--------------FL 292 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~--------------~~ 292 (558)
..++|.+.++||+|+||+||+|.. ..++.||||++..... ....+ +.
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~--~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ--GVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch--hhHHHHHhhhhhhhcccchhH
Confidence 467899999999999999999843 2356899999864321 11222 33
Q ss_pred HHHHHhcccccCCe-----eeeeeEEEe---------CcEEEEEEeccCCCHHHHHhhccC-------------------
Q 008650 293 MELGIIGHVCHPNT-----ATLVGCCIE---------NGLYLIFNFSQNGNLDAALHDERS------------------- 339 (558)
Q Consensus 293 ~E~~~l~~l~h~ni-----v~l~~~~~~---------~~~~lv~e~~~~gsL~~~l~~~~~------------------- 339 (558)
.|+.++.+++|.++ +.++++|.. +..++||||+.+++|.++++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46666666665544 667776642 348999999999999999875321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCc
Q 008650 340 ---KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416 (558)
Q Consensus 340 ---~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 416 (558)
..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..+....... .....+|+.|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y 376 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRY 376 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcce
Confidence 124567888999999999999998 899999999999999999999999999997654332111 1122358999
Q ss_pred ccchhhccCC--------------------C--CccccchhHHHHHHHHHcCCC-CCCCCch----------hHHHHhhh
Q 008650 417 LAPEYFMHGI--------------------I--DEKTDVFAFGVLLLEIITGRK-PVDSSRQ----------NLVLWAKP 463 (558)
Q Consensus 417 ~aPE~~~~~~--------------------~--~~ksDvwSlGvvl~elltg~~-Pf~~~~~----------~~~~~~~~ 463 (558)
+|||.+.... | ..+.||||+||++|+|++|.. ||..... ....|..
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~- 455 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM- 455 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-
Confidence 9999985432 1 235799999999999999875 7753211 1111111
Q ss_pred hhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 008650 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTS---AWRPSMSEVLEL 514 (558)
Q Consensus 464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp---~~RPt~~evl~~ 514 (558)
..... .+- ...........+++.++|..+| .+|+|+.|+|++
T Consensus 456 -~~~~~----~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 -YKGQK----YDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -hcccC----CCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00000 010 0112234567889999999766 689999999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=284.79 Aligned_cols=245 Identities=26% Similarity=0.385 Sum_probs=186.5
Q ss_pred CcccceEeeeCceE-EEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEEEEEe
Q 008650 248 FHSENMVGQGGYSE-VYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 248 f~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
|...+++|.|+.|+ ||+|.. +|+.||||++. .+......+|+..|+.-. |||||++|+.-.+.. .|+..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 45567899999886 699977 58899999985 334445678999988875 999999998877766 8999999
Q ss_pred ccCCCHHHHHhhc-cCC-CCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---C--CceEEEecccccc
Q 008650 325 SQNGNLDAALHDE-RSK-SLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---D--FEPQITDFGLAKW 397 (558)
Q Consensus 325 ~~~gsL~~~l~~~-~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DFG~a~~ 397 (558)
|.- +|.+++... ... ...-...+.+..|++.||++||+ .+||||||||.||||+. + ..++|+|||+++.
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 954 999999763 111 11113457789999999999999 89999999999999976 3 4689999999998
Q ss_pred CCCCCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcC-CCCCCCCchhHHHHhhhhhhcCCcccccC
Q 008650 398 LPNKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITG-RKPVDSSRQNLVLWAKPLMESGNLTELVD 475 (558)
Q Consensus 398 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d 475 (558)
+..+... ....+..||-+|+|||++....-+..+||||||||+|+.++| ..||.+.-... +..+.....+..+
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---~NIl~~~~~L~~L-- 735 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---ANILTGNYTLVHL-- 735 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---hhhhcCccceeee--
Confidence 8765443 334567799999999999998888899999999999999985 99998652221 1111111111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.. ..+. +..++|.+|++++|..||++.+|+.+
T Consensus 736 ---~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 ---EP--LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ---cc--CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11 1111 67789999999999999999999863
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=243.10 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=194.8
Q ss_pred hhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc---E
Q 008650 244 ATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG---L 318 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~---~ 318 (558)
.+++|++.+.+|+|-|++||.| +..++++++||+++ +-..+.+.+|+.||..++ ||||++|++...+.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4578999999999999999999 66788999999996 456677889999999998 999999999987643 7
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-ceEEEecccccc
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-EPQITDFGLAKW 397 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~ 397 (558)
.||+||..+.+...+. ..++...+..++.+++.||.|+|+ .||+|||+||.|++||... .++|+|+|+|..
T Consensus 111 aLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhh
Confidence 8999999987776655 346667778899999999999999 9999999999999998764 699999999988
Q ss_pred CCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchh---HHHHhhhhh--------
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN---LVLWAKPLM-------- 465 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~---~~~~~~~~~-------- 465 (558)
+.....-.. .+.+..|--||.+.. ..|+.+.|+|||||+|..|+..+.||...... ++..++.+-
T Consensus 183 YHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 183 YHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred cCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 755432211 235677889999875 46899999999999999999999999654322 222222110
Q ss_pred ------hcCCcccccCCCCC--------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 466 ------ESGNLTELVDPSLE--------GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 466 ------~~~~~~~~~d~~l~--------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
-+..+..++....+ .+...-...+..+++.+.|+.|.++|||+.|.+..
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 01111111111111 01111123578899999999999999999998763
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=250.24 Aligned_cols=259 Identities=21% Similarity=0.343 Sum_probs=195.7
Q ss_pred hCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-----c---CCeeeeeeEEEe
Q 008650 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-----H---PNTATLVGCCIE 315 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~ 315 (558)
.++|.+.++||-|.|++||++ +.++.+.||+|+.+.. .......+.|+.+|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 368999999999999999999 6677889999998543 334455678999998885 3 259999999864
Q ss_pred C---c--EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec--------
Q 008650 316 N---G--LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG-------- 382 (558)
Q Consensus 316 ~---~--~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-------- 382 (558)
. + +++|+|++ |.+|..+|.....+.++...+.+|+.||+.||.|||.. .+|||.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~~~~~ 230 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEIDPAK 230 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeeccccchhh
Confidence 2 2 88999988 56898999888888999999999999999999999995 5899999999999992
Q ss_pred --------------------------------------------------------------------------------
Q 008650 383 -------------------------------------------------------------------------------- 382 (558)
Q Consensus 383 -------------------------------------------------------------------------------- 382 (558)
T Consensus 231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n 310 (590)
T KOG1290|consen 231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN 310 (590)
T ss_pred hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence
Q ss_pred --------------------------C----------------------------------------------------C
Q 008650 383 --------------------------P----------------------------------------------------D 384 (558)
Q Consensus 383 --------------------------~----------------------------------------------------~ 384 (558)
. +
T Consensus 311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d 390 (590)
T KOG1290|consen 311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD 390 (590)
T ss_pred ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence 0 0
Q ss_pred CceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCc--------hh
Q 008650 385 FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR--------QN 456 (558)
Q Consensus 385 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~--------~~ 456 (558)
.++||+|||-|.|.... .+.-..|..|+|||++.+..|++.+||||++|++|||.||...|+... ..
T Consensus 391 i~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 391 IRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred eeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 02566777766664332 122346889999999999999999999999999999999999997531 11
Q ss_pred HHHH-------hhhhhhcCC-cccccCCC--------CC-----------CCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 008650 457 LVLW-------AKPLMESGN-LTELVDPS--------LE-----------GEYDTDQMHRLVLIADYCVRQTSAWRPSMS 509 (558)
Q Consensus 457 ~~~~-------~~~~~~~~~-~~~~~d~~--------l~-----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 509 (558)
+... .+.+...|+ ..++++.. ++ -.++.+...++.+++.-||+.+|++|||+.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 1110 111111111 11122211 11 134567788999999999999999999999
Q ss_pred HHHHH
Q 008650 510 EVLEL 514 (558)
Q Consensus 510 evl~~ 514 (558)
+.++.
T Consensus 546 ~cl~h 550 (590)
T KOG1290|consen 546 QCLKH 550 (590)
T ss_pred HHhcC
Confidence 99874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=247.15 Aligned_cols=256 Identities=23% Similarity=0.309 Sum_probs=196.4
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-------Cc
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-------NG 317 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------~~ 317 (558)
.+|..+..+|.|.- .|..+ +.-.++.||+|++..........+...+|+.++..+.|+||++++.+++. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45677788888888 55555 55678999999987664444455677899999999999999999999863 24
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.|+|||+|.. +|...+.. .++.....+|+.|++.|+.|||+ .+|+||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcc
Confidence 8999999965 88888863 47778889999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccc-----
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTE----- 472 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~----- 472 (558)
-... -..+....|..|.|||++.+..|.+.+||||+||++.||++|+.-|.+. ..+.+|.+....-|....
T Consensus 168 e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 168 EDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-DHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-hHHHHHHHHHHHhcCCCHHHHHH
Confidence 4322 2334567899999999998888999999999999999999999999853 334444433221111110
Q ss_pred -----------------------ccCCCCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 473 -----------------------LVDPSLEG--EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 473 -----------------------~~d~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+-|..... +.+........+++.+||..+|++|-++.++|++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00001110 0111223457788999999999999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=232.28 Aligned_cols=211 Identities=33% Similarity=0.591 Sum_probs=181.2
Q ss_pred EeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCHH
Q 008650 254 VGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLD 331 (558)
Q Consensus 254 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL~ 331 (558)
||+|++|.||++... +++.+++|++....... ....+.+|+..++.+.|++++++++++.... .++++|++.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999664 48999999997554322 3567889999999999999999999998754 89999999999999
Q ss_pred HHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC-CCceEEEeccccccCCCCCCccccccc
Q 008650 332 AALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP-DFEPQITDFGLAKWLPNKCTHHAAIPI 410 (558)
Q Consensus 332 ~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~ 410 (558)
+++.... ..+++..++.++.+++.+|.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 80 DLLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 9986542 458899999999999999999999 89999999999999999 89999999999987654321 12224
Q ss_pred ccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHH
Q 008650 411 EGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHR 489 (558)
Q Consensus 411 ~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 489 (558)
.+...|++||.+... .++.+.|+|+||+++++| ..
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~ 189 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PE 189 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HH
Confidence 478899999999887 888999999999999999 46
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHH
Q 008650 490 LVLIADYCVRQTSAWRPSMSEVLELL 515 (558)
Q Consensus 490 l~~li~~cl~~dp~~RPt~~evl~~L 515 (558)
+.+++.+|++.+|++||++.++++.+
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 88899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-31 Score=245.63 Aligned_cols=263 Identities=21% Similarity=0.315 Sum_probs=191.7
Q ss_pred CcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc------EEE
Q 008650 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG------LYL 320 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~l 320 (558)
.+..+.||.|+||.||.+ +-++|+.||+|++..-...-..-+.+.+|+.+|..++|.|++..++.....+ +|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 455678999999999999 4568999999998654444445677899999999999999999988765432 567
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
++|+|.. +|..+|-. ...++...+.-++.||++||.|||+ .+|.||||||.|.|++.+..+||||||+++.-..
T Consensus 135 ~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence 7777754 66666633 3467777777889999999999999 8999999999999999999999999999986443
Q ss_pred CCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchh-HHHHhhhhhh-----------c
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQN-LVLWAKPLME-----------S 467 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~-~~~~~~~~~~-----------~ 467 (558)
+...+ .+...-|..|.|||.+++. .|+...||||.|||+.||+..+..|+...+. .......++. +
T Consensus 209 d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 32222 2234468999999999876 6999999999999999999999999754321 0001000100 0
Q ss_pred CCcccccCCCCC---------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 468 GNLTELVDPSLE---------GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 468 ~~~~~~~d~~l~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
|.-..++....+ ...+.....+-+++..+++.+||..|.+..+.+..+-.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 111111111111 01111233456678899999999999999998876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=263.76 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=201.4
Q ss_pred hCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-cEEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-GLYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 322 (558)
.++|.+...+|.|+||.||++ +...++..|+|+++.... ....-...|+-+++..+||||+.++|.+... .++++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 457889999999999999999 556799999999965532 3344566799999999999999999998764 599999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
|||.+|+|.+..+. .+++++.++..+.++.++||+|||+ .+-+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 92 EycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred EecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhh--
Confidence 99999999998854 4789999999999999999999999 8889999999999999999999999999876543
Q ss_pred CcccccccccccCcccchhh---ccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYF---MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
+......+.||+.|||||+. +.+.|..++|||++|++..||---..|..+..+....+. +....+. .+.++
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L---mTkS~~q---pp~lk 238 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL---MTKSGFQ---PPTLK 238 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH---hhccCCC---CCccc
Confidence 33345567899999999987 567899999999999999999888888655443322211 1111111 11222
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+ .....+.|-+++..|+..+|.+|||++.+|+
T Consensus 239 D--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 D--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred C--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2 2334567888999999999999999987665
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=253.69 Aligned_cols=198 Identities=23% Similarity=0.331 Sum_probs=165.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHH------HHHHHHHHHHHhcccc---cCCeeeeeeEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAK------KEKEFLMELGIIGHVC---HPNTATLVGCCI 314 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 314 (558)
..+|+..+.+|+|+||.|+.|.+ ++...|+||.+.|...-.. ..-..-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 35689999999999999999944 4567799999977542111 1122446999999997 999999999999
Q ss_pred eCc-EEEEEEec-cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEec
Q 008650 315 ENG-LYLIFNFS-QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDF 392 (558)
Q Consensus 315 ~~~-~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 392 (558)
+++ .||+||-- ++.+|.++|. ....+++..+..|+.|++.|+++||+ ++|||||||-+|+.++.+|-+||+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeec
Confidence 877 77888864 4557888884 44678999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCcccchhhccCCCC-ccccchhHHHHHHHHHcCCCCCC
Q 008650 393 GLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIID-EKTDVFAFGVLLLEIITGRKPVD 451 (558)
Q Consensus 393 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvvl~elltg~~Pf~ 451 (558)
|.+.....+ ....+.||..|.|||++.+.+|- ..-|||+||++||.++....||.
T Consensus 715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876543 23456799999999999988775 56799999999999999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=250.69 Aligned_cols=261 Identities=21% Similarity=0.262 Sum_probs=196.0
Q ss_pred hhhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc------cCCeeeeeeEEEe
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC------HPNTATLVGCCIE 315 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~ 315 (558)
...++|.+....|+|-|++|.+|. ..-|..||||++... +-..+.=+.|++||++|+ --++++|+..|..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 345789999999999999999994 445789999999654 334455678999999996 3478888887765
Q ss_pred -CcEEEEEEeccCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-CceEEEec
Q 008650 316 -NGLYLIFNFSQNGNLDAALHDER-SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDF 392 (558)
Q Consensus 316 -~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DF 392 (558)
+.++||||.+.. +|.++|.... .-.+....+..++.|+..||..|-+ .+|+|.||||+|||+++. ..+|||||
T Consensus 506 knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccC
Confidence 559999998854 8999997643 3468888899999999999999998 799999999999999876 46899999
Q ss_pred cccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHH-HHhhh--------
Q 008650 393 GLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLV-LWAKP-------- 463 (558)
Q Consensus 393 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~-~~~~~-------- 463 (558)
|.|....+.... ...-+.-|.|||++.+.+|+...|+||.||+||||.||+.-|.+.....+ .+...
T Consensus 582 GSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 582 GSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred cccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 999876544221 11245569999999999999999999999999999999999987543311 11111
Q ss_pred hhhcCCcc-cccCCCCC-------------------------------------CCCCHHHHHHHHHHHHHhhccCCCCC
Q 008650 464 LMESGNLT-ELVDPSLE-------------------------------------GEYDTDQMHRLVLIADYCVRQTSAWR 505 (558)
Q Consensus 464 ~~~~~~~~-~~~d~~l~-------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~R 505 (558)
.+..+.+. +-+|..++ ..........|.+|+.+||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 11111000 00111110 01123445779999999999999999
Q ss_pred CCHHHHHHH
Q 008650 506 PSMSEVLEL 514 (558)
Q Consensus 506 Pt~~evl~~ 514 (558)
.|..+.|++
T Consensus 738 it~nqAL~H 746 (752)
T KOG0670|consen 738 ITVNQALKH 746 (752)
T ss_pred CCHHHHhcC
Confidence 999998874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=227.93 Aligned_cols=199 Identities=31% Similarity=0.530 Sum_probs=169.8
Q ss_pred CcccceEeeeCceEEEEEEECC-CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEec
Q 008650 248 FHSENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 325 (558)
|.+.+.||.|++|.||++...+ ++.+++|.+...... .....+.+|+..+..++|+|++++++++.... .++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 5667899999999999996654 889999999765432 25667889999999999999999999987654 99999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
.+++|.+++..... .+++...+.++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 80 EGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 99999999965432 17899999999999999999998 89999999999999999999999999999876554211
Q ss_pred cccccccccCcccchhh-ccCCCCccccchhHHHHHHHHHcCCCCCCC
Q 008650 406 AAIPIEGTFGYLAPEYF-MHGIIDEKTDVFAFGVLLLEIITGRKPVDS 452 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvvl~elltg~~Pf~~ 452 (558)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12234588899999999 666788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=229.04 Aligned_cols=249 Identities=15% Similarity=0.308 Sum_probs=184.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEe-Cc-EEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIE-NG-LYLI 321 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~-~~lv 321 (558)
+.|.+.+.||+|.||.+-++.+ .+...+++|.+.+. ....++|.+|...--.|. |.||+.-|+...+ .+ ..++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 5699999999999999999954 56778999998654 456788999998877775 8999998876443 33 7789
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec-C-CCceEEEeccccccCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG-P-DFEPQITDFGLAKWLP 399 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~-~~~~kl~DFG~a~~~~ 399 (558)
+||++.|+|...+.. .++.+....+++.|++.||.|+|+ +++||||||.+||||- . ..++||||||..+...
T Consensus 101 qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999998843 458888899999999999999999 9999999999999993 3 3479999999987643
Q ss_pred CCCCcccccccccccCcccchhhccC-----CCCccccchhHHHHHHHHHcCCCCCCCCchh-HHHHhhhhhhcCCcccc
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHG-----IIDEKTDVFAFGVLLLEIITGRKPVDSSRQN-LVLWAKPLMESGNLTEL 473 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~ 473 (558)
.. .....-+..|.+||..... ...+.+|+|.||+++|..|||..||+..... ...|....+..+...
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 22 1223356779999987432 2467899999999999999999999843211 112222222222222
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+...+. ...+++.++..+-|.+++++|=-+.++.+.
T Consensus 248 ---~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 ---ALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ---cCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 1221111 223456777789999999999555555444
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=229.48 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=191.5
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEEEC----CCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEe
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGNLS----DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIE 315 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 315 (558)
+....+.|...++||+|.|++||++... ..+.||+|.+..... ...+.+|+++|..+. +.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3445577899999999999999999432 467899999865433 334778999999996 8999999999976
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-CceEEEecc
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFG 393 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG 393 (558)
++ ..+|+||++.....+++. .++...+..++..++.||.++|. +|||||||||+|+|.+.. +.-.|.|||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEech
Confidence 55 999999999999988884 36677888899999999999999 999999999999999764 668899999
Q ss_pred ccccCCCCC--------------C----------------------------cccccccccccCcccchhhcc-CCCCcc
Q 008650 394 LAKWLPNKC--------------T----------------------------HHAAIPIEGTFGYLAPEYFMH-GIIDEK 430 (558)
Q Consensus 394 ~a~~~~~~~--------------~----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~k 430 (558)
+|.+..... . ........||++|.|||++.. ..-+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997321100 0 000113459999999999865 457899
Q ss_pred ccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh------------hhcCC--cc----------------cc-cCCCCC
Q 008650 431 TDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL------------MESGN--LT----------------EL-VDPSLE 479 (558)
Q Consensus 431 sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~------------~~~~~--~~----------------~~-~d~~l~ 479 (558)
+||||.|||++.+++++.||-....+....+... ...|. +. .+ ......
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 9999999999999999999965432211110000 00011 00 00 000000
Q ss_pred CCC--------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEY--------DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~--------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
... ..-....+.+++.+|+..||.+|.|+++.|+.
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000 01112368899999999999999999999985
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=266.61 Aligned_cols=196 Identities=15% Similarity=0.215 Sum_probs=138.1
Q ss_pred cccc-CCeeeeeeEE-------Ee-CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEE
Q 008650 300 HVCH-PNTATLVGCC-------IE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370 (558)
Q Consensus 300 ~l~h-~niv~l~~~~-------~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv 370 (558)
.++| .||.+++++| .+ ...++++|++ +++|.++|... ...+++..++.++.||++||.|||+ ++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 3445 5777777766 12 2356677776 66999999643 3568999999999999999999998 8999
Q ss_pred ecCCCCCceeecCC-------------------CceEEEeccccccCCCCCC--------------cccccccccccCcc
Q 008650 371 HRDIKASNVLLGPD-------------------FEPQITDFGLAKWLPNKCT--------------HHAAIPIEGTFGYL 417 (558)
Q Consensus 371 H~Dlkp~NIll~~~-------------------~~~kl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~y~ 417 (558)
||||||+||||+.. +.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4455666666653211000 00011235899999
Q ss_pred cchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHh
Q 008650 418 APEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYC 497 (558)
Q Consensus 418 aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~c 497 (558)
|||++.+..|+.++|||||||+||||++|..|+............. .+.+.. .........++.+|
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~---------~~~~~~-----~~~~~~~~~~~~~~ 248 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR---------VLPPQI-----LLNWPKEASFCLWL 248 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh---------hcChhh-----hhcCHHHHHHHHHh
Confidence 9999999999999999999999999999998876432211111110 011100 11123456788899
Q ss_pred hccCCCCCCCHHHHHHH
Q 008650 498 VRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 498 l~~dp~~RPt~~evl~~ 514 (558)
|+++|.+||++.|+++.
T Consensus 249 L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 249 LHPEPSCRPSMSELLQS 265 (793)
T ss_pred CCCChhhCcChHHHhhc
Confidence 99999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=211.49 Aligned_cols=167 Identities=19% Similarity=0.196 Sum_probs=126.1
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAA 407 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 407 (558)
|+|.+++... ...+++..++.++.|++.||.|||+ ++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6899999653 3569999999999999999999998 44 999999999999999 99998654321
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQM 487 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 487 (558)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....... .. ++.- ........
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~--~~-~~~~-~~~~~~~~ 136 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE-ILLNGMP--AD-DPRD-RSNLESVS 136 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH-HHHHHhc--cC-Cccc-cccHHHHH
Confidence 2489999999999999999999999999999999999999975432111111 1111100 00 0000 00111222
Q ss_pred H--HHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 488 H--RLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 488 ~--~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
. .+.+++.+||+.+|.+||++.|+++.+...
T Consensus 137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 137 AARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2 689999999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=218.57 Aligned_cols=168 Identities=20% Similarity=0.220 Sum_probs=130.4
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEEC--CCCEEEEEEeeccc---ccHHHHHHHHHHHHHhcccccCCeee-eeeEEEe
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNLS--DGRKIAVKRLAKDN---KDAKKEKEFLMELGIIGHVCHPNTAT-LVGCCIE 315 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 315 (558)
....++|.+.+.||+|+||+||+|... +++.+|||++.... ........|.+|+.+|++++|+|++. +++ .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 344567999999999999999999553 57778999875331 12334566889999999999999985 443 2
Q ss_pred CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCC-CCCceeecCCCceEEEeccc
Q 008650 316 NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDI-KASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 316 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFG~ 394 (558)
+..|+||||++|++|.. +. . .. ...++.++++||.|||+ +||+|||| ||+|||++.++.+||+|||+
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~-~----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR-P----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC-c----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 45899999999999963 21 1 11 14678899999999999 89999999 99999999999999999999
Q ss_pred cccCCCCCCccc------ccccccccCcccchhhcc
Q 008650 395 AKWLPNKCTHHA------AIPIEGTFGYLAPEYFMH 424 (558)
Q Consensus 395 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 424 (558)
|+.+........ ..+..+++.|+|||++.-
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 987654432211 134568999999999853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-22 Score=203.90 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=198.7
Q ss_pred CcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHH-HHHHHHHHHHHhcccccC-CeeeeeeEEEeCc-EEEEEEe
Q 008650 248 FHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAK-KEKEFLMELGIIGHVCHP-NTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~-~~lv~e~ 324 (558)
|.+...||.|+||.||++... ..+++|.+........ ....+.+|+.++..+.|+ +|+.+++++.... .++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999765 7899999976654443 577899999999999988 7999999996665 6999999
Q ss_pred ccCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-ceEEEeccccccCCCCC
Q 008650 325 SQNGNLDAALHDERS-KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-EPQITDFGLAKWLPNKC 402 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~ 402 (558)
+.++++..++..... ..+.......++.+++.++.|+|. .+++|||+||+||+++..+ .++++|||.+..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976654322 268888999999999999999998 8899999999999999998 79999999998665443
Q ss_pred Ccc----cccccccccCcccchhhcc---CCCCccccchhHHHHHHHHHcCCCCCCCCch---hHHHHhhhhhhcCC-cc
Q 008650 403 THH----AAIPIEGTFGYLAPEYFMH---GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ---NLVLWAKPLMESGN-LT 471 (558)
Q Consensus 403 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~---~~~~~~~~~~~~~~-~~ 471 (558)
... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||..... ....+......... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 221 2345679999999999987 5788999999999999999999999876543 11111111111101 01
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
....... .......+.+++..|+..+|..|.+..+....
T Consensus 237 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSN----PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCccc----cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111100 02223568889999999999999999887764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=209.00 Aligned_cols=258 Identities=17% Similarity=0.243 Sum_probs=187.1
Q ss_pred CCcccceEeeeCceEEEEEEECC--CCEEEEEEeecccccHHHHHHHHHHHHHhccccc----CCeeeeeeEEE-eCc-E
Q 008650 247 NFHSENMVGQGGYSEVYKGNLSD--GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH----PNTATLVGCCI-ENG-L 318 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~-~~~-~ 318 (558)
+|.+.+.||+|+||.||.+.... ...+|+|.......... ..+..|..++..+.. +++..+++... .+. -
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 79999999999999999996544 35788888765322111 135567777777752 57888888873 444 6
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-----CceEEEecc
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-----FEPQITDFG 393 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DFG 393 (558)
++||+.+ |.+|.++......+.++...+..|+.|++.+|.+||+ .|++||||||+|+++... ..+.|.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 7777766 7799998866656789999999999999999999999 899999999999999865 358999999
Q ss_pred ccc--cCCCCCCc---cc---ccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHh-hhh
Q 008650 394 LAK--WLPNKCTH---HA---AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA-KPL 464 (558)
Q Consensus 394 ~a~--~~~~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~-~~~ 464 (558)
+++ .+...... .. .....||..|.++..+.+...+.+.|+||++.++.+|+.|..||........... ...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 43222211 11 1235599999999999999999999999999999999999999976432211110 000
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
... ..... ........+..+...+-..+...+|....+...|+...
T Consensus 253 ~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 253 PRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred hhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 000 00000 11122335566666666689999999999999876643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=201.42 Aligned_cols=246 Identities=19% Similarity=0.332 Sum_probs=196.2
Q ss_pred cccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-cEEEEEEeccC
Q 008650 249 HSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-GLYLIFNFSQN 327 (558)
Q Consensus 249 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 327 (558)
.+..+|.+...|+.|+|+++ |..+++|++.........-.+|..|.-.|+-+.||||+.+++.|... ++.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34557888899999999886 55678898877776677778899999999999999999999999764 59999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEE-ecCCCCCceeecCCCceEEE--eccccccCCCCCCc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII-HRDIKASNVLLGPDFEPQIT--DFGLAKWLPNKCTH 404 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv-H~Dlkp~NIll~~~~~~kl~--DFG~a~~~~~~~~~ 404 (558)
|+|+..|+...+...+..++.+++.++++|+.|||+- .+++ ---|.+..++||++.+.+|+ |--++..-
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsfqe------ 343 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE------ 343 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeeeec------
Confidence 9999999988777788889999999999999999984 3444 44688999999999887764 42222210
Q ss_pred ccccccccccCcccchhhccCCCC---ccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIID---EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~---~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
....-.|.||+||.++..+-+ ..+|+|||+++||||.|...||.+-.+...... +--+.++..
T Consensus 344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----------ialeglrv~ 409 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----------IALEGLRVH 409 (448)
T ss_pred ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----------hhhcccccc
Confidence 111246889999999877654 478999999999999999999987544322111 122345555
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.++.....+.+++.-|+..||.+||.+..|+-.|++
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 666777889999999999999999999999988875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=232.44 Aligned_cols=255 Identities=20% Similarity=0.241 Sum_probs=187.8
Q ss_pred cccceEeeeCceEEEEE-EECCCCEEEEEEee----cccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 249 HSENMVGQGGYSEVYKG-NLSDGRKIAVKRLA----KDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 249 ~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
....++|.|++|.|+.. .....+.++.|... ...........+..|+.+-..+.|+|++..+..+.+.. .+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988877 33445555655543 22222223333777888999999999988777665533 44459
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++ +|..++-.. ..+....+..++.|++.|+.|||. .||.|||||++|++++.+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999888443 457777888899999999999999 899999999999999999999999999997665443
Q ss_pred Cc--ccccccccccCcccchhhccCCCCc-cccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 403 TH--HAAIPIEGTFGYLAPEYFMHGIIDE-KTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 403 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~-ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.. .....++|+..|+|||++....|++ ..||||.|++++.|++|+.||.........+ .........-...-.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----KTNNYSDQRNIFEGP 550 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----hhhccccccccccCh
Confidence 33 4556788999999999999999886 4799999999999999999997654332221 000000000000000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.........+...++.++|+.+|.+|.|+.+|++
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1112344567888999999999999999999988
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=182.48 Aligned_cols=257 Identities=18% Similarity=0.280 Sum_probs=190.3
Q ss_pred hhCCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhccccc-CCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH-PNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~-~~l 320 (558)
-.+.|.+.+.||.|+||.+|.| ...+|+.||||+-......+ .+..|..+.+.+++ ..|..+..+..+.. -.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3467999999999999999999 66789999999976554433 35677888888875 56777777766655 678
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC---ceEEEecccccc
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF---EPQITDFGLAKW 397 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~ 397 (558)
||+++ |.+|.+++.-. ...++...++-++-|++.-++|+|. +++|||||||+|+|+.-+- .+.|+|||+|+.
T Consensus 89 VMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhh
Confidence 99987 77998888543 3568999999999999999999999 8999999999999997653 588999999988
Q ss_pred CCCCCCcc-----cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccc
Q 008650 398 LPNKCTHH-----AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTE 472 (558)
Q Consensus 398 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 472 (558)
+.+..+.. ......||..|.+--.+.+...+.+-|+-|+|.+|.++.-|..||++............+.+.+...
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 75543221 2234569999999888888888999999999999999999999999865443322222222222222
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+. .+-..++ .++.-.+..|-..--++-|...-+-+.
T Consensus 244 ~ie-~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrql 280 (341)
T KOG1163|consen 244 PIE-VLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQL 280 (341)
T ss_pred CHH-HHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence 111 1122222 356666777877777778877555444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=189.26 Aligned_cols=257 Identities=16% Similarity=0.223 Sum_probs=186.1
Q ss_pred CCCcccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~lv~ 322 (558)
-+|.+++.||+|+||+.+.| +.-+++.||||.-......+. +..|....+.|. .++|...|.|-.++- -.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQ----LrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQ----LRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcch----HHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 46999999999999999999 778899999998765544333 334555555554 678888877765554 56888
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-----ceEEEecccccc
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-----EPQITDFGLAKW 397 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DFG~a~~ 397 (558)
+++ |.+|.+++.-. +..|+...+.-+|.|++.-++|+|+ +.+|.|||||+|+||..-+ .+.|+|||+|+.
T Consensus 104 dLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 877 77998888543 4679999999999999999999999 8999999999999996543 488999999998
Q ss_pred CCCCCCcc-----cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccc
Q 008650 398 LPNKCTHH-----AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTE 472 (558)
Q Consensus 398 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 472 (558)
+.+..+.. ..+...||.+||+--...+...+.+-|+-|||=++++.|-|..||++.......-....+.+.+...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 86554321 2345679999999999999999999999999999999999999999765432221111121111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
-+. .+.. ..++++..-+...-+.+-.+-|..+-+-.++.
T Consensus 259 ~i~-~Lc~----g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 259 PIE-VLCE----GFPEEFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred CHH-HHHh----cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 000 0111 12345555555555666677788765554443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=183.77 Aligned_cols=141 Identities=16% Similarity=0.148 Sum_probs=109.1
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccHHH------------------------HHHHHHHHHHhcccccCCe
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKK------------------------EKEFLMELGIIGHVCHPNT 306 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni 306 (558)
...||+|+||.||+|...+|+.||||++......... ......|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999997778999999999764321111 1122359999999988776
Q ss_pred eeeeeEEEeCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHh-hhCCCCcEEecCCCCCceeecCCC
Q 008650 307 ATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL-HKGCKRRIIHRDIKASNVLLGPDF 385 (558)
Q Consensus 307 v~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~~ivH~Dlkp~NIll~~~~ 385 (558)
.....+. ....++||||+.++++...... ...+++..+..++.|++.+|.|| |+ .+|+||||||+|||++ ++
T Consensus 82 ~~p~~~~-~~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPIL-LKSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEE-ecCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CC
Confidence 4433322 2334899999999877654322 24688899999999999999999 67 7999999999999998 47
Q ss_pred ceEEEeccccccC
Q 008650 386 EPQITDFGLAKWL 398 (558)
Q Consensus 386 ~~kl~DFG~a~~~ 398 (558)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=185.98 Aligned_cols=172 Identities=13% Similarity=0.114 Sum_probs=134.6
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHH-HHHH------HHHHHHHhcccccCCeeeeeeEEEe-
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAK-KEKE------FLMELGIIGHVCHPNTATLVGCCIE- 315 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~h~niv~l~~~~~~- 315 (558)
..++|...++||.|+||.||.++. ++..+|+|.+........ .... +.+|++.+.++.|++|..+..++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999866 577899999965543222 2222 5689999999999999999887552
Q ss_pred --------CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCce
Q 008650 316 --------NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEP 387 (558)
Q Consensus 316 --------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 387 (558)
+..+++|||++|.+|.++.. +++ ....+++.+|..||. .|++|||+||+||+++.+| +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence 23789999999999987741 222 245689999999998 8999999999999999998 9
Q ss_pred EEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHH
Q 008650 388 QITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEII 444 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ell 444 (558)
+|+|||........... ..+.....|+.++|+|+||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988654322111 11445556778999999999987764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-22 Score=209.21 Aligned_cols=269 Identities=26% Similarity=0.307 Sum_probs=196.1
Q ss_pred eEeeeCceEEEEEE----ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEEEEEecc
Q 008650 253 MVGQGGYSEVYKGN----LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIFNFSQ 326 (558)
Q Consensus 253 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e~~~ 326 (558)
++|+|.||.|+.+. ...|..||.|++.+.............|..++...+ ||.++++...+..+. ++++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999862 334778999998765432222224445777788887 999999998887654 999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccc
Q 008650 327 NGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA 406 (558)
Q Consensus 327 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 406 (558)
+|.|...+... ..+.+.....+...++-+++++|+ .+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 99998887443 456777777788899999999999 8999999999999999999999999999986543221
Q ss_pred ccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHH
Q 008650 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQ 486 (558)
Q Consensus 407 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 486 (558)
.|||..|||||++. .....+|+||||++++||+||..||...... . + .......+.+.
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~--~-------------I--l~~~~~~p~~l 210 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMK--R-------------I--LKAELEMPREL 210 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHH--H-------------H--hhhccCCchhh
Confidence 27999999999998 5677899999999999999999999872111 0 0 01112334555
Q ss_pred HHHHHHHHHHhhccCCCCCCCH--HHHHHHHhcCCCcccccccCC-------C-----CCCccccccccccccccCCCCc
Q 008650 487 MHRLVLIADYCVRQTSAWRPSM--SEVLELLTSGHDSEFAKSWRM-------P-----EFTSDELDDCSMFFGYEVPTDI 552 (558)
Q Consensus 487 ~~~l~~li~~cl~~dp~~RPt~--~evl~~L~~~~~~~~~~~~~~-------~-----~~~~~~~~~~~~~~~~~~~~~~ 552 (558)
.....+++..++..+|..|.-. .-+.+..+..... ...|+. + ..+.++..-.+.+|-.++|.|.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~--~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~ds 288 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQ--SIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADS 288 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhe--eeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccC
Confidence 6677888899999999999765 4455544443322 333441 1 1122333335666777777775
Q ss_pred c
Q 008650 553 D 553 (558)
Q Consensus 553 ~ 553 (558)
.
T Consensus 289 p 289 (612)
T KOG0603|consen 289 P 289 (612)
T ss_pred C
Confidence 4
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.9e-22 Score=212.60 Aligned_cols=254 Identities=20% Similarity=0.221 Sum_probs=180.8
Q ss_pred CCcccceEeeeCceEEEEEEECCCCEEEEEEeecccc--cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNK--DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
+|...+.||.+.|=+|.+|....|. |+||++.+... .-....+-+.|++ ...++|||.+++.-+-..+. .|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778889999999999999887787 99999876542 2233344455555 56668999999877754444 677777
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc--CCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNK 401 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~--~~~~ 401 (558)
|... +|++.|... ..+.......|+.|++.||.-+|+ .||+|||||.+||||+.-..+.|+||..-+. ++++
T Consensus 102 yvkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 7755 888888432 345555666799999999999999 8999999999999999999999999987643 3333
Q ss_pred CCcc---cccccccccCcccchhhccC----------C-CCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhh
Q 008650 402 CTHH---AAIPIEGTFGYLAPEYFMHG----------I-IDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLME 466 (558)
Q Consensus 402 ~~~~---~~~~~~gt~~y~aPE~~~~~----------~-~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 466 (558)
.... ...+...-.+|+|||-+... . .+++.||||+||++.||++ |++||.-. +.. .+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~-aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLL-AYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHH-hHhc
Confidence 2211 11223345689999988541 2 5678999999999999999 78888632 100 1111
Q ss_pred c-CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCc
Q 008650 467 S-GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDS 521 (558)
Q Consensus 467 ~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 521 (558)
+ ....+.+-..+. ...+++++..|++.||.+|.++++.|+.-++..-+
T Consensus 250 ~~~~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP 298 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFP 298 (1431)
T ss_pred cCccCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHhhhccccH
Confidence 1 111111111111 12578899999999999999999999987776544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=172.55 Aligned_cols=188 Identities=16% Similarity=0.056 Sum_probs=141.2
Q ss_pred cccceEeeeCceEEEEEEECCCCEEEEEEeecccccHH--HHHHHHHHHHHhcccc-cCCeeeeeeEEEeCcEEEEEEec
Q 008650 249 HSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAK--KEKEFLMELGIIGHVC-HPNTATLVGCCIENGLYLIFNFS 325 (558)
Q Consensus 249 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~lv~e~~ 325 (558)
.....|++|+||+||.+.. .+.+++.+.+.....-.. ....+.+|+++|+++. |+++++++++ +..+++|+|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeee
Confidence 4567899999999998866 678888887754432111 1225778999999996 5789999886 4579999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCC-CCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDI-KASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
.|.+|...+.. . ...++.+++.+|.++|. +||+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~---~------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR---G------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh---h------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99998754421 1 13477899999999999 89999999 799999999999999999999865433210
Q ss_pred ----cc-------ccccccccCcccchhhccC-CCC-ccccchhHHHHHHHHHcCCCCCCC
Q 008650 405 ----HA-------AIPIEGTFGYLAPEYFMHG-IID-EKTDVFAFGVLLLEIITGRKPVDS 452 (558)
Q Consensus 405 ----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~ksDvwSlGvvl~elltg~~Pf~~ 452 (558)
.. ......++.|++|+...-- ..+ ...++++-|.-+|.++|+..|+.+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 0112267888888865432 223 467899999999999999998754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=173.95 Aligned_cols=144 Identities=18% Similarity=0.179 Sum_probs=111.0
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccH----------------------H--HHHHHHHHHHHhcccccCCe
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDA----------------------K--KEKEFLMELGIIGHVCHPNT 306 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------~--~~~~~~~E~~~l~~l~h~ni 306 (558)
...||+|+||.||+|...+|+.||||++....... . ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999977689999999997653110 0 01223578899999999987
Q ss_pred eeeeeEEEeCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc
Q 008650 307 ATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386 (558)
Q Consensus 307 v~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 386 (558)
.....+... ..++||||+.++++...... ...++......++.+++.+|.+||+. .||+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK-KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec-CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCC
Confidence 544433332 35899999998865443212 23577788899999999999999972 6999999999999999 889
Q ss_pred eEEEeccccccCCC
Q 008650 387 PQITDFGLAKWLPN 400 (558)
Q Consensus 387 ~kl~DFG~a~~~~~ 400 (558)
++|+|||++..+..
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=188.09 Aligned_cols=216 Identities=22% Similarity=0.394 Sum_probs=160.3
Q ss_pred hcccccCCeeeeeeEEEeCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCC
Q 008650 298 IGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKA 376 (558)
Q Consensus 298 l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp 376 (558)
|+.+.|.|+.+++|.+.++. .+.|.+||..|+|.+.+.. ....+++.....+..+|+.||.|||+. .-..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence 46788999999999998866 8899999999999999976 346789999999999999999999983 2339999999
Q ss_pred CceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCC-------CCccccchhHHHHHHHHHcCCCC
Q 008650 377 SNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI-------IDEKTDVFAFGVLLLEIITGRKP 449 (558)
Q Consensus 377 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~ksDvwSlGvvl~elltg~~P 449 (558)
.|.++|....+||+|||+.................-..-|.|||.++... .+.+.||||||++++|+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999988764311111111122345699999997642 46679999999999999999999
Q ss_pred CCCCchhHH--HHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 450 VDSSRQNLV--LWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 450 f~~~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
|+....... .....+.. .....+.|.+.... +....+..++..||..+|.+||++.+|-..++....
T Consensus 158 ~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 986322111 11111111 11122222222111 333478899999999999999999999988876543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-19 Score=173.36 Aligned_cols=233 Identities=18% Similarity=0.227 Sum_probs=145.2
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH-HHHHHHHHHHHHhccccc----------CC------eee
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCH----------PN------TAT 308 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h----------~n------iv~ 308 (558)
++.....||.|+++.||.+.. .+|+.+|||+........ ...+.+.+|.-....+.+ -. +++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 345678999999999999955 469999999986554322 345556666544443221 11 122
Q ss_pred eee---EEEeC---------cEEEEEEeccCCCHHHHHhh---ccCC--CCCHHHHHHHHHHHHHHHHHhhhCCCCcEEe
Q 008650 309 LVG---CCIEN---------GLYLIFNFSQNGNLDAALHD---ERSK--SLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371 (558)
Q Consensus 309 l~~---~~~~~---------~~~lv~e~~~~gsL~~~l~~---~~~~--~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH 371 (558)
+-+ ++... +.+++|+-+ .++|..++.. .... .+....+..+..|+++.+++||. .|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 211 11111 235566666 4578776532 2111 23344556677899999999999 99999
Q ss_pred cCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccC--------CCCccccchhHHHHHHHH
Q 008650 372 RDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG--------IIDEKTDVFAFGVLLLEI 443 (558)
Q Consensus 372 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~ksDvwSlGvvl~el 443 (558)
+||+|+|+|++.+|.+.|+||+........... ...+..|.+||..... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999988764432221 2255789999987432 478899999999999999
Q ss_pred HcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCC
Q 008650 444 ITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWR 505 (558)
Q Consensus 444 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R 505 (558)
.+|+.||........ ....+. ... +..+.+..+|..+|+++|.+|
T Consensus 244 WC~~lPf~~~~~~~~-----------~~~~f~-----~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEAD-----------PEWDFS-----RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGST-----------SGGGGT-----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccc-----------ccccch-----hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999985422110 000111 112 455678899999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=199.52 Aligned_cols=251 Identities=19% Similarity=0.209 Sum_probs=180.4
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc---cCCeeeeeeEEE-eCc
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC---HPNTATLVGCCI-ENG 317 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~-~~~ 317 (558)
......|.+.+.||+|+||.||+|...+|+.||+|+-..... -+|..-.+++.+|+ -+.|+.+..++. .+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~-----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP-----WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc-----eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 344567888999999999999999777799999999754431 12333344455554 234555555443 456
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC-------CCceEEE
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP-------DFEPQIT 390 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl~ 390 (558)
.+||++|.+.|+|.++++ ..+.++|..++.++.|++..++.||. .+|||+||||+|+||.. ...++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEE
Confidence 889999999999999996 55779999999999999999999998 89999999999999932 2358999
Q ss_pred eccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCc
Q 008650 391 DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL 470 (558)
Q Consensus 391 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 470 (558)
|||.+-.+.--.........++|-.+-.+|+..+.+++..+|.|.|+.+++.||.|+.- . .. ++..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~------------q-~~-~g~~ 909 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM------------E-VK-NGSS 909 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH------------H-hc-CCcc
Confidence 99998655332222344456789999999999999999999999999999999998632 0 11 1111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 471 TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 471 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
..++..++.....+... ++...+|+++...=|...++...|++.+.
T Consensus 910 -~~~~~~~~Ry~~~~~W~---~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 910 -WMVKTNFPRYWKRDMWN---KFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred -eeccccchhhhhHHHHH---HHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 11122222222223333 34456666666666887887777776543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=163.79 Aligned_cols=136 Identities=20% Similarity=0.299 Sum_probs=104.0
Q ss_pred cccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-----ccCCeeeeeeEEEeCc----EE
Q 008650 249 HSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-----CHPNTATLVGCCIENG----LY 319 (558)
Q Consensus 249 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~----~~ 319 (558)
.-...||+|+||.||. ...++.. +||++..... .....+.+|+.+++.+ .||||++++|++.++. ++
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 3457899999999996 3334444 7998865432 2345688999999999 5799999999998752 34
Q ss_pred -EEEEe--ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHH-HHhhhCCCCcEEecCCCCCceeecC----CCceEEEe
Q 008650 320 -LIFNF--SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGL-HYLHKGCKRRIIHRDIKASNVLLGP----DFEPQITD 391 (558)
Q Consensus 320 -lv~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~D 391 (558)
+|+|| +.+|+|.+++... .+++. ..++.+++.++ .|||+ ++|+||||||+|||++. ++.++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 5579999999542 35555 34577888777 99999 89999999999999974 34799999
Q ss_pred c-cccc
Q 008650 392 F-GLAK 396 (558)
Q Consensus 392 F-G~a~ 396 (558)
| |...
T Consensus 153 g~G~~~ 158 (210)
T PRK10345 153 NIGEST 158 (210)
T ss_pred CCCCcc
Confidence 4 5433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=166.92 Aligned_cols=150 Identities=15% Similarity=0.112 Sum_probs=113.6
Q ss_pred hhhCCCcccceEeeeCceEEEEEE--ECCCCEEEEEEeeccccc--------------------HH--HHHHHHHHHHHh
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGN--LSDGRKIAVKRLAKDNKD--------------------AK--KEKEFLMELGII 298 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~--------------------~~--~~~~~~~E~~~l 298 (558)
....-|.+.+.||+|+||.||+|. ..+|+.||+|++...... .. ....+..|+.++
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 344468899999999999999997 568999999998754211 00 112356799999
Q ss_pred cccccCCeeeeeeEEEeCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCc-EEecCCCCC
Q 008650 299 GHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR-IIHRDIKAS 377 (558)
Q Consensus 299 ~~l~h~niv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-ivH~Dlkp~ 377 (558)
.++.+.+ +.+...+.....++||||+.+++|...... ...+.......++.|++.+|.+||+ .+ |+||||||+
T Consensus 105 ~~L~~~~-i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~ 178 (237)
T smart00090 105 QRLYEAG-VPVPKPIAWRRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEY 178 (237)
T ss_pred HHHHhcC-CCCCeeeEecCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChh
Confidence 9997532 222222223446899999999888765422 2345556678899999999999999 88 999999999
Q ss_pred ceeecCCCceEEEeccccccCC
Q 008650 378 NVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 378 NIll~~~~~~kl~DFG~a~~~~ 399 (558)
||+++ ++.++|+|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-18 Score=168.32 Aligned_cols=197 Identities=23% Similarity=0.267 Sum_probs=134.9
Q ss_pred ccCCeeeeeeEEEe---------------------------C-cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHH
Q 008650 302 CHPNTATLVGCCIE---------------------------N-GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG 353 (558)
Q Consensus 302 ~h~niv~l~~~~~~---------------------------~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 353 (558)
.|||||.++++|.+ + .+|+||.-.. .+|..++... ..+...+.-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999876531 1 1667776543 3788888543 3455566778899
Q ss_pred HHHHHHHhhhCCCCcEEecCCCCCceee--cCCCc--eEEEeccccccCCCCCCc----ccccccccccCcccchhhccC
Q 008650 354 VARGLHYLHKGCKRRIIHRDIKASNVLL--GPDFE--PQITDFGLAKWLPNKCTH----HAAIPIEGTFGYLAPEYFMHG 425 (558)
Q Consensus 354 i~~aL~~LH~~~~~~ivH~Dlkp~NIll--~~~~~--~kl~DFG~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~ 425 (558)
+++|+.|||. +||.|||+|++|||| |+|+. +.|+|||++---....-. ......-|...-||||+....
T Consensus 350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999998 999999999999999 45554 678999987432211000 111123478889999998543
Q ss_pred C------CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhc
Q 008650 426 I------IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVR 499 (558)
Q Consensus 426 ~------~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~ 499 (558)
+ .=.|+|.|+.|.+.||+++...||.+...... ...++++-.-|.+.... ..-+.+++...|+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------~~r~Yqe~qLPalp~~v----pp~~rqlV~~lL~ 495 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------DTRTYQESQLPALPSRV----PPVARQLVFDLLK 495 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-------chhhhhhhhCCCCcccC----ChHHHHHHHHHhc
Confidence 2 12589999999999999999999986322211 11122332223333333 3457888999999
Q ss_pred cCCCCCCCHHHHHHHHh
Q 008650 500 QTSAWRPSMSEVLELLT 516 (558)
Q Consensus 500 ~dp~~RPt~~evl~~L~ 516 (558)
+||++|++..-....|.
T Consensus 496 r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVLN 512 (598)
T ss_pred CCccccCCccHHHhHHH
Confidence 99999999866555544
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.6e-18 Score=151.49 Aligned_cols=141 Identities=21% Similarity=0.258 Sum_probs=111.8
Q ss_pred EEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccch--hhhhhHHHHHHHHHHHHHHHhHhccccCCc
Q 008650 8 KILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSM--AKRQSQIRRAKAHVISMLGEFAGTSQSKQV 85 (558)
Q Consensus 8 ~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v 85 (558)
+|+||+|.|+ .|+.||.||++.....|+.|++|||.++......... ...............++|+.+...|...++
T Consensus 1 ~ILVavD~S~-~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 79 (146)
T cd01989 1 SVAVAVDKDK-KSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGV 79 (146)
T ss_pred CEEEEecCcc-ccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcCC
Confidence 5999999999 9999999999988888999999999876432111100 001111222233355789999999988899
Q ss_pred ceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCc-c-ch-hhhhhhhhcCCCCceEEEEccc
Q 008650 86 NLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNK-M-SR-DVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 86 ~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~-~-~~-sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
+++..++.|+++.+.|+++|++.++|++|||+|+.+... + ++ |++.++.++++..|+|.+++++
T Consensus 80 ~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 80 QCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred eEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEeCc
Confidence 999999998788999999999999999999999887643 2 55 7999999999999999999764
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=189.08 Aligned_cols=210 Identities=23% Similarity=0.351 Sum_probs=143.8
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEe
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNF 324 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 324 (558)
++|..++.|..|+||.||.+.++ +.+.+|+ ++.+... +++ +++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-------ilR--nilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-------ILR--NILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccch-------hhh--ccccccCCccee-----------------
Confidence 57888999999999999999554 5677888 4433321 111 033333344333
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC---
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK--- 401 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--- 401 (558)
|+-...+... +.++.. ++.+++|||+ .+|+|||+||+|.+|+.-|++|++|||+++..-..
T Consensus 136 ---gDc~tllk~~--g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNI--GPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccC--CCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 3333333221 233322 2679999999 89999999999999999999999999998653111
Q ss_pred ----------CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 402 ----------CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 402 ----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
......+.++|||.|+|||++.-..|+..+|+|++|+|+||.+-|..||.+....... ..-+-....+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf-g~visd~i~wp 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-GQVISDDIEWP 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH-hhhhhhhcccc
Confidence 1112234678999999999999999999999999999999999999999877443211 00011111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSM 508 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 508 (558)
+- +.....+..+++.+.|+.+|..|--.
T Consensus 279 E~---------dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 279 EE---------DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred cc---------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 11 22233468889999999999999543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.5e-18 Score=159.77 Aligned_cols=148 Identities=16% Similarity=0.098 Sum_probs=113.9
Q ss_pred HHHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccH--------------------HHHHHHHHHHHHh
Q 008650 239 EEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDA--------------------KKEKEFLMELGII 298 (558)
Q Consensus 239 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l 298 (558)
+++......|.+.+.||+|+||.||++...+|+.+|||++....... .....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 34555555688899999999999999987789999999876432110 0112356788888
Q ss_pred cccccCC--eeeeeeEEEeCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCC
Q 008650 299 GHVCHPN--TATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKA 376 (558)
Q Consensus 299 ~~l~h~n--iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp 376 (558)
..+.|++ +...++ ....+++|||+++++|...... .....++.+++.++.++|+ .+|+||||||
T Consensus 88 ~~l~~~~i~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p 153 (198)
T cd05144 88 KALYEEGFPVPKPID---WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLSE 153 (198)
T ss_pred HHHHHcCCCCCceee---cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCc
Confidence 8888774 333332 3457899999999999765421 2346788999999999999 8999999999
Q ss_pred CceeecCCCceEEEeccccccCCC
Q 008650 377 SNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 377 ~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
+||+++.++.++|+|||++.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.3e-17 Score=156.44 Aligned_cols=135 Identities=19% Similarity=0.321 Sum_probs=110.5
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEeecccccH------HHHHHHHHHHHHhcccccCCeeeeeeEEEe-CcEEEEEEe
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDA------KKEKEFLMELGIIGHVCHPNTATLVGCCIE-NGLYLIFNF 324 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~ 324 (558)
+.||+|++|.||+|.. +|..+++|+........ .....+.+|+.++..+.|+++.....++.+ +..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999976 67789999865432211 122457789999999999998776666554 448899999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
++|++|.+++.... + .+..++.+++.+|.+||+ .+++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985421 2 778899999999999999 8999999999999999 78999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.1e-19 Score=178.57 Aligned_cols=172 Identities=23% Similarity=0.384 Sum_probs=129.0
Q ss_pred EEEEEEeccCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDE-RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
+|+.|++|...+|.+||... .....++.....++.|++.|+.| ++.+|+|+||.||+...+..+||+|||+..
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhee
Confidence 78999999999999999643 33456788889999999999999 489999999999999999999999999998
Q ss_pred cCCCCC----CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 397 WLPNKC----THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 397 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
...... .....+...||.+||+||.+.+..|+.|+||||||++|+||+. =..+|+... +..-+.++.+.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~------t~~d~r~g~ip 478 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA------TLTDIRDGIIP 478 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH------hhhhhhcCCCC
Confidence 765544 1223445679999999999999999999999999999999998 333433211 11112222222
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSE 510 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 510 (558)
+.....++ .=..++.+++.+.|.+||+..+
T Consensus 479 ----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 479 ----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 11111112 2235779999999999994443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.6e-17 Score=154.70 Aligned_cols=132 Identities=19% Similarity=0.352 Sum_probs=104.7
Q ss_pred eEeeeCceEEEEEEECCCCEEEEEEeeccccc------HHHHHHHHHHHHHhcccccCCeeeeeeEEEe-CcEEEEEEec
Q 008650 253 MVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKD------AKKEKEFLMELGIIGHVCHPNTATLVGCCIE-NGLYLIFNFS 325 (558)
Q Consensus 253 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~ 325 (558)
.||+|+||.||+|.. ++..+++|........ ......+.+|++++..+.|+++.....++.. +..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999974 6788999986543211 1123567789999999998875544444433 4478999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
+|++|.+.+..... .++.+++.+|.+||+ .+++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999988743210 789999999999999 8999999999999999 889999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=174.33 Aligned_cols=139 Identities=19% Similarity=0.299 Sum_probs=110.0
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeeccc-cc-----HHHHHHHHHHHHHhcccccCCeeeeeeEEEe-Cc
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDN-KD-----AKKEKEFLMELGIIGHVCHPNTATLVGCCIE-NG 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 317 (558)
...|...+.||+|+||+||+|..... .+++|+..... .. ......+.+|++++..++|++++....++.+ +.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44556788999999999999976544 34444432221 11 1223567899999999999999887766655 34
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++||||+++++|.+++. ....++.+++.+|.|||+ .+++||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 889999999999999884 346789999999999999 899999999999999 678999999999975
Q ss_pred C
Q 008650 398 L 398 (558)
Q Consensus 398 ~ 398 (558)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.6e-18 Score=183.22 Aligned_cols=254 Identities=21% Similarity=0.248 Sum_probs=188.5
Q ss_pred CCcccceEeeeCceEEEEEEE--CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL--SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~lv~ 322 (558)
.|.+.+.||+|+|+.|-.... .....+|+|.+...............|..+-..+. |.|++.+++...+.. .++..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 456666799999999988844 23455777777655433444444556777777777 999999999987766 78999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhh-hCCCCcEEecCCCCCceeecCCC-ceEEEeccccccCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH-KGCKRRIIHRDIKASNVLLGPDF-EPQITDFGLAKWLPN 400 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~ 400 (558)
+|..++++...+........+...+-.++.|+..++.|+| . .++.|+||||+|.+++..+ .++++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999988883222224556667789999999999999 6 8999999999999999999 999999999998876
Q ss_pred -CCCccccccccc-ccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 401 -KCTHHAAIPIEG-TFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 401 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++....... ....+....
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~----------~~~~~~~~~ 247 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG----------RYSSWKSNK 247 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc----------cceeecccc
Confidence 444455556778 9999999999884 567789999999999999999999975433221 111111111
Q ss_pred CC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 478 LE--GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 478 l~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.. ............++..+++..+|..|.+.+++-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00 1111222335667778899999999999887655
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.2e-16 Score=143.88 Aligned_cols=139 Identities=22% Similarity=0.256 Sum_probs=98.1
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHH----------------------HHHHHHhcccccCC--e
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEF----------------------LMELGIIGHVCHPN--T 306 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~E~~~l~~l~h~n--i 306 (558)
.+.||+|+||+||+|...+++.||||++............+ ..|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46899999999999977789999999986543222111111 24555555554432 3
Q ss_pred eeeeeEEEeCcEEEEEEeccCCCHHH-HHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC
Q 008650 307 ATLVGCCIENGLYLIFNFSQNGNLDA-ALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385 (558)
Q Consensus 307 v~l~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 385 (558)
...+++ ...++||||+.++.+.. .+.... .. .....++.+++.++.++|.. .+|+|+||||+||+++ ++
T Consensus 82 ~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec---CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CC
Confidence 333332 34689999999954321 121110 11 55678999999999999973 6899999999999999 89
Q ss_pred ceEEEeccccccCC
Q 008650 386 EPQITDFGLAKWLP 399 (558)
Q Consensus 386 ~~kl~DFG~a~~~~ 399 (558)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.7e-15 Score=132.21 Aligned_cols=134 Identities=19% Similarity=0.184 Sum_probs=109.5
Q ss_pred ccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhccccc--CCeeeeeeEEEeC-cEEEEEEecc
Q 008650 250 SENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH--PNTATLVGCCIEN-GLYLIFNFSQ 326 (558)
Q Consensus 250 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~-~~~lv~e~~~ 326 (558)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+.++..+.| .++++++.+.... ..++++||+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 35689999999999997744 7899999865432 4567789999999976 4888888877654 4899999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 327 NGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 327 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
++.+... +......++.+++.+|.+||.....+++|+|++|+||++++++.++++|||.+..
T Consensus 77 g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8777543 4455677899999999999985445899999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.5e-14 Score=140.32 Aligned_cols=135 Identities=16% Similarity=0.259 Sum_probs=104.5
Q ss_pred ceEe-eeCceEEEEEEECCCCEEEEEEeecccc-----------cHHHHHHHHHHHHHhcccccCCe--eeeeeEEEeC-
Q 008650 252 NMVG-QGGYSEVYKGNLSDGRKIAVKRLAKDNK-----------DAKKEKEFLMELGIIGHVCHPNT--ATLVGCCIEN- 316 (558)
Q Consensus 252 ~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~- 316 (558)
..|| .||.|+||.+... +..++||.+..... .......+.+|+.++.++.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999999764 77899998854221 11233567889999999998875 6666664332
Q ss_pred c----EEEEEEeccC-CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEe
Q 008650 317 G----LYLIFNFSQN-GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITD 391 (558)
Q Consensus 317 ~----~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 391 (558)
. .++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+ .||+||||||+|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 3599999997 689888753 234443 35689999999999 8999999999999999999999999
Q ss_pred cccccc
Q 008650 392 FGLAKW 397 (558)
Q Consensus 392 FG~a~~ 397 (558)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998875
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=3e-14 Score=127.09 Aligned_cols=137 Identities=18% Similarity=0.153 Sum_probs=97.6
Q ss_pred cEEEEEEecCc-cchHHHHHHHHhhccCCCCeEEEEEeecccccccccc-hhhhhhHHHHHHHHHHHHHHHhHhccccCC
Q 008650 7 SKILIGFSLDP-NDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGS-MAKRQSQIRRAKAHVISMLGEFAGTSQSKQ 84 (558)
Q Consensus 7 r~i~Vavd~~~-~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~ 84 (558)
++|+||+|+|+ ..|..||.||+. +++.+..|++|||.++........ ................+.|+.+.......+
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~-la~~~~~l~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 81 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEF-LAQDDGVIHLLHVLPGSASLSLHRFAADVRRFEEHLQHEAEERLQTMVSHFTIDP 81 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHH-HHhcCCeEEEEEEecCcccccccccccchhhHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 68999999983 279999999996 566567999999997643211100 000011111222223345555555444456
Q ss_pred cceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc-chhhhhhhhhcCCCCceEEEEc
Q 008650 85 VNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM-SRDVTRYCFQHAPGGCTIHIFG 147 (558)
Q Consensus 85 v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~-~~sv~~~c~~~~~~~c~v~~v~ 147 (558)
++++.++..| ++.+.|++.|++.++|++|||+||.+..+. +||++.++.++++ |||.++.
T Consensus 82 ~~v~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~llGS~a~~v~~~a~--~pVLvV~ 142 (142)
T PRK15456 82 SRIKQHVRFG-SVRDEVNELAEELGADVVVIGSRNPSISTHLLGSNASSVIRHAN--LPVLVVR 142 (142)
T ss_pred cceEEEEcCC-ChHHHHHHHHhhcCCCEEEEcCCCCCccceecCccHHHHHHcCC--CCEEEeC
Confidence 7889999998 567799999999999999999998764333 8999999999999 9999763
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.2e-13 Score=123.53 Aligned_cols=136 Identities=16% Similarity=0.182 Sum_probs=97.6
Q ss_pred cEEEEEEecCccc--hHHHHHHHHhhccCCCCeEEEEEeecccccccccchh--hhhhHHHHHHHHHHHHHHHhHhcccc
Q 008650 7 SKILIGFSLDPND--SKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMA--KRQSQIRRAKAHVISMLGEFAGTSQS 82 (558)
Q Consensus 7 r~i~Vavd~~~~~--s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~c~~ 82 (558)
++|+||+|.|+ . |..||.||++-..+.|..|++|||.++.......... ..............+.|+.+...+..
T Consensus 3 ~~ILv~~D~s~-~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 81 (144)
T PRK15005 3 RTILVPIDISD-SELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASLGLAYSAELPAMDDLKAEAKSQLEEIIKKFKL 81 (144)
T ss_pred ccEEEecCCCc-hhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccccccccccccchHHHHHHHHHHHHHHHHHHHhCC
Confidence 68999999999 6 5799999999877788999999999753321100000 00001111222223445544444445
Q ss_pred CCcceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc-chhhhhhhhhcCCCCceEEEE
Q 008650 83 KQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM-SRDVTRYCFQHAPGGCTIHIF 146 (558)
Q Consensus 83 ~~v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~-~~sv~~~c~~~~~~~c~v~~v 146 (558)
.+++++.++..| ++.+.|++.|++.++|++|||+|+.+..+. .||++.++.++++ |||.++
T Consensus 82 ~~~~~~~~v~~G-~p~~~I~~~a~~~~~DLIV~Gs~~~~~~~~llGS~a~~vl~~a~--cpVlvV 143 (144)
T PRK15005 82 PTDRVHVHVEEG-SPKDRILELAKKIPADMIIIASHRPDITTYLLGSNAAAVVRHAE--CSVLVV 143 (144)
T ss_pred CCCceEEEEeCC-CHHHHHHHHHHHcCCCEEEEeCCCCCchheeecchHHHHHHhCC--CCEEEe
Confidence 567788999998 567899999999999999999996544333 8999999999999 999976
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-13 Score=122.75 Aligned_cols=135 Identities=18% Similarity=0.188 Sum_probs=92.9
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhh-hhhHHHHHHHHHHHHHHHhHhccccCC
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAK-RQSQIRRAKAHVISMLGEFAGTSQSKQ 84 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~c~~~~ 84 (558)
-++|+||+|.|+ .|..||.||++-....|..|++|||.++........... .......... .....++.++...+
T Consensus 3 ~~~ILvavD~S~-~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~~~~~~~ 78 (144)
T PRK15118 3 YKHILIAVDLSP-ESKVLVEKAVSMARPYNAKVSLIHVDVNYSDLYTGLIDVNLGDMQKRISE---ETHHALTELSTNAG 78 (144)
T ss_pred ceEEEEEccCCh-hHHHHHHHHHHHHHhhCCEEEEEEEccChhhhhhhhhhcchHHHHHHHHH---HHHHHHHHHHHhCC
Confidence 479999999999 999999999997666788999999953321110000000 0011111111 22233344445556
Q ss_pred cceeEEEe-cCCchhhHHHHHHHhccCcEEEEecccccCCccchhhhhhhhhcCCCCceEEEEcc
Q 008650 85 VNLEAKVG-FSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMSRDVTRYCFQHAPGGCTIHIFGE 148 (558)
Q Consensus 85 v~~~~~v~-~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~~~sv~~~c~~~~~~~c~v~~v~~ 148 (558)
+.+...++ .| ++.+.|++.|++.++|++|||+|+.. .++++|++.++.++++ |||.++..
T Consensus 79 ~~~~~~~~~~G-~p~~~I~~~a~~~~~DLIV~Gs~~~~-~~~lgSva~~v~~~a~--~pVLvv~~ 139 (144)
T PRK15118 79 YPITETLSGSG-DLGQVLVDAIKKYDMDLVVCGHHQDF-WSKLMSSARQLINTVH--VDMLIVPL 139 (144)
T ss_pred CCceEEEEEec-CHHHHHHHHHHHhCCCEEEEeCcccH-HHHHHHHHHHHHhhCC--CCEEEecC
Confidence 77655554 56 67889999999999999999999743 3347899999999999 99999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.8e-13 Score=140.95 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=178.3
Q ss_pred CCcccceEee--eCceEEEEEE---ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EE
Q 008650 247 NFHSENMVGQ--GGYSEVYKGN---LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LY 319 (558)
Q Consensus 247 ~f~~~~~lG~--G~~g~Vy~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~ 319 (558)
.|.+.+.+|. |.+|.||.+. ..++..+|+|+-......+...+.=++|+.-...+. |+|.++.+..+.+.+ .|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4667788999 9999999983 467889999985433222222223335555555554 999999888887766 66
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHH----HHHHhhhCCCCcEEecCCCCCceeecCC-CceEEEeccc
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVAR----GLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFGL 394 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~----aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~ 394 (558)
+-+|++. .+|..+.+.. ...++....+.++.+... ||.++|. .+++|-|+||.||++..+ ...+++|||+
T Consensus 195 iqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence 6667665 6787777543 344778888888888888 9999999 899999999999999999 7899999999
Q ss_pred cccCCCCCCcc---cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 395 AKWLPNKCTHH---AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 395 a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
...+....-.. ......|..-|++||.. .+.++...|+|++|.++.+..++-.+...... ..| .
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--~~W----------~ 336 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--SSW----------S 336 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--CCc----------c
Confidence 98876654221 11233688899999988 55678899999999999999998766543210 111 1
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
++-.-.+..++-..-..++...+.++++.+|-.|++.+.+..+
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1111112222222223455668899999999999998777653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.8e-13 Score=141.80 Aligned_cols=142 Identities=18% Similarity=0.222 Sum_probs=100.3
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEeecccccHH--------------------------------------HHHHHHH
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAK--------------------------------------KEKEFLM 293 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~~~~ 293 (558)
+.||.|++|.||+|...+|+.||||+........- .+-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 68999999999999999999999999865421100 0012444
Q ss_pred HHHHhcccc----cCCeeeeeeEEE--eCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHH-HHHHhhhCCC
Q 008650 294 ELGIIGHVC----HPNTATLVGCCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVAR-GLHYLHKGCK 366 (558)
Q Consensus 294 E~~~l~~l~----h~niv~l~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~-aL~~LH~~~~ 366 (558)
|...+.++. |.+-+.+-..+. .+..++||||++|++|.+.......+ .+ ..+++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~~--- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVLR--- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHHh---
Confidence 555554442 333344434443 23478999999999998876532211 22 3456666665 4677887
Q ss_pred CcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 367 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
.|++|+|+||.||+++.++.++++|||++..+..
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.3e-13 Score=118.50 Aligned_cols=136 Identities=14% Similarity=0.123 Sum_probs=96.0
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccc-hhhhhhHHHHHHHHHHHHHHHhHhccccCC
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGS-MAKRQSQIRRAKAHVISMLGEFAGTSQSKQ 84 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~ 84 (558)
-++|+||+|.|+ .|..||.||+.-.-..|..|++|||.++........ ...........+....+.|+.+...+. .
T Consensus 3 ~k~ILvavD~S~-~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~--~ 79 (142)
T PRK09982 3 YKHIGVAISGNE-EDALLVNKALELARHNDAHLTLIHIDDGLSELYPGIYFPATEDILQLLKNKSDNKLYKLTKNIQ--W 79 (142)
T ss_pred ceEEEEEecCCc-chHHHHHHHHHHHHHhCCeEEEEEEccCcchhchhhhccchHHHHHHHHHHHHHHHHHHHHhcC--C
Confidence 378999999999 999999999997778899999999986532211100 001112222223333345555554333 2
Q ss_pred cceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCccchhhhhhhhhcCCCCceEEEEcc
Q 008650 85 VNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMSRDVTRYCFQHAPGGCTIHIFGE 148 (558)
Q Consensus 85 v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~~~sv~~~c~~~~~~~c~v~~v~~ 148 (558)
..++.++..| ++.+.|++.|++.++|++|||+|+.+..+.. +++..+.++++ |||.++..
T Consensus 80 ~~~~~~v~~G-~p~~~I~~~A~~~~aDLIVmG~~~~~~~~~~-~va~~V~~~s~--~pVLvv~~ 139 (142)
T PRK09982 80 PKTKLRIERG-EMPETLLEIMQKEQCDLLVCGHHHSFINRLM-PAYRGMINKMS--ADLLIVPF 139 (142)
T ss_pred CcceEEEEec-CHHHHHHHHHHHcCCCEEEEeCChhHHHHHH-HHHHHHHhcCC--CCEEEecC
Confidence 3467788888 6688999999999999999998733333335 59999999999 99998854
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.3e-13 Score=117.53 Aligned_cols=136 Identities=17% Similarity=0.224 Sum_probs=93.1
Q ss_pred cEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCCcc
Q 008650 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQVN 86 (558)
Q Consensus 7 r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v~ 86 (558)
|+|+|++|.++ .+.+||+||+......|+.|++|||.+....................... .........+...+..
T Consensus 3 ~~Ilv~~d~~~-~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 79 (140)
T PF00582_consen 3 KRILVAIDGSE-ESRRALRFALELAKRSGAEITLLHVIPPPPQYSFSAAEDEESEEEAEEEE--QARQAEAEEAEAEGGI 79 (140)
T ss_dssp SEEEEEESSSH-HHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHTTS
T ss_pred CEEEEEECCCH-HHHHHHHHHHHHHHhhCCeEEEEEeeccccccccccccccccccccchhh--hhhhHHHHHHhhhccc
Confidence 79999999999 99999999999888889999999999865433211111100000000000 0001111233334444
Q ss_pred eeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEc
Q 008650 87 LEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFG 147 (558)
Q Consensus 87 ~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~ 147 (558)
.....+.+.++.+.|+++++..++|++|||+++.+.... .||++.++.+++| |||.++.
T Consensus 80 ~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~--~pVlvv~ 140 (140)
T PF00582_consen 80 VIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAP--CPVLVVP 140 (140)
T ss_dssp EEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTS--SEEEEEE
T ss_pred eeEEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCC--CCEEEeC
Confidence 444444444889999999999999999999998654333 8999999999999 9998763
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=114.00 Aligned_cols=121 Identities=15% Similarity=0.165 Sum_probs=92.9
Q ss_pred EEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCCcce
Q 008650 8 KILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQVNL 87 (558)
Q Consensus 8 ~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v~~ 87 (558)
+|+|+||.++ .|++||+||.....+.+..|.+|||.++.... .. ....+.++.+...+++.++.
T Consensus 1 ~Ilv~vd~s~-~s~~al~~a~~la~~~~~~l~ll~v~~~~~~~---~~-----------~~~~~~l~~~~~~~~~~~~~- 64 (124)
T cd01987 1 RILVCISGGP-NAERLIRRAARLADRLKAPWYVVYVETPRLNR---LS-----------EAERRRLAEALRLAEELGAE- 64 (124)
T ss_pred CEEEEECCCc-chHHHHHHHHHHHHHhCCCEEEEEEecCcccc---CC-----------HHHHHHHHHHHHHHHHcCCE-
Confidence 5999999999 99999999998777778899999998753220 00 11224555666666555553
Q ss_pred eEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEE
Q 008650 88 EAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIF 146 (558)
Q Consensus 88 ~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v 146 (558)
..++.+.++.+.|+++++..++|+||||+++.+...+ .||++..+.+++ ..|++.++
T Consensus 65 -~~~~~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~Gs~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 65 -VVTLPGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFRGSLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred -EEEEeCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhcccHHHHHHHhC-CCCeEEEe
Confidence 4455566788999999999999999999998765443 899999999998 34999865
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-12 Score=125.42 Aligned_cols=201 Identities=17% Similarity=0.166 Sum_probs=135.3
Q ss_pred HhcccccCCeeeeeeEEEeC------cEEEEEEeccCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHhhhCCCCc
Q 008650 297 IIGHVCHPNTATLVGCCIEN------GLYLIFNFSQNGNLDAALHDERS--KSLEWPIRYKIVLGVARGLHYLHKGCKRR 368 (558)
Q Consensus 297 ~l~~l~h~niv~l~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ 368 (558)
-|-++.|.|||+++.++.+. ...+++||+..|+|..+|+..+. ..+....-.+++.||+.||.|||++ ...
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 34456799999999988642 27899999999999999987543 2456666678999999999999985 478
Q ss_pred EEecCCCCCceeecCCCceEEEecc--ccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcC
Q 008650 369 IIHRDIKASNVLLGPDFEPQITDFG--LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITG 446 (558)
Q Consensus 369 ivH~Dlkp~NIll~~~~~~kl~DFG--~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg 446 (558)
|+|+++..+-|++..+|-+|++--- ..................+-++|.+||+=.....+..+|||+||...++|..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999988885211 10000000000011112367899999987766778899999999999999887
Q ss_pred CCC-CCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 447 RKP-VDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 447 ~~P-f~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..- -.+.......-.. .+....+...+ =..++.+|++..|+.||+|.+++.+
T Consensus 279 Eiq~tnseS~~~~ee~i-----a~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENI-----ANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceeehhhhh-----hhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 653 2222111100000 00000000011 1235688999999999999988764
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-11 Score=107.66 Aligned_cols=130 Identities=17% Similarity=0.287 Sum_probs=102.8
Q ss_pred EEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCCcce
Q 008650 8 KILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQVNL 87 (558)
Q Consensus 8 ~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v~~ 87 (558)
+|+|+||.++ .+..||.||..-.-..+-.|+++||.+++...... . .........+.++.+..++.+.++.+
T Consensus 1 ~ILv~vd~s~-~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~~~~g~~~ 72 (132)
T cd01988 1 RILVPVANPN-TARDLLELAAALARAQNGEIIPLNVIEVPNHSSPS---Q----LEVNVQRARKLLRQAERIAASLGVPV 72 (132)
T ss_pred CEEEecCCch-hHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCcc---h----hHHHHHHHHHHHHHHHHHhhhcCCce
Confidence 5999999999 99999999998776677899999999754322110 0 11112224578888888888888988
Q ss_pred eEEEecCCchhhHHHHHHHhccCcEEEEecccccCC--ccchhhhhhhhhcCCCCceEEEEc
Q 008650 88 EAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSN--KMSRDVTRYCFQHAPGGCTIHIFG 147 (558)
Q Consensus 88 ~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~--~~~~sv~~~c~~~~~~~c~v~~v~ 147 (558)
+..+..+.++.+.||+.++..++|.+|||+++.... ..+||++.++.++++ |+|.+++
T Consensus 73 ~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~--~pvlvv~ 132 (132)
T cd01988 73 HTIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAP--CDVAVVK 132 (132)
T ss_pred EEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCC--CCEEEeC
Confidence 888876557888999999999999999999977653 338999999999999 9998763
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.2e-12 Score=117.39 Aligned_cols=130 Identities=17% Similarity=0.081 Sum_probs=94.1
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCee-eeeeEEEeCcEEEEEEeccCCCH
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA-TLVGCCIENGLYLIFNFSQNGNL 330 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~~~gsL 330 (558)
+.|+.|.++.||++... ++.|++|....... ....+..|+.+++.+.+.+++ +++.+ ..+..++||||++|.++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYF-DPETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEE-eCCCCeEEEEecCCCcc
Confidence 56889999999999764 77899999754421 122355788888887655544 34443 33346899999999887
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCC--CCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 331 DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC--KRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 331 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.... . ....++.+++++|..||... ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5430 1 11345678999999999832 12369999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.3e-12 Score=136.29 Aligned_cols=145 Identities=15% Similarity=0.157 Sum_probs=94.3
Q ss_pred CCCcccceEeeeCceEEEEEEECC-CCEEEEEEeeccccc----------------------------H----HHH----
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKD----------------------------A----KKE---- 288 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------~----~~~---- 288 (558)
..|.. +.||+|++|.||+|...+ |+.||||++.+.-.. . +..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 689999999999998877 999999999754210 0 111
Q ss_pred --HHHHHHHHHhcccc----cCCeeeeeeEEEe--CcEEEEEEeccCCCHHHHHhhccCC----CCCHHHHHHHHHHHHH
Q 008650 289 --KEFLMELGIIGHVC----HPNTATLVGCCIE--NGLYLIFNFSQNGNLDAALHDERSK----SLEWPIRYKIVLGVAR 356 (558)
Q Consensus 289 --~~~~~E~~~l~~l~----h~niv~l~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~----~l~~~~~~~i~~~i~~ 356 (558)
-++.+|...+.++. +.+.+.+-.++.+ ...++||||+.|+.+.+...-...+ .+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 12334444444442 4444444444433 3478999999999997753211111 12222222222232
Q ss_pred HHHHhhhCCCCcEEecCCCCCceeecCCC----ceEEEeccccccCCCC
Q 008650 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDF----EPQITDFGLAKWLPNK 401 (558)
Q Consensus 357 aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~a~~~~~~ 401 (558)
+. .|++|+|+||.||+++.++ .++++|||++..++..
T Consensus 277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 23 6899999999999999988 9999999999877543
|
|
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=2e-11 Score=108.78 Aligned_cols=136 Identities=12% Similarity=0.144 Sum_probs=94.5
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCCc
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQV 85 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v 85 (558)
-++|+|++|.|+ .|..||.+|+.-.-+.|..|.++||.++..................... +....++.++...++
T Consensus 3 ~~~ILv~~D~s~-~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~~~~~~~~ 78 (142)
T PRK10116 3 YSNILVAVAVTP-ESQQLLAKAVSIARPVNGKISLITLASDPEMYNQFAAPMLEDLRSVMQE---ETQSFLDKLIQDADY 78 (142)
T ss_pred CceEEEEccCCc-chHHHHHHHHHHHHHhCCEEEEEEEccCcccchhhhHHHHHHHHHHHHH---HHHHHHHHHHHhcCC
Confidence 489999999999 8999999999876666889999999865322110000000111111111 122223344444566
Q ss_pred cee-EEEecCCchhhHHHHHHHhccCcEEEEecccccCCccchhhhhhhhhcCCCCceEEEEcc
Q 008650 86 NLE-AKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMSRDVTRYCFQHAPGGCTIHIFGE 148 (558)
Q Consensus 86 ~~~-~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~~~sv~~~c~~~~~~~c~v~~v~~ 148 (558)
..+ .++..| ++.+.|+++|++.++|++|||+|+........|++.++.++++ |+|.++..
T Consensus 79 ~~~~~~~~~G-~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~s~a~~v~~~~~--~pVLvv~~ 139 (142)
T PRK10116 79 PIEKTFIAYG-ELSEHILEVCRKHHFDLVICGNHNHSFFSRASCSAKRVIASSE--VDVLLVPL 139 (142)
T ss_pred CeEEEEEecC-CHHHHHHHHHHHhCCCEEEEcCCcchHHHHHHHHHHHHHhcCC--CCEEEEeC
Confidence 554 455556 6688999999999999999999987655555689999999999 99998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.3e-12 Score=133.12 Aligned_cols=248 Identities=20% Similarity=0.222 Sum_probs=172.4
Q ss_pred hhCCCcccceEeeeCceEEEEEEE--CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEe-CcEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL--SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIE-NGLY 319 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~~ 319 (558)
.+.+|.....||.|.|+.|+.... .++..|++|.+.+..........-+.|+.+...+. |.+++.++..+.+ .+.|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 446788899999999999999843 46888999988665433333333344555544443 7788887766655 4588
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-CceEEEeccccccC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFGLAKWL 398 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~ 398 (558)
+--||+.++++...+.. ...+++...+++..+++.++.++|+ ..++|+|+||+||++..+ +..+++|||....+
T Consensus 343 ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred CchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccc
Confidence 88999999988766622 2347777889999999999999998 899999999999999876 78899999998653
Q ss_pred CCCCCcccccccccccCc-ccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 399 PNKCTHHAAIPIEGTFGY-LAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
.-... ....++..| .+|+......+-.+.|++|||..+.+.++|..--.... .|.. +..+... .
T Consensus 418 ~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~--i~~~~~p-----~ 482 (524)
T KOG0601|consen 418 AFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLT--IRSGDTP-----N 482 (524)
T ss_pred ceecc----cccccccccccchhhccccccccccccccccccccccccCcccCcccc----ccee--eeccccc-----C
Confidence 22111 111133334 35666667788899999999999999999875433221 1110 1111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
. + .....+..+...+..+++..||.+.++.....
T Consensus 483 ~----~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 483 L----P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred C----C-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1 1 11245677788899999999999888766543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.3e-11 Score=110.72 Aligned_cols=138 Identities=17% Similarity=0.138 Sum_probs=97.8
Q ss_pred cceEeeeCceEEEEEEECC-------CCEEEEEEeecccc-----------c---------HHHHHHH----HHHHHHhc
Q 008650 251 ENMVGQGGYSEVYKGNLSD-------GRKIAVKRLAKDNK-----------D---------AKKEKEF----LMELGIIG 299 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-----------~---------~~~~~~~----~~E~~~l~ 299 (558)
...||.|--+.||.|...+ +..+|||+.+.... + ....+.+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999995443 47899998742210 0 0111222 37999998
Q ss_pred cccc--CCeeeeeeEEEeCcEEEEEEeccCCCHHH-HHhhccCCCCCHHHHHHHHHHHHHHHHHh-hhCCCCcEEecCCC
Q 008650 300 HVCH--PNTATLVGCCIENGLYLIFNFSQNGNLDA-ALHDERSKSLEWPIRYKIVLGVARGLHYL-HKGCKRRIIHRDIK 375 (558)
Q Consensus 300 ~l~h--~niv~l~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~~ivH~Dlk 375 (558)
++.. -++..++.+ ...++||||+.++.+.. .+.+ ..++......+..+++.+|..| |+ .++||+||+
T Consensus 82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 8864 355566654 45789999998754422 2321 2344555667889999999999 77 799999999
Q ss_pred CCceeecCCCceEEEeccccccC
Q 008650 376 ASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 376 p~NIll~~~~~~kl~DFG~a~~~ 398 (558)
+.|||++ ++.+.|+|||.+-..
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.6e-10 Score=118.33 Aligned_cols=166 Identities=17% Similarity=0.209 Sum_probs=121.4
Q ss_pred EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCCCHHHHHhhccCCCCCH
Q 008650 266 NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEW 344 (558)
Q Consensus 266 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~ 344 (558)
...++..+.|........ .......+-+..|+.++||||++++..+..++ .|+|+|-+. .|...+... ..
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~ 103 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GK 103 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HH
Confidence 556788898888865543 34445667788999999999999999987655 999999875 466666443 24
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhcc
Q 008650 345 PIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424 (558)
Q Consensus 345 ~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 424 (558)
......+.||+.||.|||+. .+++|++|.-+-|+++..|+.||++|-++........ ......---.|..|+.+..
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence 44555778999999999973 6899999999999999999999999988765432211 0011111223566665432
Q ss_pred CCCCccccchhHHHHHHHHHcC
Q 008650 425 GIIDEKTDVFAFGVLLLEIITG 446 (558)
Q Consensus 425 ~~~~~ksDvwSlGvvl~elltg 446 (558)
.. -..|.|.|||+++|++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 346999999999999999
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.8e-10 Score=111.78 Aligned_cols=280 Identities=14% Similarity=0.135 Sum_probs=175.3
Q ss_pred cccceEeeeCceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeee--------eeeEEEeCcEE
Q 008650 249 HSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT--------LVGCCIENGLY 319 (558)
Q Consensus 249 ~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------l~~~~~~~~~~ 319 (558)
.....||+|+-+.+|.. ... .-+.|++........ .+...| +..--.||-+-. |+|--...-.-
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~--aqk~a~--la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ--AQKVAE--LAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchhh---chhheeecCCCchHH--HHHHHH--hccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 34678999999999965 222 246677765432111 111111 112223443222 11111111145
Q ss_pred EEEEeccCCC-HHHHHh----hccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 320 LIFNFSQNGN-LDAALH----DERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 320 lv~e~~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
+.|..+.+.. +..+++ .+.....+|....+.+..++.+...||+ .|.+-+|+.++|+|+++++.+.|.|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccc
Confidence 6666665542 222322 1223457899999999999999999999 8999999999999999999999987443
Q ss_pred cccCCCCCCcccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcC-CCCCCCCc-------hhHHHHh
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITG-RKPVDSSR-------QNLVLWA 461 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg-~~Pf~~~~-------~~~~~~~ 461 (558)
-....++ ....-.+|...|.+||... +..-+...|-|.||+++++|+.| +.||.+-. ......+
T Consensus 164 fqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 164 FQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred eeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 3322221 1122245899999999875 33456789999999999999886 99997531 1110111
Q ss_pred -hhhhhcCCcccccCCCCCCCCCH-HHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHhcCCCcccccccCCCCCCcccc
Q 008650 462 -KPLMESGNLTELVDPSLEGEYDT-DQMHRLVLIADYCVRQT--SAWRPSMSEVLELLTSGHDSEFAKSWRMPEFTSDEL 537 (558)
Q Consensus 462 -~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~d--p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~~ 537 (558)
..+....+...-..+. ....+. -....+.-+..+|+... +.-|||++-++..|....+...++..+..+.++++.
T Consensus 241 ~g~f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~~hl 319 (637)
T COG4248 241 HGRFAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYPVHL 319 (637)
T ss_pred cceeeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccccccCCC
Confidence 0111111111111111 111121 22345666778888754 467999999999999988888899999999999999
Q ss_pred ccccc
Q 008650 538 DDCSM 542 (558)
Q Consensus 538 ~~~~~ 542 (558)
.+|+|
T Consensus 320 ~~CPw 324 (637)
T COG4248 320 TDCPW 324 (637)
T ss_pred CCCch
Confidence 99995
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=4e-10 Score=113.96 Aligned_cols=140 Identities=13% Similarity=0.131 Sum_probs=101.4
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccc-hhhhh-hHHHHHHHHHHHHHHHhHhccccC
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGS-MAKRQ-SQIRRAKAHVISMLGEFAGTSQSK 83 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~l~~~~~~c~~~ 83 (558)
-++|+|++|.|+ .|..||+||+.-....+..|++|||.++........ ..... ...+.......+.|+.+...+...
T Consensus 3 ~~~ILv~~D~s~-~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 81 (305)
T PRK11175 3 YQNILVVIDPNQ-DDQPALRRAVYLAQRNGGKITAFLPIYDFSYEMTTLLSPDEREAMRQGVISQRTAWIREQAKPYLDA 81 (305)
T ss_pred cceEEEEcCCCc-cccHHHHHHHHHHHhcCCCEEEEEeccCchhhhhcccchhHHHHHHHHHHHHHHHHHHHHHHHHhhc
Confidence 468999999999 999999999996556678999999975432211110 00000 011111112234566666666667
Q ss_pred CcceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEcc
Q 008650 84 QVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGE 148 (558)
Q Consensus 84 ~v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~ 148 (558)
+++++..+.+++++.+.|++.|+..++|++|||+++...... .||++....++++ |||.++..
T Consensus 82 ~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~--~pvlvv~~ 146 (305)
T PRK11175 82 GIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCP--CPVLMVKD 146 (305)
T ss_pred CCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCC--CCEEEecc
Confidence 899999888755778899999999999999999998754333 7899999999999 99999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-11 Score=134.85 Aligned_cols=252 Identities=19% Similarity=0.211 Sum_probs=168.8
Q ss_pred hhhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEE-eCcEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCI-ENGLY 319 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~ 319 (558)
...+.|.+.+-+-+|.++.++.+.-. .|...+.|...+... ..........+-+++-..++|.++....-+. ....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34466777788889999999987332 343445554433211 1111222333444444445566665544433 34589
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
|+++|..+++|...|+... ..+.+-+......+..+++|||. ..+.|+|++|.|+|+..+|+.+++|||......
T Consensus 881 L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999997653 45555666677788899999998 569999999999999999999999998433211
Q ss_pred C------C---------------C---Cc-----ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCC
Q 008650 400 N------K---------------C---TH-----HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPV 450 (558)
Q Consensus 400 ~------~---------------~---~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf 450 (558)
. . . .. .......||+.|.+||.+.+......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 0 00 1122456999999999999999999999999999999999999999
Q ss_pred CCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 008650 451 DSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMS 509 (558)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 509 (558)
......... .-+.+++ -+.. .-+.....+..+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f---~ni~~~~-----~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIF---ENILNRD-----IPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhh---hccccCC-----CCCC--CCccccChhhhhhhhhhhccCchhccCcc
Confidence 876543221 0000000 0000 00122344677788889999999998776
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.2e-10 Score=95.48 Aligned_cols=127 Identities=19% Similarity=0.333 Sum_probs=100.5
Q ss_pred EEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCCcce
Q 008650 8 KILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQVNL 87 (558)
Q Consensus 8 ~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v~~ 87 (558)
+|+|++|.++ .++.++.||++-....+..|.+|||.++...... ...........+.|+.+...|...++.+
T Consensus 1 ~ilv~i~~~~-~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~-------~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 72 (130)
T cd00293 1 RILVAVDGSE-ESERALRWAARLARRLGAELVLLHVVDPPPSSAA-------ELAELLEEEARALLEALREALAEAGVKV 72 (130)
T ss_pred CEEEEeCCCH-HHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch-------hHHHHHHHHHHHHHHHHHHHHhcCCCce
Confidence 5899999999 9999999999999888999999999875433211 1111112223467888888887788999
Q ss_pred eEEEecCCchhhHHHHHHHhccCcEEEEecccccCCc--cchhhhhhhhhcCCCCceEEE
Q 008650 88 EAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNK--MSRDVTRYCFQHAPGGCTIHI 145 (558)
Q Consensus 88 ~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~--~~~sv~~~c~~~~~~~c~v~~ 145 (558)
...+..|.+ .+.|+++++..++|+||||.++..... +.++.+....++.+ ||+.+
T Consensus 73 ~~~~~~~~~-~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~~~~~~ll~~~~--~pvli 129 (130)
T cd00293 73 ETVVLEGDP-AEAILEAAEELGADLIVMGSRGRSGLRRLLLGSVAERVLRHAP--CPVLV 129 (130)
T ss_pred EEEEecCCC-HHHHHHHHHHcCCCEEEEcCCCCCccceeeeccHHHHHHhCCC--CCEEe
Confidence 889888865 789999999999999999999776542 48899999999877 98875
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.9e-10 Score=108.13 Aligned_cols=142 Identities=17% Similarity=0.235 Sum_probs=107.5
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhccccc--CCeeeeeeEEEeC----cEEEEEEec
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH--PNTATLVGCCIEN----GLYLIFNFS 325 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~lv~e~~ 325 (558)
+.|+.|.++.+|++...+|+.+++|........ .....+..|..+++.+.+ .++.+++.+..++ ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999997766789999998554321 123456788888888875 3456677766542 468999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhC-----------------------------------------
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG----------------------------------------- 364 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~----------------------------------------- 364 (558)
+|.++...+.. ..++......++.+++++|.+||+.
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99988776531 3467777778888888888888852
Q ss_pred ------------CCCcEEecCCCCCceeecC--CCceEEEecccccc
Q 008650 365 ------------CKRRIIHRDIKASNVLLGP--DFEPQITDFGLAKW 397 (558)
Q Consensus 365 ------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~ 397 (558)
....++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.1e-09 Score=96.25 Aligned_cols=144 Identities=21% Similarity=0.269 Sum_probs=104.6
Q ss_pred ccceEeeeCceEEEEEEECCCCEEEEEEe-ecccccHH-----HHHHHHHHHHHhcccccCCeeeeeeEEEe-CcEEEEE
Q 008650 250 SENMVGQGGYSEVYKGNLSDGRKIAVKRL-AKDNKDAK-----KEKEFLMELGIIGHVCHPNTATLVGCCIE-NGLYLIF 322 (558)
Q Consensus 250 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~ 322 (558)
...+|-+|+-+.|+++.+ .|+.+.||.- .+....+. ......+|.++|.++.--.|.-..-++.+ ..-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999977 4777777743 33322222 23455679999988875555544444444 3478999
Q ss_pred EeccC-CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc---eEEEecccccc
Q 008650 323 NFSQN-GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE---PQITDFGLAKW 397 (558)
Q Consensus 323 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~a~~ 397 (558)
||++| .++.+++...-...........++..|-+.+.-||. ++|+|+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 467777765543333334447788999999999998 89999999999999976653 58999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2e-09 Score=97.00 Aligned_cols=132 Identities=21% Similarity=0.340 Sum_probs=95.9
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEe-ecccccHHH-----HHHHHHHHHHhcccccCCeeeeeeEEEe-CcEEEEEEe
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRL-AKDNKDAKK-----EKEFLMELGIIGHVCHPNTATLVGCCIE-NGLYLIFNF 324 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~ 324 (558)
..+++|+-+.+|.+.+. |..+++|.= .|....+.- ...-.+|..++.++.--.|...+=+..+ +...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999764 444666643 332222221 2334578999988875544433333334 447899999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
++|..|.+.+... ...++..+-.-+.-||. .||+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888554 24567778888899998 8999999999999998765 99999999974
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=9.9e-09 Score=105.16 Aligned_cols=168 Identities=17% Similarity=0.299 Sum_probs=125.4
Q ss_pred CceEEEEE-EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEE-----eCcEEEEEEeccCC-CH
Q 008650 258 GYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI-----ENGLYLIFNFSQNG-NL 330 (558)
Q Consensus 258 ~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~lv~e~~~~g-sL 330 (558)
...+.|++ ...||..|++|+++..... .......-+++++++.|+|+|++.+++. +..+.|||+|.++. +|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 34678999 5568999999999433211 1111234567899999999999998876 23389999998764 67
Q ss_pred HHHHhhcc-------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 331 DAALHDER-------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 331 ~~~l~~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.+...... +...++...|.++.|+..||.++|+ .|+.-+-|.|.+||++.+.+++|+..|+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceee
Confidence 66543321 2346788999999999999999999 7888899999999999999999999998877
Q ss_pred CCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCC
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~P 449 (558)
+..+... | +.. -.+-|.=.||.+++.|.||..-
T Consensus 443 l~~d~~~--------------~--le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 443 LQEDPTE--------------P--LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ecCCCCc--------------c--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 6554311 0 110 1356888999999999999643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.5e-08 Score=99.62 Aligned_cols=141 Identities=16% Similarity=0.079 Sum_probs=99.9
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHH----------HHHHHHHHhcccccCCee--eeeeEEEe----
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEK----------EFLMELGIIGHVCHPNTA--TLVGCCIE---- 315 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~----------~~~~E~~~l~~l~h~niv--~l~~~~~~---- 315 (558)
+.+-......|++... +|+.|.||......... ..+ .+.+|...+.++...+|. .++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~-~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGE-IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHH-HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4455455556777765 57889999774333111 111 367888888777543333 33444432
Q ss_pred --CcEEEEEEeccCC-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC-------CC
Q 008650 316 --NGLYLIFNFSQNG-NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP-------DF 385 (558)
Q Consensus 316 --~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------~~ 385 (558)
...+||+|++++. +|.+++........+......++.+++..+.-||. .||+|+|+++.|||++. ++
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence 1378999999986 89888854333445666778899999999999999 89999999999999975 46
Q ss_pred ceEEEecccccc
Q 008650 386 EPQITDFGLAKW 397 (558)
Q Consensus 386 ~~kl~DFG~a~~ 397 (558)
.+.|+||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 789999998853
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.6e-09 Score=104.23 Aligned_cols=137 Identities=11% Similarity=0.108 Sum_probs=90.0
Q ss_pred CCcEEEEEEecCccch-------HHHHHHHHhhccCC-CCeEEEEEeecccccccccch-h-hhhhHHHHHHHHHHHHHH
Q 008650 5 APSKILIGFSLDPNDS-------KELLSWAIKVLAQP-NDRIVAIHVLVGEESKKRGSM-A-KRQSQIRRAKAHVISMLG 74 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s-------~~al~Wal~~~~~~-~d~~~llhv~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~l~ 74 (558)
..++|+||+|.|+ ++ ..||++|+.=.-.- +..|.+|||.+.......... . .........+. +..+
T Consensus 151 ~~~~Ilva~D~s~-~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 226 (305)
T PRK11175 151 EGGKILVAVNVAS-EEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIAIELPEFDPSVYNDAIRG---QHLL 226 (305)
T ss_pred CCCeEEEEeCCCC-CccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhccccccccchhhHHHHHHH---HHHH
Confidence 3579999999997 53 67999998654444 778999999864322110000 0 00011111111 1122
Q ss_pred HhHhccccCCcce-eEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEcc
Q 008650 75 EFAGTSQSKQVNL-EAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGE 148 (558)
Q Consensus 75 ~~~~~c~~~~v~~-~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~ 148 (558)
.++.+.+..++.. ...+..| ++.+.|++.|+..++|++|||+++.+.... +||++..+.++++ |+|.+++.
T Consensus 227 ~l~~~~~~~~~~~~~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS~a~~v~~~~~--~pVLvv~~ 300 (305)
T PRK11175 227 AMKALRQKFGIDEEQTHVEEG-LPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGNTAEHVIDHLN--CDLLAIKP 300 (305)
T ss_pred HHHHHHHHhCCChhheeeccC-CHHHHHHHHHHHhCCCEEEECCCccCCCcceeecchHHHHHhcCC--CCEEEEcC
Confidence 2333333345553 3556666 668899999999999999999997755433 8999999999999 99998853
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.9e-08 Score=89.00 Aligned_cols=141 Identities=17% Similarity=0.189 Sum_probs=106.5
Q ss_pred CCcEEEEEEe-cCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhh----hhhHHHHHHHHHHHHHHHhHhc
Q 008650 5 APSKILIGFS-LDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAK----RQSQIRRAKAHVISMLGEFAGT 79 (558)
Q Consensus 5 ~~r~i~Vavd-~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~~~ 79 (558)
..++|++++| .++ .+..|+.+|+......+..+.++||.............. .............+.++.++..
T Consensus 4 ~~~~il~~~d~~s~-~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (154)
T COG0589 4 MYKKILVAVDVGSE-AAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAPIPLSEEELEEEAEELLAEAKAL 82 (154)
T ss_pred ccceEEEEeCCCCH-HHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccchhhhhHHHHHHHHHHHHHHHHHH
Confidence 4579999999 998 999999999999888888899999986544321111100 0011112223334667777777
Q ss_pred cccCCcc-eeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEcc
Q 008650 80 SQSKQVN-LEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGE 148 (558)
Q Consensus 80 c~~~~v~-~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~ 148 (558)
....++. .+..+..|.+....|++.+...++|.+|||+++....+. +||++.++.++++ |+|.++..
T Consensus 83 ~~~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llGsvs~~v~~~~~--~pVlvv~~ 152 (154)
T COG0589 83 AEAAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLGSVAEKVLRHAP--CPVLVVRS 152 (154)
T ss_pred HHHcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCccccceeeehhHHHHHhcCC--CCEEEEcc
Confidence 6777777 589999997767899999999999999999997755543 9999999999999 99998764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.7e-08 Score=92.33 Aligned_cols=127 Identities=19% Similarity=0.190 Sum_probs=82.1
Q ss_pred EEEEEEECCCCEEEEEEeeccccc------------------------HHHHHHHHHHHHHhcccccC--CeeeeeeEEE
Q 008650 261 EVYKGNLSDGRKIAVKRLAKDNKD------------------------AKKEKEFLMELGIIGHVCHP--NTATLVGCCI 314 (558)
Q Consensus 261 ~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 314 (558)
.||.|...+|..+|||+....... ........+|.+.|.++... ++..++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 389998888999999987432110 11123456799999999865 45555544
Q ss_pred eCcEEEEEEecc--CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH-hhhCCCCcEEecCCCCCceeecCCCceEEEe
Q 008650 315 ENGLYLIFNFSQ--NGNLDAALHDERSKSLEWPIRYKIVLGVARGLHY-LHKGCKRRIIHRDIKASNVLLGPDFEPQITD 391 (558)
Q Consensus 315 ~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 391 (558)
+..++||||+. |..+..+.... ++......++.+++..+.. +|. .||+|+||.+.|||++++ .+.|+|
T Consensus 79 -~~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 -NRNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp -ETTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred -eCCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence 24579999998 65565444222 1123345677777775555 466 899999999999999987 999999
Q ss_pred ccccccC
Q 008650 392 FGLAKWL 398 (558)
Q Consensus 392 FG~a~~~ 398 (558)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.9e-09 Score=111.13 Aligned_cols=152 Identities=20% Similarity=0.331 Sum_probs=103.9
Q ss_pred HHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc-c------cccccccccCcccchhhcc
Q 008650 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH-H------AAIPIEGTFGYLAPEYFMH 424 (558)
Q Consensus 352 ~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~------~~~~~~gt~~y~aPE~~~~ 424 (558)
.+++.||.|+|.. .++||+.|.|++|.++.++..||+.|+++......... . ...-..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999984 68999999999999999999999999988654431110 0 0001113567999999999
Q ss_pred CCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCC
Q 008650 425 GIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSA 503 (558)
Q Consensus 425 ~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~ 503 (558)
...+.++|+|||||++|.+.. |+.-+....... .+.... ..+..-.-.+......++.+=+.+.+..++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~--------~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~ 254 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSR--------NLLNAGAFGYSNNLPSELRESLKKLLNGDSA 254 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhh--------cccccccccccccCcHHHHHHHHHHhcCCcc
Confidence 888999999999999999995 554444332211 111110 0111111112234456788888999999999
Q ss_pred CCCCHHHHHHH
Q 008650 504 WRPSMSEVLEL 514 (558)
Q Consensus 504 ~RPt~~evl~~ 514 (558)
-||++.++...
T Consensus 255 ~rp~~~~l~~~ 265 (700)
T KOG2137|consen 255 VRPTLDLLLSI 265 (700)
T ss_pred cCcchhhhhcc
Confidence 99988777653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.3e-07 Score=90.41 Aligned_cols=137 Identities=18% Similarity=0.141 Sum_probs=93.1
Q ss_pred CcccceEeeeCceEEEEEEECCCCEEEEEEeeccccc--------------------HHHHHHHHHHHHHhcccccC--C
Q 008650 248 FHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKD--------------------AKKEKEFLMELGIIGHVCHP--N 305 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~--n 305 (558)
..+++.||-|--+.||.|..+.|.++|||.=+....+ .-......+|..+|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567899999999999999889999999964221110 11234466799999988643 4
Q ss_pred eeeeeeEEEeCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC
Q 008650 306 TATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385 (558)
Q Consensus 306 iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 385 (558)
+...++ .+...+|||+++|-.|...-- +....-.++..|++-+.-+-. .||||+|+.+-||++++||
T Consensus 173 VP~P~~---~nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIA---WNRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCccc---cccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCC
Confidence 444443 345789999999976654321 111122233333333333323 7999999999999999999
Q ss_pred ceEEEecccccc
Q 008650 386 EPQITDFGLAKW 397 (558)
Q Consensus 386 ~~kl~DFG~a~~ 397 (558)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.3e-07 Score=86.62 Aligned_cols=140 Identities=14% Similarity=0.114 Sum_probs=102.3
Q ss_pred EeeeCceEEEEEEECCCCEEEEEEeeccc---cc-HHHHHHHHHHHHHhcccccCC--eeeeeeEEE--eCc---EEEEE
Q 008650 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDN---KD-AKKEKEFLMELGIIGHVCHPN--TATLVGCCI--ENG---LYLIF 322 (558)
Q Consensus 254 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~-~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~--~~~---~~lv~ 322 (558)
-|+||.+.|++.... |..+-+|+-...- .. +.....|.+|+..+.++..-+ +.+...+.. .+. .+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999998764 4478888764111 11 335677999999999886433 344442211 111 67999
Q ss_pred EeccC-CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc--eEEEecccccc
Q 008650 323 NFSQN-GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE--PQITDFGLAKW 397 (558)
Q Consensus 323 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~ 397 (558)
|-+.+ -+|.+++........+......++.+++..+.-||+ .|+.|+|+-+.|||++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 488888865444456777778999999999999999 89999999999999987677 99999976653
|
|
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=98.62 E-value=2e-07 Score=94.69 Aligned_cols=104 Identities=14% Similarity=0.160 Sum_probs=76.1
Q ss_pred CCcEEEEEEecCccchHHHHHHHHhhccCC--CCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhcccc
Q 008650 5 APSKILIGFSLDPNDSKELLSWAIKVLAQP--NDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQS 82 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s~~al~Wal~~~~~~--~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~ 82 (558)
.-+||+||||.|+ .|+.||+.|++-.-.. +..|.+|||.+....... .. .......++++.++..+.+
T Consensus 4 ~ykkILVavDGSe-~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~-----~~----~~~~~~eelle~~~~~~~~ 73 (357)
T PRK12652 4 AANRLLVPVADSV-TVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPE-----GQ----DELAAAEELLERVEVWATE 73 (357)
T ss_pred ccCeEEEEeCCCH-HHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccc-----hh----HHHHHHHHHHHHHHHHHHH
Confidence 4579999999999 9999999999976554 479999999875332111 00 1111123455555554443
Q ss_pred ------CCcceeEEEecC-------CchhhHHHHHHHhccCcEEEEecc
Q 008650 83 ------KQVNLEAKVGFS-------TSIGRGLIEEAKSISADYLVLRGS 118 (558)
Q Consensus 83 ------~~v~~~~~v~~g-------~~~~~~i~~~v~~~~~~~LV~G~~ 118 (558)
.+++++++++.+ +++.+.|+++|++.++|.+|||-.
T Consensus 74 ~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~ 122 (357)
T PRK12652 74 DLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPE 122 (357)
T ss_pred hhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCC
Confidence 589999999873 377889999999999999999987
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.7e-07 Score=86.71 Aligned_cols=125 Identities=22% Similarity=0.249 Sum_probs=88.0
Q ss_pred CCCEEEEEEeeccccc-----HHHHHHHHHHHHHhcccccCC--eeeeeeEEEeC-----cEEEEEEeccCC-CHHHHHh
Q 008650 269 DGRKIAVKRLAKDNKD-----AKKEKEFLMELGIIGHVCHPN--TATLVGCCIEN-----GLYLIFNFSQNG-NLDAALH 335 (558)
Q Consensus 269 ~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~-----~~~lv~e~~~~g-sL~~~l~ 335 (558)
.++.|-+|.+...... .-....+.+|...+..+..-+ ....+++.... ..++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 3556666654322111 112334667777776665332 34445554431 258999999885 7999886
Q ss_pred hccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC---ceEEEeccccccC
Q 008650 336 DERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF---EPQITDFGLAKWL 398 (558)
Q Consensus 336 ~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~ 398 (558)
.... .+......++.+++..+.-||. .||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 111 ~~~~--~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ--LDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc--cchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 5322 5566678899999999999999 8999999999999999887 7999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.9e-07 Score=96.28 Aligned_cols=143 Identities=16% Similarity=0.199 Sum_probs=93.3
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEeecccccH----------------------------H----------HHHHHHH
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDA----------------------------K----------KEKEFLM 293 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------~----------~~~~~~~ 293 (558)
+.|+.++-|.||+|.+.+|+.||||+.+..-... . .+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999985432110 0 0111233
Q ss_pred HHHHhcccc----cCCeeeeeeEEEe--CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHH-HHHhhhCCC
Q 008650 294 ELGIIGHVC----HPNTATLVGCCIE--NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARG-LHYLHKGCK 366 (558)
Q Consensus 294 E~~~l~~l~----h~niv~l~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~a-L~~LH~~~~ 366 (558)
|..-+.++. ...-+.+-.++.+ +...|+|||++|-.+.+...... ..++... ++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~--- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLR--- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHh---
Confidence 444444332 2233344444433 55789999999999988853333 3345332 22222222 111111
Q ss_pred CcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 367 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
.|++|.|..|.||+++.+|++.+.|||+...+++.
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 58999999999999999999999999999877543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.30 E-value=9.4e-06 Score=78.16 Aligned_cols=142 Identities=19% Similarity=0.236 Sum_probs=83.7
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC--eeeeeeEEEeC---c-EEEEEEe
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN--TATLVGCCIEN---G-LYLIFNF 324 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~---~-~~lv~e~ 324 (558)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+.... +..++.+.... . .+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 3579999999999998876 69999997543 34455667888887776433 45666654332 2 6899999
Q ss_pred ccCCCHHH----------------HH---hhcc--CCCCCHHH---------HHHH------------HHHHHH-HHHHh
Q 008650 325 SQNGNLDA----------------AL---HDER--SKSLEWPI---------RYKI------------VLGVAR-GLHYL 361 (558)
Q Consensus 325 ~~~gsL~~----------------~l---~~~~--~~~l~~~~---------~~~i------------~~~i~~-aL~~L 361 (558)
+++..+.. .+ +... ...+.... .... ...+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99988777 11 1111 11111110 0000 111222 33333
Q ss_pred hh----CCCCcEEecCCCCCceeec-CCCceEEEecccccc
Q 008650 362 HK----GCKRRIIHRDIKASNVLLG-PDFEPQITDFGLAKW 397 (558)
Q Consensus 362 H~----~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~ 397 (558)
+. .....++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 32 1346799999999999999 667778999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.4e-06 Score=76.57 Aligned_cols=139 Identities=16% Similarity=0.197 Sum_probs=90.7
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHH-HHHH------HHHHHHhccccc---CCeeeeeeEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKK-EKEF------LMELGIIGHVCH---PNTATLVGCC 313 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-~~~~------~~E~~~l~~l~h---~niv~l~~~~ 313 (558)
..++|...+++-......|.+... +|+.+++|.........+. ...| .+++..+..+.. -.+..++-+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 457888888888877777777766 5788999987654322221 1111 223333333322 2222322222
Q ss_pred E------eCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCce
Q 008650 314 I------ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEP 387 (558)
Q Consensus 314 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 387 (558)
. ....+++|||++|..|.+... +++ .++..+.+++.-||+ .|++|+|..|.|+++++++ +
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-E
Confidence 2 123568999999988866542 222 245667788999999 8999999999999998654 9
Q ss_pred EEEecccccc
Q 008650 388 QITDFGLAKW 397 (558)
Q Consensus 388 kl~DFG~a~~ 397 (558)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.5e-05 Score=76.79 Aligned_cols=138 Identities=17% Similarity=0.214 Sum_probs=80.5
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC--eeeeeeEEEeCc-EEEEEEeccCC
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN--TATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
..||+|..+.||+. .+..+++|...... .. ....+|.++++.+..-+ +.+.+.+..+++ ..+||+++.|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 25568889875432 11 23467888888776433 355566665544 67899999996
Q ss_pred C-HHHH---------------------HhhccCCCCCHHHHH-HHHH----------HHHH-HHHHhhh-CCCCcEEecC
Q 008650 329 N-LDAA---------------------LHDERSKSLEWPIRY-KIVL----------GVAR-GLHYLHK-GCKRRIIHRD 373 (558)
Q Consensus 329 s-L~~~---------------------l~~~~~~~l~~~~~~-~i~~----------~i~~-aL~~LH~-~~~~~ivH~D 373 (558)
. +... ||............. .+.. .+.. ...+|.. .....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 2111 111100111111000 0000 0111 1122221 1124679999
Q ss_pred CCCCceeecCCCceEEEecccccc
Q 008650 374 IKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 374 lkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
+.|.||++++++ +.++||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.23 E-value=8.8e-06 Score=77.25 Aligned_cols=156 Identities=21% Similarity=0.217 Sum_probs=97.6
Q ss_pred ccCHHHHHhhhCCCcccce---EeeeCceEEEEEEECCCCEEEEEEeecccccHHHH----------------------H
Q 008650 235 CFSYEEISSATNNFHSENM---VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKE----------------------K 289 (558)
Q Consensus 235 ~~~~~~~~~~~~~f~~~~~---lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~----------------------~ 289 (558)
..+.+.+....+...+... |..|--+.||+|...++..+|||++.......... .
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 3445555555556555544 55666778999987889999999985432221111 1
Q ss_pred HHHHHHHHhccccc--CCeeeeeeEEEeCcEEEEEEeccCCCH-HHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 008650 290 EFLMELGIIGHVCH--PNTATLVGCCIENGLYLIFNFSQNGNL-DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366 (558)
Q Consensus 290 ~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~ 366 (558)
-...|+.-|+++.. -.+.+-+.+. +-.|||||+....+ .-.|.+ -++.......+..++++.+.-|-..
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~---~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~-- 185 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR---NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKE-- 185 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec---CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHh--
Confidence 12346666666642 2333333332 34699999865421 111211 1222225666777788777777652
Q ss_pred CcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 367 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
.++||+||..-|||+. ++.+.|+|||-|....
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 5899999999999999 8899999999886543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.3e-05 Score=71.99 Aligned_cols=103 Identities=18% Similarity=0.202 Sum_probs=81.3
Q ss_pred HHHHHhccccc-CCeeeeeeEEEeCcEEEEEEeccCCCHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEE
Q 008650 293 MELGIIGHVCH-PNTATLVGCCIENGLYLIFNFSQNGNLDAALHD-ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370 (558)
Q Consensus 293 ~E~~~l~~l~h-~niv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv 370 (558)
.|.-+++.+.+ +++++++|+| +.+++.||...+++...-.. ......+|..+.+||.++++.+.+|+++....+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C---G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC---GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC---CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 46677777775 5999999998 55789999987766432100 1113478999999999999999999986655688
Q ss_pred ecCCCCCceeecCCCceEEEeccccccC
Q 008650 371 HRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 371 H~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
-.|++++|+-++++|++|++|...+...
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchh
Confidence 8999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.2e-07 Score=96.55 Aligned_cols=186 Identities=19% Similarity=0.176 Sum_probs=130.0
Q ss_pred CcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC-eeeeeeEEEeCc-EEEEEEec
Q 008650 248 FHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN-TATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-~~lv~e~~ 325 (558)
+...+-+++|+++.++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..+. ..+.++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 3445668899999999985433344446655332 23445788999999999 555555444333 78889999
Q ss_pred cCC-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 326 QNG-NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 326 ~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
.++ +-..... .....+...+...+...-+++|+|||+ ..-+|+| ||+..+ +..+..||+....+....
T Consensus 317 s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 317 STGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred cCCccccccCC-hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 887 2211110 001123334445566667789999997 3458998 887765 689999999988776543
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDS 452 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~ 452 (558)
...+..+|+.++|||+...+.+....|+|++|+--.+|--|..|-..
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 23346699999999999999999999999999988888888877544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.9e-05 Score=83.99 Aligned_cols=143 Identities=15% Similarity=0.173 Sum_probs=90.1
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEeecccccHH-----------------------------------HHHHHHHHHH
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAK-----------------------------------KEKEFLMELG 296 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----------------------------------~~~~~~~E~~ 296 (558)
+.||.-+.|.||+|..++|+.||||+-+..-.... .+-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 57999999999999999999999998754422110 0012333433
Q ss_pred Hhc----ccccCC---eeeeeeEEEe--CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 008650 297 IIG----HVCHPN---TATLVGCCIE--NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR 367 (558)
Q Consensus 297 ~l~----~l~h~n---iv~l~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ 367 (558)
-.. .+.|-+ -|.+-.++.+ ....|+|||++|..+.+.-.-.. ..++... ++..+.++.. +.-...
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~---i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHD---ILNKLVEAYL--EQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHH---HHHHHHHHHH--HHHHhc
Confidence 332 233444 2223333333 35789999999998866543322 2355443 3333333222 211125
Q ss_pred cEEecCCCCCceeecC----CCceEEEeccccccCCC
Q 008650 368 RIIHRDIKASNVLLGP----DFEPQITDFGLAKWLPN 400 (558)
Q Consensus 368 ~ivH~Dlkp~NIll~~----~~~~kl~DFG~a~~~~~ 400 (558)
|++|+|=.|.||+++. ++.+.+-|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999984 56899999999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.05 E-value=9.3e-05 Score=69.32 Aligned_cols=134 Identities=19% Similarity=0.297 Sum_probs=88.1
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeeccc--------------ccHHHHHHHHHHHHHhcccc------cCCeeeee
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDN--------------KDAKKEKEFLMELGIIGHVC------HPNTATLV 310 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------h~niv~l~ 310 (558)
...||+|+.-.||. ++++....||+..... ......++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46799999999995 4455668899986654 00112344555554444444 88899999
Q ss_pred eEEEeCc-EEEEEEeccC--C----CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC
Q 008650 311 GCCIENG-LYLIFNFSQN--G----NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP 383 (558)
Q Consensus 311 ~~~~~~~-~~lv~e~~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 383 (558)
|+...+. .-+|+|.+.+ | +|.+++.. ..++. ...+.+. +-..||-. ..|+.+|++|.||++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEEEe
Confidence 9987654 8899988643 2 57777733 33554 3333444 44456655 67999999999999954
Q ss_pred C--C--ceEEEe-ccccc
Q 008650 384 D--F--EPQITD-FGLAK 396 (558)
Q Consensus 384 ~--~--~~kl~D-FG~a~ 396 (558)
. + .+.|+| ||...
T Consensus 154 ~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred cCCCceEEEEEeCCCCcc
Confidence 3 2 477777 45443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.97 E-value=7.3e-05 Score=72.90 Aligned_cols=138 Identities=13% Similarity=0.082 Sum_probs=79.9
Q ss_pred EeeeCc-eEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeC-cEEEEEEeccCCCH
Q 008650 254 VGQGGY-SEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIEN-GLYLIFNFSQNGNL 330 (558)
Q Consensus 254 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~~~gsL 330 (558)
|-.|.+ ..||+.... +..+.||+..... ...+.+|+.+++.+. +--+.+++++...+ ..++||++++|.+|
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 444555 789999654 4678888875432 223456777777664 33455666666544 37899999999877
Q ss_pred HHHH-------------------hhccC--CCCCHH--HHHHHHH--------------------HHHHHHHHhhh----
Q 008650 331 DAAL-------------------HDERS--KSLEWP--IRYKIVL--------------------GVARGLHYLHK---- 363 (558)
Q Consensus 331 ~~~l-------------------~~~~~--~~l~~~--~~~~i~~--------------------~i~~aL~~LH~---- 363 (558)
.... |.... .++... ....... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 5432 11100 011100 0000000 01111222211
Q ss_pred CCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 364 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1124699999999999999987788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00036 Score=64.96 Aligned_cols=136 Identities=22% Similarity=0.324 Sum_probs=92.0
Q ss_pred CCccccCHHHHHhhhCCCcccceEeeeCc-eEEEEEEECCCCEEEEEEeec---ccc-------c---H------HHHHH
Q 008650 231 PLLTCFSYEEISSATNNFHSENMVGQGGY-SEVYKGNLSDGRKIAVKRLAK---DNK-------D---A------KKEKE 290 (558)
Q Consensus 231 ~~~~~~~~~~~~~~~~~f~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~-------~---~------~~~~~ 290 (558)
|.+..|+. -+.+++.++.||.|.- |.||+++. +|+.||+|+... ... . . .....
T Consensus 27 PKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 27 PKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred CCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 44455555 1267888999999999 99999987 577999999321 000 0 0 12235
Q ss_pred HHHHHHHhcccc---cCCe--eeeeeEEE-e---------------Cc---EEEEEEeccCCCHHHHHhhccCCCCCHHH
Q 008650 291 FLMELGIIGHVC---HPNT--ATLVGCCI-E---------------NG---LYLIFNFSQNGNLDAALHDERSKSLEWPI 346 (558)
Q Consensus 291 ~~~E~~~l~~l~---h~ni--v~l~~~~~-~---------------~~---~~lv~e~~~~gsL~~~l~~~~~~~l~~~~ 346 (558)
|..|.+...+++ +.++ ++.+||.. + .. ..+|.||.+... .+.
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~--- 166 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ--- 166 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc---
Confidence 777877777665 4455 88888862 1 00 356777765533 122
Q ss_pred HHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 347 RYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 347 ~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
.+-+.+|.+-|..+|. .||+-+|+++.|.. .-||+|||.+
T Consensus 167 -~~~~~~~~~dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 -IRDIPQMLRDLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -hhHHHHHHHHHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 2345567778888998 89999999999986 3589999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00022 Score=81.93 Aligned_cols=78 Identities=9% Similarity=0.254 Sum_probs=55.1
Q ss_pred cceEeeeCceEEEEEEECCC---CEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCe--eeeeeEEEeC----cEEE
Q 008650 251 ENMVGQGGYSEVYKGNLSDG---RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNT--ATLVGCCIEN----GLYL 320 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~----~~~l 320 (558)
...|+.|.+..+|+....++ ..+++|+....... .....+.+|+.+++.+. |.++ .+++.+|.+. ..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 46788999999999876554 46788876433211 12235678999998885 6654 7777777653 4889
Q ss_pred EEEeccCCC
Q 008650 321 IFNFSQNGN 329 (558)
Q Consensus 321 v~e~~~~gs 329 (558)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00025 Score=63.95 Aligned_cols=130 Identities=20% Similarity=0.228 Sum_probs=86.2
Q ss_pred cccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEeccCC
Q 008650 249 HSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNG 328 (558)
Q Consensus 249 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g 328 (558)
...+.|++|++|.||+|.+. |..+|+|+-..+.. ...+..|.++|..+.-.++-+=+-.+ +..++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~y--g~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFY--GEDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEe--chhhhhhhhhcCc
Confidence 44678999999999999875 55889998765543 33466788888888765554332222 2234559999998
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCC-CCceeecCCCceEEEecccccc
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIK-ASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~DFG~a~~ 397 (558)
.|.++-... +. +-...+++.-.-|-. .||-|+.|. |..++|-.++.+.|+||..|..
T Consensus 98 ~L~~~~~~~-----~r----k~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG-----DR----KHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc-----cH----HHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887765321 22 223345555444444 688888886 4444444445899999998874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00051 Score=66.44 Aligned_cols=73 Identities=16% Similarity=0.136 Sum_probs=45.6
Q ss_pred ceEeeeCceEEEEEEECC--CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCe-eeeeeEEEeCcEEEEEEeccCC
Q 008650 252 NMVGQGGYSEVYKGNLSD--GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT-ATLVGCCIENGLYLIFNFSQNG 328 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~~~g 328 (558)
+.|..|-...+|+....+ ++.|++|+...... ......+|+.+++.+...++ .++++.+ ++ .++|||++|.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~-~~--~~l~e~i~G~ 77 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF-QN--GLIYEFIPGR 77 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe-CC--cEEEEeeCCC
Confidence 467778888999997664 67899997754321 11122357777777753333 3343332 22 3799999987
Q ss_pred CH
Q 008650 329 NL 330 (558)
Q Consensus 329 sL 330 (558)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00034 Score=67.85 Aligned_cols=31 Identities=23% Similarity=0.297 Sum_probs=26.2
Q ss_pred CcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 367 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
..++|+|+.+.|||++.+...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4599999999999998765567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00021 Score=80.75 Aligned_cols=196 Identities=21% Similarity=0.198 Sum_probs=136.4
Q ss_pred HHHHHHHhcccccCCeeeeeeEEEeCc-----EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 008650 291 FLMELGIIGHVCHPNTATLVGCCIENG-----LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365 (558)
Q Consensus 291 ~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~ 365 (558)
...|+..+.+..|+|++.++.+..+.. ..+..+++..-++...+.. -..++....+.+..++.+||.|+|.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~-- 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHS-- 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHH--
Confidence 345777888889999999999876532 3344577888788777743 3567888888899999999999998
Q ss_pred CCcEEecCCCCC---ceeecCCCceEEE--eccccccCCCCCCcccccccccccCcccchhhccCCCCcc--ccchhHHH
Q 008650 366 KRRIIHRDIKAS---NVLLGPDFEPQIT--DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEK--TDVFAFGV 438 (558)
Q Consensus 366 ~~~ivH~Dlkp~---NIll~~~~~~kl~--DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k--sDvwSlGv 438 (558)
....|.-+..+ +...+.++.+.++ ||+.+..++....... ..-+..+.+||......++.+ .|+|.+|.
T Consensus 305 -~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 -LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred -hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHHH
Confidence 44445444444 4445666777777 9998887765443322 224566888988877766544 79999999
Q ss_pred HHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 439 LLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 439 vl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
.+..+..|..+-.... ....+++... ...+.+...+|+..++++|++..+++....
T Consensus 381 l~~~~~~~~~i~~~~~--------------~~~~~l~~~~--------~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA--------------VPVSLLDVLS--------TSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred HHhhhhhcCccccccc--------------chhhhhcccc--------chhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 9999999876532210 0011111111 014667789999999999999999998643
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00056 Score=79.15 Aligned_cols=125 Identities=11% Similarity=0.064 Sum_probs=91.2
Q ss_pred CCcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCC
Q 008650 5 APSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQ 84 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~ 84 (558)
...+|+|+|+.++ .|..++++|..-.-+-+..+++|||.++.... .... ....+++ ...+|++.+
T Consensus 249 ~~eriLV~v~~~~-~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~~---~~~~----------~~~~l~~-~~~lA~~lG 313 (895)
T PRK10490 249 TRDAILLCIGHNT-GSEKLVRTAARLAARLGSVWHAVYVETPRLHR---LPEK----------KRRAILS-ALRLAQELG 313 (895)
T ss_pred cCCeEEEEECCCc-chHHHHHHHHHHHHhcCCCEEEEEEecCCcCc---CCHH----------HHHHHHH-HHHHHHHcC
Confidence 4567999999999 89999999998877878899999998753211 0100 0112222 224666666
Q ss_pred cceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCccchhhhhhhhhcCCCCceEEEEc
Q 008650 85 VNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMSRDVTRYCFQHAPGGCTIHIFG 147 (558)
Q Consensus 85 v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~~~sv~~~c~~~~~~~c~v~~v~ 147 (558)
.+ +..+.|+|+.+.|.+.|+..+++.+|||.++....-+.+|+.....+.+++ =.++++.
T Consensus 314 a~--~~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~~~~~~~s~~~~l~r~~~~-idi~iv~ 373 (895)
T PRK10490 314 AE--TATLSDPAEEKAVLRYAREHNLGKIIIGRRASRRWWRRESFADRLARLGPD-LDLVIVA 373 (895)
T ss_pred CE--EEEEeCCCHHHHHHHHHHHhCCCEEEECCCCCCCCccCCCHHHHHHHhCCC-CCEEEEe
Confidence 65 556788899999999999999999999999765442256999998887764 3455554
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0015 Score=67.76 Aligned_cols=77 Identities=10% Similarity=0.099 Sum_probs=50.4
Q ss_pred ceEeeeCceEEEEEEECCC-CEEEEEEeecccc---c--HHHHHHHHHHHHHhcccc---cCCeeeeeeEEEeCcEEEEE
Q 008650 252 NMVGQGGYSEVYKGNLSDG-RKIAVKRLAKDNK---D--AKKEKEFLMELGIIGHVC---HPNTATLVGCCIENGLYLIF 322 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~---~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~lv~ 322 (558)
+.||.|.+..||++...+| +.++||.-..... . +.....+..|.+.|..+. ..++.+++.+. ++..++||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-~~~~~lVM 110 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-EELAVTVM 110 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-CCCCEEEE
Confidence 5789999999999988776 4899998532111 0 112334556777776653 23456666653 34478999
Q ss_pred EeccCCC
Q 008650 323 NFSQNGN 329 (558)
Q Consensus 323 e~~~~gs 329 (558)
|++++..
T Consensus 111 E~L~~~~ 117 (401)
T PRK09550 111 EDLSDHK 117 (401)
T ss_pred ecCCCcc
Confidence 9998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00065 Score=66.73 Aligned_cols=137 Identities=13% Similarity=0.105 Sum_probs=74.8
Q ss_pred EeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCe-eeeeeEEEeCcEEEEEEeccCCCHHH
Q 008650 254 VGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT-ATLVGCCIENGLYLIFNFSQNGNLDA 332 (558)
Q Consensus 254 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~~~gsL~~ 332 (558)
+..|-.+.+|+... +++.+++|......... .....+|..+++.+...++ .+++... .-++|++|++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~---~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN---EHWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe---CCEEEEEeccCccccc
Confidence 45677788998873 56788898764332111 0123457777777754333 2333332 2368999999876532
Q ss_pred -----------------HHhhccC--CCCCHH-HHHHHHHHH---------HHHHHHhhh-----CCCCcEEecCCCCCc
Q 008650 333 -----------------ALHDERS--KSLEWP-IRYKIVLGV---------ARGLHYLHK-----GCKRRIIHRDIKASN 378 (558)
Q Consensus 333 -----------------~l~~~~~--~~l~~~-~~~~i~~~i---------~~aL~~LH~-----~~~~~ivH~Dlkp~N 378 (558)
.||.... ..++.. ....+..++ ...+..+-. .....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1222111 111111 111111111 111221211 112468999999999
Q ss_pred eeecCCCceEEEecccccc
Q 008650 379 VLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 379 Ill~~~~~~kl~DFG~a~~ 397 (558)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0074 Score=60.66 Aligned_cols=75 Identities=9% Similarity=0.025 Sum_probs=51.8
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhccccc---CCeeeeeeEEEe----CcEEEEEE
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH---PNTATLVGCCIE----NGLYLIFN 323 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~----~~~~lv~e 323 (558)
.+.||.|..+.||+....++ .+.+|.. +... ....+..|...|+.+.. ..+.++++++.. +..++|||
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~-~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMA-RSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEe-cccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 46799999999999876555 4677774 3211 11246678877777753 356777777643 33899999
Q ss_pred eccCCCH
Q 008650 324 FSQNGNL 330 (558)
Q Consensus 324 ~~~~gsL 330 (558)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0085 Score=60.88 Aligned_cols=32 Identities=34% Similarity=0.363 Sum_probs=27.0
Q ss_pred CCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 366 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
+.++||+|+.|.||+++.+...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 46899999999999998665568999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.004 Score=61.84 Aligned_cols=31 Identities=23% Similarity=0.428 Sum_probs=26.0
Q ss_pred CcEEecCCCCCceeecCCCc-eEEEecccccc
Q 008650 367 RRIIHRDIKASNVLLGPDFE-PQITDFGLAKW 397 (558)
Q Consensus 367 ~~ivH~Dlkp~NIll~~~~~-~kl~DFG~a~~ 397 (558)
..++|+|++|.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997565 45999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.005 Score=61.82 Aligned_cols=141 Identities=18% Similarity=0.188 Sum_probs=80.3
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC--eeeeeeE-----E--EeCcEEEE
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN--TATLVGC-----C--IENGLYLI 321 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~--~~~~~~lv 321 (558)
.+.|..|....+|+....+ ..+++|+.... .. .....|+.++..+.+.+ +.+++.. + ..+..+++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~--~~---~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV--SA---EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC--Ch---HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 4567778888999986644 47899987541 11 22445666666664322 3333321 1 12347899
Q ss_pred EEeccCCCHHH--------------HHhhccC---------CCCCHHHHH----------HHHHHHHHHHHHhhh----C
Q 008650 322 FNFSQNGNLDA--------------ALHDERS---------KSLEWPIRY----------KIVLGVARGLHYLHK----G 364 (558)
Q Consensus 322 ~e~~~~gsL~~--------------~l~~~~~---------~~l~~~~~~----------~i~~~i~~aL~~LH~----~ 364 (558)
+++++|..+.. .+|.... ....|.... .....+..++.++.+ .
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99999876522 1111100 001111110 011122334444442 2
Q ss_pred CCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 365 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
...+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 235799999999999999887778999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0004 Score=68.37 Aligned_cols=135 Identities=15% Similarity=0.153 Sum_probs=90.5
Q ss_pred CcccceEeeeCceEEEEEEECCCCEEEEEEeecccccH--------------------HHHHHHHHHHHHhcccc-cCC-
Q 008650 248 FHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDA--------------------KKEKEFLMELGIIGHVC-HPN- 305 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~-h~n- 305 (558)
+..++.||-|--+-+|.+-..+|++.++|.-....... -..-...+|+..|+.+. |..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56788999999999999988889999998532111100 01123456777777775 222
Q ss_pred eeeeeeEEEeCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC
Q 008650 306 TATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385 (558)
Q Consensus 306 iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 385 (558)
+.+.++ .+..++|||++.+-.|...-+ ..+... +...+..-+--|-+ +|+||+|..--||++++++
T Consensus 174 VPkpiD---~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~---ly~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 174 VPKPID---HNRHCVVMELVDGYPLRQVRH-----VEDPPT---LYDDLMGLIVRLAN---HGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCccc---ccceeeHHHhhcccceeeeee-----cCChHH---HHHHHHHHHHHHHH---cCceecccchheeEEecCC
Confidence 223332 245789999998877765432 123333 33334444455555 8999999999999999999
Q ss_pred ceEEEeccccc
Q 008650 386 EPQITDFGLAK 396 (558)
Q Consensus 386 ~~kl~DFG~a~ 396 (558)
.++++||--+-
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999997554
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0074 Score=60.81 Aligned_cols=140 Identities=23% Similarity=0.284 Sum_probs=79.3
Q ss_pred ceEeeeCceEEEEEEECC-------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCe-eeeeeEEEeCcEEEEEE
Q 008650 252 NMVGQGGYSEVYKGNLSD-------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT-ATLVGCCIENGLYLIFN 323 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e 323 (558)
+.|..|-...+|+....+ ++.+++|+...... ......+|..++..+...++ .++++++. + .+|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~--~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFP-N--GRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeC-C--Cchhh
Confidence 456667777899987654 57899999754321 12234466666666653333 34444442 2 25789
Q ss_pred eccCCCHHHH-----------------HhhccCC-------CCC--HHHHHH--------------------------HH
Q 008650 324 FSQNGNLDAA-----------------LHDERSK-------SLE--WPIRYK--------------------------IV 351 (558)
Q Consensus 324 ~~~~gsL~~~-----------------l~~~~~~-------~l~--~~~~~~--------------------------i~ 351 (558)
|++|..+... +|..... ..+ +..... +.
T Consensus 78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (302)
T cd05156 78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL 157 (302)
T ss_pred eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence 9888765321 1111111 000 101000 11
Q ss_pred HHHHHHHHHhhh------CCCCcEEecCCCCCceeecCC----CceEEEecccccc
Q 008650 352 LGVARGLHYLHK------GCKRRIIHRDIKASNVLLGPD----FEPQITDFGLAKW 397 (558)
Q Consensus 352 ~~i~~aL~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~~ 397 (558)
..+...+.+|-. ..+..++|+|+.+.|||++.+ +.+.++||..|..
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 122223334431 134679999999999999985 8899999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0092 Score=60.05 Aligned_cols=141 Identities=17% Similarity=0.178 Sum_probs=92.8
Q ss_pred ccceEeeeCceEEEEEEECCCCEEEEEEeeccc----------------------ccHHHHH--HHHHHHHHhcccccCC
Q 008650 250 SENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDN----------------------KDAKKEK--EFLMELGIIGHVCHPN 305 (558)
Q Consensus 250 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~--~~~~E~~~l~~l~h~n 305 (558)
+...|..|--+.||.|...+|..+|||+++..- ..+.... -...|++-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345788899999999998899999999874221 0111111 1235777777777555
Q ss_pred eeeeeeEEEeCcEEEEEEeccCCCH-HHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC
Q 008650 306 TATLVGCCIENGLYLIFNFSQNGNL-DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD 384 (558)
Q Consensus 306 iv~l~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 384 (558)
|.-. .-..=.+..|||+|+..... .-.| +.-.++...+..+-.+++.-+.-|-+. .++||.||.--|+|+. +
T Consensus 228 IP~P-ePIlLk~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 228 IPCP-EPILLKNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCC-CceeeecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-C
Confidence 3322 11112335699999864222 2222 122456666777777888888877664 4699999999999995 5
Q ss_pred CceEEEecccccc
Q 008650 385 FEPQITDFGLAKW 397 (558)
Q Consensus 385 ~~~kl~DFG~a~~ 397 (558)
|.+.|+|-+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 6899999876653
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.049 Score=55.00 Aligned_cols=141 Identities=21% Similarity=0.251 Sum_probs=78.3
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC--eeeeeeEE-------EeCcEEEE
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN--TATLVGCC-------IENGLYLI 321 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~-------~~~~~~lv 321 (558)
...++.|....+|+....+| .+++|+...... .. ....|++++..+...+ +.+++... .++..+++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~-~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK-AE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC-HH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 45677777789999876544 588898754221 12 2334555555553222 33333211 12337899
Q ss_pred EEeccCCCHH-----------H---HHhhccCC---C-------CCHHHHH------------HHHHHHHHHHHHhhh--
Q 008650 322 FNFSQNGNLD-----------A---ALHDERSK---S-------LEWPIRY------------KIVLGVARGLHYLHK-- 363 (558)
Q Consensus 322 ~e~~~~gsL~-----------~---~l~~~~~~---~-------l~~~~~~------------~i~~~i~~aL~~LH~-- 363 (558)
++|++|..+. . .+|..... . -.|.... .....+...++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 9999885431 1 12211110 0 0111100 011123344555532
Q ss_pred --CCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 364 --GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 364 --~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234789999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.012 Score=60.00 Aligned_cols=76 Identities=13% Similarity=0.017 Sum_probs=44.4
Q ss_pred eEeeeCceEEEEEEECCC-CEEEEEEeecccc-----cHHHHHHHHHHHHHhcccc--cCCeeeeeeEEEeCcEEEEEEe
Q 008650 253 MVGQGGYSEVYKGNLSDG-RKIAVKRLAKDNK-----DAKKEKEFLMELGIIGHVC--HPNTATLVGCCIENGLYLIFNF 324 (558)
Q Consensus 253 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~lv~e~ 324 (558)
.||.|....||++...+| +.++||.-..... -+-.......|...|+... -|..++-+-++.++...+|||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 579999999999976654 5799996431110 0111223335666665543 3444443334444456799999
Q ss_pred ccCC
Q 008650 325 SQNG 328 (558)
Q Consensus 325 ~~~g 328 (558)
++..
T Consensus 82 L~~~ 85 (370)
T TIGR01767 82 LSHH 85 (370)
T ss_pred Cccc
Confidence 8653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.02 Score=57.46 Aligned_cols=32 Identities=22% Similarity=0.423 Sum_probs=28.8
Q ss_pred CcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 367 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
..++|+|+.+.||+++.++-+=+.||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 47999999999999999988999999998753
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.00058 Score=79.06 Aligned_cols=157 Identities=10% Similarity=-0.087 Sum_probs=110.5
Q ss_pred HHHHHhcccccCCeeeeeeEEEe---CcEEEEEEeccCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHhhhC--C
Q 008650 293 MELGIIGHVCHPNTATLVGCCIE---NGLYLIFNFSQNGNLDAALHDERS--KSLEWPIRYKIVLGVARGLHYLHKG--C 365 (558)
Q Consensus 293 ~E~~~l~~l~h~niv~l~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~--~ 365 (558)
.|...++...|+++...+.-... ...+..++++.+|.+...|-.... ..+...-+...-.+...+..-+|.. .
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 34445555679888777655433 237899999999999998865422 2233322222222324455555542 2
Q ss_pred CCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc
Q 008650 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT 445 (558)
Q Consensus 366 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt 445 (558)
+.-.+|+++|+-|.+|..+..+|++++|+.+..... ........+++.|++|+....-.++.++|+|..|+.+|++.-
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 244789999999999999999999999999832221 112223457889999999988899999999999999999999
Q ss_pred CCCCCC
Q 008650 446 GRKPVD 451 (558)
Q Consensus 446 g~~Pf~ 451 (558)
|..+|-
T Consensus 1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred ccHHHH
Confidence 888763
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.018 Score=59.14 Aligned_cols=140 Identities=18% Similarity=0.221 Sum_probs=77.9
Q ss_pred ceEeeeCceEEEEEEECC-----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCee-eeeeEEEeCcEEEEEEec
Q 008650 252 NMVGQGGYSEVYKGNLSD-----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA-TLVGCCIENGLYLIFNFS 325 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~ 325 (558)
..|-.|-...+|++...+ ++.|++|+..... .....-.+|..+++.+...++. ++++.+ .++ .|++|+
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~-~~g--~v~efi 115 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRF-PNG--RVEEFI 115 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEE-CCc--eEEEee
Confidence 345557888899986532 3679999885432 1111224577777777643333 445554 333 578998
Q ss_pred cCCCHHHH-----------------HhhccCC----CCCHHHHHHHHHH-----------------HHHHHHHh----hh
Q 008650 326 QNGNLDAA-----------------LHDERSK----SLEWPIRYKIVLG-----------------VARGLHYL----HK 363 (558)
Q Consensus 326 ~~gsL~~~-----------------l~~~~~~----~l~~~~~~~i~~~-----------------i~~aL~~L----H~ 363 (558)
++.+|... +|..... ...+....++..+ +...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 77666321 1211100 1112222222211 11111122 11
Q ss_pred -CCCCcEEecCCCCCceeecC-CCceEEEecccccc
Q 008650 364 -GCKRRIIHRDIKASNVLLGP-DFEPQITDFGLAKW 397 (558)
Q Consensus 364 -~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~ 397 (558)
.....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22357999999999999986 46899999988764
|
|
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.02 Score=45.70 Aligned_cols=81 Identities=22% Similarity=0.222 Sum_probs=60.6
Q ss_pred EEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCCccee
Q 008650 9 ILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQVNLE 88 (558)
Q Consensus 9 i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v~~~ 88 (558)
|+|+++.+. .|..+|.||.... +.+..++++|+-
T Consensus 1 ilv~~sgg~-dS~~~l~~~~~~~-~~~~~~~~~~~~-------------------------------------------- 34 (86)
T cd01984 1 ILVALSGGL-DSSVLLHLAKRLK-SGGPEVVALVVV-------------------------------------------- 34 (86)
T ss_pred CEEEeeCCH-HHHHHHHHHHHHH-hcCCCEEEEEeH--------------------------------------------
Confidence 689999999 8999999999975 455577777774
Q ss_pred EEEecCCchhhHHHHHHHhccCcEEEEecccccC--Cccch-hhhhhhhhcCCCCceEE
Q 008650 89 AKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHS--NKMSR-DVTRYCFQHAPGGCTIH 144 (558)
Q Consensus 89 ~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~--~~~~~-sv~~~c~~~~~~~c~v~ 144 (558)
...+.+.+.+++.+++.+++|.++... ....+ ++...+...++ |++.
T Consensus 35 -------~~~~~~~~~a~~~~~~~Iv~G~~~~d~~~~~~~~~~~~~~~~~~~~--~~vl 84 (86)
T cd01984 35 -------AFVRILKRLAAEEGADVIILGHNADDVAGRRLGASANVLVVIKGAG--IPVL 84 (86)
T ss_pred -------HHHHHHHHHHHHcCCCEEEEcCCchhhhhhccCchhhhhhcccccC--Ccee
Confidence 345577788889999999999996643 22244 66677766666 6653
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 558 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-55 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-46 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-28 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 398 bits (1025), Expect = e-136
Identities = 120/307 (39%), Positives = 181/307 (58%), Gaps = 15/307 (4%)
Query: 236 FSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMEL 295
FS E+ A++NF ++N++G+GG+ +VYKG L+DG +AVKRL K+ + E +F E+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERTQGGELQFQTEV 78
Query: 296 GIIGHVCHPNTATLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKS--LEWPIRYKIVL 352
+I H N L G C+ L++ + NG++ + L + L+WP R +I L
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIP--I 410
G ARGL YLH C +IIHRD+KA+N+LL +FE + DFGLAK + K TH + +
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---VTTAV 195
Query: 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR------QNLVLWAKPL 464
GT G++APEY G EKTDVF +GV+LLE+ITG++ D +R L+ W K L
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFA 524
++ L LVD L+G Y +++ +L+ +A C + + RP MSEV+ +L +E
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315
Query: 525 KSWRMPE 531
+ W+ E
Sbjct: 316 EEWQKEE 322
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-124
Identities = 111/313 (35%), Positives = 171/313 (54%), Gaps = 12/313 (3%)
Query: 210 SILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSD 269
S S N +LS+ ++ ATNNF + ++G G + +VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 270 GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG 328
G K+A+KR + ++ +EF E+ + HP+ +L+G C E + LI+ + +NG
Sbjct: 63 GAKVALKRR--TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 329 NLDAALH--DERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386
NL L+ D + S+ W R +I +G ARGLHYLH IIHRD+K+ N+LL +F
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 387 PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITG 446
P+ITDFG++K H + ++GT GY+ PEYF+ G + EK+DV++FGV+L E++
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 447 RKPVDSSR----QNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTS 502
R + S NL WA +G L ++VDP+L + + + + A C+ +S
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 503 AWRPSMSEVLELL 515
RPSM +VL L
Sbjct: 298 EDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 351 bits (904), Expect = e-118
Identities = 94/298 (31%), Positives = 154/298 (51%), Gaps = 19/298 (6%)
Query: 233 LTCFSYEEISSATNNFHSE------NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAK 286
FS+ E+ + TNNF N +G+GG+ VYKG + + +AVK+LA
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 287 K--EKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHD-ERSKSL 342
+ +++F E+ ++ H N L+G + L L++ + NG+L L + + L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 343 EWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402
W +R KI G A G+++LH+ IHRDIK++N+LL F +I+DFGLA+
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSR--QNLVLW 460
I GT Y+APE + G I K+D+++FGV+LLEIITG VD R Q L+
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 461 AKPLM-ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517
+ + E + + +D + + D+ + + +A C+ + RP + +V +LL
Sbjct: 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 5e-72
Identities = 73/309 (23%), Positives = 111/309 (35%), Gaps = 34/309 (11%)
Query: 236 FSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMEL 295
E + + + +G + V+K L +AVK K+ + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF---PIQDKQSWQNEYEV 69
Query: 296 GIIGHVCHPNTATLVGCCIENG-----LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKI 350
+ + H N +G L+LI F + G+L L + + W I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHI 126
Query: 351 VLGVARGLHYLH-------KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403
+ARGL YLH G K I HRDIK+ NVLL + I DFGLA +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 404 HHAAIPIEGTFGYLAPEYFMHGII-----DEKTDVFAFGVLLLEIITGRKPVDSSRQNLV 458
GT Y+APE I + D++A G++L E+ + D +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 459 L------WAKPL---MESGNLTELVDPSLEGEYDTDQ-MHRLVLIADYCVRQTSAWRPSM 508
L P M+ + + P L + M L + C + R S
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 509 SEVLELLTS 517
V E +T
Sbjct: 307 GCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-54
Identities = 72/322 (22%), Positives = 121/322 (37%), Gaps = 49/322 (15%)
Query: 236 FSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMEL 295
+ E S +N ++G+G Y VYKG+L D R +AVK + N + F+ E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEK 56
Query: 296 GI--IGHVCHPNTATLVGCCIENG------LYLIFNFSQNGNLDAALHDERSKSLEWPIR 347
I + + H N A + L+ + NG+L L + +W
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSS 113
Query: 348 YKIVLGVARGLHYLH------KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK----- 396
++ V RGL YLH K I HRD+ + NVL+ D I+DFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 397 -WLPNKCTHHAAIPIEGTFGYLAPEYFMHGI-------IDEKTDVFAFGVLLLEIITGRK 448
+ +AAI GT Y+APE + ++ D++A G++ EI
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 449 ---PVDSSRQNLVLWAKPLMESGNLTELVD--------PSLEGEYDTDQ--MHRLVLIAD 495
P +S + + + + ++ P + + + L +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 496 YCVRQTSAWRPSMSEVLELLTS 517
C Q + R + E +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAE 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-53
Identities = 75/293 (25%), Positives = 126/293 (43%), Gaps = 45/293 (15%)
Query: 237 SYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELG 296
S I E +VG+G + V K + +A+K++ + + K F++EL
Sbjct: 1 SLHMIDY--KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI----ESESERKAFIVELR 53
Query: 297 IIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKS-LEWPIRYKIVLGVA 355
+ V HPN L G C+ + L+ +++ G+L LH L +
Sbjct: 54 QLSRVNHPNIVKLYGACLNP-VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFE-PQITDFGLAKWLPNKCTHHAAIPIEGTF 414
+G+ YLH + +IHRD+K N+LL +I DFG A + T++ G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----GSA 167
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474
++APE F EK DVF++G++L E+IT RKP + E+
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----------FD----------EIG 207
Query: 475 DPSLEGEYDTDQMHRLVLIADY----------CVRQTSAWRPSMSEVLELLTS 517
P+ + R LI + C + + RPSM E+++++T
Sbjct: 208 GPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-51
Identities = 69/283 (24%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 251 ENMVGQGGYSEVYKGN-LSDGRKIAVKRL-----AKDNKDAKKEKEFLMELGIIGHVCHP 304
E +G+GG+ V+KG + D +A+K L + + +K +EF E+ I+ ++ HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 305 NTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
N L G N ++ F G+L L D ++ ++W ++ +++L +A G+ Y+
Sbjct: 84 NIVKLYGLMH-NPPRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQ-----ITDFGLAKWLPNKCTHHAAIPIEGTFGYLAP 419
I+HRD+++ N+ L E + DFGL++ + + G F ++AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL-----GNFQWMAP 195
Query: 420 EYFM--HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG---NLTELV 474
E EK D ++F ++L I+TG P D + + + E G + E
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDC 255
Query: 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517
P L +I C RP S +++ L+
Sbjct: 256 PPRLRN-----------VIEL-CWSGDPKKRPHFSYIVKELSE 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-50
Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 8/202 (3%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
+ +G G + V++ G +AVK L + + A++ EFL E+ I+ + HPN +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 311 GCCIENG-LYLIFNFSQNGNLDAALHD-ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
G + L ++ + G+L LH + L+ R + VA+G++YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAK-WLPNKCTHHAAIPIEGTFGYLAPEYFMHGII 427
I+HR++K+ N+L+ + ++ DFGL++ + +A GT ++APE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA---GTPEWMAPEVLRDEPS 216
Query: 428 DEKTDVFAFGVLLLEIITGRKP 449
+EK+DV++FGV+L E+ T ++P
Sbjct: 217 NEKSDVYSFGVILWELATLQQP 238
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-50
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRL--AKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
E ++G GG+ +VY+ G ++AVK D ++ + E + + HPN
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 309 LVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR 367
L G C++ L L+ F++ G L+ L K + I + +ARG++YLH
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 368 RIIHRDIKASNVLLGPDFEPQ--------ITDFGLAKWLPNKCTHHAAIPIEGTFGYLAP 419
IIHRD+K+SN+L+ E ITDFGLA+ ++ T +A G + ++AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAA---GAYAWMAP 183
Query: 420 EYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
E + + +DV+++GVLL E++TG P
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-49
Identities = 44/205 (21%), Positives = 82/205 (40%), Gaps = 15/205 (7%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
+ + E++KG G I VK L + +K ++F E + HPN ++
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 311 GCCIE---NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR 367
G C LI ++ G+L LH+ + ++ K L +ARG+ +LH +
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH--- 424
I + + +V++ D +I+ + + ++APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPEALQKKPE 185
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKP 449
D+++F VLL E++T P
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVP 210
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-49
Identities = 68/271 (25%), Positives = 121/271 (44%), Gaps = 22/271 (8%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
+G G + VYKG +AVK L ++ + F E+G++ H N +
Sbjct: 29 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 311 GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
G L ++ + + +L LH +K E I ARG+ YLH + II
Sbjct: 87 GYSTAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE---YFMHGII 427
HRD+K++N+ L D +I DFGLA H + G+ ++APE
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 428 DEKTDVFAFGVLLLEIITGRKP---VDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484
++DV+AFG++L E++TG+ P +++ Q ++ + G+L+ + +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEM---VGRGSLSPDLSKVRS---NC 254
Query: 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+ R+ + C+++ RPS +L +
Sbjct: 255 PK--RMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 64/279 (22%), Positives = 107/279 (38%), Gaps = 30/279 (10%)
Query: 251 ENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
++G+G + + K G + +K L D + ++ FL E+ ++ + HPN
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 310 VGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
+G ++ L I + + G L + S+ W R +A G+ YLH
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIE-------GTFGY 416
IIHRD+ + N L+ + + DFGLA+ + + + P G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476
+APE DEK DVF+FG++L EII L + + V
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----------DPDYLPRTMDFGLNVRG 238
Query: 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
L+ + I C RPS ++ L
Sbjct: 239 FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-46
Identities = 58/281 (20%), Positives = 112/281 (39%), Gaps = 33/281 (11%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
++G+G + +VY G ++A++ + + + + K F E+ H N +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 311 GCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
G C+ L +I + + L + + D + L+ +I + +G+ YLH + I
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAK----WLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
+H+D+K+ NV + + ITDFGL + I G +LAPE
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN-GWLCHLAPEIIRQL 209
Query: 426 II---------DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476
+ +DVFA G + E+ P + ++W M +G L
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ---MGTGMKPNLSQI 266
Query: 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517
+ E + I +C RP+ ++++++L
Sbjct: 267 GMGKE--------ISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-43
Identities = 66/296 (22%), Positives = 117/296 (39%), Gaps = 38/296 (12%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRL-AKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
VG+G Y EV++G+ G +AVK ++D K +E E + H N
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELY----NTVMLRHENILGF 67
Query: 310 VGCCI-----ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH-- 362
+ + L+LI ++ + G+L L +L+ +IVL +A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 363 ---KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIE--GTFGYL 417
K I HRD+K+ N+L+ + + I D GLA GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 418 APEYFMHGII------DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471
APE I ++ D++AFG++L E+ + + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 472 ELVD--------PSLEGEYDTDQMHRLV--LIADYCVRQTSAWRPSMSEVLELLTS 517
++ P++ + +D + L+ + C Q + R + + + LT
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE-CWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-42
Identities = 66/296 (22%), Positives = 112/296 (37%), Gaps = 38/296 (12%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRL-AKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
+G+G Y EV+ G G K+AVK + +E E + H N
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIY----QTVLMRHENILGF 96
Query: 310 VGCCIENG-----LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH-- 362
+ I+ LYLI ++ +NG+L L S +L+ K+ GL +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 363 ---KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIE--GTFGYL 417
K I HRD+K+ N+L+ + I D GLA + P GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 418 APE------YFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471
PE H D+++FG++L E+ + + + + +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 472 ELVD--------PSLEGEYDTDQMHRLV--LIADYCVRQTSAWRPSMSEVLELLTS 517
++ + PS + +D+ R + L+ + C A R + V + L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE-CWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 59/297 (19%), Positives = 119/297 (40%), Gaps = 40/297 (13%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGI--IGHVCHPNTAT 308
+ +G+G + EV++G G ++AVK + E+ + E I + H N
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILG 100
Query: 309 LVGCCIENG-----LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH- 362
+ ++ L+L+ ++ ++G+L L+ ++ K+ L A GL +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 363 ----KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIE--GTFGY 416
K I HRD+K+ N+L+ + I D GLA + P GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 417 LAPE------YFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL 470
+APE H ++ D++A G++ EI + + + ++
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 471 TELVD--------PSLEGEYDTDQMHRLV--LIADYCVRQTSAWRPSMSEVLELLTS 517
E+ P++ + + + R++ ++ + C A R + + + L+
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE-CWYANGAARLTALRIKKTLSQ 333
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-39
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 255 GQGGYSEVYKGNLSDGRK-----IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
G G + VYKG + +A+K L ++ K KE L E ++ V +P+ L
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 310 VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
+G C+ + + LI G L + + + + + +A+G++YL RR+
Sbjct: 83 LGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLE---DRRL 138
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPEYFMHG 425
+HRD+ A NVL+ +ITDFGLAK L +PI+ A E +H
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHR 194
Query: 426 IIDEKTDVFAFGVLLLEIIT-GRKP 449
I ++DV+++GV + E++T G KP
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 251 ENMVGQGGYSEVYKGNLSDGR----KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
++G+G + V +GNL K+AVK + DN ++ +EFL E + HPN
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 307 ATLVGCCIENG------LYLIFNFSQNGNLDAALHDERSKSLEWPIRYK----IVLGVAR 356
L+G CIE +I F + G+L L R ++ I + ++ +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEG 412
G+ YL R +HRD+ A N +L D + DFGL+K + + + A +P++
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 413 TFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
A E + K+DV+AFGV + EI T G P
Sbjct: 216 I----AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-37
Identities = 61/237 (25%), Positives = 109/237 (45%), Gaps = 22/237 (9%)
Query: 226 KEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGR----KIAVKRLAKD 281
++ LL I HS+ ++G+G + VY G D + A+K L
Sbjct: 1 RDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SR 59
Query: 282 NKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG--LYLIFNFSQNGNLDAALHDERS 339
+ ++ + FL E ++ + HPN L+G + +++ + +G+L + +
Sbjct: 60 ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ- 118
Query: 340 KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL- 398
++ L VARG+ YL + ++ +HRD+ A N +L F ++ DFGLA+ +
Sbjct: 119 RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175
Query: 399 -----PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+ HA +P++ T A E K+DV++FGVLL E++T G P
Sbjct: 176 DREYYSVQQHRHARLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-37
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 255 GQGGYSEVYKGNLSDGRK-----IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
G G + VYKG + +A+K L ++ K KE L E ++ V +P+ L
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 310 VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
+G C+ + + LI G L + + + + + +A+G++YL RR+
Sbjct: 83 LGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLE---DRRL 138
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPEYFMHG 425
+HRD+ A NVL+ +ITDFGLAK L +PI+ A E +H
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHR 194
Query: 426 IIDEKTDVFAFGVLLLEIIT-GRKP 449
I ++DV+++GV + E++T G KP
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRK-----IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
++G G + V+KG + + +K + +D + + + IG + H +
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 306 TATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
L+G C + L L+ + G+L + R +L + + +A+G++YL
Sbjct: 77 IVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPEY 421
+ ++HR++ A NVLL + Q+ DFG+A LP A PI+ A E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----ALES 188
Query: 422 FMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
G ++DV+++GV + E++T G +P
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-36
Identities = 64/267 (23%), Positives = 108/267 (40%), Gaps = 25/267 (9%)
Query: 195 LSNTRMRMSPGKFFTSIL---------SSPLRKRNGSLSNKEKHQPLLTCFSYEEISSAT 245
+++ + +F +++ + L R E F +
Sbjct: 133 YHASKLSIDEEVYFENLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNM 192
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+G+G + +V G+ G K+AVK + K+ + FL E ++ + H N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSN 247
Query: 306 TATLVGCCIENG--LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
L+G +E LY++ + G+L L L K L V + YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
+HRD+ A NVL+ D +++DFGL K + +P++ T APE
Sbjct: 308 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKWT----APEALR 359
Query: 424 HGIIDEKTDVFAFGVLLLEIIT-GRKP 449
K+DV++FG+LL EI + GR P
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 255 GQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314
G G + EV+ G + K+AVK L + + FL E ++ + H L
Sbjct: 22 GAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 315 ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDI 374
+ +Y+I + +NG+L L L + +A G+ ++ +R IHRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 375 KASNVLLGPDFEPQITDFGLAKWLPNK---CTHHAAIPIEGTFGYLAPEYFMHGIIDEKT 431
+A+N+L+ +I DFGLA+ + + A PI+ T APE +G K+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTFTIKS 191
Query: 432 DVFAFGVLLLEIIT-GRKP 449
DV++FG+LL EI+T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 255 GQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G+G + EV+ G L +D +AVK ++ + +FL E I+ HPN L+G C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 314 IENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
+ +Y++ Q G+ L E ++ L ++V A G+ YL + IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLES---KCCIHR 237
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFGYLAPEYFMHGIID 428
D+ A N L+ +I+DFG+++ + +P++ T APE +G
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYGRYS 293
Query: 429 EKTDVFAFGVLLLEIIT-GRKP 449
++DV++FG+LL E + G P
Sbjct: 294 SESDVWSFGILLWETFSLGASP 315
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 67/286 (23%), Positives = 121/286 (42%), Gaps = 23/286 (8%)
Query: 178 EDSSISQSPPQAPKTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQP-LLTCF 236
++ P +P G+ + + + + N + P L+
Sbjct: 20 SVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAV 79
Query: 237 SYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRK----IAVKRLAKDNKDAKKEKEFL 292
+ I ++ H ++G+G + VY G L D AVK L D + +FL
Sbjct: 80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL 138
Query: 293 MELGIIGHVCHPNTATLVGCCIENG--LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKI 350
E I+ HPN +L+G C+ + ++ + ++G+L + +E +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGF 197
Query: 351 VLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK------CTH 404
L VA+G+ +L ++ +HRD+ A N +L F ++ DFGLA+ + +K
Sbjct: 198 GLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 254
Query: 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
A +P++ A E K+DV++FGVLL E++T G P
Sbjct: 255 GAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 255 GQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314
GQG + EV+ G + ++A+K L + FL E ++ + H L
Sbjct: 193 GQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 315 ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDI 374
E +Y++ + G+L L E K L P + +A G+ Y+ + +HRD+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 375 KASNVLLGPDFEPQITDFGLAKWLPNK---CTHHAAIPIEGTFGYLAPEYFMHGIIDEKT 431
+A+N+L+G + ++ DFGLA+ + + A PI+ T APE ++G K+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTIKS 362
Query: 432 DVFAFGVLLLEIIT-GRKP 449
DV++FG+LL E+ T GR P
Sbjct: 363 DVWSFGILLTELTTKGRVP 381
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 249 HSENMVGQGGYSEVYKGNLSDGRK----IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
H ++G+G + VY G L D AVK L D + +FL E I+ HP
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 305 NTATLVGCCIENG--LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
N +L+G C+ + ++ + ++G+L + +E + L VA+G+ YL
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLA 145
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK------CTHHAAIPIEGTFGY 416
++ +HRD+ A N +L F ++ DFGLA+ + +K A +P++
Sbjct: 146 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM--- 199
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
A E K+DV++FGVLL E++T G P
Sbjct: 200 -ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 57/211 (27%), Positives = 83/211 (39%), Gaps = 12/211 (5%)
Query: 242 SSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGH 300
S +F + +G G Y EV+K + DGR AVKR + K L E+G
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 301 VC-HPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGL 358
V HP L E G LYL +L + E + + L
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW-GYLRDTLLAL 170
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLA 418
+LH + ++H D+K +N+ LGP ++ DFGL L EG Y+A
Sbjct: 171 AHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMA 224
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
PE DVF+ G+ +LE+ +
Sbjct: 225 PELLQGS-YGTAADVFSLGLTILEVACNMEL 254
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-36
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 251 ENMVGQGGYSEVYKGNLSDG----RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
M+G+G + V + L K+AVK L D + +EFL E + HP+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 307 ATLVGCCIENG-------LYLIFNFSQNGNLDAALHDERSKSLEWPIRYK----IVLGVA 355
A LVG + + +I F ++G+L A L R + + + ++ +A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIE 411
G+ YL R IHRD+ A N +L D + DFGL++ + + + + +P++
Sbjct: 148 CGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 412 GTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
A E + +DV+AFGV + EI+T G+ P
Sbjct: 205 WL----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-35
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 255 GQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314
GQG + EV+ G + ++A+K L + FL E ++ + H L
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 315 ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDI 374
E +Y++ + G+L L E K L P + +A G+ Y+ + +HRD+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 375 KASNVLLGPDFEPQITDFGLAKWLPNKC---THHAAIPIEGTFGYLAPEYFMHGIIDEKT 431
+A+N+L+G + ++ DFGLA+ + + A PI+ T APE ++G K+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTIKS 445
Query: 432 DVFAFGVLLLEIIT-GRKP 449
DV++FG+LL E+ T GR P
Sbjct: 446 DVWSFGILLTELTTKGRVP 464
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 255 GQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314
G G + EV+ + K+AVK + + + FL E ++ + H L
Sbjct: 197 GAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 315 ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDI 374
+ +Y+I F G+L L + P +A G+ ++ +R IHRD+
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 310
Query: 375 KASNVLLGPDFEPQITDFGLAKWLPNK---CTHHAAIPIEGTFGYLAPEYFMHGIIDEKT 431
+A+N+L+ +I DFGLA+ + + A PI+ T APE G K+
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFGSFTIKS 366
Query: 432 DVFAFGVLLLEIIT-GRKP 449
DV++FG+LL+EI+T GR P
Sbjct: 367 DVWSFGILLMEIVTYGRIP 385
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 61/291 (20%), Positives = 121/291 (41%), Gaps = 49/291 (16%)
Query: 242 SSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGH 300
+F ++G GG+ +V+K + DG+ +KR+ +N+ A++E + L +L
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKL----- 61
Query: 301 VCHPN-----------------TATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLE 343
H N ++ L++ F G L+ + R + L+
Sbjct: 62 -DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 344 WPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403
+ ++ + +G+ Y+H +++I+RD+K SN+ L + +I DFGL L N
Sbjct: 121 KVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463
+ GT Y++PE ++ D++A G++L E++
Sbjct: 178 RTRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV--------------CDT 220
Query: 464 LMESGNL-TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
E+ T+L D + +D + L+ + + RP+ SE+L
Sbjct: 221 AFETSKFFTDLRDGIISDIFDKKEKT---LLQK-LLSKKPEDRPNTSEILR 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 255 GQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314
G G + V+ G + K+A+K + + A E++F+ E ++ + HP L G C+
Sbjct: 17 GSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 315 ENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373
E + L+ F ++G L L +R + L V G+ YL + +IHRD
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 374 IKASNVLLGPDFEPQITDFGLAKWLPN---KCTHHAAIPIEGTFGYLAPEYFMHGIIDEK 430
+ A N L+G + +++DFG+ +++ + + P++ +PE F K
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFSRYSSK 185
Query: 431 TDVFAFGVLLLEIIT-GRKP 449
+DV++FGVL+ E+ + G+ P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
+G+G + +V G+ G K+AVK + K+ + FL E ++ + H N L+
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 311 GCCIENG--LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
G +E LY++ + G+L L L K L V + YL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NN 137
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIID 428
+HRD+ A NVL+ D +++DFGL K + +P++ T APE
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKWT----APEALREKKFS 192
Query: 429 EKTDVFAFGVLLLEIIT-GRKP 449
K+DV++FG+LL EI + GR P
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP 214
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 255 GQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
GQG + VY+G K +A+K + + ++ EFL E ++ +
Sbjct: 34 GQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 309 LVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG--------VARGLH 359
L+G + +I G+L + L R P+ L +A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFG 415
YL+ + +HRD+ A N ++ DF +I DFG+ + + + +P+
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+PE G+ +DV++FGV+L EI T +P
Sbjct: 208 --SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 67/303 (22%), Positives = 132/303 (43%), Gaps = 39/303 (12%)
Query: 223 LSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKD 281
+ + H + + + + +G+G + + + DGR+ +K +
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS 60
Query: 282 NKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSK 340
+K+ +E E+ ++ ++ HPN ENG LY++ ++ + G+L ++ ++
Sbjct: 61 RMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV 120
Query: 341 SLE----WPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396
+ +I L L ++H R+I+HRDIK+ N+ L D Q+ DFG+A+
Sbjct: 121 LFQEDQILDWFVQICLA----LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN 456
L + T A GT YL+PE + + K+D++A G +L E+ T +
Sbjct: 174 VLNS--TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA------- 224
Query: 457 LVLWAKPLMESGNLTELVDPSLEGEYD------TDQMHRLVLIADYCVRQTSAWRPSMSE 510
E+G++ LV + G + + + LV ++ RPS++
Sbjct: 225 --------FEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV---SQLFKRNPRDRPSVNS 273
Query: 511 VLE 513
+LE
Sbjct: 274 ILE 276
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 39/290 (13%)
Query: 255 GQGGYSEVYKG---NLSDGRKI--AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
G+G + +V +DG AVK L K + + + E+ I+ + H +
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 310 VGCCIENG---LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366
GCC + G L L+ + G+L L S+ + G+ YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA--- 152
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEY 421
+ IHRD+ A NVLL D +I DFGLAK +P + P+ APE
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----APEC 208
Query: 422 FMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPL--MESGNLTELVDPSL 478
+DV++FGV L E++T + L L M LTEL++
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE--- 265
Query: 479 EG------EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSE 522
G + +++ L+ C +++RP+ ++ +L + H+
Sbjct: 266 RGERLPRPDKCPAEVYHLMK---NCWETEASFRPTFENLIPILKTVHEKY 312
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-35
Identities = 66/285 (23%), Positives = 114/285 (40%), Gaps = 37/285 (12%)
Query: 255 GQGGYSEVYKG-----NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
G+G + +V + G ++AVK L K + E+ I+ ++ H N
Sbjct: 30 GEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 310 VGCCIENG---LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366
G C E+G + LI F +G+L L ++K + + K + + +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGS--- 144
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEY 421
R+ +HRD+ A NVL+ + + +I DFGL K + P+ APE
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY----APEC 200
Query: 422 FMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKP--LMESGNLTELVDPSL 478
M +DV++FGV L E++T L + M L +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK--- 257
Query: 479 EG------EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517
EG D++++L+ C + R S ++E +
Sbjct: 258 EGKRLPCPPNCPDEVYQLMR---KCWEFQPSNRTSFQNLIEGFEA 299
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 255 GQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314
G G + V G +AVK + + + E EF E + + HP G C
Sbjct: 17 GSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 315 ENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373
+ +Y++ + NG L L K LE ++ V G+ +L + IHRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRD 129
Query: 374 IKASNVLLGPDFEPQITDFGLAKWLPN---KCTHHAAIPIEGTFGYLAPEYFMHGIIDEK 430
+ A N L+ D +++DFG+ +++ + + P++ + APE F + K
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFKYSSK 185
Query: 431 TDVFAFGVLLLEIIT-GRKP 449
+DV+AFG+L+ E+ + G+ P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 71/304 (23%), Positives = 137/304 (45%), Gaps = 30/304 (9%)
Query: 239 EEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELG 296
+ + NF E +G+G +SEVY+ L DG +A+K++ + K + + E+
Sbjct: 25 DMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEID 84
Query: 297 IIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLG 353
++ + HPN IE+ L ++ + G+L + + + P R K +
Sbjct: 85 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGT 413
+ L ++H RR++HRDIK +NV + ++ D GL ++ +K T A + GT
Sbjct: 145 LCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGT 199
Query: 414 FGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473
Y++PE + K+D+++ G LL E+ + P + NL L + +
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKIEQCDY 255
Query: 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFT 533
P L ++ ++++ +LV + C+ RP ++ V ++ + RM T
Sbjct: 256 --PPLPSDHYSEELRQLV---NMCINPDPEKRPDVTYVYDV-----------AKRMHACT 299
Query: 534 SDEL 537
+ L
Sbjct: 300 ASSL 303
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 255 GQGGYSEVYKGNLSDGRK---IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
G G + V +G +K +A+K L K + +E + E I+ + +P L+G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 312 CCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
C L L+ + G L L +R + + +++ V+ G+ YL ++ +H
Sbjct: 78 VCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL---EEKNFVH 133
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEYFMHGI 426
RD+ A NVLL +I+DFGL+K L P++ APE
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECINFRK 189
Query: 427 IDEKTDVFAFGVLLLEIIT-GRKP 449
++DV+++GV + E ++ G+KP
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 255 GQGGYSEVYKGNLSDGR-KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G G Y EVY+G +AVK L +D + +EFL E ++ + HPN L+G C
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 314 IENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
Y+I F GNL L + + + + + ++ + YL K + IHR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHR 135
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPN---KCTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
D+ A N L+G + ++ DFGL++ + A PI+ T APE +
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFSI 191
Query: 430 KTDVFAFGVLLLEIIT-GRKP 449
K+DV+AFGVLL EI T G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 255 GQGGYSEVYKG--NLSDGRKI--AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
G+G + EVY+G G KI AVK K + +++F+ E I+ ++ HP+ L+
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 311 GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
G E ++I G L L ++ L+ L + + + YL +
Sbjct: 80 GIIEEEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLES---INCV 135
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKC---THHAAIPIEGTFGYLAPEYFMHGII 427
HRDI N+L+ ++ DFGL++++ ++ +PI+ +PE
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESINFRRF 191
Query: 428 DEKTDVFAFGVLLLEIIT-GRKP 449
+DV+ F V + EI++ G++P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 53/229 (23%), Positives = 102/229 (44%), Gaps = 20/229 (8%)
Query: 228 KHQPLLTCFSYE--EISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDA 285
K+ P Y EI + +G G + V G +A+K + + +
Sbjct: 6 KNAPSTAGLGYGSWEIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGS 60
Query: 286 KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEW 344
E EF+ E ++ ++ H L G C + +++I + NG L L + R + +
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQT 119
Query: 345 PIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN---K 401
++ V + YL ++ +HRD+ A N L+ +++DFGL++++ +
Sbjct: 120 QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176
Query: 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+ + P+ + PE M+ K+D++AFGVL+ EI + G+ P
Sbjct: 177 SSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 71/302 (23%), Positives = 118/302 (39%), Gaps = 40/302 (13%)
Query: 255 GQGGYSEVYKG-----NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
G+G + V + G +AVK+L D ++++F E+ I+ +
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKY 89
Query: 310 VGCCIENG---LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366
G G L L+ + +G L L R++ L+ + +G+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGS--- 145
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEY 421
RR +HRD+ A N+L+ + +I DFGLAK LP PI APE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----APES 201
Query: 422 FMHGIIDEKTDVFAFGVLLLEIIT-GRKP--VDSSRQNLVLWAKPLMESGNLTELVDPSL 478
I ++DV++FGV+L E+ T K + ++ + + L EL++
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE--- 258
Query: 479 EG------EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEF 532
EG ++H L+ C + RPS S + L + F
Sbjct: 259 EGQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLDMLWSGS--RGCETHAF 313
Query: 533 TS 534
T+
Sbjct: 314 TA 315
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 251 ENMVGQGGYSEVYKGNLSDG---RKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNT 306
++++G+G + +V K + A+KR+ K+ ++F EL ++ + HPN
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 307 ATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRY--------------KIV 351
L+G C G LYL ++ +GNL L R +
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-KCTHHAAIPI 410
VARG+ YL +++ IHRD+ A N+L+G ++ +I DFGL++ +P+
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205
Query: 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
A E + + +DV+++GVLL EI++ G P
Sbjct: 206 RWM----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 255 GQGGYSEVYKGNLSDGRK----IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
G+G + +V++G +A+K K+ ++FL E + HP+ L+
Sbjct: 24 GEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 311 GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
G EN +++I G L + L + L+ ++ L YL +R +
Sbjct: 83 GVITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKC---THHAAIPIEGTFGYLAPEYFMHGII 427
HRDI A NVL+ + ++ DFGL++++ + +PI+ APE
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESINFRRF 194
Query: 428 DEKTDVFAFGVLLLEIIT-GRKP 449
+DV+ FGV + EI+ G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-34
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 19/210 (9%)
Query: 251 ENMVGQGGYSEVYKG--NLSDGRKI--AVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPN 305
+G G + V +G + G+ + AVK L D + +F+ E+ + + H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 306 TATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
L G + + ++ + G+L L + + + VA G+ YL
Sbjct: 83 LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES-- 139
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPE 420
+R IHRD+ A N+LL +I DFGL + LP H +P APE
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----APE 194
Query: 421 YFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+D + FGV L E+ T G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 255 GQGGYSEVYKGNLSDGR---KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
G G + V KG + +AVK L + D + E L E ++ + +P ++G
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 312 CCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
C L+ ++ G L+ L R + I V V+ G+ YL + +H
Sbjct: 86 ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL--VHQVSMGMKYLE---ESNFVH 140
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEYFMHGI 426
RD+ A NVLL +I+DFGL+K L K H P++ APE +
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINYYK 196
Query: 427 IDEKTDVFAFGVLLLEIIT-GRKP 449
K+DV++FGVL+ E + G+KP
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 34/221 (15%)
Query: 255 GQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
G+ + +VYKG+L +A+K L KD + +EF E + + HPN
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 309 LVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRY--------------KIVLG 353
L+G ++ L +IF++ +G+L L S +V
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIP 409
+A G+ YL ++H+D+ NVL+ +I+D GL + + K ++ +P
Sbjct: 137 IAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
I APE M+G +D++++GV+L E+ + G +P
Sbjct: 194 IRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 69/290 (23%), Positives = 118/290 (40%), Gaps = 43/290 (14%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD----AKKEKEFLMELGIIGHV 301
++ +G+GG+S V L DG A+KR+ + A++E +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN----- 84
Query: 302 CHPNTATLVGCCIENG-----LYLIFNFSQNGNLDAALHDERSKSLEWP---IRYKIVLG 353
HPN LV C+ +L+ F + G L + + K I ++LG
Sbjct: 85 -HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLG 142
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK-WLPNKCTHHAAIPIE- 411
+ RGL +H + HRD+K +N+LLG + +P + D G + A+ ++
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 412 -----GTFGYLAPEYF---MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463
T Y APE F H +IDE+TDV++ G +L ++ G P D Q A
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
Query: 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+ L+ P + + +L+ + + RP + +L
Sbjct: 260 V--QNQLSIPQSPRH-----SSALWQLL---NSMMTVDPHQRPHIPLLLS 299
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 5e-33
Identities = 58/251 (23%), Positives = 105/251 (41%), Gaps = 23/251 (9%)
Query: 213 SSPLRKRNGSLSNKEKHQPLLTC-FSYEEISSATNNFHSENMV-----GQGGYSEVYKGN 266
+R S+S + + ++ +Y S+ E + G+G + +V++G
Sbjct: 351 KQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGI 410
Query: 267 LSDGRK----IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIF 322
+A+K K+ ++FL E + HP+ L+G EN +++I
Sbjct: 411 YMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 469
Query: 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG 382
G L + L + L+ ++ L YL +R +HRDI A NVL+
Sbjct: 470 ELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVS 525
Query: 383 PDFEPQITDFGLAKWLPNKC---THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVL 439
+ ++ DFGL++++ + +PI+ APE +DV+ FGV
Sbjct: 526 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESINFRRFTSASDVWMFGVC 581
Query: 440 LLEIIT-GRKP 449
+ EI+ G KP
Sbjct: 582 MWEILMHGVKP 592
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 32/276 (11%)
Query: 193 KGLSNTRMRMSPGKFFTSI-------------LSSPLRKRNGSLSNKEKHQPLLTCFSYE 239
S+ ++ +S F ++ L + L + K +Y+
Sbjct: 157 NTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHY---PAPKRNKPTIYGVSPNYD 213
Query: 240 EISSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGII 298
+ + ++ +G G Y EVY+G +AVK L +D + +EFL E ++
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVM 270
Query: 299 GHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARG 357
+ HPN L+G C Y+I F GNL L + + + + + ++
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN---KCTHHAAIPIEGTF 414
+ YL K + IHR++ A N L+G + ++ DFGL++ + A PI+ T
Sbjct: 331 MEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT- 386
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
APE + K+DV+AFGVLL EI T G P
Sbjct: 387 ---APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 8e-33
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 36/223 (16%)
Query: 255 GQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTA 307
G+G + +V + + + R +AVK L K+ + + + EL I+ H+ H N
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 308 TLVGCCIENG--LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG------------ 353
L+G C + G L +I F + GNL L +R++ + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 354 --VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAA 407
VA+G+ +L R+ IHRD+ A N+LL +I DFGLA+ + A
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+P++ APE + ++DV++FGVLL EI + G P
Sbjct: 212 LPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-32
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRK---IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
+ +G G + V +G +K +A+K L K + +E + E I+ + +P
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 308 TLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR 367
L+G C L L+ + G L L +R + + +++ V+ G+ YL ++
Sbjct: 400 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL---EEK 455
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEYF 422
+HR++ A NVLL +I+DFGL+K L P++ APE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 511
Query: 423 MHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
++DV+++GV + E ++ G+KP
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 59/287 (20%), Positives = 116/287 (40%), Gaps = 34/287 (11%)
Query: 242 SSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGH 300
S ++ +G G Y K SDG+ + K L + +++ + E+ ++
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 301 VCHPNTATLVGCCIE---NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVA 355
+ HPN I+ LY++ + + G+L + + + + +++ +
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 356 RGLHYLH--KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGT 413
L H ++HRD+K +NV L ++ DFGLA+ L + A GT
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGT 179
Query: 414 FGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473
Y++PE +EK+D+++ G LL E+ P + + EL
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---------------SQKEL 224
Query: 474 VDPSLEGEYD------TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514
EG++ +D+++ ++ + RPS+ E+LE
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEII---TRMLNLKDYHRPSVEEILEN 268
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 50/222 (22%), Positives = 93/222 (41%), Gaps = 38/222 (17%)
Query: 255 GQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDA--KKEKEFLMELGIIGHVCHPNT 306
G+G + +V+ + +AVK L K+A ++F E ++ + H +
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKAL----KEASESARQDFQREAELLTMLQHQHI 105
Query: 307 ATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRY-------------KIVL 352
G C E L ++F + ++G+L+ L + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAI 408
VA G+ YL +HRD+ N L+G +I DFG+++ + + + +
Sbjct: 166 QVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
PI PE ++ ++DV++FGV+L EI T G++P
Sbjct: 223 PIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 58/311 (18%), Positives = 114/311 (36%), Gaps = 50/311 (16%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
+F +G+GG+ V++ N D A+KR+ N++ +EK + E+ + + HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK-VMREVKALAKLEHP 63
Query: 305 NTATLVGCCIENG-------------LYLIFNFSQNGNLDAALHDERSKS-LEWPIRYKI 350
+E LY+ + NL ++ + E + I
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 351 VLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPI 410
L +A + +LH + ++HRD+K SN+ D ++ DFGL + +
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 411 E----------GTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW 460
GT Y++PE K D+F+ G++L E++ P + + +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237
Query: 461 AKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520
+ L P L + + ++ D + + RP ++E
Sbjct: 238 TD-------VRNLKFPPLFTQKYPCEYV---MVQD-MLSPSPMERPEAINIIE------- 279
Query: 521 SEFAKSWRMPE 531
+ + P
Sbjct: 280 NAVFEDLDFPG 290
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 66/290 (22%), Positives = 114/290 (39%), Gaps = 39/290 (13%)
Query: 255 GQGGYSEVYKG---NLSDGRKI--AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
G+G + V L D AVK+L + + + + ++F E+ I+ + H N
Sbjct: 19 GKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTE-EHLRDFEREIEILKSLQHDNIVKY 76
Query: 310 VGCCIENG---LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366
G C G L LI + G+L L + + ++ + + +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT--- 132
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEY 421
+R IHRD+ N+L+ + +I DFGL K LP K PI APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----APES 188
Query: 422 FMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAK---PLMESGNLTELVDPS 477
+DV++FGV+L E+ T K + + + M +L EL+
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-- 246
Query: 478 LEG------EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDS 521
+ D+++ ++ C RPS ++ + D+
Sbjct: 247 -NNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 255 GQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTA 307
G G + +V + K +AVK L K A +++ + EL I+ H+ H N
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 308 TLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRY------------KIVLGV 354
L+G C G + +I + G+L L + P V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAAIPI 410
A+G+ +L + IHRD+ A NVLL +I DFGLA+ + N +A +P+
Sbjct: 174 AQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+ APE + ++DV+++G+LL EI + G P
Sbjct: 231 KWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 255 GQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
G G + EVY+G +S +AVK L + + E +FLME II H N
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 309 LVGCCIENG-LYLIFNFSQNGNLDAAL-----HDERSKSLEWPIRYKIVLGVARGLHYLH 362
+G +++ +++ G+L + L + SL + +A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 363 KGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFG 415
+ IHRDI A N LL GP +I DFG+A+ + + A +P++
Sbjct: 158 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM-- 212
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
PE FM GI KTD ++FGVLL EI + G P
Sbjct: 213 --PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 42/229 (18%)
Query: 255 GQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
G+G + V++ +AVK L K+ A + +F E ++ +PN
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 309 LVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRY------------------- 348
L+G C + L+F + G+L+ L ++
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 349 ---KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----K 401
I VA G+ YL + R+ +HRD+ N L+G + +I DFGL++ + + K
Sbjct: 175 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+ AIPI PE + ++DV+A+GV+L EI + G +P
Sbjct: 232 ADGNDAIPIRWM----PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 39/290 (13%)
Query: 255 GQGGYSEVYKG---NLSDGRKI--AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
G+G + V L D AVK+L + + + +F E+ I+ + H N
Sbjct: 50 GKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLR-DFEREIEILKSLQHDNIVKY 107
Query: 310 VGCCIENG---LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366
G C G L LI + G+L L + + ++ + + +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT--- 163
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEY 421
+R IHRD+ N+L+ + +I DFGL K LP K PI APE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY----APES 219
Query: 422 FMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAK---PLMESGNLTELVDPS 477
+DV++FGV+L E+ T K + + + M +L EL+
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-- 277
Query: 478 LEG------EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDS 521
+ D+++ ++ C RPS ++ + D
Sbjct: 278 -NNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 52/223 (23%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 255 GQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDA--KKEKEFLMELGIIGHVCHPNT 306
G+G + +V+ + +AVK L KD K+F E ++ ++ H +
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKDFQREAELLTNLQHEHI 79
Query: 307 ATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRY--------------KIV 351
G C + L ++F + ++G+L+ L ++ I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHAA 407
+A G+ YL + +HRD+ N L+G + +I DFG+++ + + + H
Sbjct: 140 SQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+PI PE M+ ++DV++FGV+L EI T G++P
Sbjct: 197 LPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 42/229 (18%)
Query: 255 GQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
G+G + +V K + +AVK L K+N + ++ L E ++ V HP+
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 309 LVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG-------------- 353
L G C ++G L LI +++ G+L L + R +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 354 --------VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----K 401
+++G+ YL + +++HRD+ A N+L+ + +I+DFGL++ +
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
IP++ A E I ++DV++FGVLL EI+T G P
Sbjct: 208 KRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 255 GQGGYSEVYKGNLSDGRK--------IAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPN 305
G+G + +V K +AVK L KD+ K + + E+ ++ + H N
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG----------- 353
L+G C ++G LY+I ++ GNL L R +E+ V
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 354 ---VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHA 406
+ARG+ YL ++ IHRD+ A NVL+ + +I DFGLA+ + N K T +
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+P++ APE + ++DV++FGVL+ EI T G P
Sbjct: 266 RLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 255 GQGGYSEVYKG--NLSDGR---KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
G G + EVYKG S G+ +A+K L K K+ +FL E GI+G H N L
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 310 VGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
G + + +I + +NG LD L ++ + ++ G+A G+ YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLAN---MN 167
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC-----THHAAIPIEGTFGYLAPEYFM 423
+HRD+ A N+L+ + +++DFGL++ L + T IPI T APE
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAIS 223
Query: 424 HGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+ +DV++FG+++ E++T G +P
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 255 GQGGYSEVYKGNLSDGRK--------IAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPN 305
G+G + +V K +AVK L KD+ K + + E+ ++ + H N
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG----------- 353
L+G C ++G LY+I ++ GNL L R +E+ V
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 354 ---VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHA 406
+ARG+ YL ++ IHRD+ A NVL+ + +I DFGLA+ + N K T +
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+P++ APE + ++DV++FGVL+ EI T G P
Sbjct: 220 RLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 255 GQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT 308
G G + EVY+G +S +AVK L + + E +FLME II H N
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 309 LVGCCIENG-LYLIFNFSQNGNLDAAL-----HDERSKSLEWPIRYKIVLGVARGLHYLH 362
+G +++ +++ G+L + L + SL + +A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 363 KGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPN----KCTHHAAIPIEGTFG 415
+ IHRDI A N LL GP +I DFG+A+ + + A +P++
Sbjct: 199 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM-- 253
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
PE FM GI KTD ++FGVLL EI + G P
Sbjct: 254 --PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 255 GQGGYSEVYKGNLSDGRK----IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
G G EV G L + +A+K L K ++ ++FL E I+G HPN L
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 311 GCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRI 369
G ++ + +NG+LD L + ++ GV G+ YL
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSD---LGY 172
Query: 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEYFMH 424
+HRD+ A NVL+ + +++DFGL++ L + T IPI T APE
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAF 228
Query: 425 GIIDEKTDVFAFGVLLLEIIT-GRKP 449
+DV++FGV++ E++ G +P
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 251 ENMVGQGGYSEVYKG--NLSDGRKI--AVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
+ +VG G + EV G L ++I A+K L K K+ ++FL E I+G HPN
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 307 ATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
L G ++ + ++ + +NG+LD+ L ++ ++ G+A G+ YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSD-- 165
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPE 420
+HRD+ A N+L+ + +++DFGL + L + T IPI T +PE
Sbjct: 166 -MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPE 220
Query: 421 YFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+ +DV+++G++L E+++ G +P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 255 GQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTA 307
G G + +V + K +AVK L K + + + + EL ++ ++ H N
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 308 TLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG------------- 353
L+G C G +I + G+L L +R + I+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 354 ---VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHA 406
VA+G+ +L + IHRD+ A N+LL +I DFGLA+ + N +A
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+P++ APE + + ++DV+++G+ L E+ + G P
Sbjct: 208 RLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 255 GQGGYSEVYKGNLSDGRK--------IAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPN 305
G+G + +V K +AVK L K + K + + E+ ++ + H N
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG----------- 353
L+G C ++G LY+I ++ GNL L R LE+
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 354 ---VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----KCTHHA 406
VARG+ YL ++ IHRD+ A NVL+ D +I DFGLA+ + + K T +
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+P++ APE I ++DV++FGVLL EI T G P
Sbjct: 254 RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 42/229 (18%)
Query: 255 GQGGYSEVYKGNLSDGRK------IAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTA 307
G G + +V K +AVK L K+ D+ + + + EL ++ + H N
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 308 TLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG------------- 353
L+G C +G +YLIF + G+L L +R K E I Y+
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 354 --------VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN----K 401
VA+G+ +L + +HRD+ A NVL+ +I DFGLA+ + +
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
+A +P++ APE GI K+DV+++G+LL EI + G P
Sbjct: 230 VRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 15/203 (7%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G + VYKG + ++A L + + F E ++ + HPN
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 313 CI-----ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR 367
+ + L+ +G L L +R K ++ + + +GL +LH
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLH-TRTP 150
Query: 368 RIIHRDIKASNVLL-GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI 426
IIHRD+K N+ + GP +I D GLA + GT ++APE +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEEK- 205
Query: 427 IDEKTDVFAFGVLLLEIITGRKP 449
DE DV+AFG+ +LE+ T P
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYP 228
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 57/297 (19%), Positives = 99/297 (33%), Gaps = 49/297 (16%)
Query: 242 SSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGH 300
S T FH +G G + V+K DG A+KR K + E+ L E+
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 301 VC-HPNTATLVGCCIENG-LYLIFNFSQNGNLDAAL--HDERSKSLEWPIRYKIVLGVAR 356
+ H + E+ + + + G+L A+ + + ++L V R
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ-------------------ITDFGLAKW 397
GL Y+H ++H DIK SN+ + P I D G
Sbjct: 127 GLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQN 456
+ + EG +LA E K D+FA + ++ +N
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----PRN 233
Query: 457 LVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
W + + G L P + + + L+ + RPS +++
Sbjct: 234 GDQWHE--IRQGRL-----PRIPQVL-SQEFTELL---KVMIHPDPERRPSAMALVK 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 53/241 (21%), Positives = 92/241 (38%), Gaps = 36/241 (14%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH 303
++F ++GQG + +V K N D R A+K++ +K L E+ ++ + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNH 61
Query: 304 PNTATLVGCCIENG--------------LYLIFNFSQNGNLDAALHDERSKSLEWPIRYK 349
+E L++ + +NG L +H E +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-R 120
Query: 350 IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIP 409
+ + L Y+H + IIHRD+K N+ + +I DFGLAK +
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 410 IE------------GTFGYLAPEYFM-HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN 456
GT Y+A E G +EK D+++ G++ E+I R N
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-GMERVN 236
Query: 457 L 457
+
Sbjct: 237 I 237
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 26/277 (9%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-H 303
++ +G+G Y V K ++ G+ +AVKR+ + +K LM+L I
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISMRTVDC 65
Query: 304 PNTATLVGCCIENG-LYLIFNFSQNGNLDAALHD--ERSKSLEWPIRYKIVLGVARGLHY 360
P T T G G +++ + +LD ++ +++ I KI + + + L +
Sbjct: 66 PFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE 420
LH K +IHRD+K SNVL+ + ++ DFG++ +L + G Y+APE
Sbjct: 125 LHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPE 179
Query: 421 YFMHGII----DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476
+ K+D+++ G+ ++E+ R P DS W P + + E P
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-------WGTPFQQLKQVVEEPSP 232
Query: 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
L + + + C+++ S RP+ E+++
Sbjct: 233 QLPADKFSAEFVDFT---SQCLKKNSKERPTYPELMQ 266
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 27/217 (12%)
Query: 247 NFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPN 305
+F ++++G G + + D R +AVKR+ + A +E + L E HPN
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE-----HPN 79
Query: 306 TATLVGCCI-ENGLYLIFNFSQNGNLDAALHD---ERSKSLEWPIRYKIVLGVARGLHYL 361
Y+ A L + ++ + ++ GL +L
Sbjct: 80 VIRYFCTEKDRQFQYIAIEL-----CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 362 HKGCKRRIIHRDIKASNVLL---GPDFEPQ--ITDFGLAKWL-PNKCTHHAAIPIEGTFG 415
H I+HRD+K N+L+ + + I+DFGL K L + + + GT G
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 416 YLAPEYF---MHGIIDEKTDVFAFGVLLLEIITGRKP 449
++APE D+F+ G + +I+
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 42/214 (19%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 255 GQGGYSEVYKGNLSDGR--------KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
GQG +++++KG + ++ +K L K +++ + F ++ + H +
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY--SESFFEAASMMSKLSHKHL 74
Query: 307 ATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
G C+ L+ F + G+LD L ++ + + ++ +A +H+L +
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLEE-- 131
Query: 366 KRRIIHRDIKASNVLLGPDFEPQ--------ITDFGLAKWLPNKCTHHAAIPIEGTFGYL 417
+IH ++ A N+LL + + + ++D G++ + I
Sbjct: 132 -NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP--KDILQERIPWV---- 184
Query: 418 APEYFMHGII-DEKTDVFAFGVLLLEIIT-GRKP 449
PE + + TD ++FG L EI + G KP
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 13/204 (6%)
Query: 251 ENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKD-NKDAKKEKEFLMELGIIGHVCHPNTAT 308
+VG+GG +VY+ + R +A+K +++ + D E G + P+
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 309 L--VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366
+ G I+ LY+ +L A L + + + IV + L H
Sbjct: 99 IHDFGE-IDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQIGSALDAAHA--- 152
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP-NKCTHHAAIPIEGTFGYLAPEYFMHG 425
HRD+K N+L+ D + DFG+A K T GT Y+APE F
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV--GTLYYMAPERFSES 210
Query: 426 IIDEKTDVFAFGVLLLEIITGRKP 449
+ D++A +L E +TG P
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP 234
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 61/293 (20%), Positives = 112/293 (38%), Gaps = 50/293 (17%)
Query: 251 ENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD----AKKEKEFLMELGIIGHVCHPN 305
++ +GG++ VY+ ++ GR+ A+KRL + ++ +E F+ +L HPN
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG-----HPN 87
Query: 306 TATLVGCCI--------ENGLYLIFNFSQNGNLDAALHDERSKSL--EWPIRYKIVLGVA 355
+L+ G L L S+ + KI
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTC 146
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL----PNKCTHHAAIPIE 411
R + ++H+ K IIHRD+K N+LL ++ DFG A + + +E
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 412 ------GTFGYLAPE---YFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK 462
T Y PE + + I EK D++A G +L + + P + + ++
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV--- 262
Query: 463 PLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+G + + T H L+ ++ R S++EV+ L
Sbjct: 263 ----NGKYSIPPHDT----QYTV-FHSLI---RAMLQVNPEERLSIAEVVHQL 303
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 17/214 (7%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-H 303
+ +G+G Y V K + G+ +AVKR+ + ++ K+ LM+L ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ-KQLLMDLDVVMRSSDC 80
Query: 304 PNTATLVGCCIENG-LYLIFNFSQNGNLDAALHD---ERSKSLEWPIRYKIVLGVARGLH 359
P G G ++ + + D + I KI L + L+
Sbjct: 81 PYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAP 419
+L + +IIHRDIK SN+LL ++ DFG++ L + G Y+AP
Sbjct: 140 HLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMAP 194
Query: 420 EYFMHGII----DEKTDVFAFGVLLLEIITGRKP 449
E D ++DV++ G+ L E+ TGR P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 69/308 (22%), Positives = 123/308 (39%), Gaps = 40/308 (12%)
Query: 221 GSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLA 279
GS + K LT + + N+ + +G G +V+K G IAVK++
Sbjct: 1 GSSGSSGKQTGYLT-IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR 59
Query: 280 KDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHD- 336
+ + K LM+L ++ P G I N +++ +
Sbjct: 60 RSGNKEEN-KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL-----MGTCAEKL 113
Query: 337 --ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394
+ I K+ + + + L+YL + K +IHRD+K SN+LL + ++ DFG+
Sbjct: 114 KKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII-----DEKTDVFAFGVLLLEIITGRKP 449
+ L + + G Y+APE D + DV++ G+ L+E+ TG+ P
Sbjct: 172 SGRLVDDKAKDRSA---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
Query: 450 VDSSRQNLVLWAKPLMESGNLTELVD---PSLEGEYD-TDQMHRLVLIADYCVRQTSAWR 505
+ K E LT+++ P L G + V C+ + R
Sbjct: 229 YKNC--------KTDFEV--LTKVLQEEPPLLPGHMGFSGDFQSFV---KDCLTKDHRKR 275
Query: 506 PSMSEVLE 513
P +++LE
Sbjct: 276 PKYNKLLE 283
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 45/227 (19%), Positives = 92/227 (40%), Gaps = 21/227 (9%)
Query: 237 SYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELG 296
++ +S + +G GG S+V++ + A+K + + D + + E+
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 297 IIGHVCHPNTA--TLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG 353
+ + + L I + +Y++ N +L++ L ++S W +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSID-PWERKS-YWKN 135
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGT 413
+ +H +H + I+H D+K +N L+ D ++ DFG+A + T GT
Sbjct: 136 MLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 414 FGYLAPEYFM-----------HGIIDEKTDVFAFGVLLLEIITGRKP 449
Y+ PE I K+DV++ G +L + G+ P
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 254 VGQGGYSEVYKGN-LSDGRKIAVKRLAKD-NKDAKKEKEFLMELGIIGHVCHPNTATL-- 309
+G GG S VY K+A+K + + + K F E+ + H N ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 310 VGCCIENGL-YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
V E+ YL+ + + L + S++ I + G+ + H R
Sbjct: 79 VD--EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN--FTNQILDGIKHAHD---MR 131
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWL-PNKCTHHAAIPIEGTFGYLAPEYFMHGII 427
I+HRDIK N+L+ + +I DFG+AK L T + GT Y +PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH--VLGTVQYFSPEQAKGEAT 189
Query: 428 DEKTDVFAFGVLLLEIITGRKP 449
DE TD+++ G++L E++ G P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 20/245 (8%), Positives = 50/245 (20%), Gaps = 43/245 (17%)
Query: 240 EISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKD-NKDAKKEKEFLMELGI 297
+S + G S V+ ++ A+K + +
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 298 IGHVCHPNTATLVGCC---------------------------IENGLYLIFNFSQ--NG 328
+ + L+ +
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 329 NLDAALHD--ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386
L + L + + + R L + ++H N+ + PD
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGR 232
Query: 387 PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG--IIDEKTDVFAFGVLLLEII 444
+ D + + Y E+ + + G+ + +
Sbjct: 233 LMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 445 TGRKP 449
P
Sbjct: 288 CLFLP 292
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCH 303
+F +G+G + VY +A+K L K + A E + E+ I H+ H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 304 PNTATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
PN L G +YLI ++ G + L ++ + + +A L Y H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 126
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK-----CTHHAAIPIEGTFGYL 417
+R+IHRDIK N+LLG E +I DFG + P+ C GT YL
Sbjct: 127 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---------GTLDYL 174
Query: 418 APEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSS 453
PE + DEK D+++ GVL E + G+ P +++
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 54/246 (21%), Positives = 104/246 (42%), Gaps = 13/246 (5%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
++F + +G G V+K + G +A K + + K A + + + EL ++ P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSP 91
Query: 305 NTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
G +G + + G+LD L ++ + I K+ + V +GL YL +
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN-KCTHHAAIPIEGTFGYLAPEYF 422
K +I+HRD+K SN+L+ E ++ DFG++ L + GT Y++PE
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERL 202
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482
++D+++ G+ L+E+ GR P+ + G+ E
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 483 DTDQMH 488
++
Sbjct: 263 PLNKFG 268
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 44/218 (20%), Positives = 88/218 (40%), Gaps = 21/218 (9%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+ +G GG S+V++ + A+K + + D + + E+ + + +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 306 TA--TLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
L I + +Y++ N +L++ L ++S W + + +H +H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSID-PWERKS-YWKNMLEAVHTIH 125
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF 422
+ I+H D+K +N L+ D ++ DFG+A + T GT Y+ PE
Sbjct: 126 ---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 423 M-----------HGIIDEKTDVFAFGVLLLEIITGRKP 449
I K+DV++ G +L + G+ P
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 48/226 (21%), Positives = 90/226 (39%), Gaps = 26/226 (11%)
Query: 242 SSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGH 300
S++ + + +++GQG + V++G + G A+K + + E ++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKK 63
Query: 301 VCHPNTATLVGCCIENG----LYLIFNFSQNGNLDAALHD-ERSKSLEWPIRYKIVLGVA 355
+ H N L E LI F G+L L + + L ++ V
Sbjct: 64 LNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ----ITDFGLAKWLPNKCTHHAAIPIE 411
G+++L + I+HR+IK N++ + Q +TDFG A+ L + +
Sbjct: 123 GGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 412 GTFGYLAPEYFMHGII--------DEKTDVFAFGVLLLEIITGRKP 449
GT YL P+ + ++ D+++ GV TG P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 42/214 (19%), Positives = 77/214 (35%), Gaps = 42/214 (19%)
Query: 253 MVGQGGYSEVYKG---NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
+ GG +Y N+ +GR + +K L + DA+ + + E + V HP+
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQ- 143
Query: 310 VGCCIENGLYLIFNFSQNGNLDAA--------------LHDERSKSLEWPIRYKIVLGVA 355
IFNF ++ + L + + L +L +
Sbjct: 144 -----------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEIL 192
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415
L YLH +++ D+K N++L + + ++ D G + + GT G
Sbjct: 193 PALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGYLY--GTPG 242
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
+ APE G TD++ G L +
Sbjct: 243 FQAPEIVRTGPTV-ATDIYTVGRTLAALTLDLPT 275
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 45/266 (16%), Positives = 88/266 (33%), Gaps = 34/266 (12%)
Query: 209 TSILSSPLRKRNGSLSNKEKHQPLLTCFSYE-EISSATNNFHSENMVGQGGYSEVYKG-- 265
+LS L K S N + Q L + E + + +++G+G +++VY+
Sbjct: 28 FKLLSG-LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQ 86
Query: 266 ----NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI-ENGLYL 320
+ + +K +K N + + + + +NG L
Sbjct: 87 GDLNDAKNKQKFVLKVQKPANP--WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144
Query: 321 IFNFSQNGNLDAALHDERS---KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKAS 377
+ G L A++ ++ K + + + + + +H IIH DIK
Sbjct: 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPD 201
Query: 378 NVLLGPDFEP-----------QITDFGLA---KWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
N +LG F + D G + K P A T G+ E
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC---ETSGFQCVEMLS 258
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKP 449
+ + + D F + ++ G
Sbjct: 259 NKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 48/268 (17%), Positives = 100/268 (37%), Gaps = 21/268 (7%)
Query: 196 SNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVG 255
++ + + + R+ S + + E IS + +G
Sbjct: 6 HSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIG 65
Query: 256 QGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA--TLVGCC 313
GG S+V++ + A+K + + D + + E+ + + + L
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 314 I-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372
I + +Y++ N +L++ L ++S W + + +H +H + I+H
Sbjct: 126 ITDQYIYMVMECG-NIDLNSWLKKKKSID-PWERKS-YWKNMLEAVHTIH---QHGIVHS 179
Query: 373 DIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM--------- 423
D+K +N L+ D ++ DFG+A + T G Y+ PE
Sbjct: 180 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENG 238
Query: 424 --HGIIDEKTDVFAFGVLLLEIITGRKP 449
I K+DV++ G +L + G+ P
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 67/250 (26%), Positives = 105/250 (42%), Gaps = 22/250 (8%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+ + +G GG+ V + + G ++A+K+ ++ K + + +E+ I+ + HPN
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 306 -------TATLVGCCIENGLYLIFNFSQNGNLDAALHD-ERSKSL-EWPIRYKIVLGVAR 356
L + L + + G+L L+ E L E PIR ++ ++
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISS 132
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ---ITDFGLAKWLPNKCTHHAAIPIEGT 413
L YLH+ RIIHRD+K N++L P + I D G AK L + GT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GT 186
Query: 414 FGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473
YLAPE D ++FG L E ITG +P V W + E N +
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL-PNWQPVQWHGKVREKSNEHIV 245
Query: 474 VDPSLEGEYD 483
V L G
Sbjct: 246 VYDDLTGAVK 255
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 48/226 (21%), Positives = 90/226 (39%), Gaps = 26/226 (11%)
Query: 242 SSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGH 300
S++ + + +++GQG + V++G + G A+K + + E ++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKK 63
Query: 301 VCHPNTATLVGCCIENG----LYLIFNFSQNGNLDAALHD-ERSKSLEWPIRYKIVLGVA 355
+ H N L E LI F G+L L + + L ++ V
Sbjct: 64 LNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ----ITDFGLAKWLPNKCTHHAAIPIE 411
G+++L + I+HR+IK N++ + Q +TDFG A+ L + +
Sbjct: 123 GGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 412 GTFGYLAPEYFMHGII--------DEKTDVFAFGVLLLEIITGRKP 449
GT YL P+ + ++ D+++ GV TG P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 253 MVGQGGYSEVYKGN-LSDGRKIAVKRLAKD-NKDAKKEKEFLMELGIIGHVCHPNTATL- 309
++G GG SEV+ L D R +AVK L D +D F E + HP +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 310 -VGCCIENGL---YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
G Y++ + L +H E + + I ++ + L++ H+
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE--VIADACQALNFSHQ-- 134
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC---THHAAIPIEGTFGYLAPEYF 422
IIHRD+K +N+++ ++ DFG+A+ + + T AA + GT YL+PE
Sbjct: 135 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSPEQA 191
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKP 449
+D ++DV++ G +L E++TG P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 12/211 (5%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCH 303
++F +G+G + VY + +A+K L K + E + E+ I H+ H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 304 PNTATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
PN + +YL+ F+ G L L ++ + + +A LHY H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCH 131
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF 422
+ R++IHRDIK N+L+G E +I DFG + P+ GT YL PE
Sbjct: 132 E---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMI 184
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKPVDSS 453
DEK D++ GVL E + G P DS
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 59/234 (25%), Positives = 87/234 (37%), Gaps = 40/234 (17%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHP 304
N SE ++G G V GR +AVKR+ D A E + L E HP
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-----DDHP 69
Query: 305 NTATLVGCCIE--NGLYLIFNFSQNGNLD-----AALHDERSKSLEWPIRYKIVLGVARG 357
N C LY+ N NL + DE K + ++ +A G
Sbjct: 70 NVIRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 358 LHYLHKGCKRRIIHRDIKASNVLL-------------GPDFEPQITDFGLAKWL-PNKCT 403
+ +LH +IIHRD+K N+L+ + I+DFGL K L + +
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 404 HHAAIP-IEGTFGYLAPEYFMHGII-------DEKTDVFAFGVLLLEIITGRKP 449
+ GT G+ APE D+F+ G + I++ K
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 46/233 (19%), Positives = 97/233 (41%), Gaps = 33/233 (14%)
Query: 255 GQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLM---------------ELGIIG 299
QG ++++ D + A+K+ K + K++ EL II
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 300 HVCHPNTATLVGCCIENG--LYLIFNFSQNGNL------DAALHDERSKSLEWPIRYKIV 351
+ + T G I N +Y+I+ + +N ++ L + + + I+
Sbjct: 99 DIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIE 411
V Y+H ++ I HRD+K SN+L+ + +++DFG ++++ +K +
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR---- 211
Query: 412 GTFGYLAPEYFMH--GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK 462
GT+ ++ PE+F + K D+++ G+ L + P + L+
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
G+G ++ VY+ ++ G ++A+K + K A + E+ I + HP+ L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 313 CIE--NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
E N +YL+ NG ++ L R K + + G+ YLH I+
Sbjct: 80 -FEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMHQIITGMLYLHS---HGIL 134
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNK-------CTHHAAIPIEGTFGYLAPEYFM 423
HRD+ SN+LL + +I DFGLA L C GT Y++PE
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---------GTPNYISPEIAT 185
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPVDSS 453
++DV++ G + ++ GR P D+
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
G+GG+++ ++ + A K + K + ++ ME+ I + H + G
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 313 CIE--NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370
E + ++++ + +L LH R E RY + + G YLH+ R+I
Sbjct: 110 -FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLR-QIVLGCQYLHR---NRVI 163
Query: 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNK-------CTHHAAIPIEGTFGYLAPEYFM 423
HRD+K N+ L D E +I DFGLA + C GT Y+APE
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---------GTPNYIAPEVLS 214
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPVDSS 453
+ DV++ G ++ ++ G+ P ++S
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 61/231 (26%), Positives = 92/231 (39%), Gaps = 44/231 (19%)
Query: 241 ISSATNNFHS----ENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMEL 295
I+S + +G G Y EV + + A+K + K + + L E+
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 296 GIIGHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNL-------------DAALHDERSKS 341
++ + HPN L + YL+ + G L DAA
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-------- 139
Query: 342 LEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWL 398
I+ V G+ YLH K I+HRD+K N+LL D +I DFGL+
Sbjct: 140 -------VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189
Query: 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
N+ + GT Y+APE DEK DV++ GV+L ++ G P
Sbjct: 190 ENQKKMKERL---GTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHP 304
+ +G+GG+++ ++ + A K + K + ++ ME+ I + H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 305 NTATLVGCCIE--NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
+ G E + ++++ + +L LH R E RY + + G YLH
Sbjct: 76 HVVGFHGF-FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLR-QIVLGCQYLH 132
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK-------CTHHAAIPIEGTFG 415
+ R+IHRD+K N+ L D E +I DFGLA + C GT
Sbjct: 133 R---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---------GTPN 180
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSS 453
Y+APE + DV++ G ++ ++ G+ P ++S
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
++G+G Y VY G +LS+ +IA+K + +D++ + E+ + H+ H N +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 312 CCIENG-LYLIFNFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368
ENG + + G+L A L + K E I + GL YLH +
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHD---NQ 142
Query: 369 IIHRDIKASNVLLGP-DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII 427
I+HRDIK NVL+ +I+DFG +K L GT Y+APE G
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPR 200
Query: 428 --DEKTDVFAFGVLLLEIITGRKP 449
+ D+++ G ++E+ TG+ P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 19/219 (8%)
Query: 238 YEEISSATN---NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKR--LAKDNKDAKKEKEF 291
+E S F +G+G Y VYK + G+ +A+K+ + D ++ KE
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISI 77
Query: 292 LMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKI 350
+ + P+ G +N L+++ + G++ + E I I
Sbjct: 78 MQQCD------SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-I 130
Query: 351 VLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPI 410
+ +GL YLH R IHRDIKA N+LL + ++ DFG+A L + T +
Sbjct: 131 LQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--TMAKRNTV 185
Query: 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
GT ++APE + D+++ G+ +E+ G+ P
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 58/260 (22%), Positives = 99/260 (38%), Gaps = 18/260 (6%)
Query: 196 SNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVG 255
S K ++S + R + N+ E + + VG
Sbjct: 8 GQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVG 67
Query: 256 QGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314
+G + EV++ + G + AVK++ + + EL + P L G
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVR 120
Query: 315 ENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373
E + + + G+L + ++ L + GL YLH RRI+H D
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGD 175
Query: 374 IKASNVLLGPD-FEPQITDFGLAKWLPNKCTHHAAIPIE---GTFGYLAPEYFMHGIIDE 429
+KA NVLL D + DFG A L + + + GT ++APE M D
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 430 KTDVFAFGVLLLEIITGRKP 449
K D+++ ++L ++ G P
Sbjct: 236 KVDIWSSCCMMLHMLNGCHP 255
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
F +G+G + EV+KG + + +A+K + + + + E + E+ ++ P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 82
Query: 307 ATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSL-EWPIRYKIVLGVARGLHYLHKG 364
G +++ L++I + G+ L L E I I+ + +GL YLH
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIAT-ILREILKGLDYLHS- 137
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
+ IHRDIKA+NVLL E ++ DFG+A L + T GT ++APE
Sbjct: 138 --EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQ 193
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKP 449
D K D+++ G+ +E+ G P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPN 305
F +VG G Y +VYKG ++ G+ A+K + + +E+E E+ ++ H N
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 306 TATLVGC-------CIENGLYLIFNFSQNGNLDAALHDERSKSL-EWPIRYKIVLGVARG 357
AT G +++ L+L+ F G++ + + + +L E I Y I + RG
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRG 141
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYL 417
L +LH+ ++IHRDIK NVLL + E ++ DFG++ L T GT ++
Sbjct: 142 LSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWM 196
Query: 418 APE-----YFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
APE D K+D+++ G+ +E+ G P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 50/204 (24%), Positives = 78/204 (38%), Gaps = 42/204 (20%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G G +SEV+ G+ A+K + K ++ E+ ++ + H N TL
Sbjct: 18 GSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 314 -IENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVARGLH 359
YL+ G L DA+ ++ V +
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS---------------LVIQQVLSAVK 120
Query: 360 YLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416
YLH+ I+HRD+K N+L + + ITDFGL+K N A GT GY
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----GTPGY 173
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLL 440
+APE + D ++ GV+
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-22
Identities = 41/205 (20%), Positives = 78/205 (38%), Gaps = 14/205 (6%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G V G + V+R+ + + EL + HPN
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 314 IENG-LYLIFNFSQNGNLDAALHDERSKSL-EWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
I + L+++ +F G+ + + E I Y I+ GV + L Y+H +H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-ILQGVLKALDYIHH---MGYVH 151
Query: 372 RDIKASNVLLGPDFEPQITDFGLAKWLPN-----KCTHHAAIPIEGTFGYLAPEYFMHGI 426
R +KAS++L+ D + ++ + + + H +L+PE +
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211
Query: 427 I--DEKTDVFAFGVLLLEIITGRKP 449
D K+D+++ G+ E+ G P
Sbjct: 212 QGYDAKSDIYSVGITACELANGHVP 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 68/249 (27%), Positives = 109/249 (43%), Gaps = 45/249 (18%)
Query: 221 GSLSNKEKHQP-LLTCFSYEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRL 278
GS+ + P + S ++ + + ++G+G + EV + G++ AVK +
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIF---SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI 59
Query: 279 AKDNKDAKKEKEFLM-ELGIIGHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNL------ 330
+K K +KE L+ E+ ++ + HPN L + YL+ G L
Sbjct: 60 SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS 119
Query: 331 -------DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL-- 381
DAA +I+ V G+ Y+HK +I+HRD+K N+LL
Sbjct: 120 RKRFSEVDAA---------------RIIRQVLSGITYMHK---NKIVHRDLKPENLLLES 161
Query: 382 -GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLL 440
D +I DFGL+ I GT Y+APE HG DEK DV++ GV+L
Sbjct: 162 KSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEVL-HGTYDEKCDVWSTGVIL 217
Query: 441 LEIITGRKP 449
+++G P
Sbjct: 218 YILLSGCPP 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 4e-22
Identities = 34/242 (14%), Positives = 65/242 (26%), Gaps = 54/242 (22%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVK--------------------------RLAKDNKDA 285
++GQ + + G V R K+ K A
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 286 KKEKEFLMELGIIGHVCHPNTATLVGC---CIENGLYLIFNFSQ--NGNLDAALHD--ER 338
K F+ ++ + + ++ Q L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 339 SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398
KSL R ++ L V R L LH ++H ++ +++L +T F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 399 PNKCTHHAAIPIEGTFGYLAPEYFMH-----------GIIDEKTDVFAFGVLLLEIITGR 447
+ + G+ PE ++ D +A G+++ I
Sbjct: 257 GARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 448 KP 449
P
Sbjct: 311 LP 312
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 4e-22
Identities = 31/241 (12%), Positives = 62/241 (25%), Gaps = 53/241 (21%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLME----------------- 294
++GQ + + G V + + + E
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 295 ------LGIIGHVCHPNTATLVGCCIENGLYLIFNF--------SQNGNLDAALHD--ER 338
+ V P ++ ++ + + S L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 339 SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398
KSL R ++ L V R L LH ++H ++ +++L +T F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 399 PNKCTHHAAIPIEGTFGYLAPEYFM----------HGIIDEKTDVFAFGVLLLEIITGRK 448
A+ G+ PE ++ D + G+ + I
Sbjct: 260 ----RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 449 P 449
P
Sbjct: 316 P 316
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-22
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 40/223 (17%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH 303
++ M+G+G + EV K + ++ AVK + K + K L E+ ++ + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 304 PNTATLVGCCI-ENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYK 349
PN L + Y++ G L DAA +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---------------R 125
Query: 350 IVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHA 406
I+ V G+ Y+H K I+HRD+K N+LL D + +I DFGL+
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
I GT Y+APE G DEK DV++ GV+L +++G P
Sbjct: 183 RI---GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 56/222 (25%), Positives = 105/222 (47%), Gaps = 18/222 (8%)
Query: 238 YEEISSATN---NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM 293
YE + + + +G G + +VYK N G A K + +++ + +++++
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIV 65
Query: 294 ELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVL 352
E+ I+ HP L+G +G L+++ F G +DA + + E I+ +
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCR 124
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEG 412
+ L++LH +RIIHRD+KA NVL+ + + ++ DFG++ T G
Sbjct: 125 QMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKRDSFIG 179
Query: 413 TFGYLAPEYFMHGII-----DEKTDVFAFGVLLLEIITGRKP 449
T ++APE M + D K D+++ G+ L+E+ P
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 52/246 (21%), Positives = 106/246 (43%), Gaps = 21/246 (8%)
Query: 209 TSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATN---NFHSENMVGQGGYSEVYKG 265
+ + L ++G +++++ L + + S +G+G V
Sbjct: 11 VDLGTENLYFQSGVVTHEQFKAAL------RMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 266 -NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323
GR++AVK + D + ++ + E+ I+ H N + + L+++
Sbjct: 65 REKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122
Query: 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP 383
F Q G L + R E I + V + L YLH + +IHRDIK+ ++LL
Sbjct: 123 FLQGGALTDIVSQVRLN--EEQIAT-VCEAVLQALAYLHA---QGVIHRDIKSDSILLTL 176
Query: 384 DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEI 443
D +++DFG + ++ GT ++APE + + D+++ G++++E+
Sbjct: 177 DGRVKLSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
Query: 444 ITGRKP 449
+ G P
Sbjct: 235 VDGEPP 240
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 63/278 (22%), Positives = 112/278 (40%), Gaps = 36/278 (12%)
Query: 182 ISQSPPQAPKTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEI 241
+S + T G ++ P R GSL + + E+
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQG----AMDPMPAGGRAGSLKDPD----------VAEL 46
Query: 242 SSATN---NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELG 296
+ F +G G + VY ++ + +A+K+++ K + ++ + ++ E+
Sbjct: 47 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 106
Query: 297 IIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSL-EWPIRYKIVLGV 354
+ + HPNT GC + +L+ + D L + K L E I + G
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGA 163
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTF 414
+GL YLH +IHRD+KA N+LL ++ DFG A + + GT
Sbjct: 164 LQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTP 214
Query: 415 GYLAPE---YFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
++APE G D K DV++ G+ +E+ + P
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 46/204 (22%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT 306
+ +GQG VY +++ G+++A++++ + + K++ + E+ ++ +PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNI 79
Query: 307 ATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
+ + L+++ + G+L + + E I + + L +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAA-VCRECLQALEFLHS-- 134
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
++IHRDIK+ N+LLG D ++TDFG + + + + + GT ++APE
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVTRK 191
Query: 426 IIDEKTDVFAFGVLLLEIITGRKP 449
K D+++ G++ +E+I G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 52/335 (15%), Positives = 103/335 (30%), Gaps = 82/335 (24%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
+F +G+GG+ V++ N D A+KR+ N++ +EK + E+ + + HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK-VMREVKALAKLEHP 64
Query: 305 NTATLVGCCIENGLYLIFNF----------------SQNGNLDAALHDERSKSLEWPIRY 348
+E S + ++ R
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 349 K------------IVLGVARG--LHYLHKGCKRR-------------------------- 368
I + + R L
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIE----------GTFGYLA 418
++HRD+K SN+ D ++ DFGL + + GT Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 419 PEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478
PE K D+F+ G++L E++ R ++ ++ L P L
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFST-QMERVRII---------TDVRNLKFPLL 294
Query: 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+ + ++ D + + RP ++++E
Sbjct: 295 FTQKYPQEHM---MVQD-MLSPSPTERPEATDIIE 325
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 64/297 (21%), Positives = 105/297 (35%), Gaps = 80/297 (26%)
Query: 182 ISQSPPQAPKTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEI 241
+ + + L + ++PG + +RK+ G + Y
Sbjct: 1 MHHHHHHSSGRENLYFQGIAINPGMY--------VRKKEGKIGES-----------YF-- 39
Query: 242 SSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-----------KDAKKEK 289
+ +G G Y EV + + A+K + K K +
Sbjct: 40 ------KVRK--LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 290 EFLMELGIIGHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNL-------------DAALH 335
E E+ ++ + HPN L + YL+ F + G L DAA
Sbjct: 92 EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-- 149
Query: 336 DERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDF 392
I+ + G+ YLHK I+HRDIK N+LL +I DF
Sbjct: 150 -------------NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 393 GLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
GL+ + + GT Y+APE +EK DV++ GV++ ++ G P
Sbjct: 194 GLSSFFSKDYKLRDRL---GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 3e-20
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 41/205 (20%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G+G +S V + + + G + A K + A+ ++ E I + HPN L
Sbjct: 15 GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74
Query: 314 -IENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVARGLH 359
E+ YL+F+ G L DA+ + + +
Sbjct: 75 QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---------------HCIQQILESIA 119
Query: 360 YLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWL-PNKCTHHAAIPIEGTFG 415
Y H I+HR++K N+LL ++ DFGLA + ++ H A GT G
Sbjct: 120 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA----GTPG 172
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLL 440
YL+PE + D++A GV+L
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 58/204 (28%), Positives = 87/204 (42%), Gaps = 40/204 (19%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G+G + EV K + ++ AVK + K + K L E+ ++ + HPN L
Sbjct: 31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90
Query: 314 I-ENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVARGLH 359
+ Y++ G L DAA +I+ V G+
Sbjct: 91 EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---------------RIIKQVFSGIT 135
Query: 360 YLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416
Y+H K I+HRD+K N+LL D + +I DFGL+ I GT Y
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYY 189
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLL 440
+APE + G DEK DV++ GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 16/216 (7%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
+++ + ++G G + V K+A+KR+ + + E L E+ + HP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHP 73
Query: 305 NTATLVGCCIENG-LYLIFNFSQNGNL------DAALHDERSKSLEWPIRYKIVLGVARG 357
N + + L+L+ G++ A + +S L+ I+ V G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIP---IEGTF 414
L YLHK IHRD+KA N+LLG D QI DFG++ +L GT
Sbjct: 134 LEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 415 GYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKP 449
++APE D K D+++FG+ +E+ TG P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 5e-20
Identities = 63/259 (24%), Positives = 104/259 (40%), Gaps = 41/259 (15%)
Query: 205 GKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYK 264
G F + S R N E + L N+F ++G+GG+ EVY
Sbjct: 159 GDVFQKFIESDKFTRFCQWKNVELNIHL-----------TMNDFSVHRIIGRGGFGEVYG 207
Query: 265 GNLSDGRKI-AVKRLAKDNKDAKKEKEFLME----LGIIGHVCHPNTATLVGCC-IENGL 318
+D K+ A+K L K K+ + + L ++ P + + L
Sbjct: 208 CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267
Query: 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVARGLHYLHKGCKRRIIHRDIKA 376
I + G+L L S Y +I+LG L ++H R +++RD+K
Sbjct: 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMHN---RFVVYRDLKP 320
Query: 377 SNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKT----- 431
+N+LL +I+D GLA K H + GT GY+APE ++ +
Sbjct: 321 ANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE-----VLQKGVAYDSS 371
Query: 432 -DVFAFGVLLLEIITGRKP 449
D F+ G +L +++ G P
Sbjct: 372 ADWFSLGCMLFKLLRGHSP 390
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 60/277 (21%), Positives = 98/277 (35%), Gaps = 68/277 (24%)
Query: 220 NGSLSNKEKHQPL------------LTCFSYEEISSATNNFHSEN---------MVGQGG 258
N L K K +PL F + +++ + + + +G G
Sbjct: 88 NTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGA 147
Query: 259 YSEVYKG-NLSDGRKIAVKRLAK------DNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311
EV +K+A++ ++K ++A E+ I+ + HP +
Sbjct: 148 CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 207
Query: 312 CCIENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVARGL 358
Y++ + G L L Y+++L V
Sbjct: 208 FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-----------YFYQMLLAV---- 252
Query: 359 HYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415
YLH + IIHRD+K NVLL D +ITDFG +K L GT
Sbjct: 253 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPT 306
Query: 416 YLAPEYFMHGII---DEKTDVFAFGVLLLEIITGRKP 449
YLAPE + + D ++ GV+L ++G P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 43/224 (19%)
Query: 239 EEISSATNNFHSE----NMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM 293
E + +A+ F +G+G +S V + + + G + A K + A+ ++
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 294 ELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNL-------------DAALHDERS 339
E I + HPN L E YL+F+ G L DA+
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------ 131
Query: 340 KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAK 396
+ + + Y H I+HR++K N+LL ++ DFGLA
Sbjct: 132 ---------HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLL 440
+ + H GT GYL+PE + D++A GV+L
Sbjct: 180 EVNDSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 50/205 (24%), Positives = 79/205 (38%), Gaps = 43/205 (20%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G S VY+ + A+K L K +K E+G++ + HPN L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKK----TVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 313 C-IENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVARGL 358
+ L+ G L DAA V + +
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---------------DAVKQILEAV 161
Query: 359 HYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415
YLH+ I+HRD+K N+L PD +I DFGL+K + ++ GT G
Sbjct: 162 AYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPG 215
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLL 440
Y APE + D+++ G++
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 240 EISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKE-------KE- 290
++ S + + +G+G ++ VYK + + + +A+K++ ++ K+ +E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 291 -FLMELGIIGHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLD---AALHDERSKSLEWP 345
L EL HPN L+ ++ + L+F+F ++ + + S L
Sbjct: 64 KLLQEL------SHPNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPS 112
Query: 346 IRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNKC- 402
+L +GL YLH+ I+HRD+K +N+LL + ++ DFGLAK PN+
Sbjct: 113 HIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169
Query: 403 TH 404
TH
Sbjct: 170 TH 171
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 48/206 (23%), Positives = 80/206 (38%), Gaps = 42/206 (20%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G+G +S V + + G++ A + A+ ++ E I + HPN L
Sbjct: 20 GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79
Query: 314 IENG-LYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVARGLH 359
E G YLIF+ G L DA+ + + +
Sbjct: 80 SEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------------HCIQQILEAVL 124
Query: 360 YLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWL--PNKCTHHAAIPIEGTF 414
+ H + ++HR++K N+LL ++ DFGLA + + A GT
Sbjct: 125 HCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA----GTP 177
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLL 440
GYL+PE + D++A GV+L
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 52/213 (24%), Positives = 78/213 (36%), Gaps = 49/213 (23%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAK------DNKDAKKEKEFLMELGIIGHVCHPNTA 307
G G EV +K+A+K ++K ++A E+ I+ + HP
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 308 TLVGCCIENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGV 354
+ Y++ + G L L Y+++L V
Sbjct: 79 KIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-----------YFYQMLLAV 127
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWL-PNKCTHHAAIPI 410
YLH+ IIHRD+K NVLL D +ITDFG +K L
Sbjct: 128 ----QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--- 177
Query: 411 EGTFGYLAPEYFMHGII---DEKTDVFAFGVLL 440
GT YLAPE + + D ++ GV+L
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 54/245 (22%), Positives = 81/245 (33%), Gaps = 52/245 (21%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKD---NKDAKKEKEFLMELGIIGHVCHPNTATL 309
+GQG Y V A+K + K+ + K + E+ ++ + HPN A L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 310 VGCC-IENGLYLIFNFSQNGNL--------------------------------DAALHD 336
E + L+ G+L +A
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 337 ERSKSLEWPIRY------KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG--PDFEPQ 388
I+ + LHYLH + I HRDIK N L FE +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 389 ITDFGLAKWLPNKCTHHAAIPIE--GTFGYLAPE--YFMHGIIDEKTDVFAFGVLLLEII 444
+ DFGL+K GT ++APE + K D ++ GVLL ++
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 445 TGRKP 449
G P
Sbjct: 271 MGAVP 275
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 8e-19
Identities = 47/271 (17%), Positives = 92/271 (33%), Gaps = 23/271 (8%)
Query: 178 EDSSISQSPPQAPKTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFS 237
+P P + + K S + + +
Sbjct: 91 SKPCEPTAPVLIPGDERKRRRGYDVDEQG------KIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 238 YEEISSATNNFHS----ENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFL 292
+ + ++ +G G + V++ + G A K + ++
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVR 202
Query: 293 MELGIIGHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIV 351
E+ + + HP L +N + +I+ F G L + DE +K E + +
Sbjct: 203 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV-EYM 261
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQI--TDFGLAKWLPNKCTHHAAIP 409
V +GL ++H+ +H D+K N++ ++ DFGL L K +
Sbjct: 262 RQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT- 317
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLL 440
GT + APE + TD+++ GVL
Sbjct: 318 --GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVCH 303
+F ++G+G +S V + A+K L K + + + ++ E ++ + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 304 PNTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVARGLHY 360
P L + LY ++++NG L + S Y +IV L Y
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA----LEY 145
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE 420
LH + IIHRD+K N+LL D QITDFG AK L + A GT Y++PE
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 421 YFMHGIIDEK-----TDVFAFGVLLLEIITGRKP 449
++ EK +D++A G ++ +++ G P
Sbjct: 203 -----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/207 (24%), Positives = 81/207 (39%), Gaps = 48/207 (23%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G G YS + + + + AVK + K +D +E E L+ HPN TL
Sbjct: 31 GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRY-----GQHPNIITLKDVY 85
Query: 314 -IENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVARGLH 359
+Y++ + G L +A+ ++ + + +
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFSEREAS---------------AVLFTITKTVE 130
Query: 360 YLHKGCKRRIIHRDIKASNVLL---GPDFEP-QITDFGLAKWL--PNKCTHHAAIPIEGT 413
YLH + ++HRD+K SN+L + E +I DFG AK L N T
Sbjct: 131 YLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC----YT 183
Query: 414 FGYLAPEYFMHGIIDEKTDVFAFGVLL 440
++APE D D+++ GVLL
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 21/213 (9%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVCH 303
N F ++G+GG+ EV + K+ A K+L K +K + + E I+ V
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 304 PNTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG-VARGLHYL 361
+L ++ L L+ G+L ++ R + GL L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-RAVFYAAEICCGLEDL 302
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
H+ RI++RD+K N+LL +I+D GLA +P T + GT GY+APE
Sbjct: 303 HR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPE- 355
Query: 422 FMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
++ + D +A G LL E+I G+ P
Sbjct: 356 ----VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 42/199 (21%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G G + +V+ S G + +K + KD + ++ E+ ++ + HPN +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 313 C-IENGLYLIFNFSQNGNL-DAALHDERSKSLEWPIRY------KIVLGVARGLHYLHKG 364
+ +Y++ + G L + + + +++ + L Y H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMNALAYFHS- 142
Query: 365 CKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
+ ++H+D+K N+L P +I DFGLA+ + A GT Y+APE
Sbjct: 143 --QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAPEV 197
Query: 422 FMHGIIDEKTDVFAFGVLL 440
F + K D+++ GV++
Sbjct: 198 F-KRDVTFKCDIWSAGVVM 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 43/202 (21%), Positives = 76/202 (37%), Gaps = 36/202 (17%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G G +V + + G+K A+K L + A++E + + P+ ++
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLLYD-SPKARQEVDHHWQAS-----GGPHIVCILDVY 91
Query: 314 -----IENGLYLIFNFSQNGNL-------DAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
+ L +I + G L ER + +I+ + + +L
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-------EIMRDIGTAIQFL 144
Query: 362 HKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLA 418
H I HRD+K N+L D ++TDFG AK T Y+A
Sbjct: 145 HS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYYVA 197
Query: 419 PEYFMHGIIDEKTDVFAFGVLL 440
PE D+ D+++ GV++
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIM 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 57/298 (19%), Positives = 120/298 (40%), Gaps = 37/298 (12%)
Query: 148 ETKSENPSPRTVLDELEGESNTTEDDTFSV-EDSSISQSPPQAPKTKGLSNTRMRMSPGK 206
+ +EN +++ + + +S + ++ V ++ +++ P K + P
Sbjct: 13 DLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAP 72
Query: 207 FFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKG- 265
F I+++ + G++++ Y ++G G + +V+K
Sbjct: 73 FDHRIVTA----KQGAVNSF-----------YT--------VSKTEILGGGRFGQVHKCE 109
Query: 266 NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC-IENGLYLIFNF 324
+ G K+A K + + K ++E E+ ++ + H N L +N + L+ +
Sbjct: 110 ETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167
Query: 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD 384
G L + DE E + + G+ ++H+ I+H D+K N+L
Sbjct: 168 VDGGELFDRIIDESYNLTELDTI-LFMKQICEGIRHMHQ---MYILHLDLKPENILCVNR 223
Query: 385 FEPQI--TDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLL 440
QI DFGLA+ + GT +LAPE + + TD+++ GV+
Sbjct: 224 DAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 5e-18
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 34/219 (15%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD------AKKEKEFLMELGII 298
+ +G+G Y V+K N +A+KR+ D+ D A +E L EL
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL--- 58
Query: 299 GHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLD---AALHDERSKSLEWPIRYKIVLGV 354
H N L + L L+F F D D + L+ I + +
Sbjct: 59 ---KHKNIVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNKC-THHAAIPIE 411
+GL + H R ++HRD+K N+L+ + E ++ +FGLA+ +P +C +
Sbjct: 111 LKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---- 163
Query: 412 GTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKP 449
T Y P+ + D+++ G + E+ +P
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 61/322 (18%), Positives = 116/322 (36%), Gaps = 69/322 (21%)
Query: 148 ETKSENPSPRTVLDELEGESNTTEDDTFSVEDSSISQSPPQAPKTKGLSNTRMRMSPGKF 207
+ E R + L + SQS + K L++ + + + +
Sbjct: 14 KFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLY 73
Query: 208 FTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKG-N 266
F S+ + + Y+ ++++G+G S V + +
Sbjct: 74 FQSMGPEDELPDWAAAKEFYQK--------YD----------PKDVIGRGVSSVVRRCVH 115
Query: 267 LSDGRKIAVKRLAKDNKDAKKE------KEFLMELGIIGHVC-HPNTATLVGCCIE-NGL 318
+ G + AVK + + E + E I+ V HP+ TL+ + +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 319 YLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
+L+F+ + G L + I+ + + +LH
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETR---------------SIMRSLLEAVSFLHA-- 218
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL-PNKCTHHAAIPIEGTFGYLAPE---- 420
I+HRD+K N+LL + + +++DFG + L P + GT GYLAPE
Sbjct: 219 -NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC----GTPGYLAPEILKC 273
Query: 421 --YFMHGIIDEKTDVFAFGVLL 440
H ++ D++A GV+L
Sbjct: 274 SMDETHPGYGKEVDLWACGVIL 295
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 53/224 (23%), Positives = 82/224 (36%), Gaps = 30/224 (13%)
Query: 242 SSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD---------AKKEKEF 291
S AT+ + +G G Y VYK + G +A+K + N +E
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 292 LMELGIIGHVCHPNTATLVGCCI------ENGLYLIFNFSQNGNLDAALHDERSKSLEWP 345
L L HPN L+ C E + L+F +L L L
Sbjct: 65 LRRLE---AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE 120
Query: 346 IRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNKCT 403
++ RGL +LH I+HRD+K N+L+ ++ DFGLA+ T
Sbjct: 121 TIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT 177
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGR 447
T Y APE + D+++ G + E+ +
Sbjct: 178 PVVV-----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 27/191 (14%)
Query: 243 SATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD-----AKKEKEFLMELG 296
S+++ F +G G Y+ VYKG N + G +A+K + D+++ A +E + EL
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL- 60
Query: 297 IIGHVCHPNTATLVGCCI-ENGLYLIFNFSQN---GNLDAALHDERSKSLEWPIRYKIVL 352
H N L EN L L+F F N +D+ + LE +
Sbjct: 61 -----KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNKC-THHAAIP 409
+ +GL + H+ +I+HRD+K N+L+ + ++ DFGLA+ +P +
Sbjct: 116 QLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-- 170
Query: 410 IEGTFGYLAPE 420
T Y AP+
Sbjct: 171 ---TLWYRAPD 178
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 49/202 (24%), Positives = 77/202 (38%), Gaps = 27/202 (13%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKD---NKDAKKEKEFLMELGIIGHVCHPNTATLV 310
G+G +S V + N G++ AVK + + ++ E I + HP+ L+
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 311 GCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRY------KIVLGVARGLHYLHK 363
+G LY++F F +L E K + Y + + L Y H
Sbjct: 93 ETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 364 GCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWL--PNKCTHHAAIPIEGTFGYLA 418
IIHRD+K VLL ++ FG+A L GT ++A
Sbjct: 149 ---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV----GTPHFMA 201
Query: 419 PEYFMHGIIDEKTDVFAFGVLL 440
PE + DV+ GV+L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 33/216 (15%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD-----AKKEKEFLMELGIIG 299
+ + +G+G Y+ VYKG + +A+K + ++++ A +E L +L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL---- 57
Query: 300 HVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLD---AALHDERSKSLEWPIRYKIVLGVA 355
H N TL E L L+F + LD D+ + + +
Sbjct: 58 --KHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNKC-THHAAIPIEG 412
RGL Y H+ ++++HRD+K N+L+ E ++ DFGLA+ +P K +
Sbjct: 111 RGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----- 162
Query: 413 TFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGR 447
T Y P+ + + D++ G + E+ TGR
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 46/192 (23%), Positives = 89/192 (46%), Gaps = 12/192 (6%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH-PNTATLVGC 312
G+G ++ V + + S G++ A K L K + E L E+ ++ P L
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 313 C-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
+ + LI ++ G + + E ++ + +++ + G++YLH + I+H
Sbjct: 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVH 154
Query: 372 RDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIID 428
D+K N+LL P + +I DFG+++ + + C + GT YLAPE + I
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---GTPEYLAPEILNYDPIT 211
Query: 429 EKTDVFAFGVLL 440
TD++ G++
Sbjct: 212 TATDMWNIGIIA 223
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 50/249 (20%), Positives = 93/249 (37%), Gaps = 54/249 (21%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGC 312
G+G +S K + + AVK ++K + E E+ + HPN L
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 313 CI-ENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVARGL 358
+ +L+ G L +A+ I+ + +
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS---------------YIMRKLVSAV 119
Query: 359 HYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWL-PNKCTHHAAIPIEGTF 414
++H ++HRD+K N+L + E +I DFG A+ P+ T
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC---FTL 173
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474
Y APE DE D+++ GV+L +++G+ P S ++L + E++
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV--------EIM 225
Query: 475 DPSLEGEYD 483
+G++
Sbjct: 226 KKIKKGDFS 234
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 47/205 (22%), Positives = 76/205 (37%), Gaps = 42/205 (20%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G + EV + A K++ K + F E+ I+ + HPN L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 313 C-IENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVARGL 358
+YL+ G L DAA +I+ V +
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------------RIMKDVLSAV 119
Query: 359 HYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415
Y HK + HRD+K N L PD ++ DFGLA + GT
Sbjct: 120 AYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPY 173
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLL 440
Y++P+ G+ + D ++ GV++
Sbjct: 174 YVSPQVL-EGLYGPECDEWSAGVMM 197
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 57/276 (20%), Positives = 102/276 (36%), Gaps = 54/276 (19%)
Query: 242 SSATNNFH-----SENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMEL 295
S + F E+++G+G ++ V NL ++ AVK + K + E+
Sbjct: 4 DSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREV 61
Query: 296 GIIGHVC-HPNTATLVGCCI-ENGLYLIFNFSQNGNL-------------DAALHDERSK 340
++ H N L+ E+ YL+F + G++ +A+
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS------- 114
Query: 341 SLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKW 397
+V VA L +LH + I HRD+K N+L +I DF L
Sbjct: 115 --------VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163
Query: 398 LPNKCTHHAAIPIE-----GTFGYLAPEYFMHGII-----DEKTDVFAFGVLLLEIITGR 447
+ E G+ Y+APE D++ D+++ GV+L +++G
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223
Query: 448 KPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483
P + W + L + EG+Y+
Sbjct: 224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE 259
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 45/225 (20%), Positives = 80/225 (35%), Gaps = 21/225 (9%)
Query: 226 KEKHQPLLTCFSYEEISSATNNFHSENMV----GQGGYSEVYKG-NLSDGRKIAVKRLAK 280
+ ++ + + + + + + + G G + V++ + GR K +
Sbjct: 27 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86
Query: 281 DNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC-IENGLYLIFNFSQNGNL-DAALHDER 338
+ E+ I+ + HP L + + LI F G L D ++
Sbjct: 87 --PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY 144
Query: 339 SKSLEWPIRY-KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQI--TDFGLA 395
S I Y + GL ++H+ I+H DIK N++ + DFGLA
Sbjct: 145 KMSEAEVINYMRQACE---GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLL 440
L T + APE + TD++A GVL
Sbjct: 199 TKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 52/216 (24%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAK------DNKDAKKEKEFLM-ELGIIGHVC-HPN 305
G+G S V + + ++ AVK + ++ ++ +E + E+ I+ V HPN
Sbjct: 26 GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85
Query: 306 TATLVGCCIE-NGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIV 351
L +L+F+ + G L + KI+
Sbjct: 86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR---------------KIM 130
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL-PNKCTHHAAIPI 410
+ + LHK I+HRD+K N+LL D ++TDFG + L P +
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--- 184
Query: 411 EGTFGYLAPEYFMHGII------DEKTDVFAFGVLL 440
GT YLAPE + ++ D+++ GV++
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVCH 303
+ F ++G+GG+ EV+ + K+ A K+L K +K + M E I+ V
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 304 PNTATLVGCCIENG--LYLIFNFSQNGNLDAALHDERSKSLEWPIR----Y--KIVLGVA 355
+L E L L+ G++ +++ + + Y +IV G
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP--NKCTHHAAIPIEGT 413
L +LH+ R II+RD+K NVLL D +I+D GLA L T A GT
Sbjct: 302 --LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA----GT 352
Query: 414 FGYLAPEYFMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
G++APE ++ + D FA GV L E+I R P
Sbjct: 353 PGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 3e-17
Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 26/186 (13%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD------AKKEKEFLMELGII 298
NF +G+G Y VYK N G +A+K++ D + A +E L EL
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 299 GHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARG 357
HPN L+ EN LYL+F F +L + + P+ + + +G
Sbjct: 60 ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNKC-THHAAIPIEGTF 414
L + H R++HRD+K N+L+ + ++ DFGLA+ +P + TH T
Sbjct: 116 LAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TL 167
Query: 415 GYLAPE 420
Y APE
Sbjct: 168 WYRAPE 173
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 44/209 (21%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKD---NKDAKKEKEFLM-ELGIIGHVCHPNTATL 309
G G ++ V K G++ A K + K + +E + E+ I+ + HPN TL
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 310 VGCC-IENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVA 355
+ + LI G L +A + + +
Sbjct: 74 HDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---------------QFLKQIL 118
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLL----GPDFEPQITDFGLAKWLPNKCTHHAAIPIE 411
G+HYLH +RI H D+K N++L P+ ++ DFG+A +
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 172
Query: 412 GTFGYLAPEYFMHGIIDEKTDVFAFGVLL 440
GT ++APE + + + D+++ GV+
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 47/209 (22%), Positives = 79/209 (37%), Gaps = 44/209 (21%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKE----KEFLMELGIIGHVCHPNTATL 309
G G ++ V K S G + A K + K A + +E E+ I+ V H N TL
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 310 VGCC-IENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVA 355
+ LI G L +A + +
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------------SFIKQIL 125
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLL----GPDFEPQITDFGLAKWLPNKCTHHAAIPIE 411
G++YLH ++I H D+K N++L P ++ DFGLA + +
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--- 179
Query: 412 GTFGYLAPEYFMHGIIDEKTDVFAFGVLL 440
GT ++APE + + + D+++ GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 33/211 (15%)
Query: 224 SNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN 282
+ H + + + + + +VG+G Y V K N GR +A+K+ + +
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD 62
Query: 283 KD------AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALH 335
D A +E + L +L H N L+ C + YL+F F +D +
Sbjct: 63 DDKMVKKIAMREIKLLKQL------RHENLVNLLEVCKKKKRWYLVFEF-----VDHTIL 111
Query: 336 ---DERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDF 392
+ L++ + K + + G+ + H IIHRDIK N+L+ ++ DF
Sbjct: 112 DDLELFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDF 168
Query: 393 GLAKWL---PNKCTHHAAIPIEGTFGYLAPE 420
G A+ L A T Y APE
Sbjct: 169 GFARTLAAPGEVYDDEVA-----TRWYRAPE 194
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 33/169 (19%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD------AKKEKEFLMELGII 298
+ + +GQG + EV+K + G+K+A+K++ +N+ A +E + L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-- 74
Query: 299 GHVCHPNTATLVGCCIENG---------LYLIFNFSQNGNLD---AALHDERSKSLEWPI 346
H N L+ C +YL+F+F + A L
Sbjct: 75 ----HENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKFTLSE 125
Query: 347 RYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395
+++ + GL+Y+H+ +I+HRD+KA+NVL+ D ++ DFGLA
Sbjct: 126 IKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 48/209 (22%), Positives = 79/209 (37%), Gaps = 44/209 (21%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEK----EFLMELGIIGHVCHPNTATL 309
G G ++ V K S G + A K + K A + E E+ I+ V HPN TL
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80
Query: 310 VGCC-IENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVA 355
+ LI G L +A + +
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------------SFIKQIL 125
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLL----GPDFEPQITDFGLAKWLPNKCTHHAAIPIE 411
G++YLH ++I H D+K N++L P ++ DFGLA + +
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--- 179
Query: 412 GTFGYLAPEYFMHGIIDEKTDVFAFGVLL 440
GT ++APE + + + D+++ GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 44/225 (19%)
Query: 246 NNFHSENMVGQGGYSEVY---KGNLSDGRKI-AVKRLAKDNKDAKKEKEFLMELGIIGHV 301
+ F ++GQG + +V+ K + SD R++ A+K L K + ME I+ V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 302 CHPNTATLVG--CCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVA 355
HP +V E LYLI +F + G+L L E + E Y ++ L
Sbjct: 84 NHP---FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA-- 138
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGT 413
L +LH II+RD+K N+LL + ++TDFGL+K K + +
Sbjct: 139 --LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--------S 185
Query: 414 F-G---YLAPEYFMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
F G Y+APE +++ + D ++FGVL+ E++TG P
Sbjct: 186 FCGTVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 9e-17
Identities = 56/192 (29%), Positives = 85/192 (44%), Gaps = 32/192 (16%)
Query: 242 SSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKD------AKKEKEFLMEL 295
+ VG+G Y VYK S GR +A+KR+ D +D A +E L EL
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 296 GIIGHVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLD---AALHDERSKSLEWPIRYKIV 351
HPN +L+ E L L+F F ++ + DE L+ +
Sbjct: 77 ------HHPNIVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNKC-THHAAI 408
+ RG+ + H+ RI+HRD+K N+L+ D ++ DFGLA+ +P + TH
Sbjct: 126 YQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV- 181
Query: 409 PIEGTFGYLAPE 420
T Y AP+
Sbjct: 182 ----TLWYRAPD 189
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 48/232 (20%), Positives = 87/232 (37%), Gaps = 58/232 (25%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFL----MELGII----GHVCHPN 305
G+GG+ V+ G L+D ++A+K + ++ +E+ ++ HP
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 306 TATL--VGCCIEN--GLYLI----------FNF-SQNGNLDAALHDERSKSLEWPIRYK- 349
L E G L+ F++ ++ G L E P R
Sbjct: 100 VIRLLDW---FETQEGFMLVLERPLPAQDLFDYITEKGPLG-----------EGPSRCFF 145
Query: 350 --IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ---ITDFGLAKWLPNKCTH 404
+V + + H R ++HRDIK N+L+ D + DFG L ++
Sbjct: 146 GQVVAAI----QHCHS---RGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDEPYT 196
Query: 405 HAAIPIEGTFGYLAPEYFMHGIID-EKTDVFAFGVLLLEIITGRKPVDSSRQ 455
GT Y PE+ V++ G+LL +++ G P + ++
Sbjct: 197 DFD----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 51/230 (22%), Positives = 93/230 (40%), Gaps = 44/230 (19%)
Query: 212 LSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKG-NLSDG 270
++ G+L + P S +++ + + +G+G Y EVYK +
Sbjct: 1 MAHHHHHHMGTLEA-QTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTN 59
Query: 271 RKIAVKRLAKDNKD------AKKEKEFLMELGIIGHVCHPNTATLVGCCI-ENGLYLIFN 323
+A+KR+ ++++ A +E L EL H N L + L+LIF
Sbjct: 60 ETVAIKRIRLEHEEEGVPGTAIREVSLLKEL------QHRNIIELKSVIHHNHRLHLIFE 113
Query: 324 FSQNGNLDAALHD-----ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASN 378
+ + +D +++ + + + + G+++ H RR +HRD+K N
Sbjct: 114 Y-----AE---NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQN 162
Query: 379 VLLGPDFEPQ-----ITDFGLAKW--LPNKC-THHAAIPIEGTFGYLAPE 420
+LL + I DFGLA+ +P + TH T Y PE
Sbjct: 163 LLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-----TLWYRPPE 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 44/209 (21%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKD---NKDAKKEKEFLM-ELGIIGHVCHPNTATL 309
G G ++ V K S G + A K + K + +E + E+ I+ + HPN TL
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 310 VGCC-IENGLYLIFNFSQNGNL-------------DAALHDERSKSLEWPIRYKIVLGVA 355
+ + LI G L +A + + +
Sbjct: 80 HEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT---------------EFLKQIL 124
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLL----GPDFEPQITDFGLAKWLPNKCTHHAAIPIE 411
G++YLH +I H D+K N++L P +I DFGLA +
Sbjct: 125 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 412 GTFGYLAPEYFMHGIIDEKTDVFAFGVLL 440
GT ++APE + + + D+++ GV+
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 50/196 (25%), Positives = 79/196 (40%), Gaps = 48/196 (24%)
Query: 254 VGQGGYSEVYKG---NLSDGRKIAVKRLAKDNKD--AKKEKEFLMELGIIGHVCHPNTAT 308
VG+G Y VYK + D + A+K++ A +E L EL HPN +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL------KHPNVIS 82
Query: 309 LVGCCIENG---LYLIFNF--------------SQNGNLDAALHDERSKSLEWPIRYKIV 351
L + + ++L+F++ S+ L KSL + I
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI----- 137
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ----ITDFGLAK--WLPNKC-TH 404
G+HYLH ++HRD+K +N+L+ + + I D G A+ P K
Sbjct: 138 ---LDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 405 HAAIPIEGTFGYLAPE 420
+ + TF Y APE
Sbjct: 192 LDPVVV--TFWYRAPE 205
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 51/228 (22%), Positives = 82/228 (35%), Gaps = 52/228 (22%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFL----MELGIIGHVCH--PNTA 307
G GG+ VY G +SD +A+K + KD E ME+ ++ V
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 308 TLVGCCIEN--GLYLI----------FNF-SQNGNLDAALHDERSKSLEWPIRYK---IV 351
L+ E LI F+F ++ G L E R ++
Sbjct: 112 RLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQ-----------EELARSFFWQVL 159
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ---ITDFGLAKWLPNKCTHHAAI 408
V + H ++HRDIK N+L+ D + DFG L +
Sbjct: 160 EAV----RHCHN---CGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFD- 209
Query: 409 PIEGTFGYLAPEYFMHGIID-EKTDVFAFGVLLLEIITGRKPVDSSRQ 455
GT Y PE+ + V++ G+LL +++ G P + +
Sbjct: 210 ---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 51/222 (22%), Positives = 85/222 (38%), Gaps = 28/222 (12%)
Query: 242 SSATNNFHSENMVGQGGYSEVYKG--NLSDGRKIAVKRLAKDNKD------AKKEKEFLM 293
A + +G+G Y +V+K + GR +A+KR+ + +E L
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 294 ELGIIGHVCHPNTATLVGCCI------ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIR 347
L HPN L C E L L+F +L L +
Sbjct: 67 HLE---TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETI 122
Query: 348 YKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNKCTHH 405
++ + RGL +LH R++HRD+K N+L+ + ++ DFGLA+ T
Sbjct: 123 KDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
Query: 406 AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGR 447
T Y APE + D+++ G + E+ +
Sbjct: 180 VV-----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 44/222 (19%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD------AKKEKEFLMELGII 298
+ +G+G Y V+K N G+ +A+K+ + D A +E L +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL--- 59
Query: 299 GHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALH---DERSKSLEWPIRYKIVLGV 354
HPN L+ L+L+F + D + D + + + I
Sbjct: 60 ---KHPNLVNLLEVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL--PNKC-THHAAIPIE 411
+ +++ HK IHRD+K N+L+ ++ DFG A+ L P+ A
Sbjct: 112 LQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA---- 164
Query: 412 GTFGYLAPEYFMH------GIIDEKTDVFAFGVLLLEIITGR 447
T Y +PE + + DV+A G + E+++G
Sbjct: 165 -TRWYRSPELLVGDTQYGPPV-----DVWAIGCVFAELLSGV 200
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 39/193 (20%), Positives = 67/193 (34%), Gaps = 18/193 (9%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G + V++ S + K + D + E+ I+ H N L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHES 69
Query: 313 C-IENGLYLIFNFSQNGNL-DAALHDERSKSLEWPIRY-KIVLGVARGLHYLHKGCKRRI 369
L +IF F ++ + + + Y V L +LH I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE---ALQFLHS---HNI 123
Query: 370 IHRDIKASNVLLGPDFEPQ--ITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII 427
H DI+ N++ I +FG A+ L Y APE H ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVV 180
Query: 428 DEKTDVFAFGVLL 440
TD+++ G L+
Sbjct: 181 STATDMWSLGTLV 193
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 2e-16
Identities = 53/188 (28%), Positives = 79/188 (42%), Gaps = 32/188 (17%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKD------AKKEKEFLMELGIIG 299
+H +G+G Y VYK + G A+K++ + +D +E L EL
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL---- 57
Query: 300 HVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLD---AALHDERSKSLEWPIRYKIVLGVA 355
H N L + L L+F LD L D LE +L +
Sbjct: 58 --KHSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW--LPNKC-THHAAIPIEG 412
G+ Y H RR++HRD+K N+L+ + E +I DFGLA+ +P + TH
Sbjct: 111 NGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----- 162
Query: 413 TFGYLAPE 420
T Y AP+
Sbjct: 163 TLWYRAPD 170
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 23/202 (11%), Positives = 54/202 (26%), Gaps = 45/202 (22%)
Query: 254 VGQGGYSEVYKGNLSD---GRKIAVKRL-AKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
G + ++ D R++A+ + + +E L + + P A +
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 310 VGCCIENGL-YLIFNFSQNGNLDAALHDERSKSLEWPIR-YKIVLGVARGLHYLHKGCKR 367
+ ++ + + G+L S P+ + + +A H+
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPS-----PVGAIRAMQSLAAAADAAHR---A 148
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII 427
+ S V + D G +
Sbjct: 149 GVALSIDHPSRVRVSID--------GDVVL--------------AYPATMPDA------- 179
Query: 428 DEKTDVFAFGVLLLEIITGRKP 449
+ + D+ G L ++ R P
Sbjct: 180 NPQDDIRGIGASLYALLVNRWP 201
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAK---DNKDAKKEKEFLMELGIIGH 300
+ S VG G Y V + G K+A+K+L++ AK+ EL ++ H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELLLLKH 79
Query: 301 VCHPNTATLVGCCIE-------NGLYLIFNFSQNGNLDAALHDE-RSKSLEWPIRYKIVL 352
+ H N L+ YL+ F + L K E I+Y +V
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQY-LVY 133
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEG 412
+ +GL Y+H ++HRD+K N+ + D E +I DFGLA+ + T +
Sbjct: 134 QMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----- 185
Query: 413 TFGYLAPEYFM-HGIIDEKTDVFAFGVLLLEIITGR 447
T Y APE + ++ D+++ G ++ E++TG+
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEF-LMELGIIGHVCH 303
++F +G+G + +V +D +K+ A+K + K + E EL I+ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 304 PNTATLVGC--CIENGLYLIFNFSQNGNLDAALHDERSKSL-EWPIRY---KIVLGVARG 357
P L E+ ++++ + G+L H +++ E ++ ++V+
Sbjct: 75 PFLVNLWYSFQDEED-MFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICELVMA---- 127
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYL 417
L YL +RIIHRD+K N+LL ITDF +A LP + + GT Y+
Sbjct: 128 LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGTKPYM 181
Query: 418 APEYFMHGIIDEKT--------DVFAFGVLLLEIITGRKP 449
APE + + D ++ GV E++ GR+P
Sbjct: 182 APE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 67/288 (23%), Positives = 107/288 (37%), Gaps = 28/288 (9%)
Query: 169 TTEDDTFSVEDSSISQSPPQAPKTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEK 228
T + TF VE + A +T + + F + S +S +
Sbjct: 82 TVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKP 141
Query: 229 HQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKK 287
+ N F ++G+G + +V + A+K L K+ AK
Sbjct: 142 KHRV-----------TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD 190
Query: 288 EKEFLM-ELGIIGHVCHPNTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWP 345
E + E ++ + HP L + L + ++ G L L ER S +
Sbjct: 191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA 250
Query: 346 IRYK--IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNK 401
Y IV L YLH ++ +++RD+K N++L D +ITDFGL K
Sbjct: 251 RFYGAEIVSA----LDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304
Query: 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
GT YLAPE D + GV++ E++ GR P
Sbjct: 305 TMK----TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 57/248 (22%), Positives = 105/248 (42%), Gaps = 21/248 (8%)
Query: 213 SSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRK 272
+SPLR+ L E +P + + +F ++G+G + EV L + K
Sbjct: 43 NSPLRREKNILEYLEWAKPFTSKVKQMRLH--REDFEILKVIGRGAFGEVAVVKLKNADK 100
Query: 273 I-AVKRLAKDNKDAKKEKE-FLMELGIIGHVCHPNTATLVGCC-IENGLYLIFNFSQNGN 329
+ A+K L K + E F E ++ + TL +N LYL+ ++ G+
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160
Query: 330 LDAALHDERSKSLEWPIRY---KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386
L L + E R+ ++V+ + +H+ +HRDIK N+L+ +
Sbjct: 161 LLTLLSKFEDRLPEEMARFYLAEMVIA----IDSVHQ---LHYVHRDIKPDNILMDMNGH 213
Query: 387 PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKT-----DVFAFGVLLL 441
++ DFG L T +++ + GT Y++PE + D ++ GV +
Sbjct: 214 IRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMY 272
Query: 442 EIITGRKP 449
E++ G P
Sbjct: 273 EMLYGETP 280
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC----THHAAIP 409
VA+G+ +L R+ IHRD+ A N+LL +I DFGLA+ + A +P
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449
++ APE + ++DV++FGVLL EI + G P
Sbjct: 259 LKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 27/102 (26%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 246 NNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIG 299
+ +G+G + +V + + + R +AVK L K+ + + + EL I+
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILI 80
Query: 300 HV-CHPNTATLVGCCIENG--LYLIFNFSQNGNLDAALHDER 338
H+ H N L+G C + G L +I F + GNL L +R
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 59/218 (27%), Positives = 85/218 (38%), Gaps = 35/218 (16%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVCH 303
+ F +G G + V + A+K L K K+ E + E I+ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 304 PNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVARGLHY 360
P L +N LY++ + G + + L S Y +IVL Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEY 156
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK----CTHHAAIPIEGTFGY 416
LH +I+RD+K N+L+ Q+TDFG AK + + C GT
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---------GTPEA 204
Query: 417 LAPEYFMHGIIDEK-----TDVFAFGVLLLEIITGRKP 449
LAPE II K D +A GVL+ E+ G P
Sbjct: 205 LAPE-----IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 47/202 (23%), Positives = 75/202 (37%), Gaps = 35/202 (17%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG-- 311
G G +V + N K A+K L +D A++E E P+ +V
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWRAS-----QCPHIVRIVDVY 124
Query: 312 ---CCIENGLYLIFNFSQNGNL-------DAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
L ++ G L ER S +I+ + + YL
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EIMKSIGEAIQYL 177
Query: 362 HKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLA 418
H I HRD+K N+L P+ ++TDFG AK + + T Y+A
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTPYYVA 231
Query: 419 PEYFMHGIIDEKTDVFAFGVLL 440
PE D+ D+++ GV++
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIM 253
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAK---DNKDAKKEKEFLMELGIIGH 300
+ VG G Y V + G K+A+K+L + AK+ EL ++ H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA---YRELRLLKH 80
Query: 301 VCHPNTATLV-------GCCIENGLYLIFNFSQNGNLDAALHDE-RSKSLEWP-IRYKIV 351
+ H N L+ YL+ F + L + + L I++ +V
Sbjct: 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDRIQF-LV 134
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIE 411
+ +GL Y+H IIHRD+K N+ + D E +I DFGLA+ ++ T +
Sbjct: 135 YQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV---- 187
Query: 412 GTFGYLAPEYFM-HGIIDEKTDVFAFGVLLLEIITGR 447
T Y APE + + D+++ G ++ E+ITG+
Sbjct: 188 -TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 51/252 (20%), Positives = 91/252 (36%), Gaps = 32/252 (12%)
Query: 213 SSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRK 272
LRK + +++ + + ++ ++G+G + EV RK
Sbjct: 38 FPALRKNKNIDNFLSRYKDTINKIRDLRMK--AEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 273 I-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTATLVGCC-IENGLYLIFNFSQNGN 329
+ A+K L+K + + F E I+ P L + LY++ + G+
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 155
Query: 330 LDAALHDERSKSLEWPIRYKIVLGVAR--------GLHYLHKGCKRRIIHRDIKASNVLL 381
L + Y + AR L +H IHRD+K N+LL
Sbjct: 156 LVNLMS-----------NYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLL 201
Query: 382 GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM----HGIIDEKTDVFAFG 437
++ DFG + + + GT Y++PE G + D ++ G
Sbjct: 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 438 VLLLEIITGRKP 449
V L E++ G P
Sbjct: 261 VFLYEMLVGDTP 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 42/223 (18%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVCH 303
N+F ++G+G + +V + A+K L K+ AK E + E ++ + H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 304 PNTATLVG--CCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK--IVLGVARG 357
P L + L + ++ G L L ER + E Y IV
Sbjct: 65 P---FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA---- 117
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTF- 414
L YLH R +++RDIK N++L D +ITDFGL K TF
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--------TFC 166
Query: 415 G---YLAPEYFMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
G YLAPE ++++ D + GV++ E++ GR P
Sbjct: 167 GTPEYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 70/240 (29%), Positives = 107/240 (44%), Gaps = 42/240 (17%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL--VG 311
G+G +++V ++ GR++A+K + K + ++ E+ I+ + HPN L V
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV- 82
Query: 312 CCIENG--LYLIFNFSQNGNL-DAALHDERSKSLEWPIRYK---IVLGVARGLHYLHKGC 365
IE LYLI ++ G + D + R K E R K IV V Y H+
Sbjct: 83 --IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE--ARSKFRQIVSAV----QYCHQ-- 132
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGL-AKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
+RI+HRD+KA N+LL D +I DFG ++ G Y APE F
Sbjct: 133 -KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAPELFQG 187
Query: 425 GIID-EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483
D + DV++ GV+L +++G P D NL EL + L G+Y
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQ---------------NLKELRERVLRGKYR 232
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 51/230 (22%), Positives = 94/230 (40%), Gaps = 56/230 (24%)
Query: 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
+ + ++G G + V++ L + ++A+K++ +D + EL I+ V HP
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK------NRELQIMRIVKHP 92
Query: 305 NTATLVGCCIENG-------LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVA-- 355
N L NG L L+ + + ++ ++ + K + +
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEY-----VPETVY----RASRHYAKLKQTMPMLLI 143
Query: 356 --------RGLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFGLAKWL-PNK---- 401
R L Y+H I HRDIK N+LL P ++ DFG AK L +
Sbjct: 144 KLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
Query: 402 --CTHHAAIPIEGTFGYLAPEYFMHGIIDEKT--DVFAFGVLLLEIITGR 447
C+ + Y APE + G + T D+++ G ++ E++ G+
Sbjct: 201 YICSRY----------YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 45/224 (20%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAK---DNKDAKKEKEFLMELGIIGH 300
+ + +G G V + R +A+K+L++ + AK+ EL ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELVLMKC 80
Query: 301 VCHPNTATLV-------GCCIENGLYLIFNFSQNGNLDAALH--------DERSKSLEWP 345
V H N L+ +Y++ +DA L ER
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-----MDANLCQVIQMELDHERMSY---- 131
Query: 346 IRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC--T 403
+ Y+++ G+ +LH IIHRD+K SN+++ D +I DFGLA+ T
Sbjct: 132 LLYQML----CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGR 447
+ T Y APE + E D+++ G ++ E+I G
Sbjct: 185 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 41/223 (18%)
Query: 245 TNNFHSENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH 303
++ ++G G + VY+ L D G +A+K++ +D + EL I+ + H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMRKLDH 106
Query: 304 PNTATLVGCCIENG-------LYLIFNFSQNGNLDAALHDERSKSLEWPIRY-KIVL-GV 354
N L +G L L+ ++ + P+ Y K+ + +
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEP-QITDFGLAKWL----PNK---CTHHA 406
R L Y+H I HRDIK N+LL PD ++ DFG AK L PN C+ +
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 221
Query: 407 AIPIEGTFGYLAPEYFMHGIIDEKT--DVFAFGVLLLEIITGR 447
Y APE + G D + DV++ G +L E++ G+
Sbjct: 222 ---------YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 32/223 (14%)
Query: 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEF---------LMEL 295
+ + + + G Y V G S+G +A+KR+ D + L E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 296 GIIGHVCHPNTATLVGCCIE------NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK 349
++ H HPN L + + LYL+ + +L +HD+R I+Y
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY- 138
Query: 350 IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC--THHAA 407
+ + GLH LH+ ++HRD+ N+LL + + I DF LA+ TH+
Sbjct: 139 FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 408 IPIEGTFGYLAPE---YFMHGIIDEKTDVFAFGVLLLEIITGR 447
Y APE F + D+++ G ++ E+ +
Sbjct: 196 -----HRWYRAPELVMQFKGF--TKLVDMWSAGCVMAEMFNRK 231
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 55/251 (21%), Positives = 100/251 (39%), Gaps = 25/251 (9%)
Query: 213 SSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRK 272
+S L + + +P++ + ++F ++G+G +SEV + +
Sbjct: 30 ASELAQDKYVADFLQWAEPIVVRLKEVRLQ--RDDFEILKVIGRGAFSEVAVVKMKQTGQ 87
Query: 273 I-AVKRLAKDNKDAKKEKE-FLMELGIIGHVCHPNTATLVGCCI--ENGLYLIFNFSQNG 328
+ A+K + K + + E F E ++ + L EN LYL+ + G
Sbjct: 88 VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGG 146
Query: 329 NLDAALHDERSKSLEWPIRY---KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385
+L L + R+ +IV+ + +H+ +HRDIK N+LL
Sbjct: 147 DLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVHR---LGYVHRDIKPDNILLDRCG 199
Query: 386 EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE-------YFMHGIIDEKTDVFAFGV 438
++ DFG L T + + + GT YL+PE G + D +A GV
Sbjct: 200 HIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258
Query: 439 LLLEIITGRKP 449
E+ G+ P
Sbjct: 259 FAYEMFYGQTP 269
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 45/214 (21%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATL-- 309
+G+G YSEV++ N+++ K+ VK L K+K+ E+ I+ ++ PN TL
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLAD 98
Query: 310 -VGCCIENGLYLIFNFSQNGNLDA---ALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
V + L+F N + L D + Y+I+ + L Y H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY----MYEIL----KALDYCHS-- 148
Query: 366 KRRIIHRDIKASNVLLGPDF-EPQITDFGLAK-WLPNKC-THHAAIPIEGTFGYLAPE-- 420
I+HRD+K NV++ + + ++ D+GLA+ + P + A + + PE
Sbjct: 149 -MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA-----SRYFKGPELL 202
Query: 421 -----YFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
Y D D+++ G +L +I ++P
Sbjct: 203 VDYQMY------DYSLDMWSLGCMLASMIFRKEP 230
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 41/221 (18%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVCH 303
+F +G G + V+ + A+K L K+ K+ E E ++ V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 304 PNTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK-----IVLGVARG 357
P + G +++I ++ + G L + L + K + L
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKFYAAEVCLA---- 118
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK----CTHHAAIPIEGT 413
L YLH + II+RD+K N+LL + +ITDFG AK++P+ C GT
Sbjct: 119 LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---------GT 166
Query: 414 FGYLAPEYFMHGIIDEK-----TDVFAFGVLLLEIITGRKP 449
Y+APE ++ K D ++FG+L+ E++ G P
Sbjct: 167 PDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 43/182 (23%), Positives = 68/182 (37%), Gaps = 33/182 (18%)
Query: 237 SYEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMEL 295
+ E + F E M GQG + V G S G +A+K++ +D + +E L +
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIM 70
Query: 296 GIIGHVCHPNTATLVGCCIENG--------LYLIFNFSQNGNLDAALHDERSKSLEWPIR 347
+ + HPN L G L ++ + + LH + R
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY-----VPDTLH----RCCRNYYR 121
Query: 348 YKIVLGVA----------RGLHYLHKGCKRRIIHRDIKASNVLLGP-DFEPQITDFGLAK 396
++ R + LH + HRDIK NVL+ D ++ DFG AK
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 397 WL 398
L
Sbjct: 181 KL 182
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 37/220 (16%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAK---DNKDAKKEKEFLMELGIIGH 300
+ + +G G V + R +A+K+L++ + AK+ EL ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA---YRELVLMKC 117
Query: 301 VCHPNTATLV-----GCCIEN--GLYLIFNFSQNGNLDAALHDERSKSLEWP----IRYK 349
V H N +L+ +E +YL+ +DA L L+ + Y+
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLLYQ 172
Query: 350 IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC--THHAA 407
++ G+ +LH IIHRD+K SN+++ D +I DFGLA+ T +
Sbjct: 173 ML----CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225
Query: 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGR 447
T Y APE + E D+++ G ++ E++ +
Sbjct: 226 -----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 31/217 (14%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAK---DNKDAKKEKEFLMELGIIGH 300
+ + + VG G Y V + G ++AVK+L++ AK+ EL ++ H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKH 84
Query: 301 VCHPNTATLV-----GCCIE--NGLYLIFNFSQNGNLDAALHDE-RSKSL-EWPIRYKIV 351
+ H N L+ +E N +YL+ + + A L++ + + L + +++ ++
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQF-LI 138
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIE 411
+ RGL Y+H IIHRD+K SN+ + D E +I DFGLA+ ++ T + A
Sbjct: 139 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA---- 191
Query: 412 GTFGYLAPEYFM-HGIIDEKTDVFAFGVLLLEIITGR 447
T Y APE + ++ D+++ G ++ E++TGR
Sbjct: 192 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 43/224 (19%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVC- 302
+F ++G+G Y++V L +I A+K + K+ + ++ +++ E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 303 HPNTATLVG--CCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK--IVLGVAR 356
HP LVG C E+ L+ + + G+L + +R E Y I L
Sbjct: 69 HP---FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--- 122
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTF 414
L+YLH+ R II+RD+K NVLL + ++TD+G+ K P T TF
Sbjct: 123 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--------TF 170
Query: 415 -G---YLAPEYFMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
G Y+APE I+ + D +A GVL+ E++ GR P
Sbjct: 171 CGTPNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 54/231 (23%), Positives = 85/231 (36%), Gaps = 58/231 (25%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKD--NKDAKKEKEFLM----ELGIIGHVCHPNTA 307
G G + V+ + +++ VK + K+ +D E L E+ I+ V H N
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 308 TLVGCCIEN--GLYLI----------FNF-SQNGNLDAALHDERSKSLEWPIRYK---IV 351
++ EN L+ F F ++ LD E Y +V
Sbjct: 93 KVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLD-----------EPLASYIFRQLV 140
Query: 352 LGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA------KWLPNKCTHH 405
V YL + IIHRDIK N+++ DF ++ DFG A K C
Sbjct: 141 SAV----GYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 406 AAIPIEGTFGYLAPEYFMHGIID-EKTDVFAFGVLLLEIITGRKPVDSSRQ 455
GT Y APE M + ++++ GV L ++ P +
Sbjct: 191 ------GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 48/221 (21%), Positives = 82/221 (37%), Gaps = 44/221 (19%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKD--NKDAKKEKEFLMELGIIGHVCHPNTATL-- 309
G+G Y +V + + + AVK L K + E E+ ++ + H N L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 310 -VGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLG-----VAR------- 356
+ + +Y++ + G + + D + A
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQE--MLD------------SVPEKRFPVCQAHGYFCQLI 119
Query: 357 -GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415
GL YLH + I+H+DIK N+LL +I+ G+A+ L +G+
Sbjct: 120 DGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 416 YLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVD 451
+ PE G K D+++ GV L I TG P +
Sbjct: 177 FQPPEIANGLDTFSG---FKVDIWSAGVTLYNITTGLYPFE 214
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 47/232 (20%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-------------------- 293
G+G Y V N +D A+K L+K +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 294 ----ELGIIGHVCHPNTATLV---GCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPI 346
E+ I+ + HPN LV E+ LY++F G + + +
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ-AR 140
Query: 347 RY--KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL--PNKC 402
Y ++ G+ YLH ++IIHRDIK SN+L+G D +I DFG++ +
Sbjct: 141 FYFQDLIKGI----EYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 403 THHAAIPIEGTFGYLAPEYF--MHGIID-EKTDVFAFGVLLLEIITGRKPVD 451
+ GT ++APE I + DV+A GV L + G+ P
Sbjct: 194 LSNTV----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 1e-13
Identities = 62/227 (27%), Positives = 94/227 (41%), Gaps = 46/227 (20%)
Query: 246 NNFHSENMVGQGGYSEVY---KGNLSDGRKI-AVKRLAKDNKDAK-KEKEFLM-ELGIIG 299
F ++G+GGY +V+ K ++ KI A+K L K K+ E I+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 300 HVCHPNTATLVG--CCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLG 353
V HP +V LYLI + G L L E + Y +I +
Sbjct: 77 EVKHP---FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA 133
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIE 411
L +LH+ + II+RD+K N++L ++TDFGL K TH
Sbjct: 134 ----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH------- 179
Query: 412 GTF-G---YLAPEYFMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
TF G Y+APE I+ D ++ G L+ +++TG P
Sbjct: 180 -TFCGTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 43/224 (19%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVC- 302
+F ++G+G Y++V L +I A++ + K+ + ++ +++ E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 303 HPNTATLVG--CCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK--IVLGVAR 356
HP LVG C E+ L+ + + G+L + +R E Y I L
Sbjct: 112 HP---FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--- 165
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTF 414
L+YLH+ R II+RD+K NVLL + ++TD+G+ K P T TF
Sbjct: 166 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--------TF 213
Query: 415 -G---YLAPEYFMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
G Y+APE I+ + D +A GVL+ E++ GR P
Sbjct: 214 CGTPNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 72/340 (21%), Positives = 122/340 (35%), Gaps = 61/340 (17%)
Query: 127 RDVTRYCFQHAPGGCTIHIFGETKSENPSPRTVLDELEGESNTTEDDTFSVEDSSISQSP 186
D G + I K+ +L + EGE F+V
Sbjct: 246 WDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEY-------FNVPVPPEGSEG 298
Query: 187 PQAPKTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATN 246
+ + K R ++ G ++ + + N+++ +
Sbjct: 299 NEELRQK---FERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKL--------------T 341
Query: 247 NFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVC-H 303
+F+ ++G+G + +V ++ AVK L KD + E M E ++
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 304 PNTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK--IVLGVARGLHY 360
P L C + LY + + G+L + + Y I +G L +
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFF 457
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTF-G-- 415
L + II+RD+K NV+L + +I DFG+ K T TF G
Sbjct: 458 LQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--------TFCGTP 506
Query: 416 -YLAPEYFMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
Y+APE II + D +AFGVLL E++ G+ P
Sbjct: 507 DYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 43/224 (19%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVC- 302
+F+ ++G+G + +V ++ AVK L KD + E M E ++
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 303 HPNTATLVG--CCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK--IVLGVAR 356
P L C + LY + + G+L + + Y I +G
Sbjct: 80 PP---FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG--- 133
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTF 414
L +L + II+RD+K NV+L + +I DFG+ K T TF
Sbjct: 134 -LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--------TF 181
Query: 415 -G---YLAPEYFMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
G Y+APE II + D +AFGVLL E++ G+ P
Sbjct: 182 CGTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 61/221 (27%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVC- 302
+NF ++G+G + +V + + + AVK L KD + E M E I+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 303 HPNTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK--IVLGVARGLH 359
HP L C + L+ + F G+L + R Y I+ L
Sbjct: 83 HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA----LM 138
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTF-G- 415
+LH + II+RD+K NVLL + ++ DFG+ K T TF G
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA--------TFCGT 187
Query: 416 --YLAPEYFMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
Y+APE I+ E D +A GVLL E++ G P
Sbjct: 188 PDYIAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 57/216 (26%), Positives = 80/216 (37%), Gaps = 19/216 (8%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G+G Y EV N +AVK + E E+ I + H N G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYGH- 73
Query: 314 IENG--LYLIFNFSQNGNL-DAALHDERSKSLEWPIRYK---IVLGVARGLHYLHKGCKR 367
G YL + G L D D E + ++ GV YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMP--EPDAQRFFHQLMAGV----VYLHG---I 124
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII 427
I HRDIK N+LL +I+DFGLA + GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 428 D-EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK 462
E DV++ G++L ++ G P D + ++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 37/200 (18%), Positives = 78/200 (39%), Gaps = 33/200 (16%)
Query: 213 SSPLRKRNGSLSNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGR 271
S ++ +P + + + +++G G Y V + + + R
Sbjct: 20 VSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKR 79
Query: 272 KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE------NGLYLIFNFS 325
+A+K++ + +D K L E+ I+ + H + ++ I + LY++
Sbjct: 80 VVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI- 138
Query: 326 QNGNLDAALH----------DERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIK 375
D+ + K+ + Y ++ G+ Y+H I+HRD+K
Sbjct: 139 ----ADSDFKKLFRTPVYLTELHIKT----LLYNLL----VGVKYVHSA---GILHRDLK 183
Query: 376 ASNVLLGPDFEPQITDFGLA 395
+N L+ D ++ DFGLA
Sbjct: 184 PANCLVNQDCSVKVCDFGLA 203
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 57/298 (19%), Positives = 115/298 (38%), Gaps = 75/298 (25%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAK---DNKDAKKEKEFLMELGIIGH 300
+N+ ++++G+G Y VY + + + +A+K++ + D D K+ L E+ I+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR---ILREITILNR 81
Query: 301 VCHPNTATLVGCCIE------NGLYLIFNFSQNGNLDAALH----------DERSKSLEW 344
+ L I + LY++ D+ L +E K+
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLTEEHIKT--- 133
Query: 345 PIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404
I Y ++ G +++H+ IIHRD+K +N LL D ++ DFGLA+ + ++
Sbjct: 134 -ILYNLL----LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 405 HAAIPIEGTFG--------------------YLAPEYFMHGII------DEKTDVFAFGV 438
+ +E Y APE +I + D+++ G
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE-----LILLQENYTKSIDIWSTGC 240
Query: 439 LLLEIITGRKPVDSSRQNLVLWAKPL-MESGNLTELVDPSLEGEYDTDQMHRLVLIAD 495
+ E++ + + N PL S D + + ++ +L +I +
Sbjct: 241 IFAELLNMLQSHINDPTN----RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 43/224 (19%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIG-HVC 302
++FH ++G+G + +V AVK L K KKE++ +M E ++ +V
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 303 HPNTATLVG--CCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KIVLGVAR 356
HP LVG + LY + ++ G L L ER Y +I
Sbjct: 98 HP---FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA--- 151
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK--WLPNKCTHHAAIPIEGTF 414
L YLH I++RD+K N+LL +TDFGL K N T TF
Sbjct: 152 -LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS--------TF 199
Query: 415 -G---YLAPEYFMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
G YLAPE ++ ++ D + G +L E++ G P
Sbjct: 200 CGTPEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 39/222 (17%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKI-AVKRLAKDNKDAKKEKEFLM-ELGIIGHVC- 302
+F M+G+G + +V+ + A+K L KD + E M E ++
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 303 HPNTATLVGC-CIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK--IVLGVARGLH 359
HP + + L+ + + G+L + L Y I+LG L
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG----LQ 132
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK---WLPNK----CTHHAAIPIEG 412
+LH + I++RD+K N+LL D +I DFG+ K K C G
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC---------G 180
Query: 413 TFGYLAPEYFMHGIIDEKT-----DVFAFGVLLLEIITGRKP 449
T Y+APE I+ + D ++FGVLL E++ G+ P
Sbjct: 181 TPDYIAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (167), Expect = 9e-13
Identities = 33/201 (16%), Positives = 56/201 (27%), Gaps = 52/201 (25%)
Query: 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDA------KKEKEFLMELGI 297
T +G+G + EV++ D +A+K +A + D K +E L E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 298 IGHVC---------HPNTATLVGCCI-------------------------------ENG 317
+ L ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKAS 377
L+++ F G L R+K I+ + L R HRD+
Sbjct: 137 LFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWG 191
Query: 378 NVLLGPDFEPQITDFGLAKWL 398
NVLL ++ K
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSS 212
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 44/222 (19%), Positives = 92/222 (41%), Gaps = 28/222 (12%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNK-DAKK---EKEFLMELG--- 296
+ + +G GG V+ + +++A+K++ + K E + + L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 297 IIG--HVCHPNTATLVGCCIE----NGLYLIFNFSQNGNLDAALHDE-RSKSLEWP-IRY 348
I+ + P+ + L N +Y++ + ++ L + L R
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLEEHARL 124
Query: 349 KIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL-GPDFEPQITDFGLAKWLPNKCTHHAA 407
+ + RGL Y+H ++HRD+K +N+ + D +I DFGLA+ + +H
Sbjct: 125 -FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 408 IPIE-GTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGR 447
+ T Y +P + + D++A G + E++TG+
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 48/226 (21%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLA--KDNKDAKKEKEFLMELGIIGHV 301
+ + + +G+G Y V + + ++A+K+++ + ++ L E+ I+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIKILLRF 82
Query: 302 CHPNTATLVGCCIE------NGLYLIFNFSQNGNLDAALHDE-RSKSLEWP-IRYKIVLG 353
H N + +Y++ + ++ L+ +++ L I Y +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICY-FLYQ 136
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC------THHAA 407
+ RGL Y+H ++HRD+K SN+LL + +I DFGLA+ T + A
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 408 IPIEGTFGYLAPEYFMHGII------DEKTDVFAFGVLLLEIITGR 447
T Y APE I+ + D+++ G +L E+++ R
Sbjct: 194 -----TRWYRAPE-----IMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 48/228 (21%), Positives = 93/228 (40%), Gaps = 42/228 (18%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLA--KDNKDAKKEKEFLMELGIIGHV 301
+++F ++++G+G Y V + G +A+K++ A + L E+ I+ H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT---LREIKILKHF 66
Query: 302 CHPNTATLVGCCIE------NGLYLIFNFSQNGNLDAALHDE-RSKSLEWPIRYK-IVLG 353
H N T+ N +Y+I + LH ++ L + +
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLS-DDHIQYFIYQ 120
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGT 413
R + LH +IHRD+K SN+L+ + + ++ DFGLA+ + ++ + +
Sbjct: 121 TLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 414 FG--------YLAPEYFMHGII------DEKTDVFAFGVLLLEIITGR 447
Y APE ++ DV++ G +L E+ R
Sbjct: 178 GMVEFVATRWYRAPE-----VMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 57/216 (26%), Positives = 80/216 (37%), Gaps = 19/216 (8%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313
G+G Y EV N +AVK + E E+ I + H N G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYGH- 73
Query: 314 IENG--LYLIFNFSQNGNL-DAALHDERSKSLEWPIRYK---IVLGVARGLHYLHKGCKR 367
G YL + G L D D E + ++ GV YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMP--EPDAQRFFHQLMAGV----VYLHG---I 124
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII 427
I HRDIK N+LL +I+DFGLA + GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 428 D-EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK 462
E DV++ G++L ++ G P D + ++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 56/240 (23%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAK---DNKDAKK---EKEFLMELGI 297
+ +G+G Y V+K + G +AVK++ ++ DA++ E L EL
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS- 66
Query: 298 IGHVCHPNTATLVGCCIE---NGLYLIFNFSQNGNLDAALHDE-RSKSLEWPIRYK-IVL 352
H N L+ +YL+F++ ++ LH R+ LE P+ + +V
Sbjct: 67 ----GHENIVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILE-PVHKQYVVY 116
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEG 412
+ + + YLH G ++HRD+K SN+LL + ++ DFGL++ N IP+
Sbjct: 117 QLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 413 TFG-------------------YLAPEYFMHGII------DEKTDVFAFGVLLLEIITGR 447
Y APE I+ + D+++ G +L EI+ G+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPE-----ILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 36/166 (21%), Positives = 57/166 (34%), Gaps = 48/166 (28%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG-- 311
G G +V + N K A+K L +D A++E E P+ +V
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWRAS-----QCPHIVRIVDVY 80
Query: 312 ---CCIENGLYLIFNFSQNGNL---------------DAALHDERSKSLEWPIRYKIVLG 353
L ++ G L +A+ +I+
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---------------EIMKS 125
Query: 354 VARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAK 396
+ + YLH I HRD+K N+L P+ ++TDFG AK
Sbjct: 126 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 1e-11
Identities = 85/574 (14%), Positives = 165/574 (28%), Gaps = 158/574 (27%)
Query: 120 NHSNKMSRDVT--RYCFQHAPGGCTIHIFGETKSENPSPRTVLDELEGESNTTEDDTFSV 177
+H + M + +Y ++ + +F + +N + V D + + E +
Sbjct: 2 HHHHHMDFETGEHQYQYKD-----ILSVFEDAFVDNFDCKDVQDMPKSILSKEE-----I 51
Query: 178 EDSSISQSPPQAPKTKGLSNTRMRMSPGKFFTSILSSPLRKRNGSLSNK---EKHQPLLT 234
+ I S T L T + + + LR L + E+ QP +
Sbjct: 52 DH--IIMSKDAVSGTLRLFWT-LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM 108
Query: 235 CFSYEEISSATNN----FHSENMVGQGGYSEVYKG--NLSDGRKIAV-------KR-LAK 280
Y E N F N+ Y ++ + L + + + K +A
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL 168
Query: 281 DN-KDAKKEKEFLMELGI----IGHVCHPNTATLVGCCIENGLYLIFNFSQNG------- 328
D K + + + I + + P T +E L++ N
Sbjct: 169 DVCLSYKVQCKM--DFKIFWLNLKNCNSPET------VLEMLQKLLYQIDPNWTSRSDHS 220
Query: 329 -NLDAALHDERSKS---LEWPIRYK---IVL-GV--ARGLHYLHKGCKRRIIHRDIKASN 378
N+ +H +++ L+ Y+ +VL V A+ + + CK + R + ++
Sbjct: 221 SNIKLRIHSIQAELRRLLKSK-PYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279
Query: 379 VLLG------------PDFEPQITDFGLAKW-------LPNK-CTHH-AAIPIEGTF--- 414
L P L K+ LP + T + + I
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRD 339
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRK--------PVDS--SRQNL-VLWAKP 463
G + + H D+ T + + +LE RK P + L ++W
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399
Query: 464 LMESGN--LTELVDPSL------EGEY--------------DTDQMHRLVLIADYCVRQT 501
+ + +L SL E + +HR ++ Y + +T
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR-SIVDHYNIPKT 458
Query: 502 SAW---------------------RPSMSEVLELLTSGH-DSEF--AK------SWRMPE 531
E + L D F K +W
Sbjct: 459 FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASG 518
Query: 532 FTSDELDDCSMFFGYEVPTD-------IDLEEFL 558
+ L + Y D + +FL
Sbjct: 519 SILNTLQQLKFYKPYICDNDPKYERLVNAILDFL 552
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 36/213 (16%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTATL--V 310
G G + +V G + G K+AVK L + + + E+ + HP+ L V
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 311 GCCIENG--LYLIFNFSQNGNL-DAALHDERSKSLEWPIRY--KIVLGVARGLHYLHKGC 365
I +++ + G L D R + +E R +I+ V Y H+
Sbjct: 80 ---ISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-ARRLFQQILSAV----DYCHR-- 129
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLA------KWLPNKCTHHAAIPIEGTFGYLAP 419
++HRD+K NVLL +I DFGL+ ++L C G+ Y AP
Sbjct: 130 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---------GSPNYAAP 179
Query: 420 EYFMHGIID-EKTDVFAFGVLLLEIITGRKPVD 451
E + + D+++ GV+L ++ G P D
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 64/233 (27%), Positives = 93/233 (39%), Gaps = 54/233 (23%)
Query: 246 NNFHSENMVGQGGYSEVY---KGNLSDGRKI-AVKRLAKDNKDAKKEKEF--LME---LG 296
NF ++G G Y +V+ K + D K+ A+K L K K + E L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 297 IIGHVCHPNTATLVG--CCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY--KI 350
I P LV E L+LI ++ G L L + Y +I
Sbjct: 114 HIRQ--SP---FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168
Query: 351 VLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK---WLPNKCTHHAA 407
VL L +LHK II+RDIK N+LL + +TDFGL+K + +
Sbjct: 169 VLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY--- 218
Query: 408 IPIEGTF-G---YLAPEYFMHGIIDEKT-------DVFAFGVLLLEIITGRKP 449
F G Y+AP+ I+ D ++ GVL+ E++TG P
Sbjct: 219 -----DFCGTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 40/214 (18%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN-------T 306
G G + + +AVK + + + + E+ + HPN
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR---EIINHRSLRHPNIVRFKEVI 85
Query: 307 ATLVGCCIENGLYLIFNFSQNGNLDAALHD---ERSKSLEWPIRYK---IVLGVARGLHY 360
T L +I ++ G L ++ + E R+ ++ GV Y
Sbjct: 86 LT------PTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGV----SY 131
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDFEPQ--ITDFGLAKWLPNKCTHHAAIPIEGTFGYLA 418
H +I HRD+K N LL P+ I DFG +K + + GT Y+A
Sbjct: 132 CHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIA 185
Query: 419 PEYFMHGIID-EKTDVFAFGVLLLEIITGRKPVD 451
PE + D + DV++ GV L ++ G P +
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 46/251 (18%), Positives = 86/251 (34%), Gaps = 65/251 (25%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH 303
+ + +G G + V + ++ G++ A+K++ +D + EL I+ + H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------NRELDIMKVLDH 59
Query: 304 PNTATLVGC---CIENGLYLIFNFSQNGNLDAALHDERSKSLEWP--------------- 345
N LV + + L + +
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 346 --------IRYKIVLG--------------VARGLHYLHKGCKRRIIHRDIKASNVLLGP 383
++ I G + R + ++H I HRDIK N+L+
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176
Query: 384 -DFEPQITDFGLAKWL----PNKCTHHAAIPIEGTFGYLAPEYFMHGIID--EKTDVFAF 436
D ++ DFG AK L P+ + + Y APE M G + D+++
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPS--VAYIC-----SRFYRAPE-LMLGATEYTPSIDLWSI 228
Query: 437 GVLLLEIITGR 447
G + E+I G+
Sbjct: 229 GCVFGELILGK 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTATL--V 310
G G + +V G + G K+AVK L + + + E+ + HP+ L V
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 311 GCCIENG--LYLIFNFSQNGNL-DAALHDERSKSLEWPIRY--KIVLGVARGLHYLHKGC 365
I ++++ + G L D + R E R +I+ GV Y H+
Sbjct: 85 ---ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE-SRRLFQQILSGV----DYCHR-- 134
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
++HRD+K NVLL +I DFGL+ + + + G+ Y APE
Sbjct: 135 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGR 190
Query: 426 IID-EKTDVFAFGVLLLEIITGRKPVD 451
+ + D+++ GV+L ++ G P D
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 48/213 (22%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 255 GQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM-ELGIIGHVCHPNTATL--V 310
G+G + +V + +K+A+K +++ + E+ + + HP+ L V
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 311 GCCIENG--LYLIFNFSQNGNL-DAALHDERSKSLEWPIRY--KIVLGVARGLHYLHKGC 365
I + ++ ++ G L D + +R E R+ +I+ + Y H+
Sbjct: 78 ---ITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDE-GRRFFQQIICAI----EYCHR-- 126
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK------CTHHAAIPIEGTFGYLAP 419
+I+HRD+K N+LL + +I DFGL+ + + C G+ Y AP
Sbjct: 127 -HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---------GSPNYAAP 176
Query: 420 EYFMHGIID-EKTDVFAFGVLLLEIITGRKPVD 451
E + + DV++ G++L ++ GR P D
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 34/181 (18%), Positives = 57/181 (31%), Gaps = 24/181 (13%)
Query: 246 NNFHSENMVGQGGYSEVYKG------NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIG 299
+ +GQGG+ +Y ++ VK DN E +F
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 300 HVCHPNTATLVGCC-IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY-------KIV 351
+ + + + + + D L+ K V
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 352 LGVA----RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT--DFGLAK-WLPNKCTH 404
L ++ L Y+H+ +H DIKASN+LL Q+ D+GLA + P
Sbjct: 155 LQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 405 H 405
Sbjct: 212 A 212
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 38/176 (21%), Positives = 65/176 (36%), Gaps = 37/176 (21%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDA--KKEKEFLMELGIIGHVC 302
N + +G G + ++Y G +++ G ++A+K K E + + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 303 HPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY-------KIVLGVA 355
I G+ + + + SLE + K VL +A
Sbjct: 69 T-----------------IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 111
Query: 356 ----RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ---ITDFGLAKWLPNKCTH 404
+ Y+H + IHRD+K N L+G + I DFGLAK + TH
Sbjct: 112 DQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 Length = 175 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-08
Identities = 31/156 (19%), Positives = 59/156 (37%), Gaps = 24/156 (15%)
Query: 4 SAPSKILIG--------FSLDPNDSKELLSWAIKVLAQPND---RIVAIHVLVGEE---- 48
S P+K+++ + K W ++ + + N +I+ +HV V +E
Sbjct: 3 SEPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFD 62
Query: 49 --SKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAK 106
S + + KA + +L F V EA + + +E K
Sbjct: 63 DVDSIYASPEDFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVK 121
Query: 107 SISADYLVLRGSRNHSNKMSRD----VTRYCFQHAP 138
+ D+LV+ GSR + + V+ +C +HA
Sbjct: 122 RVRPDFLVV-GSRGL-GRFQKVFVGTVSAFCVKHAE 155
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 32/178 (17%), Positives = 67/178 (37%), Gaps = 39/178 (21%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD--AKKEKEFLMELGIIGHVC 302
++ +G+G + +++G NL + +++A+K + + + E L +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 303 HPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY-------KIVLGVA 355
+ ++ F Q G + + D SLE + K V A
Sbjct: 70 N-----------------VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAA 112
Query: 356 ----RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ-----ITDFGLAKWLPNKCTH 404
+ +H+ + +++RDIK N L+G + DFG+ K+ + T
Sbjct: 113 KQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 32/178 (17%), Positives = 58/178 (32%), Gaps = 24/178 (13%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDA---KKEKEFLMELG---II 298
N + +G GG+ +Y + K A + + ++ E +F + I
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 299 GHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY------KIVL 352
+G I + + + + L+ VL
Sbjct: 97 KKWIERKQLDYLG--IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154
Query: 353 GVA----RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT--DFGLAKWLPNKCTH 404
+ L Y+H+ +H DIKA+N+LLG Q+ D+GL+ H
Sbjct: 155 QLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 40/178 (22%), Positives = 63/178 (35%), Gaps = 39/178 (21%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDA--KKEKEFLMELGIIGHVC 302
NF +G G + E+ G NL +A+K ++ E F +LG +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 303 HPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY-------KIVLGVA 355
++ F G +A + + SLE K VL +A
Sbjct: 69 Q-----------------VYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIA 111
Query: 356 ----RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ-----ITDFGLAKWLPNKCTH 404
+ Y+H + +I+RD+K N L+G I DF LAK + T
Sbjct: 112 IQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 49/221 (22%), Positives = 81/221 (36%), Gaps = 40/221 (18%)
Query: 253 MVGQGGYSEVYKG-NLSDGRKIAVKRL---AKDNKDAKKEKEFLMEL--GIIGHVCHPNT 306
+G G +S V+ ++ + +A+K + + A+ E + L +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 307 ATLVGCCIENGLYLIFNFSQNGN----------LDAALHDERSKSLEWPIRYKIVLGVAR 356
++ L FN + N L L K I V +++
Sbjct: 86 NHILK------LLDHFNH-KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 357 ----GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ------ITDFGLAKWLPNKCTHHA 406
GL Y+H+ C IIH DIK NVL+ P+ I D G A W T+
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS- 195
Query: 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGR 447
I+ Y +PE + D+++ L+ E+ITG
Sbjct: 196 ---IQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 32/187 (17%), Positives = 64/187 (34%), Gaps = 39/187 (20%)
Query: 246 NNFHSENMVGQGGYSEVYKG---------NLSDGRKIAVKRLAKD----------NKDAK 286
+ ++ + +Y+ + +K ++K AKD + AK
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 287 KEK-EFLMELGIIGHVCHPNTATLVGCCIENGLY--LIFNFSQNGNLDAALHDERSKSLE 343
+ +L + P +G + Y L+ L +L S +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPT---CMGFGVHQDKYRFLVLPS-----LGRSLQSALDVSPK 153
Query: 344 WPIRYKIVLGVA----RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT--DFGLAKW 397
+ + VL VA L +LH+ +H ++ A N+ + P+ + Q+T +G A
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 398 LPNKCTH 404
H
Sbjct: 211 YCPSGKH 217
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 41/176 (23%), Positives = 64/176 (36%), Gaps = 37/176 (21%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDA--KKEKEFLMELGIIGHVC 302
N F +G G + E+Y G N+ ++A+K K E + L +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 303 HPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRY-------KIVLGVA 355
+ + F G+ + + D SLE + K VL +A
Sbjct: 67 N-----------------VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
Query: 356 ----RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ---ITDFGLAKWLPNKCTH 404
+ ++H + +HRDIK N L+G I DFGLAK + TH
Sbjct: 110 DQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 49/271 (18%), Positives = 84/271 (30%), Gaps = 84/271 (30%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVK---RLAKDNKDAKKEKEFLMELGIIGH 300
+H +G G +S V+ ++ + +A+K + A E L +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRN-SD 94
Query: 301 VCHPNTATLVGCCIENGLYLIFNFSQNG---------------NLDAALHDERSKSLEWP 345
PN ++ L+ +F +G +L + + L P
Sbjct: 95 PNDPNRE----MVVQ----LLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLP 146
Query: 346 IRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD--------------------- 384
KI+ V +GL YLH C+ IIH DIK N+LL +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 385 ----------------------------FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416
+ +I D G A W+ T T Y
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI-----QTRQY 259
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLLLEIITGR 447
+ E + + D+++ + E+ TG
Sbjct: 260 RSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 58/232 (25%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKD----AKKEKEFLMELG--- 296
+ + ++++G+G + +V K + + +A+K + K+ K A+ E L +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 297 ------II---------GHVCHPNTATLVGCCIENGLY-LIFNFSQNG-NLDAALHDERS 339
I+ H+C LV + LY L+ N + G +L+
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLC------LVFEMLSYNLYDLLRNTNFRGVSLNL------- 158
Query: 340 KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT--DFGLAKW 397
R K + L +L + IIH D+K N+LL I DFG +
Sbjct: 159 ------TR-KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-- 208
Query: 398 LPNKCTHHAAIP--IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGR 447
C I I+ F Y +PE + D D+++ G +L+E+ TG
Sbjct: 209 ----CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.61 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.59 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.55 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.55 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.54 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.52 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.51 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.51 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.48 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.47 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.47 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.44 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.41 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.39 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.23 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.22 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.19 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.18 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.13 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.11 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.85 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.63 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.5 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.43 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.2 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.16 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.13 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.04 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.62 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.45 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.43 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.83 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.59 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.81 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.45 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.67 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=448.94 Aligned_cols=263 Identities=22% Similarity=0.387 Sum_probs=210.4
Q ss_pred hhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIF 322 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~ 322 (558)
...++|.+.+.||+|+||+||+|.+. ..||||+++.........+.|.+|+.++++++|||||++++++.++.+++||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVm 110 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVT 110 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEE
Confidence 44567889999999999999999764 3699999977666677788999999999999999999999999888899999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|.++|+.. ...+++..+..|+.|||.||+|||+ ++||||||||+||||+.++.+||+|||+|+......
T Consensus 111 Ey~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp ECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999999754 3569999999999999999999999 899999999999999999999999999998766544
Q ss_pred CcccccccccccCcccchhhcc---CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMH---GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||........... ....+.. .+.+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~--~~~~~~~----~p~~- 259 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF--MVGRGYA----SPDL- 259 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH--HHHTTCC----CCCS-
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH--HHhcCCC----CCCc-
Confidence 4444455789999999999964 4699999999999999999999999986543221111 1111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+...+..+.+++.+||+.||++||||.||++.|+..
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112223446788999999999999999999999988653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-56 Score=443.89 Aligned_cols=256 Identities=22% Similarity=0.386 Sum_probs=211.6
Q ss_pred CCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
++|.+.+.||+|+||+||+|.+. ++..||||++... .....++|.+|+.+|++++|||||+++|+|.+++ .
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 57889999999999999999653 4778999999654 3556778999999999999999999999998765 9
Q ss_pred EEEEEeccCCCHHHHHhhcc-----------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCce
Q 008650 319 YLIFNFSQNGNLDAALHDER-----------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEP 387 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 387 (558)
++||||+++|+|.++|+... ...++|..+..|+.||+.||.|||+ ++||||||||+||||+.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcE
Confidence 99999999999999997532 3469999999999999999999999 899999999999999999999
Q ss_pred EEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhh
Q 008650 388 QITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLME 466 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 466 (558)
||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.......... . +.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~--~-i~ 244 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE--C-IT 244 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--H-HH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--H-HH
Confidence 9999999987655433333344569999999999999999999999999999999999 999998765432211 1 11
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 467 SGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 467 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.+... ..+...+.++.+++.+||+.||++|||+.||++.|++.
T Consensus 245 ~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 245 QGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22211 11223445789999999999999999999999998763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=446.45 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=209.0
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++.+..........+.+|+.+|++++|||||++++++.+++ +|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999954 57999999999887766777788999999999999999999999998876 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|++||+|.++|...+...+++..++.|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 9999999999987766778999999999999999999999 899999999999999999999999999998764321
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
....+.+||+.|||||++.+..|+.++|||||||+||||+||+.||.......... ... .+.... .+
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~--~i~-~~~~~~---------~~ 246 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL--KII-SGSFPP---------VS 246 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHH-HTCCCC---------CC
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH--HHH-cCCCCC---------CC
Confidence 12234679999999999999999999999999999999999999998765432221 111 112111 12
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2234578899999999999999999999873
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=444.95 Aligned_cols=256 Identities=22% Similarity=0.360 Sum_probs=204.4
Q ss_pred CCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
++|.+.+.||+|+||+||+|.+. +++.||||++... .....+.|.+|+.+|++++|||||+++|+|.++. .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46788899999999999999754 4788999999654 3556678999999999999999999999998765 9
Q ss_pred EEEEEeccCCCHHHHHhhcc-------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC
Q 008650 319 YLIFNFSQNGNLDAALHDER-------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 385 (558)
++||||+++|+|.++|+... ...++|..++.|+.||+.||.|||+ ++||||||||+||||+.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCC
Confidence 99999999999999997642 2468999999999999999999999 8999999999999999999
Q ss_pred ceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhh
Q 008650 386 EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPL 464 (558)
Q Consensus 386 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 464 (558)
.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||......... ..+
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~--~~i 273 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI--DCI 273 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH--HHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH--HHH
Confidence 999999999987755444444445679999999999999999999999999999999999 99999876543221 111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.. +.. ...+.....++.+++.+||+.||++|||+.||++.|+..
T Consensus 274 ~~-g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 274 TQ-GRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HH-TCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred Hc-CCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11 111 111223345788999999999999999999999999763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=444.07 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=210.4
Q ss_pred CCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.++++.+.||+|+||+||+|.+ .+++.||||++.... .....++|.+|+.++++++|||||+++|+|.++. .
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 3467788999999999999975 346789999996543 3344567999999999999999999999998765 9
Q ss_pred EEEEEeccCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC
Q 008650 319 YLIFNFSQNGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD 384 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 384 (558)
++||||+++|+|.++|.... ...++|..+..|+.|||.||+|||+ ++||||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCC
Confidence 99999999999999996532 2458999999999999999999999 899999999999999999
Q ss_pred CceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhh
Q 008650 385 FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKP 463 (558)
Q Consensus 385 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 463 (558)
+.+||+|||+|+.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||......... .
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~--~- 258 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV--E- 258 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH--H-
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH--H-
Confidence 9999999999987654443334445679999999999999999999999999999999999 89999876543221 1
Q ss_pred hhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.+..+... ..+...+..+.+++.+||+.||++||||.||++.|+.
T Consensus 259 ~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 259 MIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 12222211 1223345678899999999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-55 Score=434.92 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=210.0
Q ss_pred CCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||+||+|. ..+|+.||||++.+... .......+.+|+++|++++|||||++++++.+++ +|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 469999999999999999995 46799999999976532 2233567889999999999999999999998766 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.||+|.+++... +.+++..+..++.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999654 569999999999999999999999 899999999999999999999999999999876554
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
......+.+||+.|||||++.+..|+.++|||||||+||||++|+.||......... . ... .+.+ .+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-~-~i~-~~~~----------~~ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF-A-KII-KLEY----------DF 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-H-HHH-HTCC----------CC
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-H-HHH-cCCC----------CC
Confidence 444556678999999999999999999999999999999999999999876443221 1 111 1111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+.....++.+++.+||+.||++|||+.|++.
T Consensus 254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 254 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 2223456889999999999999999998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=434.32 Aligned_cols=252 Identities=23% Similarity=0.277 Sum_probs=203.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.+.|.+.+.||+|+||+||+|.. .+|+.||||++.+... +.+|+.+++.++|||||++++++.+++ +||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35688889999999999999954 5799999999976533 246999999999999999999998866 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-ceEEEeccccccCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-EPQITDFGLAKWLPNK 401 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~ 401 (558)
||++||+|.++|... +.+++..+..++.||+.||+|||+ ++||||||||+||||+.+| ++||+|||+|+.+...
T Consensus 130 Ey~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred eccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999999654 469999999999999999999998 8999999999999999988 6999999999887543
Q ss_pred CCc---ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 402 CTH---HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 402 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.......... .+... ... .
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~i~~~-~~~-~----- 275 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL--KIASE-PPP-I----- 275 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH--HHHHS-CCG-G-----
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH--HHHcC-CCC-c-----
Confidence 221 12334679999999999999999999999999999999999999998653321111 11111 100 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+......+.+++.+||+.||.+|||+.|+++.|...
T Consensus 276 -~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 276 -REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp -GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 011223445788999999999999999999999988654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=433.61 Aligned_cols=249 Identities=20% Similarity=0.338 Sum_probs=207.0
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
..|++.+.||+|+||+||+|.. .+|+.||||++.+.... ....+.+|+.+|+.++|||||++++++.+++ +|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4689999999999999999955 57999999999765432 2345789999999999999999999998866 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 152 y~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 152 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 9999999999964 359999999999999999999999 8999999999999999999999999999987754322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
...+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.......... . +..+. .+.+ ...
T Consensus 226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~--~-i~~~~-----~~~~--~~~ 293 (346)
T 4fih_A 226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK--M-IRDNL-----PPRL--KNL 293 (346)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--H-HHHSS-----CCCC--SCG
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH--H-HHcCC-----CCCC--Ccc
Confidence 2345789999999999999999999999999999999999999998764432211 1 11111 0111 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+.+++.+||+.||++|||+.|+++.
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2345678999999999999999999999873
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=421.23 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=201.4
Q ss_pred CcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-----CcEEEE
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-----NGLYLI 321 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~lv 321 (558)
|.+.+.||+|+||+||+|.. .+++.||+|++.+..........|.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35677899999999999954 578999999998776667777889999999999999999999999864 228999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCc--EEecCCCCCceeec-CCCceEEEeccccccC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR--IIHRDIKASNVLLG-PDFEPQITDFGLAKWL 398 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~ 398 (558)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++ ||||||||+||||+ .+|.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999999654 569999999999999999999998 66 99999999999997 4799999999999864
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
... ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.........+.. +..+.....+
T Consensus 183 ~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~--i~~~~~~~~~---- 251 (290)
T 3fpq_A 183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVKPASF---- 251 (290)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--HTTTCCCGGG----
T ss_pred CCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH--HHcCCCCCCC----
Confidence 332 2335689999999999865 6999999999999999999999999764432222111 1111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.....++.+++.+||+.||++|||+.|+++.
T Consensus 252 ----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 252 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11123468899999999999999999999873
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=435.01 Aligned_cols=268 Identities=25% Similarity=0.399 Sum_probs=218.3
Q ss_pred cCHHHHHhhhCCCcccceEeeeCceEEEEEEECC------CCEEEEEEeecccccHHHHHHHHHHHHHhccccc-CCeee
Q 008650 236 FSYEEISSATNNFHSENMVGQGGYSEVYKGNLSD------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH-PNTAT 308 (558)
Q Consensus 236 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~ 308 (558)
+...++....++|++.+.||+|+||+||+|.+.. ++.||||++.... .....+.|.+|+.+|.++.| ||||+
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 3445666777899999999999999999996432 3579999996543 35556789999999999975 89999
Q ss_pred eeeEEEeC-c-EEEEEEeccCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEec
Q 008650 309 LVGCCIEN-G-LYLIFNFSQNGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHR 372 (558)
Q Consensus 309 l~~~~~~~-~-~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~ 372 (558)
++|+|.++ + +++|||||++|+|.++|+..+ ...+++..+..++.|||.||+|||+ ++||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecC
Confidence 99999764 3 899999999999999997643 2358999999999999999999999 899999
Q ss_pred CCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCC
Q 008650 373 DIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVD 451 (558)
Q Consensus 373 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~ 451 (558)
||||+||||+.++.+||+|||+|+.+............+||+.|||||++.++.|+.++|||||||+||||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999998765544444455679999999999999999999999999999999998 999998
Q ss_pred CCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 452 SSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
........ . ..+..+.. ...+.....++.+++.+||+.||++|||+.||++.|...
T Consensus 290 ~~~~~~~~-~-~~i~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 290 GVKIDEEF-C-RRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp TCCCSHHH-H-HHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHHHHH-H-HHHHcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 75432211 1 11222211 111223345788999999999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=435.61 Aligned_cols=249 Identities=20% Similarity=0.343 Sum_probs=207.0
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
+.|++.+.||+|+||+||+|.. .+|+.||||++...... ....+.+|+.+|+.++|||||++++++.+++ +|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 5699999999999999999954 57999999999765432 2345789999999999999999999998866 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
||.||+|.+++.. ..+++..+..|+.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 229 y~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 229 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999999964 359999999999999999999999 8999999999999999999999999999987754322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
...+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.......... .+..+.. +.+. ..
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~~~~~-----~~~~--~~ 370 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRDNLP-----PRLK--NL 370 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSCC-----CCCS--CT
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHHcCCC-----CCCc--cc
Confidence 2345789999999999999999999999999999999999999998764432211 1111111 1111 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+.+++.+||+.||++|||+.|+++.
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2234578899999999999999999999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=413.34 Aligned_cols=246 Identities=20% Similarity=0.332 Sum_probs=190.6
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.... ......+.+|+.++++++|||||++++++.+++ .|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999954 57999999999765432 334567889999999999999999999998766 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+ +|+|.+++... +.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 67999988653 569999999999999999999999 899999999999999999999999999998765432
Q ss_pred CcccccccccccCcccchhhccCCC-CccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
...+.+||+.|||||++.+..| +.++|||||||++|||+||+.||........ .... ..+...
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~--~~~i-~~~~~~---------- 230 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL--FKNI-SNGVYT---------- 230 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HHTCCC----------
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH--HHHH-HcCCCC----------
Confidence 2234679999999999998876 5799999999999999999999987543321 1111 111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
++......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11223456889999999999999999999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=423.11 Aligned_cols=248 Identities=26% Similarity=0.337 Sum_probs=197.8
Q ss_pred CCCcccceEeeeCceEEEEEEE----CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
++|++.+.||+|+||+||+|.. .+++.||||++.+..........+.+|+.+|++++|||||++++++.+++ +|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999954 24789999999765433223345788999999999999999999998866 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||++||+|.+++... +.+++..+..++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999654 569999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
.. ....+.+||+.|||||++.+..|+.++|||||||+||||+||+.||.......... .... +..
T Consensus 179 ~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~--~i~~-~~~---------- 243 (304)
T 3ubd_A 179 HE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT--MILK-AKL---------- 243 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH-CCC----------
T ss_pred CC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH--HHHc-CCC----------
Confidence 32 22345689999999999999999999999999999999999999998765432211 1111 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLE 513 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 513 (558)
.++...+.++.+++.+||+.||++||| ++|+++
T Consensus 244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 112223457889999999999999998 467765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=419.24 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=199.1
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-----cEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-----GLYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~l 320 (558)
++|.+.+.||+|+||+||+|.+ +|+.||||++.... .....+..|+..+.+++|||||++++++.++ .+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4578889999999999999987 68999999996542 2222344677778899999999999999753 2799
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhC-----CCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG-----CKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
||||+++|+|.++|+.. .+++..+.+++.|++.||.|||+. ...+||||||||+||||+.++.+||+|||+|
T Consensus 79 V~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999999653 589999999999999999999972 1238999999999999999999999999999
Q ss_pred ccCCCCCCc--ccccccccccCcccchhhccC------CCCccccchhHHHHHHHHHcCCCCCCCCchh-----------
Q 008650 396 KWLPNKCTH--HAAIPIEGTFGYLAPEYFMHG------IIDEKTDVFAFGVLLLEIITGRKPVDSSRQN----------- 456 (558)
Q Consensus 396 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~----------- 456 (558)
+........ ......+||+.|||||++.+. .++.++|||||||+||||+||+.||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876543322 122345799999999999754 4778999999999999999998877532111
Q ss_pred --HHHHhhhhhhcCCcccccCCCCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 457 --LVLWAKPLMESGNLTELVDPSLEGE-YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 457 --~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
......... ...+++.+... .+.+....+.+++.+||+.||++||||.||++.|++.
T Consensus 236 ~~~~~~~~~~~-----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 236 PSVEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHT-----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHh-----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111111111 11112222211 1234567899999999999999999999999998763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=409.98 Aligned_cols=250 Identities=20% Similarity=0.379 Sum_probs=190.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-------
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG------- 317 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 317 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++.... .......+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4689999999999999999954 579999999996544 3455677899999999999999999999986432
Q ss_pred ------EEEEEEeccCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEE
Q 008650 318 ------LYLIFNFSQNGNLDAALHDERS-KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT 390 (558)
Q Consensus 318 ------~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 390 (558)
+|+||||+.+|+|.+++..... ...++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 6899999999999999975432 235667788999999999999999 899999999999999999999999
Q ss_pred eccccccCCCCCCc----------ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHH
Q 008650 391 DFGLAKWLPNKCTH----------HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW 460 (558)
Q Consensus 391 DFG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~ 460 (558)
|||+|+.+...... ....+.+||+.|||||++.+..|+.++|||||||+||||++ ||..........
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 99999876543221 11234679999999999999999999999999999999996 887543221111
Q ss_pred hhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 461 AKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 461 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
. ......... ........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~--~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 T--DVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H--HHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H--HHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 111111111 11223345678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=410.66 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=205.9
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-------C
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-------N 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------~ 316 (558)
.++|.+.+.||+|+||+||+|. ..+|+.||||++.+........+.+++|+.+|+.++|||||++++++.. +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3679999999999999999995 4679999999997766666677889999999999999999999998753 3
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
.+|+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceee
Confidence 4899999996 679999854 3579999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCC--CcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccc
Q 008650 397 WLPNKC--THHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473 (558)
Q Consensus 397 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 473 (558)
.+.... ......+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+......... .....+.....
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~-I~~~~g~p~~~ 285 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL-IMMVLGTPSPA 285 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH-HHHHHCCCCGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH-HHHhcCCCChH
Confidence 765432 12234457899999999998875 579999999999999999999999987644322111 11111111100
Q ss_pred cCCC------------CC--CCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 474 VDPS------------LE--GEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 474 ~d~~------------l~--~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.... +. ...+ +.....+.+|+.+||+.||++|||+.|+|++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00 0001 1123568899999999999999999999884
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=397.36 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=198.8
Q ss_pred HHHhhhCCCcccceEeeeCceEEEEEEE----CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEE
Q 008650 240 EISSATNNFHSENMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCI 314 (558)
Q Consensus 240 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 314 (558)
.+....+.|++.+.||+|+||+||+|.. .+++.||+|++.+... ...+.+|+++|+.+ +||||+++++++.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 3445568899999999999999999954 2467899999865432 23577899999988 5999999999998
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-CceEEEec
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDF 392 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DF 392 (558)
+++ +|+||||+++|+|.+++. .+++..+..++.||+.||+|||+ +||+||||||+|||++.+ +.+||+||
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred ECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 766 999999999999999983 48999999999999999999999 899999999999999877 79999999
Q ss_pred cccccCCCCCCc--------------------------ccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHc
Q 008650 393 GLAKWLPNKCTH--------------------------HAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIIT 445 (558)
Q Consensus 393 G~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~ellt 445 (558)
|+|+........ ....+.+||+.|+|||++.+. .|+.++||||+||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 999865432110 112345799999999999875 58999999999999999999
Q ss_pred CCCCCCCCchhHHHHhhhhhhcC------------------------C--------------cccccC----CCCCCCCC
Q 008650 446 GRKPVDSSRQNLVLWAKPLMESG------------------------N--------------LTELVD----PSLEGEYD 483 (558)
Q Consensus 446 g~~Pf~~~~~~~~~~~~~~~~~~------------------------~--------------~~~~~d----~~l~~~~~ 483 (558)
|+.||.................| . ...... ........
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 99999755433222111100000 0 000000 00000011
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....++.+++.+||+.||++|||+.|++++
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1223568899999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=387.35 Aligned_cols=289 Identities=40% Similarity=0.737 Sum_probs=245.3
Q ss_pred CccccCHHHHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeee
Q 008650 232 LLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVG 311 (558)
Q Consensus 232 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 311 (558)
....|++.++...+++|.+.+.||+|+||.||+|...+|+.||||++..... ......+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEE
Confidence 3456889999999999999999999999999999877899999999965432 222335889999999999999999999
Q ss_pred EEEeCc-EEEEEEeccCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceE
Q 008650 312 CCIENG-LYLIFNFSQNGNLDAALHDERS--KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ 388 (558)
Q Consensus 312 ~~~~~~-~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 388 (558)
++.++. .++||||+.+|+|.+++..... ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 998755 8999999999999999976532 3589999999999999999999992222999999999999999999999
Q ss_pred EEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCC------CchhHHHHhh
Q 008650 389 ITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDS------SRQNLVLWAK 462 (558)
Q Consensus 389 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~------~~~~~~~~~~ 462 (558)
|+|||++........ .......||+.|+|||++.++.++.++|||||||++|+|++|+.||+. .......|..
T Consensus 175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999987654322 223345699999999999999999999999999999999999999962 2333555666
Q ss_pred hhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCcc
Q 008650 463 PLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSE 522 (558)
Q Consensus 463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~ 522 (558)
..........+.+..+...+.......+.+++.+||+.||.+|||+.||++.|++..-..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 667777888888888888889999999999999999999999999999999999865443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=413.81 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=201.4
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc----cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK----DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.++|.+.++||+|+||+||+|.. .+|+.||||++.+... ..........++.+++.++|||||++++++.+++ +
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 46799999999999999999954 5799999999976432 1222233345577888999999999999998766 9
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
||||||+.||+|..+|... +.+++..+..++.||+.||.|||+ ++||||||||+||||+.+|++||+|||+|+.+
T Consensus 268 ylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999999654 569999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
.... ..+.+||+.|||||++.. ..|+.++|||||||+||||++|+.||..............+.....
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~------- 411 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------- 411 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-------
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC-------
Confidence 5432 234689999999999975 5799999999999999999999999976432211111111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 514 (558)
.++.....++.+++.+||+.||.+|++ +.||+++
T Consensus 412 ---~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 ---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 112233457889999999999999998 6888764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=382.90 Aligned_cols=276 Identities=38% Similarity=0.693 Sum_probs=236.2
Q ss_pred HHHHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc
Q 008650 238 YEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG 317 (558)
Q Consensus 238 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 317 (558)
+.++...+++|.+.+.||+|+||.||+|...+++.||||++..... .....+.+|+.+++.++||||+++++++.+++
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 3445567789999999999999999999888899999999865543 34567889999999999999999999998755
Q ss_pred -EEEEEEeccCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 318 -LYLIFNFSQNGNLDAALHDERS--KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 318 -~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
.++||||+.+|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999865432 358999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch----hHHHHhhhhhhcCCc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ----NLVLWAKPLMESGNL 470 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~----~~~~~~~~~~~~~~~ 470 (558)
+................||+.|+|||++.++.++.++|||||||++|||++|+.||..... ....|.......+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 9875543333333445699999999999999999999999999999999999999975422 234455555566677
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 471 TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 471 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+++.+...........+.+++.+||+.||++|||+.|+++.|+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 788888888888889999999999999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=410.77 Aligned_cols=252 Identities=19% Similarity=0.276 Sum_probs=207.5
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||+|++.+.. ......+.+|+.+|+.++|||||++++++.++. +|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999954 579999999997654 344567889999999999999999999998766 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC--CceEEEeccccccCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD--FEPQITDFGLAKWLPN 400 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFG~a~~~~~ 400 (558)
||+.||+|.++|... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 234 E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 234 EFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp ECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred eecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999998543 3569999999999999999999999 899999999999999854 8999999999998754
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||............ ......+..
T Consensus 310 ~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i-~~~~~~~~~-------- 377 (573)
T 3uto_A 310 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSCDWNMDD-------- 377 (573)
T ss_dssp TSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-HTTCCCCCS--------
T ss_pred CCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-HhCCCCCCc--------
Confidence 322 23457999999999999999999999999999999999999999876543221111 111111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.........+.+|+.+||+.||.+|||+.|++++
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111234568899999999999999999999984
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=376.20 Aligned_cols=259 Identities=25% Similarity=0.449 Sum_probs=212.5
Q ss_pred hCCCcccceEeeeCceEEEEEEE--------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEe
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL--------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIE 315 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 315 (558)
.++|.+.+.||+|+||.||+|.. .++..||||++... ........+.+|+.+++.+ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 46799999999999999999964 23567999999654 3455677899999999999 89999999999987
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCcee
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDERS--------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVL 380 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl 380 (558)
++ .|+||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence 65 9999999999999999976532 357899999999999999999999 89999999999999
Q ss_pred ecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHH
Q 008650 381 LGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVL 459 (558)
Q Consensus 381 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~ 459 (558)
++.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |+.||.........
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999987655433333334568899999999999999999999999999999999 99999865433211
Q ss_pred HhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 460 WAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 460 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
. .+..+. ....+......+.+++.+||+.+|.+|||+.|+++.|+...
T Consensus 316 ~---~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 316 K---LLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp H---HHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---HHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111111 11122234457899999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=366.90 Aligned_cols=264 Identities=26% Similarity=0.446 Sum_probs=208.2
Q ss_pred HHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 240 EISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 240 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.+....++|.+.+.||+|+||+||+|.. +|+.||||++............+.+|+.++++++||||+++++++.++. .
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3444567899999999999999999976 6889999999877767777788999999999999999999999998765 8
Q ss_pred EEEEEeccCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCc--EEecCCCCCceeecCCCceEEEecccc
Q 008650 319 YLIFNFSQNGNLDAALHDERS-KSLEWPIRYKIVLGVARGLHYLHKGCKRR--IIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
++||||+.+|+|.+++..... ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999965321 238999999999999999999998 78 999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccC
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD 475 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d 475 (558)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .....
T Consensus 187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~--~~~~~------ 256 (309)
T 3p86_A 187 RLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV--GFKCK------ 256 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH--HHSCC------
T ss_pred ccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhcCC------
Confidence 7644322 1223456999999999999999999999999999999999999999876543222111 10111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
....+......+.+++.+||+.+|.+|||+.++++.|+....
T Consensus 257 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 257 ---RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 011122334568899999999999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=367.15 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=210.4
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.+..........+.+|+.+++.++||||+++++++.+++ .|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 456899999999999999999965 68999999999877666777788999999999999999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+|+|.+++... +.+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999999654 468999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcccccccccccCcccchhhccCCCC-ccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIID-EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
. .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......... ..... +...
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~i~~-~~~~--------- 232 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR--ERVLR-GKYR--------- 232 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH-CCCC---------
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-CCCC---------
Confidence 2 23346799999999999988765 7999999999999999999999876433221 11111 1110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+......+.+++.+||+.||.+|||+.|+++.
T Consensus 233 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 -IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111233468899999999999999999999884
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=358.27 Aligned_cols=250 Identities=20% Similarity=0.379 Sum_probs=206.4
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|++.+.||+|+||+||+|. ..+++.||||++....... ...+.+|+.+++.++||||+++++++..++ .++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 4679999999999999999995 4679999999997554322 345789999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999999653 58999999999999999999999 899999999999999999999999999998765433
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ...+.. . ...
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~-~-------~~~ 238 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--ATNGTP-E-------LQN 238 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHHCSC-C-------CSC
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCC-C-------CCC
Confidence 2 223457999999999999999999999999999999999999999876543222211 111110 0 011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22334568899999999999999999999984
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=363.89 Aligned_cols=261 Identities=26% Similarity=0.320 Sum_probs=207.0
Q ss_pred hhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-----
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG----- 317 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 317 (558)
...++|++.+.||+|+||+||+|... ++.||||++.... .....+..|+.++++++||||+++++++.+..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 44578999999999999999999765 7899999996543 33344567999999999999999999987632
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCC----------cEEecCCCCCceeecCCCce
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR----------RIIHRDIKASNVLLGPDFEP 387 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~----------~ivH~Dlkp~NIll~~~~~~ 387 (558)
.++||||+.+|+|.+++... .+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 69999999999999999653 48999999999999999999998 7 99999999999999999999
Q ss_pred EEEeccccccCCCCCCcccccccccccCcccchhhcc-----CCCCccccchhHHHHHHHHHcCCCCCCCCchh------
Q 008650 388 QITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-----GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN------ 456 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~------ 456 (558)
||+|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 9999999987765444333444679999999999986 35667899999999999999999999754221
Q ss_pred --------HHHHhhhhhhcCCcccccCCCCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 457 --------LVLWAKPLMESGNLTELVDPSLEGE-YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 457 --------~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+....... . ..+.+... ........+.+++.+||+.||++|||+.||++.|+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHK-K----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTS-C----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcc-c----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111111 1 11111111 1224556799999999999999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=355.67 Aligned_cols=281 Identities=33% Similarity=0.574 Sum_probs=228.0
Q ss_pred ccccCHHHHHhhhCCCccc------ceEeeeCceEEEEEEECCCCEEEEEEeeccc--ccHHHHHHHHHHHHHhcccccC
Q 008650 233 LTCFSYEEISSATNNFHSE------NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDN--KDAKKEKEFLMELGIIGHVCHP 304 (558)
Q Consensus 233 ~~~~~~~~~~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ 304 (558)
...|++.++...+++|... +.||+|+||.||+|.. +++.||||++.... ........+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568899999999998877 8999999999999976 68899999986542 2234566788999999999999
Q ss_pred CeeeeeeEEEeCc-EEEEEEeccCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec
Q 008650 305 NTATLVGCCIENG-LYLIFNFSQNGNLDAALHDER-SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG 382 (558)
Q Consensus 305 niv~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 382 (558)
||+++++++.+++ .++||||+++++|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEc
Confidence 9999999998755 999999999999999986543 3568999999999999999999999 8999999999999999
Q ss_pred CCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh--HHHH
Q 008650 383 PDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN--LVLW 460 (558)
Q Consensus 383 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~--~~~~ 460 (558)
.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...... ...+
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999987654433333334569999999999865 5889999999999999999999999864322 1111
Q ss_pred hhhhh-hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 461 AKPLM-ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 461 ~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..... ....+...+++.+ ...+......+.+++.+||+.+|.+|||+.+|++.|++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111 1223334444433 2345677888999999999999999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=362.22 Aligned_cols=259 Identities=24% Similarity=0.413 Sum_probs=207.7
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||+||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++.++. .++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 35789999999999999999965 56899999998543 3566778999999999999999999999998766 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 87 EYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp ECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999754 3569999999999999999999999 899999999999999999999999999998765432
Q ss_pred Ccc------------cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCc
Q 008650 403 THH------------AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL 470 (558)
Q Consensus 403 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 470 (558)
... ......||+.|+|||++.+..++.++||||||+++|||++|..||............ ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------~~ 236 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------NV 236 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB------CH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh------hh
Confidence 211 111456999999999999999999999999999999999999998753221110000 00
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 471 TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 471 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
....+... +......+.+++.+||+.||++|||+.++++.|+...
T Consensus 237 ~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 237 RGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00011111 1112235888999999999999999999999988643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=368.06 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=203.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCE----EEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRK----IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 319 (558)
.++|.+.+.||+|+||+||+|.. .+++. ||+|.+... ........+.+|+.++++++||||+++++++.++..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 35699999999999999999964 34554 577777433 2234456789999999999999999999999988899
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+|++|+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 93 ~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999999764 3569999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
............||+.|+|||++.+..++.++|||||||++|||++ |+.||........... +..+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~~~~~--------- 236 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGE--------- 236 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTC---------
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH---HHcCC---------
Confidence 5444333334557889999999999999999999999999999999 9999987544322111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
....+......+.+++.+||+.+|.+|||+.|+++.|+...
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11112233457889999999999999999999999987643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=364.00 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=208.1
Q ss_pred hCCCcccceEeeeCceEEEEEEEC----CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS----DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
.++|.+.+.||+|+||+||+|... .+..||||++... ........+.+|+.+++.++||||+++++++.++. .+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 357899999999999999999663 3456999999643 34566678999999999999999999999998765 89
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 127 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999999644 3569999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcc-cccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 400 NKCTHH-AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 400 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........... ....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~--~~~~---------- 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS--VEEG---------- 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH--HHTT----------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH--HHcC----------
Confidence 432221 2223346889999999999999999999999999999999 9999986544322111 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.....+......+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 271 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111112233457889999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=372.04 Aligned_cols=268 Identities=25% Similarity=0.414 Sum_probs=216.3
Q ss_pred cCHHHHHhhhCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeee
Q 008650 236 FSYEEISSATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTAT 308 (558)
Q Consensus 236 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 308 (558)
+....+....++|.+.+.||+|+||.||+|.. .+++.||||++... ........+.+|+.++.++ +||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 44566777889999999999999999999952 34678999999654 3455567799999999999 7999999
Q ss_pred eeeEEEeCc--EEEEEEeccCCCHHHHHhhccC-----------------------------------------------
Q 008650 309 LVGCCIENG--LYLIFNFSQNGNLDAALHDERS----------------------------------------------- 339 (558)
Q Consensus 309 l~~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------- 339 (558)
+++++.+.+ .++||||+.+|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999997643 8999999999999999976532
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 340 -----------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 340 -----------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 128899999999999999999999 899999999999999999999999999998765543
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||............ ...+... .
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~--~~~~~~~---------~ 316 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGTRM---------R 316 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH--HHHTCCC---------C
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH--HHcCCCC---------C
Confidence 3333444568999999999999999999999999999999998 99999865432221111 1111111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.+......+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1112334688999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=352.92 Aligned_cols=263 Identities=22% Similarity=0.347 Sum_probs=209.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ........+.+|+.++++++||||+++++++.+++ .++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999954 578999999986543 34556678999999999999999999999998766 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+++++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999654 468999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........... .... ..... .. .
T Consensus 165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~--~~~~-~~~~~-~~----~ 235 (294)
T 4eqm_A 165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK--HIQD-SVPNV-TT----D 235 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH--HHSS-CCCCH-HH----H
T ss_pred cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--Hhhc-cCCCc-ch----h
Confidence 22 222345699999999999999999999999999999999999999987654322211 1111 11100 00 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhcCCCc
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRP-SMSEVLELLTSGHDS 521 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~~~~ 521 (558)
........+.+++.+||+.||.+|| ++.++.+.|......
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 1122345788999999999999998 999999999886543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=374.21 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=210.9
Q ss_pred hhhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
...++|.+.+.||+|+||.||+|... +++.||||++... ........|.+|+.++++++||||+++++++.++. .++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 44567999999999999999999765 7899999998643 34555667889999999999999999999998755 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 190 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999999754 2458999999999999999999999 8999999999999999999999999999986544
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
...........+++.|+|||++.++.++.++|||||||++|||++ |..||.......... ....+. .
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~---~~~~~~---------~ 333 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE---FVEKGG---------R 333 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH---HHHTTC---------C
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCC---------C
Confidence 322222122336788999999999999999999999999999998 999998764432211 111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111222345788999999999999999999999999753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=361.59 Aligned_cols=260 Identities=24% Similarity=0.426 Sum_probs=213.2
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
...++|.+.+.||+|+||.||+|.. .+++.||+|++... ........+.+|+.+++.++||||+++++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 3457899999999999999999954 34578999999644 3456667899999999999999999999999876
Q ss_pred c-EEEEEEeccCCCHHHHHhhccC----------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecC
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERS----------------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~D 373 (558)
+ .++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccc
Confidence 5 9999999999999999976532 248899999999999999999999 8999999
Q ss_pred CCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCC
Q 008650 374 IKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDS 452 (558)
Q Consensus 374 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~ 452 (558)
|||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987655433333334558899999999999999999999999999999999 9999986
Q ss_pred CchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 453 SRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
........ ....+.. ...+......+.+++.+||+.||++|||+.++++.|++.
T Consensus 256 ~~~~~~~~---~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 256 IPPERLFN---LLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CCGGGHHH---HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHH---HhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 54332111 1111111 111223345789999999999999999999999998864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=383.37 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=215.2
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEE
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLI 321 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv 321 (558)
....++|.+.+.||+|+||+||+|...++..||||++...... ...|.+|+.++++++||||+++++++.++..++|
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv 260 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYII 260 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEE
Confidence 3456789999999999999999998888899999999765432 4578999999999999999999999987779999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+|+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999999976544568999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
.. .......+|+.|+|||++..+.++.++|||||||+||||++ |+.||.......... .+..... .
T Consensus 338 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~--~i~~~~~----------~ 404 (454)
T 1qcf_A 338 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR--ALERGYR----------M 404 (454)
T ss_dssp HH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH--HHHHTCC----------C
T ss_pred ce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH--HHHcCCC----------C
Confidence 21 11223347889999999999999999999999999999999 999998754432211 1111111 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
..+......+.+++.+||+.||++|||+.+|++.|+....
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1122334578899999999999999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=346.04 Aligned_cols=257 Identities=23% Similarity=0.395 Sum_probs=211.8
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
..++|++.+.||+|+||.||+|...++..||+|++....... ..+.+|+.++++++||||+++++++.++. .++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 456799999999999999999988888899999997654433 45889999999999999999999998765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 83 EYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp ECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999999764 3458999999999999999999999 899999999999999999999999999998765442
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.. ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||............ ... . ...
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--~~~-~--~~~------- 225 (268)
T 3sxs_A 159 YV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV--SQG-H--RLY------- 225 (268)
T ss_dssp EE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--HTT-C--CCC-------
T ss_pred hh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH--HcC-C--CCC-------
Confidence 22 2233457788999999999999999999999999999999 99999865543222111 111 1 000
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
.+......+.+++.+||+.+|.+|||+.|+++.|+....
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 111123468899999999999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=366.27 Aligned_cols=265 Identities=24% Similarity=0.420 Sum_probs=215.3
Q ss_pred HHHhhhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEE
Q 008650 240 EISSATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313 (558)
Q Consensus 240 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 313 (558)
.+....++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34456688999999999999999999653 35789999996543 455667899999999999999999999999
Q ss_pred EeCc-EEEEEEeccCCCHHHHHhhcc----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEE
Q 008650 314 IENG-LYLIFNFSQNGNLDAALHDER----------------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370 (558)
Q Consensus 314 ~~~~-~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv 370 (558)
.++. .++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 8755 999999999999999997642 1568999999999999999999999 8999
Q ss_pred ecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCC
Q 008650 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKP 449 (558)
Q Consensus 371 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~P 449 (558)
||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999987644332223334568999999999999999999999999999999999 9999
Q ss_pred CCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 450 VDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 450 f~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
|.......... .+..+.... .+......+.+++.+||+.+|.+|||+.++++.|++...
T Consensus 277 ~~~~~~~~~~~---~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 277 YYGMAHEEVIY---YVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTSCHHHHHH---HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCChHHHHH---HHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 98754432211 111222111 112234578899999999999999999999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=368.95 Aligned_cols=261 Identities=28% Similarity=0.452 Sum_probs=213.7
Q ss_pred hhCCCcccceEeeeCceEEEEEEE--------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL--------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCI 314 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 314 (558)
..++|.+.+.||+|+||+||+|.. ..+..||||++... ........+.+|+.+++++ +||||+++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 446899999999999999999964 22357999999654 3456667899999999999 8999999999998
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCce
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDERS--------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNV 379 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI 379 (558)
+++ .++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceE
Confidence 765 9999999999999999976542 358999999999999999999999 8999999999999
Q ss_pred eecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHH
Q 008650 380 LLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLV 458 (558)
Q Consensus 380 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~ 458 (558)
|++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987655433333344568899999999999999999999999999999999 9999986543321
Q ss_pred HHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 459 LWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 459 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
. . .+..+.. ...+......+.+++.+||+.+|++|||+.||++.|+....
T Consensus 303 ~--~-~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 303 F--K-LLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp H--H-HHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--H-HHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 1 1111111 11122234578899999999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=361.98 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=203.1
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|++.+.||+|+||+||+|.. .+++.||||++..... ......+.+|+.+++.++||||+++++++.+++ .++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 46899999999999999999955 4799999999965432 233456889999999999999999999998766 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 85 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999999854 3469999999999999999999999 899999999999999999999999999998764333
Q ss_pred CcccccccccccCcccchhhccCCC-CccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........+....... .. . .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~---~------~ 229 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TY---L------N 229 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC-TT---S------T
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc-cc---C------C
Confidence 3333345679999999999988775 7899999999999999999999986543322211111110 00 0 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
........+.+++.+||+.||.+|||+.|+++.
T Consensus 230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 012234567889999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=346.73 Aligned_cols=253 Identities=20% Similarity=0.307 Sum_probs=209.9
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--c-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--G-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|... ++.||||++............+.+|+.++++++||||+++++++.+. . .++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357999999999999999999874 88999999987766677778899999999999999999999999864 3 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCc--EEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR--IIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
|||+++|+|.+++.......+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999987655579999999999999999999998 77 9999999999999999999999998876432
Q ss_pred CCCCcccccccccccCcccchhhccCCCCc---cccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDE---KTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
. ....||+.|+|||++.+..++. ++|||||||++|||++|+.||........... ....+.
T Consensus 165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~~~~~~------- 228 (271)
T 3kmu_A 165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK--VALEGL------- 228 (271)
T ss_dssp C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH--HHHSCC-------
T ss_pred c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH--HHhcCC-------
Confidence 2 1235899999999998765554 79999999999999999999987544322111 111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
....+......+.+++.+||+.||++|||+.++++.|+...
T Consensus 229 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 --RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11112233456889999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=364.53 Aligned_cols=265 Identities=26% Similarity=0.373 Sum_probs=197.7
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEECC-CC---EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNLSD-GR---KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG 317 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 317 (558)
....++|.+.+.||+|+||+||+|.... +. .||||++............+.+|+.++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3455789999999999999999996543 32 7999999766544556778999999999999999999999987643
Q ss_pred -E------EEEEEeccCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc
Q 008650 318 -L------YLIFNFSQNGNLDAALHDERS----KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386 (558)
Q Consensus 318 -~------~lv~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 386 (558)
. ++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCC
Confidence 3 899999999999999965432 258999999999999999999999 89999999999999999999
Q ss_pred eEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhh
Q 008650 387 PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLM 465 (558)
Q Consensus 387 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 465 (558)
+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.......... ...
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~--~~~ 253 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN--YLI 253 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH--HHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH--HHh
Confidence 99999999987655433333334457889999999999999999999999999999999 999998654332111 111
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCc
Q 008650 466 ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDS 521 (558)
Q Consensus 466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 521 (558)
.... ...+......+.+++.+||+.||++|||+.++++.|++....
T Consensus 254 ~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 254 GGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp TTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 111223345789999999999999999999999999875443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=360.64 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=205.4
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.. .|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 46799999999999999999965 4799999999975421 1223456789999999999999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999999654 468999999999999999999999 89999999999999999999999999999864332
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... +.. .
T Consensus 159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~i~~-~~~----------~ 223 (337)
T 1o6l_A 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF--ELILM-EEI----------R 223 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH-CCC----------C
T ss_pred C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH--HHHHc-CCC----------C
Confidence 1 2233467999999999999999999999999999999999999999865433221 11111 111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
++......+.+++.+||+.||.+|| ++.|+++.
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1222345788999999999999999 89999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=351.27 Aligned_cols=255 Identities=23% Similarity=0.427 Sum_probs=210.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
..++|.+.+.||+|+||.||+|...+++.||+|++....... ..+.+|+.++++++||||+++++++.++. .++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 446799999999999999999988889999999997654433 45889999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp ECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999999654 3468999999999999999999999 899999999999999999999999999998764432
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
. .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||........... .... ....
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~--~~~~----------~~~~ 227 (269)
T 4hcu_A 161 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--ISTG----------FRLY 227 (269)
T ss_dssp H-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--HHTT----------CCCC
T ss_pred c-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhcC----------ccCC
Confidence 1 12223457889999999999999999999999999999999 9999987544322111 1111 0011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.+......+.+++.+||+.+|++|||+.++++.|++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 1122235688999999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=352.93 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=203.2
Q ss_pred hhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIF 322 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~ 322 (558)
...++|++.+.||+|+||+||+|... ..+|+|++............+.+|+.++++++||||+++++++..+..++||
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~ 98 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT 98 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEE
Confidence 34568999999999999999999753 4699999987766677788899999999999999999999988777799999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999999654 3568999999999999999999999 899999999999999999999999999998665433
Q ss_pred CcccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.........||+.|+|||++. +..++.++||||||+++|+|++|+.||.......... .....+........ +
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~-~- 250 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--EMVGRGSLSPDLSK-V- 250 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH--HHHHHTSCCCCTTS-S-
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH--HHhcccccCcchhh-c-
Confidence 333334456999999999996 6678899999999999999999999998654332211 11111111111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.......+.+++.+||+.+|.+|||+.++++.|++..
T Consensus 251 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 ---RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1223457899999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=354.35 Aligned_cols=260 Identities=22% Similarity=0.340 Sum_probs=210.0
Q ss_pred ccCHHHHHhhhCC----------CcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhccccc
Q 008650 235 CFSYEEISSATNN----------FHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH 303 (558)
Q Consensus 235 ~~~~~~~~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h 303 (558)
.++++++..+++. |...+.||+|+||.||+|... +|+.||||++...... ....+.+|+.+++.++|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQH 101 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCC
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCC
Confidence 3566777666543 677789999999999999665 7999999999754422 34567899999999999
Q ss_pred CCeeeeeeEEEeCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec
Q 008650 304 PNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG 382 (558)
Q Consensus 304 ~niv~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 382 (558)
|||+++++++..+. .++||||+.+++|.+++.. ..+++..++.++.|++.||.|||+ ++|+||||||+|||++
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT 175 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence 99999999998765 9999999999999999853 358999999999999999999999 8999999999999999
Q ss_pred CCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh
Q 008650 383 PDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK 462 (558)
Q Consensus 383 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 462 (558)
.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~--~ 251 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM--K 251 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--H
T ss_pred CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H
Confidence 999999999999987654322 223456999999999999999999999999999999999999999865433211 1
Q ss_pred hhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 463 PLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
... ...... +. ........+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~-~~~~~~-----~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 RLR-DSPPPK-----LK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHH-HSSCCC-----CT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHh-cCCCCC-----cC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 111111 10 112234568899999999999999999999984
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=360.52 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=205.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH----HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA----KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||+|++.+..... .....+.+|+.++++++||||+++++++.++. .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46799999999999999999955 469999999997654321 12456889999999999999999999998765 9
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC----ceEEEeccc
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF----EPQITDFGL 394 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~ 394 (558)
++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 999999999999999954 3569999999999999999999999 8999999999999998877 799999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
+..+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... . +..+... +
T Consensus 166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~-~--i~~~~~~--~ 237 (361)
T 2yab_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-N--ITAVSYD--F 237 (361)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-H--HHTTCCC--C
T ss_pred ceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H--HHhcCCC--C
Confidence 987654322 234569999999999999999999999999999999999999998754332111 1 1111100 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
++ .........+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 238 DE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Cc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0001223568899999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=365.69 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=202.8
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhccccc--CCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH--PNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~-~~l 320 (558)
..++|.+.+.||+|+||.||++...+++.||||++............+.+|+.++..+.| +||+++++++.++. .++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 456799999999999999999988889999999998776667777889999999999986 99999999998766 889
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||| +.+++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 87 v~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999 5688999999653 568999999999999999999999 8999999999999997 67899999999987755
Q ss_pred CCCcccccccccccCcccchhhcc-----------CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMH-----------GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 469 (558)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------- 232 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA------- 232 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH-------
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH-------
Confidence 443333345679999999999965 67899999999999999999999999865433222211
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+++.....++......+.+++.+||+.||.+|||+.|+++.
T Consensus 233 ---~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 ---IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111222222223568899999999999999999999985
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=373.23 Aligned_cols=259 Identities=29% Similarity=0.410 Sum_probs=209.1
Q ss_pred hCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
.++|.+.+.||+|+||+||+|... +++.||||++... ........+.+|+.++++++||||+++++++.++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 367899999999999999999642 4678999999543 34556667899999999999999999999998765
Q ss_pred EEEEEEeccCCCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC---ceEE
Q 008650 318 LYLIFNFSQNGNLDAALHDERS-----KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF---EPQI 389 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 389 (558)
.++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 8999999999999999976542 358999999999999999999999 8999999999999999555 5999
Q ss_pred EeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcC
Q 008650 390 TDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESG 468 (558)
Q Consensus 390 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 468 (558)
+|||+++.+.............||+.|+|||++.++.++.++|||||||++|||++ |..||........... .....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~--i~~~~ 303 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF--VTSGG 303 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH--HHTTC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--HHcCC
Confidence 99999976533222222333558999999999999999999999999999999998 9999987654322111 11111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 469 NLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 469 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
. ...+......+.+++.+||+.+|.+|||+.+|++.|....
T Consensus 304 ~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 R----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1 1112223356889999999999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=371.24 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=208.1
Q ss_pred hhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
..++|.+.+.||+|+||+||+|. ..+|+.+|+|++.+..........+.+|+.+++.++||||+++++++.+++ .|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35679999999999999999995 467899999999877666666778999999999999999999999998766 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec---CCCceEEEeccccccC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG---PDFEPQITDFGLAKWL 398 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a~~~ 398 (558)
|||+.+|+|.+.+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++...
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999998654 569999999999999999999999 8999999999999998 5678999999999876
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +..+... ...+
T Consensus 164 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~---i~~~~~~-~~~~-- 235 (444)
T 3soa_A 164 EGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ---IKAGAYD-FPSP-- 235 (444)
T ss_dssp CTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHTCCC-CCTT--
T ss_pred cCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH---HHhCCCC-CCcc--
Confidence 54322 22345799999999999999999999999999999999999999987644322111 1111111 0001
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
........+.+++.+||+.||.+|||+.|+++.
T Consensus 236 ---~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 ---EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111234578899999999999999999999984
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=350.85 Aligned_cols=261 Identities=20% Similarity=0.289 Sum_probs=202.3
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||+||+|.. .+++.||+|++............+.+|+.++++++||||+++++++.++. .++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999965 56899999999876665666677889999999999999999999998766 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+ +|...+... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 9986 555555432 3569999999999999999999999 8999999999999999999999999999987643322
Q ss_pred cccccccccccCcccchhhccCC-CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC-----cc---ccc
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGI-IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN-----LT---ELV 474 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~-----~~---~~~ 474 (558)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.................+. .. ...
T Consensus 157 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 223356899999999998765 8999999999999999999888864433222111111110000 00 000
Q ss_pred C---------CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 475 D---------PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 475 d---------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+ ..............+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00001111234467889999999999999999999987
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=355.05 Aligned_cols=264 Identities=23% Similarity=0.343 Sum_probs=201.7
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
..++|++.+.||+|+||+||+|...+|+.||+|++............+.+|+.++++++||||+++++++.++. .++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34679999999999999999998888999999999765544445677889999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+ +|.+.+... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 99 e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred cCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99985 787777543 3468999999999999999999999 899999999999999999999999999998764332
Q ss_pred CcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-HhhhhhhcCCcccc-------
Q 008650 403 THHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLMESGNLTEL------- 473 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~------- 473 (558)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .............+
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 2 2223468999999999976 56899999999999999999999999865432211 11111111000000
Q ss_pred --cCCCCC--CCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 474 --VDPSLE--GEY-----DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 474 --~d~~l~--~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...... ... ......++.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 000 01123568899999999999999999999973
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=362.24 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=208.0
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.++||||+++++++.++. .|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45799999999999999999955 56899999999877666667778999999999999999999999998766 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC---ceEEEeccccccCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF---EPQITDFGLAKWLP 399 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~~ 399 (558)
||+.+|+|.+.+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999998543 568999999999999999999999 8999999999999998654 59999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... . . +..+... ..
T Consensus 183 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-~-~-i~~~~~~------~~ 250 (362)
T 2bdw_A 183 DSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-A-Q-IKAGAYD------YP 250 (362)
T ss_dssp TCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-H-H-HHHTCCC------CC
T ss_pred CCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-H-H-HHhCCCC------CC
Confidence 4322 23456999999999999999999999999999999999999999875433211 1 1 1111110 00
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..........+.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00112234578899999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=368.08 Aligned_cols=257 Identities=24% Similarity=0.422 Sum_probs=198.3
Q ss_pred hCCCcccceEeeeCceEEEEEEEC----CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS----DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
.++|.+.+.||+|+||.||+|... ++..||||++.... .......|.+|+.++++++||||+++++++.++. .+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 357999999999999999999654 57789999996543 4556678999999999999999999999998765 89
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999653 3468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcc-cccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 400 NKCTHH-AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 400 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........... +..+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~---i~~~--------- 266 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA---VDEG--------- 266 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH---HHTT---------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcC---------
Confidence 432211 1122346788999999999999999999999999999998 9999986543322111 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.....+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 267 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 11111223345789999999999999999999999998875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=363.99 Aligned_cols=265 Identities=20% Similarity=0.309 Sum_probs=209.2
Q ss_pred hhCCCcccceEeee--CceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 244 ATNNFHSENMVGQG--GYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 244 ~~~~f~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
..++|++.+.||+| +||+||+|... +|+.||||++............+.+|+.+++.++||||+++++++.+++ .+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34679999999999 99999999654 7999999999877666677788889999999999999999999998766 99
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+|+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999987666779999999999999999999999 899999999999999999999999999986542
Q ss_pred CCCC-----cccccccccccCcccchhhcc--CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccc
Q 008650 400 NKCT-----HHAAIPIEGTFGYLAPEYFMH--GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTE 472 (558)
Q Consensus 400 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 472 (558)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ . .+....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~-~~~~~~ 256 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--L-NGTVPC 256 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--h-cCCCCc
Confidence 2111 111223469999999999987 57999999999999999999999999764332111110 0 000000
Q ss_pred ccCCC------------------------------------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 473 LVDPS------------------------------------LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 473 ~~d~~------------------------------------l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.+.. ............+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000 0001122234568999999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=365.91 Aligned_cols=253 Identities=21% Similarity=0.341 Sum_probs=201.6
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc--cCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC--HPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|...+++.||||++............+.+|+.+++++. ||||+++++++..+. .|+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999998878999999999877666777788999999999996 599999999998765 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|| +.+++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++.+...
T Consensus 135 ~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred Ee-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99 6788999999654 468899999999999999999998 8999999999999995 589999999999877554
Q ss_pred CCcccccccccccCcccchhhcc-----------CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCc
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMH-----------GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL 470 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 470 (558)
..........||+.|+|||++.+ ..++.++|||||||+||||++|+.||............ ..
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~-~~----- 281 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA-II----- 281 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH-HH-----
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH-Hh-----
Confidence 33333345679999999999975 46899999999999999999999999864332221111 11
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 471 TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 471 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
++.....++......+.+++.+||+.||.+|||+.|+++.
T Consensus 282 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 ----DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111121223568899999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.53 Aligned_cols=261 Identities=25% Similarity=0.411 Sum_probs=214.1
Q ss_pred HHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEE
Q 008650 240 EISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLY 319 (558)
Q Consensus 240 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 319 (558)
++....++|.+.+.||+|+||.||+|...+++.||+|++...... ...+.+|+.+++.++||||+++++++.++..+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIY 83 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcCCCcE
Confidence 344556789999999999999999998888889999999765433 34688999999999999999999999877899
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+++|.+++.......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999975544468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
.... .......+|+.|+|||++.++.++.++||||||+++|+|++ |+.||......... ... ..+.
T Consensus 161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~~~-~~~~--------- 227 (279)
T 1qpc_A 161 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--QNL-ERGY--------- 227 (279)
T ss_dssp SSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH--HHH-HTTC---------
T ss_pred Cccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH--HHH-hccc---------
Confidence 4322 12223457889999999999999999999999999999999 99999865433211 111 1110
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
....+......+.+++.+||+.+|++|||+.++++.|+...
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 01112223457889999999999999999999999998643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=377.56 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=209.6
Q ss_pred hhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIF 322 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~ 322 (558)
...++|.+.+.||+|+||.||+|...++..||||++...... ...|.+|+.++++++||||+++++++.++..++||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~ 257 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 257 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEe
Confidence 445679999999999999999998888888999999765433 34688999999999999999999999887799999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999976555668999999999999999999999 899999999999999999999999999998765432
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
. .......+|+.|+|||++.++.++.++|||||||+||||++ |+.||.......... . +..+ .+..
T Consensus 335 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~--~-i~~~---------~~~~ 401 (452)
T 1fmk_A 335 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD--Q-VERG---------YRMP 401 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--H-HHTT---------CCCC
T ss_pred e-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH--H-HHcC---------CCCC
Confidence 1 12223447889999999999999999999999999999999 999998654332211 1 1111 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
.+......+.+++.+||+.+|++|||+.+|++.|+....
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 122344578899999999999999999999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.26 Aligned_cols=257 Identities=20% Similarity=0.358 Sum_probs=208.0
Q ss_pred hhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
...++|.+.+.||+|+||+||+|...++..||+|++....... ..+.+|+.++++++||||+++++++.++. .++|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 3456899999999999999999988888899999997654433 45889999999999999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 98 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 98 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp ECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999996533 459999999999999999999999 89999999999999999999999999999876443
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........... .... ...
T Consensus 174 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~--~~~~----------~~~ 240 (283)
T 3gen_A 174 EY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQG----------LRL 240 (283)
T ss_dssp HH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--HHTT----------CCC
T ss_pred cc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH--Hhcc----------cCC
Confidence 21 12223457889999999999999999999999999999998 9999987544322111 1111 001
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..+......+.+++.+||+.+|.+|||+.++++.|....
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 111122356889999999999999999999999997643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.28 Aligned_cols=268 Identities=23% Similarity=0.357 Sum_probs=205.7
Q ss_pred hCCCcccceEeeeCceEEEEEEE-----CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe---C
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE---N 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~ 316 (558)
.++|++.+.||+|+||+||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++.. .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 46799999999999999999963 36889999999654 35556778999999999999999999999864 3
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 3899999999999999997643 358999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhh----cCCcc
Q 008650 397 WLPNKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLME----SGNLT 471 (558)
Q Consensus 397 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~----~~~~~ 471 (558)
........ .......||..|+|||++.+..++.++||||||+++|+|++|..||................ .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76543222 12223457888999999999999999999999999999999999987643221111000000 00000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
..+........+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01111111122333446799999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=353.95 Aligned_cols=262 Identities=22% Similarity=0.373 Sum_probs=213.3
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEe
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIE 315 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 315 (558)
...++|.+.+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.+++++ +||||+++++++.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 4457899999999999999999964 356789999996543 345567789999999999 89999999999987
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCc
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDERS----------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASN 378 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N 378 (558)
++ .++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccce
Confidence 55 9999999999999999976542 248999999999999999999999 899999999999
Q ss_pred eeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhH
Q 008650 379 VLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNL 457 (558)
Q Consensus 379 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~ 457 (558)
||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999987765443333334557899999999999999999999999999999999 999998654322
Q ss_pred HHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 458 VLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 458 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.... ....+. ....+......+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 256 ~~~~--~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 256 KFYK--MIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHH--HHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH--HhccCC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1111 111110 01111223457889999999999999999999999998744
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=348.98 Aligned_cols=262 Identities=22% Similarity=0.340 Sum_probs=201.2
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
++|.+.+.||+|+||+||+|...+|+.||+|++............+.+|+.+++.++||||+++++++.+++ .++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578999999999999999998788999999999765443333466789999999999999999999998755 9999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+ +|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 986 898888653 3568999999999999999999999 8999999999999999999999999999986543221
Q ss_pred ccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh-hhhhcC---Cccc-----cc
Q 008650 405 HAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK-PLMESG---NLTE-----LV 474 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~-~~~~~~---~~~~-----~~ 474 (558)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............ ...... .... ..
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 12234689999999999764 5899999999999999999999999875433221111 000000 0000 00
Q ss_pred CCCCCC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSLEG-------EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
++.... .........+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111100 0111234578899999999999999999999873
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=359.99 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=204.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCE----EEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRK----IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 319 (558)
.++|.+.+.||+|+||+||+|.. .+++. ||+|.+.... .......+.+|+.+++.++||||+++++++.++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccE
Confidence 35799999999999999999964 44554 7777774332 112234467899999999999999999999887899
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999999654 3468899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
............||+.|+|||++.++.++.++|||||||++|+|++ |+.||........... +..+...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~~------- 236 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---LEKGERL------- 236 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH---HHTTCBC-------
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH---HHcCCCC-------
Confidence 5544444445668899999999999999999999999999999999 9999987543322111 1111100
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..+......+.+++.+||+.||.+|||+.++++.|....
T Consensus 237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 --AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp --CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred --CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011112234778999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=361.45 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=200.5
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~ 319 (558)
..++|.+.+.||+|+||+||+|.. .+|+.||||++.+... .......+.+|..++..+ +||||+++++++.++. .|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 347899999999999999999965 4689999999976432 223345677899999988 6999999999998765 99
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||+++...
T Consensus 101 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999999654 469999999999999999999999 899999999999999999999999999998643
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... +..
T Consensus 176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~--~~i~~-~~~--------- 241 (353)
T 3txo_A 176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF--EAILN-DEV--------- 241 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH-CCC---------
T ss_pred cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH--HHHHc-CCC---------
Confidence 221 2233467999999999999999999999999999999999999999876543221 11111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSM------SEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~ 514 (558)
.++......+.+++.+||+.||.+||++ .|+++.
T Consensus 242 -~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 242 -VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1122233568899999999999999998 777763
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.83 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=199.7
Q ss_pred hhhCCCcccceEeeeCceEEEEEEECC----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLSD----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGL 318 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 318 (558)
...++|.+.+.||+|+||.||+|.... +..||+|++... ........+.+|+.++++++||||+++++++.++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCcc
Confidence 345679999999999999999996532 457999998543 345566778999999999999999999999977779
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++||||+.+++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999999654 3468999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......... .+..+..
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~---~i~~~~~------- 235 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGER------- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HHHTTCC-------
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH---HHHcCCC-------
Confidence 543221 1223447889999999999999999999999999999997 999998654332111 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+......+.+++.+||+.||++|||+.|+++.|...
T Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 --LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111223345788999999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=358.56 Aligned_cols=269 Identities=22% Similarity=0.395 Sum_probs=217.0
Q ss_pred HHHHhhhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeE
Q 008650 239 EEISSATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312 (558)
Q Consensus 239 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 312 (558)
+++....++|.+.+.||+|+||.||+|... +++.||+|++... ........+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 344556678999999999999999999543 4678999999654 334556678999999999999999999999
Q ss_pred EEeCc-EEEEEEeccCCCHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC
Q 008650 313 CIENG-LYLIFNFSQNGNLDAALHDER--------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP 383 (558)
Q Consensus 313 ~~~~~-~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 383 (558)
+.++. .++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcC
Confidence 98755 899999999999999987532 1457899999999999999999999 89999999999999999
Q ss_pred CCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhh
Q 008650 384 DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAK 462 (558)
Q Consensus 384 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~ 462 (558)
++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |+.||......... .
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~ 251 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--R 251 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH--H
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH--H
Confidence 99999999999986644332223334457899999999999999999999999999999999 89999875433211 1
Q ss_pred hhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCccc
Q 008650 463 PLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEF 523 (558)
Q Consensus 463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 523 (558)
....+.... .+......+.+++.+||+.+|.+|||+.|+++.|++.....+
T Consensus 252 -~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~ 302 (322)
T 1p4o_A 252 -FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302 (322)
T ss_dssp -HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred -HHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence 111111111 122234568899999999999999999999999998766544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.24 Aligned_cols=268 Identities=18% Similarity=0.237 Sum_probs=210.2
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GLYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~l 320 (558)
.++|.+.+.||+|+||+||+|... +++.||||++..... ......+.+|+.++++++||||+++++++.+. ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 357999999999999999999654 589999999965432 22345678999999999999999999998753 3799
Q ss_pred EEEeccCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee----cCCCceEEEecccc
Q 008650 321 IFNFSQNGNLDAALHDERS-KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL----GPDFEPQITDFGLA 395 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~a 395 (558)
||||+.+++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999976433 348999999999999999999999 899999999999999 78888999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhc--------cCCCCccccchhHHHHHHHHHcCCCCCCCCchh--HHHHhhhhh
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFM--------HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN--LVLWAKPLM 465 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~--~~~~~~~~~ 465 (558)
+........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||...... .........
T Consensus 164 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 876554322 2356999999999986 578899999999999999999999999643211 111111111
Q ss_pred hcCC---ccc---------cc--CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 466 ESGN---LTE---------LV--DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 466 ~~~~---~~~---------~~--d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.... ... -+ ...............+.+++.+||+.||++|||+.|+++....+.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1100 000 00 011122345677788999999999999999999999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=359.73 Aligned_cols=263 Identities=25% Similarity=0.442 Sum_probs=209.1
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEe
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIE 315 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 315 (558)
...++|.+.+.||+|+||.||+|.. .++..||+|++.... .......+.+|+.+++++ .||||+++++++..
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 4557899999999999999999964 245689999996432 334456788999999999 89999999999987
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhccC---------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecC
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDERS---------------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~D 373 (558)
++ .++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence 65 9999999999999999976532 237899999999999999999999 8999999
Q ss_pred CCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCC
Q 008650 374 IKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDS 452 (558)
Q Consensus 374 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~ 452 (558)
|||+|||++.++.+||+|||++................||+.|+|||++.++.++.++|||||||++|+|+| |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999987654433333334558899999999999999999999999999999998 9999986
Q ss_pred CchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 453 SRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
........ .....+ .....+......+.+++.+||+.||.+|||+.++++.|+....
T Consensus 278 ~~~~~~~~--~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 278 IPVDANFY--KLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCCSHHHH--HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCcHHHHH--HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 54322111 111111 1111122234578899999999999999999999999987544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=355.87 Aligned_cols=245 Identities=26% Similarity=0.356 Sum_probs=196.3
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||+||+|... +|+.||||++............+..|+..+..+ .||||+++++++.+++ .++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999665 799999999876655566666677777666666 8999999999998876 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+ +++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 67998888654 3569999999999999999999999 899999999999999999999999999998765432
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
. .....||+.|+|||++.+ .++.++|||||||++|||++|..||...... .. +..+.... ..
T Consensus 212 ~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~~--~~~~~~~~--------~~ 273 (311)
T 3p1a_A 212 A---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----QQ--LRQGYLPP--------EF 273 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----HH--HTTTCCCH--------HH
T ss_pred C---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HH--HhccCCCc--------cc
Confidence 2 233469999999999875 7899999999999999999997776543211 10 11111110 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+......+.+++.+||+.||++|||+.|+++
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1122457899999999999999999999997
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.25 Aligned_cols=251 Identities=20% Similarity=0.252 Sum_probs=204.5
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||+||+|.. .+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.. .++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 46899999999999999999955 468899999986442 34456789999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC--CCceEEEeccccccCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP--DFEPQITDFGLAKWLPN 400 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~~~ 400 (558)
||+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++..+..
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 81 EFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999999643 3468999999999999999999999 89999999999999987 78999999999987754
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...... ... ....
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~-~~~--~~~~--- 225 (321)
T 1tki_A 157 GDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII--ENIMNA-EYT--FDEE--- 225 (321)
T ss_dssp TCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHHT-CCC--CCHH---
T ss_pred CCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH--HHHHcC-CCC--CChh---
Confidence 322 22356999999999999998999999999999999999999999875443211 111111 100 0000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
........+.+++.+||+.||.+|||+.|+++.
T Consensus 226 -~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 -AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001224578899999999999999999999984
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=359.76 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=201.5
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCE----EEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRK----IAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 319 (558)
.++|.+.+.||+|+||+||+|.. .+++. ||+|.+.... .......+.+|+.+++.++||||+++++++.++..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCce
Confidence 46799999999999999999964 45554 4677664332 233456788999999999999999999999988899
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
++++|+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999999754 3568999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
............||+.|+|||++.+..++.++|||||||++|||++ |+.||........... +..+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~~~~~--------- 236 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGE--------- 236 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTC---------
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHcCC---------
Confidence 4433333334457889999999999999999999999999999999 9999987544322111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
....+......+.+++.+||+.||.+|||+.|+++.|....
T Consensus 237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11112233456889999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=371.19 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=206.9
Q ss_pred hhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--cEEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--GLYL 320 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~l 320 (558)
...++|.+.+.||+|+||.||+|... |+.||||++.... ....|.+|+.++++++||||+++++++.+. ..++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 34567899999999999999999874 7899999996543 345688999999999999999999998764 4899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999987655568999999999999999999999 8999999999999999999999999999986433
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.. ....+|+.|+|||++.++.++.++|||||||+||||++ |+.||......... . .+..+ .+
T Consensus 342 ~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~--~-~i~~~---------~~ 404 (450)
T 1k9a_A 342 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--P-RVEKG---------YK 404 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH--H-HHHTT---------CC
T ss_pred cc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--H-HHHcC---------CC
Confidence 21 12347899999999999999999999999999999998 99999865432211 1 11111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112233445788999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=363.23 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=202.1
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.. .|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36799999999999999999955 5688999999975431 1223456889999999999999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+|+|..++.. ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||++..+...
T Consensus 94 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999964 3569999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcccccccccccCcccchhhcc---CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMH---GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............+....
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------- 236 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--------- 236 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC---------
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc---------
Confidence 2 2334679999999999964 458999999999999999999999997532221111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPS-MSEVLE 513 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~ 513 (558)
..++......+.+++.+||+.||.+||+ +.++++
T Consensus 237 -~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1112233457899999999999999998 777775
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=352.92 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=204.0
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH----HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA----KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
++|.+.+.||+|+||.||+|.. .+|+.||+|++.+..... .....+.+|+.+++.++||||+++++++.++. .+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5699999999999999999965 468999999997654221 12456889999999999999999999998765 99
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC----ceEEEecccc
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF----EPQITDFGLA 395 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~a 395 (558)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 99999999999999954 3569999999999999999999999 8999999999999999887 7999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccC
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD 475 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d 475 (558)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .........
T Consensus 166 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~--- 238 (326)
T 2y0a_A 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFED--- 238 (326)
T ss_dssp EECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-HHTCCCCCH---
T ss_pred eECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-HhcCCCcCc---
Confidence 87654322 22356999999999999999999999999999999999999999865433221111 000000000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.........+.+++.+||+.||.+|||+.|+++.
T Consensus 239 -----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 239 -----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0001123568899999999999999999999984
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=359.94 Aligned_cols=268 Identities=21% Similarity=0.243 Sum_probs=207.9
Q ss_pred cccCHHHHHhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-----cCCee
Q 008650 234 TCFSYEEISSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-----HPNTA 307 (558)
Q Consensus 234 ~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv 307 (558)
..+++.+.....++|.+.+.||+|+||+||+|.. .+++.||||++... ......+..|+.+++.+. ||||+
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3445555556778999999999999999999965 57899999999643 344455677888888886 99999
Q ss_pred eeeeEEEeCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---
Q 008650 308 TLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP--- 383 (558)
Q Consensus 308 ~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~--- 383 (558)
++++++...+ .++||||+ +++|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence 9999998765 89999999 9999999987766679999999999999999999999 89999999999999975
Q ss_pred ----------------------CCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHH
Q 008650 384 ----------------------DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLL 441 (558)
Q Consensus 384 ----------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 441 (558)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 7899999999998654322 2356999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCchhHHHHhhhhhhcC------------CcccccC-CCC----CCCC-CH---------------HHHH
Q 008650 442 EIITGRKPVDSSRQNLVLWAKPLMESG------------NLTELVD-PSL----EGEY-DT---------------DQMH 488 (558)
Q Consensus 442 elltg~~Pf~~~~~~~~~~~~~~~~~~------------~~~~~~d-~~l----~~~~-~~---------------~~~~ 488 (558)
+|++|+.||.................. .....++ ..+ .... .. ....
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 999999999865432211110000000 0000000 000 0000 00 0115
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 489 RLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 489 ~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.+.+++.+||+.||.+|||+.|+++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 6789999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=360.23 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=200.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~l 320 (558)
.++|.+.+.||+|+||+||+|.. .+++.||+|++.+.... ......+.+|..++.++ +||||+++++++.++. +|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46799999999999999999965 46889999999765432 33345577899998877 7999999999998766 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999654 469999999999999999999999 8999999999999999999999999999986332
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh------HHHHhhhhhhcCCccccc
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN------LVLWAKPLMESGNLTELV 474 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~ 474 (558)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.....
T Consensus 206 ~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 279 (396)
T 4dc2_A 206 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 279 (396)
T ss_dssp TT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----
T ss_pred CC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----
Confidence 21 2234567999999999999999999999999999999999999999642111 00111111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSM------SEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~ 514 (558)
.++......+.+++.+||+.||.+||++ .|+++.
T Consensus 280 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1122234568899999999999999985 566663
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=378.05 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=213.7
Q ss_pred hhhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
....+|.+.+.||+|+||.||+|... ++..||||++...... ...|.+|+.++++++||||+++++++.++. .++
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34567899999999999999999765 4889999999765432 456899999999999999999999998755 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999999987666679999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
... .......+|+.|+|||++.++.++.++|||||||+||||++ |+.||.......... .+.. ..+
T Consensus 371 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~---~~~~---------~~~ 437 (495)
T 1opk_A 371 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---LLEK---------DYR 437 (495)
T ss_dssp CCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---HHHT---------TCC
T ss_pred Cce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc---------CCC
Confidence 322 12223447889999999999999999999999999999999 999998654332111 1111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
...+......+.+++.+||+.||++|||+.+|++.|+....
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 12223344578899999999999999999999999987643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=347.91 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=198.8
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcc--cccCCeeeeeeEEEeC-----
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGH--VCHPNTATLVGCCIEN----- 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----- 316 (558)
..++|.+.+.||+|+||+||+|.. +++.||||++.... ...+..|.+++.. ++||||+++++++.+.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 346899999999999999999977 68999999996532 2334455555554 7899999999987542
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhh--------hCCCCcEEecCCCCCceeecCCCceE
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH--------KGCKRRIIHRDIKASNVLLGPDFEPQ 388 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~k 388 (558)
..++||||+.+|+|.+++.. ..+++..++.++.|++.||.||| + ++|+||||||+|||++.++.+|
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEE
T ss_pred eeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEE
Confidence 28899999999999999943 46999999999999999999999 6 8999999999999999999999
Q ss_pred EEeccccccCCCCCCcc--cccccccccCcccchhhccC------CCCccccchhHHHHHHHHHcC----------CCCC
Q 008650 389 ITDFGLAKWLPNKCTHH--AAIPIEGTFGYLAPEYFMHG------IIDEKTDVFAFGVLLLEIITG----------RKPV 450 (558)
Q Consensus 389 l~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvvl~elltg----------~~Pf 450 (558)
|+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997654432221 12234699999999999877 456799999999999999999 8888
Q ss_pred CCCch---hHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 451 DSSRQ---NLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 451 ~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
..... .................. ............+.+++.+||+.||++|||+.||++.|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 64321 111111111111111111 0111223467789999999999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=359.88 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=202.7
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc---HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD---AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||||++...... ......+.+|+.+++.++||||+++++++.+++ .|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35699999999999999999954 57999999998643211 112456889999999999999999999998766 89
Q ss_pred EEEEeccCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc---eEEEeccc
Q 008650 320 LIFNFSQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE---PQITDFGL 394 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~ 394 (558)
+||||+.+|+|.+.+.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988875532 3458999999999999999999999 89999999999999987654 99999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ... +....
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---i~~-~~~~~-- 251 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG---IIK-GKYKM-- 251 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHH---HHH-TCCCC--
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHH---HHc-CCCCC--
Confidence 987654322 2234569999999999999999999999999999999999999998754322111 111 11100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 252 NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 01123578899999999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=356.02 Aligned_cols=261 Identities=25% Similarity=0.450 Sum_probs=211.4
Q ss_pred hhCCCcccceEeeeCceEEEEEEE--------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL--------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCI 314 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 314 (558)
..++|.+.+.||+|+||.||+|.. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 346899999999999999999965 356789999996543 455667889999999999 8999999999998
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCce
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDERS--------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNV 379 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI 379 (558)
+++ .++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceE
Confidence 765 8999999999999999976532 248899999999999999999999 8999999999999
Q ss_pred eecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHH
Q 008650 380 LLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLV 458 (558)
Q Consensus 380 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~ 458 (558)
|++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 999999999999999987665433333334457899999999999999999999999999999999 9999986543321
Q ss_pred HHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 459 LWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 459 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
. .. +..+... ..+......+.+++.+||+.+|.+|||+.|+++.|.+...
T Consensus 269 ~--~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 269 F--KL-LKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp H--HH-HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--HH-HhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 11 1111111 1122234578899999999999999999999999987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=351.87 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=204.1
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||+|++.+.... ......+.+|..+++.++||||+++++++.+.. .|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 36799999999999999999965 47999999999754321 123456778999999999999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999999653 468999999999999999999998 89999999999999999999999999999875432
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... . ..... .. .
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~-~i~~~-~~----------~ 221 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-E-KILNA-EL----------R 221 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-H-HHHHC-CC----------C
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-H-HHHhC-CC----------C
Confidence 23457999999999999999999999999999999999999999865433211 1 11111 11 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
++......+.+++.+||+.||.+|| ++.++++.
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1122335788999999999999999 89999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=353.46 Aligned_cols=268 Identities=25% Similarity=0.399 Sum_probs=215.9
Q ss_pred CHHHHHhhhCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeee
Q 008650 237 SYEEISSATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATL 309 (558)
Q Consensus 237 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 309 (558)
...++....++|.+.+.||+|+||+||+|.. .+++.||||++.... .......+.+|+.++.++ +||||+++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 4456666778999999999999999999953 356889999996543 355567789999999999 69999999
Q ss_pred eeEEEeCc--EEEEEEeccCCCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecC
Q 008650 310 VGCCIENG--LYLIFNFSQNGNLDAALHDERS--------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRD 373 (558)
Q Consensus 310 ~~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~D 373 (558)
++++...+ .++||||+.+|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 99987643 8999999999999999976532 127899999999999999999999 8999999
Q ss_pred CCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCC
Q 008650 374 IKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDS 452 (558)
Q Consensus 374 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~ 452 (558)
|||+|||++.++.+||+|||++..+.............||+.|+|||++.+..++.++|||||||++|+|++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987655433333334568999999999999999999999999999999998 9999976
Q ss_pred CchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 453 SRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
......... ....+... ..+......+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 254 ~~~~~~~~~--~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKIDEEFCR--RLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCCSHHHHH--HHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhHHHHH--HhccCccC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 543221111 11111110 111122346889999999999999999999999998643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=348.13 Aligned_cols=265 Identities=23% Similarity=0.362 Sum_probs=214.5
Q ss_pred hCCCcccc-eEeeeCceEEEEEEEC---CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEE
Q 008650 245 TNNFHSEN-MVGQGGYSEVYKGNLS---DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYL 320 (558)
Q Consensus 245 ~~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 320 (558)
.++|.+.+ .||+|+||.||+|... ++..||+|++... ........+.+|+.+++.++||||+++++++..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEE
Confidence 35677766 9999999999999643 5778999999654 34566778999999999999999999999997777999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999999643 3569999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 401 KCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 401 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
.... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.......... .+..+..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---~i~~~~~-------- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA---FIEQGKR-------- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH---HHHTTCC--------
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH---HHhcCCc--------
Confidence 3222 12223457899999999998899999999999999999998 999998654332211 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCcccccc
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKS 526 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~ 526 (558)
...+......+.+++.+||+.+|.+|||+.++++.|+..........
T Consensus 232 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 232 -MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp -CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred -CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 11222334578999999999999999999999999998765544433
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=345.96 Aligned_cols=254 Identities=27% Similarity=0.500 Sum_probs=204.4
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH--HHH---HHHHHHHHHhcccccCCeeeeeeEEEeCcE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA--KKE---KEFLMELGIIGHVCHPNTATLVGCCIENGL 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 318 (558)
.++|.+.+.||+|+||+||+|.. .+++.||+|++....... ... ..+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36799999999999999999965 578999999986543221 111 67889999999999999999999986554
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCc--EEecCCCCCceeecCCCc-----eEEEe
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR--IIHRDIKASNVLLGPDFE-----PQITD 391 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl~D 391 (558)
++||||+.+|+|.+.+... ...+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999999888654 3569999999999999999999998 78 999999999999988776 99999
Q ss_pred ccccccCCCCCCcccccccccccCcccchhhc--cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC
Q 008650 392 FGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM--HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469 (558)
Q Consensus 392 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 469 (558)
||+++..... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||.................+.
T Consensus 173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 9999754332 23356999999999994 4568899999999999999999999998654433322222222111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 470 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
....+......+.+++.+||+.||.+|||+.|+++.|++
T Consensus 248 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 248 ---------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111222334578999999999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=342.49 Aligned_cols=251 Identities=28% Similarity=0.509 Sum_probs=196.4
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeeccccc--HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKD--AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|++.+.||+|+||.||+|... ++.||||++...... ......+.+|+.+++.++||||+++++++.++. .++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999764 889999998654322 233467889999999999999999999998765 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCc---EEecCCCCCceeecC--------CCceEEE
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR---IIHRDIKASNVLLGP--------DFEPQIT 390 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~---ivH~Dlkp~NIll~~--------~~~~kl~ 390 (558)
|||+.+++|.+++.. ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++. ++.+||+
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999843 468999999999999999999999 66 999999999999986 6789999
Q ss_pred eccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCc
Q 008650 391 DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL 470 (558)
Q Consensus 391 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 470 (558)
|||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........+.. ... .
T Consensus 159 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~~~-~- 230 (271)
T 3dtc_A 159 DFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV--AMN-K- 230 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH--HTS-C-
T ss_pred cCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh--hcC-C-
Confidence 9999986544322 2345999999999999999999999999999999999999999876543322211 111 1
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 471 TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 471 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.....+......+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 231 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 -------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111122334578999999999999999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=355.93 Aligned_cols=248 Identities=18% Similarity=0.289 Sum_probs=201.4
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH-HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|.. .+++.||+|++.+..... .....+.+|+.+++.++||||+++++++.++. .++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999965 678999999996542211 12346789999999999999999999998765 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+ +|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 78898888654 469999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcccccccccccCcccchhhccCCC-CccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
.. ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... ....+... ..
T Consensus 162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------~~~~i~~~-~~ 225 (336)
T 3h4j_B 162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------LFKKVNSC-VY 225 (336)
T ss_dssp BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT------------CBCCCCSS-CC
T ss_pred cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH------------HHHHHHcC-CC
Confidence 22 234569999999999988776 689999999999999999999997642210 00000000 01
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+......+.+++.+||+.||.+|||+.|+++.
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1122334578899999999999999999999984
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=350.04 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=209.6
Q ss_pred HhhhCCCcccc-eEeeeCceEEEEEEE---CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc
Q 008650 242 SSATNNFHSEN-MVGQGGYSEVYKGNL---SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG 317 (558)
Q Consensus 242 ~~~~~~f~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 317 (558)
....++|.+.+ .||+|+||+||+|.. .+++.||||++............+.+|+.+++.++||||+++++++..+.
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 91 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES 91 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCC
Confidence 34456788888 999999999999943 34678999999766544555678999999999999999999999997677
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++||||+.+++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999999653 468999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCcc-cccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccC
Q 008650 398 LPNKCTHH-AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVD 475 (558)
Q Consensus 398 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d 475 (558)
........ ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.......... .+..+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~~~~~~~----- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---MLEKGER----- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHTTCC-----
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHHcCCC-----
Confidence 65443221 1222347789999999999899999999999999999999 999998765432211 1111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
...+......+.+++.+||+.||.+|||+.++++.|++...
T Consensus 239 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 239 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11122334578999999999999999999999999987543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=339.40 Aligned_cols=253 Identities=22% Similarity=0.335 Sum_probs=208.4
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||.||+|.. .+++.||+|++............+.+|+.++++++||||+++++++.++. .++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999955 56899999999877666777788899999999999999999999998766 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc---eEEEeccccccCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE---PQITDFGLAKWLP 399 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~a~~~~ 399 (558)
||+.+++|.+.+... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999998888654 468999999999999999999999 89999999999999987655 9999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........... ...+... ...+
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~-~~~~--- 229 (284)
T 3kk8_A 160 DSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ---IKAGAYD-YPSP--- 229 (284)
T ss_dssp SSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHTCCC-CCTT---
T ss_pred cCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH---HHhcccc-CCch---
Confidence 4322 2235699999999999999999999999999999999999999987544322111 1111111 0000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
........+.+++.+||+.||++|||+.|+++.
T Consensus 230 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 --EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp --TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 011223568899999999999999999999984
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=353.70 Aligned_cols=264 Identities=28% Similarity=0.417 Sum_probs=202.9
Q ss_pred HHHhhhCCCcccceEeeeCceEEEEEEEC----CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe
Q 008650 240 EISSATNNFHSENMVGQGGYSEVYKGNLS----DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE 315 (558)
Q Consensus 240 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 315 (558)
++....++|.+.+.||+|+||.||+|... ++..||+|++............+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34455678999999999999999999543 34589999997766667777889999999999999999999999875
Q ss_pred Cc------EEEEEEeccCCCHHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC
Q 008650 316 NG------LYLIFNFSQNGNLDAALHDE----RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385 (558)
Q Consensus 316 ~~------~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 385 (558)
.. .++||||+.+|+|.+++... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCC
Confidence 32 59999999999999998542 23568999999999999999999998 8999999999999999999
Q ss_pred ceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhh
Q 008650 386 EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPL 464 (558)
Q Consensus 386 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 464 (558)
.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......... ..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~--~~ 262 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD--YL 262 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH--HH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--HH
Confidence 999999999987654432223333457889999999999999999999999999999999 999998654332111 11
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.. +.. ...+......+.+++.+||+.+|.+|||+.++++.|+..
T Consensus 263 ~~-~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 263 LH-GHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HT-TCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hc-CCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 110 111222345789999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=353.64 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=214.1
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
+....++|.+.+.||+|+||+||+|... ++..||+|++.... .....+.+|+.++++++||||+++++++.++. .
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 3445678999999999999999999654 58889999996543 34566889999999999999999999998765 9
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++||||+.+++|.+++.......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999999987666779999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........... +.. .
T Consensus 162 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---~~~---------~ 228 (288)
T 3kfa_A 162 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEK---------D 228 (288)
T ss_dssp CSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHT---------T
T ss_pred cCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---Hhc---------c
Confidence 54322 22233457889999999999999999999999999999999 9999986543321111 111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.....+......+.+++.+||+.||.+|||+.++++.|+...
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 111112233457899999999999999999999999988643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.82 Aligned_cols=264 Identities=21% Similarity=0.303 Sum_probs=199.2
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc---HHHHHHHHHHHHHhcccc---cCCeeeeeeEEEeC
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD---AKKEKEFLMELGIIGHVC---HPNTATLVGCCIEN 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 316 (558)
..++|++.+.||+|+||+||+|.. .+++.||||++...... ......+.+|+.+++.+. ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999964 57899999998643311 111233456666666554 99999999998763
Q ss_pred c------EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEE
Q 008650 317 G------LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT 390 (558)
Q Consensus 317 ~------~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 390 (558)
. .++||||+. ++|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 2 789999997 599999987666669999999999999999999999 899999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh-hhhhc--
Q 008650 391 DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK-PLMES-- 467 (558)
Q Consensus 391 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~-~~~~~-- 467 (558)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .....
T Consensus 163 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp SCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999987654322 23456999999999999999999999999999999999999999876543221111 11100
Q ss_pred -CCcccccC---CCCCC--C-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 468 -GNLTELVD---PSLEG--E-----YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 468 -~~~~~~~d---~~l~~--~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+..... ..+.. . ........+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000000 00000 0 001234578899999999999999999999873
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=357.04 Aligned_cols=252 Identities=20% Similarity=0.247 Sum_probs=204.8
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.++. .++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 35799999999999999999955 578999999997543 334557889999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC--CCceEEEeccccccCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP--DFEPQITDFGLAKWLPN 400 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~~~ 400 (558)
||+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++..+..
T Consensus 128 E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 128 EFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp ECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999998643 3468999999999999999999999 89999999999999974 47899999999987654
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ... ..... .++
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--~i~-~~~~~--~~~---- 271 (387)
T 1kob_A 204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ--NVK-RCDWE--FDE---- 271 (387)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH--HHH-HCCCC--CCS----
T ss_pred Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHH--HHH-hCCCC--CCc----
Confidence 322 223469999999999999999999999999999999999999998754322111 111 11110 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.........+.+++.+||+.||.+|||+.|+++.
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1112234578899999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=359.23 Aligned_cols=266 Identities=18% Similarity=0.253 Sum_probs=205.0
Q ss_pred hhCCCcccceEeeeCceEEEEEEECC------CCEEEEEEeecccccHHHH---------HHHHHHHHHhcccccCCeee
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSD------GRKIAVKRLAKDNKDAKKE---------KEFLMELGIIGHVCHPNTAT 308 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~---------~~~~~E~~~l~~l~h~niv~ 308 (558)
..++|.+.+.||+|+||+||+|.... ++.||||++.........+ ..++.|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999996654 4789999987654222211 12445667788899999999
Q ss_pred eeeEEEeC----c-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec-
Q 008650 309 LVGCCIEN----G-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG- 382 (558)
Q Consensus 309 l~~~~~~~----~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~- 382 (558)
+++++... . .++||||+ +++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence 99998753 2 79999999 99999999653 3569999999999999999999999 8999999999999999
Q ss_pred -CCCceEEEeccccccCCCCCCcc-----cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh
Q 008650 383 -PDFEPQITDFGLAKWLPNKCTHH-----AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN 456 (558)
Q Consensus 383 -~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~ 456 (558)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998765432211 113355999999999999999999999999999999999999999853222
Q ss_pred --HHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 457 --LVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 457 --~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
....... .....+..++++.+... .....+.+++..||+.+|.+||++.+|++.|+..
T Consensus 268 ~~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 268 PKYVRDSKI-RYRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHHHHH-HHHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHH-HhhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 1111111 11112333333333211 1234688999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=350.84 Aligned_cols=263 Identities=22% Similarity=0.342 Sum_probs=188.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+++ .++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 46799999999999999999955 4689999999965432 223356778999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 323 NFSQNGNLDAALHDER----SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
||+. |+|.+++.... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 59988886543 2358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh-hhhhcC--C-ccc-
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK-PLMESG--N-LTE- 472 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~-~~~~~~--~-~~~- 472 (558)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ...... . ...
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 159 GIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp TSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred CCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 43221 1223468999999999976 46899999999999999999999999876443221111 000000 0 000
Q ss_pred ----ccCCCCCC------------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 473 ----LVDPSLEG------------EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 473 ----~~d~~l~~------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+.+.. .........+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000000 0001123478899999999999999999999873
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=348.37 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=196.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH------------------------HHHHHHHHHHHHhc
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA------------------------KKEKEFLMELGIIG 299 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 299 (558)
.++|.+.+.||+|+||.||+|.. .+++.||||++.+..... .....+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999954 568899999997653211 12356889999999
Q ss_pred ccccCCeeeeeeEEEe--C-cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCC
Q 008650 300 HVCHPNTATLVGCCIE--N-GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKA 376 (558)
Q Consensus 300 ~l~h~niv~l~~~~~~--~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp 376 (558)
+++||||+++++++.+ + ..++||||+.+++|.+++. ...+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCH
Confidence 9999999999999975 2 3899999999999987653 3469999999999999999999999 8999999999
Q ss_pred CceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCC---CCccccchhHHHHHHHHHcCCCCCCCC
Q 008650 377 SNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI---IDEKTDVFAFGVLLLEIITGRKPVDSS 453 (558)
Q Consensus 377 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvvl~elltg~~Pf~~~ 453 (558)
+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999987654322 123356999999999997765 478899999999999999999999875
Q ss_pred chhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 454 RQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
..... ..... ...... + ........+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~--~~~~~-~~~~~~---~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIMCL--HSKIK-SQALEF---P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHHHH--HHHHH-HCCCCC---C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHHHH--HHHHh-cccCCC---C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 43221 11111 111110 0 01122356889999999999999999999976
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=350.27 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=203.5
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~l 320 (558)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.+... .......+.+|..++.++ +||||+++++++.++. .|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 35799999999999999999965 4688999999976543 345566788999999887 7999999999998765 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++....
T Consensus 88 v~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999999654 468999999999999999999999 8999999999999999999999999999986432
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh------HHHHhhhhhhcCCccccc
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN------LVLWAKPLMESGNLTELV 474 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~ 474 (558)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.....
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 21 2233467999999999999999999999999999999999999999742110 00111111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSM------SEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~ 514 (558)
.++......+.+++.+||+.||.+||++ .|+++.
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1122334568899999999999999995 677664
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=354.84 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=204.5
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||.||+|.. .+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++.++. .|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 5799999999999999999965 47999999999654321 123456889999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999999754 458999999999999999999999 89999999999999999999999999999876432
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... +.. .+
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~i~~-~~~----------~~ 257 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY--EKIVS-GKV----------RF 257 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH-CCC----------CC
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH--HHHHc-CCC----------CC
Confidence 23457999999999999999999999999999999999999999875433211 11111 111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 514 (558)
+......+.+++.+||+.||.+||+ +.++++.
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 2223456889999999999999998 8888874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=354.48 Aligned_cols=259 Identities=16% Similarity=0.212 Sum_probs=204.5
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|.. .+++.||||++...... ..+.+|+.+++.+ +||||+++++++.++. .++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46899999999999999999964 67899999998654322 2477899999999 8999999999998866 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc-----eEEEeccccc
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE-----PQITDFGLAK 396 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFG~a~ 396 (558)
|||+ +++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 9999 99999999754 3579999999999999999999999 89999999999999999887 9999999998
Q ss_pred cCCCCCCcc-----cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 397 WLPNKCTHH-----AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 397 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 764432211 123567999999999999999999999999999999999999999864322111110001000000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
... ..+.. ... .+.+++..||+.+|.+||++.+|++.|+..
T Consensus 239 ~~~-~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TPI-EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SCH-HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCH-HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000 00000 012 789999999999999999999999988753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=356.07 Aligned_cols=262 Identities=25% Similarity=0.403 Sum_probs=210.4
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEEC-CC-----CEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEE
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNLS-DG-----RKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCI 314 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 314 (558)
....++|.+.+.||+|+||.||+|... ++ ..||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 344578999999999999999999653 23 479999996543 345567789999999999 8999999999998
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhcc------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDER------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL 381 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 381 (558)
+++ .++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEE
Confidence 765 999999999999999997542 3468999999999999999999999 899999999999999
Q ss_pred cCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHH
Q 008650 382 GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLW 460 (558)
Q Consensus 382 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~ 460 (558)
+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999987644333222334557889999999999999999999999999999999 999998654322111
Q ss_pred hhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 461 AKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 461 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
. ....+. ....+......+.+++.+||+.||.+|||+.||++.|+..
T Consensus 278 ~--~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 278 K--LVKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp H--HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H--HHhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1 111110 0011112235688999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=350.96 Aligned_cols=256 Identities=21% Similarity=0.350 Sum_probs=198.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-----
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG----- 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 317 (558)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ........+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999964 678999999997653 34555678899999999999999999999986532
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.|+||||+.+++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 49999999999999999654 468999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 398 LPNKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 398 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........+.. .........
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~~~~~~~~~--- 240 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--VREDPIPPS--- 240 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHCCCCCHH---
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hcCCCCCcc---
Confidence 6543222 2223456999999999999999999999999999999999999999876544332221 111110000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.. .......+.+++.+||+.||++||+..+++..
T Consensus 241 ~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 241 AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 00 01123568899999999999999977766653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=381.16 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=216.4
Q ss_pred HHHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcE
Q 008650 239 EEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGL 318 (558)
Q Consensus 239 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 318 (558)
..+....++|.+.+.||+|+||.||+|...++..||||++...... ...|.+|+.+|++++||||+++++++.++..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 336 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 336 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEeeccc
Confidence 3344566789999999999999999998888888999999765433 3468899999999999999999999988779
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++||||+.+|+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 999999999999999976555668999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
..... .......+|..|+|||++.++.++.++|||||||+||||++ |+.||.......... .+..+.
T Consensus 414 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~---~i~~~~-------- 481 (535)
T 2h8h_A 414 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---QVERGY-------- 481 (535)
T ss_dssp CCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH---HHHTTC--------
T ss_pred CCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCC--------
Confidence 53211 11223347889999999999999999999999999999999 999998654332211 111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
+...+......+.+++.+||+.||++|||+.+|++.|+....
T Consensus 482 -~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 111122334578899999999999999999999999997654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=346.89 Aligned_cols=262 Identities=19% Similarity=0.297 Sum_probs=201.9
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|+||+||+|.. .+|+.||+|++............+.+|+.++++++||||+++++++.+++ .++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 6799999999999999999965 46899999999777666666778899999999999999999999998766 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|..++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999988543 568999999999999999999999 8999999999999999999999999999987653322
Q ss_pred cccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh------------hcCC-
Q 008650 404 HHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM------------ESGN- 469 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~------------~~~~- 469 (558)
......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||............... ....
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 1223469999999999976 67899999999999999999999999876433221111000 0000
Q ss_pred cccccCCCCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 LTELVDPSLEGEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 ~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+....... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000000 1234568899999999999999999999984
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=343.27 Aligned_cols=255 Identities=23% Similarity=0.416 Sum_probs=209.6
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
..++|.+.+.||+|+||.||+|...+++.||+|++....... ..+.+|+.+++.++||||+++++++.+++ .++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 346799999999999999999988888999999997654433 46889999999999999999999998755 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++++|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred eCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999999654 3468999999999999999999999 899999999999999999999999999998764321
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
. .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.......... .... +. ...
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~i~~-~~---------~~~ 225 (267)
T 3t9t_A 159 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE--DIST-GF---------RLY 225 (267)
T ss_dssp H-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHHT-TC---------CCC
T ss_pred c-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH--HHhc-CC---------cCC
Confidence 1 11223457889999999999999999999999999999999 899998754332211 1111 10 001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.+......+.+++.+||+.+|++|||+.++++.|++.
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1122345688999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=351.35 Aligned_cols=252 Identities=20% Similarity=0.351 Sum_probs=198.8
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG------ 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 317 (558)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 457999999999999999999665 79999999997544 2345567899999999999999999999986532
Q ss_pred ----------------------------------------------------EEEEEEeccCCCHHHHHhhccC-CCCCH
Q 008650 318 ----------------------------------------------------LYLIFNFSQNGNLDAALHDERS-KSLEW 344 (558)
Q Consensus 318 ----------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~-~~l~~ 344 (558)
.++||||+.+|+|.+++..... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 7899999999999999976433 23566
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc----------cccccccccc
Q 008650 345 PIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH----------HAAIPIEGTF 414 (558)
Q Consensus 345 ~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~----------~~~~~~~gt~ 414 (558)
..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 6789999999999999999 89999999999999999999999999999877554211 1223456999
Q ss_pred CcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHH
Q 008650 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIA 494 (558)
Q Consensus 415 ~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 494 (558)
.|+|||++.+..++.++|||||||++|||++|..|+...... .. ......... ........+.+++
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~----~~-~~~~~~~~~---------~~~~~~~~~~~li 306 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI----IT-DVRNLKFPL---------LFTQKYPQEHMMV 306 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH----HH-HHHTTCCCH---------HHHHHCHHHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH----HH-HhhccCCCc---------ccccCChhHHHHH
Confidence 999999999999999999999999999999998775322111 00 011111110 1123345678999
Q ss_pred HHhhccCCCCCCCHHHHHHH
Q 008650 495 DYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 495 ~~cl~~dp~~RPt~~evl~~ 514 (558)
.+||+.||.+|||+.|+++.
T Consensus 307 ~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHHS
T ss_pred HHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999973
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=354.15 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=203.2
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~ 319 (558)
..++|.+.+.||+|+||+||+|... +++.||+|++.+... .......+..|..++..+ +||||+++++++.+.. .|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999665 588999999976432 112345677899999888 7999999999998765 99
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999999654 458999999999999999999999 899999999999999999999999999998643
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.. ...
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~--~~i~~-~~~--------- 238 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF--QSIME-HNV--------- 238 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH-CCC---------
T ss_pred cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH--HHHHh-CCC---------
Confidence 221 2233567999999999999999999999999999999999999999875443221 11111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 514 (558)
.++......+.+++.+||+.||.+||+ +.++++.
T Consensus 239 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112223457889999999999999995 5777764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=357.57 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=202.4
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG- 317 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 317 (558)
....++|.+.+.||+|+||.||+|.. .+|+.||+|++.+.... ......+..|..++..+ +||||+++++++.++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999965 46899999999764211 12234567888888876 8999999999998765
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.|+||||+.+|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999654 468999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. ... +. ..
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~-i~~-~~------~~ 236 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-HS-IRM-DN------PF 236 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH-HHH-CC------CC
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH-HH-HHh-CC------CC
Confidence 43322 1234567999999999999999999999999999999999999999875443221 11 111 11 11
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMS-EVLE 513 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~ 513 (558)
++......+.+++.+||+.||++||++. ++++
T Consensus 237 ----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 237 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1112335688999999999999999997 6654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=340.85 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=206.5
Q ss_pred hhCCCcccceEeeeCceEEEEEEECC----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSD----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLY 319 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 319 (558)
..++|.+.+.||+|+||+||+|.... +..||+|++.... .......+.+|+.+++.++||||+++++++.++..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCE
Confidence 45679999999999999999995432 3369999996543 345667899999999999999999999999887899
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999999654 3458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........... ...+...
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~---~~~~~~~------- 233 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---LEKGDRL------- 233 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH---HHHTCCC-------
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH---HhcCCCC-------
Confidence 43221 1223457889999999999999999999999999999998 9999975433221111 1111100
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..+......+.+++.+||+.+|++|||+.|+++.|+...
T Consensus 234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 234 --PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 011122356889999999999999999999999998643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.49 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=204.2
Q ss_pred hCCCcccceEeeeCceEEEEEEECC----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--cE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSD----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--GL 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 318 (558)
..+|.+.+.||+|+||+||+|...+ ...+|+|.+.. .........+.+|+.++++++||||+++++++.+. ..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 4568889999999999999996532 23589999864 33456667899999999999999999999997643 38
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999999653 4568999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCc--ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccC
Q 008650 399 PNKCTH--HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVD 475 (558)
Q Consensus 399 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d 475 (558)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++ |..||........... ... +..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~--~~~-~~~----- 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--LLQ-GRR----- 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH--HHT-TCC-----
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH--Hhc-CCC-----
Confidence 543221 12233457889999999999999999999999999999999 5666665432211111 111 110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCcc
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSE 522 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~ 522 (558)
...+......+.+++.+||+.+|++|||+.|+++.|+......
T Consensus 251 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 251 ----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0011122346889999999999999999999999998765433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=348.55 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=195.0
Q ss_pred hCCCcccceEeeeCceEEEEEEE----CCCCEEEEEEeecccc--cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNK--DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35799999999999999999966 4789999999976532 2234456778999999999999999999998765
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999654 468899999999999999999999 8999999999999999999999999999976
Q ss_pred CCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ...... ..
T Consensus 171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~~~-~~------- 238 (327)
T 3a62_A 171 SIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI--DKILKC-KL------- 238 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHT-CC-------
T ss_pred cccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHhC-CC-------
Confidence 433221 223456999999999999999999999999999999999999999875443221 111111 10
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
..+......+.+++.+||+.||.+|| ++.|+++.
T Consensus 239 ---~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ---NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11122345788999999999999999 78888874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=360.02 Aligned_cols=264 Identities=21% Similarity=0.337 Sum_probs=194.8
Q ss_pred hhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeC---cE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIEN---GL 318 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~---~~ 318 (558)
..++|.+.+.||+|+||.||+|. ..+|+.||||++.+..........+.+|+.+++.+. ||||+++++++..+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 35789999999999999999995 467999999999766566677788899999999998 99999999999743 38
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
|+||||+. ++|..++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999998 589888865 368999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCC-------------------cccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHH
Q 008650 399 PNKCT-------------------HHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLV 458 (558)
Q Consensus 399 ~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~ 458 (558)
..... .......+||++|+|||++.+ ..++.++|||||||++|||++|+.||.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 43111 111234579999999999986 6799999999999999999999999987543221
Q ss_pred HHhh-hhhhcCCcccc---------------------cCCCCCCCC------------CHHHHHHHHHHHHHhhccCCCC
Q 008650 459 LWAK-PLMESGNLTEL---------------------VDPSLEGEY------------DTDQMHRLVLIADYCVRQTSAW 504 (558)
Q Consensus 459 ~~~~-~~~~~~~~~~~---------------------~d~~l~~~~------------~~~~~~~l~~li~~cl~~dp~~ 504 (558)
.... ..........+ ........+ .......+.+++.+||+.||.+
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 1110 00000000000 000000000 0012346889999999999999
Q ss_pred CCCHHHHHHH
Q 008650 505 RPSMSEVLEL 514 (558)
Q Consensus 505 RPt~~evl~~ 514 (558)
|||+.|+++.
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=352.60 Aligned_cols=251 Identities=21% Similarity=0.322 Sum_probs=189.5
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+|+.++++++||||+++++++.++. .++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 3467999999999999999999665 68899999997542 3345778999999999999999999998765 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---CCceEEEeccccccC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---DFEPQITDFGLAKWL 398 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~ 398 (558)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++..
T Consensus 127 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp ECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999999643 468999999999999999999999 89999999999999975 889999999999876
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.. .. ..... .
T Consensus 202 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-i~-~~~~~-~----- 270 (349)
T 2w4o_A 202 EHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR-IL-NCEYY-F----- 270 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH-HH-TTCCC-C-----
T ss_pred Ccccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH-HH-hCCCc-c-----
Confidence 43321 22356999999999999999999999999999999999999999765433222211 11 11110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...........+.+++.+||+.||++|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112334578899999999999999999999983
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=366.08 Aligned_cols=264 Identities=19% Similarity=0.245 Sum_probs=208.0
Q ss_pred HHHHHhhhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccH-HHHHHHHHHHHHhcccccCCeeeeeeEEEe
Q 008650 238 YEEISSATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVGCCIE 315 (558)
Q Consensus 238 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 315 (558)
+.++....++|.+.+.||+|+||+||+|... +++.||+|++.+..... .....+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455667789999999999999999999665 57889999997532111 112237789999999999999999999987
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
+. +|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 66 99999999999999999653 3569999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 469 (558)
++....... ......+||+.|+|||++. .+.++.++|||||||++|||++|+.||.......... . +....
T Consensus 222 a~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~-i~~~~- 297 (437)
T 4aw2_A 222 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-K-IMNHK- 297 (437)
T ss_dssp CEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-H-HHTHH-
T ss_pred hhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH-h-hhhcc-
Confidence 987654322 2223467999999999997 5679999999999999999999999998764332211 1 11100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 008650 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAW--RPSMSEVLEL 514 (558)
Q Consensus 470 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 514 (558)
.....+.. .......+.+++.+||..+|++ ||++.|+++.
T Consensus 298 -~~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 -ERFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -HHCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -ccccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00000111 0112346888999999888888 9999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.21 Aligned_cols=264 Identities=20% Similarity=0.248 Sum_probs=207.7
Q ss_pred CHHHHHhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEE
Q 008650 237 SYEEISSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCI 314 (558)
Q Consensus 237 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 314 (558)
.+.++....++|.+.+.||+|+||+||+|.. .+|+.||+|++.+.... ......+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3445566778999999999999999999965 57999999999754321 122344778999999999999999999998
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecc
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFG 393 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 393 (558)
+++ +|+||||+.+|+|..++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|++||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeech
Confidence 766 999999999999999997542 468999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhc-------cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhh
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFM-------HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLME 466 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 466 (558)
+++.+..... ......+||+.|+|||++. .+.++.++|||||||++|||++|+.||.......... . +..
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-~-i~~ 284 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG-K-IVH 284 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-H-HHT
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH-H-HHh
Confidence 9987654322 1223457999999999997 4578999999999999999999999998754432211 1 110
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 008650 467 SGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWR---PSMSEVLEL 514 (558)
Q Consensus 467 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~evl~~ 514 (558)
.. .....+.. +......+.+++.+||. +|.+| |++.|++++
T Consensus 285 ~~--~~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YK--EHLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HH--HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cc--cCcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00 00001111 11223578899999999 99998 699999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=352.27 Aligned_cols=271 Identities=23% Similarity=0.328 Sum_probs=211.7
Q ss_pred hCCCcccceEeeeCceEEEEEEE-----CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe--C-
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE--N- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~- 316 (558)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.. .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 36799999999999999999973 468899999996543 4556778999999999999999999999863 2
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccce
Confidence 3899999999999999997543 358999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhc---CCccc
Q 008650 397 WLPNKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES---GNLTE 472 (558)
Q Consensus 397 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~---~~~~~ 472 (558)
........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||................. .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76544322 122334588999999999999999999999999999999999999975432211110000000 00011
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCc
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDS 521 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 521 (558)
.+........+......+.+++.+||+.||.+|||+.|+++.|+.....
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1111122222334456789999999999999999999999999987654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=348.29 Aligned_cols=267 Identities=22% Similarity=0.355 Sum_probs=205.8
Q ss_pred CCCcccceEeeeCceEEEEEE-----ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---c
Q 008650 246 NNFHSENMVGQGGYSEVYKGN-----LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---G 317 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~ 317 (558)
++|++.+.||+|+||.||+|. ..+++.||+|++.... .......+.+|+.+++.++||||+++++++.++ .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 458899999999999999997 3468899999996543 223346688999999999999999999998764 3
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccc
Confidence 899999999999999996543 458999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhc---CCcccc
Q 008650 398 LPNKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES---GNLTEL 473 (558)
Q Consensus 398 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~---~~~~~~ 473 (558)
....... .......||..|+|||++.+..++.++||||||+++|+|++|..|+............+.... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6554322 222345688999999999999999999999999999999999998754321111110000000 000001
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
+........+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 11111112233344678999999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=365.50 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=198.7
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 316 (558)
.++|.+.+.||+|+||+||+|. ..+++.||||++.+..........+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4789999999999999999995 45789999999987666667778899999999999999999999998643
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..|+||||+.++ |...+. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 269999999875 656553 248999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC-------
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN------- 469 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~------- 469 (558)
...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..... .+......-+.
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 213 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHT
T ss_pred ecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 764322 2234579999999999999999999999999999999999999998754321 11111100000
Q ss_pred --------------------cccccCCCCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 --------------------LTELVDPSLEGE---YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 --------------------~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+...+...+... ........+.+++.+||+.||++|||+.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 001125678999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=365.46 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=206.2
Q ss_pred HHHHhhhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 239 EEISSATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 239 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
.++....++|.+.+.||+|+||+||+|... +++.||+|++.+.... ......+.+|+.+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 345556789999999999999999999654 6899999999653211 11123477899999999999999999999876
Q ss_pred c-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
. +|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecccee
Confidence 6 9999999999999999864 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhccCC----CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI----IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
+.+..... ....+.+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... .+.....
T Consensus 216 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~--~i~~~~~-- 290 (410)
T 3v8s_A 216 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS--KIMNHKN-- 290 (410)
T ss_dssp EECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHHTHHH--
T ss_pred EeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH--HHHhccc--
Confidence 87654322 2233567999999999998665 8899999999999999999999998754332211 1111000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAW--RPSMSEVLEL 514 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 514 (558)
.+..+ ........+.+++.+||+.+|.+ ||++.||+++
T Consensus 291 ~~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 SLTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HCCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00000 01122356889999999999988 9999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.17 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=208.3
Q ss_pred CcccceEeeeCceEEEEEEE-----CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cEE
Q 008650 248 FHSENMVGQGGYSEVYKGNL-----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GLY 319 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~ 319 (558)
|++.+.||+|+||+||++.+ .+++.||||++... ........+.+|+.++++++||||+++++++.+. ..+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 48899999999999988854 36889999999654 3456677899999999999999999999999873 389
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+|+|.+++... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 112 lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999999653 48999999999999999999999 899999999999999999999999999998875
Q ss_pred CCCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh---hhhhcCCcccccC
Q 008650 400 NKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK---PLMESGNLTELVD 475 (558)
Q Consensus 400 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~---~~~~~~~~~~~~d 475 (558)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||............ ...........+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 54322 1223345889999999999999999999999999999999999999764322111100 0000001111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.......+......+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 22222223344567999999999999999999999999998643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=342.71 Aligned_cols=258 Identities=15% Similarity=0.212 Sum_probs=205.5
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~l 320 (558)
..++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+|+.+++.+ +|+|++++++++.++. .++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 346799999999999999999964 67999999998654322 3467788899988 6999999999998766 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc-----eEEEecccc
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE-----PQITDFGLA 395 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFG~a 395 (558)
||||+ +++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 84 v~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99999 99999999654 3469999999999999999999998 89999999999999987776 999999999
Q ss_pred ccCCCCCCc-----ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh--HHHHhhh--hhh
Q 008650 396 KWLPNKCTH-----HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN--LVLWAKP--LME 466 (558)
Q Consensus 396 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~--~~~~~~~--~~~ 466 (558)
......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 876544321 1223456999999999999999999999999999999999999999864321 1111100 000
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 467 SGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 467 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
....... . ......+.+++.+||+.+|++|||+.+|++.|++..
T Consensus 239 ~~~~~~~-----~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 239 STPLREL-----C----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HSCHHHH-----T----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CccHHHH-----H----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 0111111 0 112357889999999999999999999999988743
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=355.39 Aligned_cols=245 Identities=24% Similarity=0.343 Sum_probs=192.0
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHH-hcccccCCeeeeeeEEEeCc-EEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGI-IGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
++|.+.+.||+|+||+||+|.. .+++.||+|++.+.... ......+..|..+ ++.++||||+++++++.+.+ .|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 5799999999999999999965 46889999999776532 3344566777777 57789999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|++||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999654 468899999999999999999999 89999999999999999999999999999864322
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... . ..... .. .
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-~-~i~~~-~~----------~ 257 (373)
T 2r5t_A 193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-D-NILNK-PL----------Q 257 (373)
T ss_dssp C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-H-HHHHS-CC----------C
T ss_pred C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-H-HHHhc-cc----------C
Confidence 1 2233567999999999999999999999999999999999999999875443221 1 11111 11 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSE 510 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~e 510 (558)
++......+.+++.+||+.||.+||++.+
T Consensus 258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11223356889999999999999999853
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=346.59 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=198.6
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEe
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNF 324 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 324 (558)
.++|.+.+.||+|+||+||+|... ++.||+|++... .....+.+|+.++++++||||+++++++. +..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL-NPVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT-TTTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcEEEEEc
Confidence 357899999999999999999774 788999998543 23467889999999999999999999876 458999999
Q ss_pred ccCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc-eEEEeccccccCCCCC
Q 008650 325 SQNGNLDAALHDERS-KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE-PQITDFGLAKWLPNKC 402 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DFG~a~~~~~~~ 402 (558)
+++|+|.+++..... ..+++..++.++.|++.||.|||+.+.++|+||||||+|||++.++. +||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~ 160 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM 160 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence 999999999975432 24788899999999999999999854468999999999999998886 7999999997654321
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
....||+.|+|||++.+..++.++||||||+++|||++|+.||................ +... ..
T Consensus 161 -----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~-----~~---- 225 (307)
T 2eva_A 161 -----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GTRP-----PL---- 225 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TCCC-----CC----
T ss_pred -----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CCCC-----Cc----
Confidence 22359999999999999999999999999999999999999998543322111111111 1111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.......+.+++.+||+.||.+|||+.++++.|+...
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1122346889999999999999999999999988643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=349.76 Aligned_cols=266 Identities=16% Similarity=0.205 Sum_probs=199.5
Q ss_pred hCCCcccceEeeeCceEEEEEEEC----CCCEEEEEEeecccccHHH---------HHHHHHHHHHhcccccCCeeeeee
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS----DGRKIAVKRLAKDNKDAKK---------EKEFLMELGIIGHVCHPNTATLVG 311 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~ 311 (558)
.++|.+.+.||+|+||.||+|... ++..+|+|++......... ...+.+|+.+++.+.||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999664 5788999999765422111 124667888999999999999999
Q ss_pred EEEe----Cc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-
Q 008650 312 CCIE----NG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF- 385 (558)
Q Consensus 312 ~~~~----~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~- 385 (558)
++.. +. .++||||+ +++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence 9876 34 89999999 999999996543 79999999999999999999999 8999999999999999887
Q ss_pred -ceEEEeccccccCCCCCCc-----ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh--H
Q 008650 386 -EPQITDFGLAKWLPNKCTH-----HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN--L 457 (558)
Q Consensus 386 -~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~--~ 457 (558)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876433211 1123456999999999999999999999999999999999999999653211 1
Q ss_pred HHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 458 VLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 458 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
.......... .....+..... .......+.+++.+||+.||++|||+.+|++.|+....
T Consensus 270 ~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111111 11111111000 00223478899999999999999999999999987543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=364.27 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=196.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.+... .......+.+|+.+++.++||||+++++++.+++ .++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346799999999999999999954 5799999999975432 2344566789999999999999999999998766 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|..++... ..+++..+..++.||+.||.|||+. ++|+||||||+||||+.++.+||+|||+++....
T Consensus 226 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999999654 4689999999999999999999951 6899999999999999999999999999986433
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..... ..
T Consensus 302 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~i~~~-~~---------- 366 (446)
T 4ejn_A 302 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE--LILME-EI---------- 366 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHC-CC----------
T ss_pred CC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH--HHHhC-CC----------
Confidence 22 22334679999999999999999999999999999999999999998654432211 11111 10
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
.++......+.+++.+||+.||.+|| ++.|+++.
T Consensus 367 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 01122335688999999999999999 99999984
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=357.50 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=195.2
Q ss_pred CCCcccceEeeeCceEEEEEEEC--CC--CEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--cEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS--DG--RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--GLY 319 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 319 (558)
..|.+.+.||+|+||+||+|... ++ ..||+|.+... ........|.+|+.++++++||||+++++++.+. ..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 34778899999999999999543 22 35899998643 3345567899999999999999999999997643 489
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 168 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999999643 3468899999999999999999999 899999999999999999999999999998664
Q ss_pred CCCCc--ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 400 NKCTH--HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 400 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......... . ...+.. .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~--~-~~~~~~--~--- 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV--Y-LLQGRR--L--- 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH--H-HHTTCC--C---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH--H-HHcCCC--C---
Confidence 33211 11223457889999999999999999999999999999999 777887543221111 1 111110 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCc
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDS 521 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 521 (558)
..+......+.+++.+||+.+|++|||+.|+++.|+.....
T Consensus 316 ----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 316 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11122335688999999999999999999999999875443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=338.88 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=201.4
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
..++|.+.+.||+|+||+||+|.. .+++.||+|++.+.... ......+.+|+.+++.++||||+++++++.++. .++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 346799999999999999999954 56789999999654322 122456889999999999999999999998766 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999999654 458999999999999999999998 8999999999999999999999999999865443
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........... +.... .
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~------~---- 224 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR---ISRVE------F---- 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHHTC------C----
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH---HHhCC------C----
Confidence 22 2234699999999999999999999999999999999999999986543322111 11100 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+......+.+++.+||+.+|.+|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1112233568899999999999999999999984
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=342.85 Aligned_cols=260 Identities=25% Similarity=0.454 Sum_probs=199.5
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ........+.+|+.+++.++||||+++++++.+++ .++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5699999999999999999965 579999999997533 34566778899999999999999999999998765 89999
Q ss_pred EeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 323 NFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 323 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||+.+++|.+++... ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999998652 34568999999999999999999999 8999999999999999999999999999987644
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............... ........
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~------ 259 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-QCDYPPLP------ 259 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH-TTCSCCCC------
T ss_pred CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh-cccCCCCc------
Confidence 322 122346899999999999999999999999999999999999999765433222222111 11111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.......+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 260 --~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 260 --SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp --TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1123356889999999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=345.76 Aligned_cols=256 Identities=23% Similarity=0.383 Sum_probs=207.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe---CcEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE---NGLYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~l 320 (558)
.++|++.+.||+|+||.||+|.. .+++.||+|++............+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999965 478999999998776666777889999999999999999999998864 23899
Q ss_pred EEEeccCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCc-----EEecCCCCCceeecCCCceEEEecc
Q 008650 321 IFNFSQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGCKRR-----IIHRDIKASNVLLGPDFEPQITDFG 393 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DFG 393 (558)
||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997543 3458999999999999999999998 66 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccc
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 473 (558)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... . .+..+....
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~-~i~~~~~~~- 235 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA--G-KIREGKFRR- 235 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--H-HHHHTCCCC-
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH--H-HHhhccccc-
Confidence 9987654321 112345899999999999999999999999999999999999999876433211 1 111222111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
.+......+.+++.+||+.+|.+|||+.|+++.+..
T Consensus 236 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 --------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 112234578899999999999999999999996654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=344.79 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=199.8
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--cEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--GLYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~lv 321 (558)
..++|.+.+.||+|+||+||+|.. +|+.||||++.... ....+.+|+.++++++||||+++++++.+. ..++|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 456799999999999999999976 48899999996543 345688999999999999999999997653 48999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+++|.+++.......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999999976544458899999999999999999999 89999999999999999999999999999865432
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
. ....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......... . ....+ ...
T Consensus 171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~--~-~~~~~---------~~~ 233 (278)
T 1byg_A 171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--P-RVEKG---------YKM 233 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH--H-HHTTT---------CCC
T ss_pred c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH--H-HHhcC---------CCC
Confidence 1 12347899999999999999999999999999999998 99999865432111 1 11111 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
..+......+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 12223345788999999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=352.64 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=198.9
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~l 320 (558)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++.+.... +.+|+.++.++ .||||+++++++.++. .|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 346799999999999999999955 46899999999765432 33577777777 6999999999998766 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC----CceEEEeccccc
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD----FEPQITDFGLAK 396 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~ 396 (558)
||||+.+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||+..+ +.+||+|||++.
T Consensus 94 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999998643 568999999999999999999999 899999999999998443 359999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+..+...
T Consensus 169 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~----- 241 (342)
T 2qr7_A 169 QLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS----- 241 (342)
T ss_dssp ECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC-----
T ss_pred cCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc-----
Confidence 7644322 223457999999999999888999999999999999999999999864221111111112222211
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+...........+.+++.+||+.||++|||+.++++.
T Consensus 242 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 -LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111122344578899999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=354.16 Aligned_cols=254 Identities=14% Similarity=0.138 Sum_probs=200.1
Q ss_pred HHhhhCCCcccceEeeeCceEEEEE------EECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc---cCCeeeeee
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKG------NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC---HPNTATLVG 311 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~ 311 (558)
+....++|.+.+.||+|+||+||+| ...+++.||||++.... . .++..|+.++..++ |+||+.+++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~---~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--P---WEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--H---HHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--h---hHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3455678999999999999999999 45678999999996543 2 23455555555554 999999999
Q ss_pred EEEeCc-EEEEEEeccCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC----
Q 008650 312 CCIENG-LYLIFNFSQNGNLDAALHDE---RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---- 383 (558)
Q Consensus 312 ~~~~~~-~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---- 383 (558)
++..++ .++||||+.+|+|.+++... ....+++..++.++.||+.||.|||+ ++|+||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccC
Confidence 998755 99999999999999999753 23569999999999999999999998 89999999999999998
Q ss_pred -------CCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh
Q 008650 384 -------DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN 456 (558)
Q Consensus 384 -------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~ 456 (558)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997654332333344567999999999999999999999999999999999999999643221
Q ss_pred HHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHhcCC
Q 008650 457 LVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWR-PSMSEVLELLTSGH 519 (558)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R-Pt~~evl~~L~~~~ 519 (558)
. ..+...+.... ....+.+++..|++.+|.+| |++.++.+.|++..
T Consensus 292 ~--------------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 292 E--------------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp E--------------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred c--------------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0 01111111111 24467788899999999998 67888888777543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=355.03 Aligned_cols=250 Identities=20% Similarity=0.245 Sum_probs=191.0
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||+||++.. .+++.||||++.+.... ...+.+|+.+++.++||||+++++++.++. .++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 46799999999999999999965 47999999999765332 234778999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc--eEEEeccccccCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE--PQITDFGLAKWLPN 400 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~~~~ 400 (558)
||+.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++....
T Consensus 96 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 96 EYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999999654 469999999999999999999999 89999999999999987765 99999999975332
Q ss_pred CCCcccccccccccCcccchhhccCCCCcc-ccchhHHHHHHHHHcCCCCCCCCchh--HHHHhhhhhhcCCcccccCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEK-TDVFAFGVLLLEIITGRKPVDSSRQN--LVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDvwSlGvvl~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~d~~ 477 (558)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... .......... ..
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~-~~-------- 238 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS-VK-------- 238 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT-TC--------
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc-CC--------
Confidence 21 2233469999999999988887665 89999999999999999999864321 1111111111 00
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
............+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0000111223568899999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=337.67 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=202.4
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe----Cc-EE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE----NG-LY 319 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~-~~ 319 (558)
+.|.+.+.||+|+||.||+|.. .++..||+|++............+.+|+.+++.++||||+++++++.. +. .+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4578888999999999999954 568899999998776667778889999999999999999999999864 22 89
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCc--EEecCCCCCceeec-CCCceEEEeccccc
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR--IIHRDIKASNVLLG-PDFEPQITDFGLAK 396 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DFG~a~ 396 (558)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999654 468999999999999999999998 67 99999999999997 78999999999997
Q ss_pred cCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
...... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||............ .. .+......
T Consensus 181 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-~~-~~~~~~~~-- 251 (290)
T 1t4h_A 181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-VT-SGVKPASF-- 251 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH-HT-TTCCCGGG--
T ss_pred cccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH-Hh-ccCCcccc--
Confidence 654332 22346999999999886 45899999999999999999999999865433222111 11 11111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+......+.+++.+||+.||.+|||+.|+++.
T Consensus 252 ------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 ------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11122468899999999999999999999973
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=338.76 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=204.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.+++.++||||+++++++.+++ .++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 35799999999999999999965 4789999999965432 234567889999999999999999999998766 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++.. ...+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999998853 3568999999999999999999999 899999999999999999999999999998664332
Q ss_pred CcccccccccccCcccchhhccCCC-CccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.........+......... . .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~------~ 229 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----L------N 229 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT----S------T
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc----c------C
Confidence 2222334569999999999987765 789999999999999999999998654332222111110000 0 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
........+.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01223456889999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=339.37 Aligned_cols=261 Identities=20% Similarity=0.277 Sum_probs=201.4
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ........+.+|+.++++++||||+++++++.+++ .++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46899999999999999999965 478899999997653 23455677889999999999999999999998766 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999754 468999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ..+....... ...
T Consensus 188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~---~~~--- 257 (309)
T 2h34_A 188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG---AHINQAIPRP---STV--- 257 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH---HHHHSCCCCG---GGT---
T ss_pred cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH---HHhccCCCCc---ccc---
Confidence 21 1222346999999999999999999999999999999999999999876443211 1111111000 011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhcCCCc
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRP-SMSEVLELLTSGHDS 521 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~~~~ 521 (558)
+......+.+++.+||+.||++|| ++.++++.|+.....
T Consensus 258 -~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 258 -RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 112234688899999999999999 999999999987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=350.45 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=195.2
Q ss_pred ccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 250 SENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 250 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
..+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+ .++||||+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 357899999999999955 579999999997643 345567889999999999999999999998765 9999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee--cCCCceEEEeccccccCCCCCCcc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL--GPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 171 ~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 171 GELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp CEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 9999988653 2458999999999999999999999 899999999999999 6678999999999987654322
Q ss_pred cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHH
Q 008650 406 AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 485 (558)
.....||+.|+|||++.++.++.++|||||||++|||++|+.||.......... .......... ......
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-~i~~~~~~~~--------~~~~~~ 314 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN-NILACRWDLE--------DEEFQD 314 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HHHHTCCCSC--------SGGGTT
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCCCC--------hhhhcc
Confidence 223469999999999999999999999999999999999999998764432111 1111110100 000112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 486 QMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 486 ~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
....+.+++.+||+.||.+|||+.|+++.
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 24578899999999999999999999983
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=350.22 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=204.6
Q ss_pred hhhCCCccc-ceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-E
Q 008650 243 SATNNFHSE-NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-L 318 (558)
Q Consensus 243 ~~~~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~ 318 (558)
...+.|.+. +.||+|+||+||+|.. .+++.||+|++.+..........+.+|+.++..+. ||||+++++++.++. .
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 445567776 8999999999999955 46999999999765544444567889999999995 699999999998765 8
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---CCceEEEecccc
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---DFEPQITDFGLA 395 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a 395 (558)
++||||+.+|+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 999999999999999876656779999999999999999999999 89999999999999988 789999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccC
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD 475 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d 475 (558)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ...
T Consensus 182 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~------ 251 (327)
T 3lm5_A 182 RKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-NVD------ 251 (327)
T ss_dssp EEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCC------
T ss_pred cccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc-ccc------
Confidence 87654322 22356999999999999999999999999999999999999999876543222111111 001
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
............+.+++.+||+.||.+|||+.++++.
T Consensus 252 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 252 --YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111112234568899999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.79 Aligned_cols=258 Identities=25% Similarity=0.432 Sum_probs=201.6
Q ss_pred hCCCcccceEeeeCceEEEEEEECC-----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSD-----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
..+|.+.+.||+|+||+||+|.... +..||||++.... .......+.+|+.+++.++||||+++++++.+.. .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 4578889999999999999995432 2359999996543 4556677999999999999999999999998755 9
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 122 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999999653 3568999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcc-cccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 399 PNKCTHH-AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 399 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......... . .+..+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~--~-~~~~~~------- 267 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM--K-AINDGF------- 267 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--H-HHHTTC-------
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH--H-HHHCCC-------
Confidence 5432211 1222346889999999999999999999999999999999 99999765433211 1 111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
....+......+.+++.+||+.+|.+||++.++++.|+...
T Consensus 268 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 --RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112233457889999999999999999999999988643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=351.18 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=201.9
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc---ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN---KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
+....++|.+.+.||+|+||+||+|.. .+++.||+|++.+.. ........+.+|+.+++.++||||+++++++.++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445567899999999999999999955 578899999996542 1234556788999999999999999999999876
Q ss_pred c-EEEEEEeccCCCHHHHHhhcc--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 008650 317 G-LYLIFNFSQNGNLDAALHDER--------------------------------------SKSLEWPIRYKIVLGVARG 357 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~i~~a 357 (558)
. .++||||+.+|+|.+++.... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 6 899999999999999985210 1123567788999999999
Q ss_pred HHHhhhCCCCcEEecCCCCCceeecCCC--ceEEEeccccccCCCCCCc--ccccccccccCcccchhhcc--CCCCccc
Q 008650 358 LHYLHKGCKRRIIHRDIKASNVLLGPDF--EPQITDFGLAKWLPNKCTH--HAAIPIEGTFGYLAPEYFMH--GIIDEKT 431 (558)
Q Consensus 358 L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ks 431 (558)
|.|||+ ++|+||||||+|||++.++ .+||+|||++..+...... .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999 8999999999999998776 8999999999865332111 12234569999999999975 6789999
Q ss_pred cchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 008650 432 DVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEV 511 (558)
Q Consensus 432 DvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ev 511 (558)
|||||||++|||++|+.||........... ....... . ...........+.+++.+||+.+|.+|||+.|+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~--~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQ--VLNKKLC--F-----ENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHHCCCC--T-----TSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHH--HHhcccc--c-----CCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 999999999999999999987654322211 1111100 0 000011234578899999999999999999999
Q ss_pred HHH
Q 008650 512 LEL 514 (558)
Q Consensus 512 l~~ 514 (558)
++.
T Consensus 329 l~h 331 (345)
T 3hko_A 329 LQH 331 (345)
T ss_dssp HHS
T ss_pred hcC
Confidence 984
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.04 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=198.7
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 316 (558)
.++|.+.+.||+|+||.||+|.. .+|+.||||++............+.+|+.+++.++||||+++++++..+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999955 5799999999976655666677899999999999999999999998754
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 259999999 8899999865 458999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCc-----
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL----- 470 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----- 470 (558)
..... .....||++|+|||++.+ ..++.++|||||||++|||++|+.||......... .......+..
T Consensus 177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l-~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIMKVTGTPPAEFV 250 (367)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHH
T ss_pred ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCCHHHH
Confidence 75432 223468999999999987 68999999999999999999999999865432111 1100000000
Q ss_pred ---------------ccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 471 ---------------TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 471 ---------------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.......+. .........+.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000 0112234578899999999999999999999994
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=340.77 Aligned_cols=246 Identities=21% Similarity=0.307 Sum_probs=201.1
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|... +++.||+|++............+.+|+..+..+ +||||+++++++.+++ .++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999654 799999999987655556677888999999999 8999999999998766 8999
Q ss_pred EEeccCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC---------------
Q 008650 322 FNFSQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD--------------- 384 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--------------- 384 (558)
|||+++++|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997643 2568999999999999999999999 899999999999999844
Q ss_pred ----CceEEEeccccccCCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHH
Q 008650 385 ----FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL 459 (558)
Q Consensus 385 ----~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~ 459 (558)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+...... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~- 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-H- 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH-H-
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH-H-
Confidence 479999999998765432 23499999999999876 6678999999999999999999877544221 1
Q ss_pred HhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 460 WAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 460 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+..+... .+ +......+.+++.+||+.||++|||+.|+++.
T Consensus 239 ----~~~~~~~~-----~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 ----EIRQGRLP-----RI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ----HHHTTCCC-----CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----HHHcCCCC-----CC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11111111 11 11233568899999999999999999999873
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.73 Aligned_cols=249 Identities=20% Similarity=0.351 Sum_probs=204.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH-HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.+..... .....+.+|+.+++.++||||+++++++.+.. .++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 36799999999999999999965 479999999997543211 23456889999999999999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 95 ~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999999954 3569999999999999999999998 89999999999999999999999999999876543
Q ss_pred CCcccccccccccCcccchhhccCCC-CccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
.. ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ... ..+...
T Consensus 170 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~--~~i-~~~~~~--------- 234 (476)
T 2y94_A 170 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF--KKI-CDGIFY--------- 234 (476)
T ss_dssp CC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH--HHH-HTTCCC---------
T ss_pred cc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH--HHH-hcCCcC---------
Confidence 22 234579999999999988765 68999999999999999999999865432211 111 111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+......+.+++.+||+.||.+|||+.|+++.
T Consensus 235 -~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 -TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 111223468899999999999999999999983
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=348.52 Aligned_cols=262 Identities=19% Similarity=0.296 Sum_probs=193.2
Q ss_pred hhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
..++|.+.+.||+|+||+||+|. ..+++.||||++............+.+|+.++++++||||+++++++.++. .++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 34679999999999999999995 457899999999766555555677889999999999999999999998766 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee-----cCCCceEEEeccccc
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL-----GPDFEPQITDFGLAK 396 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DFG~a~ 396 (558)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++.
T Consensus 112 ~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 999985 999998654 458999999999999999999999 899999999999999 455569999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-hhc---CCcc
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL-MES---GNLT 471 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~-~~~---~~~~ 471 (558)
....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.............. ... ....
T Consensus 186 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 7643321 12234589999999999875 589999999999999999999999987644322111100 000 0000
Q ss_pred ------cccC--CCCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 472 ------ELVD--PSLEGE-----YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 472 ------~~~d--~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.... +..... ........+.+++.+||+.||.+|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 000000 00112357889999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=377.36 Aligned_cols=258 Identities=23% Similarity=0.373 Sum_probs=204.5
Q ss_pred hCCCcccc-eEeeeCceEEEEEEEC---CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEE
Q 008650 245 TNNFHSEN-MVGQGGYSEVYKGNLS---DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYL 320 (558)
Q Consensus 245 ~~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 320 (558)
.+++.+.+ .||+|+||.||+|... ++..||||++.... .......|.+|+.+|++++||||+++++++.++..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEE
Confidence 34555555 8999999999999553 45679999996543 2334567899999999999999999999998878999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 413 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999999654 4569999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCcc-cccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 401 KCTHH-AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 401 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
..... ......+|+.|+|||++.++.++.++|||||||+||||++ |+.||.......... .+..+.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~---~i~~~~--------- 556 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA---FIEQGK--------- 556 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH---HHHTTC---------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcCC---------
Confidence 32211 1122346789999999999999999999999999999998 999998754432211 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
+...+......+.+++.+||+.+|++|||+.+|++.|+...
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11122334467899999999999999999999999998643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=369.01 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=207.5
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++.++. .|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 456799999999999999999965 47999999999754321 123456789999999999999999999998765 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|..++.......+++..++.++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||+++.+..
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999976655569999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh--HHHHhhhhhhcCCcccccCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN--LVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~d~~l 478 (558)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~--------- 405 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VP--------- 405 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CC---------
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-cc---------
Confidence 322 22357999999999999999999999999999999999999999864321 1111111111 10
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
..++......+.+++.+||+.||.+|| ++.|++++
T Consensus 406 -~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 -EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111222345788999999999999999 78998874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.87 Aligned_cols=247 Identities=24% Similarity=0.427 Sum_probs=201.5
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
+.|...+.||+|+||+||+|.. .+++.||||++..... .......+.+|+.++++++||||+++++++.++. .++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999964 6789999999976543 3445577899999999999999999999998766 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+. |+|.+.+... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 5787777543 3568999999999999999999999 89999999999999999999999999999865432
Q ss_pred CcccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||........... ..... .... .
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--~~~~~-~~~~-----~ 274 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNE-SPAL-----Q 274 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHSC-CCCC-----C
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHhcC-CCCC-----C
Confidence 2346999999999985 56789999999999999999999999986543322111 11111 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.......+.+++.+||+.+|++|||+.++++.
T Consensus 275 ---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223468899999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=348.51 Aligned_cols=255 Identities=27% Similarity=0.487 Sum_probs=202.1
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEE--EEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKI--AVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~l 320 (558)
++|.+.+.||+|+||.||+|.. .++..+ |+|.+... ........+.+|+.+++++ +||||+++++++.+++ .++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 5799999999999999999954 456654 99998643 2334456788999999999 8999999999998766 999
Q ss_pred EEEeccCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc
Q 008650 321 IFNFSQNGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 386 (558)
||||+++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 999999999999997543 2468999999999999999999999 89999999999999999999
Q ss_pred eEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhh
Q 008650 387 PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLM 465 (558)
Q Consensus 387 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 465 (558)
+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......... ...
T Consensus 181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~--~~~- 254 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY--EKL- 254 (327)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHG-
T ss_pred EEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH--HHh-
Confidence 9999999997543221 1122347889999999999999999999999999999998 99999875433211 111
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 466 ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..+ .....+......+.+++.+||+.+|.+|||+.|+++.|....
T Consensus 255 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 255 PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp GGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 111112233457889999999999999999999999988643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=379.40 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=202.0
Q ss_pred ceEeeeCceEEEEEEE---CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEeccCC
Q 008650 252 NMVGQGGYSEVYKGNL---SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNG 328 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g 328 (558)
+.||+|+||+||+|.+ .+++.||||++............+.+|+.++++++||||+++++++.++..++||||+.+|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 4799999999999944 3467899999976655555567899999999999999999999999877799999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc-ccc
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH-HAA 407 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~ 407 (558)
+|.+++... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+...... ...
T Consensus 455 ~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 455 PLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 999999643 568999999999999999999999 89999999999999999999999999999876543322 122
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQ 486 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 486 (558)
....||+.|+|||++.+..++.++|||||||+||||++ |+.||.......... .+..+. ....+...
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~---~i~~~~---------~~~~p~~~ 597 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---MLEKGE---------RMGCPAGC 597 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHTTC---------CCCCCTTC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCC---------CCCCCCCC
Confidence 23457889999999999999999999999999999998 999998765432211 111111 11112233
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 487 MHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 487 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
...+.+++.+||+.||++|||+.+|++.|+.
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 4578999999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=352.03 Aligned_cols=260 Identities=15% Similarity=0.219 Sum_probs=203.4
Q ss_pred hCCCcccceEeeeCceEEEEEEEC---------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeee-------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS---------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTAT------- 308 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 308 (558)
.++|.+.+.||+|+||.||+|... +++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 367999999999999999999665 3789999999654 24778999999999999887
Q ss_pred --------eeeEEEe-C-cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCc
Q 008650 309 --------LVGCCIE-N-GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASN 378 (558)
Q Consensus 309 --------l~~~~~~-~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N 378 (558)
+++++.. + ..++||||+ +++|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~N 189 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAEN 189 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGG
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHH
Confidence 5677765 3 389999999 9999999986645679999999999999999999999 899999999999
Q ss_pred eeecCCC--ceEEEeccccccCCCCCCc-----ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCC
Q 008650 379 VLLGPDF--EPQITDFGLAKWLPNKCTH-----HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVD 451 (558)
Q Consensus 379 Ill~~~~--~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~ 451 (558)
||++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999876543221 11233469999999999999999999999999999999999999998
Q ss_pred CCchhH--HHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 452 SSRQNL--VLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 452 ~~~~~~--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
...... ........ ......+...... .......+.+++.+||+.||++|||+.+|++.|++..
T Consensus 270 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKF-VDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GGTTCHHHHHHHHHHH-HHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCcCHHHHHHHHHhc-cCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 653211 11111111 1112222221111 0112357889999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=343.67 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=204.5
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH----HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA----KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++....... .....+.+|+.++++++||||+++++++.++. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35699999999999999999965 468999999997654221 12456889999999999999999999998765 9
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC----ceEEEeccc
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF----EPQITDFGL 394 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~ 394 (558)
++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999999964 3568999999999999999999999 8999999999999999888 799999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +...... .
T Consensus 166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~--~ 237 (321)
T 2a2a_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---ITSVSYD--F 237 (321)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---HHTTCCC--C
T ss_pred ceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHhcccc--c
Confidence 987654322 2235699999999999999999999999999999999999999986543321111 1111000 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
++.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 238 DEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred Chhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 01123468899999999999999999999984
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=350.61 Aligned_cols=262 Identities=23% Similarity=0.375 Sum_probs=203.9
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.++++++||||+++++++.++. .++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 5799999999999999999965 45899999999777666677778889999999999999999999998866 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|..++.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 105 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 105 FVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999999888643 3469999999999999999999999 8999999999999999999999999999986544322
Q ss_pred cccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-------------hhcCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL-------------MESGN 469 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~-------------~~~~~ 469 (558)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.............. .....
T Consensus 180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 12234699999999999875 789999999999999999999999987643322111100 00001
Q ss_pred cccccCCCCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 LTELVDPSLEGEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 ~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......+.+....+ ......+.+++.+||+.||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111111111111 1234679999999999999999999999873
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=349.78 Aligned_cols=259 Identities=29% Similarity=0.430 Sum_probs=203.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
.++|.+.+.||+|+||.||+|.. .+++.||||++... ........+.+|+.++++++||||+++++++.++.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 46799999999999999999963 35778999999643 34556667899999999999999999999998765
Q ss_pred EEEEEEeccCCCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---CCceEE
Q 008650 318 LYLIFNFSQNGNLDAALHDERS-----KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---DFEPQI 389 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 389 (558)
.++||||+.+++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 8999999999999999976542 348899999999999999999999 89999999999999984 446999
Q ss_pred EeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcC
Q 008650 390 TDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESG 468 (558)
Q Consensus 390 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 468 (558)
+|||++................||+.|+|||++.++.++.++||||||+++|+|++ |+.||......... . .+..+
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~-~~~~~ 261 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL--E-FVTSG 261 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--H-HHHTT
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH--H-HHhcC
Confidence 99999976543332222333458999999999999999999999999999999998 99999865433211 1 11111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 469 NLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 469 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
... ..+......+.+++.+||+.||.+|||+.++++.|....
T Consensus 262 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 262 GRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 111 111223357889999999999999999999999988643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=351.49 Aligned_cols=244 Identities=21% Similarity=0.356 Sum_probs=201.1
Q ss_pred hhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccH------HHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDA------KKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
..++|.+.+.||+|+||+||+|. ..+++.||||++.+..... .....+.+|+.++++++||||+++++++.++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 34689999999999999999995 4678999999997653211 1233567899999999999999999999876
Q ss_pred c-EEEEEEeccCC-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 317 G-LYLIFNFSQNG-NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 317 ~-~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
+ .++||||+.+| +|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 6 89999999777 999998543 469999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCC-CccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 473 (558)
+........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......
T Consensus 177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 177 AAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp CEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred ceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 987654332 223569999999999988876 88999999999999999999999753211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...... .+......+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011123468899999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=338.88 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=203.0
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCC---EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc--EEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGR---KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG--LYL 320 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~l 320 (558)
.|...+.||+|+||+||+|.. .+++ .+|+|++.. .........+.+|+.+++.++||||+++++++.+.+ .++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 466679999999999999954 2333 799999864 334556678899999999999999999999997644 599
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 101 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp EECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999999653 4568999999999999999999999 8999999999999999999999999999986644
Q ss_pred CCC--cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCC-CCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 401 KCT--HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP-VDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 401 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
... ........||+.|+|||.+.+..++.++||||||+++|+|++|..| |.......... ....+.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~---~~~~~~-------- 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH---FLAQGR-------- 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH---HHHTTC--------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH---HhhcCC--------
Confidence 321 1222335689999999999999999999999999999999996555 44332221111 111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
....+......+.+++.+||+.+|.+|||+.++++.|++...
T Consensus 246 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 246 -RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 011112233578899999999999999999999999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=342.03 Aligned_cols=261 Identities=23% Similarity=0.364 Sum_probs=197.2
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhc--ccccCCeeeeeeEEEeC---
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIG--HVCHPNTATLVGCCIEN--- 316 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~--- 316 (558)
....++|.+.+.||+|+||.||+|... ++.||||++..... ..+..|.+++. .++||||+++++++.+.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 345578999999999999999999775 89999999964321 22334444444 45899999999998765
Q ss_pred --cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCC--------cEEecCCCCCceeecCCCc
Q 008650 317 --GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR--------RIIHRDIKASNVLLGPDFE 386 (558)
Q Consensus 317 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~--------~ivH~Dlkp~NIll~~~~~ 386 (558)
..++||||+.+|+|.+++... .+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCC
Confidence 389999999999999999643 58999999999999999999998 6 9999999999999999999
Q ss_pred eEEEeccccccCCCCCCcc--cccccccccCcccchhhccCCCCcc------ccchhHHHHHHHHHcC----------CC
Q 008650 387 PQITDFGLAKWLPNKCTHH--AAIPIEGTFGYLAPEYFMHGIIDEK------TDVFAFGVLLLEIITG----------RK 448 (558)
Q Consensus 387 ~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------sDvwSlGvvl~elltg----------~~ 448 (558)
+||+|||++..+....... ......||+.|+|||++.+..++.+ +|||||||++|||++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997765432221 1224569999999999988776665 9999999999999999 66
Q ss_pred CCCCCchh---HHHHhhhhhhcCCcccccCCCCCCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 449 PVDSSRQN---LVLWAKPLMESGNLTELVDPSLEGEY-DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 449 Pf~~~~~~---~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
||...... ...... ...... ..+...... .......+.+++.+||+.||.+|||+.||++.|+...
T Consensus 261 p~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMRE-IVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTTTTSCSSCCHHHHHH-HHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHhhhcCCCCchhhhHH-HHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 66542111 111111 010001 111111111 1256778999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=353.39 Aligned_cols=250 Identities=19% Similarity=0.267 Sum_probs=189.0
Q ss_pred CCCccc-ceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHh-cccccCCeeeeeeEEEe-----Cc
Q 008650 246 NNFHSE-NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGII-GHVCHPNTATLVGCCIE-----NG 317 (558)
Q Consensus 246 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~-----~~ 317 (558)
++|.+. +.||+|+||+||+|.. .+|+.||||++... ..+.+|+.++ +..+||||+++++++.. +.
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 467666 6899999999999955 57899999999643 2355677776 44579999999998864 23
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---CCceEEEeccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---DFEPQITDFGL 394 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~ 394 (558)
+|+||||+.+|+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 8999999999999999976555679999999999999999999999 89999999999999987 78999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-HhhhhhhcCCcccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLMESGNLTEL 473 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~ 473 (558)
++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+..+...
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~-- 285 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-- 285 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC--
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc--
Confidence 98754332 223457999999999999999999999999999999999999999764321100 000011111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
............+.+++.+||+.||++|||+.|+++.
T Consensus 286 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000112234578899999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.67 Aligned_cols=252 Identities=21% Similarity=0.376 Sum_probs=199.6
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CC-------CEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DG-------RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
.++|.+.+.||+|+||+||+|... ++ ..||+|++.... ......+.+|+.++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 467999999999999999999443 34 479999986543 23446688999999999999999999999876
Q ss_pred c-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc--------e
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE--------P 387 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~ 387 (558)
+ .++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 5 899999999999999997543 348999999999999999999999 89999999999999998887 9
Q ss_pred EEEeccccccCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCC-CCCCCCchhHHHHhhhhh
Q 008650 388 QITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGR-KPVDSSRQNLVLWAKPLM 465 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~-~Pf~~~~~~~~~~~~~~~ 465 (558)
||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|. .||........... ..
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~--~~ 232 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF--YE 232 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--HH
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH--hh
Confidence 99999998754322 12348999999999987 77999999999999999999955 45544332211111 11
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCcc
Q 008650 466 ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSE 522 (558)
Q Consensus 466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~ 522 (558)
....... .....+.+++.+||+.||++|||+.++++.|++.....
T Consensus 233 ~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 233 DRHQLPA------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp TTCCCCC------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ccCCCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111111 11235788999999999999999999999999877643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=339.39 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=196.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|+||+||+|.. .++..+|+|++..... ......+.+|+.+++.++||||+++++++.+.. .++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 5699999999999999999955 5689999999976542 223456889999999999999999999998765 899999
Q ss_pred eccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee---cCCCceEEEeccccccC
Q 008650 324 FSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWL 398 (558)
Q Consensus 324 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~ 398 (558)
|+.+|+|.+.+... ....+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988653 34679999999999999999999999 899999999999999 45678999999999876
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
..... .....||+.|+|||++. +.++.++||||||+++|+|++|+.||.............. ....... .
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~-----~ 247 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY-KEPNYAV-----E 247 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCC------
T ss_pred CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc-CCccccc-----c
Confidence 54322 22356999999999985 5689999999999999999999999987644322211111 1111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 CR----PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cC----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 12346889999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.74 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=189.1
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
..++|++.+.||+|+||+||+|.. .+|+.||+|++............+..+...++.+.||||+++++++.+++ .++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999965 57899999999765444444444555666688899999999999998765 9999
Q ss_pred EEeccCCCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHhhhCCCC-cEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 322 FNFSQNGNLDAALHD--ERSKSLEWPIRYKIVLGVARGLHYLHKGCKR-RIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
|||+.+ +|.+++.. .....+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999974 88777754 234579999999999999999999998 7 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcccchhh----ccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYF----MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
...... ....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.............. .... ...
T Consensus 161 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~-~~~- 234 (290)
T 3fme_A 161 VDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV-EEPS-PQL- 234 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH-HSCC-CCC-
T ss_pred cccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh-ccCC-CCc-
Confidence 543222 223599999999996 566789999999999999999999999986433322222211 1111 110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
........+.+++.+||+.||++|||+.|+++
T Consensus 235 -------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 -------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 01122356889999999999999999999988
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=358.87 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=194.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc------cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK------DAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
..++|.+.+.||+|+||+||+|.. .+++.||||++.+... .......+.+|+.++++++||||+++++++..+
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 457899999999999999999954 5689999999976432 122233578999999999999999999999877
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC---ceEEEecc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF---EPQITDFG 393 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG 393 (558)
..++||||+.+|+|.+++.. ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecc
Confidence 79999999999999998854 3569999999999999999999999 8999999999999997544 59999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhcc---CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCc
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH---GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL 470 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 470 (558)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .+..+..
T Consensus 288 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~--~i~~~~~ 362 (419)
T 3i6u_A 288 HSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD--QITSGKY 362 (419)
T ss_dssp TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH--HHHTTCC
T ss_pred cceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH--HHhcCCC
Confidence 998765432 2234569999999999863 6788999999999999999999999975432211100 1111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 471 TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 471 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
... +. ........+.+++.+||+.||++|||+.|+++.
T Consensus 363 ~~~--~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 363 NFI--PE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCC--HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC--ch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 00 001124578899999999999999999999984
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.43 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=183.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH-HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++....... .....+.+|+.++++++||||+++++++.+++ .++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999965 579999999996543211 12356889999999999999999999998766 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999999653 3568999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ........
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~-- 229 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-----------NKVVLADY-- 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSSCC--
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----------HHHhhccc--
Confidence 321 122356999999999999999999999999999999999999999764321110 00000000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
..+......+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 112223457889999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=344.87 Aligned_cols=260 Identities=21% Similarity=0.340 Sum_probs=203.6
Q ss_pred HHHHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc--cCCeeeeeeEEEe
Q 008650 238 YEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC--HPNTATLVGCCIE 315 (558)
Q Consensus 238 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 315 (558)
++.+....++|.+.+.||+|+||.||++...+++.||||++............+.+|+.+++++. |+||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33445566789999999999999999998888999999999876666777788999999999997 4999999999987
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
+. .++||| +.+++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+++ +.+||+|||+
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccc
Confidence 66 889999 6788999999654 468999999999999999999999 89999999999999964 8999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhcc-----------CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhh
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-----------GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 463 (558)
+..+.............||+.|+|||++.+ ..++.++||||||+++|+|++|+.||............
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~- 251 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA- 251 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH-
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH-
Confidence 987654433333334569999999999975 47888999999999999999999999865433222111
Q ss_pred hhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.. ++.....++......+.+++.+||+.||.+|||+.|+++.
T Consensus 252 ~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 II---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11 1111111122223568899999999999999999999984
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=347.93 Aligned_cols=261 Identities=20% Similarity=0.270 Sum_probs=194.1
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|+||+||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++.++. .++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57999999999999999999654 789999999964431 222234567999999999999999999998765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+. |+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 81 YLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 998 5888888654 3468999999999999999999999 8999999999999999999999999999986543221
Q ss_pred cccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC----
Q 008650 404 HHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL---- 478 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l---- 478 (558)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......................+....
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 2223468999999999976 568999999999999999999999998765432211111111111111110000
Q ss_pred ---------CCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 479 ---------EGE----YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 479 ---------~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
... ........+.+++.+||+.||.+|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 001223568899999999999999999999983
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=341.14 Aligned_cols=247 Identities=23% Similarity=0.424 Sum_probs=204.6
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe--------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-------- 315 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 315 (558)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ..+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 457999999999999999999664 79999999997543 236689999999999999999998753
Q ss_pred ---------CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc
Q 008650 316 ---------NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386 (558)
Q Consensus 316 ---------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 386 (558)
...++||||+.+++|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCC
Confidence 227899999999999999987666779999999999999999999999 89999999999999999999
Q ss_pred eEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhh
Q 008650 387 PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLME 466 (558)
Q Consensus 387 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 466 (558)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... .. ...
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~-~~~ 232 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF----FT-DLR 232 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH----HH-HHH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH----HH-Hhh
Confidence 99999999987654322 22345999999999999999999999999999999999999987532111 11 111
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 467 SGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 467 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
.+. +... ....+.+++.+||+.||.+|||+.|+++.|.....
T Consensus 233 ~~~--------~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 233 DGI--------ISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp TTC--------CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ccc--------cccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 111 1111 22457889999999999999999999999987543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.93 Aligned_cols=273 Identities=17% Similarity=0.224 Sum_probs=212.5
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---cEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---GLYL 320 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~l 320 (558)
.++|.+.+.||+|+||+||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.+. ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 457999999999999999999654 589999999965432 22345677999999999999999999998753 3799
Q ss_pred EEEeccCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee----cCCCceEEEecccc
Q 008650 321 IFNFSQNGNLDAALHDERS-KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL----GPDFEPQITDFGLA 395 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~a 395 (558)
||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999976432 349999999999999999999999 899999999999999 77788999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhcc--------CCCCccccchhHHHHHHHHHcCCCCCCCCch--hHHHHhhhhh
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMH--------GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ--NLVLWAKPLM 465 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~--~~~~~~~~~~ 465 (558)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..........
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 87654322 223569999999999875 5678899999999999999999999964221 1111111111
Q ss_pred hcCCcccc-------------cC--CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCccccc
Q 008650 466 ESGNLTEL-------------VD--PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAK 525 (558)
Q Consensus 466 ~~~~~~~~-------------~d--~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~ 525 (558)
.. ..... +. ..............+.+++.+||+.||++|||+.|+++.+..........
T Consensus 241 ~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~~~ 314 (396)
T 4eut_A 241 TG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIH 314 (396)
T ss_dssp HS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEEEE
T ss_pred cC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceEEE
Confidence 11 10000 00 11122344677788999999999999999999999999988866554333
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=349.04 Aligned_cols=260 Identities=22% Similarity=0.355 Sum_probs=204.0
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||+||+|.. .+++.||+|++... ........+.+|+.+++.++||||+++++++.+++ .++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 46799999999999999999965 47899999999654 34566678999999999999999999999998766 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCC-cEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR-RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
||+.+++|.+++... ..+++..+..++.+++.||.|||+ . +|+||||||+|||++.++.+||+|||++......
T Consensus 111 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred ECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999999654 458999999999999999999998 5 8999999999999999999999999998754322
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc----------
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT---------- 471 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 471 (558)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................+...
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 122346999999999999999999999999999999999999999865443222111000000000
Q ss_pred -----------------c----ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 -----------------E----LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 -----------------~----~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+ +................+.+++.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 000000000011224568899999999999999999999984
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=331.09 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=201.1
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||+||+|.. .++..+|+|++.+.... ....+.+|+.++++++||||+++++++.++. .++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 45799999999999999999965 45789999999765432 2456889999999999999999999998766 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee---cCCCceEEEeccccccCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~~ 399 (558)
||+.+++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 86 ELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred eccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999988654 458999999999999999999999 899999999999999 788999999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.... .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||........... . ..+.... +
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~-~~~~~~~---~--- 227 (277)
T 3f3z_A 161 PGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK--I-REGTFTF---P--- 227 (277)
T ss_dssp TTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--H-HHCCCCC---C---
T ss_pred Cccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH--H-HhCCCCC---C---
Confidence 4322 2234699999999998654 89999999999999999999999987544322111 1 1111100 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
..........+.+++.+||+.||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000012357889999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.45 Aligned_cols=263 Identities=18% Similarity=0.281 Sum_probs=188.1
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe------Cc
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE------NG 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 317 (558)
.++|.+.+.||+|+||+||+|. ..+++.||||++.+........+.+.+|+.+|++++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3679999999999999999995 4579999999997766666777889999999999999999999999853 23
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
+|+||||+ +++|..++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999987 4689888854 3569999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCc-------------------------ccccccccccCcccchhh-ccCCCCccccchhHHHHHHHHHc------
Q 008650 398 LPNKCTH-------------------------HAAIPIEGTFGYLAPEYF-MHGIIDEKTDVFAFGVLLLEIIT------ 445 (558)
Q Consensus 398 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvvl~ellt------ 445 (558)
....... ......+||++|+|||++ .+..|+.++|||||||+||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6432111 122345789999999986 46679999999999999999999
Q ss_pred -----CCCCCCCCchh-------------------HHHHhhh--hhhcC------------------CcccccCCCCCCC
Q 008650 446 -----GRKPVDSSRQN-------------------LVLWAKP--LMESG------------------NLTELVDPSLEGE 481 (558)
Q Consensus 446 -----g~~Pf~~~~~~-------------------~~~~~~~--~~~~~------------------~~~~~~d~~l~~~ 481 (558)
|+.+|.+.... ....... .+... .+.......+..
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 364 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE- 364 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG-
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH-
Confidence 56666543210 0000000 00000 000000000000
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+.....+.+|+.+||+.||.+|||+.|+++.
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011224578899999999999999999999995
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=363.70 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=204.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH-HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||+|++.+..... .....+.+|+.++++++||||+++++++.+.. +|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999966 469999999997643211 22456889999999999999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 322 FNFSQNGNLDAALHDER--SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
|||+.+|+|..++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 3469999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch--hHHHHhhhhhhcCCcccccCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ--NLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ .
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~-------- 409 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-A-------- 409 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-C--------
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-c--------
Confidence 4322 12345799999999999999999999999999999999999999986432 111111111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSM-----SEVLE 513 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~ 513 (558)
..++......+.+++.+||+.||.+||++ .++++
T Consensus 410 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 --VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 01122334578899999999999999975 66765
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=354.60 Aligned_cols=201 Identities=22% Similarity=0.370 Sum_probs=169.1
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------c
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------G 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 317 (558)
.++|.+.+.||+|+||+||+|.. .+++.||||++.+........+.+.+|+.++++++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999954 5688999999977666667778899999999999999999999998653 3
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999986 599999854 3569999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCc--------------------ccccccccccCcccchhh-ccCCCCccccchhHHHHHHHHHcCCCCCC
Q 008650 398 LPNKCTH--------------------HAAIPIEGTFGYLAPEYF-MHGIIDEKTDVFAFGVLLLEIITGRKPVD 451 (558)
Q Consensus 398 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvvl~elltg~~Pf~ 451 (558)
....... ......+||++|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 6543211 112456799999999986 55679999999999999999998655543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=341.55 Aligned_cols=250 Identities=21% Similarity=0.370 Sum_probs=206.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||.||++.. .+++.||+|++.+.. ........+.+|+.+++.++||||+++++++.+++ .++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35799999999999999999965 458899999997653 34456677889999999999999999999998766 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999988654 468999999999999999999999 89999999999999999999999999999876533
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... .. .. .... .+
T Consensus 195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~-~~-~~~~------~~--- 260 (335)
T 2owb_A 195 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-LR-IK-KNEY------SI--- 260 (335)
T ss_dssp TC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH-HH-HTCC------CC---
T ss_pred cc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-HH-Hh-cCCC------CC---
Confidence 22 123356999999999999999999999999999999999999999865432211 11 11 1111 11
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 261 -~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 -PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223468889999999999999999999983
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=336.53 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=203.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc--HHHHHHHHHHHHHhcccccCCeeeeeeEEEe---CcE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD--AKKEKEFLMELGIIGHVCHPNTATLVGCCIE---NGL 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~ 318 (558)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...... ......+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999965 56889999999654321 2345678899999999999999999999853 248
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++||||+.++ |.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999887 7777766666779999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcccchhhccCC--CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGI--IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
.............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......... . .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~-~i~~~~~------ 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF--E-NIGKGSY------ 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--H-HHHHCCC------
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--H-HHhcCCC------
Confidence 5433333334456999999999997644 478999999999999999999999875432211 1 1111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+ +......+.+++.+||+.||.+|||+.|+++.
T Consensus 231 ~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 AI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 11233468899999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=334.86 Aligned_cols=250 Identities=21% Similarity=0.374 Sum_probs=206.3
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeeccc-ccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||.||+|... +++.+|+|++.+.. ........+.+|+.+++.+.||||+++++++.+++ .++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367999999999999999999654 68899999997654 33456677889999999999999999999998766 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999988654 468999999999999999999999 89999999999999999999999999999876433
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... . ...... .+
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~--~~~~~~------~~--- 234 (294)
T 2rku_A 169 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-R--IKKNEY------SI--- 234 (294)
T ss_dssp TC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-H--HHTTCC------CC---
T ss_pred cc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H--HhhccC------CC---
Confidence 22 1223569999999999999999999999999999999999999998754332111 1 111110 11
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 235 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 -PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223468889999999999999999999984
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=343.98 Aligned_cols=264 Identities=25% Similarity=0.331 Sum_probs=196.6
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe----C--c
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE----N--G 317 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~--~ 317 (558)
..++|.+.+.||+|+||.||+|.. +++.||||++..... .......|+..+..++||||+++++++.. + .
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 457899999999999999999966 689999999965432 11122245555667899999999986542 1 2
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCC---------cEEecCCCCCceeecCCCceE
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR---------RIIHRDIKASNVLLGPDFEPQ 388 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~---------~ivH~Dlkp~NIll~~~~~~k 388 (558)
.++||||+++|+|.+++... ..++..++.++.||+.||.|||+ . +|+||||||+|||++.++.+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEE
Confidence 68999999999999999653 35888999999999999999998 6 999999999999999999999
Q ss_pred EEeccccccCCCCCC------cccccccccccCcccchhhcc-------CCCCccccchhHHHHHHHHHcCCCCCCCCch
Q 008650 389 ITDFGLAKWLPNKCT------HHAAIPIEGTFGYLAPEYFMH-------GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ 455 (558)
Q Consensus 389 l~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~ 455 (558)
|+|||++..+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 112224569999999999987 4567899999999999999999877643211
Q ss_pred h----------------HHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 456 N----------------LVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 456 ~----------------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
. ...+.. ..........+.... .........+.+++.+||+.||++|||+.|+++.|....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQV-LVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHH-HHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHh-hhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 0 000000 000001111111111 112346678999999999999999999999999998755
Q ss_pred C
Q 008650 520 D 520 (558)
Q Consensus 520 ~ 520 (558)
.
T Consensus 318 ~ 318 (336)
T 3g2f_A 318 M 318 (336)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=354.41 Aligned_cols=199 Identities=21% Similarity=0.342 Sum_probs=170.8
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc------ccCCeeeeeeEEEeCc
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV------CHPNTATLVGCCIENG 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~ 317 (558)
..+|.+.+.||+|+||+||+|.. .+++.||||++... ......+.+|+.+++.+ .|+||+.+++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 46799999999999999999954 56899999999654 33344566677666665 5779999999998765
Q ss_pred -EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc--eEEEeccc
Q 008650 318 -LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE--PQITDFGL 394 (558)
Q Consensus 318 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~ 394 (558)
.++||||+. ++|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+||||+.++. +||+|||+
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 899999996 699999987766679999999999999999999999 89999999999999999987 99999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ 455 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~ 455 (558)
+...... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9764432 2235699999999999999999999999999999999999999987643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=347.32 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=195.8
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 316 (558)
.++|.+.+.||+|+||.||+|.. .+++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999954 5789999999987655666778889999999999999999999998643
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..++||||+.+ +|.+.+. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 37999999975 7877774 348999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC-------
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN------- 469 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~------- 469 (558)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ +.......+.
T Consensus 176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHT
T ss_pred cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence 654322 12235699999999999999999999999999999999999999987543211 1111100000
Q ss_pred --------------------cccccCCCCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 --------------------LTELVDPSLEGE---YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 --------------------~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+...+....... ........+.+++.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000000 012235678999999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=348.50 Aligned_cols=245 Identities=23% Similarity=0.323 Sum_probs=176.7
Q ss_pred cceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEEEEEeccC
Q 008650 251 ENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIFNFSQN 327 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e~~~~ 327 (558)
.+.||+|+||+||+|.. .+++.||||++.+. ....+.+|+.+++.+. ||||+++++++.++. .++||||+.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 37899999999999955 57899999999653 2345678999999997 999999999998765 8999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC---ceEEEeccccccCCCCCCc
Q 008650 328 GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF---EPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 328 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~~~~~~~ 404 (558)
|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 91 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 91 GELFERIKKK--KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp CBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 9999999654 569999999999999999999999 8999999999999997765 899999999987654322
Q ss_pred ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhH-----HHHhhhhhhcCCcccccCCCCC
Q 008650 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL-----VLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..... .+..+... ..
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~i~~~~~~------~~ 236 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-KIKKGDFS------FE 236 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH-HHTTTCCC------CC
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH-HHHcCCCC------CC
Confidence 2234568999999999999999999999999999999999999998643211 11111 11111110 00
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..........+.+++.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 00011234578999999999999999999998863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=341.75 Aligned_cols=262 Identities=25% Similarity=0.342 Sum_probs=204.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-----Cc
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-----NG 317 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 317 (558)
..++|.+.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 456899999999999999999965 679999999986543 4566778899999999999999999999862 23
Q ss_pred EEEEEEeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 318 LYLIFNFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
.++||||+.+|+|.+++... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 88999999999999998753 34568999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCCCcc-------cccccccccCcccchhhccCC---CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh
Q 008650 396 KWLPNKCTHH-------AAIPIEGTFGYLAPEYFMHGI---IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM 465 (558)
Q Consensus 396 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 465 (558)
.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..............
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~- 260 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV- 260 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-
Confidence 7654221110 011234799999999997554 78999999999999999999999964211100000000
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 466 ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
.. .............+.+++.+||+.||.+|||+.++++.|+....
T Consensus 261 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 QN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00 00111112234578999999999999999999999999988654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=343.05 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=196.4
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH---HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA---KKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
...++|.+.+.||+|+||.||+|.. .+|+.||||++....... .....+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999965 468999999996543221 12346789999999999999999999997755
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++||||+.+ +|..++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999986 888888543 3468899999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC-----cc
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN-----LT 471 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~-----~~ 471 (558)
+..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......... .......+. ..
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~-~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL-TRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCTTTSS
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHcCCCChhhhh
Confidence 643322 22345699999999999764 5899999999999999999999999876433221 111111000 00
Q ss_pred ------cccCCCCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ------ELVDPSLEGEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ------~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.+........+ ......+.+++.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000011 1223678999999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=332.74 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=201.4
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccH----HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDA----KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.++|.+.+.||+|+||.||+|... +++.||+|++....... .....+.+|+.++++++||||+++++++.++. .
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356999999999999999999665 68999999997653221 12456889999999999999999999998765 8
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC----ceEEEeccc
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF----EPQITDFGL 394 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~ 394 (558)
++||||+.+++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999999653 468999999999999999999999 8999999999999998877 899999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
+........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........... +...... .
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~--~ 230 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN---ISAVNYD--F 230 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHTTCCC--C
T ss_pred ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH---hHhcccC--C
Confidence 987654322 2234599999999999999999999999999999999999999987543321111 1110000 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
... ........+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 231 DEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred cch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 000 001123568899999999999999999999983
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=350.18 Aligned_cols=260 Identities=21% Similarity=0.274 Sum_probs=196.7
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC----
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN---- 316 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 316 (558)
....++|.+.+.||+|+||+||+|.. .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 34567899999999999999999954 67999999999655322 23699999999999999999998432
Q ss_pred ----------------------------------c-EEEEEEeccCCCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHH
Q 008650 317 ----------------------------------G-LYLIFNFSQNGNLDAALHD--ERSKSLEWPIRYKIVLGVARGLH 359 (558)
Q Consensus 317 ----------------------------------~-~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~ 359 (558)
. .++||||+. |+|.+.+.. .....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 1 789999998 488777754 33467999999999999999999
Q ss_pred HhhhCCCCcEEecCCCCCceeec-CCCceEEEeccccccCCCCCCcccccccccccCcccchhhccC-CCCccccchhHH
Q 008650 360 YLHKGCKRRIIHRDIKASNVLLG-PDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFG 437 (558)
Q Consensus 360 ~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlG 437 (558)
|||+ ++|+||||||+|||++ .++.+||+|||+++.+...... ....||+.|+|||++.+. .++.++||||||
T Consensus 156 ~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 156 FIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 9998 8999999999999997 6899999999999876543322 234689999999998775 589999999999
Q ss_pred HHHHHHHcCCCCCCCCchhHHHHhhhh-hh----------cCCcccccCCCCCC-----CCCHHHHHHHHHHHHHhhccC
Q 008650 438 VLLLEIITGRKPVDSSRQNLVLWAKPL-ME----------SGNLTELVDPSLEG-----EYDTDQMHRLVLIADYCVRQT 501 (558)
Q Consensus 438 vvl~elltg~~Pf~~~~~~~~~~~~~~-~~----------~~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~d 501 (558)
|++|||++|+.||.............. .. .....+..-+.+.. .++......+.+++.+||+.|
T Consensus 230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999999987543322111100 00 01111111111111 112223456899999999999
Q ss_pred CCCCCCHHHHHHH
Q 008650 502 SAWRPSMSEVLEL 514 (558)
Q Consensus 502 p~~RPt~~evl~~ 514 (558)
|.+|||+.|+++.
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=334.04 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=203.4
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccH-HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDA-KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||.||+|... +++.||+|++.+..... .....+.+|+.+++.++||||+++++++.+++ .++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999654 67889999996543211 12356889999999999999999999998765 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999999654 458999999999999999999998 89999999999999999999999999999765432
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......... .... ... . .
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~-~~~------~----~ 230 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH--RRIV-NVD------L----K 230 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHH-TTC------C----C
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH--HHHh-ccc------c----C
Confidence 2 22356999999999999999999999999999999999999999865433211 1111 111 1 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
++......+.+++.+||+.||.+|||+.++++.
T Consensus 231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 122234568899999999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=347.25 Aligned_cols=265 Identities=22% Similarity=0.320 Sum_probs=202.5
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 316 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999965 6799999999976654444455678999999999999999999998752
Q ss_pred --cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 317 --GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 317 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
..++||||+.+ +|...+... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 37899999986 777766443 3469999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCC--cccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 395 AKWLPNKCT--HHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 395 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
++.+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....................
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 987653222 122234568999999999976 46899999999999999999999999876543221111111110000
Q ss_pred cccC------------CCCCCCCC-HHH------HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ELVD------------PSLEGEYD-TDQ------MHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ~~~d------------~~l~~~~~-~~~------~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+. ........ ... ...+.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000 00000000 011 2458899999999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=349.32 Aligned_cols=258 Identities=20% Similarity=0.263 Sum_probs=200.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc--------cCCeeeeeeEEEe
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC--------HPNTATLVGCCIE 315 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~ 315 (558)
.++|.+.+.||+|+||+||+|.. .+++.||||++... ......+.+|+.+++.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 36799999999999999999954 56889999999643 445567888999998886 7889999999862
Q ss_pred ----C-cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCC-cEEecCCCCCceeecCCC----
Q 008650 316 ----N-GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR-RIIHRDIKASNVLLGPDF---- 385 (558)
Q Consensus 316 ----~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~---- 385 (558)
+ ..++||||+ +++|.+.+.......+++..++.++.||+.||.|||+ + +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhh
Confidence 2 389999999 5667666655555679999999999999999999999 7 999999999999999775
Q ss_pred ---------------------------------------------ceEEEeccccccCCCCCCcccccccccccCcccch
Q 008650 386 ---------------------------------------------EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE 420 (558)
Q Consensus 386 ---------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE 420 (558)
.+||+|||++...... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999876432 22346999999999
Q ss_pred hhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh-----HHHHhhhh--h--------h-----------cCCccccc
Q 008650 421 YFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN-----LVLWAKPL--M--------E-----------SGNLTELV 474 (558)
Q Consensus 421 ~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~-----~~~~~~~~--~--------~-----------~~~~~~~~ 474 (558)
++.+..++.++|||||||+||||++|+.||...... ........ . . .+....+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999753211 11100000 0 0 00000000
Q ss_pred CCCC---------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSL---------EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+... ....+......+.+++.+||+.||++|||+.|+++.
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000 012345667789999999999999999999999973
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.96 Aligned_cols=248 Identities=26% Similarity=0.469 Sum_probs=204.9
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
+.|.+.+.||+|+||.||+|.. .+++.||+|++...... .....+.+|+.+++.+.||||+++++++.++. .++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 4689999999999999999954 57899999999755432 34567889999999999999999999998765 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 9999999999853 468999999999999999999999 8999999999999999999999999999987654321
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||........... +..+.. +.+..
T Consensus 175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~-----~~~~~--- 241 (303)
T 3a7i_A 175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL---IPKNNP-----PTLEG--- 241 (303)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHSCC-----CCCCS---
T ss_pred --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH---hhcCCC-----CCCcc---
Confidence 22345699999999999999999999999999999999999999986544322211 111111 11112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....+.+++.+||+.+|.+|||+.++++.
T Consensus 242 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 242 -NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 223468899999999999999999999984
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=336.36 Aligned_cols=257 Identities=18% Similarity=0.264 Sum_probs=202.7
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEE-eCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI-ENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~-~~l 320 (558)
..++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+|+.+++.+.|++++..+.++. ++. .++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 357899999999999999999965 67999999998655432 24778999999999988777777664 344 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee---cCCCceEEEecccccc
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKW 397 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~ 397 (558)
||||+ +++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++..
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 99999 99999999643 3569999999999999999999999 899999999999999 4888999999999987
Q ss_pred CCCCCCcc-----cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh-----HHHHhhhhhhc
Q 008650 398 LPNKCTHH-----AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN-----LVLWAKPLMES 467 (558)
Q Consensus 398 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~-----~~~~~~~~~~~ 467 (558)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-
Confidence 65443211 123456999999999999999999999999999999999999999863211 1111100000
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 468 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..... +. ......+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 237 ~~~~~-----~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 237 TPIEV-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SCHHH-----HT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred CchHH-----HH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 00000 00 112346889999999999999999999999998643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=338.52 Aligned_cols=257 Identities=18% Similarity=0.266 Sum_probs=198.9
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEE-eCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI-ENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~-~~l 320 (558)
..++|.+.+.||+|+||+||+|.. .+++.||||++..... ...+.+|+.+++.+.|++++..+..+. ++. .++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 457899999999999999999964 6789999998755432 234778999999999988888777764 344 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee---cCCCceEEEecccccc
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKW 397 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~ 397 (558)
||||+ +++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++..
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 99999 99999999643 3469999999999999999999999 899999999999999 7889999999999987
Q ss_pred CCCCCCc-----ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh-----HHHHhhhhhhc
Q 008650 398 LPNKCTH-----HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN-----LVLWAKPLMES 467 (558)
Q Consensus 398 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~-----~~~~~~~~~~~ 467 (558)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 236 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-
Confidence 6544321 1223456999999999999999999999999999999999999999763221 0000000000
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 468 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.... . +.. .....+.+++.+||+.+|++|||+.+|++.|++..
T Consensus 237 ~~~~-~----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 237 TPIE-V----LCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SCHH-H----HTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred chhh-h----hhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0000 0 001 11347889999999999999999999999988743
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.44 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=197.2
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|+||+||+|.. .++..||+|++.+..........+.+|+.+++.++||||+++++++.+.. .++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4699999999999999999965 47899999999766544444567889999999999999999999998765 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC---CceEEEeccccccCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD---FEPQITDFGLAKWLPN 400 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~~~~~ 400 (558)
|+.+|+|.+.+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++.....
T Consensus 117 ~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 117 CYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999888654 468999999999999999999999 899999999999999764 4599999999987654
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||........... .. .+... ...+.
T Consensus 192 ~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--i~-~~~~~-~~~~~--- 260 (494)
T 3lij_A 192 QKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK--VE-KGKYT-FDSPE--- 260 (494)
T ss_dssp TBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH-HTCCC-CCSGG---
T ss_pred Ccc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HH-hCCCC-CCchh---
Confidence 322 23456999999999986 5699999999999999999999999987654322111 11 11111 00000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.......+.+++.+||+.+|.+|||+.|+++.
T Consensus 261 --~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 261 --WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp --GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 01223568899999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=340.55 Aligned_cols=265 Identities=25% Similarity=0.403 Sum_probs=186.7
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EE
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 319 (558)
....++|.+.+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.+++.++||||+++++++..++ .+
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 34567899999999999999999954 4789999999865432 334567889999999999999999999998755 99
Q ss_pred EEEEeccCCCHHHHHhhc------cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecc
Q 008650 320 LIFNFSQNGNLDAALHDE------RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFG 393 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 393 (558)
+||||+.+++|.+++... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998642 23568999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCCc---ccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC
Q 008650 394 LAKWLPNKCTH---HAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469 (558)
Q Consensus 394 ~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 469 (558)
++......... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||............ .. ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~-~~ 243 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--LQ-ND 243 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HT-SS
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--hc-cC
Confidence 99776433211 11223569999999999976 56899999999999999999999999865433221111 11 11
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
....................+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11111100111111223356889999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=337.86 Aligned_cols=258 Identities=17% Similarity=0.241 Sum_probs=202.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE--CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC------eeeeeeEEEeC
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL--SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN------TATLVGCCIEN 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 316 (558)
.++|.+.+.||+|+||+||+|.. .+++.||||++... ......+.+|+.+++.++|++ ++++++++.++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46899999999999999999965 46889999999643 344566788999988887665 99999999876
Q ss_pred c-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC------------
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP------------ 383 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~------------ 383 (558)
+ .++||||+ +++|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccc
Confidence 5 89999999 8899999977665678999999999999999999999 89999999999999987
Q ss_pred -------CCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh
Q 008650 384 -------DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN 456 (558)
Q Consensus 384 -------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~ 456 (558)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999865432 12346999999999999999999999999999999999999999865433
Q ss_pred HHHHhhhhhhcCCcc---------ccc---------------------CCC-CCCCCCHHHHHHHHHHHHHhhccCCCCC
Q 008650 457 LVLWAKPLMESGNLT---------ELV---------------------DPS-LEGEYDTDQMHRLVLIADYCVRQTSAWR 505 (558)
Q Consensus 457 ~~~~~~~~~~~~~~~---------~~~---------------------d~~-l~~~~~~~~~~~l~~li~~cl~~dp~~R 505 (558)
............... ... .+. -...........+.+++.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 221111000000000 000 000 0001123456789999999999999999
Q ss_pred CCHHHHHHH
Q 008650 506 PSMSEVLEL 514 (558)
Q Consensus 506 Pt~~evl~~ 514 (558)
||+.|+++.
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=346.92 Aligned_cols=256 Identities=22% Similarity=0.334 Sum_probs=186.9
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEe-----
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIE----- 315 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~----- 315 (558)
....+|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 4456899999999999999999965 578999999986543 455667889999999996 9999999999842
Q ss_pred ---Cc-EEEEEEeccCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCc--EEecCCCCCceeecCCCceE
Q 008650 316 ---NG-LYLIFNFSQNGNLDAALHDE-RSKSLEWPIRYKIVLGVARGLHYLHKGCKRR--IIHRDIKASNVLLGPDFEPQ 388 (558)
Q Consensus 316 ---~~-~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~k 388 (558)
.. .+++|||+. |+|.+++... ....+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEE
Confidence 22 789999996 6898888653 34569999999999999999999998 77 99999999999999999999
Q ss_pred EEeccccccCCCCCCcc----------cccccccccCcccchhh---ccCCCCccccchhHHHHHHHHHcCCCCCCCCch
Q 008650 389 ITDFGLAKWLPNKCTHH----------AAIPIEGTFGYLAPEYF---MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ 455 (558)
Q Consensus 389 l~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~ 455 (558)
|+|||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765432211 11134599999999998 566789999999999999999999999975432
Q ss_pred hHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 456 NLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
... ................+.+++.+||+.||.+|||+.|+++.|....
T Consensus 259 ~~~---------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 259 LRI---------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHh---------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 110 0001111111112234788999999999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=355.44 Aligned_cols=242 Identities=14% Similarity=0.134 Sum_probs=189.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccc-ccHHHHHHHHHHH---HHhcccccCCeeeee-------eE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDN-KDAKKEKEFLMEL---GIIGHVCHPNTATLV-------GC 312 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 312 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.+.. ........+.+|+ .+++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999964 579999999997542 2334556788999 666667899999998 55
Q ss_pred EEeC------------------cEEEEEEeccCCCHHHHHhhccCC-----CCCHHHHHHHHHHHHHHHHHhhhCCCCcE
Q 008650 313 CIEN------------------GLYLIFNFSQNGNLDAALHDERSK-----SLEWPIRYKIVLGVARGLHYLHKGCKRRI 369 (558)
Q Consensus 313 ~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~-----~l~~~~~~~i~~~i~~aL~~LH~~~~~~i 369 (558)
+.+. ..|+||||+ +|+|.+++...... .+++..++.|+.||+.||.|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 5433 278999999 68999999764211 23357888999999999999999 899
Q ss_pred EecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccC-----------CCCccccchhHHH
Q 008650 370 IHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG-----------IIDEKTDVFAFGV 438 (558)
Q Consensus 370 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDvwSlGv 438 (558)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2234567 999999999887 8999999999999
Q ss_pred HHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 439 LLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 439 vl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+||||++|+.||....... ....+.. .. . .....+.+++.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~-----------~~~~~~~-~~-~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG-----------GSEWIFR-SC-K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------C-----------CSGGGGS-SC-C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCccccccc-----------chhhhhh-hc-c----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999997542210 0011111 00 1 12346889999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=340.36 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=204.4
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccc--c----HHHHHHHHHHHHHhccc-ccCCeeeeeeE
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK--D----AKKEKEFLMELGIIGHV-CHPNTATLVGC 312 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 312 (558)
.....++|.+.+.||+|+||.||+|... +|+.||||++..... . ......+.+|+.+++++ .||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445578999999999999999999764 799999999875431 1 22345678899999999 79999999999
Q ss_pred EEeCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEe
Q 008650 313 CIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITD 391 (558)
Q Consensus 313 ~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 391 (558)
+.... .++||||+.+++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEe
Confidence 98765 99999999999999999654 468999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCcccchhhcc------CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh
Q 008650 392 FGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH------GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM 465 (558)
Q Consensus 392 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 465 (558)
||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .+
T Consensus 244 fG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~---~i 317 (365)
T 2y7j_A 244 FGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR---MI 317 (365)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HH
T ss_pred cCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH---HH
Confidence 999987654322 234569999999999863 358899999999999999999999998654322111 11
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 466 ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
..+.... ..+. .......+.+++.+||+.||++|||+.|+++
T Consensus 318 ~~~~~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEGQYQF-SSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHTCCCC-CHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCCCC-CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111100 0000 0012346889999999999999999999997
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=361.39 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=202.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||+||+|.. .+++.||||++.+..........+.+|+.++++++||||+++++++.+.. .++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 35699999999999999999965 47999999999754333334567889999999999999999999998765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec---CCCceEEEeccccccCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG---PDFEPQITDFGLAKWLP 399 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a~~~~ 399 (558)
||+.+|+|.+.+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++....
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999988654 468999999999999999999999 8999999999999995 45679999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........... +..+.... .
T Consensus 176 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~------~ 242 (486)
T 3mwu_A 176 QNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR---VETGKYAF------D 242 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHTCCCS------C
T ss_pred CCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhCCCCC------C
Confidence 4322 233569999999999975 599999999999999999999999987644322111 11111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..........+.+++.+||+.+|.+|||+.|+++.
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00012234578899999999999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=338.26 Aligned_cols=261 Identities=23% Similarity=0.374 Sum_probs=201.1
Q ss_pred hCCCcccceEeeeCceEEEEEEEC--CCC--EEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS--DGR--KIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 319 (558)
.++|.+.+.||+|+||+||+|... +++ .||+|++..... .......+.+|+.++++++||||+++++++.++..+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 457999999999999999999642 333 689999865432 234567789999999999999999999999888899
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+|+||+.+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999997543 458999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCCcc-cccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 400 NKCTHH-AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 400 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......... .......
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~~~~~~~-------- 242 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH--KIDKEGE-------- 242 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHHTSCC--------
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH--HHHccCC--------
Confidence 443221 1223457889999999999899999999999999999999 999998764432211 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
....+......+.+++.+||+.+|.+|||+.++++.|.+...
T Consensus 243 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 -RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 001122334578999999999999999999999999987653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=339.01 Aligned_cols=265 Identities=22% Similarity=0.340 Sum_probs=201.9
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE--CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc---ccCCeeeeeeEEE---
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL--SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV---CHPNTATLVGCCI--- 314 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 314 (558)
...++|.+.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.+ .||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999976 4688999999965443222223455676666665 7999999999986
Q ss_pred --e-CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEe
Q 008650 315 --E-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITD 391 (558)
Q Consensus 315 --~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 391 (558)
. ...++||||+. |+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEec
Confidence 2 23899999998 699999987666679999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHh-hhhhhcC--
Q 008650 392 FGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA-KPLMESG-- 468 (558)
Q Consensus 392 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~-~~~~~~~-- 468 (558)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... .......
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99998764322 22345699999999999999999999999999999999999999987543321111 0000000
Q ss_pred -Cccc-------ccCC---CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 469 -NLTE-------LVDP---SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 469 -~~~~-------~~d~---~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+.. .+.. .............+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0000 00001112334578899999999999999999999963
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=348.68 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=186.6
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-------C
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-------N 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------~ 316 (558)
.++|.+.+.||+|+||.||+|. ..+|+.||||++............+.+|+.+++.++||||+++++++.. .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4689999999999999999995 4678999999997665566677888999999999999999999999864 2
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..|+|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 379999998 6899988854 469999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCc-cccc
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL-TELV 474 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~ 474 (558)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ......+.. .+.+
T Consensus 181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~-~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK-LILRLVGTPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCSCCHHHH
T ss_pred ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCCHHHH
Confidence 65432 223469999999999987 679999999999999999999999998754321111 000000000 0000
Q ss_pred CCC-----------CC--CCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPS-----------LE--GEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~-----------l~--~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
... +. ...+ ......+.+++.+||+.||.+|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 00 0001 1123568899999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.37 Aligned_cols=254 Identities=11% Similarity=0.035 Sum_probs=183.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHH---HHhcccccCCeeeee-------eE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMEL---GIIGHVCHPNTATLV-------GC 312 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 312 (558)
..+|.+.+.||+|+||+||+|.. .+|+.||||++..... .......+.+|+ .+|+. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 34588999999999999999965 4789999999987654 334455666774 55555 699988755 34
Q ss_pred EEe------------------CcEEEEEEeccCCCHHHHHhhccCCCCCHHHH------HHHHHHHHHHHHHhhhCCCCc
Q 008650 313 CIE------------------NGLYLIFNFSQNGNLDAALHDERSKSLEWPIR------YKIVLGVARGLHYLHKGCKRR 368 (558)
Q Consensus 313 ~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~i~~aL~~LH~~~~~~ 368 (558)
+.. ...++||||+. |+|.+++.... ..+++..+ +.++.||+.||.|||+ ++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS---KG 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence 332 22799999999 89999997643 23455666 7888999999999999 89
Q ss_pred EEecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhcc--CCCCccccchhHHHHHHHHHcC
Q 008650 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH--GIIDEKTDVFAFGVLLLEIITG 446 (558)
Q Consensus 369 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg 446 (558)
|+||||||+|||++.++.+||+|||+++....... ...||+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999987643211 2347799999999987 6799999999999999999999
Q ss_pred CCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 447 RKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 447 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+.||......... ..........................+.+++.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKG----SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTT----CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCccccc----chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999865332110 00000000011111111111233567899999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.45 Aligned_cols=268 Identities=23% Similarity=0.342 Sum_probs=208.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE-----CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC---
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-----SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 316 (558)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 35689999999999999999973 468899999996543 34556789999999999999999999998653
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 489999999999999999754 3458999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCcc-cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh----hcCCcc
Q 008650 397 WLPNKCTHH-AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM----ESGNLT 471 (558)
Q Consensus 397 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~----~~~~~~ 471 (558)
......... ......+|..|+|||.+.+..++.++||||||+++|+|++|..||............... ....+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 775443221 122345788899999999999999999999999999999999998753221111000000 000000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
+.+........+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111112233446789999999999999999999999998864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=345.39 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=193.8
Q ss_pred CCCccc-ceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEE
Q 008650 246 NNFHSE-NMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 246 ~~f~~~-~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv 321 (558)
+.|.+. +.||+|+||+||+|. ..+++.||||++..... .....+.+|+.++.++ +||||+++++++.+++ .++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 567774 789999999999995 45799999999976532 2345678999999885 7999999999998766 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc---eEEEeccccccC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE---PQITDFGLAKWL 398 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~a~~~ 398 (558)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999999764 468999999999999999999999 89999999999999998776 999999999765
Q ss_pred CCCCC-----cccccccccccCcccchhhcc-----CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHH--------
Q 008650 399 PNKCT-----HHAAIPIEGTFGYLAPEYFMH-----GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW-------- 460 (558)
Q Consensus 399 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~-------- 460 (558)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........|
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111223469999999999975 568999999999999999999999997643211000
Q ss_pred ----hhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 461 ----AKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 461 ----~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
....+..+... +...........+.+++.+||+.||.+|||+.|+++.
T Consensus 245 ~~~~~~~~i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00011111110 0000001123568899999999999999999999983
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=331.26 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=197.5
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
+|....+||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+++ .++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 455566999999999999964 578899999997653 234566889999999999999999999998766 8999999
Q ss_pred ccCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC-CCceEEEeccccccCCCCC
Q 008650 325 SQNGNLDAALHDERS-KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP-DFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~ 402 (558)
+.+++|.+++..... ..+++..++.++.|++.||.|||+ ++|+|+||||+|||++. ++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999999976532 356788899999999999999999 89999999999999987 8999999999998765432
Q ss_pred CcccccccccccCcccchhhccCC--CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGI--IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
. ......||+.|+|||++.++. ++.++||||||+++|+|++|+.||................. ..+.
T Consensus 178 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------~~~~--- 246 (295)
T 2clq_A 178 P--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK------VHPE--- 246 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC------CCCC---
T ss_pred C--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc------cccc---
Confidence 1 122356999999999997754 88999999999999999999999975432221111111100 0111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+......+.+++.+||+.||++|||+.++++.
T Consensus 247 -~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 -IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 122334578899999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=336.20 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=199.1
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEe--C-cEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIE--N-GLY 319 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~-~~~ 319 (558)
.++|++.+.||+|+||+||+|. ..+++.||||++.... ...+.+|+.+++.+. ||||+++++++.+ . ..+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 3679999999999999999995 4679999999996432 245789999999997 9999999999986 3 389
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-ceEEEeccccccC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-EPQITDFGLAKWL 398 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~ 398 (558)
+||||+.+++|..++. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 110 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 9999999999999884 38899999999999999999999 8999999999999999776 8999999999876
Q ss_pred CCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-----------hh
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL-----------ME 466 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~-----------~~ 466 (558)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............. +.
T Consensus 182 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 182 HPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 54332 223469999999999987 6799999999999999999999999964432211111000 00
Q ss_pred c--------------CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 467 S--------------GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 467 ~--------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. ......+...............+.+++.+||+.||.+|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 00000111111112222245678999999999999999999999983
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=340.92 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=197.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc------cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK------DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 317 (558)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... .......+.+|+.++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46799999999999999999955 5688999999965432 1223345789999999999999999999998878
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc---eEEEeccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE---PQITDFGL 394 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~ 394 (558)
.++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 9999999999999999854 3568999999999999999999999 89999999999999987664 99999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
+........ .....||+.|+|||++. ...++.++|||||||++|+|++|+.||........... .+..+...
T Consensus 164 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~ 238 (322)
T 2ycf_A 164 SKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD--QITSGKYN 238 (322)
T ss_dssp CEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHH--HHHHTCCC
T ss_pred ceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHH--HHHhCccc
Confidence 987654321 12345999999999974 56789999999999999999999999975432211100 11111110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. .+.. .......+.+++.+||+.||++|||+.++++.
T Consensus 239 ~--~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 239 F--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp C--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred c--Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0 0000 01123578899999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=338.19 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=204.2
Q ss_pred HhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcc--cccCCeeeeeeEEEeC---
Q 008650 242 SSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGH--VCHPNTATLVGCCIEN--- 316 (558)
Q Consensus 242 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~--- 316 (558)
....++|.+.+.||+|+||.||+|.. +|+.||||++.... ...+.+|.+++.. ++||||+++++++..+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 34557899999999999999999977 58999999996432 3456678888776 7899999999998764
Q ss_pred --cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhh--------hCCCCcEEecCCCCCceeecCCCc
Q 008650 317 --GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH--------KGCKRRIIHRDIKASNVLLGPDFE 386 (558)
Q Consensus 317 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~ 386 (558)
..++||||+.+|+|.+++.. ..+++..++.++.|++.||.||| + .+|+||||||+|||++.++.
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSC
T ss_pred cceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCC
Confidence 48999999999999999965 35899999999999999999999 6 89999999999999999999
Q ss_pred eEEEeccccccCCCCCCcc--cccccccccCcccchhhccC------CCCccccchhHHHHHHHHHcC----------CC
Q 008650 387 PQITDFGLAKWLPNKCTHH--AAIPIEGTFGYLAPEYFMHG------IIDEKTDVFAFGVLLLEIITG----------RK 448 (558)
Q Consensus 387 ~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvvl~elltg----------~~ 448 (558)
+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999997765432211 22345699999999999776 334789999999999999999 78
Q ss_pred CCCCCch---hHHHHhhhhhhcCCcccccCCCCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 449 PVDSSRQ---NLVLWAKPLMESGNLTELVDPSLEGE-YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 449 Pf~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
||..... ....+....... ...+.+... ........+.+++.+||+.||++|||+.+|++.|+..
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTS-----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCcCcccHHHHHHHHHHH-----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 8865321 111222111111 111111111 1235667899999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=342.43 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=199.8
Q ss_pred HHHhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEe--
Q 008650 240 EISSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIE-- 315 (558)
Q Consensus 240 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 315 (558)
++....++|.+.+.||+|+||.||+|.. .+++.||||++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3344567899999999999999999965 5789999999965432 234577899999998 79999999999875
Q ss_pred -----CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEE
Q 008650 316 -----NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQIT 390 (558)
Q Consensus 316 -----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 390 (558)
+..++||||+.+|+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEEC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEe
Confidence 238999999999999999987655679999999999999999999999 899999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh
Q 008650 391 DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM 465 (558)
Q Consensus 391 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 465 (558)
|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.........+.. .
T Consensus 172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~ 247 (326)
T 2x7f_A 172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--P 247 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--H
T ss_pred eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh--h
Confidence 9999987643221 122346999999999997 567899999999999999999999999865543222211 1
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 466 ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. ....... .......+.+++.+||..||.+|||+.++++.
T Consensus 248 ~-~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 R-NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp H-SCCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred c-CccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 1111111 11223468899999999999999999999983
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.80 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=201.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||+|++..... .....+.+|+.+++.++||||+++++++.++. .++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 45799999999999999999965 4799999999975432 23356789999999999999999999998765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee---cCCCceEEEeccccccCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~~ 399 (558)
||+.+++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 86 QLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999998654 468999999999999999999999 899999999999999 788999999999997644
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .. +..+... ..
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~-i~~~~~~------~~ 227 (304)
T 2jam_A 161 NGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF--EK-IKEGYYE------FE 227 (304)
T ss_dssp CBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HH-HHHCCCC------CC
T ss_pred CCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH--HH-HHcCCCC------CC
Confidence 321 22345999999999999999999999999999999999999999865433211 11 1111110 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..........+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11112234578899999999999999999999983
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=371.81 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=204.4
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LY 319 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~ 319 (558)
..++|.+.+.||+|+||+||+|.. .+++.||||++.+... .......+..|..++..+ +||||+.+++++.+.. +|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999955 5688999999975421 122345677899999887 6999999999998755 99
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.+|++||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999764 469999999999999999999999 899999999999999999999999999998643
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||......... ..+.. ..
T Consensus 494 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~--~~i~~-~~---------- 558 (674)
T 3pfq_A 494 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF--QSIME-HN---------- 558 (674)
T ss_dssp CTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHS-SC----------
T ss_pred cCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH--HHHHh-CC----------
Confidence 322 2234567999999999999999999999999999999999999999876543221 11111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSM-----SEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~~ 514 (558)
..++.....++.+++.+||+.||.+||++ .||++.
T Consensus 559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 11222334578999999999999999997 777763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=333.09 Aligned_cols=251 Identities=22% Similarity=0.381 Sum_probs=199.9
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.+++.++||||+++++++.+++ .++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 346799999999999999999965 4689999999976432 345788999999999999999999998765 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+++|.+++... ...+++..++.++.+++.||.|||+ .+++|+||||+|||++.++.+||+|||++......
T Consensus 103 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred eecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999998643 4568999999999999999999999 89999999999999999999999999999876443
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........+.. .. ...... .
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~-~~~~~~-------~ 246 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI--PT-NPPPTF-------R 246 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH-SCCCCC-------S
T ss_pred cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hc-CCCccc-------C
Confidence 22 223356999999999999999999999999999999999999999865443222211 11 111110 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+......+.+++.+||+.||.+|||+.++++.
T Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112234578899999999999999999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.63 Aligned_cols=262 Identities=19% Similarity=0.273 Sum_probs=201.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC------c
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------G 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 317 (558)
.++|++.+.||+|+||.||+|.. .+++.||||++... ........+.+|+.++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 46899999999999999999954 57889999999643 3355567789999999999999999999998643 3
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++||||+. |+|.+++.. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 105 ~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 899999997 489998854 358999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCcc-cccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh-hhhhcCCcc---
Q 008650 398 LPNKCTHH-AAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK-PLMESGNLT--- 471 (558)
Q Consensus 398 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~-~~~~~~~~~--- 471 (558)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 65432221 1234579999999998765 45899999999999999999999999865432111110 000000000
Q ss_pred --------ccc-CCCCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 --------ELV-DPSLEGEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 --------~~~-d~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
... ........+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000001 1223568899999999999999999999984
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=355.81 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=200.0
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH-----------HHHHHHHHHHHHhcccccCCeeeeee
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA-----------KKEKEFLMELGIIGHVCHPNTATLVG 311 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~ 311 (558)
..++|.+.+.||+|+||+||+|.. .+++.||+|++.+..... .....+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 356799999999999999999965 468899999997654221 22457889999999999999999999
Q ss_pred EEEeCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC---ce
Q 008650 312 CCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF---EP 387 (558)
Q Consensus 312 ~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~ 387 (558)
++.++. .++||||+.+|+|.+.+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 998766 89999999999999988654 469999999999999999999999 8999999999999998776 69
Q ss_pred EEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhc
Q 008650 388 QITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES 467 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 467 (558)
||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++|+.||.......... . +..
T Consensus 189 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~-i~~ 261 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK--K-VEK 261 (504)
T ss_dssp EECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H-HHH
T ss_pred EEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHc
Confidence 9999999987654322 23356999999999987 568999999999999999999999998764432211 1 111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 468 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+...... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 262 ~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 262 GKYYFDF------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCCCCH------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCc------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1110000 0001123568899999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=360.19 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=203.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.+.... ......+.+|+.++++++||||+++++++.+.. .++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35699999999999999999965 47999999999765322 234566889999999999999999999998766 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee---cCCCceEEEeccccccC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWL 398 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~ 398 (558)
|||+.+|+|.+.+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++..+
T Consensus 105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999988643 568999999999999999999999 899999999999999 56789999999999876
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........... +..+....
T Consensus 180 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~------ 246 (484)
T 3nyv_A 180 EASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK---VEKGKYTF------ 246 (484)
T ss_dssp CCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHCCCCC------
T ss_pred ccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHcCCCCC------
Confidence 54322 223469999999999865 699999999999999999999999987654322111 11111110
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...........+.+++.+||+.+|.+|||+.|+++.
T Consensus 247 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 000112234578899999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=339.81 Aligned_cols=203 Identities=20% Similarity=0.302 Sum_probs=170.8
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cC-----CeeeeeeEEEe
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HP-----NTATLVGCCIE 315 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~ 315 (558)
...++|.+.+.||+|+||+||+|.. .+++.||||++... ......+..|+.+++.+. |+ +|+.+++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3457899999999999999999955 46889999999643 344556677888877775 44 49999999887
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec--CCCceEEEec
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG--PDFEPQITDF 392 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DF 392 (558)
.. .++||||+. |+|.+++.......+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+||
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 65 999999996 5999999876656799999999999999999999941 26899999999999994 4788999999
Q ss_pred cccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCch
Q 008650 393 GLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ 455 (558)
Q Consensus 393 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~ 455 (558)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999876432 2235699999999999999999999999999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=342.04 Aligned_cols=269 Identities=21% Similarity=0.288 Sum_probs=200.9
Q ss_pred HHHHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccc---------cHHHHHHHHHHHHHhcccccCCeee
Q 008650 238 YEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNK---------DAKKEKEFLMELGIIGHVCHPNTAT 308 (558)
Q Consensus 238 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~ 308 (558)
..++....++|.+.+.||+|+||.||+|...+|+.||||++..... .......+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 4577788899999999999999999999888899999999865321 2344577899999999999999999
Q ss_pred eeeEEEeC------cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec
Q 008650 309 LVGCCIEN------GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG 382 (558)
Q Consensus 309 l~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 382 (558)
+++++... ..++||||+. |+|.+.+... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLA 168 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEc
Confidence 99998531 2799999998 5888877643 3569999999999999999999999 8999999999999999
Q ss_pred CCCceEEEeccccccCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHh
Q 008650 383 PDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA 461 (558)
Q Consensus 383 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~ 461 (558)
.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999975443322 223468999999999987 6799999999999999999999999987543211111
Q ss_pred h-hhhhcCCc-----------ccccCCCCCC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 462 K-PLMESGNL-----------TELVDPSLEG-------EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 462 ~-~~~~~~~~-----------~~~~d~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. ........ ...+...... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0 00000000 0000000000 0011223568899999999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=328.94 Aligned_cols=250 Identities=19% Similarity=0.339 Sum_probs=196.0
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
..++|.+.+.||+|+||.||+|... +|+.||||++...... ......+.+|+.+++.++||||+++++++.++. .++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999664 7999999999654321 122456889999999999999999999998765 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+++|.+++... ..+++..++.++.|++.||.|||+ ++|+|+||||+|||++.++.+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999654 458999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCcccccccccccCcccchhhccCCC-CccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
... .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||......... .. +..+.. .+
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~-~~~~~~------~~- 230 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF--KK-IRGGVF------YI- 230 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHCCC------CC-
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH--HH-hhcCcc------cC-
Confidence 322 223458999999999988765 68999999999999999999999865432211 11 111110 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ---PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11223468899999999999999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.57 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=199.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E----
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L---- 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~---- 318 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46899999999999999999954 57899999999876666677788999999999999999999999997644 3
Q ss_pred --EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 319 --YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 319 --~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
++||||+. ++|...+. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999998 58887773 348999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccC
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD 475 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d 475 (558)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....................+...
T Consensus 193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 65432 223468999999999987 689999999999999999999999998754322111110000000000000
Q ss_pred ---------------CCCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 476 ---------------PSLEGE---YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 476 ---------------~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...... ........+.+++.+||+.||++|||+.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 011224578999999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=329.11 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=204.2
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-------cHHHHHHHHHHHHHhcccc-cCCeeeeeeEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-------DAKKEKEFLMELGIIGHVC-HPNTATLVGCCI 314 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 314 (558)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 346899999999999999999965 4689999999965431 1233566889999999996 999999999998
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecc
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFG 393 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 393 (558)
++. .++||||+.+++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence 766 89999999999999999654 468999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhc------cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhc
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFM------HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES 467 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 467 (558)
++........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.||......... .... .
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~-~ 243 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--RMIM-S 243 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH-H
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH--HHHh-c
Confidence 9987654322 22356999999999985 456889999999999999999999999865433211 1111 1
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 468 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+... ............+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111 001111233457899999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.62 Aligned_cols=255 Identities=27% Similarity=0.347 Sum_probs=200.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE----CCCCEEEEEEeecccc--cHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNK--DAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 317 (558)
.++|.+.+.||+|+||+||+|.. .+++.||||++.+... .......+.+|+.+++++ +||||+++++++.++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35799999999999999999966 4789999999865321 112233466789999999 5999999999998765
Q ss_pred -EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 318 -LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 318 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
.++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 89999999999999999754 468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccC--CCCccccchhHHHHHHHHHcCCCCCCCCch--hHHHHhhhhhhcCCccc
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHG--IIDEKTDVFAFGVLLLEIITGRKPVDSSRQ--NLVLWAKPLMESGNLTE 472 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~ 472 (558)
.+..... .......||+.|+|||++.++ .++.++|||||||+||||++|+.||..... ............
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----- 281 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----- 281 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-----
Confidence 7643322 222345699999999999863 578999999999999999999999974321 111111111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHh
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLELLT 516 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~L~ 516 (558)
.+ .++......+.+++.+||+.||.+|| |+.|+++...
T Consensus 282 --~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 --EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp --CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred --CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 01 11223345688999999999999999 9999998643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.92 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=194.2
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-----Cc--
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-----NG-- 317 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~-- 317 (558)
.+|.+.+.||+|+||.||+|.. .+|+.||||++..... .+.+|+.+++.++||||+++++++.. +.
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4688999999999999999966 4699999999965432 13369999999999999999998853 11
Q ss_pred EEEEEEeccCCCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-CceEEEeccc
Q 008650 318 LYLIFNFSQNGNLDAALHD--ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFGL 394 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~ 394 (558)
+++||||+.+ +|...+.. .....+++..++.++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchh
Confidence 6789999986 56555543 234579999999999999999999998 899999999999999965 6789999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHH--Hhhhh-------
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL--WAKPL------- 464 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~------- 464 (558)
++.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......... .....
T Consensus 204 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 987654322 2235689999999999765 7999999999999999999999999875432111 11100
Q ss_pred h--hcCCcccccCCCCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 465 M--ESGNLTELVDPSLEGE-----YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 465 ~--~~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+ ...+..+...+.+... +.......+.+++.+||+.||.+|||+.|+++.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 0111111111111110 112234678999999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.04 Aligned_cols=257 Identities=22% Similarity=0.299 Sum_probs=194.8
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-------E
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-------L 318 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------~ 318 (558)
.+|.+.+.||+|+||+||+|....+..+|+|++...... ..+|+.+++.++||||+++++++.... .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 469999999999999999998877777999998654321 226899999999999999999985421 7
Q ss_pred EEEEEeccCCCHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec-CCCceEEEeccccc
Q 008650 319 YLIFNFSQNGNLDAALHD-ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG-PDFEPQITDFGLAK 396 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~ 396 (558)
++||||+.++.+...... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 899999987655444322 234579999999999999999999999 8999999999999999 79999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-h---------
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL-M--------- 465 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~-~--------- 465 (558)
.+...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.............. .
T Consensus 191 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 191 ILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp ECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 76443322 234689999999999765 589999999999999999999999987643221111100 0
Q ss_pred -hcCCcccccCCCCCC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 466 -ESGNLTELVDPSLEG-----EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 466 -~~~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...+......+.... .+.......+.+++.+||+.||.+|||+.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000011100111110 1112234578999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=342.38 Aligned_cols=263 Identities=20% Similarity=0.325 Sum_probs=204.6
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHH---------------HHHHHHHHHHHhcccccCCeeee
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAK---------------KEKEFLMELGIIGHVCHPNTATL 309 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l 309 (558)
.++|.+.+.||+|+||.||+|.. +++.||+|++........ ....+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999977 899999999965422111 11678899999999999999999
Q ss_pred eeEEEeCc-EEEEEEeccCCCHHHH------HhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec
Q 008650 310 VGCCIENG-LYLIFNFSQNGNLDAA------LHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG 382 (558)
Q Consensus 310 ~~~~~~~~-~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 382 (558)
++++.+++ .++||||+.+|+|.++ +.......+++..++.++.|++.||.|||+ .++|+||||||+|||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 99998765 9999999999999998 654445779999999999999999999996 26899999999999999
Q ss_pred CCCceEEEeccccccCCCCCCcccccccccccCcccchhhccC-CCCc-cccchhHHHHHHHHHcCCCCCCCCchhHHHH
Q 008650 383 PDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDE-KTDVFAFGVLLLEIITGRKPVDSSRQNLVLW 460 (558)
Q Consensus 383 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~ 460 (558)
.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|+.||..........
T Consensus 187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999999999999876443 22335699999999999887 6766 9999999999999999999998654321111
Q ss_pred hhhhhhcCCccc----ccCCCCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 461 AKPLMESGNLTE----LVDPSLE---GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 461 ~~~~~~~~~~~~----~~d~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
............ ...+... ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111101001110 0000000 00012234578999999999999999999999983
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=329.11 Aligned_cols=252 Identities=23% Similarity=0.412 Sum_probs=194.7
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe--------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-------- 315 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 315 (558)
.++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 45799999999999999999965 57999999999543 4556778899999999999999999998754
Q ss_pred ------CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEE
Q 008650 316 ------NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQI 389 (558)
Q Consensus 316 ------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 389 (558)
+..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEE
Confidence 2389999999999999999753 3457888999999999999999999 89999999999999999999999
Q ss_pred EeccccccCCCCCC------------cccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchh
Q 008650 390 TDFGLAKWLPNKCT------------HHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQN 456 (558)
Q Consensus 390 ~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~ 456 (558)
+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 99999987643211 1122345699999999999864 78999999999999999998 66543222
Q ss_pred HHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 457 LVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...... +... ...+...++......+.+++.+||+.||.+|||+.++++.
T Consensus 235 ~~~~~~--~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILKK--LRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHH--HHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHh--cccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111 1111 1112222333445578899999999999999999999983
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.16 Aligned_cols=262 Identities=21% Similarity=0.297 Sum_probs=199.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe------Cc
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE------NG 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 317 (558)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... ........+.+|+.++++++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 46899999999999999999965 46899999999543 335556678899999999999999999998764 33
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 899999997 589998865 358999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCcc--------cccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhh-hhhhc
Q 008650 398 LPNKCTHH--------AAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK-PLMES 467 (558)
Q Consensus 398 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~-~~~~~ 467 (558)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 65332111 1223568999999998765 67899999999999999999999999876432211110 00000
Q ss_pred CCccccc------------CC--CCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 468 GNLTELV------------DP--SLEG----EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 468 ~~~~~~~------------d~--~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
....... .. .... .........+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00 0000 0001234568899999999999999999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.61 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=198.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++ .++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3467999999999999999999664 68999999986543 233467889999999999999999999998765 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+++|..++... ...+++..++.++.||+.||.|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus 95 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999988653 3568999999999999999999999 89999999999999999999999999987542211
Q ss_pred CCcccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
........||+.|+|||++. +..++.++||||||+++|+|++|+.||........... .... .....
T Consensus 171 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~-~~~~~--- 242 (302)
T 2j7t_A 171 --LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--IAKS-DPPTL--- 242 (302)
T ss_dssp --HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHS-CCCCC---
T ss_pred --ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH--Hhcc-CCccc---
Confidence 01112345999999999983 66789999999999999999999999987544322111 1111 11111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+......+.+++.+||+.||.+|||+.++++.
T Consensus 243 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 ----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ----CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1122234578899999999999999999999873
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.70 Aligned_cols=258 Identities=17% Similarity=0.224 Sum_probs=199.4
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CC-CEEEEEEeecccccHHHHHHHHHHHHHhcccccCC------eeeeeeEEEeC
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DG-RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN------TATLVGCCIEN 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 316 (558)
.++|.+.+.||+|+||+||+|... ++ +.||+|++... ......+.+|+.+++.+.|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 468999999999999999999653 44 68999999643 344566778999999888766 88999988776
Q ss_pred c-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee--------------
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL-------------- 381 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll-------------- 381 (558)
+ .++||||+ +++|.+.+.......+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccc
Confidence 5 89999999 6677777766555679999999999999999999998 899999999999999
Q ss_pred -----cCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh
Q 008650 382 -----GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN 456 (558)
Q Consensus 382 -----~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~ 456 (558)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 567899999999998644322 2346999999999999999999999999999999999999999875433
Q ss_pred HHHHhhhhhhcCCcc---------cc-cCCC---------------------CCCCCCHHHHHHHHHHHHHhhccCCCCC
Q 008650 457 LVLWAKPLMESGNLT---------EL-VDPS---------------------LEGEYDTDQMHRLVLIADYCVRQTSAWR 505 (558)
Q Consensus 457 ~~~~~~~~~~~~~~~---------~~-~d~~---------------------l~~~~~~~~~~~l~~li~~cl~~dp~~R 505 (558)
............... .. .... ............+.+++.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 211111000000000 00 0000 0001123445678999999999999999
Q ss_pred CCHHHHHHH
Q 008650 506 PSMSEVLEL 514 (558)
Q Consensus 506 Pt~~evl~~ 514 (558)
||+.|+++.
T Consensus 326 pt~~e~l~h 334 (355)
T 2eu9_A 326 ITLAEALLH 334 (355)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=338.54 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=199.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG------ 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 317 (558)
.++|.+.+.||+|+||.||+|.. .+|+.||||++............+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 36799999999999999999955 57899999999776666666778999999999999999999999997643
Q ss_pred -EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 318 -LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 318 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
.++||||+. ++|.+++. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 58877763 348999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcC-------
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG------- 468 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~------- 468 (558)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................+.
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 65432 123468999999999987 67899999999999999999999999875432111100000000
Q ss_pred ------------CcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 469 ------------NLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 469 ------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+.....+.+. .........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000010 1122345678999999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.50 Aligned_cols=266 Identities=20% Similarity=0.257 Sum_probs=189.0
Q ss_pred HHHHhhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-C
Q 008650 239 EEISSATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-N 316 (558)
Q Consensus 239 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 316 (558)
.......++|.+.+.||+|+||+||+|.. .+|+.||||++...... ...+..++..+..++||||+++++++.. +
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 34556678999999999999999999965 57899999998654322 2235567778888899999999999864 1
Q ss_pred c-------EEEEEEeccCCCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHhh--hCCCCcEEecCCCCCceeecC-C
Q 008650 317 G-------LYLIFNFSQNGNLDAALHD--ERSKSLEWPIRYKIVLGVARGLHYLH--KGCKRRIIHRDIKASNVLLGP-D 384 (558)
Q Consensus 317 ~-------~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH--~~~~~~ivH~Dlkp~NIll~~-~ 384 (558)
. .++||||+.+ +|...+.. .....+++..++.++.|++.||.||| + ++|+||||||+|||++. +
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCC
Confidence 1 7899999987 44444332 23456899999999999999999999 7 89999999999999997 8
Q ss_pred CceEEEeccccccCCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhh
Q 008650 385 FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463 (558)
Q Consensus 385 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 463 (558)
+.+||+|||++..+...... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.............
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 245 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245 (360)
T ss_dssp TEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence 99999999999876543322 234689999999999765 48999999999999999999999998754332211110
Q ss_pred hhhcC-------------CcccccCC------CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 464 LMESG-------------NLTELVDP------SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 464 ~~~~~-------------~~~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..... ......+. .............+.+++.+||+.||.+|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 00000000 00011122245689999999999999999999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.68 Aligned_cols=265 Identities=21% Similarity=0.371 Sum_probs=203.4
Q ss_pred HHHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 239 EEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 239 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
.++....++|.+.+.||+|+||.||+|.... .+|+|++............+.+|+.++++++||||+++++++.++.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3344456789999999999999999997653 4999999765433333455778999999999999999999998765
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++||||+.+++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||++..
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred eEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 99999999999999999653 3468999999999999999999999 8999999999999998 67999999999876
Q ss_pred CCCCC---CcccccccccccCcccchhhcc---------CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh
Q 008650 398 LPNKC---THHAAIPIEGTFGYLAPEYFMH---------GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM 465 (558)
Q Consensus 398 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 465 (558)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........+..
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--- 255 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--- 255 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH---
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh---
Confidence 53211 1112223459999999999974 45788999999999999999999999876544332221
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCc
Q 008650 466 ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDS 521 (558)
Q Consensus 466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 521 (558)
..+........ .....+.+++.+||+.+|.+|||+.++++.|+.....
T Consensus 256 ~~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 256 GTGMKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HTTCCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ccCCCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111111 1123588999999999999999999999999986543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=334.62 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=178.7
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHH-HhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELG-IIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ......+..|+. +++.++||||+++++++.+++ .++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 46799999999999999999965 4789999999976533 344455666665 788889999999999998765 8999
Q ss_pred EEeccCCCHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHhhhCCCC-cEEecCCCCCceeecCCCceEEEecccccc
Q 008650 322 FNFSQNGNLDAALHD---ERSKSLEWPIRYKIVLGVARGLHYLHKGCKR-RIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
|||+.+ +|.+++.. .....+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999986 77777653 234678999999999999999999998 7 999999999999999999999999999987
Q ss_pred CCCCCCcccccccccccCcccchhh----ccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccc
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYF----MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 473 (558)
...... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||............ .. .+.
T Consensus 176 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~-~~~---- 246 (327)
T 3aln_A 176 LVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ-VV-KGD---- 246 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC-CC-CSC----
T ss_pred cccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH-Hh-cCC----
Confidence 654322 1223599999999999 4567899999999999999999999999764321111100 00 011
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.+.+...........+.+++.+||+.||.+|||+.++++
T Consensus 247 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 -PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111111223457899999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=351.67 Aligned_cols=260 Identities=19% Similarity=0.265 Sum_probs=200.0
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC-eeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN-TATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+|+.+++.+.|++ +..+..++.++. .++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 47899999999999999999964 67999999998654432 23678999999998754 445545555554 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee---cCCCceEEEeccccccC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWL 398 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~ 398 (558)
|||+ +++|.+++... ...+++..++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||+++.+
T Consensus 82 me~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 9999 99999999643 3569999999999999999999999 899999999999999 68899999999999876
Q ss_pred CCCCCcc-----cccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccc
Q 008650 399 PNKCTHH-----AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473 (558)
Q Consensus 399 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 473 (558)
....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..............+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 5443221 12256799999999999999999999999999999999999999986432111100000000000000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
+.. +.. ....++.+++..||+.+|++||++.+|++.|+..
T Consensus 237 ~~~-l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 237 IEA-LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHH-HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHH-Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 000 001 1134789999999999999999999999988764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=363.47 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=208.8
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEEEC----CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGNLS----DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN 316 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 316 (558)
.....++|.+.+.||+|+||.||+|... .+..||+|++... ........+.+|+.++++++||||+++++++.++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 3344578999999999999999999653 2457999998543 3455667899999999999999999999999777
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 799999999999999999654 3468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccC
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVD 475 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d 475 (558)
........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||.......... ... .+...
T Consensus 540 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~--~i~-~~~~~---- 611 (656)
T 2j0j_A 540 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG--RIE-NGERL---- 611 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHH-HTCCC----
T ss_pred ecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHH-cCCCC----
Confidence 76543221 2223457889999999999999999999999999999997 999998754432211 111 11111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
..+......+.+++.+||+.||.+|||+.++++.|+...
T Consensus 612 -----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 612 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 112233457889999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=324.70 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=202.7
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
..++|.+.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++.+.. .++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4468999999999999999999654 7899999999766544445567889999999999999999999998765 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC---CceEEEeccccccC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD---FEPQITDFGLAKWL 398 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~~~ 398 (558)
+||+.+++|.+.+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999999888654 468999999999999999999999 899999999999999764 46999999999876
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
...... ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||......... .. +..+...... + .
T Consensus 175 ~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~-~~~~~~~~~~-~-~ 245 (287)
T 2wei_A 175 QQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL--KR-VETGKYAFDL-P-Q 245 (287)
T ss_dssp CCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHCCCCCCS-G-G
T ss_pred cCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHcCCCCCCc-h-h
Confidence 543221 22358999999999865 4899999999999999999999999875433211 11 1111111000 0 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 246 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 246 ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0122356889999999999999999999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=338.65 Aligned_cols=258 Identities=19% Similarity=0.252 Sum_probs=199.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-----------cCCeeeeeeE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-----------HPNTATLVGC 312 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~ 312 (558)
.++|.+.+.||+|+||+||+|.. .+++.||||++... ......+.+|+.+++++. |+||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 46799999999999999999965 67899999999643 344556778888888876 8999999999
Q ss_pred EEeC-----cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCC-cEEecCCCCCceeec----
Q 008650 313 CIEN-----GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR-RIIHRDIKASNVLLG---- 382 (558)
Q Consensus 313 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~---- 382 (558)
+... ..++|||++ +++|.+++.......+++..++.++.||+.||.|||+ + +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEET
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCC
Confidence 8752 378999999 8899999987666679999999999999999999999 7 999999999999994
Q ss_pred --CCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh----
Q 008650 383 --PDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN---- 456 (558)
Q Consensus 383 --~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~---- 456 (558)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4458999999999876432 12346999999999999999999999999999999999999999854311
Q ss_pred -HHHHhhhhhhcCC---------------------cccccCCC---------CCCCCCHHHHHHHHHHHHHhhccCCCCC
Q 008650 457 -LVLWAKPLMESGN---------------------LTELVDPS---------LEGEYDTDQMHRLVLIADYCVRQTSAWR 505 (558)
Q Consensus 457 -~~~~~~~~~~~~~---------------------~~~~~d~~---------l~~~~~~~~~~~l~~li~~cl~~dp~~R 505 (558)
..........-+. ...+.... ....++......+.+++.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 0000000000000 00000000 0112445677889999999999999999
Q ss_pred CCHHHHHHH
Q 008650 506 PSMSEVLEL 514 (558)
Q Consensus 506 Pt~~evl~~ 514 (558)
||+.|+++.
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=342.84 Aligned_cols=261 Identities=19% Similarity=0.350 Sum_probs=180.5
Q ss_pred CCCcc-cceEeeeCceEEEEEEEC---CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe--C-cE
Q 008650 246 NNFHS-ENMVGQGGYSEVYKGNLS---DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE--N-GL 318 (558)
Q Consensus 246 ~~f~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~-~~ 318 (558)
+.|.+ +++||+|+||+||+|... +++.||||++...... ..+.+|+.+++.++||||+++++++.. + ..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34665 458999999999999754 5788999999755433 247789999999999999999999964 3 38
Q ss_pred EEEEEeccCCCHHHHHhhcc-------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceee----cCCCce
Q 008650 319 YLIFNFSQNGNLDAALHDER-------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLL----GPDFEP 387 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~ 387 (558)
++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||| +.++.+
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcE
Confidence 999999975 7777765321 2248999999999999999999999 899999999999999 777899
Q ss_pred EEEeccccccCCCCCCc-ccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhH--------
Q 008650 388 QITDFGLAKWLPNKCTH-HAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNL-------- 457 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~-------- 457 (558)
||+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999999876543211 222346799999999999874 58999999999999999999999997543211
Q ss_pred HHHhhhhhhcC-----Cccccc-------------CCCCCCC--------CCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 008650 458 VLWAKPLMESG-----NLTELV-------------DPSLEGE--------YDTDQMHRLVLIADYCVRQTSAWRPSMSEV 511 (558)
Q Consensus 458 ~~~~~~~~~~~-----~~~~~~-------------d~~l~~~--------~~~~~~~~l~~li~~cl~~dp~~RPt~~ev 511 (558)
......+..-+ .+..+. ....... ........+.+++.+||+.||.+|||+.|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 00000000000 000000 0000000 000013467889999999999999999999
Q ss_pred HHH
Q 008650 512 LEL 514 (558)
Q Consensus 512 l~~ 514 (558)
++.
T Consensus 332 L~h 334 (405)
T 3rgf_A 332 MQD 334 (405)
T ss_dssp HTS
T ss_pred hcC
Confidence 985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=330.68 Aligned_cols=253 Identities=22% Similarity=0.362 Sum_probs=182.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+.+.||+|+||.||+|.. .+|+.||||++............+..+..+++.++||||+++++++.++. .++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 46789999999999999999966 47999999999766544444444555556788889999999999998765 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCC-cEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR-RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
||+ ++.+..+.. .....+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 445555443 334679999999999999999999998 5 8999999999999999999999999999766443
Q ss_pred CCcccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
.. .....||+.|+|||++. ...++.++|||||||++|+|++|+.||.........+.... .. ....
T Consensus 179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~-~~~~---- 249 (318)
T 2dyl_A 179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QE-EPPL---- 249 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HS-CCCC----
T ss_pred cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-cc-CCCC----
Confidence 22 22345999999999994 55788999999999999999999999986443322222211 11 1110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+.. .......+.+++.+||+.||.+|||+.++++.
T Consensus 250 -~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 -LPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -CCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 100 01123468899999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.29 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=187.9
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e 323 (558)
+.|.+.+.||+|+||+||.+...+|+.||||++.... ...+.+|+.+++.+ +||||+++++++.++. .++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 3456678999999999988877789999999986532 23467899999876 7999999999998766 899999
Q ss_pred eccCCCHHHHHhhccCCC-----CCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-------------C
Q 008650 324 FSQNGNLDAALHDERSKS-----LEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-------------F 385 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~ 385 (558)
|+. |+|.+++....... ..+..++.++.||+.||.|||+ ++|+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCce
Confidence 996 69999996543221 1233457899999999999999 899999999999999754 4
Q ss_pred ceEEEeccccccCCCCCCcc--cccccccccCcccchhhcc-------CCCCccccchhHHHHHHHHHc-CCCCCCCCch
Q 008650 386 EPQITDFGLAKWLPNKCTHH--AAIPIEGTFGYLAPEYFMH-------GIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQ 455 (558)
Q Consensus 386 ~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~ 455 (558)
.+||+|||++..+....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 89999999998875543221 1234569999999999976 678999999999999999999 9999976533
Q ss_pred hHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 456 NLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
........ .... +......+......+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~~i~~~---~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RESNIIRG---IFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHT---CCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHHHhcC---CCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 32211110 0011 11122234566788999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=330.94 Aligned_cols=251 Identities=19% Similarity=0.271 Sum_probs=172.7
Q ss_pred hCCCcccc-eEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe----Cc-
Q 008650 245 TNNFHSEN-MVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE----NG- 317 (558)
Q Consensus 245 ~~~f~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~- 317 (558)
.++|.+.+ +||+|+||+||+|... +|+.||||++... .....++. ..++.+.||||+++++++.. +.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~---~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVD---HHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHH---HHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHH---HHHHhcCCCChHHHHHHHhhccCCCce
Confidence 46788854 7999999999999654 7999999999653 22222222 23455689999999999864 22
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---CCceEEEeccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---DFEPQITDFGL 394 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~ 394 (558)
.++||||+.+|+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 8999999999999999987665679999999999999999999999 89999999999999976 45599999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHh-hhhhhcCCcccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA-KPLMESGNLTEL 473 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~-~~~~~~~~~~~~ 473 (558)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ......+.
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 249 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ---- 249 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc----
Confidence 98654322 2234689999999999988999999999999999999999999976432211000 00000000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..............+.+++.+||+.||.+|||+.|+++.
T Consensus 250 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 250 --YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001111112334578899999999999999999999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.55 Aligned_cols=259 Identities=20% Similarity=0.297 Sum_probs=192.2
Q ss_pred hCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe--------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-------- 315 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 315 (558)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 468999999999999999999664 58999999986543 5566788999999999999999999998732
Q ss_pred -------CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec-CCCce
Q 008650 316 -------NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG-PDFEP 387 (558)
Q Consensus 316 -------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 387 (558)
+..++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+ ++|+||||||+|||++ .++.+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence 23899999998 599999853 468999999999999999999999 8999999999999997 56799
Q ss_pred EEEeccccccCCCCCCc-ccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh
Q 008650 388 QITDFGLAKWLPNKCTH-HAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM 465 (558)
Q Consensus 388 kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 465 (558)
||+|||+++........ .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........... ..
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~--~~ 238 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL--IL 238 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH--HH
Confidence 99999999876433221 12223457999999999875 6789999999999999999999999987543211100 00
Q ss_pred hc-C------------CcccccCCCCC-CCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 466 ES-G------------NLTELVDPSLE-GEY-----DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 466 ~~-~------------~~~~~~d~~l~-~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.. . .....+..... ... .......+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00 0 00000000000 000 01234578999999999999999999999983
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.29 Aligned_cols=244 Identities=20% Similarity=0.361 Sum_probs=192.1
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH----HHHHHHHHHHHHhccc----ccCCeeeeeeEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA----KKEKEFLMELGIIGHV----CHPNTATLVGCC 313 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~l~~~~ 313 (558)
...++|.+.+.||+|+||.||+|.. .+++.||||++....... .....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999955 578999999996654322 2233455788888888 899999999998
Q ss_pred EeCc-EEEEEEe-ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec-CCCceEEE
Q 008650 314 IENG-LYLIFNF-SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG-PDFEPQIT 390 (558)
Q Consensus 314 ~~~~-~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~ 390 (558)
.+.+ .++|+|+ +.+++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEE
Confidence 7654 8999999 7899999999754 468999999999999999999999 8999999999999999 88999999
Q ss_pred eccccccCCCCCCcccccccccccCcccchhhccCCCC-ccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC
Q 008650 391 DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIID-EKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469 (558)
Q Consensus 391 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 469 (558)
|||++....... .....||+.|+|||++.+..+. .++||||||+++|+|++|+.||....... . ..
T Consensus 183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~-~~ 249 (312)
T 2iwi_A 183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL--------E-AE 249 (312)
T ss_dssp CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------H-TC
T ss_pred EcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh--------h-hc
Confidence 999998765432 2234599999999999877664 58999999999999999999997542210 0 00
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. .++......+.+++.+||+.+|++|||+.|+++.
T Consensus 250 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 250 L----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp C----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred c----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0112233568899999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=334.01 Aligned_cols=246 Identities=20% Similarity=0.362 Sum_probs=198.1
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccH----HHHHHHHHHHHHhcccc--cCCeeeeeeEE
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDA----KKEKEFLMELGIIGHVC--HPNTATLVGCC 313 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 313 (558)
.....++|.+.+.||+|+||.||+|. ..+++.||||++....... .....+.+|+.+++++. |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34456789999999999999999995 4578999999997653221 12234567888999886 59999999999
Q ss_pred EeCc-EEEEEEeccC-CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec-CCCceEEE
Q 008650 314 IENG-LYLIFNFSQN-GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG-PDFEPQIT 390 (558)
Q Consensus 314 ~~~~-~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~ 390 (558)
.+++ .++|+|++.+ ++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 8765 8999999976 8999999654 468999999999999999999999 8999999999999999 78999999
Q ss_pred eccccccCCCCCCcccccccccccCcccchhhccCCC-CccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC
Q 008650 391 DFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469 (558)
Q Consensus 391 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 469 (558)
|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ... .
T Consensus 193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~~~-~ 259 (320)
T 3a99_A 193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRG-Q 259 (320)
T ss_dssp CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------HHC-C
T ss_pred eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--------hcc-c
Confidence 999998765432 223469999999999987765 68899999999999999999999764221 000 0
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
. .... .....+.+++.+||+.||++|||+.|+++.
T Consensus 260 ~------~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 V------FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp C------CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c------cccc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111 223468899999999999999999999884
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.71 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=187.6
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv 321 (558)
...+|.+.+.||+|+||+||.....+|+.||||++...... .+.+|+.+++.+ +||||+++++++.++. .|+|
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 34568999999999999977666678999999999654322 245789999998 7999999999998866 8999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---C--CceEEEeccccc
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---D--FEPQITDFGLAK 396 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DFG~a~ 396 (558)
|||+. |+|.+++.... ..+.+..++.++.||+.||.|||+ ++|+||||||+|||++. + ..+||+|||+++
T Consensus 97 ~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 99996 59999996543 334555667899999999999999 89999999999999953 2 357899999998
Q ss_pred cCCCCCCc-ccccccccccCcccchhhc---cCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 397 WLPNKCTH-HAAIPIEGTFGYLAPEYFM---HGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 397 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
.+...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||.......... ........
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~---~~~~~~~~ 248 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---LLGACSLD 248 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH---HTTCCCCT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH---HhccCCcc
Confidence 76543221 2233467999999999997 4567889999999999999999 999997543322211 11111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 472 ELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 472 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
. . .........+.+++.+||+.||.+|||+.|+++
T Consensus 249 -~----~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 -C----L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -T----S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -c----c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0 112234556889999999999999999999995
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=348.39 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=198.9
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe------C-c
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE------N-G 317 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~-~ 317 (558)
++|.+.+.||+|+||+||+|.. .+|+.||||++... ........+.+|+.++++++||||+++++++.. + .
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6799999999999999999954 57899999998654 345667789999999999999999999998643 3 3
Q ss_pred EEEEEEeccCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc---eEEEecc
Q 008650 318 LYLIFNFSQNGNLDAALHDERS-KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE---PQITDFG 393 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG 393 (558)
.++||||+.+|+|.+++..... ..+++..++.++.+++.||.|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976432 368999999999999999999999 89999999999999997765 9999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccc
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 473 (558)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..|.............
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-VQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-HHSSTTCC------CC
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-hhhhhhhhcccchhhh
Confidence 9987654322 23356999999999999999999999999999999999999999764322 2222211111111111
Q ss_pred cC----------C--CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 008650 474 VD----------P--SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSE 510 (558)
Q Consensus 474 ~d----------~--~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 510 (558)
.. . .............+.+++.+||+.||++|||+.|
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 11 0 1112234556788999999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=349.18 Aligned_cols=238 Identities=18% Similarity=0.289 Sum_probs=191.9
Q ss_pred hCCCcccceEeeeCceEEEEEEEC--CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-----
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLS--DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG----- 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 317 (558)
.++|.+.+.||+|+||+||+|... +|+.||||++... ........+.+|+.++.+++||||+++++++.+.+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 478999999999999999999664 6899999998653 33556677899999999999999999999987532
Q ss_pred -EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 318 -LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 318 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
.|+||||+.+++|.+++.. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ .+||+|||+++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence 5999999999999987743 69999999999999999999999 899999999999999886 89999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
..... ....||+.|+|||++.++. +.++|||||||+||+|++|..||...... .+
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------~~--- 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------------GL--- 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------------SC---
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------------cc---
Confidence 76543 2346999999999997764 88999999999999999999888642110 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHhc
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPS-MSEVLELLTS 517 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~L~~ 517 (558)
............+.+++.+||+.||.+||+ +.++...|.+
T Consensus 285 -~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 -PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000111223457889999999999999995 5555555543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=307.21 Aligned_cols=231 Identities=13% Similarity=0.115 Sum_probs=182.4
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|.+.+.||+|+||.||+|... +++.||||++..... .......+.+|+.++.+++||||+++++++.+++ .|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999654 589999999976543 3556678999999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+++|.+++.. + .....+.+++.|++.||.|||+ ++|+||||||+|||++.+|.+||+++|
T Consensus 111 e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999999943 2 3555678899999999999999 899999999999999999999997443
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHH-HhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL-WAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
|++| ++.++|||||||++|||++|+.||......... ....... +... ....
T Consensus 175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~------~~~~ 227 (286)
T 3uqc_A 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-GQPI------EPAD 227 (286)
T ss_dssp -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT-SCBC------CHHH
T ss_pred -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc-cCCC------Chhh
Confidence 3443 688999999999999999999999864321100 0000000 0000 0000
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
........+.+++.+||+.||.+| |+.|+++.|+....
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 112234568999999999999999 99999999987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=329.74 Aligned_cols=243 Identities=14% Similarity=0.129 Sum_probs=178.4
Q ss_pred hhCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeeccc-ccHHHHHHHHHHHHHhccccc-CCee-------------
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCH-PNTA------------- 307 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~niv------------- 307 (558)
.+.+|...+.||+|+||+||+|. ..+|+.||||++.... ......+.+.+|+.+++.+.| .|..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34567888999999999999996 5679999999987433 222335678899999999977 2211
Q ss_pred --e------eeeEEEe------CcEEEEEEeccCCCHHHHHhh-----ccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCc
Q 008650 308 --T------LVGCCIE------NGLYLIFNFSQNGNLDAALHD-----ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR 368 (558)
Q Consensus 308 --~------l~~~~~~------~~~~lv~e~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ 368 (558)
. ++.++.. ...+++|++ .+++|.+++.. .....+++..++.++.||+.||.|||+ ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred hcccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 1 1111111 124555554 56899988842 223457888999999999999999999 89
Q ss_pred EEecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhh----------ccCCCCccccchhHHH
Q 008650 369 IIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF----------MHGIIDEKTDVFAFGV 438 (558)
Q Consensus 369 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDvwSlGv 438 (558)
|+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999865432 234568 999999999 5556889999999999
Q ss_pred HHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 439 LLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 439 vl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
++|||++|+.||....... .....+... .. ....+.+++.+||+.||++|||+.++++
T Consensus 306 il~elltg~~Pf~~~~~~~-----------~~~~~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALG-----------GSEWIFRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGS-----------CSGGGGSSC--CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhh-----------hHHHHHhhc--cc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999997643211 011111100 11 2256889999999999999999877754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.63 Aligned_cols=226 Identities=19% Similarity=0.299 Sum_probs=177.1
Q ss_pred CCCccc-ceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHh-cccccCCeeeeeeEEEe----Cc-
Q 008650 246 NNFHSE-NMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGII-GHVCHPNTATLVGCCIE----NG- 317 (558)
Q Consensus 246 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~- 317 (558)
++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|+.++ +...||||+++++++.. +.
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 567776 7899999999999955 67899999999643 2355677777 55689999999999865 33
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---CCceEEEeccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---DFEPQITDFGL 394 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~ 394 (558)
.++||||+.+|+|.+++.......+++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 8999999999999999987666679999999999999999999999 89999999999999998 78899999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
+.... +..++.++|||||||++|+|++|+.||......... ......+.
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~~~~~~ 215 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTRIR 215 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSCCSSC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------HHHHHHHh
Confidence 86532 234678999999999999999999999764322110 00000000
Q ss_pred CCCCCCCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSLEGEYD----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
... ...+ ......+.+++.+||+.||.+|||+.|+++.
T Consensus 216 ~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 216 MGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 0111 1234578999999999999999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=311.13 Aligned_cols=245 Identities=16% Similarity=0.166 Sum_probs=183.2
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccc------cHHHHHHHHHHHHHhcccc---------cCCeee
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNK------DAKKEKEFLMELGIIGHVC---------HPNTAT 308 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~ 308 (558)
..++|.+.+.||+|+||+||+|.. +|+.||||++..... .......+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346789999999999999999977 789999999976532 1122345667777777765 777777
Q ss_pred eeeEEE-------------------------------eCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHH
Q 008650 309 LVGCCI-------------------------------ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARG 357 (558)
Q Consensus 309 l~~~~~-------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~a 357 (558)
+.+.+. ++..|+||||+.+|++.+.+.. ..+++..++.++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 776542 3449999999999976666632 458999999999999999
Q ss_pred HHHhh-hCCCCcEEecCCCCCceeecCCC--------------------ceEEEeccccccCCCCCCcccccccccccCc
Q 008650 358 LHYLH-KGCKRRIIHRDIKASNVLLGPDF--------------------EPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416 (558)
Q Consensus 358 L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 416 (558)
|.||| + ++|+||||||+||||+.++ .+||+|||+|+..... ...||+.|
T Consensus 174 L~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 8 8999999999999999887 8999999999876432 23699999
Q ss_pred ccchhhccCCCCccccchhHHHH-HHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHH
Q 008650 417 LAPEYFMHGIIDEKTDVFAFGVL-LLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIAD 495 (558)
Q Consensus 417 ~aPE~~~~~~~~~ksDvwSlGvv-l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~ 495 (558)
+|||++.+.. +.++||||||++ .+++++|..||...... .............. ..............+.+++.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL-HYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-HHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh-hHHHHhhhhhhccC----cccchhhhhhcCHHHHHHHH
Confidence 9999998766 899999998777 77888999998532110 00000111111111 11111123456788999999
Q ss_pred HhhccCCCCCCCHHHHH-H
Q 008650 496 YCVRQTSAWRPSMSEVL-E 513 (558)
Q Consensus 496 ~cl~~dp~~RPt~~evl-~ 513 (558)
+||+.| |+.|++ +
T Consensus 318 ~~L~~d-----sa~e~l~~ 331 (336)
T 2vuw_A 318 TMLNFS-----SATDLLCQ 331 (336)
T ss_dssp HGGGSS-----SHHHHHHH
T ss_pred HHhccC-----CHHHHHhc
Confidence 999976 999988 5
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-31 Score=288.72 Aligned_cols=186 Identities=15% Similarity=0.136 Sum_probs=130.9
Q ss_pred eEeeeCceEEEEE-EECCCCEEEEEEeeccc--------ccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEEE
Q 008650 253 MVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN--------KDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 253 ~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv 321 (558)
..+.|++|.+..+ ....|+.|++|++.+.. .......+|.+|+++|+++ .|+||+++++++.+++ .|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4566777766665 44468899999997652 1234456799999999999 6999999999998876 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||++|++|.+.|... +.+++. +|+.||+.||+|||+ +|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999999643 456654 589999999999999 99999999999999999999999999999876543
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~P 449 (558)
.. ...+.+||++|||||++.+ .+..++|+||+|+++++|.++..|
T Consensus 393 ~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 32 2334679999999999965 467789999999998887666544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=259.35 Aligned_cols=187 Identities=15% Similarity=0.166 Sum_probs=145.2
Q ss_pred cccceEeeeCceEEEEEEECCCCEEEEEEeeccccc------HHHHHHHHHHHHHhcccccCCeeeeeeEEEe-CcEEEE
Q 008650 249 HSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKD------AKKEKEFLMELGIIGHVCHPNTATLVGCCIE-NGLYLI 321 (558)
Q Consensus 249 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv 321 (558)
...+.||+|+||+||+|. ..++.+++|+....... ....+.+.+|+.++++++||||+.+..++.. +..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 345789999999999994 45788999987543221 1224568899999999999999965555544 448999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+++++|.+++.. +..++.|++.||.|||+ ++|+||||||+|||++. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999854 46799999999999999 89999999999999998 9999999999987553
Q ss_pred CCcc-----cccccccccCcccchhhcc--CCCCccccchhHHHHHHHHHcCCCCCC
Q 008650 402 CTHH-----AAIPIEGTFGYLAPEYFMH--GIIDEKTDVFAFGVLLLEIITGRKPVD 451 (558)
Q Consensus 402 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~~Pf~ 451 (558)
.... ......||+.|||||++.. ..|+..+|+|+..+-.++.+.++-+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2211 1234679999999999987 568889999999999999888877663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9e-25 Score=216.91 Aligned_cols=165 Identities=13% Similarity=0.054 Sum_probs=130.7
Q ss_pred HHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccH----------------HHHHHHHHHHHHhccccc
Q 008650 240 EISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDA----------------KKEKEFLMELGIIGHVCH 303 (558)
Q Consensus 240 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h 303 (558)
.+......|.+.+.||+|+||.||+|...+|+.||+|++....... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 3444556677889999999999999977789999999996432211 24567889999999998
Q ss_pred CCeeeeeeEEEeCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC
Q 008650 304 PNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP 383 (558)
Q Consensus 304 ~niv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 383 (558)
| +++++++..+..++||||+++++|.+ +.. .....++.|++.||.|||+ .+|+||||||+|||++
T Consensus 163 -~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 163 -G-LAVPKVYAWEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp -T-SSSCCEEEEETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-
T ss_pred -C-CCcCeEEeccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-
Confidence 5 77777776667899999999999988 421 1245799999999999999 8999999999999999
Q ss_pred CCceEEEeccccccCCCCCCcccccccccccCcccchhhcc----------CCCCccccchh
Q 008650 384 DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH----------GIIDEKTDVFA 435 (558)
Q Consensus 384 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~ksDvwS 435 (558)
++.+||+|||+++. +..|+|||++.. ..|+..+|+|.
T Consensus 228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 228 EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999999999863 445789999853 34555566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=7.6e-20 Score=179.05 Aligned_cols=139 Identities=17% Similarity=0.113 Sum_probs=107.2
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCE--EEEEEeeccccc----------------------HHHHHHHHHHHHHhccc
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRK--IAVKRLAKDNKD----------------------AKKEKEFLMELGIIGHV 301 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~E~~~l~~l 301 (558)
-|.+.+.||+|+||.||+|.. .+|+. ||||++...... ......+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 366789999999999999966 68989 999997543211 11223578899999999
Q ss_pred ccCCe--eeeeeEEEeCcEEEEEEeccC-C----CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhh-hCCCCcEEecC
Q 008650 302 CHPNT--ATLVGCCIENGLYLIFNFSQN-G----NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH-KGCKRRIIHRD 373 (558)
Q Consensus 302 ~h~ni--v~l~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH-~~~~~~ivH~D 373 (558)
.|+++ ..++. .+..++||||+.+ | +|.+.... .++..+..++.|++.||.||| + .+|+|||
T Consensus 128 ~~~~i~~p~~~~---~~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYT---YMKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp HHTTCCCCCEEE---EETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred HhCCCCCCeEEE---cCCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 98864 33333 2457899999942 4 67666532 234456789999999999999 7 8999999
Q ss_pred CCCCceeecCCCceEEEeccccccC
Q 008650 374 IKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 374 lkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=7.6e-17 Score=164.53 Aligned_cols=139 Identities=12% Similarity=0.126 Sum_probs=101.3
Q ss_pred CCcccceEeeeCceEEEEEEECCCCEEEEEEeeccccc---------------H-HH----HHHHHHHHHHhcccccCCe
Q 008650 247 NFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKD---------------A-KK----EKEFLMELGIIGHVCHPNT 306 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~-~~----~~~~~~E~~~l~~l~h~ni 306 (558)
=|.+.+.||+|+||.||+|...+|+.||||+++..... . .. .....+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 48999999999999999998889999999987532110 0 00 1112356777777755544
Q ss_pred eeeeeEEEeCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-
Q 008650 307 ATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF- 385 (558)
Q Consensus 307 v~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~- 385 (558)
.- ...+.....+|||||+.|++|..+.. . .....++.||+.+|.|||+ .|||||||||.|||+++++
T Consensus 176 ~v-p~p~~~~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PV-PEPIAQSRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SC-CCEEEEETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEEC
T ss_pred CC-CeeeeccCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCC
Confidence 22 22222234579999999988865431 1 2245688999999999998 8999999999999998876
Q ss_pred ---------ceEEEecccccc
Q 008650 386 ---------EPQITDFGLAKW 397 (558)
Q Consensus 386 ---------~~kl~DFG~a~~ 397 (558)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 388999997654
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.61 E-value=3.8e-15 Score=131.93 Aligned_cols=138 Identities=14% Similarity=0.222 Sum_probs=109.6
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCCc
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQV 85 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v 85 (558)
-++|+|++|.|+ .|..||.||+.-..+.|..|++|||.++........................+.|+.+...+...++
T Consensus 5 ~~~ILv~~D~s~-~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~ 83 (146)
T 3s3t_A 5 YTNILVPVDSSD-AAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALDPVLSELLDAEAAHAKDAMRQRQQFVATTSA 83 (146)
T ss_dssp CCEEEEECCSSH-HHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGHHHHHHHHHHHHHHHHHHHHHHHHHHTTSSC
T ss_pred cceEEEEcCCCH-HHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccHHHHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 579999999999 9999999999887777899999999876543211110011222333344456788889988988899
Q ss_pred -ceeEEEecCCchhhHHHH-HHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEc
Q 008650 86 -NLEAKVGFSTSIGRGLIE-EAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFG 147 (558)
Q Consensus 86 -~~~~~v~~g~~~~~~i~~-~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~ 147 (558)
+++..+..| ++.+.|++ +|+..++|++|||+++.+.... .||++.++.++++ |||.++.
T Consensus 84 ~~~~~~~~~g-~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV~ 146 (146)
T 3s3t_A 84 PNLKTEISYG-IPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGSTTSYVVDHAP--CNVIVIR 146 (146)
T ss_dssp CCCEEEEEEE-CHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCHHHHHHHHHCS--SEEEEEC
T ss_pred cceEEEEecC-ChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcchHHHHhccCC--CCEEEeC
Confidence 999999999 67889999 9999999999999998765433 8999999999999 9998763
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=1.3e-14 Score=131.00 Aligned_cols=140 Identities=8% Similarity=0.074 Sum_probs=107.3
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeeccc-----cccccc--c--h-hh----hhhHHHHHHHHHHH
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGE-----ESKKRG--S--M-AK----RQSQIRRAKAHVIS 71 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~-----~~~~~~--~--~-~~----~~~~~~~~~~~~~~ 71 (558)
-++|+|++|.|+ .|..||.||++.....|..|++|||.++. ...... . . +. .............+
T Consensus 5 ~~~ILv~vD~s~-~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (162)
T 1mjh_A 5 YKKILYPTDFSE-TAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKN 83 (162)
T ss_dssp CCEEEEECCSCH-HHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCH-HHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHHH
Confidence 589999999999 89999999998877778999999998754 110000 0 0 10 00122223333456
Q ss_pred HHHHhHhccccCCcceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEccc
Q 008650 72 MLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 72 ~l~~~~~~c~~~~v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
.|+.+...+...+++++.++..| ++.+.|+++|++.++|++|||+++.+..++ +||++.++.++++ |||.++...
T Consensus 84 ~l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GSv~~~vl~~~~--~pVlvv~~~ 160 (162)
T 1mjh_A 84 KMENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKRK 160 (162)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHHHHcCCceEEEEcCC-CHHHHHHHHHHHcCCCEEEEcCCCCCCccceEecchHHHHHHhCC--CCEEEEeCC
Confidence 78888888888899999999988 678899999999999999999998765433 8999999999999 999998654
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.55 E-value=8.6e-15 Score=129.74 Aligned_cols=136 Identities=12% Similarity=0.084 Sum_probs=105.2
Q ss_pred cEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeeccccc-ccccc---hhhhhhHHHHHHHHHHHHHHHhHhcccc
Q 008650 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEES-KKRGS---MAKRQSQIRRAKAHVISMLGEFAGTSQS 82 (558)
Q Consensus 7 r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~l~~~~~~c~~ 82 (558)
++|+|++|.|+ .|..||.||+....+.|..|++|||.++... ..... ................+.++.+...+..
T Consensus 3 ~~ILv~vD~s~-~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 81 (147)
T 3hgm_A 3 NRIMVPVDGSK-GAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMARPEQLDIPDDALKDYATEIAVQAKTRATE 81 (147)
T ss_dssp SEEEEECCSBH-HHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCCCGGGCCCTTHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEEeCCCH-HHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccChhhhhhHHHHHHHHHHHHHHHHHHHHHh
Confidence 78999999999 9999999999977778999999999876431 10000 0000011222233345788888888888
Q ss_pred CCcce---eEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEE
Q 008650 83 KQVNL---EAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIF 146 (558)
Q Consensus 83 ~~v~~---~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v 146 (558)
.++++ +..+..| ++.+.|+++|++.++|++|||+++.+..+. .||++.++.++++ |||.++
T Consensus 82 ~g~~~~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 82 LGVPADKVRAFVKGG-RPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGSVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp TTCCGGGEEEEEEES-CHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCHHHHHHHHHCS--SCEEEC
T ss_pred cCCCccceEEEEecC-CHHHHHHHHHHHhCCCEEEEeCCCCccccceeeccHHHHHHhhCC--CCEEEC
Confidence 88888 8889998 678899999999999999999998765433 8999999999999 999864
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.6e-14 Score=125.27 Aligned_cols=133 Identities=15% Similarity=0.129 Sum_probs=105.6
Q ss_pred cEEEEEEecCccchHHHHHHHHhhc-cCCCCeEEEEEeecccccccccchhhhhhHHHHHH-HHHHHHHHHhHhccccCC
Q 008650 7 SKILIGFSLDPNDSKELLSWAIKVL-AQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAK-AHVISMLGEFAGTSQSKQ 84 (558)
Q Consensus 7 r~i~Vavd~~~~~s~~al~Wal~~~-~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~c~~~~ 84 (558)
++|+|++|.|+ .|..||.||+.-. .+.|..|.+|||.++......... .......... ....+.|+.+...+...+
T Consensus 2 ~~ILv~~D~s~-~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~g 79 (138)
T 3idf_A 2 KKLLFAIDDTE-ACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAVL-AAYDEIEMKEEEKAKLLTQKFSTFFTEKG 79 (138)
T ss_dssp EEEEEECCSSH-HHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ceEEEEeCCCH-HHHHHHHHHHHHhccCCCCEEEEEEEecCCCccccccc-CcHHHHHHHHHHHHHHHHHHHHHHHHHCC
Confidence 68999999999 9999999999998 788999999999976532211100 0112222333 445578888888888889
Q ss_pred cceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc-chhhhhhhhhcCCCCceEEEE
Q 008650 85 VNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM-SRDVTRYCFQHAPGGCTIHIF 146 (558)
Q Consensus 85 v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~-~~sv~~~c~~~~~~~c~v~~v 146 (558)
++++..+..| ++.+.|+++++ ++|++|||+++.+.... .||++.++.++++ |||.++
T Consensus 80 ~~~~~~v~~g-~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv 137 (138)
T 3idf_A 80 INPFVVIKEG-EPVEMVLEEAK--DYNLLIIGSSENSFLNKIFASHQDDFIQKAP--IPVLIV 137 (138)
T ss_dssp CCCEEEEEES-CHHHHHHHHHT--TCSEEEEECCTTSTTSSCCCCTTCHHHHHCS--SCEEEE
T ss_pred CCeEEEEecC-ChHHHHHHHHh--cCCEEEEeCCCcchHHHHhCcHHHHHHhcCC--CCEEEe
Confidence 9999999999 67889999999 99999999998765433 4999999999999 999876
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=2e-14 Score=130.06 Aligned_cols=138 Identities=14% Similarity=0.134 Sum_probs=102.5
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEE--EeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccC
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAI--HVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSK 83 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~ll--hv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~ 83 (558)
.++|+|++|.|+ .|..||.||++... .|..|++| ||.++.... ...................+.|+.+...+...
T Consensus 17 ~~~ILv~vD~s~-~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 93 (163)
T 1tq8_A 17 YKTVVVGTDGSD-SSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDAR-AADILKDESYKVTGTAPIYEILHDAKERAHNA 93 (163)
T ss_dssp CCEEEEECCSSH-HHHHHHHHHHHHHT-TTSEEEEEEECCC---------------------CCTHHHHHHHHHHHHHTT
T ss_pred CCEEEEEcCCCH-HHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccc-cccccccHHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 589999999999 99999999999887 88999999 887643210 00000001111112223456788888888878
Q ss_pred Ccc-eeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEccc
Q 008650 84 QVN-LEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 84 ~v~-~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
+++ ++..+..| ++.+.|+++|++.++|++|||+++.+..+. +||++.++.++++ |||.++...
T Consensus 94 gv~~v~~~v~~G-~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSva~~vl~~a~--~PVlvV~~~ 159 (163)
T 1tq8_A 94 GAKNVEERPIVG-APVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVHTT 159 (163)
T ss_dssp TCCEEEEEEECS-SHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEECCC
T ss_pred CCCeEEEEEecC-CHHHHHHHHHHhcCCCEEEECCCCCCcccceeeccHHHHHHHhCC--CCEEEEeCC
Confidence 898 99999998 668899999999999999999998766433 8999999999999 999998753
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.52 E-value=7.7e-14 Score=127.00 Aligned_cols=141 Identities=11% Similarity=0.048 Sum_probs=106.1
Q ss_pred CCcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeeccccccccc-chh--------hhhhHHHHHHHHHHHHHHH
Q 008650 5 APSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRG-SMA--------KRQSQIRRAKAHVISMLGE 75 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~~~l~~ 75 (558)
--++|+|++|.|+ .|..||.||+.-..+.|..|++|||.++....... ... ..............+.|+.
T Consensus 4 m~~~ILv~vD~s~-~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 82 (170)
T 2dum_A 4 MFRKVLFPTDFSE-GAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYDNAEIELKDIKEKLKEEASRKLQE 82 (170)
T ss_dssp CCSEEEEECCSSH-HHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC------------CCTTSHHHHHHHHHHHHHH
T ss_pred ccceEEEEecCCH-HHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 3589999999999 89999999999887789999999998654321110 000 0011122223334567777
Q ss_pred hHhccccCCcceeE--EEecCCchhhHHHHHHHhccCcEEEEecccccCCc--cchhhhhhhhhcCCCCceEEEEccc
Q 008650 76 FAGTSQSKQVNLEA--KVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNK--MSRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 76 ~~~~c~~~~v~~~~--~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~--~~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
+...+...+++++. .+..| ++.+.|+++|++.++|++|||+++.+..+ +.||++.++.++++ |||.++...
T Consensus 83 ~~~~~~~~g~~~~~~~~~~~g-~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~PVlvv~~~ 157 (170)
T 2dum_A 83 KAEEVKRAFRAKNVRTIIRFG-IPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGSTVMRVLRKTK--KPVLIIKEV 157 (170)
T ss_dssp HHHHHHHHTTCSEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCHHHHHHHHHCS--SCEEEECCC
T ss_pred HHHHHHHcCCceeeeeEEecC-ChHHHHHHHHHHcCCCEEEECCCCCCccccceechHHHHHHHhCC--CCEEEEccC
Confidence 77777777888887 88888 67889999999999999999999876543 38999999999999 999999754
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=7.7e-14 Score=122.97 Aligned_cols=136 Identities=13% Similarity=0.145 Sum_probs=98.1
Q ss_pred CcEEEEEEecCccc--hHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccC
Q 008650 6 PSKILIGFSLDPND--SKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSK 83 (558)
Q Consensus 6 ~r~i~Vavd~~~~~--s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~ 83 (558)
.|+|+|++|.|+ . |..||.||+.-.-..|..|++|||.++........... ............+.++.++.++.+.
T Consensus 1 ~k~ILv~vD~s~-~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~ 78 (143)
T 3fdx_A 1 SNAILVPIDISD-KEFTERIISHVESEARIDDAEVHFLTVIPSLPYYASLGMAY-TAELPGMDELREGSETQLKEIAKKF 78 (143)
T ss_dssp CCEEEEECCTTC-SSCCTTHHHHHHHHHHHHTCEEEEEEEECC-----------------CHHHHHHHHHHHHHHHHTTS
T ss_pred CCEEEEEecCCh-HhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccccccccc-cchhhhHHHHHHHHHHHHHHHHHHc
Confidence 479999999999 9 99999999987777889999999997643211110000 0001111222335666667777665
Q ss_pred C---cceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc-chhhhhhhhhcCCCCceEEEE
Q 008650 84 Q---VNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM-SRDVTRYCFQHAPGGCTIHIF 146 (558)
Q Consensus 84 ~---v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~-~~sv~~~c~~~~~~~c~v~~v 146 (558)
+ ++++..+..| ++.+.|+++++..++|++|||+++.+..+. .||++..+.++++ |||.++
T Consensus 79 ~~~~~~v~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~v~~~~~--~pVlvv 142 (143)
T 3fdx_A 79 SIPEDRMHFHVAEG-SPKDKILALAKSLPADLVIIASHRPDITTYLLGSNAAAVVRHAE--CSVLVV 142 (143)
T ss_dssp CCCGGGEEEEEEES-CHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSCHHHHHHHHHCS--SEEEEE
T ss_pred CCCCCceEEEEEec-ChHHHHHHHHHHhCCCEEEEeCCCCCCeeeeeccHHHHHHHhCC--CCEEEe
Confidence 4 5678889998 778899999999999999999996443333 8999999999999 999876
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.51 E-value=6.5e-14 Score=125.54 Aligned_cols=137 Identities=16% Similarity=0.238 Sum_probs=106.1
Q ss_pred CCcEEEEEEe--cCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhcccc
Q 008650 5 APSKILIGFS--LDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQS 82 (558)
Q Consensus 5 ~~r~i~Vavd--~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~ 82 (558)
.-++|+|++| .|+ .|..||.||++-....|..|++|||.++......... .............+.|+.+...+..
T Consensus 14 ~~~~ILv~vD~~~s~-~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~ 90 (156)
T 3fg9_A 14 VYRRILLTVDEDDNT-SSERAFRYATTLAHDYDVPLGICSVLESEDINIFDSL--TPSKIQAKRKHVEDVVAEYVQLAEQ 90 (156)
T ss_dssp CCC-EEEECCSCCCH-HHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCCCSS--HHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCceEEEEECCCCCH-HHHHHHHHHHHHHHhcCCEEEEEEEEeCCCccccccC--CHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3589999999 999 9999999999977677899999999876432111111 1223333344455788888888887
Q ss_pred CCc-ceeEEEecCCchhhHHHHH-HHhccCcEEEEecccccCCc-cchhhhhhhhhcCCCCceEEEE
Q 008650 83 KQV-NLEAKVGFSTSIGRGLIEE-AKSISADYLVLRGSRNHSNK-MSRDVTRYCFQHAPGGCTIHIF 146 (558)
Q Consensus 83 ~~v-~~~~~v~~g~~~~~~i~~~-v~~~~~~~LV~G~~~~~~~~-~~~sv~~~c~~~~~~~c~v~~v 146 (558)
.++ .++..+..++++.+.|+++ |+..++|++|||+++.+..+ ++||++.++.++++ |||.++
T Consensus 91 ~g~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~Gs~~~~vl~~a~--~PVlvV 155 (156)
T 3fg9_A 91 RGVNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSKIAGAIGPRLARKAP--ISVIVV 155 (156)
T ss_dssp HTCSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCSCHHHHHHHHCS--SEEEEE
T ss_pred cCCCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccceeecchHHHHHHhCC--CCEEEe
Confidence 888 4899999933778899999 99999999999999775433 48999999999999 999876
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=1.5e-13 Score=125.81 Aligned_cols=142 Identities=18% Similarity=0.325 Sum_probs=99.6
Q ss_pred CCcEEEEEEecCcc--------chHHHHHHHHhhccCC---CCeEEEEEeecccccccc---c--chhhhh-hHHHHHHH
Q 008650 5 APSKILIGFSLDPN--------DSKELLSWAIKVLAQP---NDRIVAIHVLVGEESKKR---G--SMAKRQ-SQIRRAKA 67 (558)
Q Consensus 5 ~~r~i~Vavd~~~~--------~s~~al~Wal~~~~~~---~d~~~llhv~~~~~~~~~---~--~~~~~~-~~~~~~~~ 67 (558)
..++|+|+||.|+. .|..||.||++.+++. |..|++|||.++...... . ...... ........
T Consensus 4 ~~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (175)
T 2gm3_A 4 EPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKA 83 (175)
T ss_dssp -CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHH
T ss_pred CccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccccCCHHHHHHHHHHHHH
Confidence 35899999999971 5899999999988764 779999999854321110 0 000000 00011112
Q ss_pred HHHHHHHHhHhccccCCcceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEE
Q 008650 68 HVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHI 145 (558)
Q Consensus 68 ~~~~~l~~~~~~c~~~~v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~ 145 (558)
...+.|+.+...+...+++++.++..| ++.+.|+++|++.++|++|||+++.+..+. +||++.++.++++ |||.+
T Consensus 84 ~~~~~l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gsva~~vl~~a~--~pVlv 160 (175)
T 2gm3_A 84 KGLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMT 160 (175)
T ss_dssp HHHHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEE
T ss_pred HHHHHHHHHHHHHHHCCCceEEEEecC-CHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCchHHHHHhCCC--CCEEE
Confidence 234677777777777789999999998 678899999999999999999998765433 8999999999999 99999
Q ss_pred Eccc
Q 008650 146 FGET 149 (558)
Q Consensus 146 v~~~ 149 (558)
+...
T Consensus 161 v~~~ 164 (175)
T 2gm3_A 161 IKRN 164 (175)
T ss_dssp EECC
T ss_pred EcCC
Confidence 9754
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.6e-13 Score=122.99 Aligned_cols=127 Identities=12% Similarity=0.063 Sum_probs=99.8
Q ss_pred CcEEEEEEec-CccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCC
Q 008650 6 PSKILIGFSL-DPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQ 84 (558)
Q Consensus 6 ~r~i~Vavd~-~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~ 84 (558)
-++|+|++|. |+ .|..||.||++-....|..|++|||.++.... . ........+.|+.+...+...+
T Consensus 24 ~~~ILv~vD~~s~-~s~~al~~A~~la~~~~a~l~llhV~~~~~~~----~-------~~~~~~~~~~l~~~~~~~~~~g 91 (155)
T 3dlo_A 24 YMPIVVAVDKKSD-RAERVLRFAAEEARLRGVPVYVVHSLPGGGRT----K-------DEDIIEAKETLSWAVSIIRKEG 91 (155)
T ss_dssp CCCEEEECCSSSH-HHHHHHHHHHHHHHHHTCCEEEEEEECCSTTS----C-------HHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCeEEEEECCCCH-HHHHHHHHHHHHHHhcCCEEEEEEEEcCCCcc----c-------HHHHHHHHHHHHHHHHHHHhcC
Confidence 4789999999 99 99999999999877778999999998754211 0 1111223466777777777777
Q ss_pred cceeEE--EecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEc
Q 008650 85 VNLEAK--VGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFG 147 (558)
Q Consensus 85 v~~~~~--v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~ 147 (558)
+.++.. +..| ++.+.|+++|++.++|++|||+++.+.... +||++..+.++++ |||.+++
T Consensus 92 ~~~~~~~~v~~G-~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSv~~~vl~~a~--~PVLvVr 155 (155)
T 3dlo_A 92 AEGEEHLLVRGK-EPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGSVARDVILKAN--KPVICIK 155 (155)
T ss_dssp CCEEEEEEESSS-CHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCHHHHHHHHHCS--SCEEEEC
T ss_pred CCceEEEEecCC-CHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEeccHHHHHHHhCC--CCEEEeC
Confidence 776654 4445 778899999999999999999998765443 8999999999999 9999873
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.7e-13 Score=119.94 Aligned_cols=131 Identities=14% Similarity=0.172 Sum_probs=94.7
Q ss_pred cEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCCc-
Q 008650 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQV- 85 (558)
Q Consensus 7 r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v- 85 (558)
++|+|++|.|+ .|..||.||+.-.-..|..|++|||.++.......... ............+.|+.+... .++
T Consensus 3 ~~ILv~~D~s~-~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~---~g~~ 76 (137)
T 2z08_A 3 KTILLAYDGSE-HARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFF--EEALRRRLERAEGVLEEARAL---TGVP 76 (137)
T ss_dssp SEEEEECCSSH-HHHHHHHHHHHHHHHHTCEEEEEEEECC----------------CHHHHHHHHHHHHHHHH---HCCC
T ss_pred ceEEEEeCCCH-HHHHHHHHHHHHHhhcCCEEEEEEEecCCCccccccch--HHHHHHHHHHHHHHHHHHHHH---cCCC
Confidence 78999999999 99999999998776778999999998753211000000 011111122233455544333 677
Q ss_pred ceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCc--cchhhhhhhhhcCCCCceEEEE
Q 008650 86 NLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNK--MSRDVTRYCFQHAPGGCTIHIF 146 (558)
Q Consensus 86 ~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~--~~~sv~~~c~~~~~~~c~v~~v 146 (558)
+++..+..| ++.+.|++++++.++|++|||+++.+..+ ..||++.++.++++ |||.++
T Consensus 77 ~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv 136 (137)
T 2z08_A 77 KEDALLLEG-VPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLV 136 (137)
T ss_dssp GGGEEEEES-SHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCHHHHHHHHHCS--SCEEEE
T ss_pred ccEEEEEec-CHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhccHHHHHHhcCC--CCEEEe
Confidence 788888888 67889999999999999999999875543 38999999999998 999876
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.3e-13 Score=120.99 Aligned_cols=138 Identities=12% Similarity=0.141 Sum_probs=93.2
Q ss_pred CCcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccc---cccchh-hhhhHHHHHHHHHHHHHHHhHhcc
Q 008650 5 APSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESK---KRGSMA-KRQSQIRRAKAHVISMLGEFAGTS 80 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~c 80 (558)
.-++|+|++|.|+ .|..||.||+.-..+.|..|++|||.++.... ...... ..............+.|+. ++
T Consensus 5 ~~~~ILv~vD~s~-~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~ 80 (150)
T 3tnj_A 5 VYHHILLAVDFSS-EDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDTETTYDAMLDVEKQKLSQ---IG 80 (150)
T ss_dssp CCSEEEEECCCST-THHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSSSCCCHHHHHHHHHHHHHH---HH
T ss_pred ccceEEEEeCCCH-HHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcCHHHHHHHHHHHHHHHHHH---HH
Confidence 3689999999999 99999999999877778999999998764321 000000 0011112222222233333 34
Q ss_pred ccCCcc-eeEEEecCCchhhHHHHHHHhccCcEEEEecccccCC-ccchhhhhhhhhcCCCCceEEEEccc
Q 008650 81 QSKQVN-LEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSN-KMSRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 81 ~~~~v~-~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~-~~~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
.+.++. ++..+..| ++.+.|++++++.++|++|||+++.+.. .++||++.++.++++ |||.++...
T Consensus 81 ~~~~~~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~~~ 148 (150)
T 3tnj_A 81 NTLGIDPAHRWLVWG-EPREEIIRIAEQENVDLIVVGSHGRHGLALLLGSTANSVLHYAK--CDVLAVRLR 148 (150)
T ss_dssp HHHTCCGGGEEEEES-CHHHHHHHHHHHTTCSEEEEEEC--------CCCHHHHHHHHCS--SEEEEEECC
T ss_pred HHcCCCcceEEEecC-CHHHHHHHHHHHcCCCEEEEecCCCCCcCeEecchHHHHHHhCC--CCEEEEeCC
Confidence 444666 57788888 6688999999999999999999976443 348999999999999 999988653
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.41 E-value=5.5e-13 Score=117.20 Aligned_cols=135 Identities=19% Similarity=0.193 Sum_probs=94.0
Q ss_pred cEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHH-HHHHHHHHHHHHHhHhccccCCc
Q 008650 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQI-RRAKAHVISMLGEFAGTSQSKQV 85 (558)
Q Consensus 7 r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~c~~~~v 85 (558)
++|+|++|.|+ .|..||.||+.-.-..|..|++|||.++...............+ ........+.|+. ++...++
T Consensus 3 ~~ILv~~D~s~-~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~~~ 78 (141)
T 1jmv_A 3 KHILVAVDLSE-ESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLD---LAESVDY 78 (141)
T ss_dssp SEEEEEECCST-THHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHH---HHHHSSS
T ss_pred ceEEEEecCch-hhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhccccccchHHHHHHHHHHHHHHHHH---HHHHcCC
Confidence 68999999999 89999999998777778999999998531111111100000000 0011112233333 3333466
Q ss_pred ce-eEEEecCCchhhHHHHHHHhccCcEEEEecccccCCccchhhhhhhhhcCCCCceEEEEccc
Q 008650 86 NL-EAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMSRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 86 ~~-~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
.+ +..+..| ++.+.|+++|+..++|++|||++ .+..+++||++.++.++++ |||.++...
T Consensus 79 ~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~-~~~~~~lgs~~~~vl~~~~--~pVlvv~~~ 139 (141)
T 1jmv_A 79 PISEKLSGSG-DLGQVLSDAIEQYDVDLLVTGHH-QDFWSKLMSSTRQVMNTIK--IDMLVVPLR 139 (141)
T ss_dssp CCCCEEEEEE-CHHHHHHHHHHHTTCCEEEEEEC-CCCHHHHHHHHHHHHTTCC--SEEEEEECC
T ss_pred CceEEEEecC-CHHHHHHHHHHhcCCCEEEEeCC-CchhhhhcchHHHHHhcCC--CCEEEeeCC
Confidence 65 5666677 67889999999999999999999 7665557899999999999 999988653
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.8e-12 Score=113.41 Aligned_cols=128 Identities=9% Similarity=0.018 Sum_probs=94.1
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEee-cc-c-cc-ccccchhhhhhHHHHHHHHHHHHHHHhHhcc-
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVL-VG-E-ES-KKRGSMAKRQSQIRRAKAHVISMLGEFAGTS- 80 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~-~~-~-~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c- 80 (558)
-++|+|++|.|+ .|..||.||++-.-+.|..|++|||. +. + .. ......+..............+.|+.+ ..|
T Consensus 4 ~~~ILv~~D~s~-~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~ 81 (138)
T 1q77_A 4 MKVLLVLTDAYS-DCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREV-WEKL 81 (138)
T ss_dssp CEEEEEEESTTC-CCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHH-HHHH
T ss_pred ccEEEEEccCCH-hHHHHHHHHHHHHHHcCCeEEEEEEecccccccccccccCCCCChHHHHHHHHHHHHHHHHH-HHHh
Confidence 479999999999 89999999998877789999999998 53 1 10 000000000112222233334566666 553
Q ss_pred -ccCCcceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCccchhhhhhhhhcCCCCceEEEE
Q 008650 81 -QSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMSRDVTRYCFQHAPGGCTIHIF 146 (558)
Q Consensus 81 -~~~~v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~~~sv~~~c~~~~~~~c~v~~v 146 (558)
...+ +++..+..| ++.+.|+++|++.++|++|||+++. |++.++.++++ |||.++
T Consensus 82 ~~~~~-~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~g~-------sv~~~vl~~a~--~PVlvv 137 (138)
T 1q77_A 82 TGSTE-IPGVEYRIG-PLSEEVKKFVEGKGYELVVWACYPS-------AYLCKVIDGLN--LASLIV 137 (138)
T ss_dssp HSCCC-CCCEEEECS-CHHHHHHHHHTTSCCSEEEECSCCG-------GGTHHHHHHSS--SEEEEC
T ss_pred hccCC-cceEEEEcC-CHHHHHHHHHHhcCCCEEEEeCCCC-------chHHHHHHhCC--CceEee
Confidence 4456 778888888 6788999999999999999999975 89999999999 999876
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2e-11 Score=119.47 Aligned_cols=137 Identities=12% Similarity=0.092 Sum_probs=103.2
Q ss_pred cEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccc--cchh-hhhhH-------HHHHHHHHHHHHHHh
Q 008650 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKR--GSMA-KRQSQ-------IRRAKAHVISMLGEF 76 (558)
Q Consensus 7 r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~--~~~~-~~~~~-------~~~~~~~~~~~l~~~ 76 (558)
++|+|++|.|+ .|..||.||+.-..+.|..|++|||.++...... .... ..... .........+.|+.+
T Consensus 1 k~ILv~vD~s~-~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 79 (268)
T 3ab8_A 1 MRILLATDGSP-QARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRTELERALALRGEAVLERV 79 (268)
T ss_dssp CCEEEECCSCG-GGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-------CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCH-HHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 57999999999 9999999999877777889999999865321100 0000 00000 122233345688888
Q ss_pred HhccccCCcceeEEEecCCchhhHHHHHHHhccCcEEEEeccccc-CCc--cchhhhhhhhhcCCCCceEEEEccc
Q 008650 77 AGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNH-SNK--MSRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 77 ~~~c~~~~v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~-~~~--~~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
...+...+++++..+..| ++.+.|+++ ..++|++|||+++.+ ..+ ..||++..+.++++ |||.++...
T Consensus 80 ~~~~~~~g~~~~~~~~~g-~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs~~~~v~~~a~--~PVlvv~~~ 150 (268)
T 3ab8_A 80 RQSALAAGVAVEAVLEEG-VPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLGSTADRVLRASP--VPVLLAPGE 150 (268)
T ss_dssp HHHHHHTTCCEEEEEEEE-CHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCHHHHHHHHHCS--SCEEEECSS
T ss_pred HHHHHhCCCCeEEEEecC-CHHHHHHhh--ccCCCEEEEeccCCCccccccccchhHHHHHHhCC--CCEEEECCC
Confidence 888888899999999988 667899998 889999999999876 443 38999999999999 999988753
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.8e-11 Score=121.69 Aligned_cols=138 Identities=12% Similarity=0.074 Sum_probs=106.0
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCCc
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQV 85 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v 85 (558)
-++|+|++|.|+ .|..||.||+.-..+.|..|++|||.++........................+.|+.+...+...++
T Consensus 22 ~~~ILv~vD~s~-~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~ 100 (294)
T 3loq_A 22 SNAMLLPTDLSE-NSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGIDIDHYIDEMSEKAEEVLPEVAQKIEAAGI 100 (294)
T ss_dssp TCEEEEECCSCT-GGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CCCTTHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hccEEEecCCCH-HHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 579999999999 9999999999977777899999999876432111100111222333344456788888888888899
Q ss_pred ceeE-EEe-cCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEccc
Q 008650 86 NLEA-KVG-FSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 86 ~~~~-~v~-~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
+++. .+. .| ++.+.| .++..++|.+|||+++.+..+. .||++..+.++++ |||.++...
T Consensus 101 ~~~~~~v~~~g-~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 163 (294)
T 3loq_A 101 KAEVIKPFPAG-DPVVEI--IKASENYSFIAMGSRGASKFKKILLGSVSEGVLHDSK--VPVYIFKHD 163 (294)
T ss_dssp EEEECSSCCEE-CHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHCCHHHHHHHHCS--SCEEEECCC
T ss_pred CcceeEeeccC-ChhHhe--eeccCCCCEEEEcCCCCccccceeeccHHHHHHhcCC--CCEEEecCc
Confidence 9988 777 66 667788 9999999999999998765433 7999999999999 999998764
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=3e-11 Score=120.95 Aligned_cols=137 Identities=13% Similarity=0.182 Sum_probs=102.1
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccC--
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSK-- 83 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~-- 83 (558)
.++|+|++|.|+ .|..||.||+.-..+.|..|++|||.++........ ...............+.|+.+...+...
T Consensus 19 ~~~ILv~~D~s~-~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 96 (309)
T 3cis_A 19 SLGIIVGIDDSP-AAQVAVRWAARDAELRKIPLTLVHAVSPEVATWLEV-PLPPGVLRWQQDHGRHLIDDALKVVEQASL 96 (309)
T ss_dssp TTEEEEECCSSH-HHHHHHHHHHHHHHHHTCCEEEEEECCCCCCCTTCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred CCeEEEEECCCH-HHHHHHHHHHHHHHhcCCcEEEEEEecCcccccccC-CCCchhhHHHHHHHHHHHHHHHHHHHHhcc
Confidence 589999999999 899999999998777789999999986432110000 0011122222233345667666666544
Q ss_pred ---CcceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCc--cchhhhhhhhhcCCCCceEEEEccc
Q 008650 84 ---QVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNK--MSRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 84 ---~v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~--~~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
+++++..+..| ++.+.|+++++ ++|++|||+++.+..+ +.||++.++.++++ |||.++...
T Consensus 97 ~~~~~~~~~~~~~g-~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 162 (309)
T 3cis_A 97 RAGPPTVHSEIVPA-AAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGSVSSGLLRHAH--CPVVIIHDE 162 (309)
T ss_dssp SSCCSCEEEEEESS-CHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCHHHHHHHHHCS--SCEEEECTT
T ss_pred cCCCceEEEEEecC-CHHHHHHHHhc--CCCEEEECCCCCccccccccCcHHHHHHHhCC--CCEEEEcCC
Confidence 88899999988 67889999987 8999999999876543 38999999999998 999988754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3e-11 Score=117.79 Aligned_cols=145 Identities=12% Similarity=0.058 Sum_probs=108.9
Q ss_pred hhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~l 320 (558)
.....|.+...++.|+++.||++... ++.+++|+....... ....+.+|+.+++.+. +.++.++++++.+++ .|+
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 33457888888899999999999754 688999998642111 1124667888888775 667888888887765 899
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhC------------------------------------
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG------------------------------------ 364 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------------------------------------ 364 (558)
||||++|.+|...+. +......++.+++++|..||+.
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999987641 1122346888999999999971
Q ss_pred --------------------CCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 365 --------------------CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 365 --------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
....++|+|++|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114599999999999998765567999987753
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.19 E-value=8.3e-11 Score=116.57 Aligned_cols=134 Identities=7% Similarity=0.003 Sum_probs=95.2
Q ss_pred CCcEEEEEEecCccc-------hHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhH
Q 008650 5 APSKILIGFSLDPND-------SKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFA 77 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~-------s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 77 (558)
..++|+||+|.|+ . |..||.||+.-.-..|..|.+|||.++...... .+. ............+.|+
T Consensus 133 ~~~~Ilva~D~s~-~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~--~~~-~~~~~~~~~~~~~~l~--- 205 (290)
T 3mt0_A 133 TGGKILAAVDVGN-NDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSA--DPT-FQLSETIEARYREACR--- 205 (290)
T ss_dssp TTCEEEEEECTTC-CSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC-----------C-HHHHHHHHHHHHHHHH---
T ss_pred CCCeEEEEECCCC-cchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCcccccc--Cch-hHHHHHHHHHHHHHHH---
Confidence 3589999999999 8 899999999987778899999999876432211 000 0111111111122222
Q ss_pred hccccCCcc-eeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEcc
Q 008650 78 GTSQSKQVN-LEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGE 148 (558)
Q Consensus 78 ~~c~~~~v~-~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~ 148 (558)
.++.+.++. +...+..| ++.+.|+++++..++|++|||+++.+..+. .||++..+.++++ |||.++..
T Consensus 206 ~~~~~~g~~~~~~~v~~g-~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~ 276 (290)
T 3mt0_A 206 TFQAEYGFSDEQLHIEEG-PADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGNTAEVVLDTLE--SDVLVLKP 276 (290)
T ss_dssp HHHHHHTCCTTTEEEEES-CHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCHHHHHHHTTCS--SEEEEECC
T ss_pred HHHHHcCCCcceEEEecc-CHHHHHHHHHHhcCCCEEEECCCCCcCCcceecchHHHHHHhcCC--CCEEEECC
Confidence 233334663 56778888 778899999999999999999998766443 8999999999999 99998864
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.1e-10 Score=117.20 Aligned_cols=142 Identities=12% Similarity=0.137 Sum_probs=105.4
Q ss_pred CCcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccch-hh-hhhHHHHHHHHHHHHHHHhHhcccc
Q 008650 5 APSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSM-AK-RQSQIRRAKAHVISMLGEFAGTSQS 82 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~l~~~~~~c~~ 82 (558)
.-++|+|++|.|+ .|..||.||+.-..+.|.+|++|||.++......... .. .............+.|+.+...+..
T Consensus 6 ~~k~ILv~~D~s~-~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 84 (319)
T 3olq_A 6 KYQNLLVVIDPNQ-DDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAMRKGVINQKTAWIKQQARYYLE 84 (319)
T ss_dssp CSCEEEEECCTTC-SCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEEECCCc-ccHHHHHHHHHHHHHcCCeEEEEEEecccchhhccccChhhHHHHHHHHHHHHHHHHHHHHHHHhh
Confidence 4589999999999 9999999999977777889999999764332111111 00 1111112222334677777777777
Q ss_pred CCcceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEccc
Q 008650 83 KQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 83 ~~v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
.+++++..+.+.+++...|+++++..++|++|||+++.+..+. .||++..+.++++ |||.++...
T Consensus 85 ~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 151 (319)
T 3olq_A 85 AGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTPLDWQLLRKCP--APVWMVKDK 151 (319)
T ss_dssp TTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCHHHHHHHHHCS--SCEEEEESS
T ss_pred cCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccccccHHHHHhcCC--CCEEEecCc
Confidence 8999999999434778899999999999999999998755433 8999999999999 999988754
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.2e-10 Score=115.36 Aligned_cols=122 Identities=12% Similarity=0.122 Sum_probs=99.2
Q ss_pred CCcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCC
Q 008650 5 APSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQ 84 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~ 84 (558)
--++|+|++|.|+ .|..||.||+.-..+.|..|++|||.++ .. ..+.|+.+...+...+
T Consensus 6 ~~~~ILv~~D~s~-~s~~al~~A~~la~~~~a~l~ll~v~~~--------~~------------~~~~l~~~~~~~~~~~ 64 (290)
T 3mt0_A 6 AIRSILVVIEPDQ-LEGLALKRAQLIAGVTQSHLHLLVCEKR--------RD------------HSAALNDLAQELREEG 64 (290)
T ss_dssp TCCEEEEECCSSC-SCCHHHHHHHHHHHHHCCEEEEEEECSS--------SC------------CHHHHHHHHHHHHHTT
T ss_pred hhceEEEEeCCCc-cchHHHHHHHHHHHhcCCeEEEEEeeCc--------HH------------HHHHHHHHHHHHhhCC
Confidence 3689999999999 9999999999987777889999999863 00 1123333444445678
Q ss_pred cceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEccc
Q 008650 85 VNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 85 v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
++++..+.+++++.+.|+++++..++|++|||+++.+..+. .||++..+.++++ |||.++...
T Consensus 65 ~~~~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~gs~~~~vl~~~~--~PVlvv~~~ 129 (290)
T 3mt0_A 65 YSVSTNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILTPDDWKLLRFAP--CPVLMTKTA 129 (290)
T ss_dssp CCEEEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCCHHHHHHHHHCS--SCEEEECCC
T ss_pred CeEEEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhcccCHHHHHHHhcCC--CCEEEecCC
Confidence 99999998766888999999999999999999998765433 8999999999999 999998743
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=2.9e-10 Score=113.72 Aligned_cols=135 Identities=15% Similarity=0.131 Sum_probs=95.3
Q ss_pred CCcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCC
Q 008650 5 APSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQ 84 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~ 84 (558)
..++|+||+|.|+ .|..||.||+.-....|..|.+|||.++......... ......+..+..+.+.++.+... ..+
T Consensus 170 ~~~~Ilv~~D~s~-~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~--~~~ 245 (309)
T 3cis_A 170 QQAPVLVGVDGSS-ASELATAIAFDEASRRNVDLVALHAWSDVDVSEWPGI-DWPATQSMAEQVLAERLAGWQER--YPN 245 (309)
T ss_dssp CCCCEEEECCSSH-HHHHHHHHHHHHHHHTTCCEEEEEESCSSCCTTCSSC-CHHHHHHHHHHHHHHHHTTHHHH--CTT
T ss_pred CCCeEEEEeCCCh-HHHHHHHHHHHHHHhcCCEEEEEEEeecccccCCCcc-cHHHHHHHHHHHHHHHHHHHHhh--CCC
Confidence 3578999999999 9999999999877777899999999865332100000 00111111122222233322211 147
Q ss_pred cceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEcc
Q 008650 85 VNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGE 148 (558)
Q Consensus 85 v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~ 148 (558)
+.++..+..| ++.+.|+++++ ++|+||||+++.+..+. .||++..+.++++ |||.++..
T Consensus 246 ~~~~~~~~~g-~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gsv~~~vl~~~~--~pVlvv~~ 306 (309)
T 3cis_A 246 VAITRVVVRD-QPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGSVGETVAQLAR--TPVIVARE 306 (309)
T ss_dssp SCEEEEEESS-CHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCHHHHHHHHHCS--SCEEEECC
T ss_pred CcEEEEEEcC-CHHHHHHHhhC--CCCEEEECCCCCCCccccccCcHHHHHHhcCC--CCEEEeCC
Confidence 8888888888 67889999998 99999999998765433 8999999999999 99998864
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.7e-10 Score=114.46 Aligned_cols=121 Identities=10% Similarity=0.184 Sum_probs=98.6
Q ss_pred CCcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCC
Q 008650 5 APSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQ 84 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~ 84 (558)
..++|+||+|.|+ .|..||.||+.-....|..|.+|||.++.. . .+.++.+...+...+
T Consensus 169 ~~~~Ilv~~d~s~-~s~~al~~a~~la~~~~~~l~ll~v~~~~~------~--------------~~~l~~~~~~l~~~~ 227 (294)
T 3loq_A 169 LFDRVLVAYDFSK-WADRALEYAKFVVKKTGGELHIIHVSEDGD------K--------------TADLRVMEEVIGAEG 227 (294)
T ss_dssp TTSEEEEECCSSH-HHHHHHHHHHHHHHHHTCEEEEEEECSSSC------C--------------HHHHHHHHHHHHHTT
T ss_pred cCCEEEEEECCCH-HHHHHHHHHHHHhhhcCCEEEEEEEccCch------H--------------HHHHHHHHHHHHHcC
Confidence 4589999999999 999999999987767788999999987532 0 123333444444467
Q ss_pred cceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEccc
Q 008650 85 VNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 85 v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
++++..+..| ++.+.|+++++..++|+||||+++.+..+. .||++....++++ |||.++..+
T Consensus 228 ~~~~~~~~~g-~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pvLvv~~~ 291 (294)
T 3loq_A 228 IEVHVHIESG-TPHKAILAKREEINATTIFMGSRGAGSVMTMILGSTSESVIRRSP--VPVFVCKRG 291 (294)
T ss_dssp CCEEEEEECS-CHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHHCHHHHHHHHCS--SCEEEECSC
T ss_pred CcEEEEEecC-CHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeCcHHHHHHhcCC--CCEEEECCC
Confidence 8888888888 778899999999999999999998766443 8999999999999 999988754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=6e-11 Score=115.14 Aligned_cols=136 Identities=15% Similarity=0.094 Sum_probs=96.1
Q ss_pred CCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC--eeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN--TATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~-~~lv~e 323 (558)
++.+..+.+.|..+.||++...+|+.+++|+..... ...+..|+.+++.+.+.+ +.+++++..+++ .++|||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 444433334566699999987778889999975431 123567888888876544 455777776544 899999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCC--------------------------------------
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC-------------------------------------- 365 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-------------------------------------- 365 (558)
|++|.+|. ... .. ...++.+++..|..||+..
T Consensus 96 ~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 96 EVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred ecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 99998884 211 11 1256777888888888631
Q ss_pred -----------------CCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 366 -----------------KRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 366 -----------------~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
...++|+|++|.|||++.++.+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998764
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.3e-09 Score=109.45 Aligned_cols=138 Identities=7% Similarity=0.031 Sum_probs=96.0
Q ss_pred CCcEEEEEEecCccc-------hHHHHHHHHhhccCC--CCeEEEEEeecccccccccchh-h-hhhHHHHHHHHHHHHH
Q 008650 5 APSKILIGFSLDPND-------SKELLSWAIKVLAQP--NDRIVAIHVLVGEESKKRGSMA-K-RQSQIRRAKAHVISML 73 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~-------s~~al~Wal~~~~~~--~d~~~llhv~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~l 73 (558)
..++|+||+|.|. + |..||.||+.-.... |..|.+|||.++.........+ . .............+.|
T Consensus 155 ~~~~Ilva~D~s~-~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (319)
T 3olq_A 155 EYGTIVVAANLSN-EESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINIAIELPDFDPNLYNNALRGQHLIAM 233 (319)
T ss_dssp TTCEEEEECCCSC-CSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSCCTTCTTCCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEECCCC-cchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhhhccCCcccHHHHHHHHHHHHHHHH
Confidence 3589999999998 5 599999999866544 8899999998764322100000 0 0111111122222333
Q ss_pred HHhHhccccCCc-ceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEccc
Q 008650 74 GEFAGTSQSKQV-NLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 74 ~~~~~~c~~~~v-~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
+ .++.+.++ .++..+..| ++.+.|+++++..++|+||||+++.+..+. +||++..+.++++ |||.++...
T Consensus 234 ~---~~~~~~~~~~~~~~v~~g-~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~~ 306 (319)
T 3olq_A 234 K---ELRQKFSIPEEKTHVKEG-LPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLGNTAEQLIDHIK--CDLLAIKPD 306 (319)
T ss_dssp H---HHHHHTTCCGGGEEEEES-CHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHHHHHHHHTTCC--SEEEEECCT
T ss_pred H---HHHHHhCCCcccEEEecC-CcHHHHHHHHHHhCCCEEEEeccCccCCccccccHHHHHHHhhCC--CCEEEECCC
Confidence 3 33344444 356777788 668899999999999999999998766543 8999999999999 999998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.6e-09 Score=109.14 Aligned_cols=142 Identities=15% Similarity=0.190 Sum_probs=104.3
Q ss_pred ccceEeeeCceEEEEEEECCCCEEEEEEee--cccccHHHHHHHHHHHHHhcccc--cCCeeeeeeEEEeC----cEEEE
Q 008650 250 SENMVGQGGYSEVYKGNLSDGRKIAVKRLA--KDNKDAKKEKEFLMELGIIGHVC--HPNTATLVGCCIEN----GLYLI 321 (558)
Q Consensus 250 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~----~~~lv 321 (558)
..+.|+.|.++.||+.... +..+++|+.. .... ......+.+|+.+++.+. +..+.+++.++.+. ..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3567899999999999765 4678899875 3221 122345677888888887 45678888888664 27999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCC------------------------------------
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC------------------------------------ 365 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------------------------------------ 365 (558)
|||++|..+.+.. ...++...+..++.+++..|..||+..
T Consensus 120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999998874321 124677888889999999999999720
Q ss_pred -------------------CCcEEecCCCCCceeecCCCc--eEEEecccccc
Q 008650 366 -------------------KRRIIHRDIKASNVLLGPDFE--PQITDFGLAKW 397 (558)
Q Consensus 366 -------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~ 397 (558)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=7.3e-10 Score=110.53 Aligned_cols=183 Identities=17% Similarity=0.149 Sum_probs=120.4
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCC--eeeeeeEEEeCc----EEEEEE
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPN--TATLVGCCIENG----LYLIFN 323 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~----~~lv~e 323 (558)
.+.++.|.+..||+.. ..+++|+... ......+.+|..+++.+. +.. +..++.....+. .|+||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999874 4588998642 234456778898888773 322 334444433222 589999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhC---------------------------------------
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG--------------------------------------- 364 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~--------------------------------------- 364 (558)
+++|.+|..... ..++...+..++.+++..|..||+.
T Consensus 97 ~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 97 KIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred ccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999988865432 2366677778888888888888851
Q ss_pred ----------------CCCcEEecCCCCCceeecC--CCceEEEeccccccCCCCCCcccccccccccCc---ccchhhc
Q 008650 365 ----------------CKRRIIHRDIKASNVLLGP--DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY---LAPEYFM 423 (558)
Q Consensus 365 ----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y---~aPE~~~ 423 (558)
....++|+|++|.||+++. +..+.|+||+.+..-....... ....+ ..|+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------SLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------TTCCTTTSCCHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------HHHhhccccCHHHHH
Confidence 1135899999999999998 4567899999887533211100 01111 2233221
Q ss_pred c-----CCC---------CccccchhHHHHHHHHHcCCCCCC
Q 008650 424 H-----GII---------DEKTDVFAFGVLLLEIITGRKPVD 451 (558)
Q Consensus 424 ~-----~~~---------~~ksDvwSlGvvl~elltg~~Pf~ 451 (558)
. +.. ....+.|++|.++|.+.+|..+|.
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0 111 122589999999999999988764
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=6.2e-09 Score=101.61 Aligned_cols=114 Identities=11% Similarity=0.005 Sum_probs=88.1
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCCc
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQV 85 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v 85 (558)
.++|+||+|.|+ .|..||.||..-....|..|.++||.++.. ...+.++.+.......++
T Consensus 154 ~~~ilv~~d~s~-~~~~al~~a~~la~~~~a~l~ll~v~~~~~-------------------~~~~~l~~~~~~l~~~~~ 213 (268)
T 3ab8_A 154 LEGALLGYDASE-SAVRALHALAPLARALGLGVRVVSVHEDPA-------------------RAEAWALEAEAYLRDHGV 213 (268)
T ss_dssp CCEEEEECCSCH-HHHHHHHHHHHHHHHHTCCEEEEEECSSHH-------------------HHHHHHHHHHHHHHHTTC
T ss_pred CCEEEEEECCCH-HHHHHHHHHHHhhhcCCCEEEEEEEcCcHH-------------------HHHHHHHHHHHHHHHcCC
Confidence 479999999999 999999999876556688899999986421 011233334444444688
Q ss_pred ceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCccchhhhhhhhhcCCCCceEEEE
Q 008650 86 NLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMSRDVTRYCFQHAPGGCTIHIF 146 (558)
Q Consensus 86 ~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~~~sv~~~c~~~~~~~c~v~~v 146 (558)
+++.++..| ++.+.|+++++.. |+||||+ +. ...+.||++..+.++++ |||.++
T Consensus 214 ~~~~~~~~g-~~~~~i~~~a~~~--dliV~G~-~~-~~~~~Gs~~~~vl~~~~--~pvlvv 267 (268)
T 3ab8_A 214 EASALVLGG-DAADHLLRLQGPG--DLLALGA-PV-RRLVFGSTAERVIRNAQ--GPVLTA 267 (268)
T ss_dssp CEEEEEECS-CHHHHHHHHCCTT--EEEEEEC-CC-SCCSSCCHHHHHHHHCS--SCEEEE
T ss_pred ceEEEEeCC-ChHHHHHHHHHhC--CEEEECC-cc-cccEeccHHHHHHhcCC--CCEEEe
Confidence 888888887 6788999999998 9999999 22 12238999999999999 999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=4.7e-06 Score=82.82 Aligned_cols=135 Identities=16% Similarity=0.107 Sum_probs=91.8
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccC---CeeeeeeEEEe--CcEEEEEEec
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP---NTATLVGCCIE--NGLYLIFNFS 325 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~--~~~~lv~e~~ 325 (558)
...++.|....||+. |..+++|+-.. ......+.+|..+|+.+.+. .+..++.+... +..++||+++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456888999999988 56688988522 33455678899999988742 24555555542 3388999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhC-----------------------------------------
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG----------------------------------------- 364 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~----------------------------------------- 364 (558)
+|..|..... ..++......++.+++..|..||+.
T Consensus 96 ~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 96 QGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9988866321 1134444444555555555555531
Q ss_pred ----------------CCCcEEecCCCCCceeecC---CCc-eEEEecccccc
Q 008650 365 ----------------CKRRIIHRDIKASNVLLGP---DFE-PQITDFGLAKW 397 (558)
Q Consensus 365 ----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DFG~a~~ 397 (558)
....++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2246799999999999987 455 47999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=4.5e-06 Score=81.11 Aligned_cols=134 Identities=13% Similarity=0.037 Sum_probs=92.4
Q ss_pred eEeeeCce-EEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 253 MVGQGGYS-EVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 253 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
.+..|..+ .||+.... ++..+++|+-... ....+.+|..+|+.+. +--+.+++.++.+++ .++||++++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 44555554 68988554 4667999986432 2345667888887775 334667778877655 89999999998
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCC-------------------------------------------
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC------------------------------------------- 365 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------------------------------------------- 365 (558)
++.+..... ......++.+++..|.-||...
T Consensus 106 ~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 106 TAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp EHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 887765321 1122345666677777777421
Q ss_pred ------------CCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 366 ------------KRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 366 ------------~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12489999999999999877677999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=3.1e-05 Score=79.83 Aligned_cols=77 Identities=10% Similarity=0.037 Sum_probs=46.4
Q ss_pred cceEeeeCceEEEEEEEC-CCCEEEEEEeecccc--cH---HHHHHHHHHHHHhccccc--CC-eeeeeeEEEeCcEEEE
Q 008650 251 ENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNK--DA---KKEKEFLMELGIIGHVCH--PN-TATLVGCCIENGLYLI 321 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~---~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~lv 321 (558)
.+.||.|.++.||++... +++.++||....... .. .....+..|..+++.+.. +. +..++.+ ..+..++|
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~lv 113 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV 113 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEEE
Confidence 467899999999999643 468899998643211 00 011234567777776642 33 3345543 33457899
Q ss_pred EEeccCC
Q 008650 322 FNFSQNG 328 (558)
Q Consensus 322 ~e~~~~g 328 (558)
||++.+.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=6.6e-05 Score=75.29 Aligned_cols=32 Identities=22% Similarity=0.387 Sum_probs=28.4
Q ss_pred CCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 366 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
...++|+|+++.|||++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 37899999999999998888899999997753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=8.6e-05 Score=75.16 Aligned_cols=81 Identities=10% Similarity=0.006 Sum_probs=51.2
Q ss_pred cceE-eeeCceEEEEEEEC-------CCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccc-c--CCeeeeeeEEEeC--
Q 008650 251 ENMV-GQGGYSEVYKGNLS-------DGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVC-H--PNTATLVGCCIEN-- 316 (558)
Q Consensus 251 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 316 (558)
.+.| +.|....+|+.... +++.+++|+...... .......+.+|+.+++.+. + ..+.+++.++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999998654 266799998654320 0000123456777776664 2 2466677776554
Q ss_pred --cEEEEEEeccCCCHH
Q 008650 317 --GLYLIFNFSQNGNLD 331 (558)
Q Consensus 317 --~~~lv~e~~~~gsL~ 331 (558)
..++|||+++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 268999999987654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.0002 Score=70.14 Aligned_cols=80 Identities=16% Similarity=0.197 Sum_probs=53.9
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccC---CeeeeeeEEEeCcEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP---NTATLVGCCIENGLYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~lv~ 322 (558)
....-...+|.|..+.||+.+..+|+.|.+|+........ ...|..|...|+.+.-. .+.+++.+ +..++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGW---DDRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEE---ETTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEec---cCceEEE
Confidence 3455567899999999999999999999999875432211 12355677777766422 23333332 3457899
Q ss_pred EeccCCCH
Q 008650 323 NFSQNGNL 330 (558)
Q Consensus 323 e~~~~gsL 330 (558)
||+.++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00047 Score=68.37 Aligned_cols=136 Identities=17% Similarity=0.199 Sum_probs=86.9
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc---cCCeeeeeeEEEeCc-EEEEEEecc
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC---HPNTATLVGCCIENG-LYLIFNFSQ 326 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~-~~lv~e~~~ 326 (558)
...|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+.+++.+....+ .++||||++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 46789999999999975 4678999987543 1344677888887775 245777777766544 899999999
Q ss_pred CCCHH-----------HHHhhccC-C-------------------CCCHHHHH---HHHH----------------HHHH
Q 008650 327 NGNLD-----------AALHDERS-K-------------------SLEWPIRY---KIVL----------------GVAR 356 (558)
Q Consensus 327 ~gsL~-----------~~l~~~~~-~-------------------~l~~~~~~---~i~~----------------~i~~ 356 (558)
+..+. ..||.... . .-+|...+ ++.. .++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87642 12333211 0 01343321 1111 1111
Q ss_pred HH-HHhhh-CCCCcEEecCCCCCceeecCCCceEEEecc
Q 008650 357 GL-HYLHK-GCKRRIIHRDIKASNVLLGPDFEPQITDFG 393 (558)
Q Consensus 357 aL-~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 393 (558)
.+ ..|.. .....++|+|+.+.|++++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 23321 1236799999999999999887 8888974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00039 Score=72.10 Aligned_cols=79 Identities=14% Similarity=0.121 Sum_probs=48.0
Q ss_pred CCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCC---CCccccchhHHHHHHH
Q 008650 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGI---IDEKTDVFAFGVLLLE 442 (558)
Q Consensus 366 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvvl~e 442 (558)
...++|+|++|.|||++.++ +.|+||+.+..-+......... ..-...|.+|+...... -....++.++...+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 37899999999999998876 9999999887633211100000 00113466666553211 1123445577778887
Q ss_pred HHcC
Q 008650 443 IITG 446 (558)
Q Consensus 443 lltg 446 (558)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00055 Score=68.48 Aligned_cols=33 Identities=33% Similarity=0.408 Sum_probs=28.4
Q ss_pred CCcEEecCCCCCceeecCC----CceEEEeccccccC
Q 008650 366 KRRIIHRDIKASNVLLGPD----FEPQITDFGLAKWL 398 (558)
Q Consensus 366 ~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~~~ 398 (558)
...++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3689999999999999875 67899999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00065 Score=66.92 Aligned_cols=137 Identities=12% Similarity=0.055 Sum_probs=72.6
Q ss_pred cceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCe-eeeeeEEEeCcEEEEEEec-cCC
Q 008650 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT-ATLVGCCIENGLYLIFNFS-QNG 328 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~-~~g 328 (558)
.+.|+.|....+|+. +.+++|+..... .......+|..+++.+...++ .++++++ .+.-+++++|+ .+.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD-PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC-TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE-CCCCEEEEeecCCCc
Confidence 678999999999999 458899875431 111112346666655543222 3444432 23357899999 654
Q ss_pred CHHH------------------HHhhccCC---CCC-HHHHHHHHH--------------HHHHHHH----Hhhh-CCCC
Q 008650 329 NLDA------------------ALHDERSK---SLE-WPIRYKIVL--------------GVARGLH----YLHK-GCKR 367 (558)
Q Consensus 329 sL~~------------------~l~~~~~~---~l~-~~~~~~i~~--------------~i~~aL~----~LH~-~~~~ 367 (558)
+|.. .+|..... ... +.....+.. .+...+. .|.. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4421 11111100 001 011111100 0111111 1111 1235
Q ss_pred cEEecCCCCCceeecCCCceEEEecccccc
Q 008650 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 368 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 6999999999999 5667889999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0012 Score=60.90 Aligned_cols=99 Identities=12% Similarity=0.102 Sum_probs=65.0
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCccccc
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAI 408 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 408 (558)
+|.++|.. .+.+++++++|.++.|.+.+|.-+-.. ..-..+=+.|..|+|..+|.+.+.+ +.+.
T Consensus 34 SL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 78899865 457899999999999999998776210 1112334457899999999988763 1111
Q ss_pred ccccccCcccchhhccCCCCccccchhHHHHHHHHHcC
Q 008650 409 PIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITG 446 (558)
Q Consensus 409 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg 446 (558)
.....+.|||... ...+.+.=|||||++||..+-=
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0233467888763 3446778899999999998863
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0034 Score=62.15 Aligned_cols=157 Identities=15% Similarity=0.212 Sum_probs=83.6
Q ss_pred cCHHHHHhhhCCCcc-----cceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC--eee
Q 008650 236 FSYEEISSATNNFHS-----ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN--TAT 308 (558)
Q Consensus 236 ~~~~~~~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 308 (558)
.+.+++.....+|.+ .+.|+.|....+|+....+| .+++|+..... ....+..|+.++..+...+ +.+
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 344555554455654 24566788899999977655 68899886521 1112334555655554222 222
Q ss_pred eeeE-------EEeCcEEEEEEeccCCCHHH--------------HHhhccCC---C----C---CHHHHHH--------
Q 008650 309 LVGC-------CIENGLYLIFNFSQNGNLDA--------------ALHDERSK---S----L---EWPIRYK-------- 349 (558)
Q Consensus 309 l~~~-------~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~---~----l---~~~~~~~-------- 349 (558)
++.. ...+..+++++|++|..+.. .+|..... . . .|...+.
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3211 11234789999999865311 12221100 0 1 1211100
Q ss_pred ----HHHHHHHHHHHhhh----CCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 350 ----IVLGVARGLHYLHK----GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 350 ----i~~~i~~aL~~LH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
+...+...+.++.. ....+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 00113444555543 1235799999999999998876568999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0011 Score=68.80 Aligned_cols=73 Identities=14% Similarity=0.137 Sum_probs=47.7
Q ss_pred cceEeeeCceEEEEEEECC--------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCe-eeeeeEEEeCcEEEE
Q 008650 251 ENMVGQGGYSEVYKGNLSD--------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT-ATLVGCCIENGLYLI 321 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv 321 (558)
.+.|+.|....+|++...+ ++.+++|+..... . ...+..|..+++.+...++ .++++.+. + .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~-~--g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFS-G--GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEET-T--EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC-C--CEE
Confidence 4578888889999997653 5789999984321 1 1234468888887764444 45565543 2 288
Q ss_pred EEeccCCCH
Q 008650 322 FNFSQNGNL 330 (558)
Q Consensus 322 ~e~~~~gsL 330 (558)
++|++|.+|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.019 Score=56.76 Aligned_cols=140 Identities=16% Similarity=0.169 Sum_probs=77.1
Q ss_pred ceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC--eeeeeeE-----E-EeCcEEEEEE
Q 008650 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN--TATLVGC-----C-IENGLYLIFN 323 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~-~~~~~~lv~e 323 (558)
..|+ |....||+....+|+.+++|+........ ..+..|..++..+...+ +..++.. . .++..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3566 88889999877778789999986432222 23445666666554222 3333332 1 1233678999
Q ss_pred eccCCCHH-----H---------HHhhccC-------CCCCHHHH----HHH---------------HHHHHHHHHHhhh
Q 008650 324 FSQNGNLD-----A---------ALHDERS-------KSLEWPIR----YKI---------------VLGVARGLHYLHK 363 (558)
Q Consensus 324 ~~~~gsL~-----~---------~l~~~~~-------~~l~~~~~----~~i---------------~~~i~~aL~~LH~ 363 (558)
+++|..+. . .+|.... ...++... ..+ ...+...+..+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875432 1 1221100 01121110 001 0011112222221
Q ss_pred ----CCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 364 ----GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 364 ----~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1236799999999999999 4 899999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0071 Score=63.21 Aligned_cols=74 Identities=15% Similarity=0.041 Sum_probs=45.1
Q ss_pred cceEeeeCceEEEEEEECC-CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCe-eeeeeEEEeCcEEEEEEeccCC
Q 008650 251 ENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT-ATLVGCCIENGLYLIFNFSQNG 328 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~~~g 328 (558)
.+.|+.|....+|++...+ +..+++|+....... .....+|..++..+...++ .++++++ .++ +|++|++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~-~~G--~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFF-TNG--RIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEE-TTE--EEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEe-CCe--EEEEeeCCc
Confidence 3578888889999997765 478899987432111 0011367777777764444 4566655 333 599999875
Q ss_pred CH
Q 008650 329 NL 330 (558)
Q Consensus 329 sL 330 (558)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0066 Score=61.78 Aligned_cols=140 Identities=14% Similarity=0.215 Sum_probs=79.1
Q ss_pred ceEeeeCceEEEEEEEC--------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC-eeeeeeEEEeCcEEEEE
Q 008650 252 NMVGQGGYSEVYKGNLS--------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN-TATLVGCCIENGLYLIF 322 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~lv~ 322 (558)
+.|..|....+|++... +++.+++|+...... ......+|..+++.+.-.+ ..++++++. ++ +||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-~g--~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVFP-EG--RLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEET-TE--EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcC-Cc--cEE
Confidence 46777888889998764 357899998643211 1234457888887775323 245555543 32 899
Q ss_pred EeccCCCHHH--------------H---Hhhcc---CCCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 008650 323 NFSQNGNLDA--------------A---LHDER---SKSLE--WPIRYKIVLGVAR-------------------GLHYL 361 (558)
Q Consensus 323 e~~~~gsL~~--------------~---l~~~~---~~~l~--~~~~~~i~~~i~~-------------------aL~~L 361 (558)
||++|.+|.. . ||... ..... +.+..++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999865521 1 12111 11112 3344444433321 22333
Q ss_pred h----h-CCCCcEEecCCCCCceeecCC----CceEEEecccccc
Q 008650 362 H----K-GCKRRIIHRDIKASNVLLGPD----FEPQITDFGLAKW 397 (558)
Q Consensus 362 H----~-~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~~ 397 (558)
. . .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 1 123579999999999999876 7899999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0027 Score=64.41 Aligned_cols=74 Identities=11% Similarity=0.109 Sum_probs=41.6
Q ss_pred cceEeeeCceEEEEEEECC---------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCe-eeeeeEEEeCcEEE
Q 008650 251 ENMVGQGGYSEVYKGNLSD---------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT-ATLVGCCIENGLYL 320 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~l 320 (558)
...|+.|....+|+....+ ++.+++|+....... ......|..+++.+...++ .++++.. + -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTF--N-GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEE--T-TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEec--C-CcE
Confidence 3467788888999997654 268889987543211 1112356666666653333 3555433 2 368
Q ss_pred EEEeccCCCH
Q 008650 321 IFNFSQNGNL 330 (558)
Q Consensus 321 v~e~~~~gsL 330 (558)
||+|++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.83 E-value=0.029 Score=56.04 Aligned_cols=31 Identities=32% Similarity=0.393 Sum_probs=27.9
Q ss_pred CcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 367 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5799999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.70 E-value=0.23 Score=51.14 Aligned_cols=73 Identities=14% Similarity=0.112 Sum_probs=44.3
Q ss_pred ceEeeeCceEEEEEEECC--------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCe-eeeeeEEEeCcEEEEE
Q 008650 252 NMVGQGGYSEVYKGNLSD--------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT-ATLVGCCIENGLYLIF 322 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~ 322 (558)
+.|..|....+|+....+ ++.|++++...... ......+|..+++.+...++ .++++.+ . -++|+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~~idR~~E~~~l~~L~~~gi~P~l~~~~--~-~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---KFYDSKVELDVFRYLSNINIAPNIIADF--P-EGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T-TEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C-CCEEE
Confidence 467778889999997653 57899998754321 11112356666666643222 3444432 2 36889
Q ss_pred EeccCCCH
Q 008650 323 NFSQNGNL 330 (558)
Q Consensus 323 e~~~~gsL 330 (558)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.59 E-value=0.66 Score=47.25 Aligned_cols=30 Identities=23% Similarity=0.431 Sum_probs=24.8
Q ss_pred cEEecCCCCCceee------cCCCceEEEecccccc
Q 008650 368 RIIHRDIKASNVLL------GPDFEPQITDFGLAKW 397 (558)
Q Consensus 368 ~ivH~Dlkp~NIll------~~~~~~kl~DFG~a~~ 397 (558)
.++|+|+.+.|||+ +++..+.++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4456799999987753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.81 E-value=1.8 Score=39.83 Aligned_cols=114 Identities=12% Similarity=0.143 Sum_probs=73.7
Q ss_pred ccCCeeeeeeEEEe-CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH-HhhhCCCCcEEecCCCCCce
Q 008650 302 CHPNTATLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLH-YLHKGCKRRIIHRDIKASNV 379 (558)
Q Consensus 302 ~h~niv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~-~LH~~~~~~ivH~Dlkp~NI 379 (558)
.||++ . ...-.+ +.+.+.|+.-+++.=...+ ..++...+++++..|+.... +++. -+|--|.|+||
T Consensus 48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 46776 2 222233 3466666665444333344 23778888999999887777 6654 57788999999
Q ss_pred eecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCC
Q 008650 380 LLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVD 451 (558)
Q Consensus 380 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~ 451 (558)
+++.++.+++.-.|+-..+++.. +.+|-+ .-++=|++..++.++..|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~lpP~e--------------~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESLPPDE--------------WDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTTBSSCS--------------CCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcccCCCCC--------------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 99999999998877654332211 122221 2356678888888888875
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.45 E-value=0.13 Score=53.58 Aligned_cols=62 Identities=10% Similarity=0.110 Sum_probs=17.6
Q ss_pred ccceEeeeCceEEEEEEECC-CCEEEE------EEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEE
Q 008650 250 SENMVGQGGYSEVYKGNLSD-GRKIAV------KRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314 (558)
Q Consensus 250 ~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 314 (558)
+.+.|| ||.||+|.+.. ...||+ |.........+....|.+|..+++.+.|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345676 99999996643 357888 766544444455567889999999999999999988764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.67 E-value=1.6 Score=40.01 Aligned_cols=121 Identities=10% Similarity=0.103 Sum_probs=77.8
Q ss_pred HHHHhcccccCCeeeeeeEEEeCc-EEEEEEeccCC-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEe
Q 008650 294 ELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNG-NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371 (558)
Q Consensus 294 E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH 371 (558)
|+.+|.. .||+++.. .+-.+++ +.+.|+.-..+ ++.. + ..++...+++++..|+....+++. =+|
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~~-----r~t 102 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNRT-----RYT 102 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGGS-----SEE
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhcC-----ceE
Confidence 4444433 47887765 3333333 44444443322 2222 3 237788889999999988876664 468
Q ss_pred cCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCC
Q 008650 372 RDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVD 451 (558)
Q Consensus 372 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~ 451 (558)
--|.|+||+++.++.+++.-.|+-..+++.. +.+| .=.-.+=|++..+++++..|+
T Consensus 103 f~L~P~NL~f~~~~~p~i~~RGik~~l~P~~--------------~~ee----------~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 103 FVLAPDELFFTRDGLPIAKTRGLQNVVDPLP--------------VSEA----------EFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CCCSGGGEEECTTSCEEESCCEETTTBSCCC--------------CCHH----------HHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEecceEEEcCCCCEEEEEccCccCCCCCC--------------CCHH----------HHHHHHHHHHHHHHcCCCCHH
Confidence 8899999999999999998877654332210 1111 123356788999999999886
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 558 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-20 | |
| d2gm3a1 | 171 | c.26.2.4 (A:5-175) Putative ethylene-responsive pr | 2e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 2e-64
Identities = 64/273 (23%), Positives = 114/273 (41%), Gaps = 16/273 (5%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+G G + VYKG +AVK L ++ + F E+G++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 306 TATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
+G L ++ + + +L LH +K E I A+G+ YLH
Sbjct: 66 ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA-- 122
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH- 424
+ IIHRD+K++N+ L D +I DFGLA H + G+ ++APE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 425 --GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482
++DV+AFG++L E++TG+ P + + + P L +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------VGRGYLSPDLS-KV 234
Query: 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
++ + + C+++ RP ++L +
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 9e-61
Identities = 60/270 (22%), Positives = 113/270 (41%), Gaps = 18/270 (6%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+G G + EV+ G + K+AVK L + + FL E ++ + H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69
Query: 306 TATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
L + +Y+I + +NG+L L L + +A G+ ++
Sbjct: 70 LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
+R IHRD++A+N+L+ +I DFGLA+ + + + A + + APE +G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINYG 185
Query: 426 IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485
K+DV++FG+LL EI+T + P M + + + ++ +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPY-----------PGMTNPEVIQNLERGYRMVRPDN 234
Query: 486 QMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
L + C ++ RP+ + +L
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 6e-59
Identities = 62/286 (21%), Positives = 118/286 (41%), Gaps = 18/286 (6%)
Query: 230 QPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEK 289
+P + + + E +GQG + EV+ G + ++A+K L +
Sbjct: 1 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPE 57
Query: 290 EFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK 349
FL E ++ + H L E +Y++ + G+L L E K L P
Sbjct: 58 AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117
Query: 350 IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIP 409
+ +A G+ Y+ + +HRD++A+N+L+G + ++ DFGLA+ + + + A
Sbjct: 118 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQG 173
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469
+ + APE ++G K+DV++FG+LL E+ T + N +
Sbjct: 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL--------- 224
Query: 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+ V+ + L + C R+ RP+ + L
Sbjct: 225 --DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-58
Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 11/231 (4%)
Query: 244 ATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC 302
++F + +G G V+K + G +A K + + K A + + + EL ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLHECN 62
Query: 303 HPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
P G +G + + G+LD L ++ + I K+ + V +GL YL
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
+ K +I+HRD+K SN+L+ E ++ DFG++ L + + GT Y++PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPER 174
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTE 472
++D+++ G+ L+E+ GR P+ + G+ E
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-57
Identities = 62/271 (22%), Positives = 117/271 (43%), Gaps = 20/271 (7%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+ +G G + V+ G + K+A+K + + A E++F+ E ++ + HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPK 61
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
L G C+E + L+F F ++G L + + L V G+ YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLS-DYLRTQRGLFAAETLLGMCLDVCEGMAYL--- 117
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
+ +IHRD+ A N L+G + +++DFG+ +++ + + + + +PE F
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSF 176
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484
K+DV++FGVL+ E+ + K +R N + L P L
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----TGFRLYKPRLAST--- 229
Query: 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+ I ++C ++ RP+ S +L L
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (481), Expect = 2e-56
Identities = 66/298 (22%), Positives = 132/298 (44%), Gaps = 35/298 (11%)
Query: 236 FSYEEISSATNNFHSE---------NMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDN 282
F++E+ + A F E ++G G + EV G+L +A+K L K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSG 65
Query: 283 KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKS 341
K+ ++FL E I+G HPN L G ++ + +I F +NG+LD+ +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS-FLRQNDGQ 124
Query: 342 LEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN- 400
++ G+A G+ YL +HRD+ A N+L+ + +++DFGL+++L +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 401 --KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNL 457
T+ +A+ + + APE + +DV+++G+++ E+++ G +P
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD----- 236
Query: 458 VLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
M + ++ ++ D L + C ++ RP +++ L
Sbjct: 237 -------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-55
Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 25/270 (9%)
Query: 251 ENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
+ +G+G + VYKG + ++A L + + F E ++ + HPN
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 310 VGCCI-----ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
+ + L+ +G L L R K ++ + + +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT- 130
Query: 365 CKRRIIHRDIKASNVLL-GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
IIHRD+K N+ + GP +I D GLA GT ++APE +
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYE 186
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483
DE DV+AFG+ +LE+ T P + ++ + +T V P+ +
Sbjct: 187 EK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------VTSGVKPASFDKVA 238
Query: 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
++ ++ C+RQ R S+ ++L
Sbjct: 239 IPEVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-54
Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 26/272 (9%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+G+G + +V G+ G K+AVK + K+ + FL E ++ + H N
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSN 61
Query: 306 TATLVGCCIE--NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
L+G +E GLY++ + G+L L L K L V + YL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
+HRD+ A NVL+ D +++DFGL K + + + APE
Sbjct: 122 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALR 173
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483
K+DV++FG+LL EI + + + + +E G + D Y+
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--VEKGYKMDAPDGCPPAVYE 231
Query: 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+ C +A RPS ++ E L
Sbjct: 232 ---------VMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (465), Expect = 3e-54
Identities = 71/281 (25%), Positives = 124/281 (44%), Gaps = 20/281 (7%)
Query: 237 SYEEISSATNNFHSENMVGQGGYSEVYKGNLSD-GRKIAVKRLAKDNKDAKKEKEFLMEL 295
+Y++ + ++ +G G Y EVY+G +AVK L +D + +EFL E
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEA 64
Query: 296 GIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGV 354
++ + HPN L+G C Y+I F GNL L + + + + + +
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTF 414
+ + YL K + IHRD+ A N L+G + ++ DFGL++ + T+ A +
Sbjct: 125 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPI 180
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474
+ APE + K+DV+AFGVLL EI T P ++ + EL+
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELL 229
Query: 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+ E ++ + C + + RPS +E+ +
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-54
Identities = 54/271 (19%), Positives = 111/271 (40%), Gaps = 20/271 (7%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+ +G G + V G +A+K + + + E EF+ E ++ ++ H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
L G C + +++I + NG L L + R + + ++ V + YL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE-- 117
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
++ +HRD+ A N L+ +++DFGL++++ + + +++ + + PE M+
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMY 175
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484
K+D++AFGVL+ EI + K N E + L
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-----------EHIAQGLRLYRPH 224
Query: 485 DQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
++ I C + + RP+ +L +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 8e-54
Identities = 58/279 (20%), Positives = 116/279 (41%), Gaps = 22/279 (7%)
Query: 243 SATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV 301
S ++ +G G Y K SDG+ + K L + +++ + E+ ++ +
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 302 CHPNTATLVGCCIE---NGLYLIFNFSQNGNLDAALHDERS--KSLEWPIRYKIVLGVAR 356
HPN I+ LY++ + + G+L + + + L+ +++ +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 357 GLHYLHK--GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTF 414
L H+ ++HRD+K +NV L ++ DFGLA+ L + + A T
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TP 178
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474
Y++PE +EK+D+++ G LL E+ P + Q + + E
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG--------KIREGK 230
Query: 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+ Y D+++ ++ + RPS+ E+LE
Sbjct: 231 FRRIPYRYS-DELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 9e-54
Identities = 60/282 (21%), Positives = 113/282 (40%), Gaps = 23/282 (8%)
Query: 240 EISSATNNFHSENMVGQGGYSEVYKGNLSDG-----RKIAVKRLAKDNKDAKKEKEFLME 294
EI + + ++G G + EVYKG L +A+K L K K+ +FL E
Sbjct: 3 EIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGE 59
Query: 295 LGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGV 354
GI+G H N L G + +I E+ ++ G+
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH-HAAIPIEGT 413
A G+ YL +HRD+ A N+L+ + +++DFGL++ L + + +
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 414 FGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473
+ APE + +DV++FG+++ E++T + N + +
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----------HEVMKA 225
Query: 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
++ D + + C +Q A RP ++++ +L
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-53
Identities = 62/270 (22%), Positives = 114/270 (42%), Gaps = 22/270 (8%)
Query: 251 ENMVGQGGYSEVYKGNLSD---GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTA 307
+ +G G + V KG + +AVK L + D + E L E ++ + +P
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 308 TLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKR 367
++G C L+ ++ G L+ L +++ ++ ++V V+ G+ YL +
Sbjct: 72 RMIGICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ES 126
Query: 368 RIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH-AAIPIEGTFGYLAPEYFMHGI 426
+HRD+ A NVLL +I+DFGL+K L ++ A + + APE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 427 IDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485
K+DV++FGVL+ E + G+KP M+ +T +++
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRG------------MKGSEVTAMLEKGERMGCPAG 234
Query: 486 QMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+ + + C RP + V L
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-53
Identities = 58/294 (19%), Positives = 113/294 (38%), Gaps = 34/294 (11%)
Query: 251 ENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLV 310
+ +G+G + EV++G G ++AVK + ++ E+ + H N +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 63
Query: 311 GCCIENG-----LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
++ L+L+ ++ ++G+L L+ ++ K+ L A GL +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 366 -----KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN--KCTHHAAIPIEGTFGYLA 418
K I HRD+K+ N+L+ + I D GLA + A GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 419 PEYF------MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQ--------NLVLWAKPL 464
PE H ++ D++A G++ EI +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 465 MESGNLTELVDPSLEGEYDTDQMHRLVL-IADYCVRQTSAWRPSMSEVLELLTS 517
M + + P++ + + + R++ I C A R + + + L+
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 1e-52
Identities = 66/297 (22%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 248 FHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPN 305
F +G G + VY ++ + +A+K+++ K +K ++ + E+ + + HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 306 TATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
T GC + +L+ + D L + K L+ + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 133
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM- 423
+IHRD+KA N+LL ++ DFG A + + GT ++APE +
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILA 185
Query: 424 --HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481
G D K DV++ G+ +E+ + P+ + L+ ++ + P+L+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------HIAQNESPALQSG 237
Query: 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMPEFTSDELD 538
+ ++ V D C+++ RP+ +L+ F R P D +
Sbjct: 238 HWSEYFRNFV---DSCLQKIPQDRPTSEVLLK-------HRFVLRERPPTVIMDLIQ 284
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-52
Identities = 68/271 (25%), Positives = 110/271 (40%), Gaps = 25/271 (9%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCH 303
+F +G+G + VY +A+K L K + A E + E+ I H+ H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 304 PNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
PN L G + +YLI ++ G + L + + + +A L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCH 123
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF 422
+R+IHRDIK N+LLG E +I DFG + P+ + GT YL PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEMI 176
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482
+ DEK D+++ GVL E + G+ P + + + + + V
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGARD-- 233
Query: 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+ ++ + RP + EVLE
Sbjct: 234 ----------LISRLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 9e-52
Identities = 64/273 (23%), Positives = 119/273 (43%), Gaps = 21/273 (7%)
Query: 248 FHSENMVGQGGYSEVYKG-NLSDGR----KIAVKRLAKDNKDAKKEKEFLMELGIIGHVC 302
F ++G G + VYKG + +G +A+K L ++ K KE L E ++ V
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVD 69
Query: 303 HPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
+P+ L+G C+ + + LI G L E ++ + +A+G++YL
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYL- 127
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF 422
RR++HRD+ A NVL+ +ITDFGLAK L + + A + ++A E
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482
+H I ++DV+++GV + E++T + + ++ +++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-----------IPASEISSILEKGERLPQ 234
Query: 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+ +I C + RP E++
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-51
Identities = 59/282 (20%), Positives = 112/282 (39%), Gaps = 21/282 (7%)
Query: 239 EEISSATNNFHSENMV-GQGGYSEVYKG---NLSDGRKIAVKRLAKDNKDAKKEKEFLME 294
+++ +N ++ G G + V +G +A+K L K + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMRE 59
Query: 295 LGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGV 354
I+ + +P L+G C L L+ + G L L +R + + +++ V
Sbjct: 60 AQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQV 118
Query: 355 ARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL-PNKCTHHAAIPIEGT 413
+ G+ YL ++ +HRD+ A NVLL +I+DFGL+K L + + A +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 414 FGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473
+ APE ++DV+++GV + E ++ + + + A +E G E
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--IEQGKRMEC 233
Query: 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
Y + C RP V + +
Sbjct: 234 PPECPPELYA---------LMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-51
Identities = 73/294 (24%), Positives = 130/294 (44%), Gaps = 24/294 (8%)
Query: 232 LLTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNLSD----GRKIAVKRLAKDNKDAKK 287
L+ + I ++ H ++G+G + VY G L D AVK L D +
Sbjct: 13 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGE 71
Query: 288 EKEFLMELGIIGHVCHPNTATLVGCCI--ENGLYLIFNFSQNGNLDAALHDERSKSLEWP 345
+FL E I+ HPN +L+G C+ E ++ + ++G+L + +
Sbjct: 72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVK 130
Query: 346 IRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK--CT 403
L VA+G+ +L ++ +HRD+ A N +L F ++ DFGLA+ + +K +
Sbjct: 131 DLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463
H + ++A E K+DV++FGVLL E++T P N
Sbjct: 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVY 246
Query: 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517
L++ L+ EY D ++ ++L C + RPS SE++ +++
Sbjct: 247 LLQG-------RRLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISA 290
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 5e-51
Identities = 68/302 (22%), Positives = 118/302 (39%), Gaps = 45/302 (14%)
Query: 246 NNFHSENMVGQGGYSEVYKG------NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIG 299
N ++G G + +V ++AVK L K+ D+ + + + EL ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMT 95
Query: 300 HVC-HPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSK----------------- 340
+ H N L+G C +G +YLIF + G+L L +R K
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 341 ----SLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396
L + VA+G+ +L + +HRD+ A NVL+ +I DFGLA+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQ 455
+ + + ++APE GI K+DV+++G+LL EI + G P
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 456 NLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+ + +L+ + + + +I C S RPS + L
Sbjct: 273 DANFY-----------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 516 TS 517
Sbjct: 322 GC 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 7e-51
Identities = 55/294 (18%), Positives = 107/294 (36%), Gaps = 38/294 (12%)
Query: 246 NNFHSENMVGQGGYSEVYKG------NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIG 299
N +G G + +V + +AVK L K + + + + EL ++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLS 81
Query: 300 HVC-HPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSK----------------S 341
++ H N L+G C G +I + G+L L +R +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 342 LEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401
L+ VA+G+ +L + IHRD+ A N+LL +I DFGLA+ + N
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA 461
+ ++APE + + ++DV+++G+ L E+ +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP------ 252
Query: 462 KPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+++ + I C RP+ ++++L+
Sbjct: 253 ----VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (440), Expect = 1e-50
Identities = 62/308 (20%), Positives = 115/308 (37%), Gaps = 44/308 (14%)
Query: 237 SYEEISSATNNFHSENMVGQGGYSEVYKG------NLSDGRKIAVKRLAKDNKDAKKEKE 290
+ NN +G+G + V++ +AVK L K+ A + +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQAD 62
Query: 291 FLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKS-------- 341
F E ++ +PN L+G C + L+F + G+L+ L +
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 342 --------------LEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEP 387
L + I VA G+ YL + R+ +HRD+ N L+G +
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179
Query: 388 QITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGR 447
+I DFGL++ + + + A ++ PE + ++DV+A+GV+L EI +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 448 KPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPS 507
+ + + GN+ + + L + C + A RPS
Sbjct: 240 LQPYYGMAHEEVIYY--VRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPS 288
Query: 508 MSEVLELL 515
+ +L
Sbjct: 289 FCSIHRIL 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-49
Identities = 66/286 (23%), Positives = 116/286 (40%), Gaps = 28/286 (9%)
Query: 238 YEEISSATN---NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM 293
YE ++ N + +G G + +VYK N A K + D K ++ +++++
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYMV 58
Query: 294 ELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVL 352
E+ I+ HPN L+ L+++ F G +DA + E + L +
Sbjct: 59 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA-VMLELERPLTESQIQVVCK 117
Query: 353 GVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEG 412
L+YLH +IIHRD+KA N+L D + ++ DFG++ + G
Sbjct: 118 QTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--G 172
Query: 413 TFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES 467
T ++APE M D K DV++ G+ L+E+ P VL +
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK---IAK 229
Query: 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
L PS + + C+ + R + S++L+
Sbjct: 230 SEPPTLAQPS----RWSSNFKDFL---KKCLEKNVDARWTTSQLLQ 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-48
Identities = 56/271 (20%), Positives = 97/271 (35%), Gaps = 19/271 (7%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
++ +G+G Y EV N +AVK + + + E+ I + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHE 63
Query: 305 NTATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
N G N YL + G L + + P + + G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
I HRDIK N+LL +I+DFGLA + GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 424 HG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482
E DV++ G++L ++ G P D + ++ + L
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL- 237
Query: 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+H+ + + + R ++ ++ +
Sbjct: 238 --ALLHK-------ILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-48
Identities = 62/290 (21%), Positives = 102/290 (35%), Gaps = 26/290 (8%)
Query: 233 LTCFSYEEISSATNNFHSENMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDN-KDAKK 287
LTC I + +G G + V +G +AVK L D +
Sbjct: 1 LTCL----IGE--KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 54
Query: 288 EKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIR 347
+F+ E+ + + H N L G + + ++ + G+L +
Sbjct: 55 MDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD-RLRKHQGHFLLGTL 113
Query: 348 YKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH-A 406
+ + VA G+ YL +R IHRD+ A N+LL +I DFGL + LP H+
Sbjct: 114 SRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLME 466
+ F + APE +D + FGV L E+ T + + K E
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
Query: 467 SGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516
L D + + + C RP+ + + L
Sbjct: 231 GERLPRPEDCPQD----------IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-47
Identities = 63/284 (22%), Positives = 117/284 (41%), Gaps = 21/284 (7%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSD----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV 301
+G+G + +V++G +A+K D+ +EK FL E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQF 65
Query: 302 CHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
HP+ L+G EN +++I G L + R SL+ ++ L YL
Sbjct: 66 DHPHIVKLIGVITENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
+R +HRDI A NVL+ + ++ DFGL++++ + T++ A + ++APE
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPES 180
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481
+DV+ FGV + EI+ +N + + +E+G +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--IENGERLPMPPNCPPTL 238
Query: 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAK 525
Y + C + RP +E+ L++ + E A+
Sbjct: 239 YS---------LMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 6e-47
Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 37/289 (12%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDG---RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC 302
N+ ++++G+G + +V K + A+KR+ K+ ++F EL ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLG 68
Query: 303 -HPNTATLVGCCIENG-LYLIFNFSQNGNLDAALH--------------DERSKSLEWPI 346
HPN L+G C G LYL ++ +GNL L + + +L
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 347 RYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA 406
VARG+ YL +++ IHRD+ A N+L+G ++ +I DFGL++
Sbjct: 129 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185
Query: 407 AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLME 466
++A E + + +DV+++GVLL EI++ M
Sbjct: 186 GR---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-----------MT 231
Query: 467 SGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
L E + E + + + C R+ RPS +++L L
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-46
Identities = 59/292 (20%), Positives = 127/292 (43%), Gaps = 25/292 (8%)
Query: 224 SNKEKHQPLLTCFSYEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN 282
S++E + L + S + + +GQG VY +++ G+++A++++
Sbjct: 1 SDEEILEKLRSIVSVGDP---KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 283 KDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKS 341
+ K++ + E+ ++ +PN + + L+++ + G+L + +
Sbjct: 58 QP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD- 114
Query: 342 LEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401
+ + L +LH ++IHRDIK+ N+LLG D ++TDFG + +
Sbjct: 115 --EGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA 461
+ + + GT ++APE K D+++ G++ +E+I G P + L+
Sbjct: 170 QSKRS--TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY- 226
Query: 462 KPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
L+ + EL +P E + + + C+ R S E+L+
Sbjct: 227 --LIATNGTPELQNP----EKLSAIFRDFL---NRCLDMDVEKRGSAKELLQ 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-45
Identities = 72/295 (24%), Positives = 123/295 (41%), Gaps = 37/295 (12%)
Query: 246 NNFHSENMVGQGGYSEVYKG------NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIG 299
+ +G+G + +V + + R +AVK L K+ + + + EL I+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILI 71
Query: 300 HVCH-PNTATLVGCCIENG--LYLIFNFSQNGNLDAALHDERSKS--------------L 342
H+ H N L+G C + G L +I F + GNL L +R++ L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 343 EWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402
VA+G+ +L R+ IHRD+ A N+LL +I DFGLA+ +
Sbjct: 132 TLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK 462
+ ++APE + ++DV++FGVLL EI + +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG-VKIDEEFC 247
Query: 463 PLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517
++ G D Y T +M++ +L C + RP+ SE++E L +
Sbjct: 248 RRLKEGTRMRAPD------YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGN 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-45
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 8/218 (3%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCHP 304
+F ++G+G +S V L+ R+ A+K L K + K E ++ + HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 305 NTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
L ++ LY ++++NG L + + S + + L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
+ IIHRD+K N+LL D QITDFG AK L + A GT Y++PE
Sbjct: 127 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA 461
+ +D++A G ++ +++ G P + + L+
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 221
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 157 bits (397), Expect = 8e-44
Identities = 49/272 (18%), Positives = 104/272 (38%), Gaps = 22/272 (8%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
+++ +G G + V++ + G A K + ++ K+ E+ + + HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET--VRKEIQTMSVLRHP 83
Query: 305 NTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
L ++ + +I+ F G L + DE +K + + + V +GL ++H+
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHE 142
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQI--TDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
+H D+K N++ ++ DFGL L K + GT + APE
Sbjct: 143 ---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 196
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481
+ TD+++ GVL +++G P + L N+ + +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-NVKSCDWNMDDSAFSGI--- 252
Query: 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
++ + + R ++ + LE
Sbjct: 253 --SEDGKDFI---RKLLLADPNTRMTIHQALE 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-43
Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 39/294 (13%)
Query: 246 NNFHSENMVGQGGYSEVYKG--------NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGI 297
+ +G+G + +V + K+AVK L K + K + + E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEM 71
Query: 298 IGHVC-HPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKS-------------- 341
+ + H N L+G C ++G LY+I ++ GNL L R
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 342 LEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401
L VARG+ YL ++ IHRD+ A NVL+ D +I DFGLA+ + +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA 461
+ ++APE I ++DV++FGVLL EI T L+
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF- 247
Query: 462 KPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
+L+ + ++ + L ++ C + RP+ +++E L
Sbjct: 248 ----------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-43
Identities = 58/306 (18%), Positives = 114/306 (37%), Gaps = 33/306 (10%)
Query: 246 NNFHSENMVGQGGYSEVYKG------NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIG 299
+GQG + VY+G ++A+K + + ++ EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMK 78
Query: 300 HVCHPNTATLVGCCI-ENGLYLIFNFSQNGNLDAALHDERSKS--------LEWPIRYKI 350
+ L+G +I G+L + L R ++
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 351 VLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPI 410
+A G+ YL + +HRD+ A N ++ DF +I DFG+ + + +
Sbjct: 139 AGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 411 EGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL 470
+++PE G+ +DV++FGV+L EI T + N + + G L
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGL 253
Query: 471 TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEFAKSWRMP 530
+ D + ++ + C + RPS E++ + + F + +
Sbjct: 254 LDKPDNCPDMLFE---------LMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE---VS 301
Query: 531 EFTSDE 536
+ S+E
Sbjct: 302 FYYSEE 307
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (379), Expect = 4e-42
Identities = 57/280 (20%), Positives = 112/280 (40%), Gaps = 23/280 (8%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVC 302
++ + ++G GG SEV+ +L R +AVK L D +D F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 303 HPNTATLVGCCIENG-----LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARG 357
HP + Y++ + L +H + +++ +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQA 123
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHA-AIPIEGTFGY 416
L++ + IIHRD+K +N+++ ++ DFG+A+ + + + GT Y
Sbjct: 124 LNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476
L+PE +D ++DV++ G +L E++TG P V + + + P
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV------REDPIPP 234
Query: 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRP-SMSEVLELL 515
S E + + +VL + + R + +E+ L
Sbjct: 235 SARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADL 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (379), Expect = 3e-41
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 18/242 (7%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLM----ELGIIGH 300
N+F ++G+GG+ EVY G+ A+K L K K+ + + L ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 301 VCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLH 359
P + L I + G+L L + + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLE 121
Query: 360 YLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAP 419
++H R +++RD+K +N+LL +I+D GLA K H GT GY+AP
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 174
Query: 420 EYFMHGI-IDEKTDVFAFGVLLLEIITGRKPVD--SSRQNLVLWAKPLMESGNLTELVDP 476
E G+ D D F+ G +L +++ G P ++ + L + L + P
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 477 SL 478
L
Sbjct: 235 EL 236
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 148 bits (374), Expect = 2e-40
Identities = 51/272 (18%), Positives = 94/272 (34%), Gaps = 22/272 (8%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
+ + +G G + V++ + GR K + + + E+ I+ + HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHP 86
Query: 305 NTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
L + + LI F G L + E K + + GL ++H+
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE 145
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQI--TDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
I+H DIK N++ + DFGLA L T + APE
Sbjct: 146 ---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEI 199
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481
+ TD++A GVL +++G P +L E S+
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRCDWEFDEDAFSSV--- 255
Query: 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+ + + +++ R ++ + LE
Sbjct: 256 --SPEAKDFI---KNLLQKEPRKRLTVHDALE 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (370), Expect = 3e-40
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 11/216 (5%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCH 303
+F +G G + V+ + +GR A+K L K+ K+ + E ++ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 304 PNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
P + G + + G +L + + ++ V L YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLHS 122
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM 423
+ II+RD+K N+LL + +ITDFG AK++P+ P Y+APE
Sbjct: 123 ---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP-----DYIAPEVVS 174
Query: 424 HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL 459
++ D ++FG+L+ E++ G P S
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (362), Expect = 1e-39
Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 33/283 (11%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKE-------FLMELGII 298
N+ + ++G+G S V + + ++ AVK + + +E L E+ I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 299 GHV-CHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVAR 356
V HPN L N +L+F+ + G L L +L KI+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLE 121
Query: 357 GLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416
+ LHK I+HRD+K N+LL D ++TDFG + L GT Y
Sbjct: 122 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSY 175
Query: 417 LAPEYFM------HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNL 470
LAPE H ++ D+++ GV++ ++ G P +Q L+L + SGN
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM---IMSGNY 232
Query: 471 TELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
S E + +D + LV + R + E L
Sbjct: 233 QF---GSPEWDDYSDTVKDLV---SRFLVVQPQKRYTAEEALA 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-39
Identities = 58/298 (19%), Positives = 104/298 (34%), Gaps = 32/298 (10%)
Query: 241 ISSATNNFHSENMVGQGGYSEVYKG--NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGII 298
+ A + +G+G Y +V+K + GR +A+KR+ + + E+ ++
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 299 GH---VCHPNTATLVGCCI------ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYK 349
H HPN L C E L L+F L +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKD 120
Query: 350 IVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIP 409
++ + RGL +LH R++HRD+K N+L+ + ++ DFGLA+ + + +
Sbjct: 121 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV- 176
Query: 410 IEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVL---------- 459
T Y APE + D+++ G + E+ + S L
Sbjct: 177 --VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234
Query: 460 ----WAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
W + + ++ TD + C+ A R S L
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 1e-39
Identities = 52/301 (17%), Positives = 102/301 (33%), Gaps = 26/301 (8%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
N + +G G + ++Y G +++ G ++A+K K + +E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGG 62
Query: 305 NTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
+ C G Y + G L + S+ + + + Y+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-- 120
Query: 365 CKRRIIHRDIKASNVL---LGPDFEPQITDFGLAKWLPNKCTH-----HAAIPIEGTFGY 416
+ IHRD+K N L I DFGLAK + TH + GT Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476
+ + + D+ + G +L+ G P + + ++ ++
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL-----TSGHDSEFAKSWRMPE 531
+G + + ++C +P S + +L G ++ W M +
Sbjct: 240 LCKG--YPSEFATYL---NFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 294
Query: 532 F 532
F
Sbjct: 295 F 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-39
Identities = 49/233 (21%), Positives = 92/233 (39%), Gaps = 8/233 (3%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
NF +G+G Y VYK N G +A+K++ D + + E+ ++ + HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 306 TATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
L+ + + +L + + P+ + + +GL +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---H 119
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPE-YFMH 424
R++HRD+K N+L+ + ++ DFGLA+ + T Y APE
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 177
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477
D+++ G + E++T R + L+ + G E+V P
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPG 229
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (357), Expect = 8e-39
Identities = 40/281 (14%), Positives = 92/281 (32%), Gaps = 23/281 (8%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
++ +G+G + +++G NL + +++A+K + + + E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGC 60
Query: 305 NTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
V + GL+ + G L D + + + +H+
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQ-----ITDFGLAKWLPNKCTHHAAIPIE-----GTF 414
+ +++RDIK N L+G + DFG+ K+ + T E GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 415 GYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474
Y++ + + D+ A G + + + G P + + + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELL 515
G ++ ++ + Y P + L
Sbjct: 238 RELCAG--FPEEFYKYM---HYARNLAFDATPDYDYLQGLF 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 49/264 (18%), Positives = 92/264 (34%), Gaps = 23/264 (8%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G+G + V++ S + K + D + E+ I+ H N L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHES 69
Query: 313 CIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIH 371
L +IF F ++ ++ + L V V L +LH I H
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 372 RDIKASNVLLGPDFEPQ--ITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDE 429
DI+ N++ I +FG A+ L + Y APE H ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVST 182
Query: 430 KTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHR 489
TD+++ G L+ +++G P + ++ + E + + +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIE-NIMNAEYTFDEEAFKEI-----SIEAMD 236
Query: 490 LVLIADYCVRQTSAWRPSMSEVLE 513
V D + + R + SE L+
Sbjct: 237 FV---DRLLVKERKSRMTASEALQ 257
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 50/219 (22%), Positives = 88/219 (40%), Gaps = 11/219 (5%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKE-FLMELGIIGHVC- 302
+F M+G+G + +V+ + A+K L KD + E ++E ++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 303 HPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYL 361
HP + L+ + + G+L + L Y + GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFL 119
Query: 362 HKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
+ I++RD+K N+LL D +I DFG+ K GT Y+APE
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEI 174
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW 460
+ + D ++FGVLL E++ G+ P + +
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 53/272 (19%), Positives = 106/272 (38%), Gaps = 26/272 (9%)
Query: 251 ENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATL 309
++G G +V + N K A+K L +D A++E E P+ +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWRA-----SQCPHIVRI 70
Query: 310 VGCC-----IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
V L ++ G L + + D ++ +I+ + + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 365 CKRRIIHRDIKASNVLL---GPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEY 421
I HRD+K N+L P+ ++TDFG AK + + T Y+APE
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEV 184
Query: 422 FMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481
D+ D+++ GV++ ++ G P S+ + + + + P+ E
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQYEFPNPEWS 242
Query: 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
++++ L+ ++ R +++E +
Sbjct: 243 EVSEEVKMLI---RNLLKTEPTQRMTITEFMN 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 3e-38
Identities = 53/278 (19%), Positives = 100/278 (35%), Gaps = 17/278 (6%)
Query: 238 YEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELG 296
+++ + + +++G G +SEV + + +A+K +AK + KE E+
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIA 59
Query: 297 IIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVA 355
++ + HPN L G LYLI G L + +++ V
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVL 117
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFG 415
+ YLH + L D + I+DFGL+K A GT G
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC---GTPG 174
Query: 416 YLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVD 475
Y+APE + D ++ GV+ ++ G P + L+ + L
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEYEFDSPYW 233
Query: 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+ +D + + + + R + + L+
Sbjct: 234 DDI-----SDSAKDFI---RHLMEKDPEKRFTCEQALQ 263
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (348), Expect = 1e-37
Identities = 51/284 (17%), Positives = 98/284 (34%), Gaps = 21/284 (7%)
Query: 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
+H +G+G Y VYK + G A+K++ + +D + E+ I+ + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 306 TATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC 365
L ++ + +L L D LE +L + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLK-KLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 366 KRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHG 425
RR++HRD+K N+L+ + E +I DFGLA+ + I +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-IVTLWYRAPDVLMGSK 176
Query: 426 IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA----------------KPLMESGN 469
D+++ G + E++ G + L L +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+ +P + + + ++ R + + LE
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-37
Identities = 63/312 (20%), Positives = 118/312 (37%), Gaps = 33/312 (10%)
Query: 234 TCFSYEEISSATNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAK----DNKDAKKE 288
T F E + + + + +G G ++ V K S G + A K + K ++
Sbjct: 1 TVFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57
Query: 289 KEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIR 347
++ E+ I+ + HPN TL + LI G L +SL
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEA 115
Query: 348 YKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ----ITDFGLAKWLPNKCT 403
+ + + G++YLH +I H D+K N++L P+ I DFGLA +
Sbjct: 116 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP 463
I GT ++APE + + + D+++ GV+ +++G P + L
Sbjct: 173 FK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-- 227
Query: 464 LMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE---LLTSGHD 520
V+ E EY ++ + + R ++ + L+ +
Sbjct: 228 -------VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280
Query: 521 SEFAKSWRMPEF 532
+ +W P+F
Sbjct: 281 QALSSAWSHPQF 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-37
Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 30/284 (10%)
Query: 252 NMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKE---KEFLMELGIIGHVCHPNTA 307
+ +G+G ++ VYK + + + +A+K++ ++ K+ + L E+ ++ + HPN
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 308 TLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCK 366
L+ + L+F+F + + + S L +L +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFM-HG 425
I+HRD+K +N+LL + ++ DFGLAK + + T Y APE
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGAR 176
Query: 426 IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTD 485
+ D++A G +L E++ + +L + G TE P + D
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 486 QMHRLVLIADY----------------CVRQTSAWRPSMSEVLE 513
I + R + ++ L+
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-36
Identities = 48/277 (17%), Positives = 98/277 (35%), Gaps = 35/277 (12%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAK----DNKDAKKEKEFLMELGIIGH 300
+ + ++G GG+ VY G +SD +A+K + K D + ME+ ++
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 301 V--CHPNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGL 358
V L+ +++ D +L+ + V +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYL 417
+ ++HRDIK N+L+ + E ++ DFG L + +GT Y
Sbjct: 124 RHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYS 176
Query: 418 APEYFM-HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476
PE+ H V++ G+LL +++ G P + + ++ + +E
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIRGQVFFRQRVSSECQH- 233
Query: 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513
+ +C+ + RP+ E+
Sbjct: 234 ----------------LIRWCLALRPSDRPTFEEIQN 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-36
Identities = 44/213 (20%), Positives = 85/213 (39%), Gaps = 15/213 (7%)
Query: 245 TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH 303
+ + + +G+G Y V + + ++A+K+++ + L E+ I+ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRH 65
Query: 304 PNTATLVGCCIE-----NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGL 358
N + + +L L + L + + RGL
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGL 122
Query: 359 HYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL-PNKCTHHAAIPIEGTFGYL 417
Y+H ++HRD+K SN+LL + +I DFGLA+ P+ T Y
Sbjct: 123 KYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 418 APEYFMHGIID-EKTDVFAFGVLLLEIITGRKP 449
APE ++ + D+++ G +L E+++ R
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 5e-36
Identities = 62/285 (21%), Positives = 119/285 (41%), Gaps = 20/285 (7%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
+ + +GQG + EV+K + G+K+A+K++ +N+ L E+ I+ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 305 NTATLVGCCI---------ENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVA 355
N L+ C + +YL+F+F ++ + +L R +L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 356 RGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL--PNKCTHHAAIPIEGT 413
L+ L+ + +I+HRD+KA+NVL+ D ++ DFGLA+ + T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 414 FGYLAPEYFMHGI-IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTE 472
Y PE + D++ G ++ E+ T + + + L A G++T
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL-ALISQLCGSITP 243
Query: 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517
V P+++ Y+ + LV V+ L+L+
Sbjct: 244 EVWPNVD-NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 287
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 7e-36
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 10/207 (4%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKE-KEFLMELGIIGHVCH 303
N+F ++G+G + +V + GR A+K L K+ AK E + E ++ + H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 304 PNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
P L + L + ++ G L L ER + E Y A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALE 119
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF 422
R +++RDIK N++L D +ITDFGL K + GT YLAPE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVL 177
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKP 449
D + GV++ E++ GR P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 247 NFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN 305
++ ++G G + VY+ G +A+K++ +D + +E + + +L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 306 TATLVGCCIENG-------LYLIFNFSQNGNLDAALHDERSK-SLEWPIRYKIVLGVARG 357
L +G L L+ ++ A H R+K +L + + R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQ-ITDFGLAKWLPNKCTHHAAIPIEGTFGY 416
L Y+H I HRDIK N+LL PD + DFG AK L + + I Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYY 188
Query: 417 LAPEYFMHGI-IDEKTDVFAFGVLLLEIITGRKP 449
APE DV++ G +L E++ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-35
Identities = 50/286 (17%), Positives = 97/286 (33%), Gaps = 23/286 (8%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
+ +G+G Y V+K N +A+KR+ D+ D L E+ ++ + H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 305 NTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG 364
N L + + F D + L+ I + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLV-FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS- 119
Query: 365 CKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMH 424
R ++HRD+K N+L+ + E ++ +FGLA+ + + + + F
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGA 176
Query: 425 GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDT 484
+ D+++ G + E+ +P+ + G TE PS+ D
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 485 DQMHRLVLIADY-----------------CVRQTSAWRPSMSEVLE 513
++ R S E L+
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 6e-35
Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 13/207 (6%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDN-KDAKKEKEFLMELGIIGHVCH 303
+ F +G G + V + G A+K L K K+ + L E I+ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 304 PNTATLVGCCIE-NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLH 362
P L + + LY++ + G + + L R P + YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 363 KGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYF 422
+I+RD+K N+L+ Q+TDFG AK + + + GT LAPE
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEII 210
Query: 423 MHGIIDEKTDVFAFGVLLLEIITGRKP 449
+ ++ D +A GVL+ E+ G P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 70/337 (20%), Positives = 126/337 (37%), Gaps = 47/337 (13%)
Query: 236 FSYEEISSATNNFHS----ENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKE 290
F +E++ + VG G Y V + G K+A+K+L + + K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 291 FLMELGIIGHVCHPNTATLVGCCIENG-------LYLIFNFSQNGNLDAALHDERSKSLE 343
EL ++ H+ H N L+ + YL+ F G L + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF--MGTDLGKLM--KHEKLG 119
Query: 344 WPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403
+V + +GL Y+H IIHRD+K N+ + D E +I DFGLA+ ++ T
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
Query: 404 HHAAIPIEGTFGYLAPEYFM-HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK 462
+ Y APE + + D+++ G ++ E+ITG+ +L +
Sbjct: 177 GYVVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK-GSDHLDQLKE 230
Query: 463 PLMESGNLTELVDPSLEGEYDTDQMHRLVLIADY-------------------CVRQTSA 503
+ +G L+ + + M L + + +
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 504 WRPSMSEVLE--LLTSGHDSEFAKSWRMPEFTSDELD 538
R + E L S HD+E + + + D++D
Sbjct: 291 QRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVD 327
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 2e-30
Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 16/214 (7%)
Query: 246 NNFHSENMVGQGGYSEVYKG----NLSDGRKIAVKRLAKDN--KDAKKEKEFLMELGIIG 299
NF ++G G Y +V+ G+ A+K L K + AK + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 300 HVCH-PNTATLVGCCIENG-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARG 357
H+ P TL L+LI ++ G L L + Y V
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEI 138
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYL 417
+ L K II+RDIK N+LL + +TDFGL+K T A GT Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYM 197
Query: 418 APEYFMHGI--IDEKTDVFAFGVLLLEIITGRKP 449
AP+ G D+ D ++ GVL+ E++TG P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (291), Expect = 2e-29
Identities = 46/224 (20%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CH 303
+++ +G+G YSEV++ N+++ K+ VK L K+K+ E+ I+ ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 89
Query: 304 PNTATLVGCC---IENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHY 360
PN TL + L+F N + + ++L + + + L Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDF-----KQLYQTLTDYDIRFYMYEILKALDY 144
Query: 361 LHKGCKRRIIHRDIKASNVLLGPDF-EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAP 419
H I+HRD+K NV++ + + ++ D+GLA++ ++ + + + P
Sbjct: 145 CH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGP 198
Query: 420 EYFM-HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAK 462
E + + + D D+++ G +L +I ++P N +
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-29
Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 21/225 (9%)
Query: 236 FSYEEISSA----TNNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKE 290
F +E++ + + + VG G Y V + G ++AVK+L++ + K
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 291 FLMELGIIGHVCHPNTATLVGCCI------ENGLYLIFNFSQNGNLDAALHDERSKSLEW 344
EL ++ H+ H N L+ E + +L+ + + + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTD 120
Query: 345 PIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404
++ + RGL Y+H IIHRD+K SN+ + D E +I DFGLA+ ++ T
Sbjct: 121 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 405 HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
+ A + ++ D+++ G ++ E++TGR
Sbjct: 178 YVATR----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 3e-28
Identities = 43/212 (20%), Positives = 83/212 (39%), Gaps = 19/212 (8%)
Query: 246 NNFHSENMVGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHP 304
+ + +G G V + R +A+K+L++ ++ K EL ++ V H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 305 NTATLVGCCIENG-------LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARG 357
N +L+ +YL+ + + ++ + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCG 131
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYL 417
+ +LH IIHRD+K SN+++ D +I DFGLA+ + T Y
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYR 185
Query: 418 APEYFMHGIIDEKTDVFAFGVLLLEIITGRKP 449
APE + E D+++ G ++ E++ +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (265), Expect = 1e-25
Identities = 41/215 (19%), Positives = 77/215 (35%), Gaps = 22/215 (10%)
Query: 254 VGQGGYSEVYKG-NLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGC 312
+G G +S V+ ++ + +A+K + D + E+ ++ V +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 313 CIENGLYLIFNFS---------------QNGNLDAALHDERSKSLEWPIRYKIVLGVARG 357
+ L L+ +F+ NL A + + + +I + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 358 LHYLHKGCKRRIIHRDIKASNVLLGP-DFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGY 416
L Y+H + IIH DIK NVL+ D + +A T Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 417 LAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVD 451
+PE + D+++ L+ E+ITG +
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 5e-20
Identities = 23/157 (14%), Positives = 48/157 (30%), Gaps = 16/157 (10%)
Query: 252 NMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKK--------EKEFLMELGIIGHVCH 303
++G+G S V+ + VK + KK + F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 304 PNTATLVGCCIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK 363
L G + + N L + + + +++ + + +
Sbjct: 66 RALQKLQGLAVPKVYA----WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120
Query: 364 GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400
R I+H D+ NVL+ + I DF + +
Sbjct: 121 --HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 171 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 40.2 bits (93), Expect = 2e-04
Identities = 29/170 (17%), Positives = 54/170 (31%), Gaps = 24/170 (14%)
Query: 6 PSKILIG--------FSLDPNDSKELLSWAIKVLAQPNDRIVAIHVL---------VGEE 48
P+K+++ + K W ++ + + N I +L +
Sbjct: 1 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDV 60
Query: 49 SKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSI 108
S + + KA + +L F V EA + + +E K +
Sbjct: 61 DSIYASPEDFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTGD-PKDVICQEVKRV 119
Query: 109 SADYLVLRGSRNHSNKMSR---DVTRYCFQHAPGGCTIHIFGETKSENPS 155
D ++ GSR V+ +C +HA C + E PS
Sbjct: 120 RPD-FLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMTIKRNADETPS 166
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.81 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.71 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.67 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.59 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.57 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.4 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.72 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.75 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.37 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 84.69 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 81.79 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=426.33 Aligned_cols=262 Identities=24% Similarity=0.408 Sum_probs=208.6
Q ss_pred hhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEE
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIF 322 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~ 322 (558)
...++|.+.+.||+|+||+||+|... ..||||++..........+.|.+|+.++++++|||||++++++.++..++||
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~ 82 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT 82 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEE
Confidence 34578999999999999999999754 4699999977665566778899999999999999999999999888899999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+......
T Consensus 83 Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp ECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred ecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999996543 469999999999999999999999 899999999999999999999999999998776544
Q ss_pred CcccccccccccCcccchhhcc---CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMH---GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.........||+.|||||++.+ +.|+.++|||||||+||||+||+.||........... ....+...... .
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~--~~~~~~~~p~~-~--- 232 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF--MVGRGYLSPDL-S--- 232 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH--HHHHTSCCCCG-G---
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH--HHhcCCCCCcc-h---
Confidence 4444455679999999999964 3589999999999999999999999987543322111 11111111100 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
..+......+.+++.+||+.||++|||+.||++.|+.
T Consensus 233 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 233 -KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp -GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122234578899999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=418.04 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=204.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|++.+.||+|+||+||+|.. .+|+.||||++.+... ....+.+.+|+.++++++||||+++++++.+++ .|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 45799999999999999999965 5799999999976532 234456889999999999999999999998876 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 83 Ey~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 83 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999999853 4579999999999999999999999 899999999999999999999999999998775444
Q ss_pred CcccccccccccCcccchhhccCCC-CccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
........+||+.|||||++.+..+ +.++|||||||+||||++|+.||.........+... ...... ..
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-~~~~~~---------~~ 227 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKTY---------LN 227 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-HTTCTT---------ST
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCC---------CC
Confidence 3344455789999999999988876 578999999999999999999997654332222111 111111 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
.......++.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11223456888999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=418.77 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=212.2
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEE
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYL 320 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 320 (558)
+....++|++.+.||+|+||+||+|..++++.||||++...... .+.|.+|+.++++++|||||++++++.++..++
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~i 84 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYI 84 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEE
Confidence 33455789999999999999999999888899999999765433 346899999999999999999999998888999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+++|+|.+++.......+++..+++|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999998876665679999999999999999999999 8999999999999999999999999999998754
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCC-CCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPV-DSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
... .......||+.|+|||++.++.++.++|||||||+||||+||..|+ ........ .. .+..+. +
T Consensus 162 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~-~~--~i~~~~---------~ 228 (272)
T d1qpca_ 162 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-IQ--NLERGY---------R 228 (272)
T ss_dssp SCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HH--HHHTTC---------C
T ss_pred Ccc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH-HH--HHHhcC---------C
Confidence 422 2233456999999999999999999999999999999999965554 43322211 11 111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
...+......+.+++.+||+.||++||||.||++.|+.
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11122334578899999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=412.05 Aligned_cols=254 Identities=23% Similarity=0.394 Sum_probs=199.6
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe---CcEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE---NGLYLI 321 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~lv 321 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++............+.+|++++++++||||+++++++.+ +.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999954 579999999998777667777889999999999999999999999864 238999
Q ss_pred EEeccCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhCC--CCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 322 FNFSQNGNLDAALHDE--RSKSLEWPIRYKIVLGVARGLHYLHKGC--KRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+.. ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998653 3457999999999999999999999821 12499999999999999999999999999988
Q ss_pred CCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
+..... ......||+.|||||++.+..|+.++|||||||++|||+||+.||......... . .+..+....
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~--~-~i~~~~~~~----- 233 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA--G-KIREGKFRR----- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--H-HHHHTCCCC-----
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHH--H-HHHcCCCCC-----
Confidence 754322 223467999999999999999999999999999999999999999875443221 1 112222221
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+ +...+.++.+++.+||+.||++|||+.|+++
T Consensus 234 ~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 I----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 1223457889999999999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=409.20 Aligned_cols=246 Identities=27% Similarity=0.449 Sum_probs=205.7
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||+||+|.. .+++.||+|++.+.... ......+.+|+.++++++||||+++++++.+++ .|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5699999999999999999965 57899999999754322 223566889999999999999999999998866 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|.......
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999999999654 469999999999999999999999 899999999999999999999999999998765432
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.....||+.|||||++.+..|+.++|||||||+||||++|+.||......... .. +..... .+
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-~~--i~~~~~----------~~ 223 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-KR--ISRVEF----------TF 223 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH--HHTTCC----------CC
T ss_pred ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-HH--HHcCCC----------CC
Confidence 23456999999999999999999999999999999999999999875433221 11 111111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+......+.+++.+||+.||++|||+.|+++
T Consensus 224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2223457889999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-53 Score=417.82 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=214.6
Q ss_pred HHHhhhCCCcccceEeeeCceEEEEEEEC-CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-
Q 008650 240 EISSATNNFHSENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG- 317 (558)
Q Consensus 240 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 317 (558)
++....++|++.+.||+|+||+||+|... +|+.||||++.++... .++|.+|+.+|++++|||||+++++|.+++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 34445678999999999999999999664 6889999999765433 346889999999999999999999998755
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++||||+++|+|..++.......+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999999999987777789999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
...... .......||+.|+|||++.++.|+.++|||||||++|||++|..||.........+. .+..+
T Consensus 165 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~--~i~~~--------- 232 (287)
T d1opja_ 165 MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE--LLEKD--------- 232 (287)
T ss_dssp CCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH--HHHTT---------
T ss_pred cCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH--HHhcC---------
Confidence 655432 222334589999999999999999999999999999999997776654322211111 11111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
.....+.....++.+++.+||+.||++|||+.||++.|+...
T Consensus 233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112223334467899999999999999999999999987643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=410.61 Aligned_cols=254 Identities=23% Similarity=0.427 Sum_probs=198.7
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.++|++.+.||+|+||+||+|.+.+++.||||++.+.... ..+|.+|+.++++++||||++++|+|.+++ .++|||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 3678999999999999999999888899999999765433 346899999999999999999999998655 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp CCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred ecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999998654 3568999999999999999999999 8999999999999999999999999999987654432
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcC-CCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITG-RKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
. ......||+.|+|||++.++.|+.++|||||||++|||+|+ +.||........ ...... +. +...
T Consensus 157 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~--~~~i~~-~~---------~~~~ 223 (263)
T d1sm2a_ 157 T-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VEDIST-GF---------RLYK 223 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH--HHHHHH-TC---------CCCC
T ss_pred e-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH--HHHHHh-cC---------CCCC
Confidence 2 22335699999999999999999999999999999999995 555654433211 111111 11 0111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
+.....++.+++.+||+.||++||||+||++.|++.
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 222345788999999999999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=409.77 Aligned_cols=248 Identities=21% Similarity=0.376 Sum_probs=206.5
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.++++++|||||++++++.+++ .|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4799999999999999999954 67999999999765432 2356889999999999999999999998766 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+|+|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 98 y~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 9999999998754 359999999999999999999999 8999999999999999999999999999987754322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
.....+||+.|+|||++.++.|+.++|||||||++|+|++|+.||............ ...+... ...+
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--~~~~~~~--------~~~~ 239 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--ATNGTPE--------LQNP 239 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHHCSCC--------CSSG
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH--HhCCCCC--------CCCc
Confidence 233457999999999999999999999999999999999999999876543322211 1111110 1112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233457889999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=410.75 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=211.4
Q ss_pred hCCCcccce-EeeeCceEEEEEEEC---CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEE
Q 008650 245 TNNFHSENM-VGQGGYSEVYKGNLS---DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYL 320 (558)
Q Consensus 245 ~~~f~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 320 (558)
.++|.+.+. ||+|+||+||+|... ++..||||++.+. ......+.|.+|+.+|++++|||||+++|++.++..|+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEE
Confidence 356777774 999999999999543 3557999999654 34566778999999999999999999999998888999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+++|+|.+++... ...+++..+.+++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 86 vmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999998543 3569999999999999999999999 8999999999999999999999999999988765
Q ss_pred CCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 401 KCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 401 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......... ..+..+..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~---~~i~~~~~-------- 230 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGKR-------- 230 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HHHHTTCC--------
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCC--------
Confidence 4322 22334568999999999999999999999999999999998 99999875443221 11222221
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+...+.++.+++.+||+.+|++|||+.+|++.|+..
T Consensus 231 -~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 231 -MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112233445788999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=409.15 Aligned_cols=249 Identities=25% Similarity=0.396 Sum_probs=202.5
Q ss_pred ceEeeeCceEEEEEEEC---CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEEeccCC
Q 008650 252 NMVGQGGYSEVYKGNLS---DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFNFSQNG 328 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g 328 (558)
+.||+|+||+||+|.+. .++.||||++.....+....+.|.+|+.+|++++|||||+++++|.++..++||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 47999999999999653 356899999976555555667899999999999999999999999877899999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc-cc
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH-AA 407 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~ 407 (558)
+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+....... ..
T Consensus 93 ~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 93 PLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred cHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999998653 569999999999999999999999 899999999999999999999999999998765443322 22
Q ss_pred cccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHH
Q 008650 408 IPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQ 486 (558)
Q Consensus 408 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 486 (558)
....||+.|+|||++.++.++.++|||||||++|||+| |+.||.......... .+..+. +...+...
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~---~i~~~~---------~~~~p~~~ 235 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---MLEKGE---------RMGCPAGC 235 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHTTC---------CCCCCTTC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH---HHHcCC---------CCCCCccc
Confidence 34569999999999999999999999999999999998 899998754432211 112221 11122233
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 487 MHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 487 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 4578899999999999999999999998875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-52 Score=413.19 Aligned_cols=256 Identities=24% Similarity=0.453 Sum_probs=197.2
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCC---EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGR---KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 320 (558)
++|++.+.||+|+||+||+|... +++ .||||++... ......+.|.+|+.+|++++|||||+++|++.+++ .++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999654 333 5889988543 34556678999999999999999999999998755 999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 105 v~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999988653 3469999999999999999999999 8999999999999999999999999999987754
Q ss_pred CCCccc---ccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCC
Q 008650 401 KCTHHA---AIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDP 476 (558)
Q Consensus 401 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 476 (558)
...... .....||+.|||||++.++.++.++|||||||+||||+| |+.||......... .....+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~--~~i~~~--------- 249 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI--NAIEQD--------- 249 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHHHTT---------
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH--HHHHcC---------
Confidence 432221 222458999999999999999999999999999999998 89999876443221 111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 477 SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 477 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.+...+......+.+++.+||+.||++|||+.||++.|++.
T Consensus 250 -~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 250 -YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11112233456789999999999999999999999998763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=401.65 Aligned_cols=253 Identities=21% Similarity=0.370 Sum_probs=212.5
Q ss_pred hCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.++|++.+.||+|+||+||+|..++++.||||++.+..... .+|.+|+.++++++||||++++|+|.+++ .++|||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 46899999999999999999998888899999998765443 46899999999999999999999998755 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+|+|..++.... ..+++..+++++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 80 y~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 80 YMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp CCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred ccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999999976543 468999999999999999999999 8999999999999999999999999999987654422
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.......||+.|+|||++.++.++.++|||||||++|||+| |+.||........... +..+. +...
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~---i~~~~---------~~~~ 222 (258)
T d1k2pa_ 156 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IAQGL---------RLYR 222 (258)
T ss_dssp -CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH---HHTTC---------CCCC
T ss_pred -eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH---HHhCC---------CCCC
Confidence 23334569999999999999999999999999999999998 8999987654433221 11111 1111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
+......+.+++.+||+.||++|||+.|+++.|.+
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 22334578999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=413.00 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=204.1
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++.+... .......+.+|+.++++++||||+++++++.+++ .|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4699999999999999999965 5799999999975432 1233456889999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+++|+|.+++... +.+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999988654 569999999999999999999999 899999999999999999999999999999876554
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
........+||+.|+|||++.+..|+.++|||||||+||||++|+.||......... .. .. .+.. .+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~~-i~-~~~~----------~~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-QK-II-KLEY----------DF 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH-HH-TTCC----------CC
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-HH-HH-cCCC----------CC
Confidence 444444567999999999999999999999999999999999999999876443221 11 11 1111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 22234568899999999999999999997653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=400.74 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=200.0
Q ss_pred CcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe----C-cEEEE
Q 008650 248 FHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE----N-GLYLI 321 (558)
Q Consensus 248 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~-~~~lv 321 (558)
|.+.+.||+|+||+||+|.. .+++.||+|++............|.+|+++|++++|||||++++++.+ + .+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 35677899999999999955 578899999998776666677789999999999999999999999864 2 27999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCc--EEecCCCCCceeec-CCCceEEEeccccccC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRR--IIHRDIKASNVLLG-PDFEPQITDFGLAKWL 398 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~ 398 (558)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+ ++ |+||||||+||||+ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999999654 468999999999999999999998 66 99999999999996 5789999999999864
Q ss_pred CCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
... .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.........+.. +..+.....+
T Consensus 166 ~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~--i~~~~~~~~~---- 234 (270)
T d1t4ha_ 166 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVKPASF---- 234 (270)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--HTTTCCCGGG----
T ss_pred cCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH--HHcCCCCccc----
Confidence 332 2234679999999999865 5999999999999999999999999765433222211 1111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+.....++.+++.+||+.||++|||+.|+++
T Consensus 235 ----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1122346889999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=415.83 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=207.3
Q ss_pred hhCCCcccceEeeeCceEEEEEEEC-CC-----CEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeC
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLS-DG-----RKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIEN 316 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 316 (558)
..++|.+.+.||+|+||+||+|... .+ ..||+|++.... .......+.+|+.++.++ +|||||++++++.++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 4467999999999999999999653 22 368999986543 344556788999999998 899999999999876
Q ss_pred c-EEEEEEeccCCCHHHHHhhccC---------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCC
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERS---------------------KSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDI 374 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dl 374 (558)
+ .|+||||+++|+|.++|+..+. ..+++..++.++.||+.||.|||+ ++||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccC
Confidence 5 9999999999999999976432 358899999999999999999999 89999999
Q ss_pred CCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCC
Q 008650 375 KASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSS 453 (558)
Q Consensus 375 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~ 453 (558)
||+|||++.++.+||+|||+|+............+..||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987655444434445678999999999999999999999999999999998 89999865
Q ss_pred chhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008650 454 RQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLT 516 (558)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 516 (558)
........ ....+ .+...+.....++.+++.+||+.||++|||++||++.|.
T Consensus 271 ~~~~~~~~--~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDANFYK--LIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHHHHH--HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHH--HHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 43322111 11111 111223334467899999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=416.42 Aligned_cols=262 Identities=21% Similarity=0.342 Sum_probs=204.8
Q ss_pred hhCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
..++|++.+.||+|+||+||+|.. .+|+.||+|++.+.. .......+.+|+.+|++++|||||+++++|.+++ .|+|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356899999999999999999965 578999999997653 2344567899999999999999999999998766 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+++|+|.+++... +.+++..+..++.||+.||.|||+. ++|+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 83 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999999654 4699999999999999999999971 38999999999999999999999999999865432
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccc--------
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL-------- 473 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------- 473 (558)
...+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.................+.....
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 22345799999999999999999999999999999999999999976543322111110000000000
Q ss_pred -----------------------cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 474 -----------------------VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 474 -----------------------~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
...............++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000001123568899999999999999999999983
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=407.87 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=207.2
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYLIFN 323 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e 323 (558)
..++|++.+.||+|+||+||+|...+++.||||++...... .+.|.+|+.++++++|||||++++++.++..++|||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~E 91 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 91 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEE
Confidence 34679999999999999999998888889999999765443 356899999999999999999999998778999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+|+|..++.......++|..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999999987766679999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYD 483 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 483 (558)
.......||+.|+|||++.++.++.++|||||||+||||++|..||............ +..+. +...+
T Consensus 169 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~--i~~~~---------~~~~~ 236 (285)
T d1fmka3 169 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--VERGY---------RMPCP 236 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--HHTTC---------CCCCC
T ss_pred -eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH--HHhcC---------CCCCC
Confidence 2233456999999999999999999999999999999999976665433222111111 11111 11122
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008650 484 TDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGH 519 (558)
Q Consensus 484 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 519 (558)
....+++.+++.+||+.||++|||+.+|++.|+...
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 334457899999999999999999999999998744
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=407.97 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=204.0
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
+.|++.+.||+|+||+||+|.. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++ .++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4689999999999999999955 579999999997653 233456889999999999999999999998766 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 90 y~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 90 FCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp CCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 99999999988654 3569999999999999999999999 899999999999999999999999999997653321
Q ss_pred cccccccccccCcccchhhc-----cCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFM-----HGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
....+..||+.|+|||++. +..|+.++|||||||++|||+||+.||........... .... ....
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~--i~~~-~~~~------ 234 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK--IAKS-EPPT------ 234 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH--HHHS-CCCC------
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH--HHcC-CCCC------
Confidence 1223467999999999984 45689999999999999999999999987544322111 1111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
...+......+.+++.+||+.||++|||+.|+++
T Consensus 235 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 -LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112334567899999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=401.42 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=200.0
Q ss_pred hCCCcccceEeeeCceEEEEEEECCC-----CEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNLSDG-----RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.+.|+..++||+|+||+||+|.+.++ ..||||++... ........|.+|+.++++++|||||+++|++.++. .
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 35688899999999999999965432 36999999644 34555677999999999999999999999998755 9
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
++||||+.+|++.+.+... ...+++..+.+++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+
T Consensus 85 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999999887654 3569999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCc-ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 399 PNKCTH-HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 399 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
...... .......||+.|+|||++.++.++.++|||||||+||||++|..|+......... .. .+..+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~-~~-~i~~~--------- 229 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MK-AINDG--------- 229 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HH-HHHTT---------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH-HH-HHhcc---------
Confidence 543222 2223356899999999999999999999999999999999976665433222111 11 11111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.+...+......+.+++.+||+.||++|||+.||++.|++.
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11222333446789999999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-50 Score=405.40 Aligned_cols=245 Identities=24% Similarity=0.421 Sum_probs=202.7
Q ss_pred CCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 247 NFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
.|+..+.||+|+||+||+|. ..+|+.||||++.+... .....+.+.+|+.+|++++|||||++++++.+++ .|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 48999999999999999995 45789999999977653 3455677999999999999999999999998765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.+|+|..++.. ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|......
T Consensus 96 ~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp CCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 9999999876643 3569999999999999999999999 89999999999999999999999999999865432
Q ss_pred cccccccccccCcccchhhcc---CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 404 HHAAIPIEGTFGYLAPEYFMH---GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||........... .... ......
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~--i~~~-~~~~~~------ 235 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQN-ESPALQ------ 235 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHS-CCCCCS------
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH--HHhC-CCCCCC------
Confidence 23569999999999864 4689999999999999999999999986544322111 1111 111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
+......+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1123457889999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-50 Score=406.02 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=190.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.+.|++.+.||+|+||+||+|.. .+|+.||||++.+.... .....+.+|+.+|++++||||+++++++.+++ .|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45699999999999999999965 57899999999765432 23456789999999999999999999998766 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec---CCCceEEEeccccccCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG---PDFEPQITDFGLAKWLP 399 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a~~~~ 399 (558)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+ ++|+||||||+|||+. +++.+||+|||+|+...
T Consensus 87 E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999954 3579999999999999999999999 8999999999999994 57899999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
.... ..+.+||+.|||||++.+..|+.++|||||||+||||++|+.||......... .. ... +.. ...
T Consensus 162 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~~-i~~-~~~------~~~ 229 (307)
T d1a06a_ 162 PGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-EQ-ILK-AEY------EFD 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HH-HHT-TCC------CCC
T ss_pred CCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH-HH-Hhc-cCC------CCC
Confidence 4322 23457999999999999999999999999999999999999999876543221 11 111 111 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11122334578999999999999999999999984
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=408.67 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=204.7
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCC----EEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGR----KIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 320 (558)
.+|++.+.||+|+||+||+|.. .+|+ +||+|++... ......+.|.+|+.++++++|||||+++|+|.++..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeE
Confidence 4699999999999999999965 3454 5888888543 23344677999999999999999999999999988999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
++||+.+|+|.+.+... ...+++..+++++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 99999999999988654 4569999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 479 (558)
...........||+.|+|||++.++.|+.++|||||||+||||+| |..||......... . .+..+. +
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~--~-~i~~~~---------~ 231 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--S-ILEKGE---------R 231 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH--H-HHHHTC---------C
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH--H-HHHcCC---------C
Confidence 544444444569999999999999999999999999999999998 89999865433221 1 111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
...+......+.+++.+||+.||.+|||+.||++.|...
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 112233445789999999999999999999999987653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9e-50 Score=406.14 Aligned_cols=251 Identities=19% Similarity=0.281 Sum_probs=206.7
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|.+.+.||+|+||+||+|.. .+|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+++ .|+|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5799999999999999999955 579999999996553 344567889999999999999999999998866 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC--CCceEEEeccccccCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP--DFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~~~~ 401 (558)
|+++|+|.+++... .+.+++..+..++.||+.||.|||+ ++||||||||+|||++. ++.+||+|||+++.+...
T Consensus 104 ~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 104 FMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred cCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999998543 3469999999999999999999999 89999999999999964 578999999999877544
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.. .....||+.|||||++.+..|+.++|||||||++|||++|+.||.......... ........... .
T Consensus 180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-~i~~~~~~~~~--------~ 247 (350)
T d1koaa2 180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-NVKSCDWNMDD--------S 247 (350)
T ss_dssp SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHTCCCSCC--------G
T ss_pred cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH-HHHhCCCCCCc--------c
Confidence 32 234569999999999999999999999999999999999999998664432211 11111111111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
........+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112234578899999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-49 Score=404.85 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=206.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.. ......+.+|+.+|++++|||||++++++.+++ +|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4699999999999999999954 679999999997654 344567889999999999999999999998765 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeec--CCCceEEEeccccccCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLG--PDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFG~a~~~~~~ 401 (558)
|+++|+|.+.+... ...+++..++.|+.||+.||.|||+ ++|+||||||+||||+ .++.+||+|||+|..+...
T Consensus 107 ~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 107 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred cCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999999887543 3469999999999999999999999 8999999999999997 5789999999999887654
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
.. .....||+.|+|||++.+..|+.++|||||||+||||+||+.||.+......... .. .+... ....
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~--i~-~~~~~------~~~~ 250 (352)
T d1koba_ 183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN--VK-RCDWE------FDED 250 (352)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH--HH-HCCCC------CCSS
T ss_pred Cc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HH-hCCCC------CCcc
Confidence 22 2345699999999999999999999999999999999999999987654322111 11 11111 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.......++.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122334578899999999999999999999884
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=397.95 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=200.5
Q ss_pred hhCCCcccceEeeeCceEEEEEEECC----CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSD----GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLY 319 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 319 (558)
..++|.+.+.||+|+||+||+|.... +..||||.+... ........|.+|+.++++++||||+++++++.++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEE
Confidence 34679999999999999999996532 346889988543 3456667899999999999999999999999877799
Q ss_pred EEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCC
Q 008650 320 LIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLP 399 (558)
Q Consensus 320 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 399 (558)
+||||+.+|+|..++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 84 iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999987654 4568999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
.... .......||+.|+|||++.++.++.++|||||||++|||++ |..||........... +..+...
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~---i~~~~~~------- 228 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERL------- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTCCC-------
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH---HHcCCCC-------
Confidence 4322 22334568999999999999999999999999999999998 8999987654322211 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
..+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 229 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12233446789999999999999999999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-50 Score=401.82 Aligned_cols=263 Identities=24% Similarity=0.407 Sum_probs=213.6
Q ss_pred HHHhhhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEE
Q 008650 240 EISSATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC 313 (558)
Q Consensus 240 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 313 (558)
++....++|++.+.||+|+||+||+|... +++.||||++... ........|.+|+.++++++||||+++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 34445678999999999999999999653 4578999999654 3455677899999999999999999999999
Q ss_pred EeCc-EEEEEEeccCCCHHHHHhhcc----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEE
Q 008650 314 IENG-LYLIFNFSQNGNLDAALHDER----------------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRII 370 (558)
Q Consensus 314 ~~~~-~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv 370 (558)
.+.+ .+++|||+.+|+|.+++.... ...+++..++.|+.|++.||+|||+ ++||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeE
Confidence 8755 999999999999999996532 2247899999999999999999999 8999
Q ss_pred ecCCCCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCC-CC
Q 008650 371 HRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGR-KP 449 (558)
Q Consensus 371 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~-~P 449 (558)
||||||+||||+.++.+||+|||+|+.+..........+..||+.|+|||++.+..|+.++|||||||++|||++|. .|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998765544444444567999999999999999999999999999999999985 57
Q ss_pred CCCCchhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 450 VDSSRQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 450 f~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
|........... +..+.... .+...+.++.+++.+||+.+|++||||.||++.|++.
T Consensus 243 ~~~~~~~e~~~~---v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 243 YYGMAHEEVIYY---VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTSCHHHHHHH---HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCHHHHHHH---HHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 776544322211 22222211 1223345788999999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=397.00 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=206.4
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH----HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA----KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.+..... ...+.+.+|+.+|++++|||||++++++.+++ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999965 579999999997653221 23567889999999999999999999998766 9
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC----ceEEEeccc
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF----EPQITDFGL 394 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~ 394 (558)
|+||||+++|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999999654 469999999999999999999999 8999999999999998876 499999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV 474 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 474 (558)
+........ ..+..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......... ..+...
T Consensus 164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i---~~~~~~--- 234 (293)
T d1jksa_ 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV---SAVNYE--- 234 (293)
T ss_dssp CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HTTCCC---
T ss_pred hhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH---HhcCCC---
Confidence 987754322 23456999999999999999999999999999999999999999876543222111 111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.........+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 235 ---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ---CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000011223568899999999999999999999873
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=401.55 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=207.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.+... .......+.+|+.+|++++||||+++++++.+++ +|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46799999999999999999954 6799999999976532 1223566889999999999999999999998876 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+.+|+|..++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999998654 468999999999999999999999 89999999999999999999999999999875443
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... .. +..+.. .
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~-i~~~~~----------~ 223 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF--EL-ILMEEI----------R 223 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHCCC----------C
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH--HH-HhcCCC----------C
Confidence 2 2234567999999999999999999999999999999999999999876543221 11 111111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLEL 514 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 514 (558)
++.....++.+++.+||+.||.+||+ +.|++++
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 12223456889999999999999995 8888874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=392.87 Aligned_cols=249 Identities=27% Similarity=0.433 Sum_probs=200.6
Q ss_pred hhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--cEEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--GLYLI 321 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~lv 321 (558)
.-++|++.+.||+|+||.||+|.. .|+.||||++.++. ..+.|.+|+.++++++||||++++|++.++ ..++|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 345788999999999999999987 47889999996543 235688999999999999999999998653 38999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+++|+|.++|.......+++..+++++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999999976655568999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEG 480 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 480 (558)
. ....+|+.|+|||++.++.++.++|||||||++|||+| |+.||........... +..+ .+.
T Consensus 157 ~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~---i~~~---------~~~ 219 (262)
T d1byga_ 157 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKG---------YKM 219 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH---HTTT---------CCC
T ss_pred C-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHcC---------CCC
Confidence 2 22458999999999999999999999999999999998 7888876543322111 1111 122
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 481 EYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 481 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
..+.....++.+++.+||+.||.+|||+.++++.|+.
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 2233334578899999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=393.47 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=200.9
Q ss_pred CCCcccceEeeeCceEEEEEEEC--CC--CEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCcEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS--DG--RKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENGLYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 320 (558)
++|++.+.||+|+||+||+|... ++ ..||||++.+... .....+.|.+|+.+|++++||||++++|++.++..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 56999999999999999999542 33 3689999876542 2345678999999999999999999999998878999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPN 400 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 400 (558)
||||+.+|+|.+.+.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999998886543 469999999999999999999999 8999999999999999999999999999998755
Q ss_pred CCCcc-cccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHHHHhhhhhhcCCcccccCCCC
Q 008650 401 KCTHH-AAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLVLWAKPLMESGNLTELVDPSL 478 (558)
Q Consensus 401 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 478 (558)
..... ......||..|+|||++.+..++.++|||||||++|||+| |+.||.......... .....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~--~i~~~~~--------- 232 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH--KIDKEGE--------- 232 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHHTSCC---------
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH--HHHhCCC---------
Confidence 43332 2233558889999999999999999999999999999998 899998765443221 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 479 EGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 479 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
+...+...+..+.+++.+||+.||++|||+.||++.|+++
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111223335788999999999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=394.46 Aligned_cols=265 Identities=25% Similarity=0.393 Sum_probs=203.7
Q ss_pred HHHHHhhhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeee
Q 008650 238 YEEISSATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLV 310 (558)
Q Consensus 238 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 310 (558)
..++....++|++.+.||+|+||+||+|... +++.||||++.... .......+.+|..++.++ +|+||+.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 3455555678999999999999999999542 34689999996443 345566788888888777 589999999
Q ss_pred eEEEeCc--EEEEEEeccCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCC
Q 008650 311 GCCIENG--LYLIFNFSQNGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDI 374 (558)
Q Consensus 311 ~~~~~~~--~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dl 374 (558)
+++.+++ .++||||+++|+|.++++... ...+++..+..++.||+.||.|||+ ++||||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcC
Confidence 9987643 899999999999999997543 2358899999999999999999999 89999999
Q ss_pred CCCceeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcC-CCCCCCC
Q 008650 375 KASNVLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITG-RKPVDSS 453 (558)
Q Consensus 375 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg-~~Pf~~~ 453 (558)
||+||||+.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+|| ..||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999877655544445567799999999999999999999999999999999996 5678654
Q ss_pred chhHHHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 454 RQNLVLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
...... . ..+..+... ..+.....++.+++.+||+.||++|||+.|++++|++
T Consensus 241 ~~~~~~-~-~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 241 KIDEEF-C-RRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp CCSHHH-H-HHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHH-H-HHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 332211 1 111222111 1122234568899999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-49 Score=395.67 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=204.9
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++.+... .......+.+|+.+++.++||||+++++++.+++ +|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999965 5799999999975432 1223567889999999999999999999998766 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.||+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999999988654 568888999999999999999998 89999999999999999999999999999876543
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
..+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.......... ..... .. .+
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~i~~~-~~----------~~ 220 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE--KILNA-EL----------RF 220 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHHHC-CC----------CC
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH--HHHcC-CC----------CC
Confidence 234679999999999999999999999999999999999999998764432211 11111 11 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
+......+.+++.+||+.||.+|+ |+++++++
T Consensus 221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 122335688999999999999996 89999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.1e-49 Score=387.53 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=203.4
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-----
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG----- 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 317 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.+... +......|.+|+.+++.++||||+++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999954 6799999999976543 4566678999999999999999999999986521
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.|+||||+++|+|..++... +.+++..++.++.||+.||+|||+ ++|+||||||+|||++.++..+|+|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence 78999999999999988654 469999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCCC-cccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC-cccccC
Q 008650 398 LPNKCT-HHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN-LTELVD 475 (558)
Q Consensus 398 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~d 475 (558)
...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.........+ ....... .....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~--~~~~~~~~~~~~~- 237 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--QHVREDPIPPSAR- 237 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHCCCCCGGGT-
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH--HHHhcCCCCCchh-
Confidence 543322 223345679999999999999999999999999999999999999998765432221 1122211 11111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhc
Q 008650 476 PSLEGEYDTDQMHRLVLIADYCVRQTSAWRP-SMSEVLELLTS 517 (558)
Q Consensus 476 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~ 517 (558)
....+..+.+++.+||+.||.+|| |+++++..|.+
T Consensus 238 -------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 238 -------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 112335788999999999999999 89999887754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-48 Score=382.13 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=206.4
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc-------HHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeC
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD-------AKKEKEFLMELGIIGHVC-HPNTATLVGCCIEN 316 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 316 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.... ......+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999955 57999999999765321 223456889999999997 99999999999886
Q ss_pred c-EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 317 G-LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 317 ~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
+ .|+||||+++|+|.++|... +.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 6 99999999999999999654 469999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCcccchhhcc------CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC
Q 008650 396 KWLPNKCTHHAAIPIEGTFGYLAPEYFMH------GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN 469 (558)
Q Consensus 396 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 469 (558)
+.+..... .....||+.|+|||++.+ ..++.++||||+||+||||++|+.||........... .. .++
T Consensus 158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~--i~-~~~ 231 (277)
T d1phka_ 158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM--IM-SGN 231 (277)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH-HTC
T ss_pred eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH--HH-hCC
Confidence 98765332 233569999999999863 3578899999999999999999999987654332211 11 111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 470 LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 470 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.. .........+.++.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 232 YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11 1111122345679999999999999999999999763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-48 Score=397.07 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=200.2
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeeccccc----HHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-E
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKD----AKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-L 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 318 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.+.... .........++.+++.++|||||++++++.+++ +
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 36899999999999999999965 57999999999654321 122223345578888999999999999998766 9
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
|+||||+++|+|..+|... ..+++..++.++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+.+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999999654 568899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCC
Q 008650 399 PNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPS 477 (558)
Q Consensus 399 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 477 (558)
.... .....||+.|+|||++.. ..|+.++|||||||+||||+||+.||..................
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~--------- 224 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------- 224 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC---------
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---------
Confidence 5432 233569999999999975 46899999999999999999999999865332111111111000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 008650 478 LEGEYDTDQMHRLVLIADYCVRQTSAWRPS-----MSEVLEL 514 (558)
Q Consensus 478 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 514 (558)
....+.....++.+++.+||+.||++||| ++|++++
T Consensus 225 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 -AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 01112223456889999999999999999 6888864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=392.70 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=208.6
Q ss_pred hhCCCcccceEeeeCceEEEEEEECC--------CCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEE
Q 008650 244 ATNNFHSENMVGQGGYSEVYKGNLSD--------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCI 314 (558)
Q Consensus 244 ~~~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 314 (558)
..++|.+.+.||+|+||.||+|.... +..||||++.++. ......++.+|...+.++ +|||||+++++|.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 44679999999999999999995422 2479999996544 455567888999999888 7999999999998
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCce
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDER--------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNV 379 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI 379 (558)
+++ .++||||+.+|+|.++|.... ...+++..+++++.||+.||+|||+ ++||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccce
Confidence 766 999999999999999997553 2358999999999999999999999 8999999999999
Q ss_pred eecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhHH
Q 008650 380 LLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNLV 458 (558)
Q Consensus 380 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~~ 458 (558)
|++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |..||........
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 999999999999999988766555444555679999999999999999999999999999999998 7889986654322
Q ss_pred HHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 459 LWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 459 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
. ..+..+. ....+.....++.+++.+||+.||++|||+.||++.|++.
T Consensus 247 ~---~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 247 F---KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp H---HHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 1112211 1111222345789999999999999999999999999764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-48 Score=396.75 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=204.8
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.+.. .++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999955 5799999999975432 1233456889999999999999999999998766 89999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKC 402 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 402 (558)
||+.+|+|..++... +.+++..++.++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999999999654 469999999999999999999999 89999999999999999999999999999876543
Q ss_pred CcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 403 THHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 403 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
..+..||+.|||||++.+..|+.++|||||||+||||+||+.||.......... ... .+.. ..
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~i~-~~~~----------~~ 257 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--KIV-SGKV----------RF 257 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHH-HCCC----------CC
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH--HHh-cCCC----------CC
Confidence 224569999999999999999999999999999999999999998764332211 111 1111 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLEL 514 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 514 (558)
+......+.+++.+||+.||.+|+ |+.+++++
T Consensus 258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 122345688999999999999994 89999873
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=392.93 Aligned_cols=261 Identities=22% Similarity=0.383 Sum_probs=213.5
Q ss_pred hhhCCCcccceEeeeCceEEEEEEE------CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEe
Q 008650 243 SATNNFHSENMVGQGGYSEVYKGNL------SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIE 315 (558)
Q Consensus 243 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 315 (558)
...++|++.+.||+|+||.||+|.. .+++.||||++.+.. .......|.+|+.+++++ +|||||++++++.+
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 4457899999999999999999964 346789999996544 455667899999999999 69999999999987
Q ss_pred Cc-EEEEEEeccCCCHHHHHhhcc----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCc
Q 008650 316 NG-LYLIFNFSQNGNLDAALHDER----------------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASN 378 (558)
Q Consensus 316 ~~-~~lv~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N 378 (558)
+. .++||||+++|+|.++++... ...+++..+..++.||+.||.|||+ ++||||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccc
Confidence 65 999999999999999997643 2358899999999999999999999 899999999999
Q ss_pred eeecCCCceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHc-CCCCCCCCchhH
Q 008650 379 VLLGPDFEPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIIT-GRKPVDSSRQNL 457 (558)
Q Consensus 379 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~Pf~~~~~~~ 457 (558)
||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |..||.......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999998776555444455679999999999999999999999999999999999 555565543322
Q ss_pred HHHhhhhhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 458 VLWAKPLMESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 458 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
..+. ....+ .+...+......+.+++.+||+.||.+|||+.||++.|++.
T Consensus 256 ~~~~--~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 256 KFYK--MIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHH--HHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH--HHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2111 11111 11122223345789999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=394.60 Aligned_cols=267 Identities=22% Similarity=0.385 Sum_probs=216.9
Q ss_pred HHhhhCCCcccceEeeeCceEEEEEEEC------CCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEE
Q 008650 241 ISSATNNFHSENMVGQGGYSEVYKGNLS------DGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCI 314 (558)
Q Consensus 241 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 314 (558)
+....++|++.+.||+|+||+||+|.+. ++..||||++.+.. .......|.+|+.++++++||||+++++++.
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 3444578999999999999999999542 35789999996543 4556678999999999999999999999997
Q ss_pred eCc-EEEEEEeccCCCHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC
Q 008650 315 ENG-LYLIFNFSQNGNLDAALHDER--------SKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF 385 (558)
Q Consensus 315 ~~~-~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 385 (558)
.+. .++||||+.+|+|.+++...+ ...+++..+.+++.|++.||.|||+ ++|+||||||+||||+.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCc
Confidence 654 999999999999999886532 2347899999999999999999999 8999999999999999999
Q ss_pred ceEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcC-CCCCCCCchhHHHHhhhh
Q 008650 386 EPQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITG-RKPVDSSRQNLVLWAKPL 464 (558)
Q Consensus 386 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg-~~Pf~~~~~~~~~~~~~~ 464 (558)
++||+|||+++.+.............||+.|+|||.+.++.++.++|||||||++|||+|| ..||......... ..+
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~--~~i 248 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--RFV 248 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH--HHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH--HHH
Confidence 9999999999877555444444455799999999999999999999999999999999998 5777665433221 111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCccc
Q 008650 465 MESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHDSEF 523 (558)
Q Consensus 465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 523 (558)
. .+.... .+......+.+++.+||+.+|++||||.+|++.|++..+..+
T Consensus 249 ~-~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~ 297 (308)
T d1p4oa_ 249 M-EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297 (308)
T ss_dssp H-TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred H-hCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 1 222111 122233579999999999999999999999999998766544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=388.00 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=202.8
Q ss_pred cceEeeeCceEEEEEEECCC----CEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC--cEEEEEEe
Q 008650 251 ENMVGQGGYSEVYKGNLSDG----RKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN--GLYLIFNF 324 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~lv~e~ 324 (558)
.++||+|+||+||+|.+.++ ..||||++.+ .........|.+|+++|++++||||++++|++.+. ..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 57899999999999976432 2589999864 34466678899999999999999999999998753 48999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.+|+|.+++... ...+++..+.+++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++.+......
T Consensus 111 ~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred eecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999998654 4567888899999999999999999 89999999999999999999999999999877544322
Q ss_pred --ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCCC
Q 008650 405 --HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGEY 482 (558)
Q Consensus 405 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 482 (558)
.......||+.|+|||++..+.++.++||||||+++|||+||..||....... .+...... +... ..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~-g~~~---------~~ 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQ-GRRL---------LQ 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHT-TCCC---------CC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHc-CCCC---------CC
Confidence 22233568999999999999999999999999999999999888886543221 11111221 1111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008650 483 DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSGHD 520 (558)
Q Consensus 483 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 520 (558)
+......+.+++.+||+.||++||||.||++.|++...
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12233568899999999999999999999999987643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=390.43 Aligned_cols=254 Identities=27% Similarity=0.453 Sum_probs=201.5
Q ss_pred CCCcccceEeeeCceEEEEEEEC-CCC--EEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEeCc-EEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLS-DGR--KIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIENG-LYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~l 320 (558)
++|++.+.||+|+||+||+|.+. +|. .||||++.... .....+.|.+|+.+|+++ +||||+++++++.+++ +++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 67899999999999999999554 454 46778775433 234556799999999998 6999999999998866 999
Q ss_pred EEEeccCCCHHHHHhhc--------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc
Q 008650 321 IFNFSQNGNLDAALHDE--------------RSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE 386 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 386 (558)
||||+++|+|.++|+.. ....+++..+++++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 99999999999999653 23579999999999999999999999 89999999999999999999
Q ss_pred eEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCC-CCCCCCchhHHHHhhhhh
Q 008650 387 PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGR-KPVDSSRQNLVLWAKPLM 465 (558)
Q Consensus 387 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~-~Pf~~~~~~~~~~~~~~~ 465 (558)
+||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|. .||.......... .+.
T Consensus 166 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~--~i~ 240 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE--KLP 240 (309)
T ss_dssp EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HGG
T ss_pred eEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH--HHH
Confidence 99999999986543222 22345899999999999999999999999999999999975 5676554332211 111
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 466 ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
.+. +...+.....++.+++.+||+.||++||||.||++.|++.
T Consensus 241 -~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 241 -QGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp -GTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1122233446799999999999999999999999988764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=382.86 Aligned_cols=262 Identities=22% Similarity=0.348 Sum_probs=201.1
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++............+.+|++++++++|||||++++++.+++ .|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999954 67999999999765444444677899999999999999999999998876 999999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
|+.++ +...+.......+++..++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 99765 4445544555679999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cccccccccccCcccchhhccCC-CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCC------
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGI-IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDP------ 476 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~------ 476 (558)
......||+.|+|||++.... ++.++|||||||++|+|++|+.||.........+.. ....+...+...+
T Consensus 158 --~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI-FRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp --CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCCCCTTTSTTGGGST
T ss_pred --cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH-HHhcCCCchhhcccccccc
Confidence 233456999999999987665 578999999999999999999999876543222211 1111111110000
Q ss_pred CCCCC------C-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 477 SLEGE------Y-----DTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 477 ~l~~~------~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..... . .......+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 0 01223578899999999999999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=390.58 Aligned_cols=251 Identities=19% Similarity=0.261 Sum_probs=197.9
Q ss_pred hCCCcccc-eEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccc-ccCCeeeeeeEEEe-----C
Q 008650 245 TNNFHSEN-MVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV-CHPNTATLVGCCIE-----N 316 (558)
Q Consensus 245 ~~~f~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~ 316 (558)
.++|.+.+ .||+|+||+||+|.. .+++.||||++.+. ..+.+|+.++.++ +|||||++++++.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 35788765 699999999999954 67999999999643 2356788886554 79999999999864 2
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---CCceEEEecc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---DFEPQITDFG 393 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG 393 (558)
.+|+|||||+||+|.++|.......+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccc
Confidence 38999999999999999976555679999999999999999999999 89999999999999975 4679999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHH-hhhhhhcCCccc
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLW-AKPLMESGNLTE 472 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~ 472 (558)
+|+....... .....||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+........ ....+..+.
T Consensus 160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~--- 233 (335)
T d2ozaa1 160 FAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--- 233 (335)
T ss_dssp TCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS---
T ss_pred eeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC---
Confidence 9987654332 234579999999999999999999999999999999999999997543221110 000000000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 473 LVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 473 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..+..........++.+++.+||+.||++|||+.|+++.
T Consensus 234 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 001111112345679999999999999999999999983
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=390.91 Aligned_cols=248 Identities=21% Similarity=0.339 Sum_probs=202.0
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccc-cHHHHHHHHHHHHHhc-ccccCCeeeeeeEEEeCc-EEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNK-DAKKEKEFLMELGIIG-HVCHPNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~-~~lv 321 (558)
++|.+.+.||+|+||+||+|.. .+|+.||||++.+... .......+..|..++. .++||||+++++++.+++ .|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999955 5799999999976432 1122345667777665 689999999999998866 9999
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNK 401 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 401 (558)
|||+++|+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999654 468999999999999999999999 89999999999999999999999999999875543
Q ss_pred CCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccccCCCCCCC
Q 008650 402 CTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELVDPSLEGE 481 (558)
Q Consensus 402 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 481 (558)
. .......||+.|+|||++.++.|+.++|||||||++|||++|+.||.+......... +..+. +.
T Consensus 157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~---i~~~~------~~---- 221 (320)
T d1xjda_ 157 D--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS---IRMDN------PF---- 221 (320)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHCC------CC----
T ss_pred c--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHcCC------CC----
Confidence 2 223345799999999999999999999999999999999999999987654432211 11111 11
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 008650 482 YDTDQMHRLVLIADYCVRQTSAWRPSMS-EVLE 513 (558)
Q Consensus 482 ~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~ 513 (558)
++......+.+++.+||+.||.+|||+. |+++
T Consensus 222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1122345688999999999999999995 7765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=384.22 Aligned_cols=257 Identities=21% Similarity=0.260 Sum_probs=194.5
Q ss_pred cceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH---HHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEec
Q 008650 251 ENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA---KKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNFS 325 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 325 (558)
+++||+|+||+||+|.. .+|+.||||++....... .....+.+|+.++++++|||||++++++.+++ .|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999965 579999999996553322 22356889999999999999999999998765 99999999
Q ss_pred cCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCcc
Q 008650 326 QNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTHH 405 (558)
Q Consensus 326 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 405 (558)
.++++..++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 83 ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp SEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred cchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence 9987776653 34568999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHh-hhhhhcCCcccc---------c
Q 008650 406 AAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA-KPLMESGNLTEL---------V 474 (558)
Q Consensus 406 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~-~~~~~~~~~~~~---------~ 474 (558)
.....+||+.|+|||++..+ .|+.++|||||||++|||++|+.||........... ............ .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 22345799999999998754 689999999999999999999999986544322111 111100000000 0
Q ss_pred CCCCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 DPSLEGEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 d~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
........+ ......+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000011 1223578999999999999999999999973
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=385.31 Aligned_cols=250 Identities=19% Similarity=0.237 Sum_probs=203.9
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIF 322 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 322 (558)
.++|.+++.||+|+||+||+|.. .+|+.||||++.+.. .....+.+|+.+|+.++||||+++++++.+++ +|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 36799999999999999999955 578899999997653 23345789999999999999999999998765 99999
Q ss_pred EeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC--CceEEEeccccccCCC
Q 008650 323 NFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD--FEPQITDFGLAKWLPN 400 (558)
Q Consensus 323 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFG~a~~~~~ 400 (558)
||+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 E~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 81 EFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999999643 3469999999999999999999999 899999999999999854 4799999999987644
Q ss_pred CCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhc-CCcccccCCCCC
Q 008650 401 KCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMES-GNLTELVDPSLE 479 (558)
Q Consensus 401 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~d~~l~ 479 (558)
... .....||+.|+|||.+.+..|+.++|||||||++|+|++|+.||........... .... ..+.....
T Consensus 157 ~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~--i~~~~~~~~~~~~---- 227 (321)
T d1tkia_ 157 GDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN--IMNAEYTFDEEAF---- 227 (321)
T ss_dssp TCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HHHTCCCCCHHHH----
T ss_pred CCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhCCCCCChhhc----
Confidence 322 2335699999999999999999999999999999999999999987654322111 1111 11111000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 480 GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 480 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.....++.+++.+||+.||++|||+.|+++.
T Consensus 228 ----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 228 ----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123468899999999999999999999983
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=386.60 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=199.0
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-----cEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-----GLYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~l 320 (558)
++|.+.+.||+|+||+||+|.. +|+.||||++.... .....+..|+..+..++||||+++++++.++ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4678889999999999999986 68899999996442 2222233567777788999999999999753 2789
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhC-----CCCcEEecCCCCCceeecCCCceEEEecccc
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKG-----CKRRIIHRDIKASNVLLGPDFEPQITDFGLA 395 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 395 (558)
||||+.+|+|.++|+.. .++|..+++++.+++.||.|||+. ..++|+||||||+||||+.++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999653 589999999999999999999962 1369999999999999999999999999999
Q ss_pred ccCCCCCCc--ccccccccccCcccchhhccC------CCCccccchhHHHHHHHHHcCCCCCCCCchhHH---------
Q 008650 396 KWLPNKCTH--HAAIPIEGTFGYLAPEYFMHG------IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLV--------- 458 (558)
Q Consensus 396 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~--------- 458 (558)
+........ .......||+.|+|||++.+. .++.++|||||||+||||+||..||........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876543322 223346799999999998754 367799999999999999999988753221100
Q ss_pred ---HHhhhhhhcCCcccccCCCCCCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 459 ---LWAKPLMESGNLTELVDPSLEGEY-DTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 459 ---~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
........ ....++.+.... .......+.+++.+||+.||++|||+.||++.|++.
T Consensus 236 ~~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 236 PSVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 00000111 111122221111 234566799999999999999999999999998753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-47 Score=378.81 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=201.9
Q ss_pred CCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEEe
Q 008650 246 NNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFNF 324 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~ 324 (558)
++|.+.+.||+|+||+||+|...+|+.||||++............+.+|+.+|++++||||+++++++.+++ .++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 579999999999999999998889999999999766544445677899999999999999999999998765 8999999
Q ss_pred ccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCCc
Q 008650 325 SQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCTH 404 (558)
Q Consensus 325 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 404 (558)
+.++.+..+.. ..+.+++..++.++.||+.||+|||+ .+||||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 98877766663 34679999999999999999999999 8999999999999999999999999999987654322
Q ss_pred ccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-hhcC------Ccccc--c
Q 008650 405 HAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL-MESG------NLTEL--V 474 (558)
Q Consensus 405 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~-~~~~------~~~~~--~ 474 (558)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+............ .... ..... .
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 22234589999999998754 579999999999999999999999987543322111100 0000 00000 0
Q ss_pred CCCCC-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 475 DPSLE-------GEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 475 d~~l~-------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
..... ..........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0111223457889999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=377.47 Aligned_cols=242 Identities=20% Similarity=0.368 Sum_probs=195.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccH----HHHHHHHHHHHHhcccc--cCCeeeeeeEEEeCc
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDA----KKEKEFLMELGIIGHVC--HPNTATLVGCCIENG 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 317 (558)
.++|++.+.||+|+||+||+|.. .+|+.||||++.+..... .....+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46799999999999999999954 579999999997543211 11233568999999886 899999999998765
Q ss_pred -EEEEEEeccC-CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCC-CceEEEeccc
Q 008650 318 -LYLIFNFSQN-GNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPD-FEPQITDFGL 394 (558)
Q Consensus 318 -~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~ 394 (558)
.++||||+.+ +++.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 5777777543 569999999999999999999999 899999999999999854 7999999999
Q ss_pred cccCCCCCCcccccccccccCcccchhhccCCC-CccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccc
Q 008650 395 AKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGII-DEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473 (558)
Q Consensus 395 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 473 (558)
|+...... ..+..||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ... ..
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--------~~~-~~--- 221 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRG-QV--- 221 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------HHC-CC---
T ss_pred ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--------hhc-cc---
Confidence 98754332 234679999999999987765 67799999999999999999999864211 111 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.+.. ..+.++.+++.+||+.||++|||+.|+++.
T Consensus 222 ---~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 ---FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111 223568899999999999999999999873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=378.28 Aligned_cols=263 Identities=21% Similarity=0.305 Sum_probs=198.3
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CC-CCEEEEEEeecccccHHHHHHHHHHHHHhccc---ccCCeeeeeeEEEe----
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SD-GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHV---CHPNTATLVGCCIE---- 315 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 315 (558)
.++|++.+.||+|+||+||+|.. .+ ++.||||++............+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999965 44 56799999976543333333455677776655 79999999999853
Q ss_pred --CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecc
Q 008650 316 --NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFG 393 (558)
Q Consensus 316 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 393 (558)
...+++|||+.++.+..... .....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 23889999999877765543 345678999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhh-hhhc-----
Q 008650 394 LAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP-LMES----- 467 (558)
Q Consensus 394 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~-~~~~----- 467 (558)
+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||............. ....
T Consensus 162 ~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 162 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 98865432 22334679999999999999999999999999999999999999998765432211110 0000
Q ss_pred ----CCcccccCC----CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 468 ----GNLTELVDP----SLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 468 ----~~~~~~~d~----~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
......... .....+.......+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 00001112234568889999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=372.30 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=199.4
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe--------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-------- 315 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 315 (558)
.++|++.+.||+|+||+||+|.. .+|+.||||++.+..........+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46899999999999999999965 689999999997665544555678899999999999999999998753
Q ss_pred -CcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccc
Q 008650 316 -NGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGL 394 (558)
Q Consensus 316 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 394 (558)
+..++||||+.++.+.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 2379999999887776554 334568999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCC--cccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcc
Q 008650 395 AKWLPNKCT--HHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLT 471 (558)
Q Consensus 395 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 471 (558)
++.+..... .......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||................ +...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~ 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC-GSIT 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc-CCCC
Confidence 987654322 1223345799999999999765 68999999999999999999999998654332211111111 1111
Q ss_pred cccC-------------CCCCCCCCH-H------HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 472 ELVD-------------PSLEGEYDT-D------QMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 472 ~~~d-------------~~l~~~~~~-~------~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.... ......... . ....+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000 000001111 1 12356789999999999999999999973
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=372.66 Aligned_cols=260 Identities=25% Similarity=0.328 Sum_probs=198.8
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN------- 316 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 316 (558)
.++|++.+.||+|+||+||+|.. .+|+.||||++.+........+.+.+|+.+|++++|||||+++++|...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999954 5799999999987666667778899999999999999999999999753
Q ss_pred cEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 317 GLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 317 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
..|+||||+ +.+|..++.. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence 269999999 5677777643 459999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcC-------
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESG------- 468 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~------- 468 (558)
...... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..................
T Consensus 170 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp ECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 765432 235699999999998764 5789999999999999999999999876433221111000000
Q ss_pred ------------CcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--Hhc
Q 008650 469 ------------NLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL--LTS 517 (558)
Q Consensus 469 ------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~ 517 (558)
.........+. .........+.+++.+||+.||.+|||+.|+++. |++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 00000000000 0111223467889999999999999999999985 544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=371.79 Aligned_cols=263 Identities=19% Similarity=0.238 Sum_probs=200.4
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-----E
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-----L 318 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 318 (558)
+.+|++.+.||+|+||+||+|. ..+|+.||||++.+.. .....+.+++|+.+|++++||||+++++++..+. .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 4579999999999999999995 5689999999996543 3556678899999999999999999999986532 4
Q ss_pred EEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccC
Q 008650 319 YLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWL 398 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 398 (558)
+++++++.+|+|.+++.. ..+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||++...
T Consensus 86 ~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 566677889999999964 359999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCc-ccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccc----
Q 008650 399 PNKCTH-HAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTE---- 472 (558)
Q Consensus 399 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---- 472 (558)
...... .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||.........+............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 543222 22344679999999999854 567899999999999999999999998765432222211110000000
Q ss_pred ---------ccCCCCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 473 ---------LVDPSLEGEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 473 ---------~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
..........+ .....++.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000001 1122468899999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=360.55 Aligned_cols=261 Identities=18% Similarity=0.246 Sum_probs=205.2
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeCc-EEEEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIENG-LYLIFN 323 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 323 (558)
++|++.+.||+|+||+||+|.. .+++.||||++............+.+|+.+++.++||||+++++++.+.. .+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999954 67899999999776666667788999999999999999999999998866 889999
Q ss_pred eccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEeccccccCCCCCC
Q 008650 324 FSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKWLPNKCT 403 (558)
Q Consensus 324 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 403 (558)
++.+++|..++.. .+.+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9999998887753 4578999999999999999999999 8999999999999999999999999999988755432
Q ss_pred cccccccccccCcccchhhccCC-CCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCC-------------
Q 008650 404 HHAAIPIEGTFGYLAPEYFMHGI-IDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGN------------- 469 (558)
Q Consensus 404 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~------------- 469 (558)
. .....+++.|+|||++.... ++.++|||||||++|||++|+.||.................+.
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred c--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2 22345788999999987664 6899999999999999999999975443222211111100000
Q ss_pred ----cccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 470 ----LTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 470 ----~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
....................+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000001112233456888999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=371.28 Aligned_cols=256 Identities=21% Similarity=0.266 Sum_probs=194.2
Q ss_pred CCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEeC-------cE
Q 008650 247 NFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIEN-------GL 318 (558)
Q Consensus 247 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~~ 318 (558)
+|+..++||+|+||+||+|.. .+|+.||||++.+.... +.+|+.+|++++||||+++++++... .+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 588889999999999999965 57999999999765422 23699999999999999999998532 17
Q ss_pred EEEEEeccCCCHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-ceEEEeccccc
Q 008650 319 YLIFNFSQNGNLDAALHD-ERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-EPQITDFGLAK 396 (558)
Q Consensus 319 ~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~ 396 (558)
++||||+.++.+..+... .....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchh
Confidence 899999987655444432 234579999999999999999999998 8999999999999999775 89999999998
Q ss_pred cCCCCCCcccccccccccCcccchhhcc-CCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhh----------
Q 008650 397 WLPNKCTHHAAIPIEGTFGYLAPEYFMH-GIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLM---------- 465 (558)
Q Consensus 397 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~---------- 465 (558)
.+..... ..+..||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...............
T Consensus 172 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 172 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp ECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred hccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 7654332 233569999999998865 57899999999999999999999999865433221111000
Q ss_pred ------hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 466 ------ESGNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 466 ------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
........................+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001111100000011112234568899999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-44 Score=362.23 Aligned_cols=252 Identities=20% Similarity=0.302 Sum_probs=196.3
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeC---cEEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIEN---GLYL 320 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~---~~~l 320 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.. .+.+.+|+.+|+.++ ||||+++++++... ..++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5799999999999999999955 679999999996532 345788999999996 99999999998742 3999
Q ss_pred EEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCC-ceEEEeccccccCC
Q 008650 321 IFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDF-EPQITDFGLAKWLP 399 (558)
Q Consensus 321 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~ 399 (558)
||||+.+++|..+. +.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+|+...
T Consensus 110 v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceecc
Confidence 99999999997654 358999999999999999999999 8999999999999998655 69999999998765
Q ss_pred CCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhh-----------hhc
Q 008650 400 NKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPL-----------MES 467 (558)
Q Consensus 400 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~-----------~~~ 467 (558)
.... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||.........+.... ...
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 4432 2345699999999998765 579999999999999999999999976543322111100 000
Q ss_pred C------Cccccc--------CCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008650 468 G------NLTELV--------DPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLE 513 (558)
Q Consensus 468 ~------~~~~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 513 (558)
. ...... ..............++.+++.+||+.||++|||++|+|+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 011111111233457889999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-44 Score=361.34 Aligned_cols=259 Identities=18% Similarity=0.265 Sum_probs=193.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEE-EeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCC-IENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~-~~lv 321 (558)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+..|+++++.++|+|++..+..+ .++. .++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 35799999999999999999955 57899999998764332 2467899999999877766655554 4554 7889
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC---CCceEEEeccccccC
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP---DFEPQITDFGLAKWL 398 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~ 398 (558)
|||+ +++|...+.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++. +..+||+|||+|+.+
T Consensus 82 me~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 82 MELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9988 4566665543 34569999999999999999999999 89999999999999854 457999999999887
Q ss_pred CCCCCc-----ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCcccc
Q 008650 399 PNKCTH-----HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTEL 473 (558)
Q Consensus 399 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 473 (558)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~- 235 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST- 235 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-
Confidence 543322 22335679999999999999999999999999999999999999997643322211110000000000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTS 517 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 517 (558)
..+.+.. ..+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 236 ~~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 236 PIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp CHHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ChhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0000111 123468899999999999999999999888775
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6e-44 Score=355.10 Aligned_cols=256 Identities=15% Similarity=0.210 Sum_probs=199.6
Q ss_pred hCCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhccccc-CCeeeeeeEEEeCc-EEEE
Q 008650 245 TNNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH-PNTATLVGCCIENG-LYLI 321 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~-~~lv 321 (558)
.++|.+.+.||+|+||+||+|.. .+|+.||||++...... ..+.+|+++++.+.| +|++.+++++.++. .++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 46899999999999999999964 57899999998654322 235567778888865 89999999988766 8899
Q ss_pred EEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecC-----CCceEEEeccccc
Q 008650 322 FNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGP-----DFEPQITDFGLAK 396 (558)
Q Consensus 322 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFG~a~ 396 (558)
|||+ +++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+
T Consensus 80 me~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 9998 68999888643 4569999999999999999999999 89999999999999964 5789999999998
Q ss_pred cCCCCCCc-----ccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHh-hhhh---hc
Q 008650 397 WLPNKCTH-----HAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWA-KPLM---ES 467 (558)
Q Consensus 397 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~-~~~~---~~ 467 (558)
.+...... .......||+.|||||++.+..++.++|||||||++|||++|+.||........... .... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 76543221 223356799999999999999999999999999999999999999975432211111 1111 11
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008650 468 GNLTELVDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRPSMSEVLELLTSG 518 (558)
Q Consensus 468 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 518 (558)
....++ ... .+.++.+++..|+..+|++||+++.+.+.|++.
T Consensus 235 ~~~~~l-----~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 235 TPLREL-----CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp SCHHHH-----TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CChHHh-----cCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111111 111 224688899999999999999999988887653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=366.34 Aligned_cols=258 Identities=21% Similarity=0.250 Sum_probs=194.1
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe-------Cc
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE-------NG 317 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------~~ 317 (558)
++|++.+.||+|+||+||+|.. .+|+.||||++.+..........+.+|+.++++++||||+++++++.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999954 579999999998776667777789999999999999999999999853 23
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
+|+||||+.++.+. .+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence 89999999776554 432 358999999999999999999999 8999999999999999999999999999886
Q ss_pred CCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhh--------------
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKP-------------- 463 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~-------------- 463 (558)
..... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.............
T Consensus 169 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred ccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 54432 2234569999999999999999999999999999999999999997654322111100
Q ss_pred ------hhhc------CCcccccCCCCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 464 ------LMES------GNLTELVDPSLEGE---YDTDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 464 ------~~~~------~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.... .............. ........+.+++.+||+.||++|||++|+|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00011111111111 112345678999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=365.97 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=200.1
Q ss_pred hCCCcccceEeeeCceEEEEEE-ECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCeeeeeeEEEe------Cc
Q 008650 245 TNNFHSENMVGQGGYSEVYKGN-LSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNTATLVGCCIE------NG 317 (558)
Q Consensus 245 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 317 (558)
.++|++.+.||+|+||+||+|. ..+|+.||||++.+........+.+.+|+.+|++++||||+++++++.. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4679999999999999999995 4679999999998776667777889999999999999999999999853 23
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence 5777888899999999853 469999999999999999999999 8999999999999999999999999999976
Q ss_pred CCCCCCcccccccccccCcccchhhccC-CCCccccchhHHHHHHHHHcCCCCCCCCchhHHHHhhhhhhcCCccccc--
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHG-IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLVLWAKPLMESGNLTELV-- 474 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 474 (558)
.... ..+..||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.....................+..
T Consensus 171 ~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 171 TDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 5332 2345699999999987765 5689999999999999999999999875433221111100000000000
Q ss_pred ----------CCCC-CCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008650 475 ----------DPSL-EGEYD-----TDQMHRLVLIADYCVRQTSAWRPSMSEVLEL 514 (558)
Q Consensus 475 ----------d~~l-~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 514 (558)
.... ..... ......+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000 00000 1123568899999999999999999999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=361.75 Aligned_cols=251 Identities=26% Similarity=0.335 Sum_probs=198.7
Q ss_pred CCCcccceEeeeCceEEEEEEE----CCCCEEEEEEeecccc--cHHHHHHHHHHHHHhccccc-CCeeeeeeEEEeCc-
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL----SDGRKIAVKRLAKDNK--DAKKEKEFLMELGIIGHVCH-PNTATLVGCCIENG- 317 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~- 317 (558)
++|.+.+.||+|+||+||+|.. .+|+.||||++.+... .......+.+|+.++++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999954 2588999999865431 12234457789999999976 89999999998766
Q ss_pred EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 318 LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 318 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.+++|||+.+|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999665 457788899999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCcccccccccccCcccchhhccC--CCCccccchhHHHHHHHHHcCCCCCCCCchhHH--HHhhhhhhcCCcccc
Q 008650 398 LPNKCTHHAAIPIEGTFGYLAPEYFMHG--IIDEKTDVFAFGVLLLEIITGRKPVDSSRQNLV--LWAKPLMESGNLTEL 473 (558)
Q Consensus 398 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~ 473 (558)
+...... ......||+.|+|||.+.+. .++.++|||||||+||||++|+.||........ ........ ..
T Consensus 179 ~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-~~---- 252 (322)
T d1vzoa_ 179 FVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SE---- 252 (322)
T ss_dssp CCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CC----
T ss_pred hcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc-CC----
Confidence 6543222 23345699999999999765 478899999999999999999999976532211 11111111 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008650 474 VDPSLEGEYDTDQMHRLVLIADYCVRQTSAWRP-----SMSEVLE 513 (558)
Q Consensus 474 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 513 (558)
...+.....++.+++.+||+.||++|| |++|+++
T Consensus 253 ------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111223456789999999999999999 4788886
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-38 Score=323.57 Aligned_cols=259 Identities=19% Similarity=0.240 Sum_probs=190.5
Q ss_pred CCCcccceEeeeCceEEEEEEE-CCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-----------cCCeeeeeeEE
Q 008650 246 NNFHSENMVGQGGYSEVYKGNL-SDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-----------HPNTATLVGCC 313 (558)
Q Consensus 246 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 313 (558)
++|++.++||+|+||+||+|.. .+|+.||||++.++. .....+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3599999999999999999965 679999999997542 33455677888877765 57899999987
Q ss_pred EeC---cEEEEEEeccCCC-HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCc---
Q 008650 314 IEN---GLYLIFNFSQNGN-LDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFE--- 386 (558)
Q Consensus 314 ~~~---~~~lv~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 386 (558)
... ..+++++++..+. ............+++..+..++.||+.||+|||+. .+|+||||||+||||+.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccc
Confidence 642 3667777765554 34444445556789999999999999999999972 68999999999999987653
Q ss_pred ---eEEEeccccccCCCCCCcccccccccccCcccchhhccCCCCccccchhHHHHHHHHHcCCCCCCCCchh-----HH
Q 008650 387 ---PQITDFGLAKWLPNKCTHHAAIPIEGTFGYLAPEYFMHGIIDEKTDVFAFGVLLLEIITGRKPVDSSRQN-----LV 458 (558)
Q Consensus 387 ---~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~Pf~~~~~~-----~~ 458 (558)
++++|||.+...... .....||+.|+|||++....++.++||||+||++++|++|+.||...... ..
T Consensus 168 ~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 999999999865432 23356999999999999999999999999999999999999999753211 00
Q ss_pred HHhhhh--------------------hhcCCcccccCCC----------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008650 459 LWAKPL--------------------MESGNLTELVDPS----------LEGEYDTDQMHRLVLIADYCVRQTSAWRPSM 508 (558)
Q Consensus 459 ~~~~~~--------------------~~~~~~~~~~d~~----------l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 508 (558)
...... .........+... ............+.+++.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 000000 0000000000000 0122345667889999999999999999999
Q ss_pred HHHHHH
Q 008650 509 SEVLEL 514 (558)
Q Consensus 509 ~evl~~ 514 (558)
.|+|+.
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHhcC
Confidence 999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=4.1e-24 Score=197.44 Aligned_cols=166 Identities=14% Similarity=0.110 Sum_probs=122.2
Q ss_pred cccceEeeeCceEEEEEEECCCCEEEEEEeecccc----------------cHHHHHHHHHHHHHhcccccCCeeeeeeE
Q 008650 249 HSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNK----------------DAKKEKEFLMELGIIGHVCHPNTATLVGC 312 (558)
Q Consensus 249 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 312 (558)
.+++.||+|+||+||+|...+|+.||||++..... .......+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 56789999999999999888999999998753211 01122345578889999999999888765
Q ss_pred EEeCcEEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCCCCcEEecCCCCCceeecCCCceEEEec
Q 008650 313 CIENGLYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGCKRRIIHRDIKASNVLLGPDFEPQITDF 392 (558)
Q Consensus 313 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 392 (558)
. ..+++|||+.+..+.. ++......++.|++.+|.|||+ ++|+||||||+|||++++ .++|+||
T Consensus 83 ~---~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 E---GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp E---TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred c---CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence 3 3479999998865532 3444567899999999999999 899999999999999865 5899999
Q ss_pred cccccCCCCCCcccccccccccCcccc------hhhccCCCCccccchhHHHHHH
Q 008650 393 GLAKWLPNKCTHHAAIPIEGTFGYLAP------EYFMHGIIDEKTDVFAFGVLLL 441 (558)
Q Consensus 393 G~a~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~ksDvwSlGvvl~ 441 (558)
|+|........ ..|... +++ .+.|+.++|+||+.--++
T Consensus 147 G~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 99976532211 112221 222 356788999999765443
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.81 E-value=3.5e-20 Score=167.54 Aligned_cols=142 Identities=19% Similarity=0.326 Sum_probs=104.9
Q ss_pred CcEEEEEEecCc--------cchHHHHHHHHhhccCCCCe---EEEEEeecccccccccchh--hhh----hHHHHHHHH
Q 008650 6 PSKILIGFSLDP--------NDSKELLSWAIKVLAQPNDR---IVAIHVLVGEESKKRGSMA--KRQ----SQIRRAKAH 68 (558)
Q Consensus 6 ~r~i~Vavd~~~--------~~s~~al~Wal~~~~~~~d~---~~llhv~~~~~~~~~~~~~--~~~----~~~~~~~~~ 68 (558)
++||+||||.|. .+|++||+||++|+++.||+ |+++||.++.......... ... .........
T Consensus 1 p~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (171)
T d2gm3a1 1 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAK 80 (171)
T ss_dssp CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHH
T ss_pred CCEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHH
Confidence 479999999984 16999999999999999995 8899998654321111110 011 111122333
Q ss_pred HHHHHHHhHhccccCCcceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEE
Q 008650 69 VISMLGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIF 146 (558)
Q Consensus 69 ~~~~l~~~~~~c~~~~v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v 146 (558)
..++|+.+...|..++++++.++.+| ++.+.||++|++.++|++|||+++.+..++ +||++.||.++++ |+|.+|
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~v~~G-~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~~~--cpVlvV 157 (171)
T d2gm3a1 81 GLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMTI 157 (171)
T ss_dssp HHHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEEE
T ss_pred HHHHHHHHHHHHHhcCCceEEEEEeC-ChHHHHHHHHhhcCCcEEEeccCCccccccCccCcHHHHHHhCCC--CCEEEE
Confidence 45799999999999999999999998 678899999999999999999998876553 8999999999999 999999
Q ss_pred cccc
Q 008650 147 GETK 150 (558)
Q Consensus 147 ~~~k 150 (558)
....
T Consensus 158 ~~~~ 161 (171)
T d2gm3a1 158 KRNA 161 (171)
T ss_dssp ECCG
T ss_pred eCCC
Confidence 7653
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.71 E-value=5.3e-17 Score=144.45 Aligned_cols=139 Identities=11% Similarity=0.123 Sum_probs=110.2
Q ss_pred cEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccch--------------hhhhhHHHHHHHHHHHH
Q 008650 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSM--------------AKRQSQIRRAKAHVISM 72 (558)
Q Consensus 7 r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~ 72 (558)
|+|+||||.|+ .|.+||+||++..-+.|..|++|||.++......... ...............+.
T Consensus 4 ~~ILvavD~s~-~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (160)
T d1mjha_ 4 KKILYPTDFSE-TAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 82 (160)
T ss_dssp CEEEEECCSCH-HHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEECCCH-HHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHHH
Confidence 79999999999 9999999999987788899999999866442211100 00111222223334568
Q ss_pred HHHhHhccccCCcceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEccc
Q 008650 73 LGEFAGTSQSKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGET 149 (558)
Q Consensus 73 l~~~~~~c~~~~v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~~ 149 (558)
|+.+...|...+++++.++..| ++.+.|++.|+..++|++|||+|+.+..+. .||++.++.++++ |||.+++.+
T Consensus 83 l~~~~~~~~~~gv~~~~~~~~G-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~--~pVlvV~~~ 158 (160)
T d1mjha_ 83 MENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKRK 158 (160)
T ss_dssp HHHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHHhcCCeEEEEEEec-cHHHHHhhhhhccccceEEeccCCCCcccccccCcHHHHHHhcCC--CCEEEEcCC
Confidence 8888888999999999999998 778899999999999999999998865444 8999999999999 999998764
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.67 E-value=8e-17 Score=138.98 Aligned_cols=132 Identities=13% Similarity=0.151 Sum_probs=95.5
Q ss_pred cEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccCCcc
Q 008650 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSKQVN 86 (558)
Q Consensus 7 r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v~ 86 (558)
|+|+|++|+|+ .|..|++||++...+.|+.|+|+||.++..... .............+.+.+.++ .+++..++.
T Consensus 2 k~Ilv~~D~s~-~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~ 75 (135)
T d2z3va1 2 KTILLAYDGSE-HARRAAEVAKAEAEAHGARLIVVHAYEPVPDYL--GEPFFEEALRRRLERAEGVLE---EARALTGVP 75 (135)
T ss_dssp CEEEEECCSSH-HHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTC--CTTHHHHHHHHHHHHHHHHHH---HHHHHHCCC
T ss_pred CEEEEEECCCH-HHHHHHHHHHHHHHHcCCEEEEEEEecCCcccc--ccchhHHHHHHHHHHHHHHHH---HHHHhcCCC
Confidence 79999999999 999999999999888999999999997543221 111111222222222333444 444444554
Q ss_pred eeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEE
Q 008650 87 LEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIF 146 (558)
Q Consensus 87 ~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v 146 (558)
.+..++.++++.+.||+.|+..++|+||||+++.....+ .||++.+++++++ |||.+|
T Consensus 76 ~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 76 KEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp GGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCS--SCEEEE
T ss_pred eEEEEEEcCChHHHHHHHhhhhheeeEEeccCCCCcccccccCcHHHHHHHhCC--CCEEeC
Confidence 444444444778999999999999999999997765433 8999999999999 999875
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.59 E-value=9.9e-16 Score=132.75 Aligned_cols=135 Identities=18% Similarity=0.179 Sum_probs=99.1
Q ss_pred cEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccchhhhh-hHHHHHHHHHHHHHHHhHhccccCCc
Q 008650 7 SKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGSMAKRQ-SQIRRAKAHVISMLGEFAGTSQSKQV 85 (558)
Q Consensus 7 r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~c~~~~v 85 (558)
++|+||+|.|+ .|..||.||.....+.|+.|+++||.++.........+... ....+.. .+....+...+...+.
T Consensus 3 k~ILv~vD~s~-~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 78 (140)
T d1jmva_ 3 KHILVAVDLSE-ESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRIS---TETQKALLDLAESVDY 78 (140)
T ss_dssp SEEEEEECCST-THHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCC---CHHHHHHHHHHHHSSS
T ss_pred CeEEEEECCCH-HHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccccccchHHHHHHHH---HHHHHHHHHHHHhcCC
Confidence 79999999999 99999999999888889999999998765433222211111 1111111 1344444555555555
Q ss_pred ceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCccchhhhhhhhhcCCCCceEEEEcc
Q 008650 86 NLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKMSRDVTRYCFQHAPGGCTIHIFGE 148 (558)
Q Consensus 86 ~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~~~sv~~~c~~~~~~~c~v~~v~~ 148 (558)
..+..++.++++.+.|++.++++++|++|||+|+.... ++||++.++.++++ |||.++..
T Consensus 79 ~~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~-~lgs~~~~li~~~~--~pVliVp~ 138 (140)
T d1jmva_ 79 PISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWS-KLMSSTRQVMNTIK--IDMLVVPL 138 (140)
T ss_dssp CCCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHH-HHHHHHHHHHTTCC--SEEEEEEC
T ss_pred ceEEEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCC-CcccHHHHHHhccC--CCEEEEec
Confidence 55555565568899999999999999999999976543 37899999999999 99998865
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.57 E-value=5.4e-15 Score=129.15 Aligned_cols=139 Identities=14% Similarity=0.137 Sum_probs=97.5
Q ss_pred CCcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEe-ecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccC
Q 008650 5 APSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHV-LVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSK 83 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~ 83 (558)
.-|+|+|+||.|+ .|++||+||++.. +.++.++++|+ .++........................+.++.++..+.+.
T Consensus 4 ~yk~ILv~vD~s~-~s~~al~~A~~la-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 81 (147)
T d1tq8a_ 4 AYKTVVVGTDGSD-SSMRAVDRAAQIA-GADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNA 81 (147)
T ss_dssp CCCEEEEECCSSH-HHHHHHHHHHHHH-TTTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTT
T ss_pred CCCEEEEEECCCH-HHHHHHHHHHHHH-hcCCCEEEEEEEecccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHc
Confidence 5689999999999 9999999999754 55555555554 4332221111111111112222223457889999999888
Q ss_pred Ccc-eeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc--chhhhhhhhhcCCCCceEEEEcc
Q 008650 84 QVN-LEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM--SRDVTRYCFQHAPGGCTIHIFGE 148 (558)
Q Consensus 84 ~v~-~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~--~~sv~~~c~~~~~~~c~v~~v~~ 148 (558)
++. ++..+..| ++.+.|++++++.++|++|||+++.+...+ .||++.++.++++ |||.+++.
T Consensus 82 ~~~~~~~~~~~G-~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~--~pVlvV~~ 146 (147)
T d1tq8a_ 82 GAKNVEERPIVG-APVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVHT 146 (147)
T ss_dssp TCCEEEEEEECS-SHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEECC
T ss_pred CCCcEEEEEEec-ChHHHHHHhhhccceeEEEecCCCCCcccccccccHHHHHHHhCC--CCEEEEec
Confidence 876 67777777 678899999999999999999998765433 8999999999999 99998874
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.40 E-value=5.3e-13 Score=114.71 Aligned_cols=118 Identities=8% Similarity=0.019 Sum_probs=84.3
Q ss_pred CcEEEEEEecCccchHHHHHHHHhhccCCCCeEEEEEeecccccccccc----hhhhhhHHHHHHHHHHHHHHHhHhccc
Q 008650 6 PSKILIGFSLDPNDSKELLSWAIKVLAQPNDRIVAIHVLVGEESKKRGS----MAKRQSQIRRAKAHVISMLGEFAGTSQ 81 (558)
Q Consensus 6 ~r~i~Vavd~~~~~s~~al~Wal~~~~~~~d~~~llhv~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~~~~c~ 81 (558)
-|+|+||+|+|+ .|..||.||++..-+.|..|+++||..+........ .+......+.......+.++.+..-..
T Consensus 4 mk~ILv~~D~S~-~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~l~~~~~~~~ 82 (138)
T d1q77a_ 4 MKVLLVLTDAYS-DCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREVWEKLT 82 (138)
T ss_dssp CEEEEEEESTTC-CCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEEeCCH-HHHHHHHHHHHhhhhccceEEEEEEccCcccccccccccccchhhhhhhhhhhhccccchhhccccc
Confidence 489999999999 999999999999988999999999986432111000 001112222222223344444444445
Q ss_pred cCCcceeEEEecCCchhhHHHHHHHhccCcEEEEecccccCCcc
Q 008650 82 SKQVNLEAKVGFSTSIGRGLIEEAKSISADYLVLRGSRNHSNKM 125 (558)
Q Consensus 82 ~~~v~~~~~v~~g~~~~~~i~~~v~~~~~~~LV~G~~~~~~~~~ 125 (558)
..+++++.++..| ++.+.|++.|++.++|++|||+++.+..++
T Consensus 83 ~~~~~~~~~v~~G-~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r 125 (138)
T d1q77a_ 83 GSTEIPGVEYRIG-PLSEEVKKFVEGKGYELVVWACYPSAYLCK 125 (138)
T ss_dssp SCCCCCCEEEECS-CHHHHHHHHHTTSCCSEEEECSCCGGGTHH
T ss_pred ccceeEEEeeecc-hhHHHHHHhhhhccCCEEEEecCCCcHHHH
Confidence 5678889999998 678899999999999999999998766443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.35 E-value=5.4e-07 Score=84.95 Aligned_cols=149 Identities=14% Similarity=0.097 Sum_probs=95.8
Q ss_pred HHHHhhhCCCcccceEeeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccc-cCCeeeeeeEEEeCc
Q 008650 239 EEISSATNNFHSENMVGQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVC-HPNTATLVGCCIENG 317 (558)
Q Consensus 239 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 317 (558)
.++......|++.+..+.++.+.||+... +++.+.+|+....... ....+.+|...+..+. +--+.+++.+..+++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 34555556777766655555679999864 5667888887543211 1122445666665553 333556677666655
Q ss_pred -EEEEEEeccCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhhCC-------------------------------
Q 008650 318 -LYLIFNFSQNGNLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHKGC------------------------------- 365 (558)
Q Consensus 318 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------------------------------- 365 (558)
.++||++++|.++....... .....++.+++..|..||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred ceEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 89999999998886554211 112334555666666666421
Q ss_pred -------------------------CCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 366 -------------------------KRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 366 -------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12489999999999999876667999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.72 E-value=2.5e-05 Score=72.70 Aligned_cols=130 Identities=17% Similarity=0.129 Sum_probs=78.9
Q ss_pred eEeeeC-ceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhccccc--CCeeeeeeEEEeCc-EEEEEEeccCC
Q 008650 253 MVGQGG-YSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCH--PNTATLVGCCIENG-LYLIFNFSQNG 328 (558)
Q Consensus 253 ~lG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~-~~lv~e~~~~g 328 (558)
.+..|. .+.||+....++..+++|.-...... .+..|...++.+.. -.+.+++.+..+++ .++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344444 36899998888888999987543321 24456666655542 23556677666554 89999999886
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------------
Q 008650 329 NLDAALHDERSKSLEWPIRYKIVLGVARGLHYLHK--------------------------------------------- 363 (558)
Q Consensus 329 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~--------------------------------------------- 363 (558)
++.... ... ..++.+++..|.-||.
T Consensus 92 ~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 92 DLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp ETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 553210 000 0111222222223331
Q ss_pred ----------CCCCcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 364 ----------GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 364 ----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.....++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 0112489999999999999876677999987753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.34 E-value=0.00026 Score=70.27 Aligned_cols=78 Identities=9% Similarity=-0.031 Sum_probs=43.8
Q ss_pred cceEeeeCceEEEEEEEC-CCCEEEEEEeeccccc-----HHHHHHHHHHHHHhcccc---cCCeeeeeeEEEeCcEEEE
Q 008650 251 ENMVGQGGYSEVYKGNLS-DGRKIAVKRLAKDNKD-----AKKEKEFLMELGIIGHVC---HPNTATLVGCCIENGLYLI 321 (558)
Q Consensus 251 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~lv 321 (558)
.+.||.|....||++... +++.++||.-...... +........|...|+.+. ...+.+++.+. ++..++|
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-~~~~~lv 109 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-TEMAVTV 109 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-TTTTEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-CCCCEEE
Confidence 347899999999999654 4678999964321100 001112234555555442 23345555443 3446789
Q ss_pred EEeccCCC
Q 008650 322 FNFSQNGN 329 (558)
Q Consensus 322 ~e~~~~gs 329 (558)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.75 E-value=0.00079 Score=64.36 Aligned_cols=156 Identities=14% Similarity=0.128 Sum_probs=80.0
Q ss_pred cCHHHHHhhhCCCcccceE-----eeeCceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCC-----
Q 008650 236 FSYEEISSATNNFHSENMV-----GQGGYSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPN----- 305 (558)
Q Consensus 236 ~~~~~~~~~~~~f~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n----- 305 (558)
.+.+++.....+|.++++. ..|---+.|+.+..+|+ |++|+...... ..++..|+.++..+...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~----~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC----HHHHHHHHHHHHhhhhccccccc
Confidence 3567777777888775544 35556778999876664 89999854321 122334555555554222
Q ss_pred eeeee-e---EEEeCcEEEEEEeccCCCHHH--------------HHhhccC-C------CCCH----------------
Q 008650 306 TATLV-G---CCIENGLYLIFNFSQNGNLDA--------------ALHDERS-K------SLEW---------------- 344 (558)
Q Consensus 306 iv~l~-~---~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~-~------~l~~---------------- 344 (558)
.+... | .........++.+..+..... .++.... . ....
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 21111 1 112233556666665533210 1110000 0 0000
Q ss_pred --HHHHHHHHHHHHHHHHhhh-CCCCcEEecCCCCCceeecCCCceEEEeccccc
Q 008650 345 --PIRYKIVLGVARGLHYLHK-GCKRRIIHRDIKASNVLLGPDFEPQITDFGLAK 396 (558)
Q Consensus 345 --~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 396 (558)
......+..+...+.-.+. ..+.++||+|+.++||+++.+...-|+||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011122222222222221 235789999999999999988777899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.43 E-value=0.014 Score=55.69 Aligned_cols=134 Identities=16% Similarity=0.181 Sum_probs=72.8
Q ss_pred ceEEEEEEECCCCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCe-----eeeee--EEEe-CcEEEEEEeccCCCH
Q 008650 259 YSEVYKGNLSDGRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT-----ATLVG--CCIE-NGLYLIFNFSQNGNL 330 (558)
Q Consensus 259 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~~--~~~~-~~~~lv~e~~~~gsL 330 (558)
--.||++...+|+.|++|+........ .++..|...+..|...++ +..-+ .+.. +..+.+++++.|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 368999999999999999986543332 234456666655542222 11111 1122 337788898876432
Q ss_pred H-----H---------HHhhc-c------CCCCCHH----------------------HHHHHHHHHHHHHHHh-hhCCC
Q 008650 331 D-----A---------ALHDE-R------SKSLEWP----------------------IRYKIVLGVARGLHYL-HKGCK 366 (558)
Q Consensus 331 ~-----~---------~l~~~-~------~~~l~~~----------------------~~~~i~~~i~~aL~~L-H~~~~ 366 (558)
. . .+|.. . ....+.. .....+..+...+.-+ ....+
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 1 1 11110 0 0111111 1112222333222221 12234
Q ss_pred CcEEecCCCCCceeecCCCceEEEecccccc
Q 008650 367 RRIIHRDIKASNVLLGPDFEPQITDFGLAKW 397 (558)
Q Consensus 367 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 397 (558)
.++||+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 689999999999999743 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.37 E-value=0.019 Score=56.31 Aligned_cols=72 Identities=13% Similarity=0.135 Sum_probs=46.2
Q ss_pred ceEeeeCceEEEEEEECC--------CCEEEEEEeecccccHHHHHHHHHHHHHhcccccCCe-eeeeeEEEeCcEEEEE
Q 008650 252 NMVGQGGYSEVYKGNLSD--------GRKIAVKRLAKDNKDAKKEKEFLMELGIIGHVCHPNT-ATLVGCCIENGLYLIF 322 (558)
Q Consensus 252 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~ 322 (558)
+.|+.|-.-.+|++...+ .+.|.+++..... .. ....+|..+++.+.-.++ .++++++. + .+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~---idr~~E~~i~~~ls~~gl~Pkll~~~~-~--g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE---SHLVAESVIFTLLSERHLGPKLYGIFS-G--GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH---HHHHHHHHHHHHHHHTTSSSCEEEEET-T--EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh---hHHHHHHHHHHHHHhCCCCCeEEEEcC-C--ceEE
Confidence 578889999999997654 3567777765322 21 234467788877763344 46666653 2 5788
Q ss_pred EeccCCCH
Q 008650 323 NFSQNGNL 330 (558)
Q Consensus 323 e~~~~gsL 330 (558)
+|++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99887544
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=84.69 E-value=1.4 Score=38.37 Aligned_cols=96 Identities=15% Similarity=-0.005 Sum_probs=57.4
Q ss_pred CCcEEEEEEecCccchHHHHHHHHhhccCC--CCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhcccc
Q 008650 5 APSKILIGFSLDPNDSKELLSWAIKVLAQP--NDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQS 82 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s~~al~Wal~~~~~~--~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~ 82 (558)
++++|+|||.-.. -|+-+|. .|..+... ...|.++||-...... + ..-....+.+|..
T Consensus 23 ~~~kv~Va~SGG~-DS~~Ll~-lL~~~~~~~~~~~i~~~~vdh~~r~~--------s----------~~~~~~~~~~~~~ 82 (216)
T d1wy5a1 23 GERRVLIAFSGGV-DSVVLTD-VLLKLKNYFSLKEVALAHFNHMLRES--------A----------ERDEEFCKEFAKE 82 (216)
T ss_dssp SCCEEEEECCSSH-HHHHHHH-HHHHSTTTTTCSEEEEEEEECCSSTH--------H----------HHHHHHHHHHHHH
T ss_pred CCCeEEEEeCCcH-HHHHHHH-HHHHHHHhcCCCcEEEEEeecccccc--------h----------hhhhhHHHHHHHh
Confidence 5679999999999 6885554 44444432 2368899996531110 0 0112334566666
Q ss_pred CCcceeEEEecC--------C-------ch-hhHHHHHHHhccCcEEEEecccc
Q 008650 83 KQVNLEAKVGFS--------T-------SI-GRGLIEEAKSISADYLVLRGSRN 120 (558)
Q Consensus 83 ~~v~~~~~v~~g--------~-------~~-~~~i~~~v~~~~~~~LV~G~~~~ 120 (558)
.++.+...-... . .. ...+.+.+++.+++.|+.|-+.-
T Consensus 83 l~i~~~i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~d 136 (216)
T d1wy5a1 83 RNMKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (216)
T ss_dssp HTCCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred hhhhhhhhccchhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeecc
Confidence 666544332210 0 11 23567888899999999998843
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=81.79 E-value=1.1 Score=39.19 Aligned_cols=67 Identities=27% Similarity=0.275 Sum_probs=42.2
Q ss_pred CCcEEEEEEecCccchHHHHHHHHhhcc-CCCCeEEEEEeecccccccccchhhhhhHHHHHHHHHHHHHHHhHhccccC
Q 008650 5 APSKILIGFSLDPNDSKELLSWAIKVLA-QPNDRIVAIHVLVGEESKKRGSMAKRQSQIRRAKAHVISMLGEFAGTSQSK 83 (558)
Q Consensus 5 ~~r~i~Vavd~~~~~s~~al~Wal~~~~-~~~d~~~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~ 83 (558)
..+||+|||--.. -|+.+|..+.+-.- .+|-.|+++||-+.-... ...-....+.+|.+.
T Consensus 12 ~~kkvlva~SGG~-DS~~Ll~ll~~~~~~~~~~~l~~~~vdh~~r~~------------------s~~~~~~~~~~~~~~ 72 (227)
T d1ni5a1 12 TSRQILVAFSGGL-DSTVLLHQLVQWRTENPGVALRAIHVHHGLSAN------------------ADAWVTHCENVCQQW 72 (227)
T ss_dssp TCSEEEEECCSBH-HHHHHHHHHHHHHTTSTTCEEEEEEECCSCCSS------------------HHHHHHHHHHHHHHT
T ss_pred CCCcEEEEecCcH-HHHHHHHHHHHHHHhCCCceEEEEEeCCCCCcc------------------hhhhHHHHHHHHhhc
Confidence 4679999999998 68866665544322 357799999997642111 012233456667777
Q ss_pred CcceeEE
Q 008650 84 QVNLEAK 90 (558)
Q Consensus 84 ~v~~~~~ 90 (558)
++.+.+.
T Consensus 73 ~i~~~i~ 79 (227)
T d1ni5a1 73 QVPLVVE 79 (227)
T ss_dssp TCCEEEE
T ss_pred cCcceee
Confidence 7765544
|